	STUDY ACCESSION	DISEASE/TRAIT	Disease trait	Parent term
0	GCST008129	Body mass index	Body mass index	Body measurement
1	GCST008129	Body mass index	Body mass index	Body measurement
2	GCST008129	Body mass index	Body mass index	Other measurement
3	GCST008128	Body mass index	Body mass index	Body measurement
4	GCST008128	Body mass index	Body mass index	Body measurement
5	GCST008128	Body mass index	Body mass index	Other measurement
6	GCST008124	Body mass index	Body mass index	Body measurement
7	GCST008124	Body mass index	Body mass index	Body measurement
8	GCST008124	Body mass index	Body mass index	Other measurement
9	GCST008126	Body mass index	Body mass index	Body measurement
10	GCST008126	Body mass index	Body mass index	Body measurement
11	GCST008126	Body mass index	Body mass index	Other measurement
12	GCST008127	Body mass index	Body mass index	Body measurement
13	GCST008127	Body mass index	Body mass index	Body measurement
14	GCST008127	Body mass index	Body mass index	Other measurement
15	GCST008125	Body mass index	Body mass index	Body measurement
16	GCST008125	Body mass index	Body mass index	Body measurement
17	GCST008125	Body mass index	Body mass index	Other measurement
18	GCST007992	Colorectal cancer	Colorectal cancer	Cancer
19	GCST008604	Urine specific gravity measurement	Urine specific gravity measurement	Other measurement
20	GCST008605	Glucosuria (moderate to severe)	Glucosuria (moderate to severe)	Other trait
21	GCST008606	Glucosuria (mild)	Glucosuria (mild)	Other trait
22	GCST008607	Ketonuria	Ketonuria	Other trait
23	GCST008608	Ketonuria (moderate to severe)	Ketonuria (moderate to severe)	Other trait
24	GCST008609	Ketonuria (mild)	Ketonuria (mild)	Other trait
25	GCST008610	Proteinuria	Proteinuria	Other trait
26	GCST008611	Proteinuria (moderate to severe)	Proteinuria (moderate to severe)	Other trait
27	GCST008612	Proteinuria (mild)	Proteinuria (mild)	Other trait
28	GCST008613	Hematuria	Hematuria	Other trait
29	GCST008617	Hematuria (moderate to severe)	Hematuria (moderate to severe)	Other trait
30	GCST008618	Hematuria (mild)	Hematuria (mild)	Other trait
31	GCST008616	Urine pH measurement	Urine pH measurement	Other measurement
32	GCST008615	Low urine pH	Low urine pH	Other measurement
33	GCST008619	Signs of urinary tract infection (nitrites and leukocyte esterase)	Signs of urinary tract infection (nitrites and leukocyte esterase)	Other measurement
34	GCST008619	Signs of urinary tract infection (nitrites and leukocyte esterase)	Signs of urinary tract infection (nitrites and leukocyte esterase)	Other measurement
35	GCST008614	Glucosuria	Glucosuria	Other trait
36	GCST008464	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
37	GCST008463	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
38	GCST003129	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
39	GCST003129	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
40	GCST008173	Alanine aminotransferase levels	Alanine aminotransferase levels	Liver enzyme measurement
41	GCST008175	Gamma glutamyl transferase levels	Gamma glutamyl transferase levels	Liver enzyme measurement
42	GCST008174	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
43	GCST007857	Fasting blood insulin adjusted for BMI	Fasting blood insulin adjusted for BMI	Other measurement
44	GCST007857	Fasting blood insulin adjusted for BMI	Fasting blood insulin adjusted for BMI	Other measurement
45	GCST007858	Fasting blood glucose adjusted for BMI	Fasting blood glucose adjusted for BMI	Other measurement
46	GCST007858	Fasting blood glucose adjusted for BMI	Fasting blood glucose adjusted for BMI	Other measurement
47	GCST008658	Ulcerative colitis	Ulcerative colitis	Immune system disorder
48	GCST008486	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
49	GCST007484	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
50	GCST007487	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
51	GCST007483	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
52	GCST007491	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
53	GCST007492	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
54	GCST007493	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
55	GCST007494	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
56	GCST007496	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
57	GCST007500	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
58	GCST007501	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
59	GCST007502	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
60	GCST007503	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
61	GCST008295	Number of decayed, missing and filled tooth surfaces or use of dentures	Number of decayed, missing and filled tooth surfaces or use of dentures	Digestive system disorder
62	GCST008295	Number of decayed, missing and filled tooth surfaces or use of dentures	Number of decayed, missing and filled tooth surfaces or use of dentures	Other trait
63	GCST008302	Number of decayed, missing and filled tooth surfaces	Number of decayed, missing and filled tooth surfaces	Digestive system disorder
64	GCST008299	Number of decayed and filled tooth surfaces per available tooth surface	Number of decayed and filled tooth surfaces per available tooth surface	Digestive system disorder
65	GCST008300	Periodontitis	Periodontitis	Digestive system disorder
66	GCST008301	Bleeding gums	Bleeding gums	Other trait
67	GCST008303	Painful gums	Painful gums	Other measurement
68	GCST008306	Dentures	Dentures	Other trait
69	GCST008305	Toothache	Toothache	Other trait
70	GCST008304	Mouth ulcers	Mouth ulcers	Other trait
71	GCST008298	Number of natural teeth	Number of natural teeth	Other measurement
72	GCST008297	Loose teeth	Loose teeth	Other measurement
73	GCST008296	Periodontitis or loose teeth	Periodontitis or loose teeth	Other measurement
74	GCST008296	Periodontitis or loose teeth	Periodontitis or loose teeth	Digestive system disorder
75	GCST007814	Sodium levels in epilepsy	Sodium levels in epilepsy	Other measurement
76	GCST007814	Sodium levels in epilepsy	Sodium levels in epilepsy	Neurological disorder
77	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
78	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Other trait
79	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Other trait
80	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
81	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Neurological disorder
82	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
83	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Other trait
84	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Other trait
85	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
86	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Neurological disorder
87	GCST007811	Carbamazepine-induced hyponatremia in epilepsy	Carbamazepine-induced hyponatremia in epilepsy	Other trait
88	GCST007811	Carbamazepine-induced hyponatremia in epilepsy	Carbamazepine-induced hyponatremia in epilepsy	Response to drug
89	GCST007811	Carbamazepine-induced hyponatremia in epilepsy	Carbamazepine-induced hyponatremia in epilepsy	Neurological disorder
90	GCST007812	Oxcarbazepine-induced hyponatremia in epilepsy	Oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
91	GCST007812	Oxcarbazepine-induced hyponatremia in epilepsy	Oxcarbazepine-induced hyponatremia in epilepsy	Other trait
92	GCST007812	Oxcarbazepine-induced hyponatremia in epilepsy	Oxcarbazepine-induced hyponatremia in epilepsy	Neurological disorder
93	GCST007813	Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	Other measurement
94	GCST007813	Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	Neurological disorder
95	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
96	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
97	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
98	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
99	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
100	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Inflammatory measurement
101	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
102	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
103	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
104	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
105	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
106	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
107	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
108	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
109	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
110	GCST008322	White blood cell count	White blood cell count	Hematological measurement
111	GCST008322	White blood cell count	White blood cell count	Inflammatory measurement
112	GCST008322	White blood cell count	White blood cell count	Hematological measurement
113	GCST008322	White blood cell count	White blood cell count	Hematological measurement
114	GCST008322	White blood cell count	White blood cell count	Hematological measurement
115	GCST008329	Red blood cell count	Red blood cell count	Hematological measurement
116	GCST008330	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
117	GCST008331	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
118	GCST008331	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
119	GCST008332	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
120	GCST008332	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
121	GCST008333	Red cell distribution width	Red cell distribution width	Hematological measurement
122	GCST008323	Hematocrit	Hematocrit	Hematological measurement
123	GCST008324	Hemoglobin	Hemoglobin	Hematological measurement
124	GCST008334	Neutrophil count	Neutrophil count	Hematological measurement
125	GCST008325	Platelet count	Platelet count	Hematological measurement
126	GCST008326	Lymphocyte counts	Lymphocyte counts	Hematological measurement
127	GCST008327	Monocyte count	Monocyte count	Hematological measurement
128	GCST008328	Basophil count	Basophil count	Inflammatory measurement
129	GCST008335	Eosinophil counts	Eosinophil counts	Hematological measurement
130	GCST008336	Mean platelet volume	Mean platelet volume	Hematological measurement
131	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
132	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
133	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
134	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
135	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
136	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Inflammatory measurement
137	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
138	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
139	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
140	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
141	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
142	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
143	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
144	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
145	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
146	GCST008315	Corneal hysteresis	Corneal hysteresis	Other measurement
147	GCST008318	Corneal resistance factor	Corneal resistance factor	Other measurement
148	GCST008319	Intraocular pressure (corneal compensated)	Intraocular pressure (corneal compensated)	Other measurement
149	GCST008320	Intraocular pressure (Goldman correlated)	Intraocular pressure (Goldman correlated)	Other measurement
150	GCST008317	Central corneal thickness	Central corneal thickness	Other measurement
151	GCST008317	Central corneal thickness	Central corneal thickness	Other measurement
152	GCST008339	Corneal endothelial cell density	Corneal endothelial cell density	Other measurement
153	GCST008316	Corneal endothelial cell size variation coefficient	Corneal endothelial cell size variation coefficient	Other measurement
154	GCST008321	Corneal endothelial cell shape (percentage of hexagonally shaped cells)	Corneal endothelial cell shape (percentage of hexagonally shaped cells)	Other measurement
155	GCST007552	Colorectal cancer	Colorectal cancer	Cancer
156	GCST007592	Handedness (Left-handed vs. non-left-handed)	Handedness (Left-handed vs. non-left-handed)	Other trait
157	GCST007594	Handedness (Right-handed vs. non-right-handed)	Handedness (Right-handed vs. non-right-handed)	Other trait
158	GCST007593	Ambidextrousness	Ambidextrousness	Other trait
159	GCST008652	same-sex sexual behaviour	same-sex sexual behaviour	Biological process
160	GCST008653	same-sex sexual behaviour	same-sex sexual behaviour	Biological process
161	GCST008654	same-sex sexual behaviour	same-sex sexual behaviour	Biological process
162	GCST008655	proportion of same-sex sexual behaviour among non-heterosexuals	proportion of same-sex sexual behaviour among non-heterosexuals	Biological process
163	GCST008656	proportion of same-sex sexual behaviour among non-heterosexuals	proportion of same-sex sexual behaviour among non-heterosexuals	Biological process
164	GCST008657	proportion of same-sex sexual behaviour among non-heterosexuals	proportion of same-sex sexual behaviour among non-heterosexuals	Biological process
165	GCST008649	same-sex sexual behaviour	same-sex sexual behaviour	Biological process
166	GCST008650	same-sex sexual behaviour	same-sex sexual behaviour	Biological process
167	GCST008651	same-sex sexual behaviour	same-sex sexual behaviour	Biological process
168	GCST008274	Cerebral microbleed progression	Cerebral microbleed progression	Other trait
169	GCST008274	Cerebral microbleed progression	Cerebral microbleed progression	Other measurement
170	GCST008275	Cerebral microbleeds	Cerebral microbleeds	Other trait
171	GCST008922	Triacylglyceride levels	Triacylglyceride levels	Lipid or lipoprotein measurement
172	GCST008923	Ceramide levels	Ceramide levels	Lipid or lipoprotein measurement
173	GCST008924	Diacylglyceride levels	Diacylglyceride levels	Lipid or lipoprotein measurement
174	GCST008925	Lysophosphatidylcholine levels	Lysophosphatidylcholine levels	Lipid or lipoprotein measurement
175	GCST008926	Lysophosphatidylethanolamine levels	Lysophosphatidylethanolamine levels	Lipid or lipoprotein measurement
176	GCST008927	Phosphatidylcholine levels	Phosphatidylcholine levels	Lipid or lipoprotein measurement
177	GCST008928	Phosphatidylcholine-ether levels	Phosphatidylcholine-ether levels	Lipid or lipoprotein measurement
178	GCST008929	Phosphatidylethanolamine levels	Phosphatidylethanolamine levels	Lipid or lipoprotein measurement
179	GCST008930	Phosphatidylethanolamine-ether levels	Phosphatidylethanolamine-ether levels	Lipid or lipoprotein measurement
180	GCST008931	Phosphatidylinositol levels	Phosphatidylinositol levels	Lipid or lipoprotein measurement
181	GCST008932	Cholesteryl ester levels	Cholesteryl ester levels	Lipid or lipoprotein measurement
182	GCST008933	Sphingomyelin levels	Sphingomyelin levels	Lipid or lipoprotein measurement
183	GCST008934	Sterol levels	Sterol levels	Lipid or lipoprotein measurement
184	GCST008935	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
185	GCST008936	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
186	GCST008937	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
187	GCST008938	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
188	GCST008833	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
189	GCST008403	Arterial stiffness index	Arterial stiffness index	Cardiovascular measurement
190	GCST008873	Non-lobar intracerebral hemorrhage	Non-lobar intracerebral hemorrhage	Cardiovascular disease
191	GCST008874	Lobar intracerebral hemorrhage	Lobar intracerebral hemorrhage	Cardiovascular disease
192	GCST008875	Intracerebral hemorrhage (MTAG)	Intracerebral hemorrhage (MTAG)	Cardiovascular disease
193	GCST008876	Non-lobar intracerebral hemorrhage (MTAG)	Non-lobar intracerebral hemorrhage (MTAG)	Cardiovascular disease
194	GCST008877	Lobar intracerebral hemorrhage (MTAG)	Lobar intracerebral hemorrhage (MTAG)	Cardiovascular disease
195	GCST008878	Intracerebral hemorrhage	Intracerebral hemorrhage	Cardiovascular disease
196	GCST007581	Carpal tunnel syndrome	Carpal tunnel syndrome	Neurological disorder
197	GCST007738	Metabolic syndrome	Metabolic syndrome	Body measurement
198	GCST007738	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
199	GCST007738	Metabolic syndrome	Metabolic syndrome	Other measurement
200	GCST007738	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
201	GCST007738	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
202	GCST008603	Total body bone mineral density (MTAG)	Total body bone mineral density (MTAG)	Other measurement
203	GCST008602	Heel bone mineral density (MTAG)	Heel bone mineral density (MTAG)	Other measurement
204	GCST008807	Smoking behaviour (age at first cigarette)	Smoking behaviour (age at first cigarette)	Other measurement
205	GCST008807	Smoking behaviour (age at first cigarette)	Smoking behaviour (age at first cigarette)	Biological process
206	GCST008804	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
207	GCST008805	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Biological process
208	GCST008805	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Other measurement
209	GCST008808	Smoking behaviour (cigarette pack-years)	Smoking behaviour (cigarette pack-years)	Other measurement
210	GCST008808	Smoking behaviour (cigarette pack-years)	Smoking behaviour (cigarette pack-years)	Other measurement
211	GCST008806	Smoking initiation (ever regular vs never regular)	Smoking initiation (ever regular vs never regular)	Other measurement
212	GCST008806	Smoking initiation (ever regular vs never regular)	Smoking initiation (ever regular vs never regular)	Biological process
213	GCST008802	Smoking behaviour (age at first cigarette)	Smoking behaviour (age at first cigarette)	Other measurement
214	GCST008802	Smoking behaviour (age at first cigarette)	Smoking behaviour (age at first cigarette)	Biological process
215	GCST008809	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
216	GCST008803	Smoking behaviour (cigarette pack-years)	Smoking behaviour (cigarette pack-years)	Other measurement
217	GCST008803	Smoking behaviour (cigarette pack-years)	Smoking behaviour (cigarette pack-years)	Other measurement
218	GCST008810	Smoking initiation (ever regular vs never regular)	Smoking initiation (ever regular vs never regular)	Other measurement
219	GCST008810	Smoking initiation (ever regular vs never regular)	Smoking initiation (ever regular vs never regular)	Biological process
220	GCST008811	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Biological process
221	GCST008811	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Other measurement
222	GCST008358	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Other trait
223	GCST008358	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Neurological disorder
224	GCST008358	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Neurological disorder
225	GCST008359	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Other trait
226	GCST008359	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Neurological disorder
227	GCST008360	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Other trait
228	GCST008360	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Neurological disorder
229	GCST008361	Response to cognitive-behavioural therapy in major depressive disorder	Response to cognitive-behavioural therapy in major depressive disorder	Other trait
230	GCST008361	Response to cognitive-behavioural therapy in major depressive disorder	Response to cognitive-behavioural therapy in major depressive disorder	Neurological disorder
231	GCST005146	Birth weight	Birth weight	Body measurement
232	GCST007557	Birth weight	Birth weight	Body measurement
233	GCST008388	Acute post-radiotherapy pain in breast cancer	Acute post-radiotherapy pain in breast cancer	Other trait
234	GCST008388	Acute post-radiotherapy pain in breast cancer	Acute post-radiotherapy pain in breast cancer	Cancer
235	GCST008388	Acute post-radiotherapy pain in breast cancer	Acute post-radiotherapy pain in breast cancer	Biological process
236	GCST008801	Thiopurine-induced myelosuppression in inflammatory bowel disease	Thiopurine-induced myelosuppression in inflammatory bowel disease	Digestive system disorder
237	GCST008801	Thiopurine-induced myelosuppression in inflammatory bowel disease	Thiopurine-induced myelosuppression in inflammatory bowel disease	Response to drug
238	GCST008801	Thiopurine-induced myelosuppression in inflammatory bowel disease	Thiopurine-induced myelosuppression in inflammatory bowel disease	Other trait
239	GCST007881	Dementia with Lewy bodies	Dementia with Lewy bodies	Other trait
240	GCST007846	Arterial stiffness	Arterial stiffness	Cardiovascular measurement
241	GCST008823	Body mass index	Body mass index	Body measurement
242	GCST008823	Body mass index	Body mass index	Body measurement
243	GCST008823	Body mass index	Body mass index	Other measurement
244	GCST007400	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
245	GCST005752	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
246	GCST007672	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other trait
247	GCST007672	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other measurement
248	GCST007673	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other trait
249	GCST007673	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other measurement
250	GCST007674	3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	Cardiovascular disease
251	GCST007674	3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	Other measurement
252	GCST007675	3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	Other trait
253	GCST007675	3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	Other measurement
254	GCST007676	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other trait
255	GCST007676	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other measurement
256	GCST008056	Alzheimer's disease (SNP x SNP interaction)	Alzheimer's disease (SNP x SNP interaction)	Neurological disorder
257	GCST008433	Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	Lipid or lipoprotein measurement
258	GCST008433	Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	Cardiovascular disease
259	GCST008502	Low susceptibility to hepatitis C infection	Low susceptibility to hepatitis C infection	Other trait
260	GCST007587	Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	Neurological disorder
261	GCST007587	Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	Other measurement
262	GCST007583	Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	Other measurement
263	GCST007583	Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	Neurological disorder
264	GCST007591	Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	Neurological disorder
265	GCST007591	Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	Other measurement
266	GCST007590	Hippocampal volume	Hippocampal volume	Other measurement
267	GCST008684	HDL cholesterol levels in never smokers	HDL cholesterol levels in never smokers	Other measurement
268	GCST008684	HDL cholesterol levels in never smokers	HDL cholesterol levels in never smokers	Lipid or lipoprotein measurement
269	GCST008685	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
270	GCST008686	LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	Other measurement
271	GCST008686	LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	Lipid or lipoprotein measurement
272	GCST008687	LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	Other measurement
273	GCST008687	LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	Lipid or lipoprotein measurement
274	GCST008688	LDL cholesterol levels in current smokers	LDL cholesterol levels in current smokers	Other measurement
275	GCST008688	LDL cholesterol levels in current smokers	LDL cholesterol levels in current smokers	Lipid or lipoprotein measurement
276	GCST008689	LDL cholesterol levels in non smokers	LDL cholesterol levels in non smokers	Other measurement
277	GCST008689	LDL cholesterol levels in non smokers	LDL cholesterol levels in non smokers	Lipid or lipoprotein measurement
278	GCST008690	LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	Other measurement
279	GCST008690	LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	Lipid or lipoprotein measurement
280	GCST008691	LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	Other measurement
281	GCST008691	LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	Lipid or lipoprotein measurement
282	GCST008692	LDL cholesterol levels in ever smokers	LDL cholesterol levels in ever smokers	Other measurement
283	GCST008692	LDL cholesterol levels in ever smokers	LDL cholesterol levels in ever smokers	Lipid or lipoprotein measurement
284	GCST008693	LDL cholesterol levels in never smokers	LDL cholesterol levels in never smokers	Other measurement
285	GCST008693	LDL cholesterol levels in never smokers	LDL cholesterol levels in never smokers	Lipid or lipoprotein measurement
286	GCST008676	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
287	GCST008676	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
288	GCST008678	HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	Other measurement
289	GCST008678	HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	Lipid or lipoprotein measurement
290	GCST008679	HDL cholesterol levels in current smokers	HDL cholesterol levels in current smokers	Other measurement
291	GCST008679	HDL cholesterol levels in current smokers	HDL cholesterol levels in current smokers	Lipid or lipoprotein measurement
292	GCST008680	HDL cholesterol levels in non smokers	HDL cholesterol levels in non smokers	Other measurement
293	GCST008680	HDL cholesterol levels in non smokers	HDL cholesterol levels in non smokers	Lipid or lipoprotein measurement
294	GCST008681	HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	Other measurement
295	GCST008681	HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	Lipid or lipoprotein measurement
296	GCST008682	HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	Other measurement
297	GCST008682	HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	Lipid or lipoprotein measurement
298	GCST008683	HDL cholesterol levels in ever smokers	HDL cholesterol levels in ever smokers	Other measurement
299	GCST008683	HDL cholesterol levels in ever smokers	HDL cholesterol levels in ever smokers	Lipid or lipoprotein measurement
300	GCST007589	Intracranial volume	Intracranial volume	Other measurement
301	GCST007586	Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	Neurological disorder
302	GCST007586	Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	Other measurement
303	GCST007582	Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	Other measurement
304	GCST007582	Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	Neurological disorder
305	GCST007588	Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	Other measurement
306	GCST007588	Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	Neurological disorder
307	GCST007585	Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	Other measurement
308	GCST007585	Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	Neurological disorder
309	GCST007584	Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	Other measurement
310	GCST007584	Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	Neurological disorder
311	GCST007477	Breast cancer specific mortality in breast cancer	Breast cancer specific mortality in breast cancer	Other measurement
312	GCST007477	Breast cancer specific mortality in breast cancer	Breast cancer specific mortality in breast cancer	Cancer
313	GCST007476	Breast cancer specific mortality in estrogen receptor negative breast cancer	Breast cancer specific mortality in estrogen receptor negative breast cancer	Other measurement
314	GCST007476	Breast cancer specific mortality in estrogen receptor negative breast cancer	Breast cancer specific mortality in estrogen receptor negative breast cancer	Cancer
315	GCST007475	Breast cancer specific mortality in estrogen receptor positive breast cancer	Breast cancer specific mortality in estrogen receptor positive breast cancer	Other measurement
316	GCST007475	Breast cancer specific mortality in estrogen receptor positive breast cancer	Breast cancer specific mortality in estrogen receptor positive breast cancer	Cancer
317	GCST008140	Metabolic syndrome	Metabolic syndrome	Body measurement
318	GCST008140	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
319	GCST008140	Metabolic syndrome	Metabolic syndrome	Other measurement
320	GCST008140	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
321	GCST008140	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
322	GCST008150	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
323	GCST008141	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
324	GCST008142	Systolic blood pressure	Systolic blood pressure	Other measurement
325	GCST008142	Systolic blood pressure	Systolic blood pressure	Other measurement
326	GCST008143	Diastolic blood pressure	Diastolic blood pressure	Other measurement
327	GCST008143	Diastolic blood pressure	Diastolic blood pressure	Other measurement
328	GCST008144	Fasting plasma glucose	Fasting plasma glucose	Other measurement
329	GCST008145	Waist circumference	Waist circumference	Body measurement
330	GCST008146	Metabolic syndrome	Metabolic syndrome	Body measurement
331	GCST008146	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
332	GCST008146	Metabolic syndrome	Metabolic syndrome	Other measurement
333	GCST008146	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
334	GCST008146	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
335	GCST007266	Adult asthma	Adult asthma	Other disease
336	GCST007842	Glioma	Glioma	Cancer
337	GCST007842	Glioma	Glioma	Cancer
338	GCST007137	Warfarin-associated bleeding	Warfarin-associated bleeding	Response to drug
339	GCST008694	Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	Other measurement
340	GCST008694	Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	Lipid or lipoprotein measurement
341	GCST008695	Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	Other measurement
342	GCST008695	Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	Lipid or lipoprotein measurement
343	GCST008696	Triglyceride levels in current smokers	Triglyceride levels in current smokers	Other measurement
344	GCST008696	Triglyceride levels in current smokers	Triglyceride levels in current smokers	Lipid or lipoprotein measurement
345	GCST008697	Triglyceride levels in non smokers	Triglyceride levels in non smokers	Other measurement
346	GCST008697	Triglyceride levels in non smokers	Triglyceride levels in non smokers	Lipid or lipoprotein measurement
347	GCST008698	Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	Other measurement
348	GCST008698	Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	Lipid or lipoprotein measurement
349	GCST008699	Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	Other measurement
350	GCST008699	Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	Lipid or lipoprotein measurement
351	GCST008700	Triglyceride levels in ever smokers	Triglyceride levels in ever smokers	Other measurement
352	GCST008700	Triglyceride levels in ever smokers	Triglyceride levels in ever smokers	Lipid or lipoprotein measurement
353	GCST008701	Triglyceride levels in never smokers	Triglyceride levels in never smokers	Other measurement
354	GCST008701	Triglyceride levels in never smokers	Triglyceride levels in never smokers	Lipid or lipoprotein measurement
355	GCST008702	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
356	GCST008677	HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	Other measurement
357	GCST008677	HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	Lipid or lipoprotein measurement
358	GCST008522	Bitter alcoholic beverage consumption	Bitter alcoholic beverage consumption	Other measurement
359	GCST008524	Bitter non-alcoholic beverage consumption	Bitter non-alcoholic beverage consumption	Other measurement
360	GCST008526	Coffee consumption	Coffee consumption	Biological process
361	GCST008526	Coffee consumption	Coffee consumption	Other measurement
362	GCST008526	Coffee consumption	Coffee consumption	Other measurement
363	GCST008529	Tea consumption	Tea consumption	Other measurement
364	GCST008531	Grapefruit juice consumption	Grapefruit juice consumption	Other measurement
365	GCST008528	Sweet beverage consumption	Sweet beverage consumption	Other measurement
366	GCST008527	Sugar-sweetened beverage consumption	Sugar-sweetened beverage consumption	Other measurement
367	GCST008525	Artificially sweetened beverage consumption	Artificially sweetened beverage consumption	Other measurement
368	GCST008523	Pure non-grapefruit juice consumption	Pure non-grapefruit juice consumption	Other measurement
369	GCST008521	Bitter beverage consumption	Bitter beverage consumption	Other measurement
370	GCST007543	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
371	GCST008067	Pemphigus foliaceus	Pemphigus foliaceus	Immune system disorder
372	GCST008069	Pemphigus	Pemphigus	Immune system disorder
373	GCST008068	Pemphigus vulgaris	Pemphigus vulgaris	Immune system disorder
374	GCST007801	Sleep duration	Sleep duration	Other measurement
375	GCST007802	Sleep duration (variability)	Sleep duration (variability)	Other measurement
376	GCST007803	Sleep efficiency	Sleep efficiency	Other measurement
377	GCST007804	Sleep (number of episodes)	Sleep (number of episodes)	Other measurement
378	GCST007805	Sleep (time to least active 5 hours)	Sleep (time to least active 5 hours)	Other measurement
379	GCST007806	Time to most active 10 hours	Time to most active 10 hours	Other measurement
380	GCST007807	Sleep (time to midpoint)	Sleep (time to midpoint)	Other measurement
381	GCST007808	Diurnal inactivity	Diurnal inactivity	Other measurement
382	GCST008257	Diverticular disease	Diverticular disease	Digestive system disorder
383	GCST008256	Diverticulitis	Diverticulitis	Digestive system disorder
384	GCST007818	Facial attractiveness (female raters)	Facial attractiveness (female raters)	Other measurement
385	GCST007817	Facial attractiveness (male raters)	Facial attractiveness (male raters)	Other measurement
386	GCST007823	Facial attractiveness (male raters)	Facial attractiveness (male raters)	Other measurement
387	GCST007822	Facial attractiveness (male raters)	Facial attractiveness (male raters)	Other measurement
388	GCST007821	Facial attractiveness (female raters)	Facial attractiveness (female raters)	Other measurement
389	GCST007820	Facial attractiveness (female raters)	Facial attractiveness (female raters)	Other measurement
390	GCST007819	Facial attractiveness (male raters)	Facial attractiveness (male raters)	Other measurement
391	GCST007364	Gallstone disease	Gallstone disease	Digestive system disorder
392	GCST007364	Gallstone disease	Gallstone disease	Digestive system disorder
393	GCST008746	Estimated glomerular filtration rate in diabetes	Estimated glomerular filtration rate in diabetes	Other measurement
394	GCST008746	Estimated glomerular filtration rate in diabetes	Estimated glomerular filtration rate in diabetes	Metabolic disorder
395	GCST008745	Estimated glomerular filtration rate in non-diabetics	Estimated glomerular filtration rate in non-diabetics	Other measurement
396	GCST008747	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
397	GCST008118	Suicide attempts in major depressive disorder	Suicide attempts in major depressive disorder	Biological process
398	GCST008118	Suicide attempts in major depressive disorder	Suicide attempts in major depressive disorder	Neurological disorder
399	GCST008123	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Biological process
400	GCST008123	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Neurological disorder
401	GCST008123	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Neurological disorder
402	GCST008123	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Neurological disorder
403	GCST008119	Suicide attempts in bipolar disorder	Suicide attempts in bipolar disorder	Biological process
404	GCST008119	Suicide attempts in bipolar disorder	Suicide attempts in bipolar disorder	Neurological disorder
405	GCST008120	Suicide attempts in schizophrenia	Suicide attempts in schizophrenia	Biological process
406	GCST008120	Suicide attempts in schizophrenia	Suicide attempts in schizophrenia	Neurological disorder
407	GCST008121	Suicide attempts in major depressive disorder or bipolar disorder	Suicide attempts in major depressive disorder or bipolar disorder	Biological process
408	GCST008121	Suicide attempts in major depressive disorder or bipolar disorder	Suicide attempts in major depressive disorder or bipolar disorder	Neurological disorder
409	GCST008121	Suicide attempts in major depressive disorder or bipolar disorder	Suicide attempts in major depressive disorder or bipolar disorder	Neurological disorder
410	GCST008122	Suicide attempts in bipolar disorder or schizophrenia	Suicide attempts in bipolar disorder or schizophrenia	Biological process
411	GCST008122	Suicide attempts in bipolar disorder or schizophrenia	Suicide attempts in bipolar disorder or schizophrenia	Neurological disorder
412	GCST008122	Suicide attempts in bipolar disorder or schizophrenia	Suicide attempts in bipolar disorder or schizophrenia	Neurological disorder
413	GCST005038	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Other disease
414	GCST005038	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Immune system disorder
415	GCST008377	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
416	GCST008223	Diabetic peripheral neuropathy in type 2 diabetes	Diabetic peripheral neuropathy in type 2 diabetes	Metabolic disorder
417	GCST008223	Diabetic peripheral neuropathy in type 2 diabetes	Diabetic peripheral neuropathy in type 2 diabetes	Neurological disorder
418	GCST007990	Coronary artery disease	Coronary artery disease	Cardiovascular disease
419	GCST007990	Coronary artery disease	Coronary artery disease	Cardiovascular disease
420	GCST008357	Mood instability	Mood instability	Other measurement
421	GCST007495	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Cardiovascular disease
422	GCST007495	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Other disease
423	GCST007495	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Other measurement
424	GCST007619	Temporomandibular joint disorder	Temporomandibular joint disorder	Other disease
425	GCST007354	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
426	GCST007433	Fulminant type 1 diabetes	Fulminant type 1 diabetes	Metabolic disorder
427	GCST007737	Anti-sp100 seropositivity in primary biliary cholangitis	Anti-sp100 seropositivity in primary biliary cholangitis	Cancer
428	GCST007737	Anti-sp100 seropositivity in primary biliary cholangitis	Anti-sp100 seropositivity in primary biliary cholangitis	Other measurement
429	GCST007736	Anti-gp210 seropositivity in primary biliary cholangitis	Anti-gp210 seropositivity in primary biliary cholangitis	Cancer
430	GCST007736	Anti-gp210 seropositivity in primary biliary cholangitis	Anti-gp210 seropositivity in primary biliary cholangitis	Other measurement
431	GCST007664	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	Response to drug
432	GCST007664	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	Cancer
433	GCST007240	Obese vs. thin	Obese vs. thin	Body measurement
434	GCST007241	Obesity (extreme)	Obesity (extreme)	Metabolic disorder
435	GCST007241	Obesity (extreme)	Obesity (extreme)	Body measurement
436	GCST007242	Normal body mass index vs. thin	Normal body mass index vs. thin	Body measurement
437	GCST008485	Crohn's disease	Crohn's disease	Digestive system disorder
438	GCST008460	Gout vs. Hyperuricemia	Gout vs. Hyperuricemia	Metabolic disorder
439	GCST008460	Gout vs. Hyperuricemia	Gout vs. Hyperuricemia	Metabolic disorder
440	GCST008422	QRS duration	QRS duration	Cardiovascular measurement
441	GCST008422	QRS duration	QRS duration	Cardiovascular measurement
442	GCST008422	QRS duration	QRS duration	Cardiovascular measurement
443	GCST008596	Opioid overdose severity score	Opioid overdose severity score	Other measurement
444	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
445	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
446	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
447	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
448	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
449	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
450	GCST008417	Psychiatric disorder	Psychiatric disorder	Metabolic disorder
451	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
452	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
453	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
454	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
455	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
456	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
457	GCST008415	Cannabis use disorder vs schizophrenia	Cannabis use disorder vs schizophrenia	Neurological disorder
458	GCST008415	Cannabis use disorder vs schizophrenia	Cannabis use disorder vs schizophrenia	Other disease
459	GCST008415	Cannabis use disorder vs schizophrenia	Cannabis use disorder vs schizophrenia	Neurological disorder
460	GCST008414	Cannabis use disorder	Cannabis use disorder	Other disease
461	GCST008414	Cannabis use disorder	Cannabis use disorder	Neurological disorder
462	GCST008459	Schizophrenia	Schizophrenia	Neurological disorder
463	GCST007920	Chronic kidney disease	Chronic kidney disease	Other disease
464	GCST007920	Chronic kidney disease	Chronic kidney disease	Other measurement
465	GCST007920	Chronic kidney disease	Chronic kidney disease	Other measurement
466	GCST007916	Hyperuricemia	Hyperuricemia	Cardiovascular measurement
467	GCST007916	Hyperuricemia	Hyperuricemia	Metabolic disorder
468	GCST007918	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
469	GCST007917	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
470	GCST007919	Creatinine levels	Creatinine levels	Other measurement
471	GCST008703	Occipital lobe volume	Occipital lobe volume	Other measurement
472	GCST008704	Parietal lobe volume	Parietal lobe volume	Other measurement
473	GCST008705	Temporal lobe volume	Temporal lobe volume	Other measurement
474	GCST008707	Occipital lobe volume	Occipital lobe volume	Other measurement
475	GCST008710	Parietal lobe volume	Parietal lobe volume	Other measurement
476	GCST008711	Temporal lobe volume	Temporal lobe volume	Other measurement
477	GCST008715	Frontal lobe volume	Frontal lobe volume	Other measurement
478	GCST008717	Frontal lobe volume	Frontal lobe volume	Other measurement
479	GCST008109	Fasting blood proinsulin levels	Fasting blood proinsulin levels	Other measurement
480	GCST008110	Insulinogenic index	Insulinogenic index	Other measurement
481	GCST008111	Insulin disposition index	Insulin disposition index	Other measurement
482	GCST008113	Proinsulin levels (late-phase conversion)	Proinsulin levels (late-phase conversion)	Other measurement
483	GCST008112	Proinsulin levels (early-phase conversion)	Proinsulin levels (early-phase conversion)	Other measurement
484	GCST007677	Rumination (response to stress)	Rumination (response to stress)	Biological process
485	GCST007678	Brooding (response to stress)	Brooding (response to stress)	Biological process
486	GCST007679	Reflection (response to stress)	Reflection (response to stress)	Biological process
487	GCST008749	Systolic blood pressure	Systolic blood pressure	Other measurement
488	GCST008749	Systolic blood pressure	Systolic blood pressure	Other measurement
489	GCST008750	Diastolic blood pressure	Diastolic blood pressure	Other measurement
490	GCST008750	Diastolic blood pressure	Diastolic blood pressure	Other measurement
491	GCST007700	Substance use disorder	Substance use disorder	Neurological disorder
492	GCST008641	C-peptide levels	C-peptide levels	Other measurement
493	GCST001482	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
494	GCST001482	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
495	GCST007691	Femoral neck bone mineral density	Femoral neck bone mineral density	Other measurement
496	GCST008835	Squamous cell lung carcinoma	Squamous cell lung carcinoma	Cancer
497	GCST008836	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
498	GCST008834	Non-small cell lung cancer	Non-small cell lung cancer	Cancer
499	GCST008506	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Neurological disorder
500	GCST008506	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Other measurement
501	GCST008507	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Neurological disorder
502	GCST008507	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Other measurement
503	GCST008508	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Neurological disorder
504	GCST008508	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Other measurement
505	GCST008509	Major depressive disorder	Major depressive disorder	Neurological disorder
506	GCST008510	Neuroticism	Neuroticism	Neurological disorder
507	GCST008510	Neuroticism	Neuroticism	Other measurement
508	GCST008559	Anxiety and stress-related disorders	Anxiety and stress-related disorders	Neurological disorder
509	GCST008559	Anxiety and stress-related disorders	Anxiety and stress-related disorders	Neurological disorder
510	GCST008567	Stress-related disorders	Stress-related disorders	Neurological disorder
511	GCST008566	Anxiety disorders	Anxiety disorders	Neurological disorder
512	GCST008565	Anxiety and stress-related disorders (excluding adjustment disorder)	Anxiety and stress-related disorders (excluding adjustment disorder)	Neurological disorder
513	GCST008565	Anxiety and stress-related disorders (excluding adjustment disorder)	Anxiety and stress-related disorders (excluding adjustment disorder)	Neurological disorder
514	GCST008564	Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	Neurological disorder
515	GCST008564	Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	Neurological disorder
516	GCST008563	Anxiety and stress-related disorders (including obsessive-compulsive disorder)	Anxiety and stress-related disorders (including obsessive-compulsive disorder)	Neurological disorder
517	GCST008563	Anxiety and stress-related disorders (including obsessive-compulsive disorder)	Anxiety and stress-related disorders (including obsessive-compulsive disorder)	Neurological disorder
518	GCST008562	Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	Neurological disorder
519	GCST008562	Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	Neurological disorder
520	GCST008561	Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	Neurological disorder
521	GCST008561	Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	Neurological disorder
522	GCST008560	Anxiety and stress-related disorders (propensity-score-matching design)	Anxiety and stress-related disorders (propensity-score-matching design)	Neurological disorder
523	GCST008560	Anxiety and stress-related disorders (propensity-score-matching design)	Anxiety and stress-related disorders (propensity-score-matching design)	Neurological disorder
524	GCST008387	Cognitive ability in schizophrenia	Cognitive ability in schizophrenia	Biological process
525	GCST008387	Cognitive ability in schizophrenia	Cognitive ability in schizophrenia	Neurological disorder
526	GCST008456	Childhood steroid-sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	Other disease
527	GCST001439	Mean platelet volume	Mean platelet volume	Hematological measurement
528	GCST008047	Platelet count	Platelet count	Hematological measurement
529	GCST008016	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
530	GCST008530	Neuropathy in Charcot-Marie-Tooth disease type 1A	Neuropathy in Charcot-Marie-Tooth disease type 1A	Neurological disorder
531	GCST008530	Neuropathy in Charcot-Marie-Tooth disease type 1A	Neuropathy in Charcot-Marie-Tooth disease type 1A	Neurological disorder
532	GCST008533	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Other trait
533	GCST008533	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Neurological disorder
534	GCST008534	Hearing loss in Charcot-Marie-Tooth disease 1A	Hearing loss in Charcot-Marie-Tooth disease 1A	Neurological disorder
535	GCST008534	Hearing loss in Charcot-Marie-Tooth disease 1A	Hearing loss in Charcot-Marie-Tooth disease 1A	Neurological disorder
536	GCST008537	Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Neurological disorder
537	GCST008537	Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Other trait
538	GCST008538	Balance difficulty in Charcot-Marie-Tooth disease type 1A	Balance difficulty in Charcot-Marie-Tooth disease type 1A	Neurological disorder
539	GCST008538	Balance difficulty in Charcot-Marie-Tooth disease type 1A	Balance difficulty in Charcot-Marie-Tooth disease type 1A	Other trait
540	GCST008540	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Other trait
541	GCST008540	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Neurological disorder
542	GCST008543	Walking difficulty in Charcot-Marie-Tooth disease 1A	Walking difficulty in Charcot-Marie-Tooth disease 1A	Other trait
543	GCST008543	Walking difficulty in Charcot-Marie-Tooth disease 1A	Walking difficulty in Charcot-Marie-Tooth disease 1A	Neurological disorder
544	GCST008544	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Neurological disorder
545	GCST008544	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Other measurement
546	GCST008542	First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	Neurological disorder
547	GCST008542	First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	Other measurement
548	GCST008541	Foot deformity in Charcot-Marie-Tooth disease 1A	Foot deformity in Charcot-Marie-Tooth disease 1A	Neurological disorder
549	GCST008541	Foot deformity in Charcot-Marie-Tooth disease 1A	Foot deformity in Charcot-Marie-Tooth disease 1A	Other trait
550	GCST008539	Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Neurological disorder
551	GCST008539	Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Other measurement
552	GCST008536	Scoliosis in Charcot-Marie-Tooth disease 1A	Scoliosis in Charcot-Marie-Tooth disease 1A	Other disease
553	GCST008536	Scoliosis in Charcot-Marie-Tooth disease 1A	Scoliosis in Charcot-Marie-Tooth disease 1A	Neurological disorder
554	GCST008535	Arthritic-like pain in Charcot-Marie-Tooth type 1A	Arthritic-like pain in Charcot-Marie-Tooth type 1A	Other trait
555	GCST008535	Arthritic-like pain in Charcot-Marie-Tooth type 1A	Arthritic-like pain in Charcot-Marie-Tooth type 1A	Neurological disorder
556	GCST008532	Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Neurological disorder
557	GCST008532	Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Neurological disorder
558	GCST008225	Renal cell carcinoma	Renal cell carcinoma	Cancer
559	GCST008224	Renal cell carcinoma x sex interaction	Renal cell carcinoma x sex interaction	Cancer
560	GCST008224	Renal cell carcinoma x sex interaction	Renal cell carcinoma x sex interaction	Other measurement
561	GCST008226	Renal cell carcinoma	Renal cell carcinoma	Cancer
562	GCST000510	Platelet count	Platelet count	Hematological measurement
563	GCST008427	Basophil count	Basophil count	Inflammatory measurement
564	GCST008428	Eosinophil counts	Eosinophil counts	Hematological measurement
565	GCST008429	Hemoglobin levels	Hemoglobin levels	Hematological measurement
566	GCST008429	Hemoglobin levels	Hemoglobin levels	Hematological measurement
567	GCST008429	Hemoglobin levels	Hemoglobin levels	Hematological measurement
568	GCST008429	Hemoglobin levels	Hemoglobin levels	Hematological measurement
569	GCST008430	Hematocrit	Hematocrit	Hematological measurement
570	GCST008431	Lymphocyte counts	Lymphocyte counts	Hematological measurement
571	GCST008432	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
572	GCST008432	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
573	GCST008418	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
574	GCST008418	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
575	GCST008420	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
576	GCST008421	Monocyte count	Monocyte count	Hematological measurement
577	GCST008425	Neutrophil count	Neutrophil count	Hematological measurement
578	GCST008426	Red blood cell count	Red blood cell count	Hematological measurement
579	GCST008419	White blood cell count	White blood cell count	Hematological measurement
580	GCST008419	White blood cell count	White blood cell count	Inflammatory measurement
581	GCST008419	White blood cell count	White blood cell count	Hematological measurement
582	GCST008419	White blood cell count	White blood cell count	Hematological measurement
583	GCST008419	White blood cell count	White blood cell count	Hematological measurement
584	GCST007850	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
585	GCST007848	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
586	GCST007848	LDL cholesterol	LDL cholesterol	Other measurement
587	GCST007848	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
588	GCST007849	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
589	GCST008284	Alcohol dependence	Alcohol dependence	Other measurement
590	GCST008284	Alcohol dependence	Alcohol dependence	Neurological disorder
591	GCST008283	Alcohol dependence symptom count	Alcohol dependence symptom count	Other measurement
592	GCST008285	Alcohol dependence (tolerance)	Alcohol dependence (tolerance)	Other measurement
593	GCST008286	Alcohol dependence (withdrawal)	Alcohol dependence (withdrawal)	Other measurement
594	GCST008287	Alcohol dependence (drinking more than intended)	Alcohol dependence (drinking more than intended)	Other measurement
595	GCST008288	Alcohol dependence (desire to cut drinking)	Alcohol dependence (desire to cut drinking)	Other measurement
596	GCST008289	Alcohol dependence (giving up activities)	Alcohol dependence (giving up activities)	Other measurement
597	GCST008290	Alcohol dependence (time spent drinking)	Alcohol dependence (time spent drinking)	Other measurement
598	GCST008291	Alcohol dependence (drinking despite problems)	Alcohol dependence (drinking despite problems)	Other measurement
599	GCST007643	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Immune system disorder
600	GCST007643	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Response to drug
601	GCST007643	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Cancer
602	GCST007208	Obsessive-compulsive disorder	Obsessive-compulsive disorder	Neurological disorder
603	GCST007207	Obsessive-compulsive disorder x sex interaction	Obsessive-compulsive disorder x sex interaction	Neurological disorder
604	GCST007207	Obsessive-compulsive disorder x sex interaction	Obsessive-compulsive disorder x sex interaction	Other measurement
605	GCST007434	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Cancer
606	GCST007434	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Other measurement
607	GCST007434	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Other measurement
608	GCST008913	Idiopathic osteonecrosis of the femoral head	Idiopathic osteonecrosis of the femoral head	Other disease
609	GCST008114	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
610	GCST007362	Acute anterior uveitis (with or without ankylosing spondylitis)	Acute anterior uveitis (with or without ankylosing spondylitis)	Neurological disorder
611	GCST007361	Acute anterior uveitis in ankylosing spondylitis	Acute anterior uveitis in ankylosing spondylitis	Immune system disorder
612	GCST007361	Acute anterior uveitis in ankylosing spondylitis	Acute anterior uveitis in ankylosing spondylitis	Neurological disorder
613	GCST008756	Serum platinum levels after completion of cisplatin chemotherapy	Serum platinum levels after completion of cisplatin chemotherapy	Other measurement
614	GCST008756	Serum platinum levels after completion of cisplatin chemotherapy	Serum platinum levels after completion of cisplatin chemotherapy	Response to drug
615	GCST008496	Nicotine dependence	Nicotine dependence	Neurological disorder
616	GCST003484	Periodontal disease-related phenotype (Socransky)	Periodontal disease-related phenotype (Socransky)	Other measurement
617	GCST003484	Periodontal disease-related phenotype (Socransky)	Periodontal disease-related phenotype (Socransky)	Digestive system disorder
618	GCST008439	Periodontal disease related phenotype (PCT2)	Periodontal disease related phenotype (PCT2)	Other measurement
619	GCST008440	Periodontal disease related phenotype (PCT3)	Periodontal disease related phenotype (PCT3)	Other measurement
620	GCST008441	Periodontal disease related phenotype (PCT4)	Periodontal disease related phenotype (PCT4)	Other measurement
621	GCST008442	Periodontal disease related phenotype (PCT5)	Periodontal disease related phenotype (PCT5)	Other measurement
622	GCST008443	Periodontal disease related phenotype (PCT6)	Periodontal disease related phenotype (PCT6)	Other measurement
623	GCST007639	Femoral neck length	Femoral neck length	Other measurement
624	GCST007640	Narrowest width of the femoral neck	Narrowest width of the femoral neck	Other measurement
625	GCST007641	Femoral neck section modulus	Femoral neck section modulus	Other measurement
626	GCST007642	Femoral neck-shaft angle	Femoral neck-shaft angle	Other measurement
627	GCST008461	Plasma factor V levels in venous thrombosis	Plasma factor V levels in venous thrombosis	Cardiovascular disease
628	GCST008461	Plasma factor V levels in venous thrombosis	Plasma factor V levels in venous thrombosis	Other measurement
629	GCST008462	Plasma factor V levels in venous thrombosis (conditioned on rs6027)	Plasma factor V levels in venous thrombosis (conditioned on rs6027)	Cardiovascular disease
630	GCST008462	Plasma factor V levels in venous thrombosis (conditioned on rs6027)	Plasma factor V levels in venous thrombosis (conditioned on rs6027)	Other measurement
631	GCST008458	Platelet reactivity measurement (collagen-ADP)	Platelet reactivity measurement (collagen-ADP)	Cardiovascular measurement
632	GCST008457	Platelet reactivity measurement (collagen-epinephrine)	Platelet reactivity measurement (collagen-epinephrine)	Cardiovascular measurement
633	GCST007302	Breast cancer in BRCA2 mutation carriers	Breast cancer in BRCA2 mutation carriers	Cancer
634	GCST008399	Cocaine dependence	Cocaine dependence	Neurological disorder
635	GCST007998	Intraocular pressure	Intraocular pressure	Other measurement
636	GCST008668	Proliferative diabetic retinopathy	Proliferative diabetic retinopathy	Metabolic disorder
637	GCST008795	Differential aging in older adults (frontal cortex)	Differential aging in older adults (frontal cortex)	Biological process
638	GCST008795	Differential aging in older adults (frontal cortex)	Differential aging in older adults (frontal cortex)	Other measurement
639	GCST008796	Differential aging in younger adults (frontal cortex)	Differential aging in younger adults (frontal cortex)	Biological process
640	GCST008796	Differential aging in younger adults (frontal cortex)	Differential aging in younger adults (frontal cortex)	Other measurement
641	GCST008797	Differential aging (cerebellum)	Differential aging (cerebellum)	Biological process
642	GCST008797	Differential aging (cerebellum)	Differential aging (cerebellum)	Other measurement
643	GCST008798	Differential aging in older adults (cerebellum)	Differential aging in older adults (cerebellum)	Biological process
644	GCST008798	Differential aging in older adults (cerebellum)	Differential aging in older adults (cerebellum)	Other measurement
645	GCST008799	Differential aging (frontal cortex)	Differential aging (frontal cortex)	Biological process
646	GCST008799	Differential aging (frontal cortex)	Differential aging (frontal cortex)	Other measurement
647	GCST008800	Differential aging (frontal cortex)	Differential aging (frontal cortex)	Biological process
648	GCST008800	Differential aging (frontal cortex)	Differential aging (frontal cortex)	Other measurement
649	GCST007287	Diastolic blood pressure x alcohol consumption interaction (1df test)	Diastolic blood pressure x alcohol consumption interaction (1df test)	Biological process
650	GCST007287	Diastolic blood pressure x alcohol consumption interaction (1df test)	Diastolic blood pressure x alcohol consumption interaction (1df test)	Other measurement
651	GCST007288	Systolic blood pressure x alcohol consumption interaction (1df test)	Systolic blood pressure x alcohol consumption interaction (1df test)	Biological process
652	GCST007288	Systolic blood pressure x alcohol consumption interaction (1df test)	Systolic blood pressure x alcohol consumption interaction (1df test)	Other measurement
653	GCST008446	Number of alcoholic drinks required to feel an effect (first five times drinking)	Number of alcoholic drinks required to feel an effect (first five times drinking)	Biological process
654	GCST008447	Number of alcoholic drinks required to feel an effect (long-term average)	Number of alcoholic drinks required to feel an effect (long-term average)	Biological process
655	GCST008708	Chronic mountain sickness	Chronic mountain sickness	Cardiovascular disease
656	GCST006080	Prostate cancer aggressiveness (high vs low)	Prostate cancer aggressiveness (high vs low)	Cancer
657	GCST006082	Prostate cancer aggressiveness (high vs low/intermediate)	Prostate cancer aggressiveness (high vs low/intermediate)	Cancer
658	GCST006081	Prostate cancer (advanced vs non-advanced)	Prostate cancer (advanced vs non-advanced)	Cancer
659	GCST006083	Prostate cancer (advanced)	Prostate cancer (advanced)	Cancer
660	GCST006089	Prostate cancer (early onset)	Prostate cancer (early onset)	Cancer
661	GCST006084	Prostate cancer (Gleason score)	Prostate cancer (Gleason score)	Cancer
662	GCST006085	Prostate cancer	Prostate cancer	Cancer
663	GCST007993	Asthma (adult onset)	Asthma (adult onset)	Other disease
664	GCST007995	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
665	GCST007995	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
666	GCST007994	Asthma (age of onset)	Asthma (age of onset)	Other disease
667	GCST007996	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
668	GCST004903	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
669	GCST007951	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
670	GCST007954	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
671	GCST007952	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
672	GCST007953	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
673	GCST007825	Alzheimer's disease or fasting glucose levels (pleiotropy)	Alzheimer's disease or fasting glucose levels (pleiotropy)	Neurological disorder
674	GCST007825	Alzheimer's disease or fasting glucose levels (pleiotropy)	Alzheimer's disease or fasting glucose levels (pleiotropy)	Other measurement
675	GCST007826	Alzheimer's disease or fasting insulin levels (pleiotropy)	Alzheimer's disease or fasting insulin levels (pleiotropy)	Neurological disorder
676	GCST007826	Alzheimer's disease or fasting insulin levels (pleiotropy)	Alzheimer's disease or fasting insulin levels (pleiotropy)	Other measurement
677	GCST007827	Alzheimer's disease or HDL levels (pleiotropy)	Alzheimer's disease or HDL levels (pleiotropy)	Neurological disorder
678	GCST007827	Alzheimer's disease or HDL levels (pleiotropy)	Alzheimer's disease or HDL levels (pleiotropy)	Lipid or lipoprotein measurement
679	GCST008737	Esotropia	Esotropia	Other trait
680	GCST008738	Accommodative esotropia	Accommodative esotropia	Neurological disorder
681	GCST008739	Amblyopia	Amblyopia	Neurological disorder
682	GCST008740	Hyperopia	Hyperopia	Other trait
683	GCST008740	Hyperopia	Hyperopia	Neurological disorder
684	GCST008741	Non-accommodative esotropia	Non-accommodative esotropia	Neurological disorder
685	GCST008716	Anti-Helicobacter pylori IgG seropositivity	Anti-Helicobacter pylori IgG seropositivity	Other measurement
686	GCST008713	Severe gastric atrophy	Severe gastric atrophy	Digestive system disorder
687	GCST008709	Pepsinogen-I levels	Pepsinogen-I levels	Other measurement
688	GCST008712	Pepsinogen I/II ratio	Pepsinogen I/II ratio	Other measurement
689	GCST008714	Gastric atrophy	Gastric atrophy	Digestive system disorder
690	GCST008397	Infliximab-induced mucosal healing in Crohn's disease	Infliximab-induced mucosal healing in Crohn's disease	Digestive system disorder
691	GCST008397	Infliximab-induced mucosal healing in Crohn's disease	Infliximab-induced mucosal healing in Crohn's disease	Response to drug
692	GCST008816	Ischemic heart disease	Ischemic heart disease	Cardiovascular disease
693	GCST008817	Bilirubin levels	Bilirubin levels	Other measurement
694	GCST008555	Breakfast cereal skipping frequency	Breakfast cereal skipping frequency	Other measurement
695	GCST008556	Breakfast skipping	Breakfast skipping	Other measurement
696	GCST008870	Keratinocyte cancer (MTAG)		
697	GCST008871	Basal cell carcinoma	Basal cell carcinoma	Cancer
698	GCST008872	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
699	GCST008872	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
700	GCST007278	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Neurological disorder
701	GCST007278	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Immune system disorder
702	GCST007278	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Immune system disorder
703	GCST007278	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Immune system disorder
704	GCST008647	Urinary sodium excretion	Urinary sodium excretion	Other measurement
705	GCST008648	Urinary potassium excretion	Urinary potassium excretion	Other measurement
706	GCST007637	Diffusing capacity of carbon monoxide	Diffusing capacity of carbon monoxide	Other measurement
707	GCST008498	Meningococcal C IgG concentrations post childhood immunization	Meningococcal C IgG concentrations post childhood immunization	Response to drug
708	GCST008498	Meningococcal C IgG concentrations post childhood immunization	Meningococcal C IgG concentrations post childhood immunization	Other measurement
709	GCST008499	Meningococcal C functional antibody titers post childhood immunization	Meningococcal C functional antibody titers post childhood immunization	Response to drug
710	GCST008499	Meningococcal C functional antibody titers post childhood immunization	Meningococcal C functional antibody titers post childhood immunization	Other measurement
711	GCST008500	Tetanus toxoid IgG concentrations post childhood immunization	Tetanus toxoid IgG concentrations post childhood immunization	Response to drug
712	GCST008500	Tetanus toxoid IgG concentrations post childhood immunization	Tetanus toxoid IgG concentrations post childhood immunization	Other measurement
713	GCST008501	Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	Response to drug
714	GCST008501	Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	Other measurement
715	GCST007732	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Other disease
716	GCST007732	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Immune system disorder
717	GCST008314	Response to intravenous immunoglobulin treatment in Kawasaki disease	Response to intravenous immunoglobulin treatment in Kawasaki disease	Immune system disorder
718	GCST008314	Response to intravenous immunoglobulin treatment in Kawasaki disease	Response to intravenous immunoglobulin treatment in Kawasaki disease	Other trait
719	GCST007989	Facial morphology traits (63 three-dimensional facial segments)	Facial morphology traits (63 three-dimensional facial segments)	Other measurement
720	GCST008057	Varicose veins	Varicose veins	Other trait
721	GCST007319	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
722	GCST007319	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
723	GCST007321	Family history of Alzheimer's disease	Family history of Alzheimer's disease	Other measurement
724	GCST007320	Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease or family history of Alzheimer's disease	Neurological disorder
725	GCST007320	Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease or family history of Alzheimer's disease	Other measurement
726	GCST008278	Femoral neck size	Femoral neck size	Body measurement
727	GCST008279	Trochanter size	Trochanter size	Body measurement
728	GCST008280	Intertrochanteric region size	Intertrochanteric region size	Body measurement
729	GCST008282	Spine bone size	Spine bone size	Other measurement
730	GCST008281	Hip bone size	Hip bone size	Body measurement
731	GCST008551	Simvastatin-induced myopathy	Simvastatin-induced myopathy	Other disease
732	GCST008551	Simvastatin-induced myopathy	Simvastatin-induced myopathy	Response to drug
733	GCST008554	Atorvastatin-induced myopathy	Atorvastatin-induced myopathy	Response to drug
734	GCST008554	Atorvastatin-induced myopathy	Atorvastatin-induced myopathy	Other disease
735	GCST008553	Statin-induced myopathy (severe)	Statin-induced myopathy (severe)	Other disease
736	GCST008553	Statin-induced myopathy (severe)	Statin-induced myopathy (severe)	Response to drug
737	GCST008552	Statin-induced myopathy	Statin-induced myopathy	Other disease
738	GCST008552	Statin-induced myopathy	Statin-induced myopathy	Response to drug
739	GCST008598	Longevity (age >90th survival percentile)	Longevity (age >90th survival percentile)	Other measurement
740	GCST008601	Longevity (age >99th survival percentile)	Longevity (age >99th survival percentile)	Other measurement
741	GCST008600	Longevity (age >90th survival percentile)	Longevity (age >90th survival percentile)	Other measurement
742	GCST008599	Longevity (age >99th survival percentile)	Longevity (age >99th survival percentile)	Other measurement
743	GCST008891	Cognitive performance (processing speed)	Cognitive performance (processing speed)	Biological process
744	GCST008891	Cognitive performance (processing speed)	Cognitive performance (processing speed)	Other measurement
745	GCST008892	Working memory	Working memory	Biological process
746	GCST008893	Inhibitory control	Inhibitory control	Other measurement
747	GCST008748	Epigenetic age acceleration in alcohol use disorder	Epigenetic age acceleration in alcohol use disorder	Biological process
748	GCST008748	Epigenetic age acceleration in alcohol use disorder	Epigenetic age acceleration in alcohol use disorder	Other measurement
749	GCST007355	Antidepressant treatment resistance (> 2 drugs prescribed)	Antidepressant treatment resistance (> 2 drugs prescribed)	Response to drug
750	GCST007356	Antidepressant treatment resistance (number of drugs prescribed)	Antidepressant treatment resistance (number of drugs prescribed)	Response to drug
751	GCST008138	Allergic rhinitis x sex interaction	Allergic rhinitis x sex interaction	Immune system disorder
752	GCST008138	Allergic rhinitis x sex interaction	Allergic rhinitis x sex interaction	Other measurement
753	GCST008672	Knee pain	Knee pain	Other trait
754	GCST008371	Thyroid cancer	Thyroid cancer	Cancer
755	GCST008370	Coronary artery disease	Coronary artery disease	Cardiovascular disease
756	GCST008370	Coronary artery disease	Coronary artery disease	Cardiovascular disease
757	GCST008373	Glaucoma	Glaucoma	Neurological disorder
758	GCST008372	Colorectal cancer	Colorectal cancer	Cancer
759	GCST007728	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
760	GCST007728	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
761	GCST008412	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Other measurement
762	GCST008412	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Biological process
763	GCST008411	Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	Other measurement
764	GCST008411	Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	Biological process
765	GCST008410	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Other measurement
766	GCST008410	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Biological process
767	GCST008409	Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Other measurement
768	GCST008409	Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Biological process
769	GCST008408	Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	Other measurement
770	GCST008408	Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	Biological process
771	GCST008402	Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Other measurement
772	GCST008402	Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Biological process
773	GCST008393	Systolic blood pressure x physical activity interaction (2df)	Systolic blood pressure x physical activity interaction (2df)	Other measurement
774	GCST008393	Systolic blood pressure x physical activity interaction (2df)	Systolic blood pressure x physical activity interaction (2df)	Other measurement
775	GCST008407	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Other measurement
776	GCST008407	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Biological process
777	GCST008406	Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	Other measurement
778	GCST008406	Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	Biological process
779	GCST008405	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Other measurement
780	GCST008405	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Biological process
781	GCST008404	Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Other measurement
782	GCST008404	Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Biological process
783	GCST008401	Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	Other measurement
784	GCST008401	Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	Biological process
785	GCST008400	Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Other measurement
786	GCST008400	Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Biological process
787	GCST008392	Systolic blood pressure x physical activity interaction (1df)	Systolic blood pressure x physical activity interaction (1df)	Other measurement
788	GCST008392	Systolic blood pressure x physical activity interaction (1df)	Systolic blood pressure x physical activity interaction (1df)	Other measurement
789	GCST008389	Diastolic blood pressure x physical activity interaction (1df)	Diastolic blood pressure x physical activity interaction (1df)	Other measurement
790	GCST008389	Diastolic blood pressure x physical activity interaction (1df)	Diastolic blood pressure x physical activity interaction (1df)	Other measurement
791	GCST008390	DIastolic blood pressure x physical activity interaction (2df)	DIastolic blood pressure x physical activity interaction (2df)	Other measurement
792	GCST008390	DIastolic blood pressure x physical activity interaction (2df)	DIastolic blood pressure x physical activity interaction (2df)	Other measurement
793	GCST007519	Adult asthma	Adult asthma	Other disease
794	GCST007520	Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Other disease
795	GCST007520	Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Other disease
796	GCST007521	Asthma-chronic obstructive  pulmonary disease overlap syndrome	Asthma-chronic obstructive  pulmonary disease overlap syndrome	Other disease
797	GCST008545	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Metabolic disorder
798	GCST008545	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Metabolic disorder
799	GCST008545	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Other measurement
800	GCST008546	Diabetic maculopathy in type 2 diabetes	Diabetic maculopathy in type 2 diabetes	Metabolic disorder
801	GCST008546	Diabetic maculopathy in type 2 diabetes	Diabetic maculopathy in type 2 diabetes	Metabolic disorder
802	GCST008840	Depressive symptom (depressed mood) (binary trait)	Depressive symptom (depressed mood) (binary trait)	Other measurement
803	GCST008841	Depressive symptom (sleep problems) (binary trait)	Depressive symptom (sleep problems) (binary trait)	Other measurement
804	GCST008842	Depressive symptom (fatigue) (binary trait)	Depressive symptom (fatigue) (binary trait)	Other measurement
805	GCST008843	Depressive symptom (appetite changes) (binary trait)	Depressive symptom (appetite changes) (binary trait)	Other measurement
806	GCST008844	Depressive symptom (low self-esteem) (binary trait)	Depressive symptom (low self-esteem) (binary trait)	Other measurement
807	GCST008845	Depressive symptom (concentration problems) (binary trait)	Depressive symptom (concentration problems) (binary trait)	Other measurement
808	GCST008846	Depressive symptom (psychomotor changes) (binary trait)	Depressive symptom (psychomotor changes) (binary trait)	Other measurement
809	GCST008847	Depressive symptom (suicidal ideation) (binary trait)	Depressive symptom (suicidal ideation) (binary trait)	Other measurement
810	GCST008849	Depressive symptoms (binary sum-score)	Depressive symptoms (binary sum-score)	Other measurement
811	GCST008848	Depressive symptoms (sum-score)	Depressive symptoms (sum-score)	Other measurement
812	GCST008850	Depressive symptom (sleep problems) (ordinal trait)	Depressive symptom (sleep problems) (ordinal trait)	Other measurement
813	GCST008851	Depressive symptom (fatigue) (ordinal trait)	Depressive symptom (fatigue) (ordinal trait)	Other measurement
814	GCST008852	Depressive symptom (appetite changes) (ordinal trait)	Depressive symptom (appetite changes) (ordinal trait)	Other measurement
815	GCST008853	Depressive symptom (low self-esteem) (ordinal trait)	Depressive symptom (low self-esteem) (ordinal trait)	Other measurement
816	GCST008854	Depressive symptom (concentration problems) (ordinal trait)	Depressive symptom (concentration problems) (ordinal trait)	Other measurement
817	GCST008855	Depressive symptom (psychomotor changes) (ordinal trait)	Depressive symptom (psychomotor changes) (ordinal trait)	Other measurement
818	GCST008856	Depressive symptom (suicidal ideation) (ordinal trait)	Depressive symptom (suicidal ideation) (ordinal trait)	Other measurement
819	GCST008857	Depressive symptom (anhedonia) (ordinal trait)	Depressive symptom (anhedonia) (ordinal trait)	Other measurement
820	GCST008858	Depressive symptom (depressed mood) (ordinal trait)	Depressive symptom (depressed mood) (ordinal trait)	Other measurement
821	GCST008859	Depressive symptom (anhedonia) (binary trait)	Depressive symptom (anhedonia) (binary trait)	Other measurement
822	GCST007229	Thiopurine-induced early leukopenia in Crohn's disease	Thiopurine-induced early leukopenia in Crohn's disease	Digestive system disorder
823	GCST007229	Thiopurine-induced early leukopenia in Crohn's disease	Thiopurine-induced early leukopenia in Crohn's disease	Other trait
824	GCST007229	Thiopurine-induced early leukopenia in Crohn's disease	Thiopurine-induced early leukopenia in Crohn's disease	Response to drug
825	GCST007050	Gallstone disease	Gallstone disease	Digestive system disorder
826	GCST007050	Gallstone disease	Gallstone disease	Digestive system disorder
827	GCST008642	Annualised percent change of cerebrospinal fluid AB1-42 levels	Annualised percent change of cerebrospinal fluid AB1-42 levels	Other measurement
828	GCST007847	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
829	GCST008838	Asthma (time to onset)	Asthma (time to onset)	Other disease
830	GCST008838	Asthma (time to onset)	Asthma (time to onset)	Other measurement
831	GCST008516	Skin pigmentation (conditioned on rs1426654 and rs35397)	Skin pigmentation (conditioned on rs1426654 and rs35397)	Other measurement
832	GCST008518	Skin pigmentation	Skin pigmentation	Other trait
833	GCST008518	Skin pigmentation	Skin pigmentation	Other measurement
834	GCST008519	Skin pigmentation	Skin pigmentation	Other trait
835	GCST008519	Skin pigmentation	Skin pigmentation	Other measurement
836	GCST007665	Treatment resistant depression	Treatment resistant depression	Neurological disorder
837	GCST007665	Treatment resistant depression	Treatment resistant depression	Response to drug
838	GCST007667	Treatment resistant depression	Treatment resistant depression	Neurological disorder
839	GCST007667	Treatment resistant depression	Treatment resistant depression	Response to drug
840	GCST007666	Depressive symptom improvement	Depressive symptom improvement	Other measurement
841	GCST007666	Depressive symptom improvement	Depressive symptom improvement	Response to drug
842	GCST008511	Chronic widespread pain	Chronic widespread pain	Other trait
843	GCST008512	Multisite chronic pain	Multisite chronic pain	Other trait
844	GCST007304	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Neurological disorder
845	GCST007304	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Other measurement
846	GCST007796	Tinnitus in cisplatin-treated testicular cancer	Tinnitus in cisplatin-treated testicular cancer	Cancer
847	GCST007796	Tinnitus in cisplatin-treated testicular cancer	Tinnitus in cisplatin-treated testicular cancer	Response to drug
848	GCST007796	Tinnitus in cisplatin-treated testicular cancer	Tinnitus in cisplatin-treated testicular cancer	Other trait
849	GCST008230	Asthma control x inhaled corticosteroid treatment interaction (2df)	Asthma control x inhaled corticosteroid treatment interaction (2df)	Response to drug
850	GCST008230	Asthma control x inhaled corticosteroid treatment interaction (2df)	Asthma control x inhaled corticosteroid treatment interaction (2df)	Other measurement
851	GCST008229	Asthma control x inhaled corticosteroid treatment interaction (1df)	Asthma control x inhaled corticosteroid treatment interaction (1df)	Response to drug
852	GCST008229	Asthma control x inhaled corticosteroid treatment interaction (1df)	Asthma control x inhaled corticosteroid treatment interaction (1df)	Other measurement
853	GCST008228	Asthma control	Asthma control	Other measurement
854	GCST007687	Photic sneeze reflex	Photic sneeze reflex	Other trait
855	GCST008240	Airway obstruction (FEV1/FVC<70%) in never smokers	Airway obstruction (FEV1/FVC<70%) in never smokers	Other measurement
856	GCST008240	Airway obstruction (FEV1/FVC<70%) in never smokers	Airway obstruction (FEV1/FVC<70%) in never smokers	Other measurement
857	GCST008242	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Other measurement
858	GCST008242	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Other measurement
859	GCST008241	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Other measurement
860	GCST008241	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Other measurement
861	GCST008243	Airway obstruction (FEV1/FVC<70%) in ever smokers	Airway obstruction (FEV1/FVC<70%) in ever smokers	Other measurement
862	GCST008243	Airway obstruction (FEV1/FVC<70%) in ever smokers	Airway obstruction (FEV1/FVC<70%) in ever smokers	Other measurement
863	GCST008244	Airway obstruction (FEV1/FVC<70%) in ever smokers	Airway obstruction (FEV1/FVC<70%) in ever smokers	Other measurement
864	GCST008244	Airway obstruction (FEV1/FVC<70%) in ever smokers	Airway obstruction (FEV1/FVC<70%) in ever smokers	Other measurement
865	GCST008247	Airway obstruction (FEV1/FVC<70%) in never smokers	Airway obstruction (FEV1/FVC<70%) in never smokers	Other measurement
866	GCST008247	Airway obstruction (FEV1/FVC<70%) in never smokers	Airway obstruction (FEV1/FVC<70%) in never smokers	Other measurement
867	GCST008245	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Other measurement
868	GCST008245	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Other measurement
869	GCST008246	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Other measurement
870	GCST008246	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Other measurement
871	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
872	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
873	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
874	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
875	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
876	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
877	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
878	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
879	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
880	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
881	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
882	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
883	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
884	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
885	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
886	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
887	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
888	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
889	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
890	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
891	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
892	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
893	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
894	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
895	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
896	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
897	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
898	GCST007384	Plasma free proline levels	Plasma free proline levels	Other measurement
899	GCST007386	Plasma free asparagine levels	Plasma free asparagine levels	Other measurement
900	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
901	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
902	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
903	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
904	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
905	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
906	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
907	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
908	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
909	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
910	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
911	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
912	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
913	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
914	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
915	GCST008477	Emphysema annual change measurement in smokers (adjusted lung density)	Emphysema annual change measurement in smokers (adjusted lung density)	Other measurement
916	GCST008477	Emphysema annual change measurement in smokers (adjusted lung density)	Emphysema annual change measurement in smokers (adjusted lung density)	Other measurement
917	GCST008476	Emphysema annual change measurement in smokers (percent low attenuation area)	Emphysema annual change measurement in smokers (percent low attenuation area)	Other measurement
918	GCST008476	Emphysema annual change measurement in smokers (percent low attenuation area)	Emphysema annual change measurement in smokers (percent low attenuation area)	Other measurement
919	GCST008217	Non-muscle-invasive bladder cancer age at diagnosis	Non-muscle-invasive bladder cancer age at diagnosis	Cancer
920	GCST008217	Non-muscle-invasive bladder cancer age at diagnosis	Non-muscle-invasive bladder cancer age at diagnosis	Other measurement
921	GCST008218	Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs  70 years)	Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs  70 years)	Cancer
922	GCST008218	Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs  70 years)	Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs  70 years)	Other measurement
923	GCST008216	Non-muscle-invasive bladder cancer tumour size	Non-muscle-invasive bladder cancer tumour size	Cancer
924	GCST008216	Non-muscle-invasive bladder cancer tumour size	Non-muscle-invasive bladder cancer tumour size	Other measurement
925	GCST008219	Non-muscle-invasive bladder cancer tumour size (< 3 cm vs  3 cm)	Non-muscle-invasive bladder cancer tumour size (< 3 cm vs  3 cm)	Cancer
926	GCST008219	Non-muscle-invasive bladder cancer tumour size (< 3 cm vs  3 cm)	Non-muscle-invasive bladder cancer tumour size (< 3 cm vs  3 cm)	Other measurement
927	GCST008220	Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	Cancer
928	GCST008220	Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	Other measurement
929	GCST008221	Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	Cancer
930	GCST008221	Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	Other measurement
931	GCST008222	Non-muscle-invasive bladder cancer EORTC risk category	Non-muscle-invasive bladder cancer EORTC risk category	Cancer
932	GCST008222	Non-muscle-invasive bladder cancer EORTC risk category	Non-muscle-invasive bladder cancer EORTC risk category	Other measurement
933	GCST007402	Factor VII activity or levels	Factor VII activity or levels	Other measurement
934	GCST007401	Factor VII activity	Factor VII activity	Other measurement
935	GCST005586	Breast milk fatty acid composition (maternal genotype effect)	Breast milk fatty acid composition (maternal genotype effect)	Lipid or lipoprotein measurement
936	GCST005586	Breast milk fatty acid composition (maternal genotype effect)	Breast milk fatty acid composition (maternal genotype effect)	Other measurement
937	GCST005586	Breast milk fatty acid composition (maternal genotype effect)	Breast milk fatty acid composition (maternal genotype effect)	Other measurement
938	GCST005587	Breast milk fatty acid composition (infant genotype effect)	Breast milk fatty acid composition (infant genotype effect)	Lipid or lipoprotein measurement
939	GCST005587	Breast milk fatty acid composition (infant genotype effect)	Breast milk fatty acid composition (infant genotype effect)	Other measurement
940	GCST005587	Breast milk fatty acid composition (infant genotype effect)	Breast milk fatty acid composition (infant genotype effect)	Other measurement
941	GCST008904	Height	Height	Other measurement
942	GCST008904	Height	Height	Body measurement
943	GCST008276	Corneal resistance factor	Corneal resistance factor	Other measurement
944	GCST008277	Corneal hysteresis	Corneal hysteresis	Other measurement
945	GCST007816	Trunk fat mass adjusted for trunk lean mass	Trunk fat mass adjusted for trunk lean mass	Other measurement
946	GCST008794	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
947	GCST008793	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
948	GCST008792	Urinary albumin-to-creatinine ratio in diabetes	Urinary albumin-to-creatinine ratio in diabetes	Other measurement
949	GCST008792	Urinary albumin-to-creatinine ratio in diabetes	Urinary albumin-to-creatinine ratio in diabetes	Metabolic disorder
950	GCST008791	Microalbuminuria	Microalbuminuria	Other trait
951	GCST008790	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
952	GCST007344	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
953	GCST007898	Fasting blood insulin	Fasting blood insulin	Other measurement
954	GCST007899	Fasting blood glucose	Fasting blood glucose	Other measurement
955	GCST008097	Bisphosphonate-associated atypical femoral fracture	Bisphosphonate-associated atypical femoral fracture	Response to drug
956	GCST008097	Bisphosphonate-associated atypical femoral fracture	Bisphosphonate-associated atypical femoral fracture	Other disease
957	GCST008098	Atypical femoral fracture in phosphonate treatment	Atypical femoral fracture in phosphonate treatment	Response to drug
958	GCST008098	Atypical femoral fracture in phosphonate treatment	Atypical femoral fracture in phosphonate treatment	Other disease
959	GCST008473	Visceral fat	Visceral fat	Other measurement
960	GCST008445	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
961	GCST007948	KANNO antigen negativity	KANNO antigen negativity	Other measurement
962	GCST007444	Chronic rhinosinusitis	Chronic rhinosinusitis	Neurological disorder
963	GCST007443	Nasal polyps	Nasal polyps	Cancer
964	GCST007605	Glycated hemoglobin levels in type 1 diabetes	Glycated hemoglobin levels in type 1 diabetes	Other measurement
965	GCST007605	Glycated hemoglobin levels in type 1 diabetes	Glycated hemoglobin levels in type 1 diabetes	Metabolic disorder
966	GCST007896	Primary central nervous system lymphoma	Primary central nervous system lymphoma	Cancer
967	GCST008310	Cardiac Troponin-T levels	Cardiac Troponin-T levels	Cardiovascular measurement
968	GCST008309	Cardiac troponin-I levels	Cardiac troponin-I levels	Cardiovascular measurement
969	GCST007635	Fatty acid desaturase activity (serum)	Fatty acid desaturase activity (serum)	Other measurement
970	GCST007636	Fatty acid desaturase activity (adipose tissue)	Fatty acid desaturase activity (adipose tissue)	Other measurement
971	GCST007251	Postburn scar height	Postburn scar height	Other measurement
972	GCST007252	Postburn scar pliability	Postburn scar pliability	Other measurement
973	GCST007511	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
974	GCST007511	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
975	GCST008940	Chromosomal aberration frequency (total)	Chromosomal aberration frequency (total)	Other measurement
976	GCST008941	High chromosomal aberration frequency (chromatid type)	High chromosomal aberration frequency (chromatid type)	Other measurement
977	GCST008942	Chromosomal aberration frequency (chromatid type)	Chromosomal aberration frequency (chromatid type)	Other measurement
978	GCST008943	High chromosomal aberration frequency (chromosome type)	High chromosomal aberration frequency (chromosome type)	Other measurement
979	GCST008944	Chromosomal aberration frequency (chromosome type)	Chromosomal aberration frequency (chromosome type)	Other measurement
980	GCST008945	High chromosomal aberration frequency (total) in genotoxic compound exposure	High chromosomal aberration frequency (total) in genotoxic compound exposure	Other measurement
981	GCST008945	High chromosomal aberration frequency (total) in genotoxic compound exposure	High chromosomal aberration frequency (total) in genotoxic compound exposure	Other measurement
982	GCST008946	Chromosomal aberration frequency (total) in genotoxic compound exposure	Chromosomal aberration frequency (total) in genotoxic compound exposure	Other measurement
983	GCST008946	Chromosomal aberration frequency (total) in genotoxic compound exposure	Chromosomal aberration frequency (total) in genotoxic compound exposure	Other measurement
984	GCST008947	High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	Other measurement
985	GCST008947	High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	Other measurement
986	GCST008948	Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	Other measurement
987	GCST008948	Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	Other measurement
988	GCST008949	High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	Other measurement
989	GCST008949	High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	Other measurement
990	GCST008939	Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	Other measurement
991	GCST008939	Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	Other measurement
992	GCST008950	High chromosomal aberration frequency (total)	High chromosomal aberration frequency (total)	Other measurement
993	GCST008951	Chromosomal aberration frequency (total)	Chromosomal aberration frequency (total)	Other measurement
994	GCST008952	High chromosomal aberration frequency (chromatid type)	High chromosomal aberration frequency (chromatid type)	Other measurement
995	GCST008953	Chromosomal aberration frequency (chromatid type)	Chromosomal aberration frequency (chromatid type)	Other measurement
996	GCST008954	High chromosomal aberration frequency (chromosome type)	High chromosomal aberration frequency (chromosome type)	Other measurement
997	GCST008955	Chromosomal aberration frequency (chromosome type)	Chromosomal aberration frequency (chromosome type)	Other measurement
998	GCST008956	High chromosomal aberration frequency (total)	High chromosomal aberration frequency (total)	Other measurement
999	GCST008364	Thyrotoxic hypokalemic periodic paralysis in Graves disease	Thyrotoxic hypokalemic periodic paralysis in Graves disease	Immune system disorder
1000	GCST008364	Thyrotoxic hypokalemic periodic paralysis in Graves disease	Thyrotoxic hypokalemic periodic paralysis in Graves disease	Metabolic disorder
1001	GCST008365	Thyrotoxic hypokalemic periodic paralysis and Graves disease	Thyrotoxic hypokalemic periodic paralysis and Graves disease	Immune system disorder
1002	GCST008365	Thyrotoxic hypokalemic periodic paralysis and Graves disease	Thyrotoxic hypokalemic periodic paralysis and Graves disease	Metabolic disorder
1003	GCST007815	Male-pattern baldness	Male-pattern baldness	Other measurement
1004	GCST007815	Male-pattern baldness	Male-pattern baldness	Other disease
1005	GCST007815	Male-pattern baldness	Male-pattern baldness	Other disease
1006	GCST008592	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1007	GCST008591	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
1008	GCST008593	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1009	GCST008594	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
1010	GCST007551	Behcet's disease	Behcet's disease	Cardiovascular disease
1011	GCST008260	group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	Other measurement
1012	GCST008260	group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	Inflammatory measurement
1013	GCST008915	Leukocyte count in ischemic stroke	Leukocyte count in ischemic stroke	Hematological measurement
1014	GCST008915	Leukocyte count in ischemic stroke	Leukocyte count in ischemic stroke	Other trait
1015	GCST008292	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other disease
1016	GCST008292	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1017	GCST008292	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other measurement
1018	GCST008292	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1019	GCST008294	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other disease
1020	GCST008294	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1021	GCST008294	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1022	GCST008294	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other measurement
1023	GCST008293	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other disease
1024	GCST008293	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1025	GCST008293	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other measurement
1026	GCST008293	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1027	GCST002045	Educational attainment	Educational attainment	Other measurement
1028	GCST002047	Educational attainment (college completion)	Educational attainment (college completion)	Other measurement
1029	GCST008396	Educational attainment (years of education)	Educational attainment (years of education)	Other measurement
1030	GCST008736	Response to beta blocker use in hypertension (systolic blood pressure)	Response to beta blocker use in hypertension (systolic blood pressure)	Other measurement
1031	GCST008736	Response to beta blocker use in hypertension (systolic blood pressure)	Response to beta blocker use in hypertension (systolic blood pressure)	Response to drug
1032	GCST008736	Response to beta blocker use in hypertension (systolic blood pressure)	Response to beta blocker use in hypertension (systolic blood pressure)	Cardiovascular disease
1033	GCST008735	Response to beta blocker use in hypertension (diastolic blood pressure)	Response to beta blocker use in hypertension (diastolic blood pressure)	Other measurement
1034	GCST008735	Response to beta blocker use in hypertension (diastolic blood pressure)	Response to beta blocker use in hypertension (diastolic blood pressure)	Response to drug
1035	GCST008735	Response to beta blocker use in hypertension (diastolic blood pressure)	Response to beta blocker use in hypertension (diastolic blood pressure)	Cardiovascular disease
1036	GCST008375	Adenocarcinoma in never smokers	Adenocarcinoma in never smokers	Other measurement
1037	GCST008375	Adenocarcinoma in never smokers	Adenocarcinoma in never smokers	Cancer
1038	GCST008376	Lung cancer in never smokers	Lung cancer in never smokers	Other measurement
1039	GCST008376	Lung cancer in never smokers	Lung cancer in never smokers	Cancer
1040	GCST007949	Type 2 diabetes and end-stage kidney disease	Type 2 diabetes and end-stage kidney disease	Metabolic disorder
1041	GCST007950	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	Metabolic disorder
1042	GCST007950	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	Other measurement
1043	GCST008675	Maximum habitual alcohol consumption	Maximum habitual alcohol consumption	Other measurement
1044	GCST007840	Low HDL-cholesterol levels	Low HDL-cholesterol levels	Lipid or lipoprotein measurement
1045	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1046	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1047	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1048	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1049	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1050	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1051	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1052	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1053	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1054	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1055	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1056	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1057	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1058	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1059	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1060	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1061	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1062	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1063	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1064	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1065	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1066	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1067	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1068	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1069	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1070	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1071	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1072	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1073	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1074	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1075	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1076	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1077	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1078	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1079	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1080	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1081	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1082	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1083	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1084	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1085	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1086	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1087	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1088	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1089	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1090	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1091	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Cardiovascular measurement
1092	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1093	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1094	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1095	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Inflammatory measurement
1096	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1097	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1098	GCST008484	Autistic traits score (Social and Communication Disorders Checklist)	Autistic traits score (Social and Communication Disorders Checklist)	Other measurement
1099	GCST008269	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Other disease
1100	GCST008269	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Response to drug
1101	GCST008269	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Other measurement
1102	GCST008268	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Other disease
1103	GCST008268	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Response to drug
1104	GCST008268	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Other measurement
1105	GCST008368	Plasma anti-thyroid peroxidase levels	Plasma anti-thyroid peroxidase levels	Other measurement
1106	GCST008367	Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	Other measurement
1107	GCST008367	Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	Other measurement
1108	GCST008369	Plasma anti-thyroglobulin levels	Plasma anti-thyroglobulin levels	Other measurement
1109	GCST008789	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
1110	GCST008789	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
1111	GCST008788	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
1112	GCST008788	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
1113	GCST008272	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Other measurement
1114	GCST008272	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Other disease
1115	GCST008272	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Other measurement
1116	GCST008273	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Other measurement
1117	GCST008273	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Other disease
1118	GCST008273	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Other measurement
1119	GCST008548	Fagerstrm test for nicotine dependence	Fagerstrm test for nicotine dependence	Other measurement
1120	GCST008547	Time to smoke first cigarette in the morning	Time to smoke first cigarette in the morning	Other measurement
1121	GCST008435	Response to hepatitis B vaccine	Response to hepatitis B vaccine	Response to drug
1122	GCST008435	Response to hepatitis B vaccine	Response to hepatitis B vaccine	Other measurement
1123	GCST008231	Prostate cancer	Prostate cancer	Cancer
1124	GCST008755	Phenylephrine infusion rate during anesthesia	Phenylephrine infusion rate during anesthesia	Response to drug
1125	GCST007690	Metabolic coherence (transcriptomic)	Metabolic coherence (transcriptomic)	Other measurement
1126	GCST007690	Metabolic coherence (transcriptomic)	Metabolic coherence (transcriptomic)	Other measurement
1127	GCST008721	Chronic lymphocytic leukemia or multiple sclerosis	Chronic lymphocytic leukemia or multiple sclerosis	Immune system disorder
1128	GCST008721	Chronic lymphocytic leukemia or multiple sclerosis	Chronic lymphocytic leukemia or multiple sclerosis	Cancer
1129	GCST008722	Diffuse large B-cell lymphoma or multiple sclerosis	Diffuse large B-cell lymphoma or multiple sclerosis	Immune system disorder
1130	GCST008722	Diffuse large B-cell lymphoma or multiple sclerosis	Diffuse large B-cell lymphoma or multiple sclerosis	Cancer
1131	GCST008718	Follicular lymphoma or multiple sclerosis	Follicular lymphoma or multiple sclerosis	Immune system disorder
1132	GCST008723	Marginal zone lymphoma or multiple sclerosis	Marginal zone lymphoma or multiple sclerosis	Immune system disorder
1133	GCST008723	Marginal zone lymphoma or multiple sclerosis	Marginal zone lymphoma or multiple sclerosis	Cancer
1134	GCST008724	Chronic lymphocytic leukemia or rheumatoid arthritis	Chronic lymphocytic leukemia or rheumatoid arthritis	Immune system disorder
1135	GCST008724	Chronic lymphocytic leukemia or rheumatoid arthritis	Chronic lymphocytic leukemia or rheumatoid arthritis	Cancer
1136	GCST008725	Diffuse large B-cell lymphoma or rheumatoid arthritis	Diffuse large B-cell lymphoma or rheumatoid arthritis	Immune system disorder
1137	GCST008725	Diffuse large B-cell lymphoma or rheumatoid arthritis	Diffuse large B-cell lymphoma or rheumatoid arthritis	Cancer
1138	GCST008719	Follicular lymphoma or rheumatoid arthritis	Follicular lymphoma or rheumatoid arthritis	Immune system disorder
1139	GCST008726	Marginal zone lymphoma or rheumatoid arthritis	Marginal zone lymphoma or rheumatoid arthritis	Immune system disorder
1140	GCST008726	Marginal zone lymphoma or rheumatoid arthritis	Marginal zone lymphoma or rheumatoid arthritis	Cancer
1141	GCST008727	Chronic lymphocytic leukemia or systemic lupus erythematosus	Chronic lymphocytic leukemia or systemic lupus erythematosus	Immune system disorder
1142	GCST008727	Chronic lymphocytic leukemia or systemic lupus erythematosus	Chronic lymphocytic leukemia or systemic lupus erythematosus	Cancer
1143	GCST008728	Diffuse large B-cell lymphoma or systemic lupus erythematosus	Diffuse large B-cell lymphoma or systemic lupus erythematosus	Immune system disorder
1144	GCST008728	Diffuse large B-cell lymphoma or systemic lupus erythematosus	Diffuse large B-cell lymphoma or systemic lupus erythematosus	Cancer
1145	GCST008720	Follicular lymphoma or systemic lupus erythematosus	Follicular lymphoma or systemic lupus erythematosus	Immune system disorder
1146	GCST008729	Marginal zone lymphoma or systemic lupus erythematosus	Marginal zone lymphoma or systemic lupus erythematosus	Cancer
1147	GCST008729	Marginal zone lymphoma or systemic lupus erythematosus	Marginal zone lymphoma or systemic lupus erythematosus	Immune system disorder
1148	GCST008881	Estradiol levels	Estradiol levels	Other measurement
1149	GCST008882	Cortisol levels (plasma)	Cortisol levels (plasma)	Other measurement
1150	GCST008883	DHEAS levels	DHEAS levels	Other measurement
1151	GCST008884	Testosterone levels	Testosterone levels	Other measurement
1152	GCST008884	Testosterone levels	Testosterone levels	Other measurement
1153	GCST008885	Progesterone levels	Progesterone levels	Other measurement
1154	GCST008879	17-hydroxyprogesterone (17-OHP) levels	17-hydroxyprogesterone (17-OHP) levels	Other measurement
1155	GCST008886	Androstenedione levels	Androstenedione levels	Other measurement
1156	GCST008880	Aldosterone levels	Aldosterone levels	Other measurement
1157	GCST008733	Waist-to-hip ratio adjusted for BMI	Waist-to-hip ratio adjusted for BMI	Body measurement
1158	GCST008734	Waist-hip ratio	Waist-hip ratio	Other measurement
1159	GCST008734	Waist-hip ratio	Waist-hip ratio	Body measurement
1160	GCST008234	Cognitive impairment and C-reactive protein levels (pleiotropy)	Cognitive impairment and C-reactive protein levels (pleiotropy)	Other trait
1161	GCST008234	Cognitive impairment and C-reactive protein levels (pleiotropy)	Cognitive impairment and C-reactive protein levels (pleiotropy)	Inflammatory measurement
1162	GCST008233	Cognitive impairment and LDL levels (pleiotropy)	Cognitive impairment and LDL levels (pleiotropy)	Lipid or lipoprotein measurement
1163	GCST008233	Cognitive impairment and LDL levels (pleiotropy)	Cognitive impairment and LDL levels (pleiotropy)	Other trait
1164	GCST008232	Cognitive impairment and total cholesterol levels (pleiotropy)	Cognitive impairment and total cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
1165	GCST008232	Cognitive impairment and total cholesterol levels (pleiotropy)	Cognitive impairment and total cholesterol levels (pleiotropy)	Other trait
1166	GCST008235	Cognitive impairment	Cognitive impairment	Other trait
1167	GCST008236	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
1168	GCST008237	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1169	GCST008238	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1170	GCST008239	Serum total cholesterol levels	Serum total cholesterol levels	Lipid or lipoprotein measurement
1171	GCST008101	Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Other measurement
1172	GCST008101	Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Lipid or lipoprotein measurement
1173	GCST008100	Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Other measurement
1174	GCST008100	Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Lipid or lipoprotein measurement
1175	GCST008099	Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Other measurement
1176	GCST008099	Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Lipid or lipoprotein measurement
1177	GCST008102	Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Other measurement
1178	GCST008102	Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Lipid or lipoprotein measurement
1179	GCST008271	Anti-adalimumab antibody production in response to treatment in Crohn's disease	Anti-adalimumab antibody production in response to treatment in Crohn's disease	Digestive system disorder
1180	GCST008271	Anti-adalimumab antibody production in response to treatment in Crohn's disease	Anti-adalimumab antibody production in response to treatment in Crohn's disease	Response to drug
1181	GCST007991	Large artery stroke	Large artery stroke	Cardiovascular disease
1182	GCST008106	Candidemia	Candidemia	Other disease
1183	GCST008491	Whole-brain volume	Whole-brain volume	Other measurement
1184	GCST008905	Bipolar disorder	Bipolar disorder	Neurological disorder
1185	GCST008906	Schizophrenia	Schizophrenia	Neurological disorder
1186	GCST007415	Breast cancer (estrogen-receptor positive)	Breast cancer (estrogen-receptor positive)	Cancer
1187	GCST007416	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
1188	GCST007416	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
1189	GCST007420	Breast cancer (progesterone-receptor positive)	Breast cancer (progesterone-receptor positive)	Cancer
1190	GCST007417	Breast cancer (progesterone-receptor negative)	Breast cancer (progesterone-receptor negative)	Cancer
1191	GCST007419	Breast cancer (HER2 positive)	Breast cancer (HER2 positive)	Cancer
1192	GCST007418	Breast cancer (HER2 negative)	Breast cancer (HER2 negative)	Cancer
1193	GCST007414	Breast cancer	Breast cancer	Cancer
1194	GCST008899	Adult hearing difficulty	Adult hearing difficulty	Neurological disorder
1195	GCST008898	Adult hearing aid use	Adult hearing aid use	Neurological disorder
1196	GCST008895	Psychotic experience	Psychotic experience	Other trait
1197	GCST008897	Psychotic experience (multiple occurrences)	Psychotic experience (multiple occurrences)	Other trait
1198	GCST008896	Psychotic experience (distressing)	Psychotic experience (distressing)	Other trait
1199	GCST008474	Peripheral artery disease	Peripheral artery disease	Cardiovascular disease
1200	GCST008475	Minimum anklebrachial index	Minimum anklebrachial index	Cardiovascular measurement
1201	GCST008423	Uterine fibroids	Uterine fibroids	Cancer
1202	GCST008771	Age at suicide	Age at suicide	Other measurement
1203	GCST008772	Suicide	Suicide	Biological process
1204	GCST008115	Bipolar I disorder	Bipolar I disorder	Neurological disorder
1205	GCST008115	Bipolar I disorder	Bipolar I disorder	Neurological disorder
1206	GCST008116	Bipolar II disorder	Bipolar II disorder	Neurological disorder
1207	GCST008117	Schizoaffective disorder-bipolar type	Schizoaffective disorder-bipolar type	Neurological disorder
1208	GCST008103	Bipolar disorder	Bipolar disorder	Neurological disorder
1209	GCST007515	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1210	GCST007517	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1211	GCST007516	Type 2 diabetes (adjusted for BMI)	Type 2 diabetes (adjusted for BMI)	Metabolic disorder
1212	GCST007518	Type 2 diabetes (adjusted for BMI)	Type 2 diabetes (adjusted for BMI)	Metabolic disorder
1213	GCST007387	Insomnia symptoms (never/rarely vs. sometimes/usually)	Insomnia symptoms (never/rarely vs. sometimes/usually)	Other measurement
1214	GCST007388	Insomnia symptoms (never/rarely vs. usually)	Insomnia symptoms (never/rarely vs. usually)	Other measurement
1215	GCST008517	Response to interferon treatment in hepatitis C virus genotype 3	Response to interferon treatment in hepatitis C virus genotype 3	Response to drug
1216	GCST008517	Response to interferon treatment in hepatitis C virus genotype 3	Response to interferon treatment in hepatitis C virus genotype 3	Digestive system disorder
1217	GCST008520	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	Response to drug
1218	GCST008520	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	Digestive system disorder
1219	GCST008515	Pre-treatment viral load in hepatitis C virus genotype 3	Pre-treatment viral load in hepatitis C virus genotype 3	Other measurement
1220	GCST008515	Pre-treatment viral load in hepatitis C virus genotype 3	Pre-treatment viral load in hepatitis C virus genotype 3	Digestive system disorder
1221	GCST008754	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other measurement
1222	GCST008754	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other trait
1223	GCST008753	Early spontaneous preterm birth	Early spontaneous preterm birth	Other trait
1224	GCST008752	Post-term birth	Post-term birth	Other measurement
1225	GCST008752	Post-term birth	Post-term birth	Other measurement
1226	GCST008751	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
1227	GCST008751	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
1228	GCST008674	Glycemic traits (pleiotropy)	Glycemic traits (pleiotropy)	Other measurement
1229	GCST008674	Glycemic traits (pleiotropy)	Glycemic traits (pleiotropy)	Other measurement
1230	GCST008674	Glycemic traits (pleiotropy)	Glycemic traits (pleiotropy)	Other measurement
1231	GCST008659	Lung function in heavy smokers (low FEV1 vs high FEV1)	Lung function in heavy smokers (low FEV1 vs high FEV1)	Other measurement
1232	GCST008659	Lung function in heavy smokers (low FEV1 vs high FEV1)	Lung function in heavy smokers (low FEV1 vs high FEV1)	Other measurement
1233	GCST008660	Lung function in never smokers (high FEV1 vs average FEV1)	Lung function in never smokers (high FEV1 vs average FEV1)	Other measurement
1234	GCST008660	Lung function in never smokers (high FEV1 vs average FEV1)	Lung function in never smokers (high FEV1 vs average FEV1)	Other measurement
1235	GCST008661	Lung function in heavy smokers (high FEV1 vs average FEV1)	Lung function in heavy smokers (high FEV1 vs average FEV1)	Other measurement
1236	GCST008661	Lung function in heavy smokers (high FEV1 vs average FEV1)	Lung function in heavy smokers (high FEV1 vs average FEV1)	Other measurement
1237	GCST008663	Lung function in never smokers (low FEV1 vs average FEV1)	Lung function in never smokers (low FEV1 vs average FEV1)	Other measurement
1238	GCST008663	Lung function in never smokers (low FEV1 vs average FEV1)	Lung function in never smokers (low FEV1 vs average FEV1)	Other measurement
1239	GCST008665	Lung function in heavy smokers (low FEV1 vs average FEV1)	Lung function in heavy smokers (low FEV1 vs average FEV1)	Other measurement
1240	GCST008665	Lung function in heavy smokers (low FEV1 vs average FEV1)	Lung function in heavy smokers (low FEV1 vs average FEV1)	Other measurement
1241	GCST008667	Smoking status (heavy vs never)	Smoking status (heavy vs never)	Other measurement
1242	GCST008666	Lung function (low FEV1 vs high FEV1) x smoking interaction	Lung function (low FEV1 vs high FEV1) x smoking interaction	Other measurement
1243	GCST008666	Lung function (low FEV1 vs high FEV1) x smoking interaction	Lung function (low FEV1 vs high FEV1) x smoking interaction	Other measurement
1244	GCST008664	Lung function (low FEV1 vs high FEV1)	Lung function (low FEV1 vs high FEV1)	Other measurement
1245	GCST008662	Lung function in never smokers (low FEV1 vs high FEV1)	Lung function in never smokers (low FEV1 vs high FEV1)	Other measurement
1246	GCST008662	Lung function in never smokers (low FEV1 vs high FEV1)	Lung function in never smokers (low FEV1 vs high FEV1)	Other measurement
1247	GCST007727	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
1248	GCST007226	PR interval	PR interval	Cardiovascular measurement
1249	GCST007227	QRS duration	QRS duration	Cardiovascular measurement
1250	GCST007227	QRS duration	QRS duration	Cardiovascular measurement
1251	GCST007227	QRS duration	QRS duration	Cardiovascular measurement
1252	GCST007218	QT interval	QT interval	Cardiovascular measurement
1253	GCST007217	RR interval (heart rate)	RR interval (heart rate)	Cardiovascular measurement
1254	GCST007497	Crohn's disease (time to progression)	Crohn's disease (time to progression)	Digestive system disorder
1255	GCST007497	Crohn's disease (time to progression)	Crohn's disease (time to progression)	Other measurement
1256	GCST007498	Crohn's disease (time to first abdominal surgery)	Crohn's disease (time to first abdominal surgery)	Digestive system disorder
1257	GCST007498	Crohn's disease (time to first abdominal surgery)	Crohn's disease (time to first abdominal surgery)	Other measurement
1258	GCST007499	Crohn's disease (indolent vs progressive)	Crohn's disease (indolent vs progressive)	Digestive system disorder
1259	GCST007499	Crohn's disease (indolent vs progressive)	Crohn's disease (indolent vs progressive)	Other measurement
1260	GCST007999	Heart rate in heart failure with reduced ejection fraction	Heart rate in heart failure with reduced ejection fraction	Other trait
1261	GCST007999	Heart rate in heart failure with reduced ejection fraction	Heart rate in heart failure with reduced ejection fraction	Cardiovascular measurement
1262	GCST007999	Heart rate in heart failure with reduced ejection fraction	Heart rate in heart failure with reduced ejection fraction	Cardiovascular disease
1263	GCST008482	Lung function (FVC)	Lung function (FVC)	Other measurement
1264	GCST008481	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
1265	GCST008480	Lung function (FEV1)	Lung function (FEV1)	Other measurement
1266	GCST007689	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1267	GCST007701	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1268	GCST007702	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
1269	GCST007688	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
1270	GCST008262	Psychological wellbeing index 1 (lack of subjective wellbeing and health)	Psychological wellbeing index 1 (lack of subjective wellbeing and health)	Other measurement
1271	GCST008263	Psychological wellbeing index 3 (fatigue and loss of appetite)	Psychological wellbeing index 3 (fatigue and loss of appetite)	Other measurement
1272	GCST008264	Psychological wellbeing index 12 (lack of enjoying daily life)	Psychological wellbeing index 12 (lack of enjoying daily life)	Other measurement
1273	GCST008265	Psychological wellbeing (social role performance and self-confidence)	Psychological wellbeing (social role performance and self-confidence)	Other measurement
1274	GCST008261	Psychological wellbeing (depressiveness)	Psychological wellbeing (depressiveness)	Other measurement
1275	GCST008266	Psychological wellbeing (health and vitality)	Psychological wellbeing (health and vitality)	Other measurement
1276	GCST008267	Psychological wellbeing index (total score)	Psychological wellbeing index (total score)	Other measurement
1277	GCST007731	Postoperative survival time in hepatocellular carcinoma	Postoperative survival time in hepatocellular carcinoma	Other measurement
1278	GCST007731	Postoperative survival time in hepatocellular carcinoma	Postoperative survival time in hepatocellular carcinoma	Cancer
1279	GCST007686	Plasma norclozapine levels in treatment-resistant schizophrenia	Plasma norclozapine levels in treatment-resistant schizophrenia	Response to drug
1280	GCST007686	Plasma norclozapine levels in treatment-resistant schizophrenia	Plasma norclozapine levels in treatment-resistant schizophrenia	Neurological disorder
1281	GCST007684	Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	Response to drug
1282	GCST007684	Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	Neurological disorder
1283	GCST007685	Plasma clozapine levels in treatment-resistant schizophrenia	Plasma clozapine levels in treatment-resistant schizophrenia	Response to drug
1284	GCST007685	Plasma clozapine levels in treatment-resistant schizophrenia	Plasma clozapine levels in treatment-resistant schizophrenia	Neurological disorder
1285	GCST007833	Urolithiasis	Urolithiasis	Other disease
1286	GCST008488	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	Other disease
1287	GCST008488	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	Other measurement
1288	GCST007064	Body fat percentage	Body fat percentage	Body measurement
1289	GCST007063	Fat-free mass	Fat-free mass	Other measurement
1290	GCST007692	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
1291	GCST007744	Hyperglycemia	Hyperglycemia	Other measurement
1292	GCST007745	Hyperglycemia in obesity	Hyperglycemia in obesity	Metabolic disorder
1293	GCST007745	Hyperglycemia in obesity	Hyperglycemia in obesity	Other measurement
1294	GCST007746	Hyperglycemia in non-obese individuals	Hyperglycemia in non-obese individuals	Other measurement
1295	GCST007747	Hyperglycemia in lower physical activity	Hyperglycemia in lower physical activity	Other measurement
1296	GCST007747	Hyperglycemia in lower physical activity	Hyperglycemia in lower physical activity	Other measurement
1297	GCST007748	Hyperglycemia in higher physical activity	Hyperglycemia in higher physical activity	Other measurement
1298	GCST007748	Hyperglycemia in higher physical activity	Hyperglycemia in higher physical activity	Other measurement
1299	GCST007749	Hyperglycemia in more-fat diet	Hyperglycemia in more-fat diet	Lipid or lipoprotein measurement
1300	GCST007749	Hyperglycemia in more-fat diet	Hyperglycemia in more-fat diet	Other measurement
1301	GCST007750	Hyperglycemia in less-fat diet	Hyperglycemia in less-fat diet	Lipid or lipoprotein measurement
1302	GCST007750	Hyperglycemia in less-fat diet	Hyperglycemia in less-fat diet	Other measurement
1303	GCST007751	Homeostasis model assessment of insulin resistance in obesity	Homeostasis model assessment of insulin resistance in obesity	Metabolic disorder
1304	GCST007751	Homeostasis model assessment of insulin resistance in obesity	Homeostasis model assessment of insulin resistance in obesity	Other trait
1305	GCST007752	Homeostasis model assessment of insulin resistance in non-obese individuals	Homeostasis model assessment of insulin resistance in non-obese individuals	Other trait
1306	GCST007753	Homeostasis model assessment of insulin resistance in higher physical activity	Homeostasis model assessment of insulin resistance in higher physical activity	Other measurement
1307	GCST007753	Homeostasis model assessment of insulin resistance in higher physical activity	Homeostasis model assessment of insulin resistance in higher physical activity	Other trait
1308	GCST007754	Homeostasis model assessment of insulin resistance in lower physical activity	Homeostasis model assessment of insulin resistance in lower physical activity	Other measurement
1309	GCST007754	Homeostasis model assessment of insulin resistance in lower physical activity	Homeostasis model assessment of insulin resistance in lower physical activity	Other trait
1310	GCST007755	Homeostasis model assessment of insulin resistance in more-fat diet	Homeostasis model assessment of insulin resistance in more-fat diet	Lipid or lipoprotein measurement
1311	GCST007755	Homeostasis model assessment of insulin resistance in more-fat diet	Homeostasis model assessment of insulin resistance in more-fat diet	Other trait
1312	GCST007756	Homeostasis model assessment of insulin resistance in less-fat diet	Homeostasis model assessment of insulin resistance in less-fat diet	Lipid or lipoprotein measurement
1313	GCST007756	Homeostasis model assessment of insulin resistance in less-fat diet	Homeostasis model assessment of insulin resistance in less-fat diet	Other trait
1314	GCST007757	Hyperglycemia x BMI interaction	Hyperglycemia x BMI interaction	Body measurement
1315	GCST007757	Hyperglycemia x BMI interaction	Hyperglycemia x BMI interaction	Other measurement
1316	GCST007758	Hyperglycemia x physical activity interaction	Hyperglycemia x physical activity interaction	Other measurement
1317	GCST007758	Hyperglycemia x physical activity interaction	Hyperglycemia x physical activity interaction	Other measurement
1318	GCST007759	Hyperglycemia x saturated fatty acids interaction	Hyperglycemia x saturated fatty acids interaction	Lipid or lipoprotein measurement
1319	GCST007759	Hyperglycemia x saturated fatty acids interaction	Hyperglycemia x saturated fatty acids interaction	Other measurement
1320	GCST007760	Hyperinsulinemia	Hyperinsulinemia	Other measurement
1321	GCST007761	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other measurement
1322	GCST007761	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other trait
1323	GCST007762	Hyperinsulinemia x BMI interaction	Hyperinsulinemia x BMI interaction	Body measurement
1324	GCST007762	Hyperinsulinemia x BMI interaction	Hyperinsulinemia x BMI interaction	Other measurement
1325	GCST007763	Homeostasis model assessment of insulin resistance x BMI interaction	Homeostasis model assessment of insulin resistance x BMI interaction	Body measurement
1326	GCST007763	Homeostasis model assessment of insulin resistance x BMI interaction	Homeostasis model assessment of insulin resistance x BMI interaction	Other trait
1327	GCST007764	Hyperinsulinemia x physical activity interaction	Hyperinsulinemia x physical activity interaction	Other measurement
1328	GCST007764	Hyperinsulinemia x physical activity interaction	Hyperinsulinemia x physical activity interaction	Other measurement
1329	GCST007765	Homeostasis model assessment of insulin resistance x physical activity interaction	Homeostasis model assessment of insulin resistance x physical activity interaction	Other measurement
1330	GCST007765	Homeostasis model assessment of insulin resistance x physical activity interaction	Homeostasis model assessment of insulin resistance x physical activity interaction	Other trait
1331	GCST007766	Hyperinsulinemia x saturated fatty acids interaction	Hyperinsulinemia x saturated fatty acids interaction	Lipid or lipoprotein measurement
1332	GCST007766	Hyperinsulinemia x saturated fatty acids interaction	Hyperinsulinemia x saturated fatty acids interaction	Other measurement
1333	GCST007767	Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	Lipid or lipoprotein measurement
1334	GCST007767	Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	Other trait
1335	GCST007768	Hyperinsulinemia in obesity	Hyperinsulinemia in obesity	Metabolic disorder
1336	GCST007768	Hyperinsulinemia in obesity	Hyperinsulinemia in obesity	Other measurement
1337	GCST007769	Hyperinsulinemia in non-obese individuals	Hyperinsulinemia in non-obese individuals	Other measurement
1338	GCST007770	Hyperinsulinemia in higher physical activity	Hyperinsulinemia in higher physical activity	Other measurement
1339	GCST007770	Hyperinsulinemia in higher physical activity	Hyperinsulinemia in higher physical activity	Other measurement
1340	GCST007771	Hyperinsulinemia in lower physical activity	Hyperinsulinemia in lower physical activity	Other measurement
1341	GCST007771	Hyperinsulinemia in lower physical activity	Hyperinsulinemia in lower physical activity	Other measurement
1342	GCST007772	Hyperinsulinemia in more-fat diet	Hyperinsulinemia in more-fat diet	Lipid or lipoprotein measurement
1343	GCST007772	Hyperinsulinemia in more-fat diet	Hyperinsulinemia in more-fat diet	Other measurement
1344	GCST007773	Hyperinsulinemia in less-fat diet	Hyperinsulinemia in less-fat diet	Lipid or lipoprotein measurement
1345	GCST007773	Hyperinsulinemia in less-fat diet	Hyperinsulinemia in less-fat diet	Other measurement
1346	GCST007342	Depression	Depression	Neurological disorder
1347	GCST007342	Depression	Depression	Other measurement
1348	GCST007824	Monoclonal gammopathy of undetermined significance	Monoclonal gammopathy of undetermined significance	Other disease
1349	GCST007703	Systolic blood pressure	Systolic blood pressure	Other measurement
1350	GCST007703	Systolic blood pressure	Systolic blood pressure	Other measurement
1351	GCST007704	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1352	GCST007704	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1353	GCST007705	Pulse pressure	Pulse pressure	Cardiovascular measurement
1354	GCST007706	Mean arterial pressure	Mean arterial pressure	Other measurement
1355	GCST007707	Hypertension	Hypertension	Cardiovascular disease
1356	GCST007839	Mouth ulcers	Mouth ulcers	Other trait
1357	GCST007694	executive function (trail making test B)	executive function (trail making test B)	Other measurement
1358	GCST007695	perceptual and visual search speed and executive function (trail making test BA)	perceptual and visual search speed and executive function (trail making test BA)	Other measurement
1359	GCST007695	perceptual and visual search speed and executive function (trail making test BA)	perceptual and visual search speed and executive function (trail making test BA)	Biological process
1360	GCST007696	perceptual and visual search speed (trail making test A) (age interaction)	perceptual and visual search speed (trail making test A) (age interaction)	Biological process
1361	GCST007697	executive function (trail making test B) (age interaction)	executive function (trail making test B) (age interaction)	Other measurement
1362	GCST007698	perceptual and visual search speed and executive function (trail making test BA) (age interaction)	perceptual and visual search speed and executive function (trail making test BA) (age interaction)	Other measurement
1363	GCST007698	perceptual and visual search speed and executive function (trail making test BA) (age interaction)	perceptual and visual search speed and executive function (trail making test BA) (age interaction)	Biological process
1364	GCST007693	perceptual and visual search speed (trail making test A)	perceptual and visual search speed (trail making test A)	Biological process
1365	GCST007708	Worry/vulnerability (special factor of neuroticism)	Worry/vulnerability (special factor of neuroticism)	Other measurement
1366	GCST007710	Anxiety/tension (special factor of neuroticism)	Anxiety/tension (special factor of neuroticism)	Other measurement
1367	GCST007709	General factor of neuroticism	General factor of neuroticism	Other measurement
1368	GCST008176	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
1369	GCST008176	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
1370	GCST008177	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other measurement
1371	GCST008177	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other trait
1372	GCST008178	Early spontaneous preterm birth	Early spontaneous preterm birth	Other trait
1373	GCST008179	Moderate-to-late spontaneous preterm birth	Moderate-to-late spontaneous preterm birth	Other trait
1374	GCST008180	Spontaneous preterm birth with premature rupture of membranes	Spontaneous preterm birth with premature rupture of membranes	Other trait
1375	GCST008180	Spontaneous preterm birth with premature rupture of membranes	Spontaneous preterm birth with premature rupture of membranes	Other disease
1376	GCST008181	Spontaneous preterm birth without premature rupture of membranes	Spontaneous preterm birth without premature rupture of membranes	Other trait
1377	GCST008478	Neurological blood protein biomarker levels	Neurological blood protein biomarker levels	Other measurement
1378	GCST007844	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
1379	GCST008398	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
1380	GCST008706	Cerebrospinal fluid sTREM-2 levels	Cerebrospinal fluid sTREM-2 levels	Other measurement
1381	GCST007280	Number of twin births	Number of twin births	Other measurement
1382	GCST008487	Coffee consumption	Coffee consumption	Biological process
1383	GCST008487	Coffee consumption	Coffee consumption	Other measurement
1384	GCST008487	Coffee consumption	Coffee consumption	Other measurement
1385	GCST008025	Body mass index	Body mass index	Body measurement
1386	GCST008025	Body mass index	Body mass index	Body measurement
1387	GCST008025	Body mass index	Body mass index	Other measurement
1388	GCST008026	Chronic kidney disease	Chronic kidney disease	Other disease
1389	GCST008026	Chronic kidney disease	Chronic kidney disease	Other measurement
1390	GCST008026	Chronic kidney disease	Chronic kidney disease	Other measurement
1391	GCST008027	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
1392	GCST008028	Coffee consumption (cups per day)	Coffee consumption (cups per day)	Biological process
1393	GCST008028	Coffee consumption (cups per day)	Coffee consumption (cups per day)	Other measurement
1394	GCST008029	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1395	GCST008029	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1396	GCST008030	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
1397	GCST008031	End-stage renal disease	End-stage renal disease	Other disease
1398	GCST008032	Fasting blood glucose	Fasting blood glucose	Other measurement
1399	GCST008033	Fasting blood insulin	Fasting blood insulin	Other measurement
1400	GCST008034	Hemoglobin A1c levels	Hemoglobin A1c levels	Other measurement
1401	GCST008034	Hemoglobin A1c levels	Hemoglobin A1c levels	Hematological measurement
1402	GCST008035	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1403	GCST008036	Hypertension	Hypertension	Cardiovascular disease
1404	GCST008037	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1405	GCST008038	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
1406	GCST008038	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
1407	GCST008039	Platelet count	Platelet count	Hematological measurement
1408	GCST008042	PR interval	PR interval	Cardiovascular measurement
1409	GCST008043	QT interval	QT interval	Cardiovascular measurement
1410	GCST008044	Systolic blood pressure	Systolic blood pressure	Other measurement
1411	GCST008044	Systolic blood pressure	Systolic blood pressure	Other measurement
1412	GCST008045	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
1413	GCST008046	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
1414	GCST008048	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1415	GCST008049	White blood cell count	White blood cell count	Hematological measurement
1416	GCST008049	White blood cell count	White blood cell count	Inflammatory measurement
1417	GCST008049	White blood cell count	White blood cell count	Hematological measurement
1418	GCST008049	White blood cell count	White blood cell count	Hematological measurement
1419	GCST008049	White blood cell count	White blood cell count	Hematological measurement
1420	GCST008050	Waist-hip ratio	Waist-hip ratio	Other measurement
1421	GCST008050	Waist-hip ratio	Waist-hip ratio	Body measurement
1422	GCST008051	Waist-hip ratio	Waist-hip ratio	Other measurement
1423	GCST008051	Waist-hip ratio	Waist-hip ratio	Body measurement
1424	GCST008052	Waist-hip ratio	Waist-hip ratio	Other measurement
1425	GCST008052	Waist-hip ratio	Waist-hip ratio	Body measurement
1426	GCST008053	Height	Height	Other measurement
1427	GCST008053	Height	Height	Body measurement
1428	GCST008040	Height	Height	Other measurement
1429	GCST008040	Height	Height	Body measurement
1430	GCST008041	Height	Height	Other measurement
1431	GCST008041	Height	Height	Body measurement
1432	GCST008054	QRS duration	QRS duration	Cardiovascular measurement
1433	GCST008054	QRS duration	QRS duration	Cardiovascular measurement
1434	GCST008054	QRS duration	QRS duration	Cardiovascular measurement
1435	GCST008055	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
1436	GCST007988	Insomnia	Insomnia	Neurological disorder
1437	GCST007988	Insomnia	Insomnia	Other measurement
1438	GCST007987	Daytime nap	Daytime nap	Other measurement
1439	GCST007983	Morningness	Morningness	Other measurement
1440	GCST007982	Sleep duration	Sleep duration	Other measurement
1441	GCST007986	Ease of getting up in the morning	Ease of getting up in the morning	Other measurement
1442	GCST007984	Daytime sleepiness	Daytime sleepiness	Other measurement
1443	GCST007985	Snoring	Snoring	Other measurement
1444	GCST007293	Body fat distribution (arm fat ratio)	Body fat distribution (arm fat ratio)	Body measurement
1445	GCST007295	Body fat distribution (leg fat ratio)	Body fat distribution (leg fat ratio)	Body measurement
1446	GCST007294	Body fat distribution (trunk fat ratio)	Body fat distribution (trunk fat ratio)	Body measurement
1447	GCST007556	Autism spectrum disorder	Autism spectrum disorder	Neurological disorder
1448	GCST007553	Autism and major depressive disorder (MTAG)	Autism and major depressive disorder (MTAG)	Neurological disorder
1449	GCST007553	Autism and major depressive disorder (MTAG)	Autism and major depressive disorder (MTAG)	Neurological disorder
1450	GCST007555	Autism and schizophrenia (MTAG)	Autism and schizophrenia (MTAG)	Neurological disorder
1451	GCST007555	Autism and schizophrenia (MTAG)	Autism and schizophrenia (MTAG)	Neurological disorder
1452	GCST007554	Autism and educational attainment (MTAG)	Autism and educational attainment (MTAG)	Other measurement
1453	GCST007554	Autism and educational attainment (MTAG)	Autism and educational attainment (MTAG)	Neurological disorder
1454	GCST008444	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1455	GCST007445	Factor VIII levels	Factor VIII levels	Hematological measurement
1456	GCST007446	vWF levels	vWF levels	Hematological measurement
1457	GCST007447	vWF and FVIII levels	vWF and FVIII levels	Hematological measurement
1458	GCST007447	vWF and FVIII levels	vWF and FVIII levels	Other measurement
1459	GCST007447	vWF and FVIII levels	vWF and FVIII levels	Hematological measurement
1460	GCST006228	Systolic blood pressure	Systolic blood pressure	Other measurement
1461	GCST006228	Systolic blood pressure	Systolic blood pressure	Other measurement
1462	GCST006231	Mean arterial pressure	Mean arterial pressure	Other measurement
1463	GCST006227	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1464	GCST006227	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1465	GCST006230	Pulse pressure	Pulse pressure	Cardiovascular measurement
1466	GCST006229	Hypertension	Hypertension	Cardiovascular disease
1467	GCST004781	Sulfasalazine-induced agranulocytosis	Sulfasalazine-induced agranulocytosis	Other trait
1468	GCST004781	Sulfasalazine-induced agranulocytosis	Sulfasalazine-induced agranulocytosis	Response to drug
1469	GCST004137	Optic cup area	Optic cup area	Other measurement
1470	GCST004075	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
1471	GCST004075	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
1472	GCST004076	Optic disc area	Optic disc area	Other measurement
1473	GCST004076	Optic disc area	Optic disc area	Other measurement
1474	GCST004074	Intraocular pressure	Intraocular pressure	Other measurement
1475	GCST006200	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
1476	GCST006200	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Other trait
1477	GCST006200	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
1478	GCST006201	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Digestive system disorder
1479	GCST006201	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Other trait
1480	GCST006201	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Response to drug
1481	GCST006202	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
1482	GCST006202	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Other trait
1483	GCST006202	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
1484	GCST006204	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Digestive system disorder
1485	GCST006204	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Other trait
1486	GCST006204	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Response to drug
1487	GCST006205	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Digestive system disorder
1488	GCST006205	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Other trait
1489	GCST006205	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Response to drug
1490	GCST006206	Thiopurine-induced alopecia in inflammatory bowel disease	Thiopurine-induced alopecia in inflammatory bowel disease	Digestive system disorder
1491	GCST006206	Thiopurine-induced alopecia in inflammatory bowel disease	Thiopurine-induced alopecia in inflammatory bowel disease	Other disease
1492	GCST006206	Thiopurine-induced alopecia in inflammatory bowel disease	Thiopurine-induced alopecia in inflammatory bowel disease	Response to drug
1493	GCST006207	Thiopurine-induced severe alopecia in inflammatory bowel disease	Thiopurine-induced severe alopecia in inflammatory bowel disease	Digestive system disorder
1494	GCST006207	Thiopurine-induced severe alopecia in inflammatory bowel disease	Thiopurine-induced severe alopecia in inflammatory bowel disease	Other disease
1495	GCST006207	Thiopurine-induced severe alopecia in inflammatory bowel disease	Thiopurine-induced severe alopecia in inflammatory bowel disease	Response to drug
1496	GCST006208	Thiopurine-induced pancreatitis in inflammatory bowel disease	Thiopurine-induced pancreatitis in inflammatory bowel disease	Digestive system disorder
1497	GCST006208	Thiopurine-induced pancreatitis in inflammatory bowel disease	Thiopurine-induced pancreatitis in inflammatory bowel disease	Digestive system disorder
1498	GCST006208	Thiopurine-induced pancreatitis in inflammatory bowel disease	Thiopurine-induced pancreatitis in inflammatory bowel disease	Response to drug
1499	GCST006209	Thiopurine-induced fever in inflammatory bowel disease	Thiopurine-induced fever in inflammatory bowel disease	Other trait
1500	GCST006209	Thiopurine-induced fever in inflammatory bowel disease	Thiopurine-induced fever in inflammatory bowel disease	Digestive system disorder
1501	GCST006209	Thiopurine-induced fever in inflammatory bowel disease	Thiopurine-induced fever in inflammatory bowel disease	Response to drug
1502	GCST006210	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Digestive system disorder
1503	GCST006210	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Response to drug
1504	GCST006210	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Other disease
1505	GCST006211	Thiopurine-induced infection in inflammatory bowel disease	Thiopurine-induced infection in inflammatory bowel disease	Digestive system disorder
1506	GCST006211	Thiopurine-induced infection in inflammatory bowel disease	Thiopurine-induced infection in inflammatory bowel disease	Response to drug
1507	GCST006211	Thiopurine-induced infection in inflammatory bowel disease	Thiopurine-induced infection in inflammatory bowel disease	Other measurement
1508	GCST006212	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Digestive system disorder
1509	GCST006212	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Response to drug
1510	GCST006212	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Digestive system disorder
1511	GCST006213	Thiopurine-induced skin symptoms in inflammatory bowel disease	Thiopurine-induced skin symptoms in inflammatory bowel disease	Other disease
1512	GCST006213	Thiopurine-induced skin symptoms in inflammatory bowel disease	Thiopurine-induced skin symptoms in inflammatory bowel disease	Digestive system disorder
1513	GCST006213	Thiopurine-induced skin symptoms in inflammatory bowel disease	Thiopurine-induced skin symptoms in inflammatory bowel disease	Response to drug
1514	GCST006214	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
1515	GCST006214	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Other disease
1516	GCST006214	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
1517	GCST006215	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
1518	GCST006215	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Other trait
1519	GCST006215	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
1520	GCST006199	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
1521	GCST006199	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Other disease
1522	GCST006199	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
1523	GCST006397	Relative amplitude of rest-activity cycles	Relative amplitude of rest-activity cycles	Biological process
1524	GCST006396	Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	Biological process
1525	GCST005556	Pollinosis	Pollinosis	Immune system disorder
1526	GCST005194	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1527	GCST005194	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1528	GCST005195	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1529	GCST005195	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1530	GCST005196	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1531	GCST005196	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1532	GCST005076	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
1533	GCST005076	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
1534	GCST005077	Breast cancer	Breast cancer	Cancer
1535	GCST005075	Breast Cancer in BRCA1 mutation carriers	Breast Cancer in BRCA1 mutation carriers	Cancer
1536	GCST005075	Breast Cancer in BRCA1 mutation carriers	Breast Cancer in BRCA1 mutation carriers	Other measurement
1537	GCST006368	Body mass index	Body mass index	Body measurement
1538	GCST006368	Body mass index	Body mass index	Body measurement
1539	GCST006368	Body mass index	Body mass index	Other measurement
1540	GCST008583	Cognitive performance (processing speed) x major depressive disorder status interaction	Cognitive performance (processing speed) x major depressive disorder status interaction	Neurological disorder
1541	GCST008583	Cognitive performance (processing speed) x major depressive disorder status interaction	Cognitive performance (processing speed) x major depressive disorder status interaction	Biological process
1542	GCST008583	Cognitive performance (processing speed) x major depressive disorder status interaction	Cognitive performance (processing speed) x major depressive disorder status interaction	Other measurement
1543	GCST008584	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Other measurement
1544	GCST008584	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Neurological disorder
1545	GCST008584	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Other measurement
1546	GCST008585	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Other measurement
1547	GCST008585	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Neurological disorder
1548	GCST008585	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Other measurement
1549	GCST008586	Cognitive performance (processing speed) x major depressive disorder type interaction	Cognitive performance (processing speed) x major depressive disorder type interaction	Neurological disorder
1550	GCST008586	Cognitive performance (processing speed) x major depressive disorder type interaction	Cognitive performance (processing speed) x major depressive disorder type interaction	Biological process
1551	GCST008586	Cognitive performance (processing speed) x major depressive disorder type interaction	Cognitive performance (processing speed) x major depressive disorder type interaction	Other measurement
1552	GCST008587	Cognitive performance (language ability)	Cognitive performance (language ability)	Other measurement
1553	GCST008587	Cognitive performance (language ability)	Cognitive performance (language ability)	Other measurement
1554	GCST008588	Cognitive performance (language ability)	Cognitive performance (language ability)	Other measurement
1555	GCST008588	Cognitive performance (language ability)	Cognitive performance (language ability)	Other measurement
1556	GCST008589	Cognitive performance (processing speed) in major depressive disorder	Cognitive performance (processing speed) in major depressive disorder	Neurological disorder
1557	GCST008589	Cognitive performance (processing speed) in major depressive disorder	Cognitive performance (processing speed) in major depressive disorder	Biological process
1558	GCST008589	Cognitive performance (processing speed) in major depressive disorder	Cognitive performance (processing speed) in major depressive disorder	Other measurement
1559	GCST008590	Cognitive performance (processing speed)	Cognitive performance (processing speed)	Biological process
1560	GCST008590	Cognitive performance (processing speed)	Cognitive performance (processing speed)	Other measurement
1561	GCST007216	Crohn's disease	Crohn's disease	Digestive system disorder
1562	GCST007358	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Response to drug
1563	GCST007358	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Cancer
1564	GCST007358	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Other measurement
1565	GCST006430	Body mass index and waist-hip ratio (pleiotropy)	Body mass index and waist-hip ratio (pleiotropy)	Body measurement
1566	GCST006430	Body mass index and waist-hip ratio (pleiotropy)	Body mass index and waist-hip ratio (pleiotropy)	Body measurement
1567	GCST004824	P wave terminal force	P wave terminal force	Cardiovascular measurement
1568	GCST004826	P wave duration	P wave duration	Cardiovascular measurement
1569	GCST008839	Height	Height	Other measurement
1570	GCST008839	Height	Height	Body measurement
1571	GCST005240	Caudate volume in trauma-exposed individuals	Caudate volume in trauma-exposed individuals	Biological process
1572	GCST005240	Caudate volume in trauma-exposed individuals	Caudate volume in trauma-exposed individuals	Other measurement
1573	GCST005241	Nucleus accumbens volume in trauma-exposed individuals	Nucleus accumbens volume in trauma-exposed individuals	Other measurement
1574	GCST005241	Nucleus accumbens volume in trauma-exposed individuals	Nucleus accumbens volume in trauma-exposed individuals	Biological process
1575	GCST005242	Pallidum volume in trauma-exposed individuals	Pallidum volume in trauma-exposed individuals	Other measurement
1576	GCST005242	Pallidum volume in trauma-exposed individuals	Pallidum volume in trauma-exposed individuals	Biological process
1577	GCST005239	Amygdala volume in trauma-exposed individuals	Amygdala volume in trauma-exposed individuals	Other measurement
1578	GCST005239	Amygdala volume in trauma-exposed individuals	Amygdala volume in trauma-exposed individuals	Biological process
1579	GCST005243	Hippocampal volume in trauma-exposed individuals	Hippocampal volume in trauma-exposed individuals	Other measurement
1580	GCST005243	Hippocampal volume in trauma-exposed individuals	Hippocampal volume in trauma-exposed individuals	Biological process
1581	GCST005244	Putamen volume in trauma-exposed individuals	Putamen volume in trauma-exposed individuals	Other measurement
1582	GCST005244	Putamen volume in trauma-exposed individuals	Putamen volume in trauma-exposed individuals	Biological process
1583	GCST005286	Lateral ventricle volume in trauma-exposed individuals	Lateral ventricle volume in trauma-exposed individuals	Biological process
1584	GCST005286	Lateral ventricle volume in trauma-exposed individuals	Lateral ventricle volume in trauma-exposed individuals	Other measurement
1585	GCST005245	Thalamus volume in trauma-exposed individuals	Thalamus volume in trauma-exposed individuals	Other measurement
1586	GCST005245	Thalamus volume in trauma-exposed individuals	Thalamus volume in trauma-exposed individuals	Biological process
1587	GCST004576	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
1588	GCST004576	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
1589	GCST004561	Waist circumference adjusted for BMI (physical activity interaction)	Waist circumference adjusted for BMI (physical activity interaction)	Body measurement
1590	GCST004561	Waist circumference adjusted for BMI (physical activity interaction)	Waist circumference adjusted for BMI (physical activity interaction)	Other measurement
1591	GCST004565	Waist circumference adjusted for BMI in inactive individuals	Waist circumference adjusted for BMI in inactive individuals	Body measurement
1592	GCST004565	Waist circumference adjusted for BMI in inactive individuals	Waist circumference adjusted for BMI in inactive individuals	Other measurement
1593	GCST004558	Body mass index (joint analysis main effects and physical activity interaction)	Body mass index (joint analysis main effects and physical activity interaction)	Body measurement
1594	GCST004558	Body mass index (joint analysis main effects and physical activity interaction)	Body mass index (joint analysis main effects and physical activity interaction)	Other measurement
1595	GCST004567	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	Body measurement
1596	GCST004567	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	Other measurement
1597	GCST004557	Body mass index	Body mass index	Body measurement
1598	GCST004557	Body mass index	Body mass index	Body measurement
1599	GCST004557	Body mass index	Body mass index	Other measurement
1600	GCST004562	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
1601	GCST004562	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
1602	GCST004566	Waist-to-hip ratio adjusted for BMI (physical activity interaction)	Waist-to-hip ratio adjusted for BMI (physical activity interaction)	Body measurement
1603	GCST004566	Waist-to-hip ratio adjusted for BMI (physical activity interaction)	Waist-to-hip ratio adjusted for BMI (physical activity interaction)	Other measurement
1604	GCST004568	Body mass index (physical activity interaction)	Body mass index (physical activity interaction)	Body measurement
1605	GCST004568	Body mass index (physical activity interaction)	Body mass index (physical activity interaction)	Other measurement
1606	GCST004568	Body mass index (physical activity interaction)	Body mass index (physical activity interaction)	Biological process
1607	GCST004563	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	Body measurement
1608	GCST004563	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	Other measurement
1609	GCST004559	Body mass index in physically active individuals	Body mass index in physically active individuals	Body measurement
1610	GCST004559	Body mass index in physically active individuals	Body mass index in physically active individuals	Other measurement
1611	GCST004560	Body mass index in physically inactive individuals	Body mass index in physically inactive individuals	Body measurement
1612	GCST004560	Body mass index in physically inactive individuals	Body mass index in physically inactive individuals	Other measurement
1613	GCST004564	Waist circumference adjusted for BMI in active individuals	Waist circumference adjusted for BMI in active individuals	Body measurement
1614	GCST004564	Waist circumference adjusted for BMI in active individuals	Waist circumference adjusted for BMI in active individuals	Other measurement
1615	GCST004578	Waist-to-hip ratio adjusted for BMI in active individuals	Waist-to-hip ratio adjusted for BMI in active individuals	Body measurement
1616	GCST004578	Waist-to-hip ratio adjusted for BMI in active individuals	Waist-to-hip ratio adjusted for BMI in active individuals	Other measurement
1617	GCST004577	Waist-to-hip ratio adjusted for BMI in inactive individuals	Waist-to-hip ratio adjusted for BMI in inactive individuals	Body measurement
1618	GCST004577	Waist-to-hip ratio adjusted for BMI in inactive individuals	Waist-to-hip ratio adjusted for BMI in inactive individuals	Other measurement
1619	GCST004328	Facial morphology (factor 1, breadth of lateral portion of upper face)	Facial morphology (factor 1, breadth of lateral portion of upper face)	Other measurement
1620	GCST004314	Facial morphology (factor 10, width of nasal floor)	Facial morphology (factor 10, width of nasal floor)	Other measurement
1621	GCST004307	Facial morphology (factor 3, length of philtrum)	Facial morphology (factor 3, length of philtrum)	Other measurement
1622	GCST004319	Facial morphology (factor 15, philtrum width)	Facial morphology (factor 15, philtrum width)	Other measurement
1623	GCST004320	Facial morphology (factor 16)	Facial morphology (factor 16)	Other measurement
1624	GCST004321	Facial morphology (factor 17, height of vermillion upper lip)	Facial morphology (factor 17, height of vermillion upper lip)	Other measurement
1625	GCST004322	Facial morphology (factor 18)	Facial morphology (factor 18)	Other measurement
1626	GCST004323	Facial morphology (factor 19)	Facial morphology (factor 19)	Other measurement
1627	GCST004324	Facial morphology (factor 20)	Facial morphology (factor 20)	Other measurement
1628	GCST004306	Facial morphology (factor 2, vertical position of orbits relative to midface)	Facial morphology (factor 2, vertical position of orbits relative to midface)	Other measurement
1629	GCST004308	Facial morphology (factor 4, facial height related to vertical position of gnathion)	Facial morphology (factor 4, facial height related to vertical position of gnathion)	Other measurement
1630	GCST004309	Facial morphology (factor 5, width of mouth relative to central midface)	Facial morphology (factor 5, width of mouth relative to central midface)	Other measurement
1631	GCST004310	Facial morphology (factor 6, height of vermillion lower lip)	Facial morphology (factor 6, height of vermillion lower lip)	Other measurement
1632	GCST004311	Facial morphology (factor 7, width of cartilaginous portion of nose)	Facial morphology (factor 7, width of cartilaginous portion of nose)	Other measurement
1633	GCST004312	Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)	Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)	Other measurement
1634	GCST004313	Facial morphology (factor 9, facial height related to vertical position of nasion)	Facial morphology (factor 9, facial height related to vertical position of nasion)	Other measurement
1635	GCST004315	Facial morphology (factor 11, projection of the nose)	Facial morphology (factor 11, projection of the nose)	Other measurement
1636	GCST004316	Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)	Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)	Other measurement
1637	GCST004317	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	Other measurement
1638	GCST004317	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	Other measurement
1639	GCST004318	Facial morphology (factor 14, intercanthal width)	Facial morphology (factor 14, intercanthal width)	Other measurement
1640	GCST004325	Facial morphology (factor 21, depth of nasal alae)	Facial morphology (factor 21, depth of nasal alae)	Other measurement
1641	GCST004326	Facial morphology (factor 22)	Facial morphology (factor 22)	Other measurement
1642	GCST004327	Facial morphology (factor 23)	Facial morphology (factor 23)	Other measurement
1643	GCST006804	Red cell distribution width	Red cell distribution width	Hematological measurement
1644	GCST008151	Waist circumference	Waist circumference	Body measurement
1645	GCST008152	Weight	Weight	Body measurement
1646	GCST008153	Lean body mass	Lean body mass	Other measurement
1647	GCST008154	Trunk fat mass	Trunk fat mass	Other measurement
1648	GCST008155	Waist-hip ratio	Waist-hip ratio	Other measurement
1649	GCST008155	Waist-hip ratio	Waist-hip ratio	Body measurement
1650	GCST008156	Hip circumference adjusted for BMI	Hip circumference adjusted for BMI	Body measurement
1651	GCST008163	Height	Height	Other measurement
1652	GCST008163	Height	Height	Body measurement
1653	GCST008157	Body fat mass	Body fat mass	Other measurement
1654	GCST008158	Body mass index	Body mass index	Body measurement
1655	GCST008158	Body mass index	Body mass index	Body measurement
1656	GCST008158	Body mass index	Body mass index	Other measurement
1657	GCST008159	Waist-to-hip ratio adjusted for BMI	Waist-to-hip ratio adjusted for BMI	Body measurement
1658	GCST008161	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
1659	GCST008161	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
1660	GCST008160	Waist circumference	Waist circumference	Body measurement
1661	GCST008162	Hip circumference	Hip circumference	Body measurement
1662	GCST005348	Total body bone mineral density	Total body bone mineral density	Other measurement
1663	GCST005345	Total body bone mineral density (age 0-15)	Total body bone mineral density (age 0-15)	Other measurement
1664	GCST005344	Total body bone mineral density (age 15-30)	Total body bone mineral density (age 15-30)	Other measurement
1665	GCST005346	Total body bone mineral density (age 30-45)	Total body bone mineral density (age 30-45)	Other measurement
1666	GCST005350	Total body bone mineral density (age 45-60)	Total body bone mineral density (age 45-60)	Other measurement
1667	GCST005349	Total body bone mineral density (age over 60)	Total body bone mineral density (age over 60)	Other measurement
1668	GCST005647	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
1669	GCST006108	Facial morphology	Facial morphology	Other trait
1670	GCST006108	Facial morphology	Facial morphology	Other measurement
1671	GCST006106	Forehead morphology	Forehead morphology	Other measurement
1672	GCST006105	Eye morphology	Eye morphology	Other measurement
1673	GCST006110	Nose morphology	Nose morphology	Other measurement
1674	GCST006109	Lip morphology	Lip morphology	Other measurement
1675	GCST006107	Upper eyelid morphology	Upper eyelid morphology	Other measurement
1676	GCST007458	Age of smoking initiation	Age of smoking initiation	Biological process
1677	GCST007458	Age of smoking initiation	Age of smoking initiation	Other measurement
1678	GCST007459	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
1679	GCST007460	Smoking cessation	Smoking cessation	Biological process
1680	GCST007474	Smoking initiation (ever regular vs never regular)	Smoking initiation (ever regular vs never regular)	Other measurement
1681	GCST007474	Smoking initiation (ever regular vs never regular)	Smoking initiation (ever regular vs never regular)	Biological process
1682	GCST007461	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Biological process
1683	GCST007461	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Other measurement
1684	GCST007462	Age of smoking initiation (MTAG)	Age of smoking initiation (MTAG)	Biological process
1685	GCST007463	Cigarettes smoked per day (MTAG)	Cigarettes smoked per day (MTAG)	Other measurement
1686	GCST007464	Smoking cessation (MTAG)	Smoking cessation (MTAG)	Biological process
1687	GCST007468	Smoking initiation (ever regular vs never regular) (MTAG)	Smoking initiation (ever regular vs never regular) (MTAG)	Other measurement
1688	GCST007472	Alcohol consumption (drinks per week) (MTAG)	Alcohol consumption (drinks per week) (MTAG)	Other measurement
1689	GCST005316	Intelligence (MTAG)	Intelligence (MTAG)	Biological process
1690	GCST006666	Lipid traits (pleiotropy) (HIPO component 1)	Lipid traits (pleiotropy) (HIPO component 1)	Lipid or lipoprotein measurement
1691	GCST006666	Lipid traits (pleiotropy) (HIPO component 1)	Lipid traits (pleiotropy) (HIPO component 1)	Lipid or lipoprotein measurement
1692	GCST006666	Lipid traits (pleiotropy) (HIPO component 1)	Lipid traits (pleiotropy) (HIPO component 1)	Lipid or lipoprotein measurement
1693	GCST006666	Lipid traits (pleiotropy) (HIPO component 1)	Lipid traits (pleiotropy) (HIPO component 1)	Lipid or lipoprotein measurement
1694	GCST006667	Lipid traits (pleiotropy) (HIPO component 2)	Lipid traits (pleiotropy) (HIPO component 2)	Lipid or lipoprotein measurement
1695	GCST006667	Lipid traits (pleiotropy) (HIPO component 2)	Lipid traits (pleiotropy) (HIPO component 2)	Lipid or lipoprotein measurement
1696	GCST006667	Lipid traits (pleiotropy) (HIPO component 2)	Lipid traits (pleiotropy) (HIPO component 2)	Lipid or lipoprotein measurement
1697	GCST006667	Lipid traits (pleiotropy) (HIPO component 2)	Lipid traits (pleiotropy) (HIPO component 2)	Lipid or lipoprotein measurement
1698	GCST006665	Social science traits (pleiotropy) (HIPO component 1)	Social science traits (pleiotropy) (HIPO component 1)	Other measurement
1699	GCST006665	Social science traits (pleiotropy) (HIPO component 1)	Social science traits (pleiotropy) (HIPO component 1)	Other measurement
1700	GCST006665	Social science traits (pleiotropy) (HIPO component 1)	Social science traits (pleiotropy) (HIPO component 1)	Other measurement
1701	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
1702	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
1703	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
1704	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
1705	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
1706	GCST006253	Short-term memory (digit-span task)	Short-term memory (digit-span task)	Biological process
1707	GCST006253	Short-term memory (digit-span task)	Short-term memory (digit-span task)	Other measurement
1708	GCST006254	Short-term memory (visuospatial task)	Short-term memory (visuospatial task)	Other measurement
1709	GCST006255	Short-term memory (shared component of digit-span and visuospatial tasks)	Short-term memory (shared component of digit-span and visuospatial tasks)	Other measurement
1710	GCST006256	Long-term memory (delayed word recall task)	Long-term memory (delayed word recall task)	Other measurement
1711	GCST005589	Vision loss in proton beam irradiation treatment of choroidal melanoma	Vision loss in proton beam irradiation treatment of choroidal melanoma	Cancer
1712	GCST005589	Vision loss in proton beam irradiation treatment of choroidal melanoma	Vision loss in proton beam irradiation treatment of choroidal melanoma	Biological process
1713	GCST005589	Vision loss in proton beam irradiation treatment of choroidal melanoma	Vision loss in proton beam irradiation treatment of choroidal melanoma	Other measurement
1714	GCST006611	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
1715	GCST006612	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
1716	GCST006612	LDL cholesterol	LDL cholesterol	Other measurement
1717	GCST006612	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
1718	GCST006613	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
1719	GCST006614	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
1720	GCST008837	Estimated glomerular filtration rate reduction (30%)	Estimated glomerular filtration rate reduction (30%)	Other measurement
1721	GCST007734	Incident chronic kidney disease	Incident chronic kidney disease	Other disease
1722	GCST004946	Schizophrenia	Schizophrenia	Neurological disorder
1723	GCST007131	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1724	GCST007140	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1725	GCST007141	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1726	GCST007132	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1727	GCST007133	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
1728	GCST007134	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
1729	GCST007142	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
1730	GCST007143	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
1731	GCST006497	Nose wing breadth	Nose wing breadth	Other measurement
1732	GCST006499	Nose length	Nose length	Other measurement
1733	GCST006500	Nosetip height	Nosetip height	Other measurement
1734	GCST006501	Nasal root breadth	Nasal root breadth	Other measurement
1735	GCST006502	Nasal root height	Nasal root height	Other measurement
1736	GCST006503	Eye length	Eye length	Other measurement
1737	GCST006504	Interorbital distance	Interorbital distance	Other measurement
1738	GCST006505	Labial fissure length	Labial fissure length	Other measurement
1739	GCST006506	Lip thickness	Lip thickness	Other measurement
1740	GCST006507	Lower face length	Lower face length	Other measurement
1741	GCST006498	Brow ridge morphology (principal component model)	Brow ridge morphology (principal component model)	Other measurement
1742	GCST006508	Eye morphology (principal component model)	Eye morphology (principal component model)	Other measurement
1743	GCST006509	Side of face morphology (principal component model)	Side of face morphology (principal component model)	Other measurement
1744	GCST006510	Cheek morphology (principal component model)	Cheek morphology (principal component model)	Other measurement
1745	GCST006511	Nose morphology (principal component model)	Nose morphology (principal component model)	Other measurement
1746	GCST006512	Mouth morphology (principal component model)	Mouth morphology (principal component model)	Other measurement
1747	GCST006513	Brow ridge morphology (partial least square model)	Brow ridge morphology (partial least square model)	Other measurement
1748	GCST006514	Eye morphology (partial least square model)	Eye morphology (partial least square model)	Other measurement
1749	GCST006515	Side of face morphology (partial least square model)	Side of face morphology (partial least square model)	Other measurement
1750	GCST006516	Cheek morphology (partial least square model)	Cheek morphology (partial least square model)	Other measurement
1751	GCST006517	Nose morphology (partial least square model)	Nose morphology (partial least square model)	Other measurement
1752	GCST006518	Mouth morphology (partial least square model)	Mouth morphology (partial least square model)	Other measurement
1753	GCST006808	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Neurological disorder
1754	GCST006808	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Response to drug
1755	GCST006808	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Other measurement
1756	GCST007945	Psychological resilience (outcome-based) in high deployment stress exposure	Psychological resilience (outcome-based) in high deployment stress exposure	Other measurement
1757	GCST007945	Psychological resilience (outcome-based) in high deployment stress exposure	Psychological resilience (outcome-based) in high deployment stress exposure	Other measurement
1758	GCST007946	Psychological resilience (self-assessed)	Psychological resilience (self-assessed)	Other measurement
1759	GCST007947	Psychological resilience (outcome-based)	Psychological resilience (outcome-based)	Other measurement
1760	GCST001026	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
1761	GCST001026	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
1762	GCST000085	Fasting plasma glucose	Fasting plasma glucose	Other measurement
1763	GCST000108	Diabetes (incident)	Diabetes (incident)	Metabolic disorder
1764	GCST000077	Diabetes related insulin traits	Diabetes related insulin traits	Other measurement
1765	GCST000077	Diabetes related insulin traits	Diabetes related insulin traits	Other measurement
1766	GCST000077	Diabetes related insulin traits	Diabetes related insulin traits	Other measurement
1767	GCST000077	Diabetes related insulin traits	Diabetes related insulin traits	Other trait
1768	GCST000819	Asthma	Asthma	Other disease
1769	GCST000138	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
1770	GCST000134	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
1771	GCST000134	LDL cholesterol	LDL cholesterol	Other measurement
1772	GCST000134	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
1773	GCST000133	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
1774	GCST000116	Skin sensitivity to sun	Skin sensitivity to sun	Immune system disorder
1775	GCST000115	Red vs non-red hair color	Red vs non-red hair color	Other trait
1776	GCST000119	Freckles	Freckles	Other trait
1777	GCST000118	Blond vs. brown hair color	Blond vs. brown hair color	Other trait
1778	GCST000117	Blue vs. green eyes	Blue vs. green eyes	Other trait
1779	GCST000120	Blue vs. brown eyes	Blue vs. brown eyes	Other trait
1780	GCST000092	Bone mineral density	Bone mineral density	Other measurement
1781	GCST000101	Hip geometry	Hip geometry	Body measurement
1782	GCST000020	End-stage renal disease	End-stage renal disease	Other disease
1783	GCST001983	Job-related exhaustion	Job-related exhaustion	Neurological disorder
1784	GCST000616	Smoking cessation	Smoking cessation	Biological process
1785	GCST002630	Systolic blood pressure	Systolic blood pressure	Other measurement
1786	GCST002630	Systolic blood pressure	Systolic blood pressure	Other measurement
1787	GCST002631	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1788	GCST002631	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1789	GCST002627	Hypertension	Hypertension	Cardiovascular disease
1790	GCST000093	Major CVD	Major CVD	Other disease
1791	GCST000109	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
1792	GCST000104	Heart failure	Heart failure	Cardiovascular disease
1793	GCST003162	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
1794	GCST003162	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
1795	GCST003165	Subcutaneous adipose tissue adjusted for BMI	Subcutaneous adipose tissue adjusted for BMI	Other measurement
1796	GCST003167	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
1797	GCST003167	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
1798	GCST003169	Total adipose tissue adjusted for BMI	Total adipose tissue adjusted for BMI	Other measurement
1799	GCST003163	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Other measurement
1800	GCST003163	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Body measurement
1801	GCST003170	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
1802	GCST003171	Visceral adipose tissue	Visceral adipose tissue	Other measurement
1803	GCST003172	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
1804	GCST003172	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
1805	GCST003173	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
1806	GCST003173	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
1807	GCST003166	Visceral adipose tissue	Visceral adipose tissue	Other measurement
1808	GCST003168	Total adipose tissue	Total adipose tissue	Other measurement
1809	GCST003164	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
1810	GCST000751	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
1811	GCST000088	Volumetric brain MRI	Volumetric brain MRI	Other measurement
1812	GCST000098	Cognitive test performance	Cognitive test performance	Other measurement
1813	GCST000089	Exercise treadmill test traits	Exercise treadmill test traits	Cardiovascular measurement
1814	GCST000110	Echocardiographic traits	Echocardiographic traits	Other trait
1815	GCST000110	Echocardiographic traits	Echocardiographic traits	Other measurement
1816	GCST000110	Echocardiographic traits	Echocardiographic traits	Other trait
1817	GCST000102	Endothelial function traits	Endothelial function traits	Other measurement
1818	GCST001805	Leishmaniasis (visceral)	Leishmaniasis (visceral)	Other disease
1819	GCST000078	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
1820	GCST000078	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
1821	GCST000078	Lipid traits	Lipid traits	Other measurement
1822	GCST000078	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
1823	GCST000078	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
1824	GCST001097	Educational attainment	Educational attainment	Other measurement
1825	GCST003112	Sleep duration	Sleep duration	Other measurement
1826	GCST003111	Sleep duration	Sleep duration	Other measurement
1827	GCST000042	Crohn's disease	Crohn's disease	Digestive system disorder
1828	GCST000041	Hypertension	Hypertension	Cardiovascular disease
1829	GCST000047	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1830	GCST000040	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
1831	GCST000045	Coronary heart disease	Coronary heart disease	Cardiovascular disease
1832	GCST000044	Bipolar disorder	Bipolar disorder	Neurological disorder
1833	GCST000043	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
1834	GCST001160	Systemic sclerosis	Systemic sclerosis	Neurological disorder
1835	GCST001156	Systemic sclerosis	Systemic sclerosis	Neurological disorder
1836	GCST000028	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1837	GCST000026	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
1838	GCST004919	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
1839	GCST004920	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
1840	GCST004920	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
1841	GCST004921	Apolipoprotein A1 levels	Apolipoprotein A1 levels	Lipid or lipoprotein measurement
1842	GCST002871	Psychotic symptoms and prion disease	Psychotic symptoms and prion disease	Neurological disorder
1843	GCST002871	Psychotic symptoms and prion disease	Psychotic symptoms and prion disease	Other trait
1844	GCST002862	Mood disorder and prion disease	Mood disorder and prion disease	Neurological disorder
1845	GCST002862	Mood disorder and prion disease	Mood disorder and prion disease	Neurological disorder
1846	GCST002866	Behavioral disturbance or psychiatric symptoms and prion disease	Behavioral disturbance or psychiatric symptoms and prion disease	Neurological disorder
1847	GCST002866	Behavioral disturbance or psychiatric symptoms and prion disease	Behavioral disturbance or psychiatric symptoms and prion disease	Other trait
1848	GCST002867	Psychotic symptoms in prion disease	Psychotic symptoms in prion disease	Neurological disorder
1849	GCST002867	Psychotic symptoms in prion disease	Psychotic symptoms in prion disease	Other trait
1850	GCST002864	Mood disorder in prion disease	Mood disorder in prion disease	Neurological disorder
1851	GCST002864	Mood disorder in prion disease	Mood disorder in prion disease	Neurological disorder
1852	GCST002863	Behavioral disturbance or psychiatric symptoms in prion disease	Behavioral disturbance or psychiatric symptoms in prion disease	Neurological disorder
1853	GCST002863	Behavioral disturbance or psychiatric symptoms in prion disease	Behavioral disturbance or psychiatric symptoms in prion disease	Other trait
1854	GCST001931	Attention deficit hyperactivity disorder (combined symptoms)	Attention deficit hyperactivity disorder (combined symptoms)	Neurological disorder
1855	GCST001944	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	Neurological disorder
1856	GCST001943	Attention deficit hyperactivity disorder (inattention symptoms)	Attention deficit hyperactivity disorder (inattention symptoms)	Neurological disorder
1857	GCST003440	Response to carboplatin in ovarian cancer (MTT IC50)	Response to carboplatin in ovarian cancer (MTT IC50)	Other measurement
1858	GCST003440	Response to carboplatin in ovarian cancer (MTT IC50)	Response to carboplatin in ovarian cancer (MTT IC50)	Response to drug
1859	GCST003440	Response to carboplatin in ovarian cancer (MTT IC50)	Response to carboplatin in ovarian cancer (MTT IC50)	Cancer
1860	GCST003443	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Other measurement
1861	GCST003443	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to drug
1862	GCST003443	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to drug
1863	GCST003443	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Cancer
1864	GCST003439	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Other measurement
1865	GCST003439	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to drug
1866	GCST003439	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Cancer
1867	GCST003442	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Other measurement
1868	GCST003442	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Response to drug
1869	GCST003442	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Cancer
1870	GCST003441	Response to paclitaxel in ovarian cancer (MTT IC50)	Response to paclitaxel in ovarian cancer (MTT IC50)	Other measurement
1871	GCST003441	Response to paclitaxel in ovarian cancer (MTT IC50)	Response to paclitaxel in ovarian cancer (MTT IC50)	Response to drug
1872	GCST003441	Response to paclitaxel in ovarian cancer (MTT IC50)	Response to paclitaxel in ovarian cancer (MTT IC50)	Cancer
1873	GCST003444	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Other measurement
1874	GCST003444	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to drug
1875	GCST003444	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to drug
1876	GCST003444	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Cancer
1877	GCST000035	Breast cancer	Breast cancer	Cancer
1878	GCST002199	Follicule stimulating hormone	Follicule stimulating hormone	Other measurement
1879	GCST002195	Hormone measurements	Hormone measurements	Other measurement
1880	GCST002195	Hormone measurements	Hormone measurements	Other measurement
1881	GCST002195	Hormone measurements	Hormone measurements	Other measurement
1882	GCST002195	Hormone measurements	Hormone measurements	Other measurement
1883	GCST002195	Hormone measurements	Hormone measurements	Other measurement
1884	GCST002195	Hormone measurements	Hormone measurements	Other measurement
1885	GCST002195	Hormone measurements	Hormone measurements	Other measurement
1886	GCST002195	Hormone measurements	Hormone measurements	Other measurement
1887	GCST002105	Odorant perception (isobutyraldehyde)	Odorant perception (isobutyraldehyde)	Biological process
1888	GCST002106	Odorant perception (&beta;-damascenone)	Odorant perception (&beta;-damascenone)	Biological process
1889	GCST002107	Odorant perception (&beta;-ionone)	Odorant perception (&beta;-ionone)	Biological process
1890	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
1891	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
1892	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
1893	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
1894	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
1895	GCST001953	Obesity	Obesity	Other measurement
1896	GCST001953	Obesity	Obesity	Metabolic disorder
1897	GCST001954	Waist-hip ratio	Waist-hip ratio	Other measurement
1898	GCST001954	Waist-hip ratio	Waist-hip ratio	Body measurement
1899	GCST001955	Body mass index	Body mass index	Body measurement
1900	GCST001955	Body mass index	Body mass index	Body measurement
1901	GCST001955	Body mass index	Body mass index	Other measurement
1902	GCST001956	Height	Height	Other measurement
1903	GCST001956	Height	Height	Body measurement
1904	GCST004296	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
1905	GCST004297	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
1906	GCST004298	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
1907	GCST004299	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
1908	GCST004295	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
1909	GCST004300	Incident atrial fibrillation	Incident atrial fibrillation	Cardiovascular disease
1910	GCST004301	Prevalent atrial fibrillation	Prevalent atrial fibrillation	Cardiovascular disease
1911	GCST001537	Immune reponse to smallpox (secreted IL-12p40)	Immune reponse to smallpox (secreted IL-12p40)	Response to drug
1912	GCST001537	Immune reponse to smallpox (secreted IL-12p40)	Immune reponse to smallpox (secreted IL-12p40)	Other measurement
1913	GCST001535	Immune reponse to smallpox (secreted IL-2)	Immune reponse to smallpox (secreted IL-2)	Response to drug
1914	GCST001535	Immune reponse to smallpox (secreted IL-2)	Immune reponse to smallpox (secreted IL-2)	Other measurement
1915	GCST001534	Immune reponse to smallpox (secreted IL-10)	Immune reponse to smallpox (secreted IL-10)	Response to drug
1916	GCST001534	Immune reponse to smallpox (secreted IL-10)	Immune reponse to smallpox (secreted IL-10)	Other measurement
1917	GCST001533	Immune reponse to smallpox (secreted IL-1beta)	Immune reponse to smallpox (secreted IL-1beta)	Response to drug
1918	GCST001533	Immune reponse to smallpox (secreted IL-1beta)	Immune reponse to smallpox (secreted IL-1beta)	Other measurement
1919	GCST001532	Immune response to smallpox vaccine (IL-6)	Immune response to smallpox vaccine (IL-6)	Response to drug
1920	GCST001532	Immune response to smallpox vaccine (IL-6)	Immune response to smallpox vaccine (IL-6)	Other measurement
1921	GCST001536	Immune reponse to smallpox (secreted TNF-alpha)	Immune reponse to smallpox (secreted TNF-alpha)	Response to drug
1922	GCST001536	Immune reponse to smallpox (secreted TNF-alpha)	Immune reponse to smallpox (secreted TNF-alpha)	Other measurement
1923	GCST001538	Immune reponse to smallpox (secreted IFN-alpha)	Immune reponse to smallpox (secreted IFN-alpha)	Response to drug
1924	GCST001538	Immune reponse to smallpox (secreted IFN-alpha)	Immune reponse to smallpox (secreted IFN-alpha)	Other measurement
1925	GCST002765	Optic disc area	Optic disc area	Other measurement
1926	GCST002765	Optic disc area	Optic disc area	Other measurement
1927	GCST002764	Optic cup area	Optic cup area	Other measurement
1928	GCST002762	Optic cup area	Optic cup area	Other measurement
1929	GCST002763	Optic disc area	Optic disc area	Other measurement
1930	GCST002763	Optic disc area	Optic disc area	Other measurement
1931	GCST005871	Metabolic syndrome	Metabolic syndrome	Body measurement
1932	GCST005871	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
1933	GCST005871	Metabolic syndrome	Metabolic syndrome	Other measurement
1934	GCST005871	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
1935	GCST005871	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
1936	GCST005872	Waist circumference	Waist circumference	Body measurement
1937	GCST005873	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
1938	GCST005874	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
1939	GCST005875	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1940	GCST005875	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1941	GCST005876	Systolic blood pressure	Systolic blood pressure	Other measurement
1942	GCST005876	Systolic blood pressure	Systolic blood pressure	Other measurement
1943	GCST005877	Fasting blood glucose	Fasting blood glucose	Other measurement
1944	GCST004883	Neuroblastoma (11q deletion)	Neuroblastoma (11q deletion)	Cancer
1945	GCST004882	Neuroblastoma (11q deletion vs 11q undeleted and MYCN amplification)	Neuroblastoma (11q deletion vs 11q undeleted and MYCN amplification)	Cancer
1946	GCST004884	Neuroblastoma (1p deletion)	Neuroblastoma (1p deletion)	Cancer
1947	GCST004885	Neuroblastoma (MYCN amplification)	Neuroblastoma (MYCN amplification)	Cancer
1948	GCST003837	Chronotype	Chronotype	Biological process
1949	GCST003837	Chronotype	Chronotype	Other measurement
1950	GCST003839	Sleep duration	Sleep duration	Other measurement
1951	GCST003838	Morning vs. evening chronotype	Morning vs. evening chronotype	Biological process
1952	GCST003840	Sleep duration (oversleepers vs undersleepers)	Sleep duration (oversleepers vs undersleepers)	Other measurement
1953	GCST006685	Sleep duration (oversleepers)	Sleep duration (oversleepers)	Other measurement
1954	GCST006686	Sleep duration (undersleepers)	Sleep duration (undersleepers)	Other measurement
1955	GCST005571	Osteoarthritis of the hip or knee (with total joint replacement)	Osteoarthritis of the hip or knee (with total joint replacement)	Other disease
1956	GCST005571	Osteoarthritis of the hip or knee (with total joint replacement)	Osteoarthritis of the hip or knee (with total joint replacement)	Other disease
1957	GCST005573	Osteoarthritis of the hip or knee	Osteoarthritis of the hip or knee	Other disease
1958	GCST005573	Osteoarthritis of the hip or knee	Osteoarthritis of the hip or knee	Other disease
1959	GCST005572	Osteoarthritis of the hip (with total joint replacement)	Osteoarthritis of the hip (with total joint replacement)	Other disease
1960	GCST005574	Osteoarthritis of the knee (with total joint replacement)	Osteoarthritis of the knee (with total joint replacement)	Other disease
1961	GCST003401	Glomerular filtration rate in non diabetics (creatinine)	Glomerular filtration rate in non diabetics (creatinine)	Other measurement
1962	GCST003401	Glomerular filtration rate in non diabetics (creatinine)	Glomerular filtration rate in non diabetics (creatinine)	Other measurement
1963	GCST003373	Glomerular filtration rate in diabetics (creatinine)	Glomerular filtration rate in diabetics (creatinine)	Other measurement
1964	GCST003373	Glomerular filtration rate in diabetics (creatinine)	Glomerular filtration rate in diabetics (creatinine)	Other measurement
1965	GCST003373	Glomerular filtration rate in diabetics (creatinine)	Glomerular filtration rate in diabetics (creatinine)	Metabolic disorder
1966	GCST003375	Glomerular filtration rate (cystatin C)	Glomerular filtration rate (cystatin C)	Other measurement
1967	GCST003375	Glomerular filtration rate (cystatin C)	Glomerular filtration rate (cystatin C)	Other measurement
1968	GCST003374	Chronic kidney disease	Chronic kidney disease	Other disease
1969	GCST003374	Chronic kidney disease	Chronic kidney disease	Other measurement
1970	GCST003374	Chronic kidney disease	Chronic kidney disease	Other measurement
1971	GCST003372	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
1972	GCST003372	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
1973	GCST003371	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
1974	GCST003371	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
1975	GCST004203	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1976	GCST004203	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1977	GCST004204	Systolic blood pressure	Systolic blood pressure	Other measurement
1978	GCST004204	Systolic blood pressure	Systolic blood pressure	Other measurement
1979	GCST004205	Pulse pressure	Pulse pressure	Cardiovascular measurement
1980	GCST004206	Fasting plasma glucose	Fasting plasma glucose	Other measurement
1981	GCST004207	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
1982	GCST004208	Body mass index	Body mass index	Body measurement
1983	GCST004208	Body mass index	Body mass index	Body measurement
1984	GCST004208	Body mass index	Body mass index	Other measurement
1985	GCST004209	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
1986	GCST004210	Body fat percentage	Body fat percentage	Body measurement
1987	GCST004211	Urate levels	Urate levels	Metabolic disorder
1988	GCST004211	Urate levels	Urate levels	Other measurement
1989	GCST004212	Height	Height	Other measurement
1990	GCST004212	Height	Height	Body measurement
1991	GCST004213	Resting heart rate	Resting heart rate	Cardiovascular measurement
1992	GCST004214	Creatinine levels	Creatinine levels	Other measurement
1993	GCST004215	Urea levels	Urea levels	Other measurement
1994	GCST004215	Urea levels	Urea levels	Other measurement
1995	GCST004216	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
1996	GCST004216	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
1997	GCST006803	Schizophrenia	Schizophrenia	Neurological disorder
1998	GCST006409	Allergic rhinitis	Allergic rhinitis	Immune system disorder
1999	GCST006409	Allergic rhinitis	Allergic rhinitis	Immune system disorder
2000	GCST006408	Allergic sensitization	Allergic sensitization	Other measurement
2001	GCST006474	Non-allergic rhinitis	Non-allergic rhinitis	Neurological disorder
2002	GCST004032	JT interval (sulfonylurea treatment interaction)	JT interval (sulfonylurea treatment interaction)	Response to drug
2003	GCST004032	JT interval (sulfonylurea treatment interaction)	JT interval (sulfonylurea treatment interaction)	Cardiovascular measurement
2004	GCST004031	QT interval (sulfonylurea treatment interaction)	QT interval (sulfonylurea treatment interaction)	Cardiovascular measurement
2005	GCST004031	QT interval (sulfonylurea treatment interaction)	QT interval (sulfonylurea treatment interaction)	Response to drug
2006	GCST004033	QRS interval (sulfonylurea treatment interaction)	QRS interval (sulfonylurea treatment interaction)	Cardiovascular measurement
2007	GCST004033	QRS interval (sulfonylurea treatment interaction)	QRS interval (sulfonylurea treatment interaction)	Response to drug
2008	GCST005337	Headache	Headache	Other trait
2009	GCST005828	Estradiol levels	Estradiol levels	Other measurement
2010	GCST005827	Estrone levels	Estrone levels	Other measurement
2011	GCST006440	Motor composite score	Motor composite score	Other measurement
2012	GCST006441	Mental composite score	Mental composite score	Other measurement
2013	GCST008773	Birth weight or body mass index (pleiotropy)	Birth weight or body mass index (pleiotropy)	Body measurement
2014	GCST008773	Birth weight or body mass index (pleiotropy)	Birth weight or body mass index (pleiotropy)	Body measurement
2015	GCST008774	Birth weight or waist-hip ratio (pleiotropy)	Birth weight or waist-hip ratio (pleiotropy)	Body measurement
2016	GCST008774	Birth weight or waist-hip ratio (pleiotropy)	Birth weight or waist-hip ratio (pleiotropy)	Body measurement
2017	GCST008775	Birth weight or waist circumference (pleiotropy)	Birth weight or waist circumference (pleiotropy)	Body measurement
2018	GCST008775	Birth weight or waist circumference (pleiotropy)	Birth weight or waist circumference (pleiotropy)	Body measurement
2019	GCST008776	Birth weight or type 2 diabetes (pleiotropy)	Birth weight or type 2 diabetes (pleiotropy)	Body measurement
2020	GCST008776	Birth weight or type 2 diabetes (pleiotropy)	Birth weight or type 2 diabetes (pleiotropy)	Metabolic disorder
2021	GCST008777	Birth weight or fasting glucose levels (pleiotropy)	Birth weight or fasting glucose levels (pleiotropy)	Body measurement
2022	GCST008777	Birth weight or fasting glucose levels (pleiotropy)	Birth weight or fasting glucose levels (pleiotropy)	Other measurement
2023	GCST008778	Birth weight or fasting insulin levels (pleiotropy)	Birth weight or fasting insulin levels (pleiotropy)	Body measurement
2024	GCST008778	Birth weight or fasting insulin levels (pleiotropy)	Birth weight or fasting insulin levels (pleiotropy)	Other measurement
2025	GCST008779	Birth weight or hemoglobin A1C levels (pleiotropy)	Birth weight or hemoglobin A1C levels (pleiotropy)	Body measurement
2026	GCST008779	Birth weight or hemoglobin A1C levels (pleiotropy)	Birth weight or hemoglobin A1C levels (pleiotropy)	Other measurement
2027	GCST008780	Birth weight or insulin secretion (pleiotropy)	Birth weight or insulin secretion (pleiotropy)	Body measurement
2028	GCST008780	Birth weight or insulin secretion (pleiotropy)	Birth weight or insulin secretion (pleiotropy)	Other measurement
2029	GCST008781	Birth weight or insulin sensitivity index (pleiotropy)	Birth weight or insulin sensitivity index (pleiotropy)	Body measurement
2030	GCST008781	Birth weight or insulin sensitivity index (pleiotropy)	Birth weight or insulin sensitivity index (pleiotropy)	Other measurement
2031	GCST008782	Birth weight or coronary artery disease (pleiotropy)	Birth weight or coronary artery disease (pleiotropy)	Cardiovascular disease
2032	GCST008782	Birth weight or coronary artery disease (pleiotropy)	Birth weight or coronary artery disease (pleiotropy)	Body measurement
2033	GCST008783	Birth weight or myocardial infarction (pleiotropy)	Birth weight or myocardial infarction (pleiotropy)	Body measurement
2034	GCST008783	Birth weight or myocardial infarction (pleiotropy)	Birth weight or myocardial infarction (pleiotropy)	Cardiovascular disease
2035	GCST008784	Birth weight or LDL cholesterol levels (pleiotropy)	Birth weight or LDL cholesterol levels (pleiotropy)	Body measurement
2036	GCST008784	Birth weight or LDL cholesterol levels (pleiotropy)	Birth weight or LDL cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
2037	GCST008785	Birth weight or HDL cholesterol levels (pleiotropy)	Birth weight or HDL cholesterol levels (pleiotropy)	Body measurement
2038	GCST008785	Birth weight or HDL cholesterol levels (pleiotropy)	Birth weight or HDL cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
2039	GCST008786	Birth weight or total cholesterol levels (pleiotropy)	Birth weight or total cholesterol levels (pleiotropy)	Body measurement
2040	GCST008786	Birth weight or total cholesterol levels (pleiotropy)	Birth weight or total cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
2041	GCST008787	Birth weight or triglycerides levels (pleiotropy)	Birth weight or triglycerides levels (pleiotropy)	Body measurement
2042	GCST008787	Birth weight or triglycerides levels (pleiotropy)	Birth weight or triglycerides levels (pleiotropy)	Lipid or lipoprotein measurement
2043	GCST007157	Corneal astigmatism	Corneal astigmatism	Neurological disorder
2044	GCST007157	Corneal astigmatism	Corneal astigmatism	Other trait
2045	GCST007158	Refractive astigmatism	Refractive astigmatism	Other trait
2046	GCST007159	Corneal astigmatism	Corneal astigmatism	Neurological disorder
2047	GCST007159	Corneal astigmatism	Corneal astigmatism	Other trait
2048	GCST007160	Refractive astigmatism	Refractive astigmatism	Other trait
2049	GCST007542	High IL-1beta levels in gingival crevicular fluid	High IL-1beta levels in gingival crevicular fluid	Inflammatory measurement
2050	GCST005946	Cleft palate	Cleft palate	Other trait
2051	GCST005948	Cleft palate	Cleft palate	Other trait
2052	GCST005947	Cleft palate	Cleft palate	Other trait
2053	GCST007880	Emotional lability in attention deficit hyperactivity disorder	Emotional lability in attention deficit hyperactivity disorder	Neurological disorder
2054	GCST007880	Emotional lability in attention deficit hyperactivity disorder	Emotional lability in attention deficit hyperactivity disorder	Other measurement
2055	GCST003921	Whole body bone mineral density and alcohol drinking	Whole body bone mineral density and alcohol drinking	Other measurement
2056	GCST003921	Whole body bone mineral density and alcohol drinking	Whole body bone mineral density and alcohol drinking	Other measurement
2057	GCST003920	Hip bone mineral density and alcohol drinking	Hip bone mineral density and alcohol drinking	Other measurement
2058	GCST003920	Hip bone mineral density and alcohol drinking	Hip bone mineral density and alcohol drinking	Other measurement
2059	GCST003919	Spine bone mineral density and alcohol drinking	Spine bone mineral density and alcohol drinking	Other measurement
2060	GCST003919	Spine bone mineral density and alcohol drinking	Spine bone mineral density and alcohol drinking	Other measurement
2061	GCST007301	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
2062	GCST007300	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Lipid or lipoprotein measurement
2063	GCST007300	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Response to drug
2064	GCST007300	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Lipid or lipoprotein measurement
2065	GCST007299	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
2066	GCST007298	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Response to drug
2067	GCST007298	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Lipid or lipoprotein measurement
2068	GCST007298	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Lipid or lipoprotein measurement
2069	GCST001227	Systolic blood pressure	Systolic blood pressure	Other measurement
2070	GCST001227	Systolic blood pressure	Systolic blood pressure	Other measurement
2071	GCST001238	Hypertension	Hypertension	Cardiovascular disease
2072	GCST001228	Diastolic blood pressure	Diastolic blood pressure	Other measurement
2073	GCST001228	Diastolic blood pressure	Diastolic blood pressure	Other measurement
2074	GCST000588	Red blood cell count	Red blood cell count	Hematological measurement
2075	GCST000589	White blood cell count	White blood cell count	Hematological measurement
2076	GCST000589	White blood cell count	White blood cell count	Inflammatory measurement
2077	GCST000589	White blood cell count	White blood cell count	Hematological measurement
2078	GCST000589	White blood cell count	White blood cell count	Hematological measurement
2079	GCST000589	White blood cell count	White blood cell count	Hematological measurement
2080	GCST000582	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
2081	GCST000582	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
2082	GCST000584	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
2083	GCST000580	Platelet count	Platelet count	Hematological measurement
2084	GCST000587	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
2085	GCST000587	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
2086	GCST000581	Urate levels	Urate levels	Metabolic disorder
2087	GCST000581	Urate levels	Urate levels	Other measurement
2088	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Other measurement
2089	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Liver enzyme measurement
2090	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Liver enzyme measurement
2091	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Cardiovascular measurement
2092	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Hematological measurement
2093	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Lipid or lipoprotein measurement
2094	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Hematological measurement
2095	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Other measurement
2096	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Other measurement
2097	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Cardiovascular measurement
2098	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Liver enzyme measurement
2099	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Liver enzyme measurement
2100	GCST000585	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
2101	GCST004868	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
2102	GCST004868	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
2103	GCST004868	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
2104	GCST004869	Age-related macular degeneration (SNP x mitochondrial T5004C interaction)	Age-related macular degeneration (SNP x mitochondrial T5004C interaction)	Neurological disorder
2105	GCST004870	Age-related macular degeneration (SNP x mitochondrial A4917G interaction)	Age-related macular degeneration (SNP x mitochondrial A4917G interaction)	Neurological disorder
2106	GCST004871	Age-related macular degeneration (SNP x mitochondrial G12771A interaction)	Age-related macular degeneration (SNP x mitochondrial G12771A interaction)	Neurological disorder
2107	GCST004872	Age-related macular degeneration (SNP x mitochondrial C16069T interaction)	Age-related macular degeneration (SNP x mitochondrial C16069T interaction)	Neurological disorder
2108	GCST007042	Response to SSRI (symptom improvement)	Response to SSRI (symptom improvement)	Response to drug
2109	GCST007059	Response to antidepressants (symptom improvement)	Response to antidepressants (symptom improvement)	Response to drug
2110	GCST007060	Response to SSRI (symptom remission)	Response to SSRI (symptom remission)	Response to drug
2111	GCST007061	Response to antidepressants (symptom remission)	Response to antidepressants (symptom remission)	Response to drug
2112	GCST004257	Systolic blood pressure (long-term average)	Systolic blood pressure (long-term average)	Other measurement
2113	GCST004258	Diastolic blood pressure (long-term average)	Diastolic blood pressure (long-term average)	Other measurement
2114	GCST004260	Pulse pressure (long-term average)	Pulse pressure (long-term average)	Cardiovascular measurement
2115	GCST004259	Mean arterial pressure (long-term average)	Mean arterial pressure (long-term average)	Other measurement
2116	GCST004110	Gait speed in old age	Gait speed in old age	Other measurement
2117	GCST005052	Platelet-to-lymphocyte ratio	Platelet-to-lymphocyte ratio	Hematological measurement
2118	GCST005056	Neutrophil count	Neutrophil count	Hematological measurement
2119	GCST005055	Lymphocyte counts	Lymphocyte counts	Hematological measurement
2120	GCST005054	Platelet count	Platelet count	Hematological measurement
2121	GCST005053	Neutrophil-to-lymphocyte ratio	Neutrophil-to-lymphocyte ratio	Hematological measurement
2122	GCST006519	Growth differentiation factor-15 levels	Growth differentiation factor-15 levels	Hematological measurement
2123	GCST001923	Glomerular filtration rate	Glomerular filtration rate	Other measurement
2124	GCST004481	Low-grade serous and serous borderline ovarian cancer	Low-grade serous and serous borderline ovarian cancer	Cancer
2125	GCST004416	Ovarian cancer in BRCA2 mutation carriers	Ovarian cancer in BRCA2 mutation carriers	Other measurement
2126	GCST004416	Ovarian cancer in BRCA2 mutation carriers	Ovarian cancer in BRCA2 mutation carriers	Cancer
2127	GCST004462	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
2128	GCST004462	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
2129	GCST004417	Ovarian clear cell cancer	Ovarian clear cell cancer	Cancer
2130	GCST004418	Endometrioid ovarian cancer	Endometrioid ovarian cancer	Cancer
2131	GCST004419	Mucinous ovarian carcinoma	Mucinous ovarian carcinoma	Cancer
2132	GCST004478	Serous invasive ovarian cancer	Serous invasive ovarian cancer	Cancer
2133	GCST004479	Serous borderline ovarian cancer	Serous borderline ovarian cancer	Cancer
2134	GCST004480	High-grade serous ovarian cancer	High-grade serous ovarian cancer	Cancer
2135	GCST004461	Low-grade serous ovarian cancer	Low-grade serous ovarian cancer	Cancer
2136	GCST004414	Ovarian cancer in BRCA1 mutation carriers	Ovarian cancer in BRCA1 mutation carriers	Other measurement
2137	GCST004414	Ovarian cancer in BRCA1 mutation carriers	Ovarian cancer in BRCA1 mutation carriers	Cancer
2138	GCST004415	Invasive epithelial ovarian cancer	Invasive epithelial ovarian cancer	Cancer
2139	GCST003186	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Other disease
2140	GCST003186	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Cardiovascular disease
2141	GCST003186	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Response to drug
2142	GCST003205	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Response to drug
2143	GCST003205	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Other disease
2144	GCST003205	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Cardiovascular disease
2145	GCST003206	Myocardial infarction in hypertension (calcium channel blocker interaction)	Myocardial infarction in hypertension (calcium channel blocker interaction)	Response to drug
2146	GCST003206	Myocardial infarction in hypertension (calcium channel blocker interaction)	Myocardial infarction in hypertension (calcium channel blocker interaction)	Cardiovascular disease
2147	GCST003206	Myocardial infarction in hypertension (calcium channel blocker interaction)	Myocardial infarction in hypertension (calcium channel blocker interaction)	Cardiovascular disease
2148	GCST003204	Cardiovascular disease in hypertension (diuretic interaction)	Cardiovascular disease in hypertension (diuretic interaction)	Other disease
2149	GCST003204	Cardiovascular disease in hypertension (diuretic interaction)	Cardiovascular disease in hypertension (diuretic interaction)	Cardiovascular disease
2150	GCST003204	Cardiovascular disease in hypertension (diuretic interaction)	Cardiovascular disease in hypertension (diuretic interaction)	Response to drug
2151	GCST003203	Cardiovascular disease in hypertension (beta blocker interaction)	Cardiovascular disease in hypertension (beta blocker interaction)	Response to drug
2152	GCST003203	Cardiovascular disease in hypertension (beta blocker interaction)	Cardiovascular disease in hypertension (beta blocker interaction)	Other disease
2153	GCST003203	Cardiovascular disease in hypertension (beta blocker interaction)	Cardiovascular disease in hypertension (beta blocker interaction)	Cardiovascular disease
2154	GCST003187	Myocardial infarction in hypertension (ACE inhibitor interaction)	Myocardial infarction in hypertension (ACE inhibitor interaction)	Cardiovascular disease
2155	GCST003187	Myocardial infarction in hypertension (ACE inhibitor interaction)	Myocardial infarction in hypertension (ACE inhibitor interaction)	Cardiovascular disease
2156	GCST003187	Myocardial infarction in hypertension (ACE inhibitor interaction)	Myocardial infarction in hypertension (ACE inhibitor interaction)	Response to drug
2157	GCST003201	Myocardial infarction in hypertension (beta blocker interaction)	Myocardial infarction in hypertension (beta blocker interaction)	Response to drug
2158	GCST003201	Myocardial infarction in hypertension (beta blocker interaction)	Myocardial infarction in hypertension (beta blocker interaction)	Cardiovascular disease
2159	GCST003201	Myocardial infarction in hypertension (beta blocker interaction)	Myocardial infarction in hypertension (beta blocker interaction)	Cardiovascular disease
2160	GCST003202	Myocardial infarction in hypertension (diuretic interaction)	Myocardial infarction in hypertension (diuretic interaction)	Cardiovascular disease
2161	GCST003202	Myocardial infarction in hypertension (diuretic interaction)	Myocardial infarction in hypertension (diuretic interaction)	Cardiovascular disease
2162	GCST003202	Myocardial infarction in hypertension (diuretic interaction)	Myocardial infarction in hypertension (diuretic interaction)	Response to drug
2163	GCST005845	Heart rate increase in response to exercise	Heart rate increase in response to exercise	Cardiovascular measurement
2164	GCST005850	Heart rate response to recovery post exercise (30 sec)	Heart rate response to recovery post exercise (30 sec)	Cardiovascular measurement
2165	GCST005849	Heart rate response to recovery post exercise (40 sec)	Heart rate response to recovery post exercise (40 sec)	Cardiovascular measurement
2166	GCST005848	Heart rate response to recovery post exercise (50 sec)	Heart rate response to recovery post exercise (50 sec)	Cardiovascular measurement
2167	GCST005847	Heart rate response to recovery post exercise (20 sec)	Heart rate response to recovery post exercise (20 sec)	Cardiovascular measurement
2168	GCST005846	Heart rate response to recovery post exercise (10 sec)	Heart rate response to recovery post exercise (10 sec)	Cardiovascular measurement
2169	GCST007620	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
2170	GCST005134	Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	Response to drug
2171	GCST005134	Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	Cardiovascular measurement
2172	GCST005135	Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	Response to drug
2173	GCST005135	Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	Cardiovascular measurement
2174	GCST005140	Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	Response to drug
2175	GCST005140	Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	Cardiovascular measurement
2176	GCST005136	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Response to drug
2177	GCST005136	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Cardiovascular measurement
2178	GCST005136	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Cardiovascular measurement
2179	GCST005136	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Cardiovascular measurement
2180	GCST005138	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Response to drug
2181	GCST005138	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Cardiovascular measurement
2182	GCST005138	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Cardiovascular measurement
2183	GCST005138	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Cardiovascular measurement
2184	GCST005139	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Response to drug
2185	GCST005139	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Cardiovascular measurement
2186	GCST005139	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Cardiovascular measurement
2187	GCST005139	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Cardiovascular measurement
2188	GCST005137	Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	Response to drug
2189	GCST005137	Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	Cardiovascular measurement
2190	GCST005039	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Other measurement
2191	GCST005039	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
2192	GCST005039	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
2193	GCST005040	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
2194	GCST005040	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Other measurement
2195	GCST005040	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
2196	GCST005041	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
2197	GCST005041	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Other measurement
2198	GCST005041	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
2199	GCST003745	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
2200	GCST004768	Motor development (prenatal lead exposure interaction)	Motor development (prenatal lead exposure interaction)	Other measurement
2201	GCST004768	Motor development (prenatal lead exposure interaction)	Motor development (prenatal lead exposure interaction)	Other measurement
2202	GCST004769	Mental development (prenatal lead exposure interaction)	Mental development (prenatal lead exposure interaction)	Other measurement
2203	GCST004769	Mental development (prenatal lead exposure interaction)	Mental development (prenatal lead exposure interaction)	Other measurement
2204	GCST005648	Serum metabolite concentrations in chronic kidney disease	Serum metabolite concentrations in chronic kidney disease	Other disease
2205	GCST005648	Serum metabolite concentrations in chronic kidney disease	Serum metabolite concentrations in chronic kidney disease	Other measurement
2206	GCST005649	Urinary metabolite ratios in chronic kidney disease	Urinary metabolite ratios in chronic kidney disease	Other disease
2207	GCST005649	Urinary metabolite ratios in chronic kidney disease	Urinary metabolite ratios in chronic kidney disease	Other measurement
2208	GCST005650	Serum metabolite ratios in chronic kidney disease	Serum metabolite ratios in chronic kidney disease	Other disease
2209	GCST005650	Serum metabolite ratios in chronic kidney disease	Serum metabolite ratios in chronic kidney disease	Other measurement
2210	GCST005651	Urinary metabolite concentrations in chronic kidney disease	Urinary metabolite concentrations in chronic kidney disease	Other disease
2211	GCST005651	Urinary metabolite concentrations in chronic kidney disease	Urinary metabolite concentrations in chronic kidney disease	Other measurement
2212	GCST005666	Fractional excretion of metabolites in chronic kidney disease	Fractional excretion of metabolites in chronic kidney disease	Other disease
2213	GCST005666	Fractional excretion of metabolites in chronic kidney disease	Fractional excretion of metabolites in chronic kidney disease	Other measurement
2214	GCST006923	Loneliness	Loneliness	Other measurement
2215	GCST006918	Social isolation	Social isolation	Other measurement
2216	GCST006919	Ability to confide in someone	Ability to confide in someone	Other measurement
2217	GCST006920	Regular attendance at a gym or sports club	Regular attendance at a gym or sports club	Other measurement
2218	GCST006921	Regular attendance at a pub or social club	Regular attendance at a pub or social club	Other measurement
2219	GCST006922	Regular attendance at a religious group	Regular attendance at a religious group	Other measurement
2220	GCST006924	Loneliness (MTAG)	Loneliness (MTAG)	Other measurement
2221	GCST006813	End stage renal disease x APOL1 genotype interaction	End stage renal disease x APOL1 genotype interaction	Other disease
2222	GCST006813	End stage renal disease x APOL1 genotype interaction	End stage renal disease x APOL1 genotype interaction	Other measurement
2223	GCST006815	End stage renal disease in APOL1 risk genotype-negative individuals	End stage renal disease in APOL1 risk genotype-negative individuals	Other disease
2224	GCST006815	End stage renal disease in APOL1 risk genotype-negative individuals	End stage renal disease in APOL1 risk genotype-negative individuals	Other measurement
2225	GCST006816	End stage renal disease in APOL1 risk genotype-positive individuals	End stage renal disease in APOL1 risk genotype-positive individuals	Other disease
2226	GCST006816	End stage renal disease in APOL1 risk genotype-positive individuals	End stage renal disease in APOL1 risk genotype-positive individuals	Other measurement
2227	GCST006814	End-stage renal disease	End-stage renal disease	Other disease
2228	GCST003485	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Lipid or lipoprotein measurement
2229	GCST003485	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Response to drug
2230	GCST003485	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Lipid or lipoprotein measurement
2231	GCST003486	Response to fenofibrate (LDL cholesterol levels)	Response to fenofibrate (LDL cholesterol levels)	Lipid or lipoprotein measurement
2232	GCST003486	Response to fenofibrate (LDL cholesterol levels)	Response to fenofibrate (LDL cholesterol levels)	Response to drug
2233	GCST003487	Response to fenofibrate (total cholesterol levels)	Response to fenofibrate (total cholesterol levels)	Lipid or lipoprotein measurement
2234	GCST003487	Response to fenofibrate (total cholesterol levels)	Response to fenofibrate (total cholesterol levels)	Response to drug
2235	GCST003488	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Response to drug
2236	GCST003488	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Lipid or lipoprotein measurement
2237	GCST003488	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Lipid or lipoprotein measurement
2238	GCST007244	Intra-individual response time variability (response selection)	Intra-individual response time variability (response selection)	Other measurement
2239	GCST007243	Intra-individual response time variability (selective attention)	Intra-individual response time variability (selective attention)	Other measurement
2240	GCST006656	Dysmenorrheic pain severity	Dysmenorrheic pain severity	Other measurement
2241	GCST006636	Menstruation quality of life impact (dysmenorrhea)	Menstruation quality of life impact (dysmenorrhea)	Other measurement
2242	GCST006636	Menstruation quality of life impact (dysmenorrhea)	Menstruation quality of life impact (dysmenorrhea)	Other measurement
2243	GCST006637	Pain medicine use during menstruation	Pain medicine use during menstruation	Other measurement
2244	GCST006637	Pain medicine use during menstruation	Pain medicine use during menstruation	Other measurement
2245	GCST006638	Menstruation quality of life impact (fever)	Menstruation quality of life impact (fever)	Other trait
2246	GCST006638	Menstruation quality of life impact (fever)	Menstruation quality of life impact (fever)	Other measurement
2247	GCST006639	Heavy vaginal discharge	Heavy vaginal discharge	Other trait
2248	GCST006639	Heavy vaginal discharge	Heavy vaginal discharge	Other measurement
2249	GCST006640	Menstruation quality of life impact (acne)	Menstruation quality of life impact (acne)	Other disease
2250	GCST006640	Menstruation quality of life impact (acne)	Menstruation quality of life impact (acne)	Other measurement
2251	GCST006641	Menstruation quality of life impact (aggressiveness)	Menstruation quality of life impact (aggressiveness)	Biological process
2252	GCST006641	Menstruation quality of life impact (aggressiveness)	Menstruation quality of life impact (aggressiveness)	Other measurement
2253	GCST006642	Menstruation quality of life impact (increased appetite)	Menstruation quality of life impact (increased appetite)	Biological process
2254	GCST006642	Menstruation quality of life impact (increased appetite)	Menstruation quality of life impact (increased appetite)	Other measurement
2255	GCST006643	Menstruation quality of life impact (bowel movement)	Menstruation quality of life impact (bowel movement)	Other trait
2256	GCST006643	Menstruation quality of life impact (bowel movement)	Menstruation quality of life impact (bowel movement)	Other measurement
2257	GCST006644	Menstruation quality of life impact (depression)	Menstruation quality of life impact (depression)	Neurological disorder
2258	GCST006644	Menstruation quality of life impact (depression)	Menstruation quality of life impact (depression)	Other measurement
2259	GCST006645	Menstruation quality of life impact (edema)	Menstruation quality of life impact (edema)	Other measurement
2260	GCST006645	Menstruation quality of life impact (edema)	Menstruation quality of life impact (edema)	Other disease
2261	GCST006646	Menstruation quality of life impact (headache)	Menstruation quality of life impact (headache)	Other trait
2262	GCST006646	Menstruation quality of life impact (headache)	Menstruation quality of life impact (headache)	Other measurement
2263	GCST006647	Menstruation quality of life impact (joint pain)	Menstruation quality of life impact (joint pain)	Other trait
2264	GCST006647	Menstruation quality of life impact (joint pain)	Menstruation quality of life impact (joint pain)	Other measurement
2265	GCST006648	Menstruation quality of life impact (loss of concentration)	Menstruation quality of life impact (loss of concentration)	Neurological disorder
2266	GCST006648	Menstruation quality of life impact (loss of concentration)	Menstruation quality of life impact (loss of concentration)	Other measurement
2267	GCST006649	Menstruation quality of life impact (nervousness)	Menstruation quality of life impact (nervousness)	Neurological disorder
2268	GCST006649	Menstruation quality of life impact (nervousness)	Menstruation quality of life impact (nervousness)	Other measurement
2269	GCST006650	Menstruation quality of life impact (pressure in breast)	Menstruation quality of life impact (pressure in breast)	Body measurement
2270	GCST006650	Menstruation quality of life impact (pressure in breast)	Menstruation quality of life impact (pressure in breast)	Other measurement
2271	GCST006651	Menstruation quality of life impact (sleepiness)	Menstruation quality of life impact (sleepiness)	Neurological disorder
2272	GCST006651	Menstruation quality of life impact (sleepiness)	Menstruation quality of life impact (sleepiness)	Other measurement
2273	GCST006652	Menstruation quality of life impact (stiff neck)	Menstruation quality of life impact (stiff neck)	Other trait
2274	GCST006652	Menstruation quality of life impact (stiff neck)	Menstruation quality of life impact (stiff neck)	Other measurement
2275	GCST006653	Vaginal discharge (itching)	Vaginal discharge (itching)	Other trait
2276	GCST006657	Vaginal discharge (metrorrhagia)	Vaginal discharge (metrorrhagia)	Other trait
2277	GCST006657	Vaginal discharge (metrorrhagia)	Vaginal discharge (metrorrhagia)	Other trait
2278	GCST006654	Vaginal discharge (smell)	Vaginal discharge (smell)	Other trait
2279	GCST006655	Breast size	Breast size	Body measurement
2280	GCST006859	Infant death in continuous marriage (Proportion of children died <1 year)	Infant death in continuous marriage (Proportion of children died <1 year)	Other measurement
2281	GCST006720	Hemoglobin levels	Hemoglobin levels	Hematological measurement
2282	GCST006720	Hemoglobin levels	Hemoglobin levels	Hematological measurement
2283	GCST006720	Hemoglobin levels	Hemoglobin levels	Hematological measurement
2284	GCST006720	Hemoglobin levels	Hemoglobin levels	Hematological measurement
2285	GCST006721	Infant and Child death (Number of children died <5 years)	Infant and Child death (Number of children died <5 years)	Other measurement
2286	GCST006722	Infant and Child death in continuous marriage (Number of children died <5 years)	Infant and Child death in continuous marriage (Number of children died <5 years)	Other measurement
2287	GCST006723	Infant and Child death (Proportion of children died <5 years)	Infant and Child death (Proportion of children died <5 years)	Other measurement
2288	GCST006724	Infant and Child death in continuous marriage (Proportion of children died <5 years)	Infant and Child death in continuous marriage (Proportion of children died <5 years)	Other measurement
2289	GCST006725	Infant, child and juvenile death (number of children died <15 years)	Infant, child and juvenile death (number of children died <15 years)	Other measurement
2290	GCST006726	Infant, child and juvenile death in continuous marriage (number of children died <15 years)	Infant, child and juvenile death in continuous marriage (number of children died <15 years)	Other measurement
2291	GCST006727	Infant, child and juvenile death (proportion of children died <15 years)	Infant, child and juvenile death (proportion of children died <15 years)	Other measurement
2292	GCST006730	Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)	Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)	Other measurement
2293	GCST006728	Infant death (Number of children died <1 year)	Infant death (Number of children died <1 year)	Other measurement
2294	GCST006729	Infant death in continuous marriage (Number of children died <1 year)	Infant death in continuous marriage (Number of children died <1 year)	Other measurement
2295	GCST006731	Infant death (Proportion of children died <1 year)	Infant death (Proportion of children died <1 year)	Other measurement
2296	GCST006733	Infant survival (Number of children surviving at 1 year)	Infant survival (Number of children surviving at 1 year)	Other measurement
2297	GCST006734	Infant survival in continuous marriage (Number of children surviving at 1 year)	Infant survival in continuous marriage (Number of children surviving at 1 year)	Other measurement
2298	GCST006735	Infant survival (Proportion of children surviving at 1 year)	Infant survival (Proportion of children surviving at 1 year)	Other measurement
2299	GCST006736	Infant survival in continuous marriage (Proportion of children surviving at 1 year)	Infant survival in continuous marriage (Proportion of children surviving at 1 year)	Other measurement
2300	GCST006737	Number of miscarriages	Number of miscarriages	Other measurement
2301	GCST006738	Number of miscarriages in continuous marriage	Number of miscarriages in continuous marriage	Other measurement
2302	GCST006739	Proportion of miscarriages	Proportion of miscarriages	Other measurement
2303	GCST006740	Proportion of miscarriages in continuous marriage	Proportion of miscarriages in continuous marriage	Other measurement
2304	GCST006741	Number of stillbirths	Number of stillbirths	Other measurement
2305	GCST006742	Number of stillbirths in continuous marriage	Number of stillbirths in continuous marriage	Other measurement
2306	GCST006743	Proportion of stillbirths	Proportion of stillbirths	Other measurement
2307	GCST006744	Proportion of stillbirths in continuous marriage	Proportion of stillbirths in continuous marriage	Other measurement
2308	GCST006745	Oxygen saturation of hemoglobin levels	Oxygen saturation of hemoglobin levels	Other measurement
2309	GCST006746	Pulse rate	Pulse rate	Cardiovascular measurement
2310	GCST006746	Pulse rate	Pulse rate	Cardiovascular measurement
2311	GCST006747	Oxygenated hemoglobin levels	Oxygenated hemoglobin levels	Hematological measurement
2312	GCST006748	Deoxygenated hemoglobin levels	Deoxygenated hemoglobin levels	Hematological measurement
2313	GCST006749	Child death (Number of children surviving at 1 year but died <5 years)	Child death (Number of children surviving at 1 year but died <5 years)	Other measurement
2314	GCST006750	Child death in continuous marriage (Number of children surviving at 1 year but died <5 years)	Child death in continuous marriage (Number of children surviving at 1 year but died <5 years)	Other measurement
2315	GCST006751	Child survival (Number of children surviving at 5 years)	Child survival (Number of children surviving at 5 years)	Other measurement
2316	GCST006752	Child survival in continuous marriage (Number of children surviving at 5 years)	Child survival in continuous marriage (Number of children surviving at 5 years)	Other measurement
2317	GCST006753	Child death (Proportion of children surviving at 1 year but died <5 years)	Child death (Proportion of children surviving at 1 year but died <5 years)	Other measurement
2318	GCST006754	Child death in continuous marriage (Proportion of children surviving at 1 year but died <5 years)	Child death in continuous marriage (Proportion of children surviving at 1 year but died <5 years)	Other measurement
2319	GCST006755	Child survival (Proportion of children surviving at 5 years)	Child survival (Proportion of children surviving at 5 years)	Other measurement
2320	GCST006756	Child survival in continuous marriage (Proportion of children surviving at 5 years)	Child survival in continuous marriage (Proportion of children surviving at 5 years)	Other measurement
2321	GCST006757	Juvenile death (Number of children surviving at 5 years but died <15 years)	Juvenile death (Number of children surviving at 5 years but died <15 years)	Other measurement
2322	GCST006758	Juvenile death in continuous marriage (Number of children surviving at 5 years but died <15 years)	Juvenile death in continuous marriage (Number of children surviving at 5 years but died <15 years)	Other measurement
2323	GCST006759	Juvenile death (Proportion of children surviving at 5 years but died <15 years)	Juvenile death (Proportion of children surviving at 5 years but died <15 years)	Other measurement
2324	GCST006760	Juvenile death in continuous marriage (Proportion of children surviving at 5 years but died <15 years)	Juvenile death in continuous marriage (Proportion of children surviving at 5 years but died <15 years)	Other measurement
2325	GCST006761	Juvenile survival (Number of children surviving at 15 years)	Juvenile survival (Number of children surviving at 15 years)	Other measurement
2326	GCST006762	Juvenile survival in continuous marriage (Number of children surviving at 15 years)	Juvenile survival in continuous marriage (Number of children surviving at 15 years)	Other measurement
2327	GCST006763	Juvenile survival (Proportion of children surviving at 15 years)	Juvenile survival (Proportion of children surviving at 15 years)	Other measurement
2328	GCST006764	Juvenile survival in continuous marriage (Proportion of children surviving at 15 years)	Juvenile survival in continuous marriage (Proportion of children surviving at 15 years)	Other measurement
2329	GCST006765	Number of live births	Number of live births	Other measurement
2330	GCST006766	Number of live births in continuous marriage	Number of live births in continuous marriage	Other measurement
2331	GCST006767	Proportion of live births	Proportion of live births	Other measurement
2332	GCST006768	Proportion of live births in continuous marriage	Proportion of live births in continuous marriage	Other measurement
2333	GCST006771	Number of pregnancies	Number of pregnancies	Other measurement
2334	GCST006771	Number of pregnancies	Number of pregnancies	Other trait
2335	GCST006771	Number of pregnancies	Number of pregnancies	Other measurement
2336	GCST006772	Number of pregnancies in continuous marriage	Number of pregnancies in continuous marriage	Other measurement
2337	GCST006773	Number of twin births	Number of twin births	Other measurement
2338	GCST006774	Number of twin births in continuous marriage	Number of twin births in continuous marriage	Other measurement
2339	GCST006775	Age at last pregnancy	Age at last pregnancy	Other measurement
2340	GCST006776	Age at last pregnancy in continuous marriage	Age at last pregnancy in continuous marriage	Other measurement
2341	GCST006769	Age at first birth	Age at first birth	Other measurement
2342	GCST006770	Age at first birth in continuous marriage	Age at first birth in continuous marriage	Other measurement
2343	GCST008107	Radioiodine-refractory disease in thyroid cancer	Radioiodine-refractory disease in thyroid cancer	Biological process
2344	GCST008107	Radioiodine-refractory disease in thyroid cancer	Radioiodine-refractory disease in thyroid cancer	Cancer
2345	GCST003800	Response to bupropion in depression	Response to bupropion in depression	Neurological disorder
2346	GCST003800	Response to bupropion in depression	Response to bupropion in depression	Neurological disorder
2347	GCST003800	Response to bupropion in depression	Response to bupropion in depression	Response to drug
2348	GCST003801	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Response to drug
2349	GCST003801	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Neurological disorder
2350	GCST003801	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Neurological disorder
2351	GCST003802	Response to citalopram or escitalopram in depression	Response to citalopram or escitalopram in depression	Neurological disorder
2352	GCST003802	Response to citalopram or escitalopram in depression	Response to citalopram or escitalopram in depression	Neurological disorder
2353	GCST003802	Response to citalopram or escitalopram in depression	Response to citalopram or escitalopram in depression	Response to drug
2354	GCST003802	Response to citalopram or escitalopram in depression	Response to citalopram or escitalopram in depression	Response to drug
2355	GCST003803	Response to antidepressants in depression	Response to antidepressants in depression	Neurological disorder
2356	GCST003803	Response to antidepressants in depression	Response to antidepressants in depression	Neurological disorder
2357	GCST003803	Response to antidepressants in depression	Response to antidepressants in depression	Response to drug
2358	GCST003804	Non-response to bupropion and depression	Non-response to bupropion and depression	Neurological disorder
2359	GCST003804	Non-response to bupropion and depression	Non-response to bupropion and depression	Neurological disorder
2360	GCST003804	Non-response to bupropion and depression	Non-response to bupropion and depression	Response to drug
2361	GCST003806	Response to bupropion and depression	Response to bupropion and depression	Neurological disorder
2362	GCST003806	Response to bupropion and depression	Response to bupropion and depression	Neurological disorder
2363	GCST003806	Response to bupropion and depression	Response to bupropion and depression	Response to drug
2364	GCST003809	Response to selective serotonin reuptake inhibitors and depression	Response to selective serotonin reuptake inhibitors and depression	Response to drug
2365	GCST003809	Response to selective serotonin reuptake inhibitors and depression	Response to selective serotonin reuptake inhibitors and depression	Neurological disorder
2366	GCST003809	Response to selective serotonin reuptake inhibitors and depression	Response to selective serotonin reuptake inhibitors and depression	Neurological disorder
2367	GCST003810	Non-response to citalopram or escitalopram and depression	Non-response to citalopram or escitalopram and depression	Neurological disorder
2368	GCST003810	Non-response to citalopram or escitalopram and depression	Non-response to citalopram or escitalopram and depression	Neurological disorder
2369	GCST003810	Non-response to citalopram or escitalopram and depression	Non-response to citalopram or escitalopram and depression	Response to drug
2370	GCST003810	Non-response to citalopram or escitalopram and depression	Non-response to citalopram or escitalopram and depression	Response to drug
2371	GCST003811	Response to citalopram or escitalopram and depression	Response to citalopram or escitalopram and depression	Neurological disorder
2372	GCST003811	Response to citalopram or escitalopram and depression	Response to citalopram or escitalopram and depression	Neurological disorder
2373	GCST003811	Response to citalopram or escitalopram and depression	Response to citalopram or escitalopram and depression	Response to drug
2374	GCST003811	Response to citalopram or escitalopram and depression	Response to citalopram or escitalopram and depression	Response to drug
2375	GCST003812	Non-response to antidepressants and depression	Non-response to antidepressants and depression	Neurological disorder
2376	GCST003812	Non-response to antidepressants and depression	Non-response to antidepressants and depression	Neurological disorder
2377	GCST003812	Non-response to antidepressants and depression	Non-response to antidepressants and depression	Response to drug
2378	GCST003808	Non-response to selective serotonin reuptake inhibitors and depression	Non-response to selective serotonin reuptake inhibitors and depression	Response to drug
2379	GCST003808	Non-response to selective serotonin reuptake inhibitors and depression	Non-response to selective serotonin reuptake inhibitors and depression	Neurological disorder
2380	GCST003808	Non-response to selective serotonin reuptake inhibitors and depression	Non-response to selective serotonin reuptake inhibitors and depression	Neurological disorder
2381	GCST003813	Response to antidepressants and depression	Response to antidepressants and depression	Neurological disorder
2382	GCST003813	Response to antidepressants and depression	Response to antidepressants and depression	Neurological disorder
2383	GCST003813	Response to antidepressants and depression	Response to antidepressants and depression	Response to drug
2384	GCST003089	Manic episodes in bipolar disorder	Manic episodes in bipolar disorder	Other trait
2385	GCST003089	Manic episodes in bipolar disorder	Manic episodes in bipolar disorder	Neurological disorder
2386	GCST003091	Depressive episodes in bipolar disorder	Depressive episodes in bipolar disorder	Other measurement
2387	GCST003091	Depressive episodes in bipolar disorder	Depressive episodes in bipolar disorder	Neurological disorder
2388	GCST003090	Depressive and manic episodes in bipolar disorder	Depressive and manic episodes in bipolar disorder	Other measurement
2389	GCST003090	Depressive and manic episodes in bipolar disorder	Depressive and manic episodes in bipolar disorder	Other measurement
2390	GCST003090	Depressive and manic episodes in bipolar disorder	Depressive and manic episodes in bipolar disorder	Neurological disorder
2391	GCST001838	Palmitic acid (16:0) levels	Palmitic acid (16:0) levels	Lipid or lipoprotein measurement
2392	GCST001841	Palmitoleic acid (16:1n-7) levels	Palmitoleic acid (16:1n-7) levels	Lipid or lipoprotein measurement
2393	GCST001841	Palmitoleic acid (16:1n-7) levels	Palmitoleic acid (16:1n-7) levels	Lipid or lipoprotein measurement
2394	GCST001840	Stearic acid (18:0) levels	Stearic acid (18:0) levels	Lipid or lipoprotein measurement
2395	GCST001834	Oleic acid (18:1n-9) levels	Oleic acid (18:1n-9) levels	Lipid or lipoprotein measurement
2396	GCST001834	Oleic acid (18:1n-9) levels	Oleic acid (18:1n-9) levels	Lipid or lipoprotein measurement
2397	GCST004302	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
2398	GCST004302	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
2399	GCST004795	Brain volume in infants (white matter)	Brain volume in infants (white matter)	Other measurement
2400	GCST004796	Brain volume in infants (cerebrospinal fluid)	Brain volume in infants (cerebrospinal fluid)	Other measurement
2401	GCST004797	Brain volume in infants (grey matter)	Brain volume in infants (grey matter)	Other measurement
2402	GCST004794	Brain volume in infants (intracranial brain volume)	Brain volume in infants (intracranial brain volume)	Other measurement
2403	GCST002690	Very long-chain saturated fatty acid levels (fatty acid 20:0)	Very long-chain saturated fatty acid levels (fatty acid 20:0)	Lipid or lipoprotein measurement
2404	GCST002688	Very long-chain saturated fatty acid levels (fatty acid 22:0)	Very long-chain saturated fatty acid levels (fatty acid 22:0)	Lipid or lipoprotein measurement
2405	GCST002689	Very long-chain saturated fatty acid levels (fatty acid 24:0)	Very long-chain saturated fatty acid levels (fatty acid 24:0)	Lipid or lipoprotein measurement
2406	GCST003926	Renal underexcretion gout	Renal underexcretion gout	Metabolic disorder
2407	GCST003925	Gout	Gout	Metabolic disorder
2408	GCST003924	Renal overload gout	Renal overload gout	Metabolic disorder
2409	GCST002948	Peak creatinine levels in vancomycin therapy	Peak creatinine levels in vancomycin therapy	Response to drug
2410	GCST002948	Peak creatinine levels in vancomycin therapy	Peak creatinine levels in vancomycin therapy	Other measurement
2411	GCST002946	Vancomycin trough in vancomycin therapy	Vancomycin trough in vancomycin therapy	Other measurement
2412	GCST002946	Vancomycin trough in vancomycin therapy	Vancomycin trough in vancomycin therapy	Response to drug
2413	GCST002947	Renal elimination rate in vancomycin therapy	Renal elimination rate in vancomycin therapy	Response to drug
2414	GCST002947	Renal elimination rate in vancomycin therapy	Renal elimination rate in vancomycin therapy	Other measurement
2415	GCST006468	Straight vs curly hair	Straight vs curly hair	Other measurement
2416	GCST006468	Straight vs curly hair	Straight vs curly hair	Other trait
2417	GCST004004	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
2418	GCST004005	Hemoglobin levels	Hemoglobin levels	Hematological measurement
2419	GCST004005	Hemoglobin levels	Hemoglobin levels	Hematological measurement
2420	GCST004005	Hemoglobin levels	Hemoglobin levels	Hematological measurement
2421	GCST004005	Hemoglobin levels	Hemoglobin levels	Hematological measurement
2422	GCST004007	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
2423	GCST004007	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
2424	GCST004008	Red blood cell count	Red blood cell count	Hematological measurement
2425	GCST004006	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
2426	GCST004006	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
2427	GCST004003	Hematocrit	Hematocrit	Hematological measurement
2428	GCST002002	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	Response to drug
2429	GCST002002	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	Response to drug
2430	GCST002001	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	Response to drug
2431	GCST002001	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	Response to drug
2432	GCST001999	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	Response to drug
2433	GCST001999	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	Response to drug
2434	GCST001995	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	Response to drug
2435	GCST001995	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	Response to drug
2436	GCST001994	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	Response to drug
2437	GCST001994	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	Response to drug
2438	GCST001993	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	Response to drug
2439	GCST001993	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	Response to drug
2440	GCST002000	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	Response to drug
2441	GCST002000	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	Response to drug
2442	GCST002004	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	Response to drug
2443	GCST002004	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	Response to drug
2444	GCST002005	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	Response to drug
2445	GCST002005	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	Response to drug
2446	GCST002006	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Response to drug
2447	GCST002006	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Response to drug
2448	GCST002006	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Response to drug
2449	GCST002007	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	Response to drug
2450	GCST002007	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	Response to drug
2451	GCST002008	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	Response to drug
2452	GCST002008	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	Response to drug
2453	GCST002009	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	Response to drug
2454	GCST002009	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	Response to drug
2455	GCST001996	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	Response to drug
2456	GCST001996	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	Response to drug
2457	GCST001997	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	Response to drug
2458	GCST001997	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	Response to drug
2459	GCST001998	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	Response to drug
2460	GCST001998	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	Response to drug
2461	GCST002003	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	Response to drug
2462	GCST002003	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	Response to drug
2463	GCST002994	Ear protrusion	Ear protrusion	Other trait
2464	GCST003002	Tragus size	Tragus size	Other trait
2465	GCST003003	Antitragus size	Antitragus size	Other trait
2466	GCST003004	Crus helix expression	Crus helix expression	Other trait
2467	GCST003005	Superior crus of antihelix expression	Superior crus of antihelix expression	Other trait
2468	GCST003000	Darwin's tubercle	Darwin's tubercle	Other trait
2469	GCST003001	Ear morphology	Ear morphology	Other trait
2470	GCST002999	Lobe size	Lobe size	Other trait
2471	GCST002998	Lobe attachment	Lobe attachment	Other trait
2472	GCST002997	Helix rolling	Helix rolling	Other trait
2473	GCST002996	Folding of antihelix	Folding of antihelix	Other trait
2474	GCST004375	Resistance to antipsychotic treatment in schizophrenia	Resistance to antipsychotic treatment in schizophrenia	Response to drug
2475	GCST004375	Resistance to antipsychotic treatment in schizophrenia	Resistance to antipsychotic treatment in schizophrenia	Neurological disorder
2476	GCST004374	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Response to drug
2477	GCST004374	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Neurological disorder
2478	GCST004374	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Other measurement
2479	GCST003850	Caffeine metabolism (plasma 1,3,7-trimethyluric acid level)	Caffeine metabolism (plasma 1,3,7-trimethyluric acid level)	Other measurement
2480	GCST003847	Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)	Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)	Other measurement
2481	GCST003849	Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)	Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)	Other measurement
2482	GCST003846	Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)	Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)	Other measurement
2483	GCST003848	Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)	Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)	Other measurement
2484	GCST003851	Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)	Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)	Other measurement
2485	GCST006438	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
2486	GCST006437	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
2487	GCST006439	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
2488	GCST006436	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
2489	GCST002923	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Response to drug
2490	GCST002923	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
2491	GCST002923	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Other measurement
2492	GCST002923	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
2493	GCST002924	Paclitaxel-induced cytotoxicity	Paclitaxel-induced cytotoxicity	Other measurement
2494	GCST002924	Paclitaxel-induced cytotoxicity	Paclitaxel-induced cytotoxicity	Response to drug
2495	GCST004978	Cow's milk allergy	Cow's milk allergy	Other measurement
2496	GCST004979	Food allergy	Food allergy	Other measurement
2497	GCST004980	Peanut allergy	Peanut allergy	Other measurement
2498	GCST004977	Hen's egg allergy	Hen's egg allergy	Other measurement
2499	GCST002175	Reading disability and language impairment	Reading disability and language impairment	Neurological disorder
2500	GCST002175	Reading disability and language impairment	Reading disability and language impairment	Neurological disorder
2501	GCST004533	Fasting blood insulin	Fasting blood insulin	Other measurement
2502	GCST004530	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
2503	GCST004531	Diastolic blood pressure	Diastolic blood pressure	Other measurement
2504	GCST004531	Diastolic blood pressure	Diastolic blood pressure	Other measurement
2505	GCST004532	Fasting blood glucose	Fasting blood glucose	Other measurement
2506	GCST004762	Fasting blood insulin adjusted for BMI	Fasting blood insulin adjusted for BMI	Other measurement
2507	GCST004762	Fasting blood insulin adjusted for BMI	Fasting blood insulin adjusted for BMI	Other measurement
2508	GCST004534	Height	Height	Other measurement
2509	GCST004534	Height	Height	Body measurement
2510	GCST004543	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
2511	GCST004543	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
2512	GCST004544	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
2513	GCST004535	Hematocrit	Hematocrit	Hematological measurement
2514	GCST004759	Very low density lipoprotein cholesterol levels	Very low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
2515	GCST004551	Waist circumference	Waist circumference	Body measurement
2516	GCST004552	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
2517	GCST004552	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
2518	GCST004554	Weight	Weight	Body measurement
2519	GCST004555	Waist-hip ratio	Waist-hip ratio	Other measurement
2520	GCST004555	Waist-hip ratio	Waist-hip ratio	Body measurement
2521	GCST004556	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
2522	GCST004556	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
2523	GCST004536	Hemoglobin	Hemoglobin	Hematological measurement
2524	GCST004539	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other measurement
2525	GCST004539	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other trait
2526	GCST004540	Homeostasis model assessment of insulin resistance adjusted for BMI	Homeostasis model assessment of insulin resistance adjusted for BMI	Other measurement
2527	GCST004541	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
2528	GCST004542	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
2529	GCST004542	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
2530	GCST004545	Platelet count	Platelet count	Hematological measurement
2531	GCST004546	Red blood cell count	Red blood cell count	Hematological measurement
2532	GCST004547	Systolic blood pressure	Systolic blood pressure	Other measurement
2533	GCST004547	Systolic blood pressure	Systolic blood pressure	Other measurement
2534	GCST004548	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
2535	GCST004550	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
2536	GCST004553	White blood cell count	White blood cell count	Hematological measurement
2537	GCST004553	White blood cell count	White blood cell count	Inflammatory measurement
2538	GCST004553	White blood cell count	White blood cell count	Hematological measurement
2539	GCST004553	White blood cell count	White blood cell count	Hematological measurement
2540	GCST004553	White blood cell count	White blood cell count	Hematological measurement
2541	GCST004529	Body mass index	Body mass index	Body measurement
2542	GCST004529	Body mass index	Body mass index	Body measurement
2543	GCST004529	Body mass index	Body mass index	Other measurement
2544	GCST004537	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
2545	GCST004538	Hip bone size	Hip bone size	Body measurement
2546	GCST004760	Hip bone size adjusted for BMI	Hip bone size adjusted for BMI	Body measurement
2547	GCST004761	Fasting blood glucose adjusted for BMI	Fasting blood glucose adjusted for BMI	Other measurement
2548	GCST004761	Fasting blood glucose adjusted for BMI	Fasting blood glucose adjusted for BMI	Other measurement
2549	GCST004814	Interleukin-6 (red blood cell fatty acid level interaction)	Interleukin-6 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2550	GCST004814	Interleukin-6 (red blood cell fatty acid level interaction)	Interleukin-6 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2551	GCST004814	Interleukin-6 (red blood cell fatty acid level interaction)	Interleukin-6 (red blood cell fatty acid level interaction)	Inflammatory measurement
2552	GCST004814	Interleukin-6 (red blood cell fatty acid level interaction)	Interleukin-6 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2553	GCST004816	Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2554	GCST004816	Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2555	GCST004818	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2556	GCST004818	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2557	GCST004818	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Cardiovascular measurement
2558	GCST004820	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2559	GCST004820	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2560	GCST004820	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Other measurement
2561	GCST004821	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Other measurement
2562	GCST004821	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2563	GCST004821	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2564	GCST004817	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2565	GCST004817	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2566	GCST004817	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Other measurement
2567	GCST004815	C-reactive protein (red blood cell fatty acid level interaction)	C-reactive protein (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2568	GCST004815	C-reactive protein (red blood cell fatty acid level interaction)	C-reactive protein (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2569	GCST004815	C-reactive protein (red blood cell fatty acid level interaction)	C-reactive protein (red blood cell fatty acid level interaction)	Inflammatory measurement
2570	GCST004815	C-reactive protein (red blood cell fatty acid level interaction)	C-reactive protein (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2571	GCST004819	Osteoprotegerin (red blood cell fatty acid level interaction)	Osteoprotegerin (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2572	GCST004819	Osteoprotegerin (red blood cell fatty acid level interaction)	Osteoprotegerin (red blood cell fatty acid level interaction)	Cardiovascular measurement
2573	GCST004822	P-Selectin (red blood cell fatty acid level interaction)	P-Selectin (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
2574	GCST004822	P-Selectin (red blood cell fatty acid level interaction)	P-Selectin (red blood cell fatty acid level interaction)	Other measurement
2575	GCST005910	Smoking interaction in non-small cell lung cancer (1df test)	Smoking interaction in non-small cell lung cancer (1df test)	Biological process
2576	GCST005910	Smoking interaction in non-small cell lung cancer (1df test)	Smoking interaction in non-small cell lung cancer (1df test)	Cancer
2577	GCST005909	Smoking interaction in lung adenocarcinoma (1df test)	Smoking interaction in lung adenocarcinoma (1df test)	Biological process
2578	GCST005909	Smoking interaction in lung adenocarcinoma (1df test)	Smoking interaction in lung adenocarcinoma (1df test)	Cancer
2579	GCST005911	Smoking interaction in squamous cell lung cancer (1df test)	Smoking interaction in squamous cell lung cancer (1df test)	Biological process
2580	GCST005911	Smoking interaction in squamous cell lung cancer (1df test)	Smoking interaction in squamous cell lung cancer (1df test)	Cancer
2581	GCST004406	Neurocognitive impairment in HIV-1 infection (continuous)	Neurocognitive impairment in HIV-1 infection (continuous)	Other disease
2582	GCST004406	Neurocognitive impairment in HIV-1 infection (continuous)	Neurocognitive impairment in HIV-1 infection (continuous)	Other measurement
2583	GCST004411	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	Other measurement
2584	GCST004411	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	Other measurement
2585	GCST004411	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	Other measurement
2586	GCST004408	HIV-associated neurocognitive disorder (mild neurocognitive disorder)	HIV-associated neurocognitive disorder (mild neurocognitive disorder)	Other measurement
2587	GCST004408	HIV-associated neurocognitive disorder (mild neurocognitive disorder)	HIV-associated neurocognitive disorder (mild neurocognitive disorder)	Other measurement
2588	GCST004409	HIV-associated neurocognitive disorder	HIV-associated neurocognitive disorder	Other measurement
2589	GCST004407	Neurocognitive impairment in HIV-1 infection (dichotomous)	Neurocognitive impairment in HIV-1 infection (dichotomous)	Other disease
2590	GCST004407	Neurocognitive impairment in HIV-1 infection (dichotomous)	Neurocognitive impairment in HIV-1 infection (dichotomous)	Other measurement
2591	GCST004410	HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	Other measurement
2592	GCST004410	HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	Other measurement
2593	GCST005721	Food allergy (parent-of-origin effect)	Food allergy (parent-of-origin effect)	Other measurement
2594	GCST005721	Food allergy (parent-of-origin effect)	Food allergy (parent-of-origin effect)	Other measurement
2595	GCST005728	Egg allergy (maternal genetic effects)	Egg allergy (maternal genetic effects)	Other measurement
2596	GCST005728	Egg allergy (maternal genetic effects)	Egg allergy (maternal genetic effects)	Other measurement
2597	GCST005727	Peanut allergy (parent-of-origin effect)	Peanut allergy (parent-of-origin effect)	Other measurement
2598	GCST005727	Peanut allergy (parent-of-origin effect)	Peanut allergy (parent-of-origin effect)	Other measurement
2599	GCST005726	Milk allergy (parent-of-origin effect)	Milk allergy (parent-of-origin effect)	Other measurement
2600	GCST005726	Milk allergy (parent-of-origin effect)	Milk allergy (parent-of-origin effect)	Other measurement
2601	GCST005725	Egg allergy (parent-of-origin effect)	Egg allergy (parent-of-origin effect)	Other measurement
2602	GCST005725	Egg allergy (parent-of-origin effect)	Egg allergy (parent-of-origin effect)	Other measurement
2603	GCST005724	Food allergy (maternal genetic effects)	Food allergy (maternal genetic effects)	Other measurement
2604	GCST005724	Food allergy (maternal genetic effects)	Food allergy (maternal genetic effects)	Other measurement
2605	GCST005723	Peanut allergy (maternal genetic effects)	Peanut allergy (maternal genetic effects)	Other measurement
2606	GCST005723	Peanut allergy (maternal genetic effects)	Peanut allergy (maternal genetic effects)	Other measurement
2607	GCST005722	Milk allergy (maternal genetic effects)	Milk allergy (maternal genetic effects)	Other measurement
2608	GCST005722	Milk allergy (maternal genetic effects)	Milk allergy (maternal genetic effects)	Other measurement
2609	GCST006391	Chronic kidney disease	Chronic kidney disease	Other disease
2610	GCST006391	Chronic kidney disease	Chronic kidney disease	Other measurement
2611	GCST006391	Chronic kidney disease	Chronic kidney disease	Other measurement
2612	GCST006392	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
2613	GCST006393	Serum creatinine levels	Serum creatinine levels	Other measurement
2614	GCST005908	Height	Height	Other measurement
2615	GCST005908	Height	Height	Body measurement
2616	GCST005032	Early gestational weight gain (fetal effect)	Early gestational weight gain (fetal effect)	Other measurement
2617	GCST005032	Early gestational weight gain (fetal effect)	Early gestational weight gain (fetal effect)	Other measurement
2618	GCST005031	Gestational weight gain (fetal effect)	Gestational weight gain (fetal effect)	Other measurement
2619	GCST005031	Gestational weight gain (fetal effect)	Gestational weight gain (fetal effect)	Other measurement
2620	GCST005030	Late gestational weight gain (fetal effect)	Late gestational weight gain (fetal effect)	Other measurement
2621	GCST005030	Late gestational weight gain (fetal effect)	Late gestational weight gain (fetal effect)	Other measurement
2622	GCST005029	Early gestation weight gain (maternal effect)	Early gestation weight gain (maternal effect)	Other measurement
2623	GCST005034	Late gestational weight gain (maternal effect)	Late gestational weight gain (maternal effect)	Other measurement
2624	GCST005033	Gestational weight gain (maternal effect)	Gestational weight gain (maternal effect)	Other measurement
2625	GCST005189	Tanning	Tanning	Other trait
2626	GCST005188	Skin pigmentation	Skin pigmentation	Other trait
2627	GCST005188	Skin pigmentation	Skin pigmentation	Other measurement
2628	GCST006070	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	Other disease
2629	GCST006070	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	Response to drug
2630	GCST006070	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	Other measurement
2631	GCST006071	Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	Other disease
2632	GCST006071	Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	Response to drug
2633	GCST006069	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Other disease
2634	GCST006069	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Response to drug
2635	GCST006069	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Other measurement
2636	GCST006072	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	Other disease
2637	GCST006072	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	Response to drug
2638	GCST006072	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	Other measurement
2639	GCST006073	Tenofovir clearance in HIV infection	Tenofovir clearance in HIV infection	Other disease
2640	GCST006073	Tenofovir clearance in HIV infection	Tenofovir clearance in HIV infection	Response to drug
2641	GCST006074	Bilirubin levels in tenofovir-treated HIV infection	Bilirubin levels in tenofovir-treated HIV infection	Other disease
2642	GCST006074	Bilirubin levels in tenofovir-treated HIV infection	Bilirubin levels in tenofovir-treated HIV infection	Other measurement
2643	GCST006074	Bilirubin levels in tenofovir-treated HIV infection	Bilirubin levels in tenofovir-treated HIV infection	Response to drug
2644	GCST002928	Nickel levels	Nickel levels	Other measurement
2645	GCST002929	Chromium levels	Chromium levels	Other measurement
2646	GCST002930	Cobalt levels	Cobalt levels	Other measurement
2647	GCST002931	Aluminium levels	Aluminium levels	Other measurement
2648	GCST002932	Manganese levels	Manganese levels	Other measurement
2649	GCST002937	Molybdenum levels	Molybdenum levels	Other measurement
2650	GCST002935	Lead levels	Lead levels	Other measurement
2651	GCST002934	Zinc levels	Zinc levels	Other measurement
2652	GCST002927	Mercury levels	Mercury levels	Other measurement
2653	GCST002936	Cadmium levels	Cadmium levels	Other measurement
2654	GCST002938	Copper levels	Copper levels	Other measurement
2655	GCST005965	B cell acute lymphoblastic leukaemia (normal cytogenetics)	B cell acute lymphoblastic leukaemia (normal cytogenetics)	Cancer
2656	GCST005966	B cell acute lymphoblastic leukaemia (hyperdiploid negative)	B cell acute lymphoblastic leukaemia (hyperdiploid negative)	Cancer
2657	GCST005967	B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)	B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)	Cancer
2658	GCST005968	B cell acute lymphoblastic leukaemia (abnormal cytogenetics)	B cell acute lymphoblastic leukaemia (abnormal cytogenetics)	Cancer
2659	GCST005969	Acute lymphoblastic leukemia in childhood (B cell precursor)	Acute lymphoblastic leukemia in childhood (B cell precursor)	Cancer
2660	GCST005970	B cell acute lymphoblastic leukaemia in young adulthood	B cell acute lymphoblastic leukaemia in young adulthood	Cancer
2661	GCST005971	B cell acute lymphoblastic leukaemia in adulthood	B cell acute lymphoblastic leukaemia in adulthood	Cancer
2662	GCST005972	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
2663	GCST005972	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
2664	GCST006138	Resting-state electroencephalogram vigilance	Resting-state electroencephalogram vigilance	Other measurement
2665	GCST006413	Lung cancer x radon exposure interaction (1df)	Lung cancer x radon exposure interaction (1df)	Cancer
2666	GCST006413	Lung cancer x radon exposure interaction (1df)	Lung cancer x radon exposure interaction (1df)	Other measurement
2667	GCST003630	Left ventricular QRS voltage	Left ventricular QRS voltage	Cardiovascular measurement
2668	GCST003630	Left ventricular QRS voltage	Left ventricular QRS voltage	Cardiovascular measurement
2669	GCST003630	Left ventricular QRS voltage	Left ventricular QRS voltage	Cardiovascular measurement
2670	GCST006867	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
2671	GCST006868	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
2672	GCST007392	Mitochondrial DNA copy number (white blood cells)	Mitochondrial DNA copy number (white blood cells)	Other measurement
2673	GCST007393	Mitochondrial DNA copy number	Mitochondrial DNA copy number	Other measurement
2674	GCST007394	Mitochondrial DNA copy number	Mitochondrial DNA copy number	Other measurement
2675	GCST007395	Mitochondrial DNA copy number	Mitochondrial DNA copy number	Other measurement
2676	GCST007396	Mitochondrial DNA copy number (white blood cells)	Mitochondrial DNA copy number (white blood cells)	Other measurement
2677	GCST007397	Mitochondrial DNA copy number (white blood cells)	Mitochondrial DNA copy number (white blood cells)	Other measurement
2678	GCST007398	Mitochondrial DNA copy number (white blood cells)	Mitochondrial DNA copy number (white blood cells)	Other measurement
2679	GCST007399	Mitochondrial DNA copy number	Mitochondrial DNA copy number	Other measurement
2680	GCST007190	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
2681	GCST007187	Visceral adipose tissue	Visceral adipose tissue	Other measurement
2682	GCST007188	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
2683	GCST007188	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
2684	GCST007189	visceral adipose tissue/total adipose tissue ratio	visceral adipose tissue/total adipose tissue ratio	Other measurement
2685	GCST004748	Lung cancer	Lung cancer	Cancer
2686	GCST004748	Lung cancer	Lung cancer	Cancer
2687	GCST004748	Lung cancer	Lung cancer	Cancer
2688	GCST004744	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
2689	GCST004750	Squamous cell lung carcinoma	Squamous cell lung carcinoma	Cancer
2690	GCST004746	Small cell lung carcinoma	Small cell lung carcinoma	Cancer
2691	GCST004749	Lung cancer in ever smokers	Lung cancer in ever smokers	Other measurement
2692	GCST004749	Lung cancer in ever smokers	Lung cancer in ever smokers	Cancer
2693	GCST004747	Lung cancer in never smokers	Lung cancer in never smokers	Other measurement
2694	GCST004747	Lung cancer in never smokers	Lung cancer in never smokers	Cancer
2695	GCST005949	Body mass index x sex interaction	Body mass index x sex interaction	Body measurement
2696	GCST005949	Body mass index x sex interaction	Body mass index x sex interaction	Other measurement
2697	GCST005950	Body mass index x sex x age interaction (4df test)	Body mass index x sex x age interaction (4df test)	Body measurement
2698	GCST005950	Body mass index x sex x age interaction (4df test)	Body mass index x sex x age interaction (4df test)	Other measurement
2699	GCST005950	Body mass index x sex x age interaction (4df test)	Body mass index x sex x age interaction (4df test)	Other measurement
2700	GCST005951	Body mass index	Body mass index	Body measurement
2701	GCST005951	Body mass index	Body mass index	Body measurement
2702	GCST005951	Body mass index	Body mass index	Other measurement
2703	GCST005952	Body mass index (age>50)	Body mass index (age>50)	Body measurement
2704	GCST005953	Body mass index (age <50)	Body mass index (age <50)	Body measurement
2705	GCST005954	Body mass index x age interaction	Body mass index x age interaction	Body measurement
2706	GCST005954	Body mass index x age interaction	Body mass index x age interaction	Other measurement
2707	GCST005955	Body mass index x sex x age interaction	Body mass index x sex x age interaction	Body measurement
2708	GCST005955	Body mass index x sex x age interaction	Body mass index x sex x age interaction	Other measurement
2709	GCST005955	Body mass index x sex x age interaction	Body mass index x sex x age interaction	Other measurement
2710	GCST005956	Waist-to-hip ratio adjusted for BMI	Waist-to-hip ratio adjusted for BMI	Body measurement
2711	GCST005957	Waist-to-hip ratio adjusted for BMI (age <50)	Waist-to-hip ratio adjusted for BMI (age <50)	Body measurement
2712	GCST005958	Waist-to-hip ratio adjusted for BMI (age >50)	Waist-to-hip ratio adjusted for BMI (age >50)	Body measurement
2713	GCST005959	Waist-to-hip ratio adjusted for BMI x sex interaction	Waist-to-hip ratio adjusted for BMI x sex interaction	Body measurement
2714	GCST005959	Waist-to-hip ratio adjusted for BMI x sex interaction	Waist-to-hip ratio adjusted for BMI x sex interaction	Other measurement
2715	GCST005960	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Body measurement
2716	GCST005960	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Other measurement
2717	GCST005960	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Other measurement
2718	GCST005961	Waist-to-hip ratio adjusted for BMI x age interaction	Waist-to-hip ratio adjusted for BMI x age interaction	Body measurement
2719	GCST005961	Waist-to-hip ratio adjusted for BMI x age interaction	Waist-to-hip ratio adjusted for BMI x age interaction	Other measurement
2720	GCST005962	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Body measurement
2721	GCST005962	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Other measurement
2722	GCST005962	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Other measurement
2723	GCST003681	C-reactive protein levels or triglyceride levels (pleiotropy)	C-reactive protein levels or triglyceride levels (pleiotropy)	Lipid or lipoprotein measurement
2724	GCST003681	C-reactive protein levels or triglyceride levels (pleiotropy)	C-reactive protein levels or triglyceride levels (pleiotropy)	Inflammatory measurement
2725	GCST003680	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
2726	GCST003680	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	Inflammatory measurement
2727	GCST003679	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
2728	GCST003679	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	Inflammatory measurement
2729	GCST003678	C-reactive protein levels or total cholesterol levels (pleiotropy)	C-reactive protein levels or total cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
2730	GCST003678	C-reactive protein levels or total cholesterol levels (pleiotropy)	C-reactive protein levels or total cholesterol levels (pleiotropy)	Inflammatory measurement
2731	GCST004987	Antipsychotic drug-induced QTc interval change in schizophrenia	Antipsychotic drug-induced QTc interval change in schizophrenia	Response to drug
2732	GCST004987	Antipsychotic drug-induced QTc interval change in schizophrenia	Antipsychotic drug-induced QTc interval change in schizophrenia	Neurological disorder
2733	GCST004987	Antipsychotic drug-induced QTc interval change in schizophrenia	Antipsychotic drug-induced QTc interval change in schizophrenia	Cardiovascular measurement
2734	GCST004861	Itch intensity from mosquito bite	Itch intensity from mosquito bite	Other measurement
2735	GCST004862	Itch intensity from mosquito bite adjusted by bite size	Itch intensity from mosquito bite adjusted by bite size	Other measurement
2736	GCST004862	Itch intensity from mosquito bite adjusted by bite size	Itch intensity from mosquito bite adjusted by bite size	Other measurement
2737	GCST004863	Mosquito bite size	Mosquito bite size	Other measurement
2738	GCST004864	Perceived unattractiveness to mosquitoes	Perceived unattractiveness to mosquitoes	Other measurement
2739	GCST004865	Itch intensity from mosquito bite adjusted by bite size	Itch intensity from mosquito bite adjusted by bite size	Other measurement
2740	GCST004865	Itch intensity from mosquito bite adjusted by bite size	Itch intensity from mosquito bite adjusted by bite size	Other measurement
2741	GCST003984	Parkinson's disease	Parkinson's disease	Neurological disorder
2742	GCST003985	Breast size	Breast size	Body measurement
2743	GCST003986	Migraine	Migraine	Cardiovascular disease
2744	GCST003987	Asthma	Asthma	Other disease
2745	GCST003989	Chin dimples	Chin dimples	Other measurement
2746	GCST003990	Allergy	Allergy	Immune system disorder
2747	GCST003991	Childhood ear infection	Childhood ear infection	Other measurement
2748	GCST003992	Photic sneeze reflex	Photic sneeze reflex	Other trait
2749	GCST003993	Menarche (age at onset)	Menarche (age at onset)	Other measurement
2750	GCST003994	Age at voice drop	Age at voice drop	Other measurement
2751	GCST003995	Tonsillectomy	Tonsillectomy	Other measurement
2752	GCST003996	Monobrow	Monobrow	Other measurement
2753	GCST003997	Myopia	Myopia	Other trait
2754	GCST003998	Joint mobility (Beighton score)	Joint mobility (Beighton score)	Other measurement
2755	GCST003999	Nose size	Nose size	Other measurement
2756	GCST003983	Male-pattern baldness	Male-pattern baldness	Other measurement
2757	GCST003983	Male-pattern baldness	Male-pattern baldness	Other disease
2758	GCST003983	Male-pattern baldness	Male-pattern baldness	Other disease
2759	GCST003988	Hypothyroidism	Hypothyroidism	Other disease
2760	GCST004763	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Lipid or lipoprotein measurement
2761	GCST004763	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
2762	GCST004763	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Metabolic disorder
2763	GCST004763	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
2764	GCST004764	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Lipid or lipoprotein measurement
2765	GCST004764	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
2766	GCST004764	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Metabolic disorder
2767	GCST004764	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
2768	GCST004765	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Lipid or lipoprotein measurement
2769	GCST004765	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
2770	GCST004765	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Metabolic disorder
2771	GCST004765	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
2772	GCST004766	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
2773	GCST004766	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Lipid or lipoprotein measurement
2774	GCST004766	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Metabolic disorder
2775	GCST004766	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
2776	GCST006492	Obesity without metabolic disease	Obesity without metabolic disease	Metabolic disorder
2777	GCST006541	Axial length	Axial length	Other measurement
2778	GCST006539	Spherical error	Spherical error	Other measurement
2779	GCST006864	Axial length or spherical error (univariate decomposition analysis)	Axial length or spherical error (univariate decomposition analysis)	Other measurement
2780	GCST006864	Axial length or spherical error (univariate decomposition analysis)	Axial length or spherical error (univariate decomposition analysis)	Other measurement
2781	GCST006631	Nicotine dependence and major depression (severity of comorbidity)	Nicotine dependence and major depression (severity of comorbidity)	Other measurement
2782	GCST006631	Nicotine dependence and major depression (severity of comorbidity)	Nicotine dependence and major depression (severity of comorbidity)	Other measurement
2783	GCST007845	Progressive supranuclear palsy	Progressive supranuclear palsy	Neurological disorder
2784	GCST006940	Neurociticism	Neurociticism	Other measurement
2785	GCST006941	Irritable mood	Irritable mood	Other measurement
2786	GCST006942	Feeling lonely	Feeling lonely	Other measurement
2787	GCST006943	Feeling miserable	Feeling miserable	Other measurement
2788	GCST006944	Experiencing mood swings	Experiencing mood swings	Other measurement
2789	GCST006945	Feeling guilty	Feeling guilty	Other measurement
2790	GCST006946	Worry too long after an embarrassing experience	Worry too long after an embarrassing experience	Other measurement
2791	GCST006947	Feeling fed-up	Feeling fed-up	Other measurement
2792	GCST006948	Feeling nervous	Feeling nervous	Other measurement
2793	GCST006949	Suffering from nerves	Suffering from nerves	Neurological disorder
2794	GCST006950	Feeling worry	Feeling worry	Other measurement
2795	GCST006951	Feeling hurt	Feeling hurt	Other measurement
2796	GCST006952	Feeling tense	Feeling tense	Other measurement
2797	GCST004231	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
2798	GCST004233	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
2799	GCST004233	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
2800	GCST004234	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
2801	GCST004235	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
2802	GCST004236	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
2803	GCST004236	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
2804	GCST004237	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
2805	GCST004238	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
2806	GCST004232	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
2807	GCST007036	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
2808	GCST007036	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
2809	GCST006615	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Other measurement
2810	GCST006615	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Cancer
2811	GCST006615	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Response to drug
2812	GCST005928	Refractory celiac disease type II	Refractory celiac disease type II	Digestive system disorder
2813	GCST006305	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
2814	GCST006306	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
2815	GCST006307	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
2816	GCST006307	LDL cholesterol	LDL cholesterol	Other measurement
2817	GCST006307	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
2818	GCST006308	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
2819	GCST006469	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
2820	GCST006470	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
2821	GCST006471	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
2822	GCST006471	LDL cholesterol	LDL cholesterol	Other measurement
2823	GCST006471	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
2824	GCST006472	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
2825	GCST005626	Extremely high intelligence	Extremely high intelligence	Biological process
2826	GCST005442	Apolipoprotein B levels	Apolipoprotein B levels	Lipid or lipoprotein measurement
2827	GCST005443	Ratio of apolipoprotein A1 to apolipoprotein B	Ratio of apolipoprotein A1 to apolipoprotein B	Lipid or lipoprotein measurement
2828	GCST005443	Ratio of apolipoprotein A1 to apolipoprotein B	Ratio of apolipoprotein A1 to apolipoprotein B	Lipid or lipoprotein measurement
2829	GCST005444	Esterified cholesterol levels	Esterified cholesterol levels	Lipid or lipoprotein measurement
2830	GCST005445	Free cholesterol levels	Free cholesterol levels	Lipid or lipoprotein measurement
2831	GCST005446	Total cholesterol levels in HDL	Total cholesterol levels in HDL	Lipid or lipoprotein measurement
2832	GCST005447	Total cholesterol levels in LDL	Total cholesterol levels in LDL	Lipid or lipoprotein measurement
2833	GCST005448	Serum total cholesterol levels	Serum total cholesterol levels	Lipid or lipoprotein measurement
2834	GCST005449	Total triglycerides levels	Total triglycerides levels	Lipid or lipoprotein measurement
2835	GCST005455	Mean diameter of HDL particles	Mean diameter of HDL particles	Lipid or lipoprotein measurement
2836	GCST005456	Mean diameter of LDL particles	Mean diameter of LDL particles	Lipid or lipoprotein measurement
2837	GCST005457	Mean diameter of VLDL particles	Mean diameter of VLDL particles	Lipid or lipoprotein measurement
2838	GCST005450	Very large VLDL particle concentration	Very large VLDL particle concentration	Lipid or lipoprotein measurement
2839	GCST005451	Phospholipid levels in very large VLDL	Phospholipid levels in very large VLDL	Lipid or lipoprotein measurement
2840	GCST005451	Phospholipid levels in very large VLDL	Phospholipid levels in very large VLDL	Lipid or lipoprotein measurement
2841	GCST005452	Triglyceride levels in very large VLDL	Triglyceride levels in very large VLDL	Lipid or lipoprotein measurement
2842	GCST005452	Triglyceride levels in very large VLDL	Triglyceride levels in very large VLDL	Lipid or lipoprotein measurement
2843	GCST005453	Very large VLDL particle concentration	Very large VLDL particle concentration	Lipid or lipoprotein measurement
2844	GCST005454	Phospholipid levels in large VLDL	Phospholipid levels in large VLDL	Lipid or lipoprotein measurement
2845	GCST005454	Phospholipid levels in large VLDL	Phospholipid levels in large VLDL	Lipid or lipoprotein measurement
2846	GCST005458	Total cholesterol levels in large VLDL	Total cholesterol levels in large VLDL	Lipid or lipoprotein measurement
2847	GCST005459	Free cholesterol levels in large VLDL	Free cholesterol levels in large VLDL	Lipid or lipoprotein measurement
2848	GCST005459	Free cholesterol levels in large VLDL	Free cholesterol levels in large VLDL	Lipid or lipoprotein measurement
2849	GCST005460	Triglyceride levels in large VLDL	Triglyceride levels in large VLDL	Lipid or lipoprotein measurement
2850	GCST005460	Triglyceride levels in large VLDL	Triglyceride levels in large VLDL	Lipid or lipoprotein measurement
2851	GCST005461	Cholesterol ester levels in large VLDL	Cholesterol ester levels in large VLDL	Lipid or lipoprotein measurement
2852	GCST005461	Cholesterol ester levels in large VLDL	Cholesterol ester levels in large VLDL	Lipid or lipoprotein measurement
2853	GCST005462	Medium VLDL particle concentration	Medium VLDL particle concentration	Lipid or lipoprotein measurement
2854	GCST005463	Phospholipid levels in medium VLDL	Phospholipid levels in medium VLDL	Lipid or lipoprotein measurement
2855	GCST005463	Phospholipid levels in medium VLDL	Phospholipid levels in medium VLDL	Lipid or lipoprotein measurement
2856	GCST005464	Total cholesterol levels in medium VLDL	Total cholesterol levels in medium VLDL	Lipid or lipoprotein measurement
2857	GCST005465	Cholesterol ester levels in medium VLDL	Cholesterol ester levels in medium VLDL	Lipid or lipoprotein measurement
2858	GCST005465	Cholesterol ester levels in medium VLDL	Cholesterol ester levels in medium VLDL	Lipid or lipoprotein measurement
2859	GCST005466	Free cholesterol levels in medium VLDL	Free cholesterol levels in medium VLDL	Lipid or lipoprotein measurement
2860	GCST005466	Free cholesterol levels in medium VLDL	Free cholesterol levels in medium VLDL	Lipid or lipoprotein measurement
2861	GCST005467	Triglyceride levels in medium VLDL	Triglyceride levels in medium VLDL	Lipid or lipoprotein measurement
2862	GCST005467	Triglyceride levels in medium VLDL	Triglyceride levels in medium VLDL	Lipid or lipoprotein measurement
2863	GCST005468	Small VLDL particle concentration	Small VLDL particle concentration	Lipid or lipoprotein measurement
2864	GCST005469	Phospholipid levels in small VLDL	Phospholipid levels in small VLDL	Lipid or lipoprotein measurement
2865	GCST005469	Phospholipid levels in small VLDL	Phospholipid levels in small VLDL	Lipid or lipoprotein measurement
2866	GCST005470	Total cholesterol levels in small VLDL	Total cholesterol levels in small VLDL	Lipid or lipoprotein measurement
2867	GCST005471	Free cholesterol levels in small VLDL	Free cholesterol levels in small VLDL	Lipid or lipoprotein measurement
2868	GCST005471	Free cholesterol levels in small VLDL	Free cholesterol levels in small VLDL	Lipid or lipoprotein measurement
2869	GCST005472	Triglyceride levels in small VLDL	Triglyceride levels in small VLDL	Lipid or lipoprotein measurement
2870	GCST005472	Triglyceride levels in small VLDL	Triglyceride levels in small VLDL	Lipid or lipoprotein measurement
2871	GCST005473	Very small VLDL particle concentration	Very small VLDL particle concentration	Lipid or lipoprotein measurement
2872	GCST005474	Phospholipid levels in very small VLDL	Phospholipid levels in very small VLDL	Lipid or lipoprotein measurement
2873	GCST005474	Phospholipid levels in very small VLDL	Phospholipid levels in very small VLDL	Lipid or lipoprotein measurement
2874	GCST005475	Triglyceride levels in very small VLDL	Triglyceride levels in very small VLDL	Lipid or lipoprotein measurement
2875	GCST005475	Triglyceride levels in very small VLDL	Triglyceride levels in very small VLDL	Lipid or lipoprotein measurement
2876	GCST005476	IDL particle concentration	IDL particle concentration	Lipid or lipoprotein measurement
2877	GCST005477	Phospholipid levels in IDL	Phospholipid levels in IDL	Lipid or lipoprotein measurement
2878	GCST005477	Phospholipid levels in IDL	Phospholipid levels in IDL	Lipid or lipoprotein measurement
2879	GCST005478	IDL particle concentration	IDL particle concentration	Lipid or lipoprotein measurement
2880	GCST005479	Free cholesterol levels in IDL	Free cholesterol levels in IDL	Lipid or lipoprotein measurement
2881	GCST005479	Free cholesterol levels in IDL	Free cholesterol levels in IDL	Lipid or lipoprotein measurement
2882	GCST005480	Triglyceride levels in IDL	Triglyceride levels in IDL	Lipid or lipoprotein measurement
2883	GCST005480	Triglyceride levels in IDL	Triglyceride levels in IDL	Lipid or lipoprotein measurement
2884	GCST005481	Large LDL particle concentration	Large LDL particle concentration	Lipid or lipoprotein measurement
2885	GCST005482	Phospholipid levels in large LDL	Phospholipid levels in large LDL	Lipid or lipoprotein measurement
2886	GCST005482	Phospholipid levels in large LDL	Phospholipid levels in large LDL	Lipid or lipoprotein measurement
2887	GCST005483	Total cholesterol levels in large LDL	Total cholesterol levels in large LDL	Lipid or lipoprotein measurement
2888	GCST005484	Cholesterol ester levels in large LDL	Cholesterol ester levels in large LDL	Lipid or lipoprotein measurement
2889	GCST005484	Cholesterol ester levels in large LDL	Cholesterol ester levels in large LDL	Lipid or lipoprotein measurement
2890	GCST005485	Free cholesterol levels in large LDL	Free cholesterol levels in large LDL	Lipid or lipoprotein measurement
2891	GCST005485	Free cholesterol levels in large LDL	Free cholesterol levels in large LDL	Lipid or lipoprotein measurement
2892	GCST005486	Medium LDL particle concentration	Medium LDL particle concentration	Lipid or lipoprotein measurement
2893	GCST005487	Phospholipid levels in medium LDL	Phospholipid levels in medium LDL	Lipid or lipoprotein measurement
2894	GCST005487	Phospholipid levels in medium LDL	Phospholipid levels in medium LDL	Lipid or lipoprotein measurement
2895	GCST005488	Total cholesterol levels in medium LDL	Total cholesterol levels in medium LDL	Lipid or lipoprotein measurement
2896	GCST005489	Cholesterol ester levels in medium LDL	Cholesterol ester levels in medium LDL	Lipid or lipoprotein measurement
2897	GCST005489	Cholesterol ester levels in medium LDL	Cholesterol ester levels in medium LDL	Lipid or lipoprotein measurement
2898	GCST005490	Small LDL particle concentration	Small LDL particle concentration	Lipid or lipoprotein measurement
2899	GCST005491	Total cholesterol levels in small LDL	Total cholesterol levels in small LDL	Lipid or lipoprotein measurement
2900	GCST005492	Very large HDL particle concentration	Very large HDL particle concentration	Lipid or lipoprotein measurement
2901	GCST005493	Phospholipid levels in very large HDL	Phospholipid levels in very large HDL	Lipid or lipoprotein measurement
2902	GCST005493	Phospholipid levels in very large HDL	Phospholipid levels in very large HDL	Lipid or lipoprotein measurement
2903	GCST005494	Total cholesterol levels in very large HDL	Total cholesterol levels in very large HDL	Lipid or lipoprotein measurement
2904	GCST005495	Cholesterol ester levels in very large HDL	Cholesterol ester levels in very large HDL	Lipid or lipoprotein measurement
2905	GCST005495	Cholesterol ester levels in very large HDL	Cholesterol ester levels in very large HDL	Lipid or lipoprotein measurement
2906	GCST005496	Free cholesterol levels in very large HDL	Free cholesterol levels in very large HDL	Lipid or lipoprotein measurement
2907	GCST005496	Free cholesterol levels in very large HDL	Free cholesterol levels in very large HDL	Lipid or lipoprotein measurement
2908	GCST005498	Triglyceride levels in very large HDL	Triglyceride levels in very large HDL	Lipid or lipoprotein measurement
2909	GCST005498	Triglyceride levels in very large HDL	Triglyceride levels in very large HDL	Lipid or lipoprotein measurement
2910	GCST005497	Large HDL particle concentration	Large HDL particle concentration	Lipid or lipoprotein measurement
2911	GCST005499	Phospholipid levels in large HDL	Phospholipid levels in large HDL	Lipid or lipoprotein measurement
2912	GCST005499	Phospholipid levels in large HDL	Phospholipid levels in large HDL	Lipid or lipoprotein measurement
2913	GCST005500	Total cholesterol levels in large HDL	Total cholesterol levels in large HDL	Lipid or lipoprotein measurement
2914	GCST005501	Cholesterol ester levels in very large HDL	Cholesterol ester levels in very large HDL	Lipid or lipoprotein measurement
2915	GCST005501	Cholesterol ester levels in very large HDL	Cholesterol ester levels in very large HDL	Lipid or lipoprotein measurement
2916	GCST005502	Free cholesterol levels in large HDL	Free cholesterol levels in large HDL	Lipid or lipoprotein measurement
2917	GCST005502	Free cholesterol levels in large HDL	Free cholesterol levels in large HDL	Lipid or lipoprotein measurement
2918	GCST005503	Medium HDL particle concentration	Medium HDL particle concentration	Lipid or lipoprotein measurement
2919	GCST005504	Phospholipid levels in medium HDL	Phospholipid levels in medium HDL	Lipid or lipoprotein measurement
2920	GCST005504	Phospholipid levels in medium HDL	Phospholipid levels in medium HDL	Lipid or lipoprotein measurement
2921	GCST005505	Total cholesterol levels in medium HDL	Total cholesterol levels in medium HDL	Lipid or lipoprotein measurement
2922	GCST005506	Cholesterol ester levels in medium HDL	Cholesterol ester levels in medium HDL	Lipid or lipoprotein measurement
2923	GCST005506	Cholesterol ester levels in medium HDL	Cholesterol ester levels in medium HDL	Lipid or lipoprotein measurement
2924	GCST005507	Free cholesterol levels in medium HDL	Free cholesterol levels in medium HDL	Lipid or lipoprotein measurement
2925	GCST005508	Small HDL particle concentration	Small HDL particle concentration	Lipid or lipoprotein measurement
2926	GCST005509	Triglyceride levels in small HDL	Triglyceride levels in small HDL	Lipid or lipoprotein measurement
2927	GCST005509	Triglyceride levels in small HDL	Triglyceride levels in small HDL	Lipid or lipoprotein measurement
2928	GCST005510	Chylomicron and largest VLDL particle concentration	Chylomicron and largest VLDL particle concentration	Lipid or lipoprotein measurement
2929	GCST005510	Chylomicron and largest VLDL particle concentration	Chylomicron and largest VLDL particle concentration	Lipid or lipoprotein measurement
2930	GCST005511	Phospholipid levels in chylomicrons and largest VLDL	Phospholipid levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
2931	GCST005511	Phospholipid levels in chylomicrons and largest VLDL	Phospholipid levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
2932	GCST005511	Phospholipid levels in chylomicrons and largest VLDL	Phospholipid levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
2933	GCST005512	Triglyceride levels in chylomicrons and largest VLDL	Triglyceride levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
2934	GCST005512	Triglyceride levels in chylomicrons and largest VLDL	Triglyceride levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
2935	GCST005512	Triglyceride levels in chylomicrons and largest VLDL	Triglyceride levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
2936	GCST005513	Apolipoprotein A1 levels	Apolipoprotein A1 levels	Lipid or lipoprotein measurement
2937	GCST005691	Major depressive disorder	Major depressive disorder	Neurological disorder
2938	GCST005690	Major depressive disorder (exposed to adversity)	Major depressive disorder (exposed to adversity)	Neurological disorder
2939	GCST005689	Major depressive disorder (unexposed to adversity)	Major depressive disorder (unexposed to adversity)	Neurological disorder
2940	GCST005096	Iris color (b* coordinate)	Iris color (b* coordinate)	Other measurement
2941	GCST005096	Iris color (b* coordinate)	Iris color (b* coordinate)	Other trait
2942	GCST005095	Iris heterochromicity	Iris heterochromicity	Other measurement
2943	GCST005095	Iris heterochromicity	Iris heterochromicity	Other trait
2944	GCST005084	Skin pigmentation	Skin pigmentation	Other trait
2945	GCST005084	Skin pigmentation	Skin pigmentation	Other measurement
2946	GCST005094	Iris color (L* coordinate)	Iris color (L* coordinate)	Other measurement
2947	GCST005094	Iris color (L* coordinate)	Iris color (L* coordinate)	Other trait
2948	GCST005093	Iris color (a* coordinate)	Iris color (a* coordinate)	Other measurement
2949	GCST005093	Iris color (a* coordinate)	Iris color (a* coordinate)	Other trait
2950	GCST004496	BMI (smoking interaction)	BMI (smoking interaction)	Biological process
2951	GCST004496	BMI (smoking interaction)	BMI (smoking interaction)	Body measurement
2952	GCST004500	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	Biological process
2953	GCST004500	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	Body measurement
2954	GCST004506	Waist-to-hip ratio adjusted for BMI (smoking interaction)	Waist-to-hip ratio adjusted for BMI (smoking interaction)	Biological process
2955	GCST004506	Waist-to-hip ratio adjusted for BMI (smoking interaction)	Waist-to-hip ratio adjusted for BMI (smoking interaction)	Body measurement
2956	GCST004501	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	Biological process
2957	GCST004501	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	Body measurement
2958	GCST004497	Body mass index (joint analysis main effects and smoking interaction)	Body mass index (joint analysis main effects and smoking interaction)	Biological process
2959	GCST004497	Body mass index (joint analysis main effects and smoking interaction)	Body mass index (joint analysis main effects and smoking interaction)	Body measurement
2960	GCST004502	Waist circumference adjusted for BMI (smoking interaction)	Waist circumference adjusted for BMI (smoking interaction)	Biological process
2961	GCST004502	Waist circumference adjusted for BMI (smoking interaction)	Waist circumference adjusted for BMI (smoking interaction)	Body measurement
2962	GCST004505	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	Biological process
2963	GCST004505	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	Body measurement
2964	GCST004504	Waist circumference adjusted for BMI in non-smokers	Waist circumference adjusted for BMI in non-smokers	Body measurement
2965	GCST004499	BMI in non-smokers	BMI in non-smokers	Body measurement
2966	GCST004503	Waist circumference adjusted for BMI in smokers	Waist circumference adjusted for BMI in smokers	Biological process
2967	GCST004503	Waist circumference adjusted for BMI in smokers	Waist circumference adjusted for BMI in smokers	Body measurement
2968	GCST004498	BMI in smokers	BMI in smokers	Biological process
2969	GCST004498	BMI in smokers	BMI in smokers	Body measurement
2970	GCST004508	Waist-to-hip ratio adjusted for BMI in non-smokers	Waist-to-hip ratio adjusted for BMI in non-smokers	Body measurement
2971	GCST004495	BMI (adjusted for smoking behaviour)	BMI (adjusted for smoking behaviour)	Biological process
2972	GCST004495	BMI (adjusted for smoking behaviour)	BMI (adjusted for smoking behaviour)	Body measurement
2973	GCST004507	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	Biological process
2974	GCST004507	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	Body measurement
2975	GCST004509	Waist-to-hip ratio adjusted for BMI in smokers	Waist-to-hip ratio adjusted for BMI in smokers	Biological process
2976	GCST004509	Waist-to-hip ratio adjusted for BMI in smokers	Waist-to-hip ratio adjusted for BMI in smokers	Body measurement
2977	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Digestive system disorder
2978	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Immune system disorder
2979	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Immune system disorder
2980	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Neurological disorder
2981	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Immune system disorder
2982	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Immune system disorder
2983	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Digestive system disorder
2984	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Immune system disorder
2985	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Immune system disorder
2986	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Neurological disorder
2987	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Immune system disorder
2988	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Immune system disorder
2989	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Metabolic disorder
2990	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Digestive system disorder
2991	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Immune system disorder
2992	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Immune system disorder
2993	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Neurological disorder
2994	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Immune system disorder
2995	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Immune system disorder
2996	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Metabolic disorder
2997	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Digestive system disorder
2998	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Immune system disorder
2999	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Immune system disorder
3000	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Neurological disorder
3001	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Immune system disorder
3002	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Immune system disorder
3003	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Metabolic disorder
3004	GCST005159	Insulin levels in response to oral glucose tolerance test (fasting)	Insulin levels in response to oral glucose tolerance test (fasting)	Other measurement
3005	GCST005159	Insulin levels in response to oral glucose tolerance test (fasting)	Insulin levels in response to oral glucose tolerance test (fasting)	Other measurement
3006	GCST005162	Glucagon levels in response to oral glucose tolerance test (fasting)	Glucagon levels in response to oral glucose tolerance test (fasting)	Other measurement
3007	GCST005162	Glucagon levels in response to oral glucose tolerance test (fasting)	Glucagon levels in response to oral glucose tolerance test (fasting)	Other measurement
3008	GCST005167	GIP levels in response to oral glucose tolerance test (fasting)	GIP levels in response to oral glucose tolerance test (fasting)	Other measurement
3009	GCST005167	GIP levels in response to oral glucose tolerance test (fasting)	GIP levels in response to oral glucose tolerance test (fasting)	Other measurement
3010	GCST005164	GLP-1 levels in response to oral glucose tolerance test (fasting)	GLP-1 levels in response to oral glucose tolerance test (fasting)	Other measurement
3011	GCST005164	GLP-1 levels in response to oral glucose tolerance test (fasting)	GLP-1 levels in response to oral glucose tolerance test (fasting)	Other measurement
3012	GCST005160	Insulin levels in response to oral glucose tolerance test (30 minutes)	Insulin levels in response to oral glucose tolerance test (30 minutes)	Other measurement
3013	GCST005160	Insulin levels in response to oral glucose tolerance test (30 minutes)	Insulin levels in response to oral glucose tolerance test (30 minutes)	Other measurement
3014	GCST005161	Insulin levels in response to oral glucose tolerance test (120 minutes)	Insulin levels in response to oral glucose tolerance test (120 minutes)	Other measurement
3015	GCST005161	Insulin levels in response to oral glucose tolerance test (120 minutes)	Insulin levels in response to oral glucose tolerance test (120 minutes)	Other measurement
3016	GCST005165	GLP-1 levels in response to oral glucose tolerance test (120 minutes)	GLP-1 levels in response to oral glucose tolerance test (120 minutes)	Other measurement
3017	GCST005165	GLP-1 levels in response to oral glucose tolerance test (120 minutes)	GLP-1 levels in response to oral glucose tolerance test (120 minutes)	Other measurement
3018	GCST005166	GIP levels in response to oral glucose tolerance test (120 minutes)	GIP levels in response to oral glucose tolerance test (120 minutes)	Other measurement
3019	GCST005166	GIP levels in response to oral glucose tolerance test (120 minutes)	GIP levels in response to oral glucose tolerance test (120 minutes)	Other measurement
3020	GCST005163	Glucagon levels in response to oral glucose tolerance test (120 minutes)	Glucagon levels in response to oral glucose tolerance test (120 minutes)	Other measurement
3021	GCST005163	Glucagon levels in response to oral glucose tolerance test (120 minutes)	Glucagon levels in response to oral glucose tolerance test (120 minutes)	Other measurement
3022	GCST007046	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Response to drug
3023	GCST007046	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Cancer
3024	GCST007046	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Other measurement
3025	GCST007049	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Response to drug
3026	GCST007049	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Cancer
3027	GCST007049	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Other measurement
3028	GCST007048	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Other measurement
3029	GCST007048	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Response to drug
3030	GCST007048	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Cancer
3031	GCST007048	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Response to drug
3032	GCST007047	Pathological complete response in breast cancer treated with or without bevacizumab	Pathological complete response in breast cancer treated with or without bevacizumab	Other measurement
3033	GCST007047	Pathological complete response in breast cancer treated with or without bevacizumab	Pathological complete response in breast cancer treated with or without bevacizumab	Response to drug
3034	GCST007047	Pathological complete response in breast cancer treated with or without bevacizumab	Pathological complete response in breast cancer treated with or without bevacizumab	Cancer
3035	GCST005514	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Metabolic disorder
3036	GCST005514	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Other measurement
3037	GCST005514	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Other measurement
3038	GCST005516	Neuritic plaques or neurofibrillary tangles (pleiotropy)	Neuritic plaques or neurofibrillary tangles (pleiotropy)	Other measurement
3039	GCST005516	Neuritic plaques or neurofibrillary tangles (pleiotropy)	Neuritic plaques or neurofibrillary tangles (pleiotropy)	Other measurement
3040	GCST005515	Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	Metabolic disorder
3041	GCST005515	Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	Other measurement
3042	GCST005517	Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Metabolic disorder
3043	GCST005517	Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Other measurement
3044	GCST004956	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Other measurement
3045	GCST004956	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Neurological disorder
3046	GCST004956	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Other measurement
3047	GCST004955	Risky sexual behaviors in alcohol dependence	Risky sexual behaviors in alcohol dependence	Neurological disorder
3048	GCST004955	Risky sexual behaviors in alcohol dependence	Risky sexual behaviors in alcohol dependence	Other measurement
3049	GCST003898	Cisplatin-induced ototoxicity	Cisplatin-induced ototoxicity	Other trait
3050	GCST003898	Cisplatin-induced ototoxicity	Cisplatin-induced ototoxicity	Response to drug
3051	GCST004400	Bone erosion in rheumatoid arthritis	Bone erosion in rheumatoid arthritis	Other measurement
3052	GCST007343	Epilepsy	Epilepsy	Neurological disorder
3053	GCST007343	Epilepsy	Epilepsy	Neurological disorder
3054	GCST007343	Epilepsy	Epilepsy	Neurological disorder
3055	GCST007345	Childhood absence epilepsy	Childhood absence epilepsy	Neurological disorder
3056	GCST007346	Juvenile absence epilepsy	Juvenile absence epilepsy	Neurological disorder
3057	GCST007347	Juvenile myoclonic epilepsy	Juvenile myoclonic epilepsy	Neurological disorder
3058	GCST007348	Epilepsy (generalized, with tonic-clonic seizures alone)	Epilepsy (generalized, with tonic-clonic seizures alone)	Neurological disorder
3059	GCST007349	Focal epilepsy (lesion negative)	Focal epilepsy (lesion negative)	Neurological disorder
3060	GCST007350	Focal epilepsy (with hippocampal sclerosis)	Focal epilepsy (with hippocampal sclerosis)	Neurological disorder
3061	GCST007351	Focal epilepsy (with lesion other than hippocampal sclerosis)	Focal epilepsy (with lesion other than hippocampal sclerosis)	Neurological disorder
3062	GCST007352	Focal epilepsy	Focal epilepsy	Neurological disorder
3063	GCST007353	Generalized epilepsy	Generalized epilepsy	Neurological disorder
3064	GCST007353	Generalized epilepsy	Generalized epilepsy	Neurological disorder
3065	GCST006331	Anti-cytomegalovirus IgG seropositivity	Anti-cytomegalovirus IgG seropositivity	Other measurement
3066	GCST006332	Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG seropositivity	Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG seropositivity	Other measurement
3067	GCST006333	Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG seropositivity	Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG seropositivity	Other measurement
3068	GCST006330	Anti-Epstein-Barr virus early antigen (EA) IgG seropositivity	Anti-Epstein-Barr virus early antigen (EA) IgG seropositivity	Other measurement
3069	GCST006334	Anti-herpes simplex virus 1 IgG seropositivity	Anti-herpes simplex virus 1 IgG seropositivity	Other measurement
3070	GCST006335	Anti-herpes simplex virus 2 IgG seropositivity	Anti-herpes simplex virus 2 IgG seropositivity	Other measurement
3071	GCST006336	Anti-varicella zoster virus IgG seropositivity	Anti-varicella zoster virus IgG seropositivity	Other measurement
3072	GCST006337	Anti-Helicobacter pylori IgG seropositivity	Anti-Helicobacter pylori IgG seropositivity	Other measurement
3073	GCST006338	Anti-Toxoplasma gondii IgG seropositivity	Anti-Toxoplasma gondii IgG seropositivity	Other measurement
3074	GCST006339	Anti-influenza A virus IgG seropositivity	Anti-influenza A virus IgG seropositivity	Other measurement
3075	GCST006340	Anti-measles virus IgG seropositivity	Anti-measles virus IgG seropositivity	Other measurement
3076	GCST006341	Anti-mumps virus IgG seropositivity	Anti-mumps virus IgG seropositivity	Other measurement
3077	GCST006342	Anti-rubella virus IgG seropositivity	Anti-rubella virus IgG seropositivity	Other measurement
3078	GCST006356	Anti-hepatitis B virus surface antigen (HBs) IgG seropositivity	Anti-hepatitis B virus surface antigen (HBs) IgG seropositivity	Other measurement
3079	GCST006343	Anti-hepatitis B virus core antigen (HBc) IgG seropositivity	Anti-hepatitis B virus core antigen (HBc) IgG seropositivity	Other measurement
3080	GCST006357	IgG levels	IgG levels	Other measurement
3081	GCST006359	IgM levels	IgM levels	Other measurement
3082	GCST006360	IgA levels	IgA levels	Other measurement
3083	GCST006358	IgE levels	IgE levels	Other measurement
3084	GCST006344	Anti-cytomegalovirus IgG levels	Anti-cytomegalovirus IgG levels	Other measurement
3085	GCST006361	Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels	Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels	Other measurement
3086	GCST006362	Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels	Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels	Other measurement
3087	GCST006345	Anti-Epstein-Barr virus early antigen (EA) IgG levels	Anti-Epstein-Barr virus early antigen (EA) IgG levels	Other measurement
3088	GCST006346	Anti-herpes simplex virus 1 IgG levels	Anti-herpes simplex virus 1 IgG levels	Other measurement
3089	GCST006347	Anti-herpes simplex virus 2 IgG levels	Anti-herpes simplex virus 2 IgG levels	Other measurement
3090	GCST006348	Anti-varicella zoster virus IgG levels	Anti-varicella zoster virus IgG levels	Other measurement
3091	GCST006363	Anti-Helicobacter pylori IgG levels	Anti-Helicobacter pylori IgG levels	Other measurement
3092	GCST006349	Anti-Toxoplasma gondii IgG levels	Anti-Toxoplasma gondii IgG levels	Other measurement
3093	GCST006350	Anti-influenza A virus IgG levels	Anti-influenza A virus IgG levels	Other measurement
3094	GCST006351	Anti-measles virus IgG levels	Anti-measles virus IgG levels	Other measurement
3095	GCST006352	Anti-mumps virus IgG levels	Anti-mumps virus IgG levels	Other measurement
3096	GCST006353	Anti-rubella virus IgG levels	Anti-rubella virus IgG levels	Other measurement
3097	GCST006354	Anti-hepatitis B virus surface antigen (HBs) IgG levels	Anti-hepatitis B virus surface antigen (HBs) IgG levels	Other measurement
3098	GCST006355	Anti-hepatitis B virus core antigen (HBc) IgG levels	Anti-hepatitis B virus core antigen (HBc) IgG levels	Other measurement
3099	GCST005418	FEV1	FEV1	Other measurement
3100	GCST005419	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
3101	GCST005416	Airflow obstruction	Airflow obstruction	Other measurement
3102	GCST005417	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
3103	GCST007775	Anxiety disorder or brain volume (pleiotropy)	Anxiety disorder or brain volume (pleiotropy)	Other measurement
3104	GCST007775	Anxiety disorder or brain volume (pleiotropy)	Anxiety disorder or brain volume (pleiotropy)	Neurological disorder
3105	GCST007776	Post-traumatic stress disorder or brain volume (pleiotropy)	Post-traumatic stress disorder or brain volume (pleiotropy)	Other measurement
3106	GCST007776	Post-traumatic stress disorder or brain volume (pleiotropy)	Post-traumatic stress disorder or brain volume (pleiotropy)	Neurological disorder
3107	GCST006659	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
3108	GCST008597	Fish intake frequency	Fish intake frequency	Other measurement
3109	GCST006217	Coronary heart disease events during statin therapy	Coronary heart disease events during statin therapy	Cardiovascular measurement
3110	GCST006217	Coronary heart disease events during statin therapy	Coronary heart disease events during statin therapy	Response to drug
3111	GCST006624	Systolic blood pressure	Systolic blood pressure	Other measurement
3112	GCST006624	Systolic blood pressure	Systolic blood pressure	Other measurement
3113	GCST006630	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3114	GCST006630	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3115	GCST006629	Pulse pressure	Pulse pressure	Cardiovascular measurement
3116	GCST006628	Systolic blood pressure	Systolic blood pressure	Other measurement
3117	GCST006628	Systolic blood pressure	Systolic blood pressure	Other measurement
3118	GCST006627	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3119	GCST006627	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3120	GCST006626	Pulse pressure	Pulse pressure	Cardiovascular measurement
3121	GCST006292	Response to antipsychotic treatment in schizophrenia	Response to antipsychotic treatment in schizophrenia	Response to drug
3122	GCST006292	Response to antipsychotic treatment in schizophrenia	Response to antipsychotic treatment in schizophrenia	Neurological disorder
3123	GCST006298	Response to haloperidol in schizophrenia	Response to haloperidol in schizophrenia	Response to drug
3124	GCST006298	Response to haloperidol in schizophrenia	Response to haloperidol in schizophrenia	Neurological disorder
3125	GCST006297	Response to perphenazine in schizophrenia	Response to perphenazine in schizophrenia	Response to drug
3126	GCST006297	Response to perphenazine in schizophrenia	Response to perphenazine in schizophrenia	Neurological disorder
3127	GCST006296	Response to ziprazidone in schizophrenia	Response to ziprazidone in schizophrenia	Response to drug
3128	GCST006296	Response to ziprazidone in schizophrenia	Response to ziprazidone in schizophrenia	Neurological disorder
3129	GCST006295	Response to quetiapine in schizophrenia	Response to quetiapine in schizophrenia	Response to drug
3130	GCST006295	Response to quetiapine in schizophrenia	Response to quetiapine in schizophrenia	Neurological disorder
3131	GCST006285	Response to aripiprazole in schizophrenia	Response to aripiprazole in schizophrenia	Response to drug
3132	GCST006285	Response to aripiprazole in schizophrenia	Response to aripiprazole in schizophrenia	Neurological disorder
3133	GCST006285	Response to aripiprazole in schizophrenia	Response to aripiprazole in schizophrenia	Response to drug
3134	GCST006294	Response to risperidone in schizophrenia	Response to risperidone in schizophrenia	Response to drug
3135	GCST006294	Response to risperidone in schizophrenia	Response to risperidone in schizophrenia	Neurological disorder
3136	GCST006293	Response to olanzapine in schizophrenia	Response to olanzapine in schizophrenia	Response to drug
3137	GCST006293	Response to olanzapine in schizophrenia	Response to olanzapine in schizophrenia	Neurological disorder
3138	GCST006521	Pemphigus vulgaris	Pemphigus vulgaris	Immune system disorder
3139	GCST006520	Pemphigus foliaceus	Pemphigus foliaceus	Immune system disorder
3140	GCST006050	Central corneal thickness	Central corneal thickness	Other measurement
3141	GCST006050	Central corneal thickness	Central corneal thickness	Other measurement
3142	GCST006049	Central corneal thickness	Central corneal thickness	Other measurement
3143	GCST006049	Central corneal thickness	Central corneal thickness	Other measurement
3144	GCST001679	Complement C3 and C4 levels	Complement C3 and C4 levels	Other measurement
3145	GCST001679	Complement C3 and C4 levels	Complement C3 and C4 levels	Other measurement
3146	GCST000135	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
3147	GCST000132	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
3148	GCST000132	LDL cholesterol	LDL cholesterol	Other measurement
3149	GCST000132	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
3150	GCST000139	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
3151	GCST000282	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
3152	GCST000282	LDL cholesterol	LDL cholesterol	Other measurement
3153	GCST000282	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
3154	GCST000289	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
3155	GCST000288	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
3156	GCST000082	Factor VII	Factor VII	Other measurement
3157	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
3158	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Inflammatory measurement
3159	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Other measurement
3160	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Cardiovascular measurement
3161	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
3162	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
3163	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Other measurement
3164	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
3165	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Biological process
3166	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
3167	GCST001232	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
3168	GCST001232	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
3169	GCST001342	Alzheimer's disease	Alzheimer's disease	Neurological disorder
3170	GCST001231	Carotid intima media thickness	Carotid intima media thickness	Other measurement
3171	GCST001231	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular measurement
3172	GCST001231	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular disease
3173	GCST000285	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
3174	GCST001229	Thoracic aortic aneurysms and dissections	Thoracic aortic aneurysms and dissections	Cardiovascular disease
3175	GCST002295	Schizophrenia or bipolar disorder	Schizophrenia or bipolar disorder	Neurological disorder
3176	GCST002295	Schizophrenia or bipolar disorder	Schizophrenia or bipolar disorder	Neurological disorder
3177	GCST000269	Multiple sclerosis	Multiple sclerosis	Immune system disorder
3178	GCST000267	Multiple sclerosis (age of onset)	Multiple sclerosis (age of onset)	Immune system disorder
3179	GCST000267	Multiple sclerosis (age of onset)	Multiple sclerosis (age of onset)	Other measurement
3180	GCST000268	Normalized brain volume	Normalized brain volume	Immune system disorder
3181	GCST000265	Brain lesion load	Brain lesion load	Immune system disorder
3182	GCST000266	Multiple sclerosis (severity)	Multiple sclerosis (severity)	Immune system disorder
3183	GCST001760	White matter integrity	White matter integrity	Other measurement
3184	GCST001764	White matter integrity (bipolar disorder risk interaction)	White matter integrity (bipolar disorder risk interaction)	Neurological disorder
3185	GCST001764	White matter integrity (bipolar disorder risk interaction)	White matter integrity (bipolar disorder risk interaction)	Other measurement
3186	GCST000192	Blue vs. green eyes	Blue vs. green eyes	Other trait
3187	GCST000196	Burning and freckling	Burning and freckling	Other disease
3188	GCST000196	Burning and freckling	Burning and freckling	Other trait
3189	GCST000197	Freckles	Freckles	Other trait
3190	GCST000195	Skin sensitivity to sun	Skin sensitivity to sun	Immune system disorder
3191	GCST000194	Blond vs. brown hair color	Blond vs. brown hair color	Other trait
3192	GCST000193	Red vs. non-red hair color	Red vs. non-red hair color	Other trait
3193	GCST000095	Prostate cancer	Prostate cancer	Cancer
3194	GCST000079	Breast cancer	Breast cancer	Cancer
3195	GCST002977	Advanced glycation end-product levels	Advanced glycation end-product levels	Other measurement
3196	GCST002977	Advanced glycation end-product levels	Advanced glycation end-product levels	Other measurement
3197	GCST002977	Advanced glycation end-product levels	Advanced glycation end-product levels	Metabolic disorder
3198	GCST002426	Puberty onset (genital enlargement)	Puberty onset (genital enlargement)	Other measurement
3199	GCST002427	Puberty onset (breast development)	Puberty onset (breast development)	Other measurement
3200	GCST002425	Puberty onset	Puberty onset	Other measurement
3201	GCST002257	Tooth agenesis (maxillary third molar)	Tooth agenesis (maxillary third molar)	Digestive system disorder
3202	GCST002258	Tooth agenesis (mandibular third molar)	Tooth agenesis (mandibular third molar)	Digestive system disorder
3203	GCST002256	Tooth agenesis (third molar)	Tooth agenesis (third molar)	Digestive system disorder
3204	GCST000086	Heart rate variability traits	Heart rate variability traits	Cardiovascular measurement
3205	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
3206	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
3207	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
3208	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
3209	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
3210	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
3211	GCST000894	Entorhinal cortical thickness	Entorhinal cortical thickness	Other measurement
3212	GCST000899	Entorhinal cortical volume	Entorhinal cortical volume	Other measurement
3213	GCST000891	Whole-brain volume	Whole-brain volume	Other measurement
3214	GCST000890	Hippocampal volume	Hippocampal volume	Other measurement
3215	GCST000889	Entorhinal cortical thickness (Alzheimer's disease interaction)	Entorhinal cortical thickness (Alzheimer's disease interaction)	Neurological disorder
3216	GCST000889	Entorhinal cortical thickness (Alzheimer's disease interaction)	Entorhinal cortical thickness (Alzheimer's disease interaction)	Other measurement
3217	GCST000898	Total ventricular volume	Total ventricular volume	Other measurement
3218	GCST000893	Entorhinal cortical volume (Alzheimer's disease interaction)	Entorhinal cortical volume (Alzheimer's disease interaction)	Neurological disorder
3219	GCST000893	Entorhinal cortical volume (Alzheimer's disease interaction)	Entorhinal cortical volume (Alzheimer's disease interaction)	Other measurement
3220	GCST000892	Total ventricular volume (Alzheimer's disease interaction)	Total ventricular volume (Alzheimer's disease interaction)	Other measurement
3221	GCST000892	Total ventricular volume (Alzheimer's disease interaction)	Total ventricular volume (Alzheimer's disease interaction)	Neurological disorder
3222	GCST000895	Whole-brain volume (Alzheimer's disease interaction)	Whole-brain volume (Alzheimer's disease interaction)	Neurological disorder
3223	GCST000895	Whole-brain volume (Alzheimer's disease interaction)	Whole-brain volume (Alzheimer's disease interaction)	Other measurement
3224	GCST000897	Hippocampal volume (Alzheimer's disease interaction)	Hippocampal volume (Alzheimer's disease interaction)	Neurological disorder
3225	GCST000897	Hippocampal volume (Alzheimer's disease interaction)	Hippocampal volume (Alzheimer's disease interaction)	Other measurement
3226	GCST000397	Renal function and chronic kidney disease	Renal function and chronic kidney disease	Other measurement
3227	GCST000397	Renal function and chronic kidney disease	Renal function and chronic kidney disease	Other disease
3228	GCST002042	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
3229	GCST002042	LDL cholesterol	LDL cholesterol	Other measurement
3230	GCST002042	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
3231	GCST002044	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
3232	GCST002043	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
3233	GCST002418	Free thyroxine concentration	Free thyroxine concentration	Other measurement
3234	GCST002416	Thyroid peroxidase antibody positivity	Thyroid peroxidase antibody positivity	Other measurement
3235	GCST002417	Plasma thyroid-stimulating hormone levels	Plasma thyroid-stimulating hormone levels	Other measurement
3236	GCST000099	Mean forced vital capacity from 2 exams	Mean forced vital capacity from 2 exams	Other measurement
3237	GCST000106	Pulmonary function	Pulmonary function	Other measurement
3238	GCST000106	Pulmonary function	Pulmonary function	Other measurement
3239	GCST000106	Pulmonary function	Pulmonary function	Other measurement
3240	GCST000106	Pulmonary function	Pulmonary function	Other measurement
3241	GCST000430	C-reactive protein	C-reactive protein	Inflammatory measurement
3242	GCST002933	Magnesium levels	Magnesium levels	Other measurement
3243	GCST000403	Menarche and menopause (age at onset)	Menarche and menopause (age at onset)	Other measurement
3244	GCST000403	Menarche and menopause (age at onset)	Menarche and menopause (age at onset)	Other measurement
3245	GCST006796	Excitement-seeking behaviour	Excitement-seeking behaviour	Other measurement
3246	GCST003965	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
3247	GCST003966	Visceral adipose tissue	Visceral adipose tissue	Other measurement
3248	GCST003968	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
3249	GCST003968	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
3250	GCST003968	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Other measurement
3251	GCST003967	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
3252	GCST003967	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
3253	GCST003971	Pericardial fat	Pericardial fat	Other measurement
3254	GCST003970	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Other measurement
3255	GCST003969	Visceral adipose tissue attenuation (Hounslow unit scale)	Visceral adipose tissue attenuation (Hounslow unit scale)	Other measurement
3256	GCST003972	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
3257	GCST003972	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
3258	GCST003973	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Other measurement
3259	GCST003973	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Body measurement
3260	GCST006534	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
3261	GCST006534	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
3262	GCST006533	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
3263	GCST006533	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
3264	GCST006537	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
3265	GCST006538	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
3266	GCST006540	Visceral adipose tissue	Visceral adipose tissue	Other measurement
3267	GCST006542	Visceral adipose tissue	Visceral adipose tissue	Other measurement
3268	GCST006543	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
3269	GCST006543	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
3270	GCST006543	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Other measurement
3271	GCST006544	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
3272	GCST006544	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
3273	GCST006544	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Other measurement
3274	GCST006550	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Other measurement
3275	GCST006549	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Other measurement
3276	GCST006545	Pericardial fat	Pericardial fat	Other measurement
3277	GCST006546	Pericardial fat	Pericardial fat	Other measurement
3278	GCST006547	Visceral adipose tissue attenuation (Hounslow unit scale)	Visceral adipose tissue attenuation (Hounslow unit scale)	Other measurement
3279	GCST006548	Visceral adipose tissue attenuation (Hounslow unit scale)	Visceral adipose tissue attenuation (Hounslow unit scale)	Other measurement
3280	GCST006552	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
3281	GCST006552	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
3282	GCST006551	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
3283	GCST006551	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
3284	GCST006553	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Other measurement
3285	GCST006553	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Body measurement
3286	GCST006554	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Other measurement
3287	GCST006554	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Body measurement
3288	GCST003688	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
3289	GCST003688	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
3290	GCST003688	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
3291	GCST003687	Gestational age at birth in labor-initiated deliveries (child effect)	Gestational age at birth in labor-initiated deliveries (child effect)	Other measurement
3292	GCST003687	Gestational age at birth in labor-initiated deliveries (child effect)	Gestational age at birth in labor-initiated deliveries (child effect)	Other measurement
3293	GCST003689	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	Other measurement
3294	GCST003689	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	Other measurement
3295	GCST003684	Gestational age at birth in labor-initiated deliveries (maternal effect)	Gestational age at birth in labor-initiated deliveries (maternal effect)	Other measurement
3296	GCST003684	Gestational age at birth in labor-initiated deliveries (maternal effect)	Gestational age at birth in labor-initiated deliveries (maternal effect)	Other measurement
3297	GCST003685	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	Other measurement
3298	GCST003685	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	Other measurement
3299	GCST003686	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
3300	GCST003686	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
3301	GCST001933	Sunburns	Sunburns	Other disease
3302	GCST001929	Eye color	Eye color	Other measurement
3303	GCST001929	Eye color	Eye color	Other trait
3304	GCST001932	Hair color	Hair color	Other measurement
3305	GCST001932	Hair color	Hair color	Other trait
3306	GCST001940	Non-melanoma skin cancer	Non-melanoma skin cancer	Other trait
3307	GCST001940	Non-melanoma skin cancer	Non-melanoma skin cancer	Cancer
3308	GCST001939	Tanning	Tanning	Other trait
3309	GCST003023	Blond vs non-blond hair color	Blond vs non-blond hair color	Other trait
3310	GCST003021	Brown vs. non-brown hair color	Brown vs. non-brown hair color	Other trait
3311	GCST003022	Light vs. dark hair color	Light vs. dark hair color	Other trait
3312	GCST003020	Red vs non-red hair color	Red vs non-red hair color	Other trait
3313	GCST003019	Black vs. non-black hair color	Black vs. non-black hair color	Other trait
3314	GCST001885	Height	Height	Other measurement
3315	GCST001885	Height	Height	Body measurement
3316	GCST004220	Adult onset asthma (smoking interaction)	Adult onset asthma (smoking interaction)	Biological process
3317	GCST004220	Adult onset asthma (smoking interaction)	Adult onset asthma (smoking interaction)	Other disease
3318	GCST004221	Adult onset asthma in non-smokers	Adult onset asthma in non-smokers	Other disease
3319	GCST004222	Adult onset asthma in ever-smokers	Adult onset asthma in ever-smokers	Biological process
3320	GCST004222	Adult onset asthma in ever-smokers	Adult onset asthma in ever-smokers	Other disease
3321	GCST003384	Bladder cancer	Bladder cancer	Cancer
3322	GCST004124	Factor XI	Factor XI	Hematological measurement
3323	GCST002370	Fibromyalgia	Fibromyalgia	Immune system disorder
3324	GCST004100	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Other disease
3325	GCST004100	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Body measurement
3326	GCST004100	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Cancer
3327	GCST004103	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Other disease
3328	GCST004103	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Cancer
3329	GCST004103	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Body measurement
3330	GCST004104	Body mass index (change over time) in lung cancer	Body mass index (change over time) in lung cancer	Body measurement
3331	GCST004104	Body mass index (change over time) in lung cancer	Body mass index (change over time) in lung cancer	Cancer
3332	GCST004101	Body mass index (change over time) in gastrointestinal cancer	Body mass index (change over time) in gastrointestinal cancer	Body measurement
3333	GCST004101	Body mass index (change over time) in gastrointestinal cancer	Body mass index (change over time) in gastrointestinal cancer	Cancer
3334	GCST004105	Body mass index (change over time) in chronic obstructive pulmonary disease	Body mass index (change over time) in chronic obstructive pulmonary disease	Other disease
3335	GCST004105	Body mass index (change over time) in chronic obstructive pulmonary disease	Body mass index (change over time) in chronic obstructive pulmonary disease	Body measurement
3336	GCST004102	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Other disease
3337	GCST004102	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Body measurement
3338	GCST004102	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Cancer
3339	GCST004106	Body mass index (change over time) in cancer	Body mass index (change over time) in cancer	Cancer
3340	GCST004106	Body mass index (change over time) in cancer	Body mass index (change over time) in cancer	Body measurement
3341	GCST006053	Dermatomyositis or juvenile dermatomyositis	Dermatomyositis or juvenile dermatomyositis	Neurological disorder
3342	GCST006053	Dermatomyositis or juvenile dermatomyositis	Dermatomyositis or juvenile dermatomyositis	Neurological disorder
3343	GCST006052	Polymyositis	Polymyositis	Neurological disorder
3344	GCST006051	Idiopathic inflammatory myopathy	Idiopathic inflammatory myopathy	Immune system disorder
3345	GCST004695	Insomnia complaints	Insomnia complaints	Neurological disorder
3346	GCST004694	Sleep duration	Sleep duration	Other measurement
3347	GCST004700	Insomnia complaints (sex interaction)	Insomnia complaints (sex interaction)	Neurological disorder
3348	GCST004701	Insomnia complaints (continuous)	Insomnia complaints (continuous)	Neurological disorder
3349	GCST004702	Insomnia complaints (dichotomous)	Insomnia complaints (dichotomous)	Neurological disorder
3350	GCST004696	Chronotype	Chronotype	Biological process
3351	GCST004696	Chronotype	Chronotype	Other measurement
3352	GCST004697	Ease of getting up in the morning	Ease of getting up in the morning	Other measurement
3353	GCST004693	Daytime nap	Daytime nap	Other measurement
3354	GCST004698	Snoring	Snoring	Other measurement
3355	GCST004699	Daytime sleepiness	Daytime sleepiness	Other measurement
3356	GCST006487	Insomnia complaints	Insomnia complaints	Neurological disorder
3357	GCST006488	Insomnia complaints	Insomnia complaints	Neurological disorder
3358	GCST004483	Multiple myeloma	Multiple myeloma	Cancer
3359	GCST002181	Adverse response to chemotherapy in breast cancer (alopecia)	Adverse response to chemotherapy in breast cancer (alopecia)	Other disease
3360	GCST002176	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Other disease
3361	GCST002176	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Response to drug
3362	GCST002176	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Response to drug
3363	GCST002176	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Response to drug
3364	GCST002178	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Other disease
3365	GCST002178	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Response to drug
3366	GCST002178	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Response to drug
3367	GCST002178	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Response to drug
3368	GCST002179	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	Response to drug
3369	GCST002179	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	Other disease
3370	GCST002180	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	Other disease
3371	GCST002180	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	Response to drug
3372	GCST002177	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	Other disease
3373	GCST002177	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	Response to drug
3374	GCST003817	Mortality in sepsis	Mortality in sepsis	Other measurement
3375	GCST003817	Mortality in sepsis	Mortality in sepsis	Other trait
3376	GCST003934	Carotenoid levels (cryptoxanthin)	Carotenoid levels (cryptoxanthin)	Other measurement
3377	GCST003938	Carotenoid levels (alpha-carotene)	Carotenoid levels (alpha-carotene)	Other measurement
3378	GCST003935	Vitamin E levels (alpha-tocopherol)	Vitamin E levels (alpha-tocopherol)	Other measurement
3379	GCST003931	Carotenoid levels (beta-carotene)	Carotenoid levels (beta-carotene)	Other measurement
3380	GCST003932	Carotenoid levels (lutein)	Carotenoid levels (lutein)	Other measurement
3381	GCST003933	Carotenoid levels (zeaxanthin)	Carotenoid levels (zeaxanthin)	Other measurement
3382	GCST003936	Vitamin E levels (gamma-tocopherol)	Vitamin E levels (gamma-tocopherol)	Other measurement
3383	GCST003937	Retinol levels	Retinol levels	Other measurement
3384	GCST003937	Retinol levels	Retinol levels	Other measurement
3385	GCST005113	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
3386	GCST003449	Erythrocyte cadmium concentration	Erythrocyte cadmium concentration	Other measurement
3387	GCST003448	Erythrocyte cadmium concentration in never smokers	Erythrocyte cadmium concentration in never smokers	Other measurement
3388	GCST002078	Migraine without aura	Migraine without aura	Cardiovascular disease
3389	GCST002078	Migraine without aura	Migraine without aura	Cardiovascular disease
3390	GCST002080	Migraine with aura	Migraine with aura	Cardiovascular disease
3391	GCST002080	Migraine with aura	Migraine with aura	Cardiovascular disease
3392	GCST002081	Migraine	Migraine	Cardiovascular disease
3393	GCST002079	Migraine - clinic-based	Migraine - clinic-based	Cardiovascular disease
3394	GCST004950	Breast cancer	Breast cancer	Cancer
3395	GCST007236	Breast cancer	Breast cancer	Cancer
3396	GCST007547	Coronary artery disease and HDL cholesterol levels (multivariate analysis)	Coronary artery disease and HDL cholesterol levels (multivariate analysis)	Cardiovascular disease
3397	GCST007547	Coronary artery disease and HDL cholesterol levels (multivariate analysis)	Coronary artery disease and HDL cholesterol levels (multivariate analysis)	Lipid or lipoprotein measurement
3398	GCST007546	Coronary artery disease and LDL cholesterol levels (multivariate analysis)	Coronary artery disease and LDL cholesterol levels (multivariate analysis)	Cardiovascular disease
3399	GCST007546	Coronary artery disease and LDL cholesterol levels (multivariate analysis)	Coronary artery disease and LDL cholesterol levels (multivariate analysis)	Lipid or lipoprotein measurement
3400	GCST007545	Coronary artery disease and triglyceride levels (multivariate analysis)	Coronary artery disease and triglyceride levels (multivariate analysis)	Cardiovascular disease
3401	GCST007545	Coronary artery disease and triglyceride levels (multivariate analysis)	Coronary artery disease and triglyceride levels (multivariate analysis)	Lipid or lipoprotein measurement
3402	GCST007544	Coronary artery disease and total cholesterol levels (multivariate analysis)	Coronary artery disease and total cholesterol levels (multivariate analysis)	Cardiovascular disease
3403	GCST007544	Coronary artery disease and total cholesterol levels (multivariate analysis)	Coronary artery disease and total cholesterol levels (multivariate analysis)	Lipid or lipoprotein measurement
3404	GCST004239	Metabolic syndrome	Metabolic syndrome	Body measurement
3405	GCST004239	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
3406	GCST004239	Metabolic syndrome	Metabolic syndrome	Other measurement
3407	GCST004239	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
3408	GCST004239	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
3409	GCST004240	Fasting blood glucose	Fasting blood glucose	Other measurement
3410	GCST004241	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
3411	GCST004242	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
3412	GCST004243	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
3413	GCST004243	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
3414	GCST004244	Waist-hip ratio	Waist-hip ratio	Other measurement
3415	GCST004244	Waist-hip ratio	Waist-hip ratio	Body measurement
3416	GCST004245	Body mass index	Body mass index	Body measurement
3417	GCST004245	Body mass index	Body mass index	Body measurement
3418	GCST004245	Body mass index	Body mass index	Other measurement
3419	GCST005389	Tooth agenesis	Tooth agenesis	Digestive system disorder
3420	GCST005390	Tooth agenesis (mandibular second premolars)	Tooth agenesis (mandibular second premolars)	Digestive system disorder
3421	GCST005391	Tooth agenesis (maxillary lateral incisors)	Tooth agenesis (maxillary lateral incisors)	Digestive system disorder
3422	GCST005392	Tooth agenesis (maxillary second premolars)	Tooth agenesis (maxillary second premolars)	Digestive system disorder
3423	GCST003633	middle facial morphology traits (ordinal measurement)	middle facial morphology traits (ordinal measurement)	Other measurement
3424	GCST003633	middle facial morphology traits (ordinal measurement)	middle facial morphology traits (ordinal measurement)	Other measurement
3425	GCST003634	lower facial morphology traits (ordinal measurement)	lower facial morphology traits (ordinal measurement)	Other measurement
3426	GCST003634	lower facial morphology traits (ordinal measurement)	lower facial morphology traits (ordinal measurement)	Other measurement
3427	GCST003635	middle facial morphology traits (quantitative measurement)	middle facial morphology traits (quantitative measurement)	Other measurement
3428	GCST003636	lower facial morphology traits (quantitative measurement)	lower facial morphology traits (quantitative measurement)	Other measurement
3429	GCST003636	lower facial morphology traits (quantitative measurement)	lower facial morphology traits (quantitative measurement)	Other measurement
3430	GCST003637	facial morphology traits (multivariate analysis)	facial morphology traits (multivariate analysis)	Other measurement
3431	GCST003638	upper facial morphology traits (ordinal measurement)	upper facial morphology traits (ordinal measurement)	Other measurement
3432	GCST004010	QT interval (tricyclic/tetracyclic antidepressant use interaction)	QT interval (tricyclic/tetracyclic antidepressant use interaction)	Cardiovascular measurement
3433	GCST004010	QT interval (tricyclic/tetracyclic antidepressant use interaction)	QT interval (tricyclic/tetracyclic antidepressant use interaction)	Response to drug
3434	GCST004010	QT interval (tricyclic/tetracyclic antidepressant use interaction)	QT interval (tricyclic/tetracyclic antidepressant use interaction)	Response to drug
3435	GCST004011	RR interval (tricyclic/tetracyclic antidepressant use interaction)	RR interval (tricyclic/tetracyclic antidepressant use interaction)	Cardiovascular measurement
3436	GCST004011	RR interval (tricyclic/tetracyclic antidepressant use interaction)	RR interval (tricyclic/tetracyclic antidepressant use interaction)	Response to drug
3437	GCST004011	RR interval (tricyclic/tetracyclic antidepressant use interaction)	RR interval (tricyclic/tetracyclic antidepressant use interaction)	Response to drug
3438	GCST002785	Facial pigmentation	Facial pigmentation	Other measurement
3439	GCST004835	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
3440	GCST004835	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
3441	GCST004834	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
3442	GCST004834	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
3443	GCST005853	Autoimmune hepatitis in primary sclerosing cholangitis	Autoimmune hepatitis in primary sclerosing cholangitis	Immune system disorder
3444	GCST005853	Autoimmune hepatitis in primary sclerosing cholangitis	Autoimmune hepatitis in primary sclerosing cholangitis	Digestive system disorder
3445	GCST005854	Primary sclerosing cholangitis (small duct vs large duct)	Primary sclerosing cholangitis (small duct vs large duct)	Digestive system disorder
3446	GCST005859	Liver transplant-free survival in primary sclerosing cholangitis (time to event)	Liver transplant-free survival in primary sclerosing cholangitis (time to event)	Digestive system disorder
3447	GCST005859	Liver transplant-free survival in primary sclerosing cholangitis (time to event)	Liver transplant-free survival in primary sclerosing cholangitis (time to event)	Other measurement
3448	GCST005852	Colectomy in primary sclerosing cholangitis	Colectomy in primary sclerosing cholangitis	Digestive system disorder
3449	GCST005855	Cholangiocarcinoma in primary sclerosing cholangitis	Cholangiocarcinoma in primary sclerosing cholangitis	Digestive system disorder
3450	GCST005855	Cholangiocarcinoma in primary sclerosing cholangitis	Cholangiocarcinoma in primary sclerosing cholangitis	Cancer
3451	GCST005860	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Digestive system disorder
3452	GCST005860	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Other measurement
3453	GCST005860	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Cancer
3454	GCST005856	Colorectal carcinoma in primary sclerosing cholangitis	Colorectal carcinoma in primary sclerosing cholangitis	Digestive system disorder
3455	GCST005856	Colorectal carcinoma in primary sclerosing cholangitis	Colorectal carcinoma in primary sclerosing cholangitis	Cancer
3456	GCST005857	Gallbladder carcinoma in primary sclerosing cholangitis	Gallbladder carcinoma in primary sclerosing cholangitis	Digestive system disorder
3457	GCST005857	Gallbladder carcinoma in primary sclerosing cholangitis	Gallbladder carcinoma in primary sclerosing cholangitis	Cancer
3458	GCST005858	Hepatocellular carcinoma in primary sclerosing cholangitis	Hepatocellular carcinoma in primary sclerosing cholangitis	Digestive system disorder
3459	GCST005858	Hepatocellular carcinoma in primary sclerosing cholangitis	Hepatocellular carcinoma in primary sclerosing cholangitis	Cancer
3460	GCST006458	Eye movement (horizontal position gain)	Eye movement (horizontal position gain)	Other measurement
3461	GCST006459	Eye movement in schizophrenia (scanpath length)	Eye movement in schizophrenia (scanpath length)	Neurological disorder
3462	GCST006459	Eye movement in schizophrenia (scanpath length)	Eye movement in schizophrenia (scanpath length)	Other measurement
3463	GCST006457	Eye movement (horizontal position gain)	Eye movement (horizontal position gain)	Other measurement
3464	GCST006456	Eye movement (scanpath length)	Eye movement (scanpath length)	Other measurement
3465	GCST006455	Eye movement (scanpath length)	Eye movement (scanpath length)	Other measurement
3466	GCST006454	Eye movement in schizophrenia (duration of fixations)	Eye movement in schizophrenia (duration of fixations)	Neurological disorder
3467	GCST006454	Eye movement in schizophrenia (duration of fixations)	Eye movement in schizophrenia (duration of fixations)	Other measurement
3468	GCST006453	Eye movement (duration of fixations)	Eye movement (duration of fixations)	Other measurement
3469	GCST006452	Eye movement (duration of fixations)	Eye movement (duration of fixations)	Other measurement
3470	GCST006451	Eye movement in schizophrenia (integrated eye movement score)	Eye movement in schizophrenia (integrated eye movement score)	Neurological disorder
3471	GCST006451	Eye movement in schizophrenia (integrated eye movement score)	Eye movement in schizophrenia (integrated eye movement score)	Other measurement
3472	GCST006450	Eye movement (integrated eye movement score)	Eye movement (integrated eye movement score)	Other measurement
3473	GCST006449	Eye movement (integrated eye movement score)	Eye movement (integrated eye movement score)	Other measurement
3474	GCST006448	Eye movement in schizophrenia (horizontal position gain)	Eye movement in schizophrenia (horizontal position gain)	Neurological disorder
3475	GCST006448	Eye movement in schizophrenia (horizontal position gain)	Eye movement in schizophrenia (horizontal position gain)	Other measurement
3476	GCST005964	Neuromyelitis optica	Neuromyelitis optica	Immune system disorder
3477	GCST006937	Neuromyelitis optica (AQP4-IgG-positive)	Neuromyelitis optica (AQP4-IgG-positive)	Immune system disorder
3478	GCST006938	Neuromyelitis optica (AQP4-IgG-negative)	Neuromyelitis optica (AQP4-IgG-negative)	Immune system disorder
3479	GCST004360	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Cancer
3480	GCST004360	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Other measurement
3481	GCST004360	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Other measurement
3482	GCST004361	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Cancer
3483	GCST004361	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Other measurement
3484	GCST004361	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Other measurement
3485	GCST004362	Plasma estrone levels in resected estrogen-receptor positive breast cancer	Plasma estrone levels in resected estrogen-receptor positive breast cancer	Cancer
3486	GCST004362	Plasma estrone levels in resected estrogen-receptor positive breast cancer	Plasma estrone levels in resected estrogen-receptor positive breast cancer	Other measurement
3487	GCST004363	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	Cancer
3488	GCST004363	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	Other measurement
3489	GCST004359	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	Cancer
3490	GCST004359	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	Other measurement
3491	GCST006917	Monoclonal gammopathy of undetermined significance	Monoclonal gammopathy of undetermined significance	Other disease
3492	GCST006985	Breast cancer	Breast cancer	Cancer
3493	GCST006906	Stroke	Stroke	Cardiovascular disease
3494	GCST005838	Stroke	Stroke	Cardiovascular disease
3495	GCST006907	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Cardiovascular disease
3496	GCST006907	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Other trait
3497	GCST006908	Ischemic stroke	Ischemic stroke	Cardiovascular disease
3498	GCST006908	Ischemic stroke	Ischemic stroke	Other trait
3499	GCST005840	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Cardiovascular disease
3500	GCST005840	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Other trait
3501	GCST005841	Ischemic stroke (small-vessel)	Ischemic stroke (small-vessel)	Cardiovascular disease
3502	GCST005842	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
3503	GCST005842	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
3504	GCST005842	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
3505	GCST005843	Ischemic stroke	Ischemic stroke	Cardiovascular disease
3506	GCST005843	Ischemic stroke	Ischemic stroke	Other trait
3507	GCST006909	Ischemic stroke (small-vessel)	Ischemic stroke (small-vessel)	Cardiovascular disease
3508	GCST006910	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
3509	GCST006910	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
3510	GCST006910	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
3511	GCST004078	Drug-induced liver injury (terbinafine)	Drug-induced liver injury (terbinafine)	Digestive system disorder
3512	GCST004078	Drug-induced liver injury (terbinafine)	Drug-induced liver injury (terbinafine)	Response to drug
3513	GCST004079	Drug-induced hepatocellular liver injury	Drug-induced hepatocellular liver injury	Digestive system disorder
3514	GCST004080	Drug-induced liver injury (statins)	Drug-induced liver injury (statins)	Digestive system disorder
3515	GCST004080	Drug-induced liver injury (statins)	Drug-induced liver injury (statins)	Response to drug
3516	GCST004081	Drug-induced cholestatic/mixed liver injury	Drug-induced cholestatic/mixed liver injury	Digestive system disorder
3517	GCST004082	Drug-induced liver injury (nitrofurantoin)	Drug-induced liver injury (nitrofurantoin)	Digestive system disorder
3518	GCST004082	Drug-induced liver injury (nitrofurantoin)	Drug-induced liver injury (nitrofurantoin)	Response to drug
3519	GCST004083	Drug-induced liver injury (diclofenac)	Drug-induced liver injury (diclofenac)	Digestive system disorder
3520	GCST004083	Drug-induced liver injury (diclofenac)	Drug-induced liver injury (diclofenac)	Response to drug
3521	GCST004084	Drug-induced liver injury (anti-tuberculosis drugs)	Drug-induced liver injury (anti-tuberculosis drugs)	Digestive system disorder
3522	GCST004084	Drug-induced liver injury (anti-tuberculosis drugs)	Drug-induced liver injury (anti-tuberculosis drugs)	Response to drug
3523	GCST004085	Drug-induced liver injury (fluoroquinolones)	Drug-induced liver injury (fluoroquinolones)	Digestive system disorder
3524	GCST004085	Drug-induced liver injury (fluoroquinolones)	Drug-induced liver injury (fluoroquinolones)	Response to drug
3525	GCST004087	Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	Digestive system disorder
3526	GCST004087	Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	Response to drug
3527	GCST004086	Drug-induced liver injury	Drug-induced liver injury	Response to drug
3528	GCST004086	Drug-induced liver injury	Drug-induced liver injury	Digestive system disorder
3529	GCST002961	Acylcarnitine levels	Acylcarnitine levels	Other measurement
3530	GCST002961	Acylcarnitine levels	Acylcarnitine levels	Other measurement
3531	GCST002966	Amino acid levels	Amino acid levels	Other measurement
3532	GCST002966	Amino acid levels	Amino acid levels	Other measurement
3533	GCST002965	Glycerophospholipid levels	Glycerophospholipid levels	Other measurement
3534	GCST002965	Glycerophospholipid levels	Glycerophospholipid levels	Lipid or lipoprotein measurement
3535	GCST002964	Sphingolipid levels	Sphingolipid levels	Other measurement
3536	GCST002964	Sphingolipid levels	Sphingolipid levels	Lipid or lipoprotein measurement
3537	GCST002959	Hexose levels	Hexose levels	Other measurement
3538	GCST002959	Hexose levels	Hexose levels	Other measurement
3539	GCST005963	Epstein Barr virus nuclear antigen 1 IgG levels	Epstein Barr virus nuclear antigen 1 IgG levels	Other measurement
3540	GCST005941	Epstein Barr virus nuclear antigen 1 IgG seropositivity	Epstein Barr virus nuclear antigen 1 IgG seropositivity	Other measurement
3541	GCST005942	Viral capsid antigen IgG levels	Viral capsid antigen IgG levels	Other measurement
3542	GCST005944	Viral capsid antigen IgG seropositivity	Viral capsid antigen IgG seropositivity	Other measurement
3543	GCST005943	Epstein-Barr virus immune response (multivariate analysis)	Epstein-Barr virus immune response (multivariate analysis)	Other measurement
3544	GCST006929	Attention function	Attention function	Other measurement
3545	GCST006930	Working memory	Working memory	Biological process
3546	GCST006931	Verbal memory	Verbal memory	Other measurement
3547	GCST006928	Visual memory	Visual memory	Other measurement
3548	GCST006932	Reasoning	Reasoning	Biological process
3549	GCST006933	Cognitive function	Cognitive function	Biological process
3550	GCST006933	Cognitive function	Cognitive function	Biological process
3551	GCST006933	Cognitive function	Cognitive function	Other measurement
3552	GCST006933	Cognitive function	Cognitive function	Biological process
3553	GCST006934	Information processing speed	Information processing speed	Biological process
3554	GCST005815	Childhood onset ulcerative colitis	Childhood onset ulcerative colitis	Immune system disorder
3555	GCST005148	Colorectal cancer	Colorectal cancer	Cancer
3556	GCST005149	Colorectal cancer	Colorectal cancer	Cancer
3557	GCST005150	Colorectal cancer	Colorectal cancer	Cancer
3558	GCST005151	Colorectal adenoma (advanced)	Colorectal adenoma (advanced)	Cancer
3559	GCST005152	Colorectal cancer	Colorectal cancer	Cancer
3560	GCST005153	Colorectal adenoma (advanced)	Colorectal adenoma (advanced)	Cancer
3561	GCST005147	Colonoscopy-negative controls vs population controls	Colonoscopy-negative controls vs population controls	Other trait
3562	GCST005558	Plantar fascial disorders	Plantar fascial disorders	Other trait
3563	GCST005558	Plantar fascial disorders	Plantar fascial disorders	Cancer
3564	GCST005844	Placental abruption	Placental abruption	Other disease
3565	GCST007125	Multiple sclerosis and systolic blood pressure (pleiotropy)	Multiple sclerosis and systolic blood pressure (pleiotropy)	Immune system disorder
3566	GCST007125	Multiple sclerosis and systolic blood pressure (pleiotropy)	Multiple sclerosis and systolic blood pressure (pleiotropy)	Other measurement
3567	GCST007126	Multiple sclerosis and body mass index (pleiotropy)	Multiple sclerosis and body mass index (pleiotropy)	Immune system disorder
3568	GCST007126	Multiple sclerosis and body mass index (pleiotropy)	Multiple sclerosis and body mass index (pleiotropy)	Body measurement
3569	GCST007127	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	Immune system disorder
3570	GCST007127	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	Body measurement
3571	GCST007120	Multiple sclerosis and type 2 diabetes (pleiotropy)	Multiple sclerosis and type 2 diabetes (pleiotropy)	Immune system disorder
3572	GCST007120	Multiple sclerosis and type 2 diabetes (pleiotropy)	Multiple sclerosis and type 2 diabetes (pleiotropy)	Metabolic disorder
3573	GCST007121	Multiple sclerosis and C-reactive protein levels (pleiotropy)	Multiple sclerosis and C-reactive protein levels (pleiotropy)	Immune system disorder
3574	GCST007121	Multiple sclerosis and C-reactive protein levels (pleiotropy)	Multiple sclerosis and C-reactive protein levels (pleiotropy)	Inflammatory measurement
3575	GCST007122	Multiple sclerosis and triglyceride levels (pleiotropy)	Multiple sclerosis and triglyceride levels (pleiotropy)	Immune system disorder
3576	GCST007122	Multiple sclerosis and triglyceride levels (pleiotropy)	Multiple sclerosis and triglyceride levels (pleiotropy)	Lipid or lipoprotein measurement
3577	GCST007123	Multiple sclerosis and LDL levels (pleiotropy)	Multiple sclerosis and LDL levels (pleiotropy)	Immune system disorder
3578	GCST007123	Multiple sclerosis and LDL levels (pleiotropy)	Multiple sclerosis and LDL levels (pleiotropy)	Lipid or lipoprotein measurement
3579	GCST007124	Multiple sclerosis and HDL levels (pleiotropy)	Multiple sclerosis and HDL levels (pleiotropy)	Immune system disorder
3580	GCST007124	Multiple sclerosis and HDL levels (pleiotropy)	Multiple sclerosis and HDL levels (pleiotropy)	Lipid or lipoprotein measurement
3581	GCST005216	Corrected insulin response adjusted for insulin sensitivity index	Corrected insulin response adjusted for insulin sensitivity index	Other measurement
3582	GCST005216	Corrected insulin response adjusted for insulin sensitivity index	Corrected insulin response adjusted for insulin sensitivity index	Other measurement
3583	GCST005221	Insulin sensitivity index	Insulin sensitivity index	Other measurement
3584	GCST005220	Insulin levels	Insulin levels	Other measurement
3585	GCST005217	Insulin levels adjusted for BMI	Insulin levels adjusted for BMI	Other measurement
3586	GCST005223	Ratio of the area under the curve for insulin and the area under the curve for glucose	Ratio of the area under the curve for insulin and the area under the curve for glucose	Other measurement
3587	GCST005219	Incremental insulin	Incremental insulin	Other measurement
3588	GCST005215	Corrected insulin response	Corrected insulin response	Other measurement
3589	GCST005218	Area under the curve of insulin levels	Area under the curve of insulin levels	Other measurement
3590	GCST005222	Insulin disposition index	Insulin disposition index	Other measurement
3591	GCST002969	Suicide behavior	Suicide behavior	Biological process
3592	GCST002974	Suicide ideation score in major depressive disorder	Suicide ideation score in major depressive disorder	Neurological disorder
3593	GCST002974	Suicide ideation score in major depressive disorder	Suicide ideation score in major depressive disorder	Other measurement
3594	GCST002973	Suicide	Suicide	Biological process
3595	GCST002972	Suicide attempts in major depressive disorder	Suicide attempts in major depressive disorder	Biological process
3596	GCST002972	Suicide attempts in major depressive disorder	Suicide attempts in major depressive disorder	Neurological disorder
3597	GCST001934	Ulcerative colitis	Ulcerative colitis	Immune system disorder
3598	GCST001938	Ulcerative colitis	Ulcerative colitis	Immune system disorder
3599	GCST001666	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
3600	GCST003456	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Other trait
3601	GCST003456	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Response to drug
3602	GCST003456	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Response to drug
3603	GCST003456	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Cancer
3604	GCST001261	Corneal structure	Corneal structure	Other measurement
3605	GCST001261	Corneal structure	Corneal structure	Neurological disorder
3606	GCST006583	Ulcerative colitis	Ulcerative colitis	Immune system disorder
3607	GCST002402	Serum IgA levels	Serum IgA levels	Other measurement
3608	GCST005569	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
3609	GCST005567	Rheumatoid arthritis (ACPA-negative)	Rheumatoid arthritis (ACPA-negative)	Immune system disorder
3610	GCST005568	Rheumatoid arthritis (ACPA-positive)	Rheumatoid arthritis (ACPA-positive)	Immune system disorder
3611	GCST001234	Gamma glutamyl transpeptidase	Gamma glutamyl transpeptidase	Liver enzyme measurement
3612	GCST001237	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
3613	GCST001233	Metabolite levels	Metabolite levels	Other trait
3614	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3615	GCST001233	Metabolite levels	Metabolite levels	Liver enzyme measurement
3616	GCST001233	Metabolite levels	Metabolite levels	Cardiovascular measurement
3617	GCST001233	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
3618	GCST001233	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
3619	GCST001233	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
3620	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3621	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3622	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3623	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3624	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3625	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3626	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3627	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3628	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3629	GCST001233	Metabolite levels	Metabolite levels	Other measurement
3630	GCST001230	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
3631	GCST001204	Response to platinum-based chemotherapy (carboplatin)	Response to platinum-based chemotherapy (carboplatin)	Response to drug
3632	GCST001201	Response to platinum-based chemotherapy (cisplatin)	Response to platinum-based chemotherapy (cisplatin)	Response to drug
3633	GCST001926	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Immune system disorder
3634	GCST001926	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Response to drug
3635	GCST001927	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Immune system disorder
3636	GCST001927	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Response to drug
3637	GCST001280	Alzheimer's disease (age of onset)	Alzheimer's disease (age of onset)	Neurological disorder
3638	GCST001280	Alzheimer's disease (age of onset)	Alzheimer's disease (age of onset)	Other measurement
3639	GCST001928	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Cancer
3640	GCST001928	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Other measurement
3641	GCST001928	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Digestive system disorder
3642	GCST003963	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	Other disease
3643	GCST003963	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	Other trait
3644	GCST002451	Obsessive-compulsive disorder	Obsessive-compulsive disorder	Neurological disorder
3645	GCST002530	Serum lipase activity	Serum lipase activity	Other measurement
3646	GCST002532	High serum lipase activity	High serum lipase activity	Other measurement
3647	GCST004720	Conotruncal heart defects (inherited effects)	Conotruncal heart defects (inherited effects)	Cardiovascular disease
3648	GCST004719	Left ventricular obstructive tract defect (inherited effect)	Left ventricular obstructive tract defect (inherited effect)	Cardiovascular disease
3649	GCST004723	Conotruncal heart defects (maternal effects)	Conotruncal heart defects (maternal effects)	Cardiovascular disease
3650	GCST004722	Left ventricular obstructive tract defect (maternal effect)	Left ventricular obstructive tract defect (maternal effect)	Cardiovascular disease
3651	GCST004718	Congenital heart disease (inherited effect)	Congenital heart disease (inherited effect)	Cardiovascular disease
3652	GCST004721	Congenital heart disease (maternal effect)	Congenital heart disease (maternal effect)	Cardiovascular disease
3653	GCST005710	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Immune system disorder
3654	GCST005710	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Response to drug
3655	GCST005710	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Other measurement
3656	GCST005706	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Immune system disorder
3657	GCST005706	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Response to drug
3658	GCST005706	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Other measurement
3659	GCST005707	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Immune system disorder
3660	GCST005707	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Response to drug
3661	GCST005707	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Other measurement
3662	GCST005708	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Immune system disorder
3663	GCST005708	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Response to drug
3664	GCST005708	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Other measurement
3665	GCST005709	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Immune system disorder
3666	GCST005709	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Response to drug
3667	GCST005709	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Other measurement
3668	GCST005426	Intracranial haemorrhage in renal transplantation (donors)	Intracranial haemorrhage in renal transplantation (donors)	Cardiovascular disease
3669	GCST005427	End stage renal failure in renal transplantation (recipient effect)	End stage renal failure in renal transplantation (recipient effect)	Other disease
3670	GCST005427	End stage renal failure in renal transplantation (recipient effect)	End stage renal failure in renal transplantation (recipient effect)	Other measurement
3671	GCST005428	Graft survival time in renal transplantation (recipient effect)	Graft survival time in renal transplantation (recipient effect)	Other measurement
3672	GCST005429	Graft survival time in renal transplantation (donor effect)	Graft survival time in renal transplantation (donor effect)	Other measurement
3673	GCST005429	Graft survival time in renal transplantation (donor effect)	Graft survival time in renal transplantation (donor effect)	Other measurement
3674	GCST005430	Graft survival time in renal transplantation (donor-recipient interaction)	Graft survival time in renal transplantation (donor-recipient interaction)	Other measurement
3675	GCST005430	Graft survival time in renal transplantation (donor-recipient interaction)	Graft survival time in renal transplantation (donor-recipient interaction)	Other measurement
3676	GCST005431	Acute graft rejection in renal transplantation (recipient effect)	Acute graft rejection in renal transplantation (recipient effect)	Other measurement
3677	GCST005432	Acute graft rejection in renal transplantation (donor effect)	Acute graft rejection in renal transplantation (donor effect)	Other measurement
3678	GCST005432	Acute graft rejection in renal transplantation (donor effect)	Acute graft rejection in renal transplantation (donor effect)	Other measurement
3679	GCST005433	Acute graft rejection in renal transplantation (donor-recipient interaction)	Acute graft rejection in renal transplantation (donor-recipient interaction)	Other measurement
3680	GCST005433	Acute graft rejection in renal transplantation (donor-recipient interaction)	Acute graft rejection in renal transplantation (donor-recipient interaction)	Other measurement
3681	GCST002450	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Lipid or lipoprotein measurement
3682	GCST002450	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Lipid or lipoprotein measurement
3683	GCST002449	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Lipid or lipoprotein measurement
3684	GCST002449	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Lipid or lipoprotein measurement
3685	GCST002448	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	Lipid or lipoprotein measurement
3686	GCST002446	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Lipid or lipoprotein measurement
3687	GCST002446	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Lipid or lipoprotein measurement
3688	GCST002444	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Lipid or lipoprotein measurement
3689	GCST002444	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Lipid or lipoprotein measurement
3690	GCST003229	Survival in colorectal cancer	Survival in colorectal cancer	Other measurement
3691	GCST003229	Survival in colorectal cancer	Survival in colorectal cancer	Cancer
3692	GCST003231	Survival in colorectal cancer (non-distant metastatic)	Survival in colorectal cancer (non-distant metastatic)	Other measurement
3693	GCST003231	Survival in colorectal cancer (non-distant metastatic)	Survival in colorectal cancer (non-distant metastatic)	Other measurement
3694	GCST003231	Survival in colorectal cancer (non-distant metastatic)	Survival in colorectal cancer (non-distant metastatic)	Cancer
3695	GCST003230	Survival in colorectal cancer (distant metastatic)	Survival in colorectal cancer (distant metastatic)	Other measurement
3696	GCST003230	Survival in colorectal cancer (distant metastatic)	Survival in colorectal cancer (distant metastatic)	Other measurement
3697	GCST003230	Survival in colorectal cancer (distant metastatic)	Survival in colorectal cancer (distant metastatic)	Cancer
3698	GCST002667	Mammographic density (dense area)	Mammographic density (dense area)	Other measurement
3699	GCST002667	Mammographic density (dense area)	Mammographic density (dense area)	Other measurement
3700	GCST002668	Mammographic density (non-dense area)	Mammographic density (non-dense area)	Other measurement
3701	GCST002668	Mammographic density (non-dense area)	Mammographic density (non-dense area)	Other measurement
3702	GCST002669	Percent mammographic density	Percent mammographic density	Other measurement
3703	GCST002669	Percent mammographic density	Percent mammographic density	Cancer
3704	GCST002669	Percent mammographic density	Percent mammographic density	Other measurement
3705	GCST001974	Idiopathic pulmonary fibrosis	Idiopathic pulmonary fibrosis	Cancer
3706	GCST005668	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	Other measurement
3707	GCST005668	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	Biological process
3708	GCST005669	Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	Other measurement
3709	GCST005669	Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	Biological process
3710	GCST004984	White coat effect (clinic systolic blood pressure minus home systolic blood pressure)	White coat effect (clinic systolic blood pressure minus home systolic blood pressure)	Other measurement
3711	GCST004984	White coat effect (clinic systolic blood pressure minus home systolic blood pressure)	White coat effect (clinic systolic blood pressure minus home systolic blood pressure)	Biological process
3712	GCST004985	White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)	White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)	Other measurement
3713	GCST004985	White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)	White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)	Biological process
3714	GCST005881	Diabetic kidney disease in diabetes	Diabetic kidney disease in diabetes	Metabolic disorder
3715	GCST005881	Diabetic kidney disease in diabetes	Diabetic kidney disease in diabetes	Metabolic disorder
3716	GCST005882	Chronic kidney disease in type 2 diabetes	Chronic kidney disease in type 2 diabetes	Other disease
3717	GCST005882	Chronic kidney disease in type 2 diabetes	Chronic kidney disease in type 2 diabetes	Metabolic disorder
3718	GCST005880	Chronic kidney disease in diabetes	Chronic kidney disease in diabetes	Other disease
3719	GCST005880	Chronic kidney disease in diabetes	Chronic kidney disease in diabetes	Metabolic disorder
3720	GCST005883	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Other disease
3721	GCST005883	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Metabolic disorder
3722	GCST005883	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Metabolic disorder
3723	GCST005884	Chronic kidney disease and diabetic kidney disease in diabetes	Chronic kidney disease and diabetic kidney disease in diabetes	Other disease
3724	GCST005884	Chronic kidney disease and diabetic kidney disease in diabetes	Chronic kidney disease and diabetic kidney disease in diabetes	Metabolic disorder
3725	GCST005884	Chronic kidney disease and diabetic kidney disease in diabetes	Chronic kidney disease and diabetic kidney disease in diabetes	Metabolic disorder
3726	GCST005885	End-stage renal disease in type 2 diabetes	End-stage renal disease in type 2 diabetes	Other disease
3727	GCST005885	End-stage renal disease in type 2 diabetes	End-stage renal disease in type 2 diabetes	Metabolic disorder
3728	GCST005886	End-stage renal disease in diabetes	End-stage renal disease in diabetes	Other disease
3729	GCST005886	End-stage renal disease in diabetes	End-stage renal disease in diabetes	Metabolic disorder
3730	GCST005887	Late diabetic kidney disease in type 2 diabetes	Late diabetic kidney disease in type 2 diabetes	Metabolic disorder
3731	GCST005887	Late diabetic kidney disease in type 2 diabetes	Late diabetic kidney disease in type 2 diabetes	Metabolic disorder
3732	GCST005888	Late diabetic kidney disease in diabetes	Late diabetic kidney disease in diabetes	Metabolic disorder
3733	GCST005888	Late diabetic kidney disease in diabetes	Late diabetic kidney disease in diabetes	Metabolic disorder
3734	GCST005889	Early diabetic kidney disease in type 2 diabetes	Early diabetic kidney disease in type 2 diabetes	Metabolic disorder
3735	GCST005889	Early diabetic kidney disease in type 2 diabetes	Early diabetic kidney disease in type 2 diabetes	Metabolic disorder
3736	GCST005890	Early diabetic kidney disease in diabetes	Early diabetic kidney disease in diabetes	Metabolic disorder
3737	GCST005890	Early diabetic kidney disease in diabetes	Early diabetic kidney disease in diabetes	Metabolic disorder
3738	GCST005892	Glomerular filtration rate in type 2 diabetes	Glomerular filtration rate in type 2 diabetes	Other measurement
3739	GCST005892	Glomerular filtration rate in type 2 diabetes	Glomerular filtration rate in type 2 diabetes	Metabolic disorder
3740	GCST005891	Glomerular filtration rate in diabetes	Glomerular filtration rate in diabetes	Other measurement
3741	GCST005891	Glomerular filtration rate in diabetes	Glomerular filtration rate in diabetes	Metabolic disorder
3742	GCST005893	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	Other disease
3743	GCST005893	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	Metabolic disorder
3744	GCST005894	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	Metabolic disorder
3745	GCST005894	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	Metabolic disorder
3746	GCST005895	Diabetic kidney disease in type 2 diabetes	Diabetic kidney disease in type 2 diabetes	Metabolic disorder
3747	GCST005895	Diabetic kidney disease in type 2 diabetes	Diabetic kidney disease in type 2 diabetes	Metabolic disorder
3748	GCST003392	Parental longevity (father's age at death)	Parental longevity (father's age at death)	Other measurement
3749	GCST003393	Parental longevity (mother's age at death)	Parental longevity (mother's age at death)	Other measurement
3750	GCST003394	Parental longevity (combined parental age at death)	Parental longevity (combined parental age at death)	Other measurement
3751	GCST003395	Parental extreme longevity (95 years and older)	Parental extreme longevity (95 years and older)	Other measurement
3752	GCST006041	Major depressive disorder	Major depressive disorder	Neurological disorder
3753	GCST003134	Cerebrospinal fluid clusterin levels	Cerebrospinal fluid clusterin levels	Lipid or lipoprotein measurement
3754	GCST003133	Plasma clusterin levels	Plasma clusterin levels	Lipid or lipoprotein measurement
3755	GCST003137	Cerebrospinal fluid clusterin levels in APOEe4- carriers	Cerebrospinal fluid clusterin levels in APOEe4- carriers	Neurological disorder
3756	GCST003137	Cerebrospinal fluid clusterin levels in APOEe4- carriers	Cerebrospinal fluid clusterin levels in APOEe4- carriers	Lipid or lipoprotein measurement
3757	GCST003131	Cerebrospinal fluid clusterin levels in APOEe4+ carriers	Cerebrospinal fluid clusterin levels in APOEe4+ carriers	Other measurement
3758	GCST003131	Cerebrospinal fluid clusterin levels in APOEe4+ carriers	Cerebrospinal fluid clusterin levels in APOEe4+ carriers	Lipid or lipoprotein measurement
3759	GCST002677	Iron status biomarkers (ferritin levels)	Iron status biomarkers (ferritin levels)	Other measurement
3760	GCST002677	Iron status biomarkers (ferritin levels)	Iron status biomarkers (ferritin levels)	Other measurement
3761	GCST002680	Iron status biomarkers (transferrin saturation)	Iron status biomarkers (transferrin saturation)	Other measurement
3762	GCST002680	Iron status biomarkers (transferrin saturation)	Iron status biomarkers (transferrin saturation)	Other measurement
3763	GCST002679	Iron status biomarkers (iron levels)	Iron status biomarkers (iron levels)	Other measurement
3764	GCST002679	Iron status biomarkers (iron levels)	Iron status biomarkers (iron levels)	Other measurement
3765	GCST002678	Iron status biomarkers (transferrin levels)	Iron status biomarkers (transferrin levels)	Other measurement
3766	GCST002678	Iron status biomarkers (transferrin levels)	Iron status biomarkers (transferrin levels)	Other measurement
3767	GCST004229	Survival in breast cancer (TP53 expression interaction)	Survival in breast cancer (TP53 expression interaction)	Cancer
3768	GCST004229	Survival in breast cancer (TP53 expression interaction)	Survival in breast cancer (TP53 expression interaction)	Other measurement
3769	GCST004229	Survival in breast cancer (TP53 expression interaction)	Survival in breast cancer (TP53 expression interaction)	Other measurement
3770	GCST004228	Survival in TP53 positive breast cancer	Survival in TP53 positive breast cancer	Cancer
3771	GCST004228	Survival in TP53 positive breast cancer	Survival in TP53 positive breast cancer	Other measurement
3772	GCST003364	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
3773	GCST003363	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
3774	GCST003361	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
3775	GCST003361	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
3776	GCST003362	Phospholipid levels	Phospholipid levels	Lipid or lipoprotein measurement
3777	GCST005201	Pulse pressure (dietary potassium intake interaction)	Pulse pressure (dietary potassium intake interaction)	Other measurement
3778	GCST005201	Pulse pressure (dietary potassium intake interaction)	Pulse pressure (dietary potassium intake interaction)	Cardiovascular measurement
3779	GCST005204	Systolic blood pressure (dietary potassium intake interaction)	Systolic blood pressure (dietary potassium intake interaction)	Other measurement
3780	GCST005204	Systolic blood pressure (dietary potassium intake interaction)	Systolic blood pressure (dietary potassium intake interaction)	Other measurement
3781	GCST005202	Diastolic blood pressure (dietary potassium intake interaction)	Diastolic blood pressure (dietary potassium intake interaction)	Other measurement
3782	GCST005202	Diastolic blood pressure (dietary potassium intake interaction)	Diastolic blood pressure (dietary potassium intake interaction)	Other measurement
3783	GCST005203	Mean arterial pressure (dietary potassium intake interaction)	Mean arterial pressure (dietary potassium intake interaction)	Other measurement
3784	GCST005203	Mean arterial pressure (dietary potassium intake interaction)	Mean arterial pressure (dietary potassium intake interaction)	Other measurement
3785	GCST005904	Major depressive disorder (probable)	Major depressive disorder (probable)	Neurological disorder
3786	GCST005903	Major depressive disorder (ICD-10 coded)	Major depressive disorder (ICD-10 coded)	Neurological disorder
3787	GCST005902	Depression (broad)	Depression (broad)	Neurological disorder
3788	GCST005762	Death	Death	Other trait
3789	GCST005769	Body mass index	Body mass index	Body measurement
3790	GCST005769	Body mass index	Body mass index	Body measurement
3791	GCST005769	Body mass index	Body mass index	Other measurement
3792	GCST005770	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
3793	GCST005771	Creatinine levels	Creatinine levels	Other measurement
3794	GCST005772	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3795	GCST005772	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3796	GCST005773	Lung function (forced vital capacity)	Lung function (forced vital capacity)	Other measurement
3797	GCST005774	Heart rate	Heart rate	Cardiovascular measurement
3798	GCST005775	Hematocrit	Hematocrit	Hematological measurement
3799	GCST005776	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
3800	GCST005777	Systolic blood pressure	Systolic blood pressure	Other measurement
3801	GCST005777	Systolic blood pressure	Systolic blood pressure	Other measurement
3802	GCST005781	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
3803	GCST005780	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
3804	GCST005779	Alzheimer's disease	Alzheimer's disease	Neurological disorder
3805	GCST005778	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
3806	GCST005768	Cancer	Cancer	Cancer
3807	GCST005768	Cancer	Cancer	Cancer
3808	GCST005768	Cancer	Cancer	Cancer
3809	GCST005768	Cancer	Cancer	Cancer
3810	GCST005768	Cancer	Cancer	Cancer
3811	GCST005768	Cancer	Cancer	Cancer
3812	GCST005768	Cancer	Cancer	Cancer
3813	GCST005768	Cancer	Cancer	Cancer
3814	GCST005768	Cancer	Cancer	Cancer
3815	GCST005768	Cancer	Cancer	Cancer
3816	GCST005768	Cancer	Cancer	Cancer
3817	GCST005767	Coronary heart disease	Coronary heart disease	Cardiovascular disease
3818	GCST005766	Diabetes mellitus	Diabetes mellitus	Metabolic disorder
3819	GCST005765	Heart failure	Heart failure	Cardiovascular disease
3820	GCST005764	Stroke	Stroke	Cardiovascular disease
3821	GCST005763	Blood glucose levels	Blood glucose levels	Other measurement
3822	GCST007316	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Neurological disorder
3823	GCST007316	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Neurological disorder
3824	GCST007316	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to drug
3825	GCST007316	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Other measurement
3826	GCST007317	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Neurological disorder
3827	GCST007317	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Neurological disorder
3828	GCST007317	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to drug
3829	GCST007317	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Other measurement
3830	GCST004941	Dehydroepiandrosterone sulphate levels	Dehydroepiandrosterone sulphate levels	Other measurement
3831	GCST004941	Dehydroepiandrosterone sulphate levels	Dehydroepiandrosterone sulphate levels	Other measurement
3832	GCST004939	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
3833	GCST004940	Alanine transaminase levels	Alanine transaminase levels	Liver enzyme measurement
3834	GCST005059	Serum albumin level	Serum albumin level	Other measurement
3835	GCST005061	Serum alkaline phosphatase levels	Serum alkaline phosphatase levels	Liver enzyme measurement
3836	GCST005062	Fibrinogen levels	Fibrinogen levels	Hematological measurement
3837	GCST005064	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
3838	GCST005065	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
3839	GCST005066	Creatinine levels	Creatinine levels	Other measurement
3840	GCST005069	Gamma glutamyl transferase levels	Gamma glutamyl transferase levels	Liver enzyme measurement
3841	GCST005058	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
3842	GCST005060	Hemoglobin levels	Hemoglobin levels	Hematological measurement
3843	GCST005060	Hemoglobin levels	Hemoglobin levels	Hematological measurement
3844	GCST005060	Hemoglobin levels	Hemoglobin levels	Hematological measurement
3845	GCST005060	Hemoglobin levels	Hemoglobin levels	Hematological measurement
3846	GCST005067	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
3847	GCST005071	Insulin-like growth factor 1 levels	Insulin-like growth factor 1 levels	Other measurement
3848	GCST005072	Ferritin levels	Ferritin levels	Other measurement
3849	GCST005074	Testosterone levels	Testosterone levels	Other measurement
3850	GCST005074	Testosterone levels	Testosterone levels	Other measurement
3851	GCST005073	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
3852	GCST005070	Urea levels	Urea levels	Other measurement
3853	GCST005070	Urea levels	Urea levels	Other measurement
3854	GCST005068	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
3855	GCST005068	LDL cholesterol	LDL cholesterol	Other measurement
3856	GCST005068	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
3857	GCST005063	Glomerular filtration rate	Glomerular filtration rate	Other measurement
3858	GCST002992	Gastric cancer	Gastric cancer	Cancer
3859	GCST002990	Gastric adenocarcinoma (histologically verified)	Gastric adenocarcinoma (histologically verified)	Cancer
3860	GCST004886	Alcohol consumption	Alcohol consumption	Biological process
3861	GCST004886	Alcohol consumption	Alcohol consumption	Other measurement
3862	GCST004887	Alcohol consumption in current drinkers	Alcohol consumption in current drinkers	Other measurement
3863	GCST006871	Total hippocampal volume	Total hippocampal volume	Other measurement
3864	GCST006872	Presubiculum volume (corrected for total hippocampal volume)	Presubiculum volume (corrected for total hippocampal volume)	Other measurement
3865	GCST006873	Subiculum volume (corrected for total hippocampal volume)	Subiculum volume (corrected for total hippocampal volume)	Other measurement
3866	GCST006874	Hippocampal subfield CA1 volume (corrected for total hippocampal volume)	Hippocampal subfield CA1 volume (corrected for total hippocampal volume)	Other measurement
3867	GCST006875	Hippocampal subfield CA3 volume (corrected for total hippocampal volume)	Hippocampal subfield CA3 volume (corrected for total hippocampal volume)	Other measurement
3868	GCST006876	Hippocampal subfield CA4 volume (corrected for total hippocampal volume)	Hippocampal subfield CA4 volume (corrected for total hippocampal volume)	Other measurement
3869	GCST006877	Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)	Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)	Other measurement
3870	GCST006878	Dentate gyrus molecular layer volume (corrected for total hippocampal volume)	Dentate gyrus molecular layer volume (corrected for total hippocampal volume)	Other measurement
3871	GCST006880	Hippocampal fissure volume (corrected for total hippocampal volume)	Hippocampal fissure volume (corrected for total hippocampal volume)	Other measurement
3872	GCST006881	Hippocampal tail volume (corrected for total hippocampal volume)	Hippocampal tail volume (corrected for total hippocampal volume)	Other measurement
3873	GCST006882	Fimbria volume (corrected for total hippocampal volume)	Fimbria volume (corrected for total hippocampal volume)	Other measurement
3874	GCST006883	HATA volume (corrected for total hippocampal volume)	HATA volume (corrected for total hippocampal volume)	Other measurement
3875	GCST006884	Parasubiculum volume (corrected for total hippocampal volume)	Parasubiculum volume (corrected for total hippocampal volume)	Other measurement
3876	GCST006885	Presubiculum volume	Presubiculum volume	Other measurement
3877	GCST006886	Subiculum volume	Subiculum volume	Other measurement
3878	GCST006887	Hippocampal subfield CA1 volume	Hippocampal subfield CA1 volume	Other measurement
3879	GCST006888	Hippocampal subfield CA3 volume	Hippocampal subfield CA3 volume	Other measurement
3880	GCST006889	Hippocampal subfield CA4 volume	Hippocampal subfield CA4 volume	Other measurement
3881	GCST006890	Dentate gyrus granule cell layer volume	Dentate gyrus granule cell layer volume	Other measurement
3882	GCST006891	Dentate gyrus molecular layer volume	Dentate gyrus molecular layer volume	Other measurement
3883	GCST006892	Hippocampal fissure volume	Hippocampal fissure volume	Other measurement
3884	GCST006870	Hippocampal tail volume	Hippocampal tail volume	Other measurement
3885	GCST006893	Fimbria volume	Fimbria volume	Other measurement
3886	GCST006894	HATA volume	HATA volume	Other measurement
3887	GCST006895	Parasubiculum volume	Parasubiculum volume	Other measurement
3888	GCST005192	Lobe attachment (rater-scored or self-reported)	Lobe attachment (rater-scored or self-reported)	Other trait
3889	GCST005193	Lobe attachment (rater scored)	Lobe attachment (rater scored)	Other trait
3890	GCST008169	Benign prostatic hyperplasia	Benign prostatic hyperplasia	Other disease
3891	GCST006128	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
3892	GCST006127	Uveitis (juvenile idiopathic arthritis-associated)	Uveitis (juvenile idiopathic arthritis-associated)	Neurological disorder
3893	GCST006127	Uveitis (juvenile idiopathic arthritis-associated)	Uveitis (juvenile idiopathic arthritis-associated)	Immune system disorder
3894	GCST006126	Uveitis in juvenile idiopathic arthritis	Uveitis in juvenile idiopathic arthritis	Neurological disorder
3895	GCST006126	Uveitis in juvenile idiopathic arthritis	Uveitis in juvenile idiopathic arthritis	Immune system disorder
3896	GCST007838	Glycine levels	Glycine levels	Other measurement
3897	GCST007837	Glycine levels	Glycine levels	Other measurement
3898	GCST007836	Glycine levels	Glycine levels	Other measurement
3899	GCST003045	Ulcerative colitis	Ulcerative colitis	Immune system disorder
3900	GCST003044	Crohn's disease	Crohn's disease	Digestive system disorder
3901	GCST003043	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
3902	GCST003043	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
3903	GCST003043	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
3904	GCST007428	Thyroxine levels	Thyroxine levels	Other measurement
3905	GCST007426	Triiodothyronine levels	Triiodothyronine levels	Other measurement
3906	GCST007427	Triiodothyronine/thyroxine ratio	Triiodothyronine/thyroxine ratio	Other measurement
3907	GCST006186	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Other measurement
3908	GCST006186	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Other measurement
3909	GCST006195	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Other measurement
3910	GCST006195	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Other measurement
3911	GCST006194	Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Other measurement
3912	GCST006194	Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Other measurement
3913	GCST006193	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Other measurement
3914	GCST006193	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Other measurement
3915	GCST006192	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	Other measurement
3916	GCST006192	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	Other measurement
3917	GCST006191	Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	Other measurement
3918	GCST006191	Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	Other measurement
3919	GCST006190	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	Other measurement
3920	GCST006190	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	Other measurement
3921	GCST006189	Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	Other measurement
3922	GCST006189	Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	Other measurement
3923	GCST006188	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
3924	GCST006188	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
3925	GCST006188	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
3926	GCST006187	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
3927	GCST006187	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
3928	GCST006187	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
3929	GCST005667	Central corneal thickness	Central corneal thickness	Other measurement
3930	GCST005667	Central corneal thickness	Central corneal thickness	Other measurement
3931	GCST006366	Central corneal thickness	Central corneal thickness	Other measurement
3932	GCST006366	Central corneal thickness	Central corneal thickness	Other measurement
3933	GCST006367	Central corneal thickness	Central corneal thickness	Other measurement
3934	GCST006367	Central corneal thickness	Central corneal thickness	Other measurement
3935	GCST006389	Brain imaging measurements	Brain imaging measurements	Other measurement
3936	GCST006914	Sleep duration	Sleep duration	Other measurement
3937	GCST006913	Sedentary behaviour duration	Sedentary behaviour duration	Other measurement
3938	GCST007110	Physical activity (walking duration)	Physical activity (walking duration)	Other measurement
3939	GCST006915	Physical activity (moderate intensity activity duration)	Physical activity (moderate intensity activity duration)	Other measurement
3940	GCST006912	Physical activity (overall physical activity time)	Physical activity (overall physical activity time)	Other measurement
3941	GCST004421	beta-nerve growth factor levels	beta-nerve growth factor levels	Other measurement
3942	GCST004422	Vascular endothelial growth factor levels	Vascular endothelial growth factor levels	Cardiovascular measurement
3943	GCST004420	CTACK levels	CTACK levels	Other measurement
3944	GCST004460	Eotaxin levels	Eotaxin levels	Other measurement
3945	GCST004459	Fibroblast growth factor basic levels	Fibroblast growth factor basic levels	Other measurement
3946	GCST004458	Granulocyte-colony stimulating factor levels	Granulocyte-colony stimulating factor levels	Other measurement
3947	GCST004457	Growth-regulated protein alpha levels	Growth-regulated protein alpha levels	Other measurement
3948	GCST004449	Hepatocyte growth factor levels	Hepatocyte growth factor levels	Cardiovascular measurement
3949	GCST004456	Interferon gamma levels	Interferon gamma levels	Other measurement
3950	GCST004448	Interleukin-1-beta levels	Interleukin-1-beta levels	Inflammatory measurement
3951	GCST004447	Interleukin-1-receptor antagonist levels	Interleukin-1-receptor antagonist levels	Inflammatory measurement
3952	GCST004455	Interleukin-2 levels	Interleukin-2 levels	Other measurement
3953	GCST004454	Interleukin-2 receptor antagonist levels	Interleukin-2 receptor antagonist levels	Other measurement
3954	GCST004453	Interleukin-4 levels	Interleukin-4 levels	Other measurement
3955	GCST004452	Interleukin-5 levels	Interleukin-5 levels	Other measurement
3956	GCST004446	Interleukin-6 levels	Interleukin-6 levels	Inflammatory measurement
3957	GCST004451	Interleukin-7 levels	Interleukin-7 levels	Other measurement
3958	GCST004445	Interleukin-8 levels	Interleukin-8 levels	Other measurement
3959	GCST004445	Interleukin-8 levels	Interleukin-8 levels	Inflammatory measurement
3960	GCST004450	Interleukin-9 levels	Interleukin-9 levels	Other measurement
3961	GCST004444	Interleukin-10 levels	Interleukin-10 levels	Inflammatory measurement
3962	GCST004443	Interleukin-13 levels	Interleukin-13 levels	Other measurement
3963	GCST004442	Interleukin-17 levels	Interleukin-17 levels	Other measurement
3964	GCST004441	Interleukin-18 levels	Interleukin-18 levels	Inflammatory measurement
3965	GCST004423	Macrophage Migration Inhibitory Factor levels	Macrophage Migration Inhibitory Factor levels	Other measurement
3966	GCST004440	Interferon gamma-induced protein 10 levels	Interferon gamma-induced protein 10 levels	Other measurement
3967	GCST004439	Interleukin-12p70 levels	Interleukin-12p70 levels	Other measurement
3968	GCST004430	Interleukin-16 levels	Interleukin-16 levels	Other measurement
3969	GCST004438	Monocyte chemoattractant protein-1 levels	Monocyte chemoattractant protein-1 levels	Other measurement
3970	GCST004437	Monocyte chemoattractant protein-3 levels	Monocyte chemoattractant protein-3 levels	Other measurement
3971	GCST004436	Macrophage colony stimulating factor levels	Macrophage colony stimulating factor levels	Other measurement
3972	GCST004435	Monokine induced by gamma interferon levels	Monokine induced by gamma interferon levels	Other measurement
3973	GCST004434	Macrophage inflammatory protein 1a levels	Macrophage inflammatory protein 1a levels	Other measurement
3974	GCST004433	Macrophage inflammatory protein 1b levels	Macrophage inflammatory protein 1b levels	Other measurement
3975	GCST004432	Platelet-derived growth factor BB levels	Platelet-derived growth factor BB levels	Other measurement
3976	GCST004431	RANTES levels	RANTES levels	Inflammatory measurement
3977	GCST004429	Stem cell factor levels	Stem cell factor levels	Other measurement
3978	GCST004428	Stem cell growth factor beta levels	Stem cell growth factor beta levels	Other measurement
3979	GCST004427	Stromal-cell-derived factor 1 alpha levels	Stromal-cell-derived factor 1 alpha levels	Other measurement
3980	GCST004426	Tumor necrosis factor alpha levels	Tumor necrosis factor alpha levels	Inflammatory measurement
3981	GCST004425	Tumor necrosis factor beta levels	Tumor necrosis factor beta levels	Other measurement
3982	GCST004424	TRAIL levels	TRAIL levels	Other measurement
3983	GCST000297	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
3984	GCST000297	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
3985	GCST000295	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
3986	GCST000295	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
3987	GCST001467	Hypertension	Hypertension	Cardiovascular disease
3988	GCST000291	Fasting plasma glucose	Fasting plasma glucose	Other measurement
3989	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Cardiovascular measurement
3990	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Cardiovascular measurement
3991	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Other trait
3992	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Cardiovascular measurement
3993	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Cardiovascular measurement
3994	GCST000097	Coronary artery calcification	Coronary artery calcification	Other trait
3995	GCST001284	Premature ovarian failure	Premature ovarian failure	Other disease
3996	GCST001946	PCA3 expression level	PCA3 expression level	Other measurement
3997	GCST001935	Body mass index in non-asthmatics	Body mass index in non-asthmatics	Body measurement
3998	GCST001945	Body mass index in asthmatics	Body mass index in asthmatics	Body measurement
3999	GCST001945	Body mass index in asthmatics	Body mass index in asthmatics	Other disease
4000	GCST000096	Aging traits	Aging traits	Other measurement
4001	GCST000096	Aging traits	Aging traits	Cardiovascular measurement
4002	GCST000096	Aging traits	Aging traits	Biological process
4003	GCST000096	Aging traits	Aging traits	Other measurement
4004	GCST000103	Morbidity-free survival	Morbidity-free survival	Other measurement
4005	GCST002158	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
4006	GCST002158	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
4007	GCST002671	Toenail selenium levels	Toenail selenium levels	Other measurement
4008	GCST002670	Blood and toenail selenium levels	Blood and toenail selenium levels	Other measurement
4009	GCST000091	Cystatin C	Cystatin C	Other measurement
4010	GCST000100	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
4011	GCST000100	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
4012	GCST000105	Urinary albumin excretion	Urinary albumin excretion	Other trait
4013	GCST000335	Thyroid cancer	Thyroid cancer	Cancer
4014	GCST000094	Blood pressure	Blood pressure	Other measurement
4015	GCST000094	Blood pressure	Blood pressure	Other measurement
4016	GCST000094	Blood pressure	Blood pressure	Other measurement
4017	GCST000094	Blood pressure	Blood pressure	Other measurement
4018	GCST000094	Blood pressure	Blood pressure	Cardiovascular measurement
4019	GCST000107	Tonometry	Tonometry	Other measurement
4020	GCST002846	Lifespan	Lifespan	Other measurement
4021	GCST000081	Sleep-related phenotypes	Sleep-related phenotypes	Other measurement
4022	GCST001780	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
4023	GCST001780	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
4024	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4025	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4026	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4027	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4028	GCST001779	Hematology traits	Hematology traits	Cardiovascular measurement
4029	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4030	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4031	GCST001779	Hematology traits	Hematology traits	Other measurement
4032	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4033	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4034	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4035	GCST001779	Hematology traits	Hematology traits	Hematological measurement
4036	GCST001782	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
4037	GCST001782	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
4038	GCST001781	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
4039	GCST001783	Platelet count	Platelet count	Hematological measurement
4040	GCST000392	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
4041	GCST000464	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
4042	GCST000497	Mean platelet volume	Mean platelet volume	Hematological measurement
4043	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
4044	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
4045	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
4046	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
4047	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
4048	GCST001506	Intraocular pressure	Intraocular pressure	Other measurement
4049	GCST001343	Fat distribution (HIV)	Fat distribution (HIV)	Body measurement
4050	GCST001343	Fat distribution (HIV)	Fat distribution (HIV)	Other disease
4051	GCST001922	QT interval	QT interval	Cardiovascular measurement
4052	GCST001921	Heart rate	Heart rate	Cardiovascular measurement
4053	GCST001925	PR interval	PR interval	Cardiovascular measurement
4054	GCST001920	QRS duration	QRS duration	Cardiovascular measurement
4055	GCST001920	QRS duration	QRS duration	Cardiovascular measurement
4056	GCST001920	QRS duration	QRS duration	Cardiovascular measurement
4057	GCST001682	Personality disorders	Personality disorders	Neurological disorder
4058	GCST000956	Substance dependence	Substance dependence	Neurological disorder
4059	GCST002108	Allergic dermatitis (nickel)	Allergic dermatitis (nickel)	Immune system disorder
4060	GCST001007	Metabolic syndrome (bivariate traits)	Metabolic syndrome (bivariate traits)	Metabolic disorder
4061	GCST001003	Metabolic syndrome	Metabolic syndrome	Body measurement
4062	GCST001003	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
4063	GCST001003	Metabolic syndrome	Metabolic syndrome	Other measurement
4064	GCST001003	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
4065	GCST001003	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
4066	GCST001006	Waist Circumference - Triglycerides (WC-TG)	Waist Circumference - Triglycerides (WC-TG)	Metabolic disorder
4067	GCST001006	Waist Circumference - Triglycerides (WC-TG)	Waist Circumference - Triglycerides (WC-TG)	Lipid or lipoprotein measurement
4068	GCST001005	HDL Cholesterol - Triglycerides (HDLC-TG)	HDL Cholesterol - Triglycerides (HDLC-TG)	Lipid or lipoprotein measurement
4069	GCST001005	HDL Cholesterol - Triglycerides (HDLC-TG)	HDL Cholesterol - Triglycerides (HDLC-TG)	Lipid or lipoprotein measurement
4070	GCST001004	Triglycerides-Blood Pressure (TG-BP)	Triglycerides-Blood Pressure (TG-BP)	Other measurement
4071	GCST001004	Triglycerides-Blood Pressure (TG-BP)	Triglycerides-Blood Pressure (TG-BP)	Lipid or lipoprotein measurement
4072	GCST003339	Epstein Barr virus nuclear antigen 1 IgG levels	Epstein Barr virus nuclear antigen 1 IgG levels	Other measurement
4073	GCST003340	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Immune system disorder
4074	GCST003340	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Other measurement
4075	GCST000247	Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	Neurological disorder
4076	GCST000247	Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	Other measurement
4077	GCST000245	Conduct disorder (maternal expressed emotions interaction)	Conduct disorder (maternal expressed emotions interaction)	Neurological disorder
4078	GCST000245	Conduct disorder (maternal expressed emotions interaction)	Conduct disorder (maternal expressed emotions interaction)	Other measurement
4079	GCST000284	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
4080	GCST000283	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4081	GCST000283	LDL cholesterol	LDL cholesterol	Other measurement
4082	GCST000283	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4083	GCST000292	Metabolic traits	Metabolic traits	Other measurement
4084	GCST000292	Metabolic traits	Metabolic traits	Biological process
4085	GCST000292	Metabolic traits	Metabolic traits	Lipid or lipoprotein measurement
4086	GCST000292	Metabolic traits	Metabolic traits	Other measurement
4087	GCST000292	Metabolic traits	Metabolic traits	Other measurement
4088	GCST006112	Diastolic blood pressure x sodium interaction (1df test)	Diastolic blood pressure x sodium interaction (1df test)	Other measurement
4089	GCST006112	Diastolic blood pressure x sodium interaction (1df test)	Diastolic blood pressure x sodium interaction (1df test)	Other measurement
4090	GCST006113	Systolic blood pressure x sodium interaction (2df test)	Systolic blood pressure x sodium interaction (2df test)	Other measurement
4091	GCST006113	Systolic blood pressure x sodium interaction (2df test)	Systolic blood pressure x sodium interaction (2df test)	Other measurement
4092	GCST006111	Diastolic blood pressure x sodium interaction (2df test)	Diastolic blood pressure x sodium interaction (2df test)	Other measurement
4093	GCST006111	Diastolic blood pressure x sodium interaction (2df test)	Diastolic blood pressure x sodium interaction (2df test)	Other measurement
4094	GCST006114	Mean arterial pressure x sodium interaction (2df test)	Mean arterial pressure x sodium interaction (2df test)	Other measurement
4095	GCST006114	Mean arterial pressure x sodium interaction (2df test)	Mean arterial pressure x sodium interaction (2df test)	Other measurement
4096	GCST006115	Systolic blood pressure x sodium interaction (1df test)	Systolic blood pressure x sodium interaction (1df test)	Other measurement
4097	GCST006115	Systolic blood pressure x sodium interaction (1df test)	Systolic blood pressure x sodium interaction (1df test)	Other measurement
4098	GCST006116	Mean arterial pressure x sodium interaction (1df test)	Mean arterial pressure x sodium interaction (1df test)	Other measurement
4099	GCST006116	Mean arterial pressure x sodium interaction (1df test)	Mean arterial pressure x sodium interaction (1df test)	Other measurement
4100	GCST006117	Pulse pressure x sodium interaction (1df test)	Pulse pressure x sodium interaction (1df test)	Other measurement
4101	GCST006117	Pulse pressure x sodium interaction (1df test)	Pulse pressure x sodium interaction (1df test)	Cardiovascular measurement
4102	GCST006118	Pulse pressure x sodium interaction (2df test)	Pulse pressure x sodium interaction (2df test)	Other measurement
4103	GCST006118	Pulse pressure x sodium interaction (2df test)	Pulse pressure x sodium interaction (2df test)	Cardiovascular measurement
4104	GCST003040	Hearing function (high tone)	Hearing function (high tone)	Other measurement
4105	GCST003040	Hearing function (high tone)	Hearing function (high tone)	Other measurement
4106	GCST003039	Hearing function (0.25 kHz)	Hearing function (0.25 kHz)	Other measurement
4107	GCST003039	Hearing function (0.25 kHz)	Hearing function (0.25 kHz)	Other measurement
4108	GCST003037	Hearing function (0.5 kHz)	Hearing function (0.5 kHz)	Other measurement
4109	GCST003037	Hearing function (0.5 kHz)	Hearing function (0.5 kHz)	Other measurement
4110	GCST003041	Hearing function (1 kHz)	Hearing function (1 kHz)	Other measurement
4111	GCST003041	Hearing function (1 kHz)	Hearing function (1 kHz)	Other measurement
4112	GCST003032	Hearing function (2 kHz)	Hearing function (2 kHz)	Other measurement
4113	GCST003032	Hearing function (2 kHz)	Hearing function (2 kHz)	Other measurement
4114	GCST003035	Hearing function (4 kHz)	Hearing function (4 kHz)	Other measurement
4115	GCST003035	Hearing function (4 kHz)	Hearing function (4 kHz)	Other measurement
4116	GCST003034	Hearing function (8 kHz)	Hearing function (8 kHz)	Other measurement
4117	GCST003034	Hearing function (8 kHz)	Hearing function (8 kHz)	Other measurement
4118	GCST003036	Hearing function (low tone)	Hearing function (low tone)	Other measurement
4119	GCST003036	Hearing function (low tone)	Hearing function (low tone)	Other measurement
4120	GCST003033	Hearing function (medium tone)	Hearing function (medium tone)	Other measurement
4121	GCST003033	Hearing function (medium tone)	Hearing function (medium tone)	Other measurement
4122	GCST001654	Sarcoidosis	Sarcoidosis	Other disease
4123	GCST001185	Coronary heart disease	Coronary heart disease	Cardiovascular disease
4124	GCST001771	Neuroticism	Neuroticism	Neurological disorder
4125	GCST001771	Neuroticism	Neuroticism	Other measurement
4126	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4127	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4128	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4129	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4130	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4131	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4132	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4133	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4134	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4135	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4136	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4137	GCST003587	Cancer	Cancer	Cancer
4138	GCST003587	Cancer	Cancer	Cancer
4139	GCST003587	Cancer	Cancer	Cancer
4140	GCST003587	Cancer	Cancer	Cancer
4141	GCST003587	Cancer	Cancer	Cancer
4142	GCST003587	Cancer	Cancer	Cancer
4143	GCST003587	Cancer	Cancer	Cancer
4144	GCST003587	Cancer	Cancer	Cancer
4145	GCST003587	Cancer	Cancer	Cancer
4146	GCST003587	Cancer	Cancer	Cancer
4147	GCST003587	Cancer	Cancer	Cancer
4148	GCST001519	Economic and political preferences	Economic and political preferences	Other trait
4149	GCST001512	Economic and political preferences (environmentalism)	Economic and political preferences (environmentalism)	Other trait
4150	GCST001513	Economic and political preferences (fairness)	Economic and political preferences (fairness)	Other trait
4151	GCST001514	Economic and political preferences (feminism/equality)	Economic and political preferences (feminism/equality)	Other trait
4152	GCST001515	Economic and political preferences (immigration/crime)	Economic and political preferences (immigration/crime)	Other trait
4153	GCST001511	Economic and political preferences (time)	Economic and political preferences (time)	Other trait
4154	GCST008731	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4155	GCST008731	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
4156	GCST008731	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4157	GCST008730	Crohn's disease	Crohn's disease	Digestive system disorder
4158	GCST008732	Ulcerative colitis	Ulcerative colitis	Immune system disorder
4159	GCST001754	Waist-to-hip circumference ratio (ever vs never smoking interaction)	Waist-to-hip circumference ratio (ever vs never smoking interaction)	Other measurement
4160	GCST001754	Waist-to-hip circumference ratio (ever vs never smoking interaction)	Waist-to-hip circumference ratio (ever vs never smoking interaction)	Body measurement
4161	GCST001753	Body mass index (alcohol intake interaction)	Body mass index (alcohol intake interaction)	Body measurement
4162	GCST001753	Body mass index (alcohol intake interaction)	Body mass index (alcohol intake interaction)	Other measurement
4163	GCST004587	Body mass index (dietary energy interaction)	Body mass index (dietary energy interaction)	Body measurement
4164	GCST004587	Body mass index (dietary energy interaction)	Body mass index (dietary energy interaction)	Other measurement
4165	GCST004580	Body mass index (recreational physical activity interaction)	Body mass index (recreational physical activity interaction)	Body measurement
4166	GCST004580	Body mass index (recreational physical activity interaction)	Body mass index (recreational physical activity interaction)	Other measurement
4167	GCST004586	Body mass index (ever vs never smoking interaction)	Body mass index (ever vs never smoking interaction)	Body measurement
4168	GCST004586	Body mass index (ever vs never smoking interaction)	Body mass index (ever vs never smoking interaction)	Other measurement
4169	GCST004581	Body mass index  (smoking years interaction)	Body mass index  (smoking years interaction)	Body measurement
4170	GCST004581	Body mass index  (smoking years interaction)	Body mass index  (smoking years interaction)	Other measurement
4171	GCST004582	Waist-to-hip circumference ratio (dietary energy interaction)	Waist-to-hip circumference ratio (dietary energy interaction)	Body measurement
4172	GCST004582	Waist-to-hip circumference ratio (dietary energy interaction)	Waist-to-hip circumference ratio (dietary energy interaction)	Other measurement
4173	GCST004584	Waist-to-hip circumference ratio (smoking years interaction)	Waist-to-hip circumference ratio (smoking years interaction)	Other measurement
4174	GCST004584	Waist-to-hip circumference ratio (smoking years interaction)	Waist-to-hip circumference ratio (smoking years interaction)	Body measurement
4175	GCST004583	Waist-to-hip circumference ratio (recreational physical activity interaction)	Waist-to-hip circumference ratio (recreational physical activity interaction)	Body measurement
4176	GCST004583	Waist-to-hip circumference ratio (recreational physical activity interaction)	Waist-to-hip circumference ratio (recreational physical activity interaction)	Other measurement
4177	GCST004579	Waist-to-hip circumference ratio (alcohol intake interaction)	Waist-to-hip circumference ratio (alcohol intake interaction)	Body measurement
4178	GCST004579	Waist-to-hip circumference ratio (alcohol intake interaction)	Waist-to-hip circumference ratio (alcohol intake interaction)	Other measurement
4179	GCST002638	Gastritis	Gastritis	Digestive system disorder
4180	GCST004029	Angiotensin-converting enzyme inhibitor intolerance	Angiotensin-converting enzyme inhibitor intolerance	Response to drug
4181	GCST002060	Word reading	Word reading	Biological process
4182	GCST002062	Reading and spelling	Reading and spelling	Biological process
4183	GCST002059	Non-word repetition	Non-word repetition	Biological process
4184	GCST004727	Facial emotion recognition	Facial emotion recognition	Other measurement
4185	GCST004729	Facial emotion recognition (happy faces)	Facial emotion recognition (happy faces)	Other measurement
4186	GCST004730	Facial emotion recognition (sad faces)	Facial emotion recognition (sad faces)	Other measurement
4187	GCST004728	Facial emotion recognition (angry faces)	Facial emotion recognition (angry faces)	Other measurement
4188	GCST004731	Facial emotion recognition (fearful faces)	Facial emotion recognition (fearful faces)	Other measurement
4189	GCST002196	Homoarginine levels	Homoarginine levels	Other measurement
4190	GCST001729	Crohn's disease	Crohn's disease	Digestive system disorder
4191	GCST001728	Ulcerative colitis	Ulcerative colitis	Immune system disorder
4192	GCST001725	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4193	GCST001725	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
4194	GCST001725	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4195	GCST004968	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Cardiovascular disease
4196	GCST004968	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Cardiovascular disease
4197	GCST004968	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Cardiovascular measurement
4198	GCST004968	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Response to drug
4199	GCST004966	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Cardiovascular disease
4200	GCST004966	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Cardiovascular disease
4201	GCST004966	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Cardiovascular measurement
4202	GCST004966	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Response to drug
4203	GCST004961	Major coronary event in placebo-treated cardiovascular disease (time to event)	Major coronary event in placebo-treated cardiovascular disease (time to event)	Cardiovascular measurement
4204	GCST004961	Major coronary event in placebo-treated cardiovascular disease (time to event)	Major coronary event in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
4205	GCST004961	Major coronary event in placebo-treated cardiovascular disease (time to event)	Major coronary event in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
4206	GCST004961	Major coronary event in placebo-treated cardiovascular disease (time to event)	Major coronary event in placebo-treated cardiovascular disease (time to event)	Biological process
4207	GCST004962	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4208	GCST004962	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4209	GCST004962	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Other trait
4210	GCST004962	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Response to drug
4211	GCST004964	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4212	GCST004964	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4213	GCST004964	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4214	GCST004964	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Response to drug
4215	GCST004965	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
4216	GCST004965	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
4217	GCST004965	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
4218	GCST004965	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Biological process
4219	GCST004958	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular measurement
4220	GCST004958	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
4221	GCST004958	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
4222	GCST004958	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Response to drug
4223	GCST004960	Odor events in darapladib-treated cardiovascular disease (time to event)	Odor events in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4224	GCST004960	Odor events in darapladib-treated cardiovascular disease (time to event)	Odor events in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4225	GCST004960	Odor events in darapladib-treated cardiovascular disease (time to event)	Odor events in darapladib-treated cardiovascular disease (time to event)	Response to drug
4226	GCST004960	Odor events in darapladib-treated cardiovascular disease (time to event)	Odor events in darapladib-treated cardiovascular disease (time to event)	Other measurement
4227	GCST004957	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Cardiovascular measurement
4228	GCST004957	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4229	GCST004957	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4230	GCST004957	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Response to drug
4231	GCST004963	Lipoprotein phospholipase A2 activity in cardiovascular disease	Lipoprotein phospholipase A2 activity in cardiovascular disease	Lipid or lipoprotein measurement
4232	GCST004963	Lipoprotein phospholipase A2 activity in cardiovascular disease	Lipoprotein phospholipase A2 activity in cardiovascular disease	Cardiovascular disease
4233	GCST004963	Lipoprotein phospholipase A2 activity in cardiovascular disease	Lipoprotein phospholipase A2 activity in cardiovascular disease	Cardiovascular disease
4234	GCST004959	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
4235	GCST004959	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
4236	GCST004959	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
4237	GCST004959	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Response to drug
4238	GCST004967	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4239	GCST004967	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
4240	GCST004967	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Other trait
4241	GCST004967	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Response to drug
4242	GCST002135	Nicotine use	Nicotine use	Biological process
4243	GCST002130	Alcohol consumption	Alcohol consumption	Biological process
4244	GCST002130	Alcohol consumption	Alcohol consumption	Other measurement
4245	GCST002134	Alcohol dependence	Alcohol dependence	Other measurement
4246	GCST002134	Alcohol dependence	Alcohol dependence	Neurological disorder
4247	GCST002133	Illicit drug use	Illicit drug use	Biological process
4248	GCST002132	Non-substance related behavioral disinhibition	Non-substance related behavioral disinhibition	Biological process
4249	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Biological process
4250	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Neurological disorder
4251	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Biological process
4252	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Biological process
4253	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Biological process
4254	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Other measurement
4255	GCST005931	Glioma	Glioma	Cancer
4256	GCST005931	Glioma	Glioma	Cancer
4257	GCST005932	Glioblastoma	Glioblastoma	Cancer
4258	GCST005932	Glioblastoma	Glioblastoma	Cancer
4259	GCST005932	Glioblastoma	Glioblastoma	Cancer
4260	GCST005933	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
4261	GCST005933	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
4262	GCST005127	Lung function (maximal voluntary ventilation)	Lung function (maximal voluntary ventilation)	Other measurement
4263	GCST005127	Lung function (maximal voluntary ventilation)	Lung function (maximal voluntary ventilation)	Other measurement
4264	GCST005132	Lung function (forced expiratory volume in 1 second)	Lung function (forced expiratory volume in 1 second)	Other measurement
4265	GCST005129	Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	Other measurement
4266	GCST005131	Lung function (forced vital capacity)	Lung function (forced vital capacity)	Other measurement
4267	GCST005130	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
4268	GCST002050	Sleep time	Sleep time	Other measurement
4269	GCST002049	Sleep quality	Sleep quality	Other measurement
4270	GCST002054	Sleep depth	Sleep depth	Other measurement
4271	GCST002053	Sleep duration	Sleep duration	Other measurement
4272	GCST002052	Insomnia	Insomnia	Neurological disorder
4273	GCST002052	Insomnia	Insomnia	Other measurement
4274	GCST002051	Sleep latency	Sleep latency	Other measurement
4275	GCST003088	Soluble interleukin-2 receptor subunit alpha	Soluble interleukin-2 receptor subunit alpha	Other measurement
4276	GCST002870	LDL cholesterol subfractions	LDL cholesterol subfractions	Lipid or lipoprotein measurement
4277	GCST002865	Response to statin therapy (LDL cholesterol subfractions)	Response to statin therapy (LDL cholesterol subfractions)	Lipid or lipoprotein measurement
4278	GCST002865	Response to statin therapy (LDL cholesterol subfractions)	Response to statin therapy (LDL cholesterol subfractions)	Response to drug
4279	GCST002708	Acoustic startle blink response	Acoustic startle blink response	Other measurement
4280	GCST003862	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	Other disease
4281	GCST003862	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	Metabolic disorder
4282	GCST003861	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	Other disease
4283	GCST003861	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	Metabolic disorder
4284	GCST003863	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	Other disease
4285	GCST003863	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	Metabolic disorder
4286	GCST003864	Kidney disease (early and late stages) in type 1 diabetes	Kidney disease (early and late stages) in type 1 diabetes	Other disease
4287	GCST003864	Kidney disease (early and late stages) in type 1 diabetes	Kidney disease (early and late stages) in type 1 diabetes	Metabolic disorder
4288	GCST003865	Kidney disease (early stage) in type 1 diabetes	Kidney disease (early stage) in type 1 diabetes	Other disease
4289	GCST003865	Kidney disease (early stage) in type 1 diabetes	Kidney disease (early stage) in type 1 diabetes	Metabolic disorder
4290	GCST003866	Kidney disease (late stage) in type 1 diabetes	Kidney disease (late stage) in type 1 diabetes	Other disease
4291	GCST003866	Kidney disease (late stage) in type 1 diabetes	Kidney disease (late stage) in type 1 diabetes	Metabolic disorder
4292	GCST003867	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	Other disease
4293	GCST003867	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	Metabolic disorder
4294	GCST003959	Crohn's disease	Crohn's disease	Digestive system disorder
4295	GCST003960	Ulcerative colitis	Ulcerative colitis	Immune system disorder
4296	GCST003958	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4297	GCST003958	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
4298	GCST003958	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4299	GCST003474	Scalp hair shape	Scalp hair shape	Other measurement
4300	GCST003475	Beard thickness	Beard thickness	Other measurement
4301	GCST003476	Eyebrow thickness	Eyebrow thickness	Other measurement
4302	GCST003477	Monobrow thickness	Monobrow thickness	Other measurement
4303	GCST003478	Hair greying	Hair greying	Other measurement
4304	GCST003479	Hair color	Hair color	Other measurement
4305	GCST003479	Hair color	Hair color	Other trait
4306	GCST003480	Balding	Balding	Other measurement
4307	GCST006280	Velopharyngeal dysfunction	Velopharyngeal dysfunction	Other trait
4308	GCST003302	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
4309	GCST003303	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4310	GCST003303	LDL cholesterol	LDL cholesterol	Other measurement
4311	GCST003303	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4312	GCST003301	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
4313	GCST003304	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
4314	GCST004831	Verbal memory performance (delayed recall level)	Verbal memory performance (delayed recall level)	Other measurement
4315	GCST004830	Verbal memory performance (residualized delayed recall change)	Verbal memory performance (residualized delayed recall change)	Other measurement
4316	GCST004827	Verbal memory performance (immediate recall change)	Verbal memory performance (immediate recall change)	Other measurement
4317	GCST004829	Verbal memory performance (residualized delayed recall level)	Verbal memory performance (residualized delayed recall level)	Other measurement
4318	GCST004828	Verbal memory performance (immediate recall level)	Verbal memory performance (immediate recall level)	Other measurement
4319	GCST004832	Verbal memory performance (delayed recall change)	Verbal memory performance (delayed recall change)	Other measurement
4320	GCST006620	Self-rated health	Self-rated health	Other trait
4321	GCST004263	Achilles tendinopathy	Achilles tendinopathy	Other disease
4322	GCST004265	Anterior cruciate ligament rupture	Anterior cruciate ligament rupture	Other disease
4323	GCST002220	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4324	GCST002220	LDL cholesterol	LDL cholesterol	Other measurement
4325	GCST002220	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4326	GCST002219	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
4327	GCST002223	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
4328	GCST002222	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4329	GCST002222	LDL cholesterol	LDL cholesterol	Other measurement
4330	GCST002222	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4331	GCST002221	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
4332	GCST002216	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
4333	GCST002282	Parasitemia in Tripanosoma cruzi seropositivity	Parasitemia in Tripanosoma cruzi seropositivity	Other measurement
4334	GCST002282	Parasitemia in Tripanosoma cruzi seropositivity	Parasitemia in Tripanosoma cruzi seropositivity	Other measurement
4335	GCST002284	QRS duration in Tripanosoma cruzi seropositivity	QRS duration in Tripanosoma cruzi seropositivity	Other measurement
4336	GCST002284	QRS duration in Tripanosoma cruzi seropositivity	QRS duration in Tripanosoma cruzi seropositivity	Cardiovascular measurement
4337	GCST002285	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Cardiovascular disease
4338	GCST002285	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Other measurement
4339	GCST002280	Antibody status in Tripanosoma cruzi seropositivity	Antibody status in Tripanosoma cruzi seropositivity	Other measurement
4340	GCST002280	Antibody status in Tripanosoma cruzi seropositivity	Antibody status in Tripanosoma cruzi seropositivity	Other measurement
4341	GCST002279	PR interval in Tripanosoma cruzi seropositivity	PR interval in Tripanosoma cruzi seropositivity	Other measurement
4342	GCST002279	PR interval in Tripanosoma cruzi seropositivity	PR interval in Tripanosoma cruzi seropositivity	Cardiovascular measurement
4343	GCST002278	QT interval in Tripanosoma cruzi seropositivity	QT interval in Tripanosoma cruzi seropositivity	Cardiovascular measurement
4344	GCST002278	QT interval in Tripanosoma cruzi seropositivity	QT interval in Tripanosoma cruzi seropositivity	Other measurement
4345	GCST002281	Ejection fraction in Tripanosoma cruzi seropositivity	Ejection fraction in Tripanosoma cruzi seropositivity	Cardiovascular measurement
4346	GCST002281	Ejection fraction in Tripanosoma cruzi seropositivity	Ejection fraction in Tripanosoma cruzi seropositivity	Other measurement
4347	GCST004653	Peak velocity of the mitral E-wave	Peak velocity of the mitral E-wave	Cardiovascular measurement
4348	GCST004649	Isovolumetric relaxation time	Isovolumetric relaxation time	Cardiovascular measurement
4349	GCST004658	Peak velocity of excursion of lateral mitral annulus in early diastolic phase	Peak velocity of excursion of lateral mitral annulus in early diastolic phase	Cardiovascular measurement
4350	GCST004652	Peak velocity of the mitral A-wave	Peak velocity of the mitral A-wave	Cardiovascular measurement
4351	GCST004656	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.	Cardiovascular measurement
4352	GCST004654	Deceleration time of the mitral E-wave	Deceleration time of the mitral E-wave	Cardiovascular measurement
4353	GCST004657	Ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral E-wave	Ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral E-wave	Cardiovascular measurement
4354	GCST004650	Diastolic dysfunction with preserved ejection pressure	Diastolic dysfunction with preserved ejection pressure	Cardiovascular measurement
4355	GCST004660	Heart failure with preserved ejection fraction	Heart failure with preserved ejection fraction	Cardiovascular measurement
4356	GCST004651	Aortic root size	Aortic root size	Cardiovascular measurement
4357	GCST004647	Left atrial antero-posterior diameter	Left atrial antero-posterior diameter	Cardiovascular measurement
4358	GCST004655	Left ventricle diastolic internal dimension	Left ventricle diastolic internal dimension	Cardiovascular measurement
4359	GCST004646	Left ventricle wall thickness	Left ventricle wall thickness	Cardiovascular measurement
4360	GCST004659	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
4361	GCST004659	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
4362	GCST004645	Left ventricular fractional shortening	Left ventricular fractional shortening	Cardiovascular measurement
4363	GCST004648	Left  ventricle systolic dysfunction	Left  ventricle systolic dysfunction	Cardiovascular measurement
4364	GCST006716	Alcohol use disorder (total score)	Alcohol use disorder (total score)	Other measurement
4365	GCST006718	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
4366	GCST006718	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
4367	GCST006718	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
4368	GCST006717	Alcohol use disorder (dependence and problematic use scores)	Alcohol use disorder (dependence and problematic use scores)	Other measurement
4369	GCST005086	Visceral adipose tissue (sex interaction)	Visceral adipose tissue (sex interaction)	Other measurement
4370	GCST005086	Visceral adipose tissue (sex interaction)	Visceral adipose tissue (sex interaction)	Other measurement
4371	GCST005092	Subcutaneous adipose tissue (sex interaction)	Subcutaneous adipose tissue (sex interaction)	Other measurement
4372	GCST005092	Subcutaneous adipose tissue (sex interaction)	Subcutaneous adipose tissue (sex interaction)	Other measurement
4373	GCST005091	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
4374	GCST005090	Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	Other measurement
4375	GCST005090	Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	Other measurement
4376	GCST005089	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
4377	GCST005089	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
4378	GCST005088	Visceral adipose tissue adjusted for BMI (sex interaction)	Visceral adipose tissue adjusted for BMI (sex interaction)	Other measurement
4379	GCST005088	Visceral adipose tissue adjusted for BMI (sex interaction)	Visceral adipose tissue adjusted for BMI (sex interaction)	Other measurement
4380	GCST005087	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
4381	GCST005087	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
4382	GCST005085	Visceral adipose tissue	Visceral adipose tissue	Other measurement
4383	GCST007021	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
4384	GCST007021	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
4385	GCST007022	Type 2 diabetes nephropathy including microalbuminuria	Type 2 diabetes nephropathy including microalbuminuria	Other trait
4386	GCST007022	Type 2 diabetes nephropathy including microalbuminuria	Type 2 diabetes nephropathy including microalbuminuria	Metabolic disorder
4387	GCST008172	Liver iron content	Liver iron content	Other measurement
4388	GCST007452	Skin pigmentation	Skin pigmentation	Other trait
4389	GCST007452	Skin pigmentation	Skin pigmentation	Other measurement
4390	GCST007457	Eye color (saturation)	Eye color (saturation)	Other measurement
4391	GCST007453	Eye color	Eye color	Other measurement
4392	GCST007453	Eye color	Eye color	Other trait
4393	GCST007454	Hair color	Hair color	Other measurement
4394	GCST007454	Hair color	Hair color	Other trait
4395	GCST007455	Eye color (brightness)	Eye color (brightness)	Other measurement
4396	GCST007456	Eye color (hue)	Eye color (hue)	Other measurement
4397	GCST007451	Skin, hair and eye pigmentation (multivariate analysis)	Skin, hair and eye pigmentation (multivariate analysis)	Other measurement
4398	GCST007451	Skin, hair and eye pigmentation (multivariate analysis)	Skin, hair and eye pigmentation (multivariate analysis)	Other measurement
4399	GCST007451	Skin, hair and eye pigmentation (multivariate analysis)	Skin, hair and eye pigmentation (multivariate analysis)	Other measurement
4400	GCST006463	Urinary albumin excretion (no hypertensive medication)	Urinary albumin excretion (no hypertensive medication)	Other trait
4401	GCST006586	Urinary albumin excretion	Urinary albumin excretion	Other trait
4402	GCST004999	Chickenpox	Chickenpox	Other measurement
4403	GCST005001	Shingles	Shingles	Other disease
4404	GCST005001	Shingles	Shingles	Other measurement
4405	GCST005000	Cold sores	Cold sores	Other measurement
4406	GCST005003	Mumps	Mumps	Other measurement
4407	GCST005005	Plantar warts	Plantar warts	Other measurement
4408	GCST005006	Tuberculosis	Tuberculosis	Other disease
4409	GCST005006	Tuberculosis	Tuberculosis	Other measurement
4410	GCST005006	Tuberculosis	Tuberculosis	Other measurement
4411	GCST005010	Bacterial meningitis	Bacterial meningitis	Other measurement
4412	GCST005011	Yeast infection	Yeast infection	Other measurement
4413	GCST005015	Myringotomy	Myringotomy	Other measurement
4414	GCST005016	Measles	Measles	Other measurement
4415	GCST005017	Hepatitis A	Hepatitis A	Other measurement
4416	GCST005018	Rheumatic fever	Rheumatic fever	Other measurement
4417	GCST005019	Number of common colds	Number of common colds	Other measurement
4418	GCST005021	Chronic sinus infection	Chronic sinus infection	Other measurement
4419	GCST005012	Urinary tract infection frequency	Urinary tract infection frequency	Other measurement
4420	GCST005014	Tonsillectomy	Tonsillectomy	Other measurement
4421	GCST005013	Childhood ear infection	Childhood ear infection	Other measurement
4422	GCST005020	Rubella	Rubella	Other measurement
4423	GCST005002	Mononucleosis	Mononucleosis	Other measurement
4424	GCST005004	Hepatitis B	Hepatitis B	Digestive system disorder
4425	GCST005004	Hepatitis B	Hepatitis B	Other measurement
4426	GCST005007	Strep throat	Strep throat	Other measurement
4427	GCST005008	Scarlet fever	Scarlet fever	Other measurement
4428	GCST005009	Pneumonia	Pneumonia	Other measurement
4429	GCST005336	Systemic sclerosis	Systemic sclerosis	Neurological disorder
4430	GCST005334	Limited cutaneous systemic scleroderma	Limited cutaneous systemic scleroderma	Neurological disorder
4431	GCST005335	Diffuse cutaneous systemic sclerosis	Diffuse cutaneous systemic sclerosis	Neurological disorder
4432	GCST005333	Systemic sclerosis (anti-centromere-positive)	Systemic sclerosis (anti-centromere-positive)	Neurological disorder
4433	GCST005332	Systemic sclerosis (anti-topoisomerase-positive)	Systemic sclerosis (anti-topoisomerase-positive)	Neurological disorder
4434	GCST005554	Systemic sclerosis	Systemic sclerosis	Neurological disorder
4435	GCST005555	Limited cutaneous systemic scleroderma	Limited cutaneous systemic scleroderma	Neurological disorder
4436	GCST005553	Diffuse cutaneous systemic sclerosis	Diffuse cutaneous systemic sclerosis	Neurological disorder
4437	GCST005552	Systemic sclerosis (anti-centromere-positive)	Systemic sclerosis (anti-centromere-positive)	Neurological disorder
4438	GCST005551	Systemic sclerosis (anti-topoisomerase-positive)	Systemic sclerosis (anti-topoisomerase-positive)	Neurological disorder
4439	GCST006091	Freckles	Freckles	Other trait
4440	GCST006092	Double-edged eyelids	Double-edged eyelids	Other measurement
4441	GCST006093	Thick vs thin eyebrows	Thick vs thin eyebrows	Other measurement
4442	GCST006094	Straight vs curly hair	Straight vs curly hair	Other measurement
4443	GCST006094	Straight vs curly hair	Straight vs curly hair	Other trait
4444	GCST006095	Excessive hairiness	Excessive hairiness	Other trait
4445	GCST006090	Excessive sweating	Excessive sweating	Other trait
4446	GCST006096	Age spots	Age spots	Other measurement
4447	GCST005809	Photic sneeze reflex	Photic sneeze reflex	Other trait
4448	GCST008413	Core binding factor acute myeloid leukemia	Core binding factor acute myeloid leukemia	Cancer
4449	GCST007337	Life satisfaction	Life satisfaction	Other measurement
4450	GCST007338	Positive affect	Positive affect	Other measurement
4451	GCST007339	Neuroticism	Neuroticism	Neurological disorder
4452	GCST007339	Neuroticism	Neuroticism	Other measurement
4453	GCST007340	Depressive symptoms	Depressive symptoms	Neurological disorder
4454	GCST007340	Depressive symptoms	Depressive symptoms	Other measurement
4455	GCST007341	Well-being spectrum (multivariate analysis)	Well-being spectrum (multivariate analysis)	Other measurement
4456	GCST004992	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	Other measurement
4457	GCST004992	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	Neurological disorder
4458	GCST004992	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	Other measurement
4459	GCST004996	Total mean fractional anisotropy measurement in first episode schizophrenia	Total mean fractional anisotropy measurement in first episode schizophrenia	Other measurement
4460	GCST004996	Total mean fractional anisotropy measurement in first episode schizophrenia	Total mean fractional anisotropy measurement in first episode schizophrenia	Neurological disorder
4461	GCST004996	Total mean fractional anisotropy measurement in first episode schizophrenia	Total mean fractional anisotropy measurement in first episode schizophrenia	Other measurement
4462	GCST004995	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	Other measurement
4463	GCST004995	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	Neurological disorder
4464	GCST004995	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	Other measurement
4465	GCST004991	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	Other measurement
4466	GCST004991	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	Neurological disorder
4467	GCST004991	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	Other measurement
4468	GCST004997	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Other measurement
4469	GCST004997	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Neurological disorder
4470	GCST004997	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Other measurement
4471	GCST004997	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Other measurement
4472	GCST004994	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	Other measurement
4473	GCST004994	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	Neurological disorder
4474	GCST004994	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	Other measurement
4475	GCST004993	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	Other measurement
4476	GCST004993	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	Neurological disorder
4477	GCST004993	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	Other measurement
4478	GCST004227	Obstetric antiphospholipid syndrome	Obstetric antiphospholipid syndrome	Immune system disorder
4479	GCST008307	Response to belimumab (SLE response index) in systemic lupus erythematosus	Response to belimumab (SLE response index) in systemic lupus erythematosus	Response to drug
4480	GCST008307	Response to belimumab (SLE response index) in systemic lupus erythematosus	Response to belimumab (SLE response index) in systemic lupus erythematosus	Immune system disorder
4481	GCST007205	Schizophrenia	Schizophrenia	Neurological disorder
4482	GCST007201	Schizophrenia	Schizophrenia	Neurological disorder
4483	GCST004988	Breast cancer	Breast cancer	Cancer
4484	GCST006990	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Neurological disorder
4485	GCST006990	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Other measurement
4486	GCST006991	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Other measurement
4487	GCST006991	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Neurological disorder
4488	GCST006992	Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Other measurement
4489	GCST006992	Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Neurological disorder
4490	GCST006993	Hippocampal volume in Alzheimer's disease dementia	Hippocampal volume in Alzheimer's disease dementia	Neurological disorder
4491	GCST006993	Hippocampal volume in Alzheimer's disease dementia	Hippocampal volume in Alzheimer's disease dementia	Other measurement
4492	GCST006994	Logical memory (immediate recall) in Alzheimer's disease dementia	Logical memory (immediate recall) in Alzheimer's disease dementia	Neurological disorder
4493	GCST006994	Logical memory (immediate recall) in Alzheimer's disease dementia	Logical memory (immediate recall) in Alzheimer's disease dementia	Other measurement
4494	GCST006995	Logical memory (delayed recall) in Alzheimer's disease dementia	Logical memory (delayed recall) in Alzheimer's disease dementia	Neurological disorder
4495	GCST006995	Logical memory (delayed recall) in Alzheimer's disease dementia	Logical memory (delayed recall) in Alzheimer's disease dementia	Other measurement
4496	GCST006997	Cerebrospinal fluid t-tau levels in mild cognitive impairment	Cerebrospinal fluid t-tau levels in mild cognitive impairment	Other measurement
4497	GCST006997	Cerebrospinal fluid t-tau levels in mild cognitive impairment	Cerebrospinal fluid t-tau levels in mild cognitive impairment	Other measurement
4498	GCST006998	Cerebrospinal fluid p-tau levels in mild cognitive impairment	Cerebrospinal fluid p-tau levels in mild cognitive impairment	Other measurement
4499	GCST006998	Cerebrospinal fluid p-tau levels in mild cognitive impairment	Cerebrospinal fluid p-tau levels in mild cognitive impairment	Other measurement
4500	GCST006999	Logical memory (immediate recall) in mild cognitive impairment	Logical memory (immediate recall) in mild cognitive impairment	Other measurement
4501	GCST006999	Logical memory (immediate recall) in mild cognitive impairment	Logical memory (immediate recall) in mild cognitive impairment	Other measurement
4502	GCST007000	Logical memory (delayed recall) in mild cognitive impairment	Logical memory (delayed recall) in mild cognitive impairment	Other measurement
4503	GCST007000	Logical memory (delayed recall) in mild cognitive impairment	Logical memory (delayed recall) in mild cognitive impairment	Other measurement
4504	GCST007001	Cerebrospinal AB1-42 levels in normal cognition	Cerebrospinal AB1-42 levels in normal cognition	Other measurement
4505	GCST007002	Cerebrospinal fluid t-tau levels in normal cognition	Cerebrospinal fluid t-tau levels in normal cognition	Other measurement
4506	GCST007003	Cerebrospinal fluid p-tau levels in normal cognition	Cerebrospinal fluid p-tau levels in normal cognition	Other measurement
4507	GCST007004	Hippocampal volume in normal cognition	Hippocampal volume in normal cognition	Other measurement
4508	GCST007005	Logical memory (immediate recall) in normal cognition	Logical memory (immediate recall) in normal cognition	Other measurement
4509	GCST007007	Cerebrospinal fluid t-tau levels	Cerebrospinal fluid t-tau levels	Other measurement
4510	GCST007008	Cerebrospinal fluid p-tau levels	Cerebrospinal fluid p-tau levels	Other measurement
4511	GCST007009	Hippocampal volume	Hippocampal volume	Other measurement
4512	GCST007010	Logical memory (delayed recall)	Logical memory (delayed recall)	Other measurement
4513	GCST007011	Logical memory (immediate recall)	Logical memory (immediate recall)	Other measurement
4514	GCST006996	Cerebrospinal AB1-42 levels in mild cognitive impairment	Cerebrospinal AB1-42 levels in mild cognitive impairment	Other measurement
4515	GCST006996	Cerebrospinal AB1-42 levels in mild cognitive impairment	Cerebrospinal AB1-42 levels in mild cognitive impairment	Other measurement
4516	GCST007006	Logical memory (delayed recall) in normal cognition	Logical memory (delayed recall) in normal cognition	Other measurement
4517	GCST007012	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
4518	GCST007012	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
4519	GCST007013	Hippocampal volume in mild cognitive impairment	Hippocampal volume in mild cognitive impairment	Other measurement
4520	GCST007013	Hippocampal volume in mild cognitive impairment	Hippocampal volume in mild cognitive impairment	Other measurement
4521	GCST006066	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
4522	GCST006067	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
4523	GCST006065	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
4524	GCST007843	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
4525	GCST005924	Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	Other measurement
4526	GCST005924	Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	Response to drug
4527	GCST005925	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Response to drug
4528	GCST005925	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Response to drug
4529	GCST005925	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Other measurement
4530	GCST005925	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Other disease
4531	GCST005926	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Response to drug
4532	GCST005926	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Response to drug
4533	GCST005926	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Other measurement
4534	GCST005926	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Other disease
4535	GCST005927	Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	Other measurement
4536	GCST005927	Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	Response to drug
4537	GCST006566	Developmental dysplasia of the hip	Developmental dysplasia of the hip	Other disease
4538	GCST000008	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4539	GCST000008	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
4540	GCST000008	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4541	GCST000007	Memory performance	Memory performance	Other measurement
4542	GCST000006	Age-related macular degeneration (wet)	Age-related macular degeneration (wet)	Neurological disorder
4543	GCST000005	Parkinson's disease	Parkinson's disease	Neurological disorder
4544	GCST000004	QT interval	QT interval	Cardiovascular measurement
4545	GCST000003	Obesity	Obesity	Other measurement
4546	GCST000003	Obesity	Obesity	Metabolic disorder
4547	GCST000002	Parkinson's disease	Parkinson's disease	Neurological disorder
4548	GCST000001	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
4549	GCST000001	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
4550	GCST006442	Educational attainment (years of education)	Educational attainment (years of education)	Other measurement
4551	GCST006568	Highest math class taken (MTAG)	Highest math class taken (MTAG)	Biological process
4552	GCST006574	Highest math class taken	Highest math class taken	Biological process
4553	GCST006569	Self-reported math ability (MTAG)	Self-reported math ability (MTAG)	Biological process
4554	GCST006573	Self-reported math ability	Self-reported math ability	Biological process
4555	GCST006570	Cognitive performance (MTAG)	Cognitive performance (MTAG)	Other measurement
4556	GCST006572	Cognitive performance	Cognitive performance	Other measurement
4557	GCST006572	Cognitive performance	Cognitive performance	Other measurement
4558	GCST006571	Educational attainment (MTAG)	Educational attainment (MTAG)	Other measurement
4559	GCST006275	Vestibular neuritis	Vestibular neuritis	Neurological disorder
4560	GCST006272	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
4561	GCST005934	Neuropathic pain in head and neck cancer	Neuropathic pain in head and neck cancer	Cancer
4562	GCST005934	Neuropathic pain in head and neck cancer	Neuropathic pain in head and neck cancer	Other trait
4563	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4564	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4565	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4566	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4567	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4568	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4569	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4570	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4571	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4572	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4573	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4574	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4575	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4576	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4577	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4578	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4579	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4580	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4581	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4582	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4583	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4584	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4585	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4586	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4587	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4588	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4589	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4590	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4591	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4592	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4593	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4594	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4595	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4596	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4597	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4598	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4599	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4600	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4601	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4602	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4603	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4604	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4605	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4606	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4607	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4608	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4609	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4610	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4611	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4612	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4613	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4614	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4615	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4616	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4617	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4618	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4619	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4620	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4621	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4622	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4623	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4624	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4625	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4626	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4627	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4628	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4629	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4630	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4631	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4632	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4633	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4634	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4635	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4636	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4637	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4638	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4639	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4640	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4641	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4642	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4643	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4644	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4645	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4646	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4647	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4648	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4649	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4650	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4651	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4652	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4653	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4654	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4655	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4656	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4657	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4658	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4659	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4660	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4661	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4662	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4663	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4664	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4665	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4666	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4667	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4668	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4669	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4670	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4671	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4672	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4673	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4674	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4675	GCST005806	Blood protein levels	Blood protein levels	Hematological measurement
4676	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4677	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4678	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4679	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4680	GCST005806	Blood protein levels	Blood protein levels	Lipid or lipoprotein measurement
4681	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4682	GCST005806	Blood protein levels	Blood protein levels	Hematological measurement
4683	GCST005806	Blood protein levels	Blood protein levels	Hematological measurement
4684	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4685	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4686	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4687	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4688	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4689	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4690	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4691	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4692	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4693	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4694	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4695	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4696	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4697	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4698	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4699	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4700	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4701	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4702	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4703	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4704	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4705	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4706	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4707	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4708	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4709	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4710	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4711	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4712	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4713	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4714	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4715	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4716	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4717	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4718	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4719	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4720	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4721	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4722	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4723	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4724	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4725	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4726	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4727	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4728	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4729	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4730	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4731	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4732	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4733	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4734	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4735	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4736	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4737	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4738	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4739	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4740	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4741	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4742	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4743	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4744	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4745	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4746	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4747	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4748	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4749	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4750	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4751	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4752	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4753	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4754	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4755	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4756	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4757	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4758	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4759	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4760	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4761	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4762	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4763	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4764	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4765	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4766	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4767	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4768	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4769	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4770	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4771	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4772	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4773	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4774	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4775	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4776	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4777	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4778	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4779	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4780	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4781	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4782	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4783	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4784	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4785	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4786	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4787	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4788	GCST005806	Blood protein levels	Blood protein levels	Hematological measurement
4789	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4790	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4791	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4792	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4793	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4794	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4795	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4796	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4797	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4798	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4799	GCST005806	Blood protein levels	Blood protein levels	Cardiovascular measurement
4800	GCST005806	Blood protein levels	Blood protein levels	Liver enzyme measurement
4801	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4802	GCST005806	Blood protein levels	Blood protein levels	Inflammatory measurement
4803	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4804	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4805	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4806	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4807	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4808	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4809	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4810	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4811	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4812	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4813	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4814	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4815	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4816	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4817	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4818	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4819	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4820	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4821	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4822	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4823	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4824	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4825	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4826	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4827	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4828	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4829	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4830	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4831	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4832	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4833	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4834	GCST005806	Blood protein levels	Blood protein levels	Inflammatory measurement
4835	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4836	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4837	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4838	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4839	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4840	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4841	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4842	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4843	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4844	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4845	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4846	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4847	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4848	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4849	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4850	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4851	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4852	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4853	GCST005806	Blood protein levels	Blood protein levels	Other measurement
4854	GCST006056	Fructosamine levels	Fructosamine levels	Other measurement
4855	GCST006584	Pemphigus vulgaris	Pemphigus vulgaris	Immune system disorder
4856	GCST006068	Sub-foveal choroidal thickness	Sub-foveal choroidal thickness	Other measurement
4857	GCST006269	General cognitive ability	General cognitive ability	Biological process
4858	GCST006060	Hemoglobin A1c levels	Hemoglobin A1c levels	Other measurement
4859	GCST006060	Hemoglobin A1c levels	Hemoglobin A1c levels	Hematological measurement
4860	GCST006059	Fasting blood glucose	Fasting blood glucose	Other measurement
4861	GCST006058	Total glycated albumin levels	Total glycated albumin levels	Other measurement
4862	GCST006057	Percent glycated albumin	Percent glycated albumin	Other measurement
4863	GCST006268	Reaction time	Reaction time	Other measurement
4864	GCST006131	Colorectal cancer	Colorectal cancer	Cancer
4865	GCST006252	Childhood steroid-sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	Other disease
4866	GCST006218	Erosive tooth wear (severe vs non-severe)	Erosive tooth wear (severe vs non-severe)	Other measurement
4867	GCST006226	Erosive tooth wear (severe vs none or mild)	Erosive tooth wear (severe vs none or mild)	Other measurement
4868	GCST006411	Mucinous adenocarcinoma in colorectal cancer	Mucinous adenocarcinoma in colorectal cancer	Cancer
4869	GCST006411	Mucinous adenocarcinoma in colorectal cancer	Mucinous adenocarcinoma in colorectal cancer	Cancer
4870	GCST006099	Accelerometer-based physical activity measurement (average acceleration)	Accelerometer-based physical activity measurement (average acceleration)	Other measurement
4871	GCST006100	Strenuous sports or other exercises	Strenuous sports or other exercises	Other measurement
4872	GCST006098	Vigorous physical activity	Vigorous physical activity	Other measurement
4873	GCST006097	Moderate to vigorous physical activity levels	Moderate to vigorous physical activity levels	Other measurement
4874	GCST006079	Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)	Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)	Other measurement
4875	GCST006061	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
4876	GCST006134	Hippocampal volume	Hippocampal volume	Other measurement
4877	GCST005831	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
4878	GCST006136	Alzheimer's disease progression score	Alzheimer's disease progression score	Other measurement
4879	GCST006135	Cortical amyloid beta load	Cortical amyloid beta load	Other measurement
4880	GCST006143	Bone mineral density (total hip)	Bone mineral density (total hip)	Other measurement
4881	GCST006142	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
4882	GCST006142	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
4883	GCST006141	High bone mineral density	High bone mineral density	Other measurement
4884	GCST006225	Chlamydia trachomatis seropositivity	Chlamydia trachomatis seropositivity	Other measurement
4885	GCST006395	Glaucoma	Glaucoma	Neurological disorder
4886	GCST006394	Intraocular pressure	Intraocular pressure	Other measurement
4887	GCST006433	Heel bone mineral density	Heel bone mineral density	Other measurement
4888	GCST006473	Diffusing capacity of the lung for carbon monoxide traits	Diffusing capacity of the lung for carbon monoxide traits	Other measurement
4889	GCST007045	PR interval	PR interval	Cardiovascular measurement
4890	GCST006809	Kawasaki disease	Kawasaki disease	Immune system disorder
4891	GCST006279	Cerebrospinal fluid -synuclein levels	Cerebrospinal fluid -synuclein levels	Other measurement
4892	GCST006279	Cerebrospinal fluid -synuclein levels	Cerebrospinal fluid -synuclein levels	Other measurement
4893	GCST006939	Skin hydration	Skin hydration	Other measurement
4894	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
4895	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
4896	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
4897	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
4898	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
4899	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
4900	GCST006477	Depression	Depression	Neurological disorder
4901	GCST006477	Depression	Depression	Other measurement
4902	GCST006137	Serum folate levels	Serum folate levels	Other measurement
4903	GCST006250	Intelligence	Intelligence	Biological process
4904	GCST006476	Neuroticism	Neuroticism	Neurological disorder
4905	GCST006476	Neuroticism	Neuroticism	Other measurement
4906	GCST006478	Worry	Worry	Other measurement
4907	GCST006478	Worry	Worry	Other trait
4908	GCST006475	Depressed affect	Depressed affect	Neurological disorder
4909	GCST006475	Depressed affect	Depressed affect	Neurological disorder
4910	GCST006271	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
4911	GCST006428	Suicide attempts	Suicide attempts	Biological process
4912	GCST006429	Suicidal ideation	Suicidal ideation	Biological process
4913	GCST006429	Suicidal ideation	Suicidal ideation	Other measurement
4914	GCST006287	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
4915	GCST006287	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
4916	GCST006270	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Immune system disorder
4917	GCST006270	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Response to drug
4918	GCST006270	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Digestive system disorder
4919	GCST006139	Hematoma volume in lobar spontaneous intracerebral hemorrhage	Hematoma volume in lobar spontaneous intracerebral hemorrhage	Cardiovascular disease
4920	GCST006171	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	Cardiovascular measurement
4921	GCST006171	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
4922	GCST006166	Diastolic blood pressure x alcohol consumption interaction (2df test)	Diastolic blood pressure x alcohol consumption interaction (2df test)	Biological process
4923	GCST006166	Diastolic blood pressure x alcohol consumption interaction (2df test)	Diastolic blood pressure x alcohol consumption interaction (2df test)	Other measurement
4924	GCST006172	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
4925	GCST006172	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
4926	GCST006167	Mean arterial pressure x alcohol consumption interaction (2df test)	Mean arterial pressure x alcohol consumption interaction (2df test)	Biological process
4927	GCST006167	Mean arterial pressure x alcohol consumption interaction (2df test)	Mean arterial pressure x alcohol consumption interaction (2df test)	Other measurement
4928	GCST006168	Pulse pressure x alcohol consumption interaction (2df test)	Pulse pressure x alcohol consumption interaction (2df test)	Biological process
4929	GCST006168	Pulse pressure x alcohol consumption interaction (2df test)	Pulse pressure x alcohol consumption interaction (2df test)	Cardiovascular measurement
4930	GCST006170	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
4931	GCST006170	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
4932	GCST006434	Systolic blood pressure x alcohol consumption interaction (2df test)	Systolic blood pressure x alcohol consumption interaction (2df test)	Biological process
4933	GCST006434	Systolic blood pressure x alcohol consumption interaction (2df test)	Systolic blood pressure x alcohol consumption interaction (2df test)	Other measurement
4934	GCST006140	Hematoma volume in non-lobar spontaneous intracerebral hemorrhage	Hematoma volume in non-lobar spontaneous intracerebral hemorrhage	Cardiovascular disease
4935	GCST006169	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
4936	GCST006169	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
4937	GCST006286	Age at loss of ambulation in Duchenne muscular dystrophy	Age at loss of ambulation in Duchenne muscular dystrophy	Neurological disorder
4938	GCST006286	Age at loss of ambulation in Duchenne muscular dystrophy	Age at loss of ambulation in Duchenne muscular dystrophy	Other measurement
4939	GCST006246	Childhood steroid-sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	Other disease
4940	GCST006567	Response to ketogenic dietary therapies in epilepsy	Response to ketogenic dietary therapies in epilepsy	Biological process
4941	GCST006567	Response to ketogenic dietary therapies in epilepsy	Response to ketogenic dietary therapies in epilepsy	Neurological disorder
4942	GCST006386	Cannabis use (age at onset)	Cannabis use (age at onset)	Biological process
4943	GCST006386	Cannabis use (age at onset)	Cannabis use (age at onset)	Other measurement
4944	GCST006405	Coronary artery disease in diabetes	Coronary artery disease in diabetes	Cardiovascular disease
4945	GCST006405	Coronary artery disease in diabetes	Coronary artery disease in diabetes	Metabolic disorder
4946	GCST006388	Dietary macronutrient intake	Dietary macronutrient intake	Biological process
4947	GCST008493	Prostate cancer mortality	Prostate cancer mortality	Cancer
4948	GCST008493	Prostate cancer mortality	Prostate cancer mortality	Other measurement
4949	GCST008493	Prostate cancer mortality	Prostate cancer mortality	Cancer
4950	GCST006267	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Response to drug
4951	GCST006267	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Neurological disorder
4952	GCST006267	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Neurological disorder
4953	GCST006266	Remission after SSRI treatment in major depression	Remission after SSRI treatment in major depression	Response to drug
4954	GCST006266	Remission after SSRI treatment in major depression	Remission after SSRI treatment in major depression	Neurological disorder
4955	GCST006088	Familial squamous cell lung carcinoma	Familial squamous cell lung carcinoma	Other measurement
4956	GCST006088	Familial squamous cell lung carcinoma	Familial squamous cell lung carcinoma	Cancer
4957	GCST006087	Familial lung adenocarcinoma	Familial lung adenocarcinoma	Other measurement
4958	GCST006087	Familial lung adenocarcinoma	Familial lung adenocarcinoma	Cancer
4959	GCST006086	Familial lung cancer	Familial lung cancer	Other measurement
4960	GCST006086	Familial lung cancer	Familial lung cancer	Cancer
4961	GCST006260	Childhood onset systemic lupus erythematosus	Childhood onset systemic lupus erythematosus	Immune system disorder
4962	GCST006260	Childhood onset systemic lupus erythematosus	Childhood onset systemic lupus erythematosus	Other measurement
4963	GCST006257	Elevated fasting plasma glucose	Elevated fasting plasma glucose	Other measurement
4964	GCST006406	Cognitive flexibility	Cognitive flexibility	Other measurement
4965	GCST006369	Body mass index	Body mass index	Body measurement
4966	GCST006369	Body mass index	Body mass index	Body measurement
4967	GCST006369	Body mass index	Body mass index	Other measurement
4968	GCST007422	Socioeconomic status of place of residence	Socioeconomic status of place of residence	Other measurement
4969	GCST007421	Population density of place of residence	Population density of place of residence	Other measurement
4970	GCST006144	Heparin-induced thrombocytopenia	Heparin-induced thrombocytopenia	Response to drug
4971	GCST006144	Heparin-induced thrombocytopenia	Heparin-induced thrombocytopenia	Other trait
4972	GCST006312	Childhood dental caries in primary teeth	Childhood dental caries in primary teeth	Digestive system disorder
4973	GCST006311	Childhood dental caries in permanent teeth	Childhood dental caries in permanent teeth	Digestive system disorder
4974	GCST006364	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Digestive system disorder
4975	GCST006364	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Other measurement
4976	GCST006274	Systolic blood pressure night-to-day ratio in hypertension	Systolic blood pressure night-to-day ratio in hypertension	Other measurement
4977	GCST006274	Systolic blood pressure night-to-day ratio in hypertension	Systolic blood pressure night-to-day ratio in hypertension	Cardiovascular disease
4978	GCST006273	Diastolic blood pressure night-to-day ratio in hypertension	Diastolic blood pressure night-to-day ratio in hypertension	Other measurement
4979	GCST006273	Diastolic blood pressure night-to-day ratio in hypertension	Diastolic blood pressure night-to-day ratio in hypertension	Cardiovascular disease
4980	GCST006219	Executive function in ADHD	Executive function in ADHD	Neurological disorder
4981	GCST006219	Executive function in ADHD	Executive function in ADHD	Other measurement
4982	GCST005790	Rosacea symptom severity	Rosacea symptom severity	Other measurement
4983	GCST005789	Resting heart rate	Resting heart rate	Cardiovascular measurement
4984	GCST005788	Heart rate response to recovery post exercise	Heart rate response to recovery post exercise	Cardiovascular measurement
4985	GCST006042	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other disease
4986	GCST006042	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
4987	GCST006042	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
4988	GCST005747	Non-small cell lung cancer in heavy smokers	Non-small cell lung cancer in heavy smokers	Biological process
4989	GCST005747	Non-small cell lung cancer in heavy smokers	Non-small cell lung cancer in heavy smokers	Cancer
4990	GCST005746	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Digestive system disorder
4991	GCST005746	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Cancer
4992	GCST006412	Intraocular pressure	Intraocular pressure	Other measurement
4993	GCST005920	Paternal history of Alzheimer's disease	Paternal history of Alzheimer's disease	Other measurement
4994	GCST005923	Maternal history of Alzheimer's disease	Maternal history of Alzheimer's disease	Other measurement
4995	GCST006289	Spherical equivalent	Spherical equivalent	Other measurement
4996	GCST006291	Spherical equivalent or myopia (age of diagnosis)	Spherical equivalent or myopia (age of diagnosis)	Other measurement
4997	GCST006291	Spherical equivalent or myopia (age of diagnosis)	Spherical equivalent or myopia (age of diagnosis)	Other measurement
4998	GCST006291	Spherical equivalent or myopia (age of diagnosis)	Spherical equivalent or myopia (age of diagnosis)	Other trait
4999	GCST006290	Myopia (age of diagnosis)	Myopia (age of diagnosis)	Other measurement
5000	GCST006290	Myopia (age of diagnosis)	Myopia (age of diagnosis)	Other trait
5001	GCST007423	Clinical remission in asthma	Clinical remission in asthma	Other disease
5002	GCST007423	Clinical remission in asthma	Clinical remission in asthma	Other trait
5003	GCST007424	Complete remission in asthma	Complete remission in asthma	Other disease
5004	GCST007424	Complete remission in asthma	Complete remission in asthma	Other trait
5005	GCST005922	Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease or family history of Alzheimer's disease	Neurological disorder
5006	GCST005922	Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease or family history of Alzheimer's disease	Other measurement
5007	GCST005921	Family history of Alzheimer's disease	Family history of Alzheimer's disease	Other measurement
5008	GCST005863	Menopause (age at onset)	Menopause (age at onset)	Other measurement
5009	GCST006536	Serum erythropoietin levels	Serum erythropoietin levels	Other measurement
5010	GCST005864	Late age at menarche	Late age at menarche	Other measurement
5011	GCST005865	Early age at menarche	Early age at menarche	Other measurement
5012	GCST005867	Menarche (age at onset)	Menarche (age at onset)	Other measurement
5013	GCST005787	Heart rate response to exercise	Heart rate response to exercise	Cardiovascular measurement
5014	GCST006282	Diabetic macular edema in type 2 diabetes	Diabetic macular edema in type 2 diabetes	Metabolic disorder
5015	GCST006282	Diabetic macular edema in type 2 diabetes	Diabetic macular edema in type 2 diabetes	Metabolic disorder
5016	GCST006283	Proliferative diabetic retinopathy in type 2 diabetes	Proliferative diabetic retinopathy in type 2 diabetes	Metabolic disorder
5017	GCST006283	Proliferative diabetic retinopathy in type 2 diabetes	Proliferative diabetic retinopathy in type 2 diabetes	Metabolic disorder
5018	GCST005861	Circulating odd-numbered chain saturated fatty acid levels (C23:0)	Circulating odd-numbered chain saturated fatty acid levels (C23:0)	Lipid or lipoprotein measurement
5019	GCST005862	Circulating odd-numbered chain saturated fatty acid levels (C19:0)	Circulating odd-numbered chain saturated fatty acid levels (C19:0)	Lipid or lipoprotein measurement
5020	GCST005866	Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)	Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)	Lipid or lipoprotein measurement
5021	GCST005868	Circulating odd-numbered chain saturated fatty acid levels (C17:0)	Circulating odd-numbered chain saturated fatty acid levels (C17:0)	Lipid or lipoprotein measurement
5022	GCST005896	Non-melanoma skin cancer	Non-melanoma skin cancer	Other trait
5023	GCST005896	Non-melanoma skin cancer	Non-melanoma skin cancer	Cancer
5024	GCST005897	Low tan response	Low tan response	Other trait
5025	GCST005869	Circulating odd-numbered chain saturated fatty acid levels (C15:0)	Circulating odd-numbered chain saturated fatty acid levels (C15:0)	Lipid or lipoprotein measurement
5026	GCST006146	Behavioural changes in frontotemporal lobe dementia	Behavioural changes in frontotemporal lobe dementia	Neurological disorder
5027	GCST006146	Behavioural changes in frontotemporal lobe dementia	Behavioural changes in frontotemporal lobe dementia	Biological process
5028	GCST006154	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
5029	GCST006153	Parkinsonism in frontotemporal lobe dementia	Parkinsonism in frontotemporal lobe dementia	Neurological disorder
5030	GCST006153	Parkinsonism in frontotemporal lobe dementia	Parkinsonism in frontotemporal lobe dementia	Neurological disorder
5031	GCST006152	Language impairment in frontotemporal lobe dementia	Language impairment in frontotemporal lobe dementia	Neurological disorder
5032	GCST006152	Language impairment in frontotemporal lobe dementia	Language impairment in frontotemporal lobe dementia	Neurological disorder
5033	GCST006151	Memory dysfunction in frontotemporal lobe dementia	Memory dysfunction in frontotemporal lobe dementia	Neurological disorder
5034	GCST006151	Memory dysfunction in frontotemporal lobe dementia	Memory dysfunction in frontotemporal lobe dementia	Other trait
5035	GCST006150	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
5036	GCST006149	Frontotemporal dementia with GRN mutation (age at onset)	Frontotemporal dementia with GRN mutation (age at onset)	Neurological disorder
5037	GCST006149	Frontotemporal dementia with GRN mutation (age at onset)	Frontotemporal dementia with GRN mutation (age at onset)	Other measurement
5038	GCST006148	Frontotemporal dementia with GRN mutation	Frontotemporal dementia with GRN mutation	Neurological disorder
5039	GCST006147	Frontotemporal dementia (age at onset)	Frontotemporal dementia (age at onset)	Neurological disorder
5040	GCST006147	Frontotemporal dementia (age at onset)	Frontotemporal dementia (age at onset)	Other measurement
5041	GCST006818	Remission after antidepressant treatment in major depression	Remission after antidepressant treatment in major depression	Neurological disorder
5042	GCST006818	Remission after antidepressant treatment in major depression	Remission after antidepressant treatment in major depression	Response to drug
5043	GCST005715	Myopic maculopathy	Myopic maculopathy	Other measurement
5044	GCST006812	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Biological process
5045	GCST006812	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Other measurement
5046	GCST006811	Body mass index	Body mass index	Body measurement
5047	GCST006811	Body mass index	Body mass index	Body measurement
5048	GCST006811	Body mass index	Body mass index	Other measurement
5049	GCST006810	Self-reported risk-taking behaviour	Self-reported risk-taking behaviour	Biological process
5050	GCST006817	Response to antidepressants in depression	Response to antidepressants in depression	Neurological disorder
5051	GCST006817	Response to antidepressants in depression	Response to antidepressants in depression	Neurological disorder
5052	GCST006817	Response to antidepressants in depression	Response to antidepressants in depression	Response to drug
5053	GCST006248	Response to lurasidone in schizophrenia	Response to lurasidone in schizophrenia	Response to drug
5054	GCST006248	Response to lurasidone in schizophrenia	Response to lurasidone in schizophrenia	Neurological disorder
5055	GCST006284	Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease	Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease	Other measurement
5056	GCST005672	Cholesteryl ester transfer protein levels	Cholesteryl ester transfer protein levels	Hematological measurement
5057	GCST005870	Meningioma	Meningioma	Cancer
5058	GCST007113	Huntington's disease (age at onset)	Huntington's disease (age at onset)	Neurological disorder
5059	GCST007113	Huntington's disease (age at onset)	Huntington's disease (age at onset)	Other measurement
5060	GCST006062	White matter hyperintensity volume	White matter hyperintensity volume	Other measurement
5061	GCST006064	White matter integrity (mean diffusivity)	White matter integrity (mean diffusivity)	Other measurement
5062	GCST006063	White matter integrity (fractional anisotropy)	White matter integrity (fractional anisotropy)	Other measurement
5063	GCST005714	Cerebrospinal fluid beta-site APP cleaving enzyme levels	Cerebrospinal fluid beta-site APP cleaving enzyme levels	Other measurement
5064	GCST005713	Plasma neurofilament light levels	Plasma neurofilament light levels	Other measurement
5065	GCST005839	Depression	Depression	Neurological disorder
5066	GCST005839	Depression	Depression	Other measurement
5067	GCST006035	Breast cancer and/or colorectal cancer	Breast cancer and/or colorectal cancer	Cancer
5068	GCST006035	Breast cancer and/or colorectal cancer	Breast cancer and/or colorectal cancer	Cancer
5069	GCST005940	Maximum cranial width	Maximum cranial width	Other measurement
5070	GCST005939	Cephalic index	Cephalic index	Other measurement
5071	GCST006281	Coronary artery disease in type 1 diabetes	Coronary artery disease in type 1 diabetes	Cardiovascular disease
5072	GCST006281	Coronary artery disease in type 1 diabetes	Coronary artery disease in type 1 diabetes	Metabolic disorder
5073	GCST005830	Hand grip strength	Hand grip strength	Other measurement
5074	GCST006494	Type 2 diabetes (SNP x SNP interaction, 1df)	Type 2 diabetes (SNP x SNP interaction, 1df)	Metabolic disorder
5075	GCST006495	Type 2 diabetes (SNP x SNP interaction, 2df)	Type 2 diabetes (SNP x SNP interaction, 2df)	Metabolic disorder
5076	GCST005829	Hand grip strength	Hand grip strength	Other measurement
5077	GCST006220	Basal ganglia growth	Basal ganglia growth	Other measurement
5078	GCST005919	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Other disease
5079	GCST005919	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Other measurement
5080	GCST005919	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Other measurement
5081	GCST005918	Smoking cessation in chronic obstructive pulmonary disease	Smoking cessation in chronic obstructive pulmonary disease	Other disease
5082	GCST005918	Smoking cessation in chronic obstructive pulmonary disease	Smoking cessation in chronic obstructive pulmonary disease	Biological process
5083	GCST005917	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other disease
5084	GCST005917	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
5085	GCST005917	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
5086	GCST005832	Acute lymphoblastic leukemia in childhood (B cell precursor)	Acute lymphoblastic leukemia in childhood (B cell precursor)	Cancer
5087	GCST005878	Metabolic syndrome (multivariate analysis)	Metabolic syndrome (multivariate analysis)	Metabolic disorder
5088	GCST005905	Global electrical heterogeneity phenotypes	Global electrical heterogeneity phenotypes	Cardiovascular measurement
5089	GCST005718	Anhedonia	Anhedonia	Other measurement
5090	GCST005717	Paranoia and hallucinations	Paranoia and hallucinations	Other measurement
5091	GCST005720	Parent-rated negative symptoms	Parent-rated negative symptoms	Other measurement
5092	GCST005719	Cognitive disorganisation	Cognitive disorganisation	Other measurement
5093	GCST005783	Bone mineral density (lumbar spine) in inflammatory bowel disease	Bone mineral density (lumbar spine) in inflammatory bowel disease	Digestive system disorder
5094	GCST005783	Bone mineral density (lumbar spine) in inflammatory bowel disease	Bone mineral density (lumbar spine) in inflammatory bowel disease	Other measurement
5095	GCST005784	Bone mineral density (femoral neck) in inflammatory bowel disease	Bone mineral density (femoral neck) in inflammatory bowel disease	Other measurement
5096	GCST005784	Bone mineral density (femoral neck) in inflammatory bowel disease	Bone mineral density (femoral neck) in inflammatory bowel disease	Digestive system disorder
5097	GCST005688	Idiopathic intracranial hypertension	Idiopathic intracranial hypertension	Cardiovascular disease
5098	GCST005579	Low white blood cell count	Low white blood cell count	Hematological measurement
5099	GCST005578	Low white blood cell count (conditioned on rs2814778)	Low white blood cell count (conditioned on rs2814778)	Hematological measurement
5100	GCST005580	Intraocular pressure	Intraocular pressure	Other measurement
5101	GCST006075	Hair color	Hair color	Other measurement
5102	GCST006075	Hair color	Hair color	Other trait
5103	GCST006365	Upper eyelid sagging severity	Upper eyelid sagging severity	Other measurement
5104	GCST005748	Digit length ratio (right hand)	Digit length ratio (right hand)	Body measurement
5105	GCST005671	Cholesterol efflux capacity	Cholesterol efflux capacity	Lipid or lipoprotein measurement
5106	GCST005753	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Response to drug
5107	GCST005753	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Other measurement
5108	GCST005753	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Metabolic disorder
5109	GCST005749	Digit length ratio (left hand)	Digit length ratio (left hand)	Body measurement
5110	GCST005750	Digit length ratio	Digit length ratio	Body measurement
5111	GCST006431	Plasma parathyroid hormone levels	Plasma parathyroid hormone levels	Other measurement
5112	GCST005916	Cotinine levels in smokers with chronic obstructive pulmonary disease	Cotinine levels in smokers with chronic obstructive pulmonary disease	Other disease
5113	GCST005916	Cotinine levels in smokers with chronic obstructive pulmonary disease	Cotinine levels in smokers with chronic obstructive pulmonary disease	Other measurement
5114	GCST005916	Cotinine levels in smokers with chronic obstructive pulmonary disease	Cotinine levels in smokers with chronic obstructive pulmonary disease	Other measurement
5115	GCST006224	Right lateral prefrontal cortical growth	Right lateral prefrontal cortical growth	Other measurement
5116	GCST006223	Cerebral cortical growth	Cerebral cortical growth	Other measurement
5117	GCST006222	Cerebellum growth	Cerebellum growth	Other measurement
5118	GCST006221	White matter growth	White matter growth	Other measurement
5119	GCST006535	Irritable bowel syndrome	Irritable bowel syndrome	Digestive system disorder
5120	GCST006819	Emotional support seeking	Emotional support seeking	Other measurement
5121	GCST005686	Clostridium difficile infection in multiple myeloma	Clostridium difficile infection in multiple myeloma	Other disease
5122	GCST005686	Clostridium difficile infection in multiple myeloma	Clostridium difficile infection in multiple myeloma	Cancer
5123	GCST005646	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Cardiovascular measurement
5124	GCST005646	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Response to drug
5125	GCST005646	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Cardiovascular disease
5126	GCST005687	Aortic coarctation	Aortic coarctation	Cardiovascular disease
5127	GCST005807	Urinary haptoglobin levels in type 2 diabetes	Urinary haptoglobin levels in type 2 diabetes	Hematological measurement
5128	GCST005807	Urinary haptoglobin levels in type 2 diabetes	Urinary haptoglobin levels in type 2 diabetes	Metabolic disorder
5129	GCST005808	Plasma haptoglobin levels in type 2 diabetes	Plasma haptoglobin levels in type 2 diabetes	Hematological measurement
5130	GCST005808	Plasma haptoglobin levels in type 2 diabetes	Plasma haptoglobin levels in type 2 diabetes	Metabolic disorder
5131	GCST005711	Growth differentiation factor-15 levels	Growth differentiation factor-15 levels	Hematological measurement
5132	GCST005712	Growth differentiation factor-15 levels (conditioned on rs888663)	Growth differentiation factor-15 levels (conditioned on rs888663)	Hematological measurement
5133	GCST005670	Plasma trimethyllysine levels	Plasma trimethyllysine levels	Hematological measurement
5134	GCST005929	Severity of nausea and vomiting of pregnancy	Severity of nausea and vomiting of pregnancy	Other measurement
5135	GCST005912	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5136	GCST005914	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
5137	GCST005915	Fasting blood insulin	Fasting blood insulin	Other measurement
5138	GCST005913	Fasting blood glucose	Fasting blood glucose	Other measurement
5139	GCST006805	Infective endocarditis in Staphylococcus aureus infection	Infective endocarditis in Staphylococcus aureus infection	Other disease
5140	GCST006805	Infective endocarditis in Staphylococcus aureus infection	Infective endocarditis in Staphylococcus aureus infection	Cardiovascular disease
5141	GCST005936	Supraventricular ectopy	Supraventricular ectopy	Cardiovascular disease
5142	GCST005937	Ventricular ectopy	Ventricular ectopy	Cardiovascular disease
5143	GCST005935	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Cardiovascular disease
5144	GCST005935	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Cardiovascular disease
5145	GCST005935	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Cardiovascular disease
5146	GCST005906	Endometriosis or endometrial cancer (pleiotropy)	Endometriosis or endometrial cancer (pleiotropy)	Cancer
5147	GCST005906	Endometriosis or endometrial cancer (pleiotropy)	Endometriosis or endometrial cancer (pleiotropy)	Other disease
5148	GCST006043	Plasma renin activity levels	Plasma renin activity levels	Cardiovascular measurement
5149	GCST005938	Maximum cranial length	Maximum cranial length	Other measurement
5150	GCST006826	Emotional expression	Emotional expression	Other measurement
5151	GCST006825	Perceived stress	Perceived stress	Other measurement
5152	GCST006824	Approach coping (positive reappraisal/problem solving)	Approach coping (positive reappraisal/problem solving)	Other measurement
5153	GCST006823	Emotional coping (emotional expression/emotional support seeking)	Emotional coping (emotional expression/emotional support seeking)	Other measurement
5154	GCST006822	Disengagement	Disengagement	Other measurement
5155	GCST006821	Problem solving	Problem solving	Other measurement
5156	GCST006820	Positive reappraisal	Positive reappraisal	Other measurement
5157	GCST005576	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
5158	GCST005606	Response to hepatitis B vaccine	Response to hepatitis B vaccine	Response to drug
5159	GCST005606	Response to hepatitis B vaccine	Response to hepatitis B vaccine	Other measurement
5160	GCST005751	Empathy quotient	Empathy quotient	Other measurement
5161	GCST005561	Aortic valve stenosis	Aortic valve stenosis	Cardiovascular disease
5162	GCST005836	Response to SSRI in MDD or conscientiouness	Response to SSRI in MDD or conscientiouness	Response to drug
5163	GCST005836	Response to SSRI in MDD or conscientiouness	Response to SSRI in MDD or conscientiouness	Neurological disorder
5164	GCST005836	Response to SSRI in MDD or conscientiouness	Response to SSRI in MDD or conscientiouness	Other measurement
5165	GCST005834	Response to SSRI in MDD or openness	Response to SSRI in MDD or openness	Response to drug
5166	GCST005834	Response to SSRI in MDD or openness	Response to SSRI in MDD or openness	Neurological disorder
5167	GCST005834	Response to SSRI in MDD or openness	Response to SSRI in MDD or openness	Other measurement
5168	GCST005557	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
5169	GCST005833	Remission after SSRI treatment in MDD or openness	Remission after SSRI treatment in MDD or openness	Response to drug
5170	GCST005833	Remission after SSRI treatment in MDD or openness	Remission after SSRI treatment in MDD or openness	Neurological disorder
5171	GCST005833	Remission after SSRI treatment in MDD or openness	Remission after SSRI treatment in MDD or openness	Other measurement
5172	GCST005835	Remission after SSRI treatment in MDD or neuroticism	Remission after SSRI treatment in MDD or neuroticism	Response to drug
5173	GCST005835	Remission after SSRI treatment in MDD or neuroticism	Remission after SSRI treatment in MDD or neuroticism	Neurological disorder
5174	GCST005835	Remission after SSRI treatment in MDD or neuroticism	Remission after SSRI treatment in MDD or neuroticism	Other measurement
5175	GCST006526	Barrett's esophagus x gastroesophageal reflux disease interaction	Barrett's esophagus x gastroesophageal reflux disease interaction	Digestive system disorder
5176	GCST006526	Barrett's esophagus x gastroesophageal reflux disease interaction	Barrett's esophagus x gastroesophageal reflux disease interaction	Digestive system disorder
5177	GCST006527	Barrett's esophagus x smoking interaction	Barrett's esophagus x smoking interaction	Other measurement
5178	GCST006527	Barrett's esophagus x smoking interaction	Barrett's esophagus x smoking interaction	Digestive system disorder
5179	GCST006528	Barrett's esophagus x pack-years of smoking exposure interaction	Barrett's esophagus x pack-years of smoking exposure interaction	Other measurement
5180	GCST006528	Barrett's esophagus x pack-years of smoking exposure interaction	Barrett's esophagus x pack-years of smoking exposure interaction	Digestive system disorder
5181	GCST006529	Barrett's esophagus x BMI interaction	Barrett's esophagus x BMI interaction	Body measurement
5182	GCST006529	Barrett's esophagus x BMI interaction	Barrett's esophagus x BMI interaction	Digestive system disorder
5183	GCST006531	Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Cancer
5184	GCST006531	Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Digestive system disorder
5185	GCST006532	Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Other measurement
5186	GCST006532	Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Cancer
5187	GCST006530	Esophageal adenocarcinoma x smoking interaction	Esophageal adenocarcinoma x smoking interaction	Other measurement
5188	GCST006530	Esophageal adenocarcinoma x smoking interaction	Esophageal adenocarcinoma x smoking interaction	Cancer
5189	GCST006525	Esophageal adenocarcinoma x BMI interaction	Esophageal adenocarcinoma x BMI interaction	Body measurement
5190	GCST006525	Esophageal adenocarcinoma x BMI interaction	Esophageal adenocarcinoma x BMI interaction	Cancer
5191	GCST005851	Delirium	Delirium	Neurological disorder
5192	GCST005577	Change in glucose in response to thiazide diuretic treatment in hypertension	Change in glucose in response to thiazide diuretic treatment in hypertension	Cardiovascular disease
5193	GCST005577	Change in glucose in response to thiazide diuretic treatment in hypertension	Change in glucose in response to thiazide diuretic treatment in hypertension	Other measurement
5194	GCST005577	Change in glucose in response to thiazide diuretic treatment in hypertension	Change in glucose in response to thiazide diuretic treatment in hypertension	Response to drug
5195	GCST005590	Nontyphoidal Salmonella bacteraemia	Nontyphoidal Salmonella bacteraemia	Other disease
5196	GCST006133	Bone mineral density x blood lead interaction in current smokers (2df test)	Bone mineral density x blood lead interaction in current smokers (2df test)	Biological process
5197	GCST006133	Bone mineral density x blood lead interaction in current smokers (2df test)	Bone mineral density x blood lead interaction in current smokers (2df test)	Other measurement
5198	GCST006133	Bone mineral density x blood lead interaction in current smokers (2df test)	Bone mineral density x blood lead interaction in current smokers (2df test)	Other measurement
5199	GCST006132	Bone mineral density x blood lead interaction in current smokers (1df test)	Bone mineral density x blood lead interaction in current smokers (1df test)	Biological process
5200	GCST006132	Bone mineral density x blood lead interaction in current smokers (1df test)	Bone mineral density x blood lead interaction in current smokers (1df test)	Other measurement
5201	GCST006132	Bone mineral density x blood lead interaction in current smokers (1df test)	Bone mineral density x blood lead interaction in current smokers (1df test)	Other measurement
5202	GCST007044	Extremely high intelligence	Extremely high intelligence	Biological process
5203	GCST005566	Insomnia	Insomnia	Neurological disorder
5204	GCST005566	Insomnia	Insomnia	Other measurement
5205	GCST005785	Calcific aortic valve stenosis	Calcific aortic valve stenosis	Cardiovascular disease
5206	GCST005785	Calcific aortic valve stenosis	Calcific aortic valve stenosis	Cardiovascular disease
5207	GCST005930	Hyperemesis gravidarum	Hyperemesis gravidarum	Other disease
5208	GCST005791	Creatinine levels	Creatinine levels	Other measurement
5209	GCST005794	Blood urea nitrogen levels	Blood urea nitrogen levels	Other measurement
5210	GCST005811	Osteoarthritis (self-reported)	Osteoarthritis (self-reported)	Other disease
5211	GCST005812	Osteoarthritis of the hip or knee (hospital diagnosed)	Osteoarthritis of the hip or knee (hospital diagnosed)	Other disease
5212	GCST005812	Osteoarthritis of the hip or knee (hospital diagnosed)	Osteoarthritis of the hip or knee (hospital diagnosed)	Other disease
5213	GCST005813	Osteoarthritis of the knee (hospital diagnosed)	Osteoarthritis of the knee (hospital diagnosed)	Other disease
5214	GCST005814	Osteoarthritis (hospital diagnosed)	Osteoarthritis (hospital diagnosed)	Other disease
5215	GCST005810	Osteoarthritis of the hip (hospital diagnosed)	Osteoarthritis of the hip (hospital diagnosed)	Other disease
5216	GCST005793	Uric acid levels	Uric acid levels	Cardiovascular measurement
5217	GCST005792	Glomerular filtration rate	Glomerular filtration rate	Other measurement
5218	GCST006404	Glycemic traits (multi-trait analysis)	Glycemic traits (multi-trait analysis)	Other measurement
5219	GCST006404	Glycemic traits (multi-trait analysis)	Glycemic traits (multi-trait analysis)	Other measurement
5220	GCST006404	Glycemic traits (multi-trait analysis)	Glycemic traits (multi-trait analysis)	Other measurement
5221	GCST006981	Facial wrinkles	Facial wrinkles	Other trait
5222	GCST005800	Surgical necrotising enterocolitis in extremely premature birth	Surgical necrotising enterocolitis in extremely premature birth	Other trait
5223	GCST005800	Surgical necrotising enterocolitis in extremely premature birth	Surgical necrotising enterocolitis in extremely premature birth	Digestive system disorder
5224	GCST005761	Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels	Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels	Other measurement
5225	GCST005407	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
5226	GCST005408	Open-angle glaucoma and intra-ocular pressure	Open-angle glaucoma and intra-ocular pressure	Other measurement
5227	GCST005408	Open-angle glaucoma and intra-ocular pressure	Open-angle glaucoma and intra-ocular pressure	Neurological disorder
5228	GCST005409	Open-angle glaucoma and vertical cup-disc ratio	Open-angle glaucoma and vertical cup-disc ratio	Other measurement
5229	GCST005409	Open-angle glaucoma and vertical cup-disc ratio	Open-angle glaucoma and vertical cup-disc ratio	Neurological disorder
5230	GCST005559	Virologic severity in Herpes simplex virus type 2 infection	Virologic severity in Herpes simplex virus type 2 infection	Other measurement
5231	GCST005795	Femoral neck bone mineral density	Femoral neck bone mineral density	Other measurement
5232	GCST005796	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
5233	GCST005796	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
5234	GCST005588	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
5235	GCST005588	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
5236	GCST005653	Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	Other measurement
5237	GCST005653	Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	Other trait
5238	GCST005654	Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	Other measurement
5239	GCST005654	Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	Other trait
5240	GCST005656	IgG glycosylation patterns	IgG glycosylation patterns	Other measurement
5241	GCST005652	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	Other measurement
5242	GCST005652	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	Other trait
5243	GCST005521	Heart rate response to beta blockers (atenolol monotherapy)	Heart rate response to beta blockers (atenolol monotherapy)	Cardiovascular measurement
5244	GCST005521	Heart rate response to beta blockers (atenolol monotherapy)	Heart rate response to beta blockers (atenolol monotherapy)	Response to drug
5245	GCST005519	Heart rate response to beta blockers	Heart rate response to beta blockers	Cardiovascular measurement
5246	GCST005519	Heart rate response to beta blockers	Heart rate response to beta blockers	Response to drug
5247	GCST005520	Heart rate response to beta blockers (atenolol add-on therapy)	Heart rate response to beta blockers (atenolol add-on therapy)	Cardiovascular measurement
5248	GCST005520	Heart rate response to beta blockers (atenolol add-on therapy)	Heart rate response to beta blockers (atenolol add-on therapy)	Response to drug
5249	GCST005582	Coronary artery disease	Coronary artery disease	Cardiovascular disease
5250	GCST005582	Coronary artery disease	Coronary artery disease	Cardiovascular disease
5251	GCST005797	Theory of mind score in adolescence (Emotional Triangles Task)	Theory of mind score in adolescence (Emotional Triangles Task)	Other measurement
5252	GCST005440	Alcohol dependence symptom count	Alcohol dependence symptom count	Other measurement
5253	GCST005410	Open-angle glaucoma and optic disc area	Open-angle glaucoma and optic disc area	Other measurement
5254	GCST005410	Open-angle glaucoma and optic disc area	Open-angle glaucoma and optic disc area	Neurological disorder
5255	GCST005570	Hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	Digestive system disorder
5256	GCST005570	Hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	Cancer
5257	GCST005406	Open-angle glaucoma and optic cup area	Open-angle glaucoma and optic cup area	Other measurement
5258	GCST005406	Open-angle glaucoma and optic cup area	Open-angle glaucoma and optic cup area	Neurological disorder
5259	GCST005388	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
5260	GCST005805	Acute respiratory distress syndrome	Acute respiratory distress syndrome	Other disease
5261	GCST005518	Premature menopause in childhood cancer survivors	Premature menopause in childhood cancer survivors	Other disease
5262	GCST005434	Pancreatic cancer	Pancreatic cancer	Cancer
5263	GCST005591	Colorectal cancer	Colorectal cancer	Cancer
5264	GCST005798	Sperm motility	Sperm motility	Other measurement
5265	GCST005802	Hyperuricemia	Hyperuricemia	Cardiovascular measurement
5266	GCST005802	Hyperuricemia	Hyperuricemia	Metabolic disorder
5267	GCST005801	Gout vs. Hyperuricemia	Gout vs. Hyperuricemia	Metabolic disorder
5268	GCST005801	Gout vs. Hyperuricemia	Gout vs. Hyperuricemia	Metabolic disorder
5269	GCST005799	Gout	Gout	Metabolic disorder
5270	GCST005760	Dimensional psychopathology (Cognitive)	Dimensional psychopathology (Cognitive)	Other measurement
5271	GCST005759	Dimensional psychopathology (Social)	Dimensional psychopathology (Social)	Other measurement
5272	GCST005758	Dimensional psychopathology (Arousal)	Dimensional psychopathology (Arousal)	Other measurement
5273	GCST005757	Dimensional psychopathology (Positive)	Dimensional psychopathology (Positive)	Other measurement
5274	GCST005439	Response to alcohol consumption (flushing response)	Response to alcohol consumption (flushing response)	Biological process
5275	GCST005441	Alcohol consumption (max-drinks)	Alcohol consumption (max-drinks)	Biological process
5276	GCST005441	Alcohol consumption (max-drinks)	Alcohol consumption (max-drinks)	Other measurement
5277	GCST005756	Dimensional psychopathology (Negative)	Dimensional psychopathology (Negative)	Other measurement
5278	GCST005414	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5279	GCST005898	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5280	GCST005899	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5281	GCST005413	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5282	GCST005786	Prostate cancer	Prostate cancer	Cancer
5283	GCST006806	Late-onset Alzheimer's disease	Late-onset Alzheimer's disease	Neurological disorder
5284	GCST005315	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
5285	GCST005366	Vitamin D levels (dietary vitamin D intake interaction)	Vitamin D levels (dietary vitamin D intake interaction)	Other measurement
5286	GCST005366	Vitamin D levels (dietary vitamin D intake interaction)	Vitamin D levels (dietary vitamin D intake interaction)	Other measurement
5287	GCST005367	Vitamin D levels	Vitamin D levels	Other measurement
5288	GCST005359	Disease progression in age-related macular degeneration	Disease progression in age-related macular degeneration	Neurological disorder
5289	GCST005359	Disease progression in age-related macular degeneration	Disease progression in age-related macular degeneration	Other measurement
5290	GCST005436	C-peptide levels in type I diabetes	C-peptide levels in type I diabetes	Other measurement
5291	GCST005436	C-peptide levels in type I diabetes	C-peptide levels in type I diabetes	Metabolic disorder
5292	GCST005289	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
5293	GCST005288	Extrinsic epigenetic age acceleration	Extrinsic epigenetic age acceleration	Biological process
5294	GCST005287	Intrinsic epigenetic age acceleration	Intrinsic epigenetic age acceleration	Biological process
5295	GCST005352	Paclitaxel disposition in epithelial ovarian cancer	Paclitaxel disposition in epithelial ovarian cancer	Cancer
5296	GCST005352	Paclitaxel disposition in epithelial ovarian cancer	Paclitaxel disposition in epithelial ovarian cancer	Response to drug
5297	GCST005330	Coffee consumption	Coffee consumption	Biological process
5298	GCST005330	Coffee consumption	Coffee consumption	Other measurement
5299	GCST005330	Coffee consumption	Coffee consumption	Other measurement
5300	GCST005329	Coffee consumption	Coffee consumption	Biological process
5301	GCST005329	Coffee consumption	Coffee consumption	Other measurement
5302	GCST005329	Coffee consumption	Coffee consumption	Other measurement
5303	GCST005351	Carboplatin disposition in epthelial ovarian cancer	Carboplatin disposition in epthelial ovarian cancer	Cancer
5304	GCST005351	Carboplatin disposition in epthelial ovarian cancer	Carboplatin disposition in epthelial ovarian cancer	Response to drug
5305	GCST005331	CSF tryptophan concentration in tuberculous meningitis	CSF tryptophan concentration in tuberculous meningitis	Other measurement
5306	GCST005331	CSF tryptophan concentration in tuberculous meningitis	CSF tryptophan concentration in tuberculous meningitis	Neurological disorder
5307	GCST005437	Random C-peptide levels in type I diabetes	Random C-peptide levels in type I diabetes	Other measurement
5308	GCST005437	Random C-peptide levels in type I diabetes	Random C-peptide levels in type I diabetes	Metabolic disorder
5309	GCST005438	Fasting C-peptide levels in type I diabetes	Fasting C-peptide levels in type I diabetes	Other measurement
5310	GCST005438	Fasting C-peptide levels in type I diabetes	Fasting C-peptide levels in type I diabetes	Metabolic disorder
5311	GCST005803	Corneal astigmatism	Corneal astigmatism	Neurological disorder
5312	GCST005803	Corneal astigmatism	Corneal astigmatism	Other trait
5313	GCST005369	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
5314	GCST005386	Binge eating behaviour and bipolar disorder	Binge eating behaviour and bipolar disorder	Metabolic disorder
5315	GCST005386	Binge eating behaviour and bipolar disorder	Binge eating behaviour and bipolar disorder	Neurological disorder
5316	GCST005365	Serum C3d:C3 ratio (systemic complement activation)	Serum C3d:C3 ratio (systemic complement activation)	Hematological measurement
5317	GCST005411	Thrombin-activatable fibrinolysis inhibitor activation peptide	Thrombin-activatable fibrinolysis inhibitor activation peptide	Hematological measurement
5318	GCST005804	Taxane-induced peripheral neuropathy in breast cancer	Taxane-induced peripheral neuropathy in breast cancer	Cancer
5319	GCST005804	Taxane-induced peripheral neuropathy in breast cancer	Taxane-induced peripheral neuropathy in breast cancer	Response to drug
5320	GCST005804	Taxane-induced peripheral neuropathy in breast cancer	Taxane-induced peripheral neuropathy in breast cancer	Neurological disorder
5321	GCST005309	Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	Cancer
5322	GCST005309	Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	Digestive system disorder
5323	GCST005308	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
5324	GCST005311	Hepatocyte fat droplet content in nonalcoholic fatty liver disease	Hepatocyte fat droplet content in nonalcoholic fatty liver disease	Other measurement
5325	GCST005310	Brunt grade in nonalcoholic fatty liver disease	Brunt grade in nonalcoholic fatty liver disease	Other measurement
5326	GCST005358	Disease progression to choroidal neovascularization form in age-related macular degeneration	Disease progression to choroidal neovascularization form in age-related macular degeneration	Neurological disorder
5327	GCST005358	Disease progression to choroidal neovascularization form in age-related macular degeneration	Disease progression to choroidal neovascularization form in age-related macular degeneration	Other measurement
5328	GCST005360	Disease progression to geographic atrophy form in age-related macular degeneration	Disease progression to geographic atrophy form in age-related macular degeneration	Neurological disorder
5329	GCST005360	Disease progression to geographic atrophy form in age-related macular degeneration	Disease progression to geographic atrophy form in age-related macular degeneration	Other measurement
5330	GCST005341	Idiopathic inflammatory myopathy	Idiopathic inflammatory myopathy	Immune system disorder
5331	GCST005338	Clinically amyopathic dermatomyositis	Clinically amyopathic dermatomyositis	Neurological disorder
5332	GCST005339	Dermatomyositis	Dermatomyositis	Neurological disorder
5333	GCST005340	Polymyositis	Polymyositis	Neurological disorder
5334	GCST005267	Schizophrenia or lung cancer (pleiotropy)	Schizophrenia or lung cancer (pleiotropy)	Neurological disorder
5335	GCST005267	Schizophrenia or lung cancer (pleiotropy)	Schizophrenia or lung cancer (pleiotropy)	Cancer
5336	GCST005266	Schizophrenia or cigarettes per day (pleiotropy)	Schizophrenia or cigarettes per day (pleiotropy)	Other measurement
5337	GCST005266	Schizophrenia or cigarettes per day (pleiotropy)	Schizophrenia or cigarettes per day (pleiotropy)	Neurological disorder
5338	GCST005368	Opioid dependence	Opioid dependence	Neurological disorder
5339	GCST005307	Brunt stage in nonalcoholic fatty liver disease	Brunt stage in nonalcoholic fatty liver disease	Other measurement
5340	GCST005357	Severe malaria (adjusted for sickle cell variant rs334)	Severe malaria (adjusted for sickle cell variant rs334)	Digestive system disorder
5341	GCST005356	Severe malaria	Severe malaria	Digestive system disorder
5342	GCST005318	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	Neurological disorder
5343	GCST005318	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	Response to drug
5344	GCST005729	Serum 25-Hydroxyvitamin D levels	Serum 25-Hydroxyvitamin D levels	Other measurement
5345	GCST005754	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
5346	GCST005387	Binge eating behaviour in bipolar disorder	Binge eating behaviour in bipolar disorder	Metabolic disorder
5347	GCST005387	Binge eating behaviour in bipolar disorder	Binge eating behaviour in bipolar disorder	Neurological disorder
5348	GCST005415	Self-reported risk-taking behaviour	Self-reported risk-taking behaviour	Biological process
5349	GCST005412	Thrombin-activatable fibrinolysis inhibitor levels	Thrombin-activatable fibrinolysis inhibitor levels	Other measurement
5350	GCST005435	Stimulated C-peptide levels in type I diabetes	Stimulated C-peptide levels in type I diabetes	Other measurement
5351	GCST005435	Stimulated C-peptide levels in type I diabetes	Stimulated C-peptide levels in type I diabetes	Metabolic disorder
5352	GCST006862	Asthma	Asthma	Other disease
5353	GCST005213	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
5354	GCST005213	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
5355	GCST005212	Asthma	Asthma	Other disease
5356	GCST005172	Coronary artery disease	Coronary artery disease	Cardiovascular disease
5357	GCST005172	Coronary artery disease	Coronary artery disease	Cardiovascular disease
5358	GCST005214	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Cancer
5359	GCST005214	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Other measurement
5360	GCST005214	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Response to drug
5361	GCST005268	Chronic rhinosinusitis with nasal polyps	Chronic rhinosinusitis with nasal polyps	Neurological disorder
5362	GCST005232	Neuroticism	Neuroticism	Neurological disorder
5363	GCST005232	Neuroticism	Neuroticism	Other measurement
5364	GCST006174	Depressive symptoms	Depressive symptoms	Neurological disorder
5365	GCST006174	Depressive symptoms	Depressive symptoms	Other measurement
5366	GCST005177	Rubella-specific interferon-gamma secretion	Rubella-specific interferon-gamma secretion	Response to drug
5367	GCST005177	Rubella-specific interferon-gamma secretion	Rubella-specific interferon-gamma secretion	Other measurement
5368	GCST006130	Pediatric areal bone mineral density (concordant skeletal phenotype)	Pediatric areal bone mineral density (concordant skeletal phenotype)	Other measurement
5369	GCST006129	Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype)	Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype)	Other measurement
5370	GCST006247	Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)	Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)	Other measurement
5371	GCST005176	Rubella-specific interleukin-6 secretion	Rubella-specific interleukin-6 secretion	Response to drug
5372	GCST005176	Rubella-specific interleukin-6 secretion	Rubella-specific interleukin-6 secretion	Inflammatory measurement
5373	GCST005277	Lumbar spondylosis (Kellgren-Lawrence grade)	Lumbar spondylosis (Kellgren-Lawrence grade)	Other disease
5374	GCST005278	Lumbar spondylosis (presence and severity of osteophytes)	Lumbar spondylosis (presence and severity of osteophytes)	Other disease
5375	GCST005328	Subjective well-being	Subjective well-being	Other measurement
5376	GCST005324	Depressive symptoms	Depressive symptoms	Neurological disorder
5377	GCST005324	Depressive symptoms	Depressive symptoms	Other measurement
5378	GCST005276	Dementia with Lewy bodies	Dementia with Lewy bodies	Other trait
5379	GCST005279	Lumbar spondylosis (disc space narrowing)	Lumbar spondylosis (disc space narrowing)	Other disease
5380	GCST005327	Neuroticism	Neuroticism	Neurological disorder
5381	GCST005327	Neuroticism	Neuroticism	Other measurement
5382	GCST005326	Neuroticism (MTAG)	Neuroticism (MTAG)	Other measurement
5383	GCST005325	Subjective well-being (MTAG)	Subjective well-being (MTAG)	Other measurement
5384	GCST005323	Depressive symptoms (MTAG)	Depressive symptoms (MTAG)	Other measurement
5385	GCST005197	Antiepileptic drug-induced maculopapular exanthema	Antiepileptic drug-induced maculopapular exanthema	Other disease
5386	GCST005197	Antiepileptic drug-induced maculopapular exanthema	Antiepileptic drug-induced maculopapular exanthema	Response to drug
5387	GCST005200	Phenytoin-induced maculopapular exanthema	Phenytoin-induced maculopapular exanthema	Response to drug
5388	GCST005200	Phenytoin-induced maculopapular exanthema	Phenytoin-induced maculopapular exanthema	Other disease
5389	GCST005199	Lamotrigine-induced maculopapular exanthema	Lamotrigine-induced maculopapular exanthema	Response to drug
5390	GCST005199	Lamotrigine-induced maculopapular exanthema	Lamotrigine-induced maculopapular exanthema	Other disease
5391	GCST005198	Carbamazepine-induced maculopapular exanthema	Carbamazepine-induced maculopapular exanthema	Other disease
5392	GCST005198	Carbamazepine-induced maculopapular exanthema	Carbamazepine-induced maculopapular exanthema	Response to drug
5393	GCST005190	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
5394	GCST005347	Pseudoexfoliation syndrome	Pseudoexfoliation syndrome	Neurological disorder
5395	GCST005575	Moyamoya disease	Moyamoya disease	Cardiovascular disease
5396	GCST006203	Atazanavir levels	Atazanavir levels	Other measurement
5397	GCST005782	Serum 25-Hydroxyvitamin D levels	Serum 25-Hydroxyvitamin D levels	Other measurement
5398	GCST005313	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other measurement
5399	GCST005313	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other trait
5400	GCST006196	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Other measurement
5401	GCST006196	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Metabolic disorder
5402	GCST006196	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Other measurement
5403	GCST006197	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Other measurement
5404	GCST006197	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Other measurement
5405	GCST006197	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Metabolic disorder
5406	GCST006197	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Other measurement
5407	GCST005306	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
5408	GCST005314	Offspring birth weight	Offspring birth weight	Body measurement
5409	GCST005314	Offspring birth weight	Offspring birth weight	Other measurement
5410	GCST005353	GLP-1-stimulated insulin secretion	GLP-1-stimulated insulin secretion	Other measurement
5411	GCST005317	Femoral neck bone mineral density or plasma lipids (pleiotropy)	Femoral neck bone mineral density or plasma lipids (pleiotropy)	Other measurement
5412	GCST005317	Femoral neck bone mineral density or plasma lipids (pleiotropy)	Femoral neck bone mineral density or plasma lipids (pleiotropy)	Other measurement
5413	GCST005355	Helping behaviour (self reported)	Helping behaviour (self reported)	Other measurement
5414	GCST005231	Major depressive disorder	Major depressive disorder	Neurological disorder
5415	GCST005230	Recurrent major depressive disorder	Recurrent major depressive disorder	Neurological disorder
5416	GCST005343	Plasma kynurenine to tryptophan ratio in major depressive disorder	Plasma kynurenine to tryptophan ratio in major depressive disorder	Neurological disorder
5417	GCST005343	Plasma kynurenine to tryptophan ratio in major depressive disorder	Plasma kynurenine to tryptophan ratio in major depressive disorder	Other measurement
5418	GCST005342	Plasma kynurenine levels in major depressive disorder	Plasma kynurenine levels in major depressive disorder	Neurological disorder
5419	GCST005342	Plasma kynurenine levels in major depressive disorder	Plasma kynurenine levels in major depressive disorder	Other measurement
5420	GCST005158	Overall survival in osteosarcoma	Overall survival in osteosarcoma	Cancer
5421	GCST005158	Overall survival in osteosarcoma	Overall survival in osteosarcoma	Other measurement
5422	GCST005191	Hair shape	Hair shape	Other measurement
5423	GCST005168	Systolic blood pressure	Systolic blood pressure	Other measurement
5424	GCST005168	Systolic blood pressure	Systolic blood pressure	Other measurement
5425	GCST005171	QT interval	QT interval	Cardiovascular measurement
5426	GCST005364	Opioid requirements during laparoscopic-assisted colectomy	Opioid requirements during laparoscopic-assisted colectomy	Response to drug
5427	GCST005364	Opioid requirements during laparoscopic-assisted colectomy	Opioid requirements during laparoscopic-assisted colectomy	Other measurement
5428	GCST005182	Common carotid intima-media thickness in HIV negative individuals	Common carotid intima-media thickness in HIV negative individuals	Cardiovascular measurement
5429	GCST005109	Progranulin levels	Progranulin levels	Other measurement
5430	GCST006216	Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	Neurological disorder
5431	GCST006216	Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	Other measurement
5432	GCST005275	Cancer	Cancer	Cancer
5433	GCST005275	Cancer	Cancer	Cancer
5434	GCST005275	Cancer	Cancer	Cancer
5435	GCST005275	Cancer	Cancer	Cancer
5436	GCST005275	Cancer	Cancer	Cancer
5437	GCST005275	Cancer	Cancer	Cancer
5438	GCST005275	Cancer	Cancer	Cancer
5439	GCST005275	Cancer	Cancer	Cancer
5440	GCST005275	Cancer	Cancer	Cancer
5441	GCST005275	Cancer	Cancer	Cancer
5442	GCST005275	Cancer	Cancer	Cancer
5443	GCST005170	Intraocular pressure	Intraocular pressure	Other measurement
5444	GCST005248	Delayed reward discounting	Delayed reward discounting	Other measurement
5445	GCST005173	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	Other trait
5446	GCST005173	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	Metabolic disorder
5447	GCST005175	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	Other trait
5448	GCST005175	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	Metabolic disorder
5449	GCST005174	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	Other trait
5450	GCST005174	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	Metabolic disorder
5451	GCST005247	Male sexual orientation	Male sexual orientation	Other trait
5452	GCST005169	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5453	GCST005169	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5454	GCST005237	Mood instability	Mood instability	Other measurement
5455	GCST005108	Major depressive disorder	Major depressive disorder	Neurological disorder
5456	GCST005238	Mood instability	Mood instability	Other measurement
5457	GCST006800	Childhood insulin resistance	Childhood insulin resistance	Other trait
5458	GCST005206	B-type natriuretic peptide levels	B-type natriuretic peptide levels	Cardiovascular measurement
5459	GCST005246	Inhibitory control	Inhibitory control	Other measurement
5460	GCST005187	Matrix metalloproteinase-8 levels	Matrix metalloproteinase-8 levels	Inflammatory measurement
5461	GCST005205	N-terminal pro B-type natriuretic peptide levels	N-terminal pro B-type natriuretic peptide levels	Cardiovascular measurement
5462	GCST005207	Midregional pro atrial natriuretic peptide levels	Midregional pro atrial natriuretic peptide levels	Cardiovascular measurement
5463	GCST005183	Common carotid intima-media thickness	Common carotid intima-media thickness	Cardiovascular measurement
5464	GCST005184	Common carotid intima-media thickness in HIV infection	Common carotid intima-media thickness in HIV infection	Other disease
5465	GCST005184	Common carotid intima-media thickness in HIV infection	Common carotid intima-media thickness in HIV infection	Cardiovascular measurement
5466	GCST005361	Attention deficit hyperactivity disorder (sex interaction)	Attention deficit hyperactivity disorder (sex interaction)	Neurological disorder
5467	GCST005361	Attention deficit hyperactivity disorder (sex interaction)	Attention deficit hyperactivity disorder (sex interaction)	Other measurement
5468	GCST005362	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
5469	GCST005655	Seborrheic dermatitis	Seborrheic dermatitis	Other disease
5470	GCST005363	Sex difference in attention deficit hyperactivity disorder	Sex difference in attention deficit hyperactivity disorder	Neurological disorder
5471	GCST005363	Sex difference in attention deficit hyperactivity disorder	Sex difference in attention deficit hyperactivity disorder	Other trait
5472	GCST005211	Nodular sclerosis Hodgkin lymphoma	Nodular sclerosis Hodgkin lymphoma	Cancer
5473	GCST005145	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
5474	GCST005097	Fractures (vertebral)	Fractures (vertebral)	Other disease
5475	GCST005154	Alloimmunization response to pregnancy (HLA class I and II)	Alloimmunization response to pregnancy (HLA class I and II)	Biological process
5476	GCST005155	Alloimmunization response to pregnancy	Alloimmunization response to pregnancy	Biological process
5477	GCST005157	Alloimmunization response to pregnancy (HLA class II)	Alloimmunization response to pregnancy (HLA class II)	Biological process
5478	GCST005156	Alloimmunization response to pregnancy (HLA class I)	Alloimmunization response to pregnancy (HLA class I)	Biological process
5479	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Other measurement
5480	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Cancer
5481	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Cancer
5482	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Cancer
5483	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Other measurement
5484	GCST005208	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	Cardiovascular measurement
5485	GCST005209	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
5486	GCST005210	Mixed cellularity Hodgkin lymphoma	Mixed cellularity Hodgkin lymphoma	Cancer
5487	GCST005142	Cognitive ability	Cognitive ability	Biological process
5488	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Other measurement
5489	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Cancer
5490	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Cancer
5491	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Response to drug
5492	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Other measurement
5493	GCST005901	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Other measurement
5494	GCST005901	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Cancer
5495	GCST005901	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Cancer
5496	GCST005901	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Other measurement
5497	GCST005141	Cognitive ability (MTAG)	Cognitive ability (MTAG)	Other measurement
5498	GCST005141	Cognitive ability (MTAG)	Cognitive ability (MTAG)	Biological process
5499	GCST005051	Obstructive sleep apnea trait (apnea hypopnea index)	Obstructive sleep apnea trait (apnea hypopnea index)	Other measurement
5500	GCST005051	Obstructive sleep apnea trait (apnea hypopnea index)	Obstructive sleep apnea trait (apnea hypopnea index)	Neurological disorder
5501	GCST005050	Obstructive sleep apnea during REM sleep (apnea hypopnea index)	Obstructive sleep apnea during REM sleep (apnea hypopnea index)	Other measurement
5502	GCST005049	Obstructive sleep apnea during non-REM sleep (apnea hypopnea index)	Obstructive sleep apnea during non-REM sleep (apnea hypopnea index)	Other measurement
5503	GCST006121	Alzheimer's disease	Alzheimer's disease	Neurological disorder
5504	GCST006120	Alzheimer's disease (age of onset)	Alzheimer's disease (age of onset)	Neurological disorder
5505	GCST006120	Alzheimer's disease (age of onset)	Alzheimer's disease (age of onset)	Other measurement
5506	GCST005115	Response to mepolizumab in severe asthma	Response to mepolizumab in severe asthma	Other disease
5507	GCST005115	Response to mepolizumab in severe asthma	Response to mepolizumab in severe asthma	Response to drug
5508	GCST005022	Major depression and alcohol dependence	Major depression and alcohol dependence	Neurological disorder
5509	GCST005022	Major depression and alcohol dependence	Major depression and alcohol dependence	Neurological disorder
5510	GCST004998	Severe progression in rheumatoid arthritis	Severe progression in rheumatoid arthritis	Immune system disorder
5511	GCST004998	Severe progression in rheumatoid arthritis	Severe progression in rheumatoid arthritis	Other measurement
5512	GCST005028	Pursuit maintenance gain in psychotic disorders	Pursuit maintenance gain in psychotic disorders	Neurological disorder
5513	GCST005028	Pursuit maintenance gain in psychotic disorders	Pursuit maintenance gain in psychotic disorders	Neurological disorder
5514	GCST005028	Pursuit maintenance gain in psychotic disorders	Pursuit maintenance gain in psychotic disorders	Neurological disorder
5515	GCST005028	Pursuit maintenance gain in psychotic disorders	Pursuit maintenance gain in psychotic disorders	Other measurement
5516	GCST005126	Fractional excretion of magnesium	Fractional excretion of magnesium	Other measurement
5517	GCST005111	Breast cancer in childhood cancer survivors	Breast cancer in childhood cancer survivors	Cancer
5518	GCST005111	Breast cancer in childhood cancer survivors	Breast cancer in childhood cancer survivors	Cancer
5519	GCST005112	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Cancer
5520	GCST005112	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Biological process
5521	GCST005112	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Cancer
5522	GCST005110	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	Cancer
5523	GCST005110	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	Cancer
5524	GCST005124	Urinary magnesium-to-creatinine ratio	Urinary magnesium-to-creatinine ratio	Other measurement
5525	GCST005236	Problematic alcohol use in trauma-exposed individuals	Problematic alcohol use in trauma-exposed individuals	Other measurement
5526	GCST005236	Problematic alcohol use in trauma-exposed individuals	Problematic alcohol use in trauma-exposed individuals	Biological process
5527	GCST005082	Bipolar disorder lithium response (categorical) or schizophrenia	Bipolar disorder lithium response (categorical) or schizophrenia	Response to drug
5528	GCST005082	Bipolar disorder lithium response (categorical) or schizophrenia	Bipolar disorder lithium response (categorical) or schizophrenia	Neurological disorder
5529	GCST005082	Bipolar disorder lithium response (categorical) or schizophrenia	Bipolar disorder lithium response (categorical) or schizophrenia	Neurological disorder
5530	GCST005081	Bipolar disorder lithium response (continuous) or schizophrenia	Bipolar disorder lithium response (continuous) or schizophrenia	Response to drug
5531	GCST005081	Bipolar disorder lithium response (continuous) or schizophrenia	Bipolar disorder lithium response (continuous) or schizophrenia	Neurological disorder
5532	GCST005081	Bipolar disorder lithium response (continuous) or schizophrenia	Bipolar disorder lithium response (continuous) or schizophrenia	Neurological disorder
5533	GCST005048	Idiopathic osteonecrosis of the femoral head	Idiopathic osteonecrosis of the femoral head	Other disease
5534	GCST005128	Cannabis dependence symptom count	Cannabis dependence symptom count	Other measurement
5535	GCST005133	Cannabis dependence	Cannabis dependence	Neurological disorder
5536	GCST005107	Restless legs syndrome	Restless legs syndrome	Neurological disorder
5537	GCST005044	Primary vesicoureteric reflux	Primary vesicoureteric reflux	Other disease
5538	GCST005045	Primary vesicoureteric reflux	Primary vesicoureteric reflux	Other disease
5539	GCST005116	Male-pattern baldness	Male-pattern baldness	Other measurement
5540	GCST005116	Male-pattern baldness	Male-pattern baldness	Other disease
5541	GCST005116	Male-pattern baldness	Male-pattern baldness	Other disease
5542	GCST005083	Putamen volume	Putamen volume	Other measurement
5543	GCST005114	Osteoporosis or obesity (pleiotropy)	Osteoporosis or obesity (pleiotropy)	Other disease
5544	GCST005114	Osteoporosis or obesity (pleiotropy)	Osteoporosis or obesity (pleiotropy)	Metabolic disorder
5545	GCST006632	Decline in glucose metabolism in posterior cingulate cortex	Decline in glucose metabolism in posterior cingulate cortex	Other measurement
5546	GCST006632	Decline in glucose metabolism in posterior cingulate cortex	Decline in glucose metabolism in posterior cingulate cortex	Other measurement
5547	GCST005080	PR interval	PR interval	Cardiovascular measurement
5548	GCST005079	Orofacial clefts (cleft lip vs. cleft lip and palate)	Orofacial clefts (cleft lip vs. cleft lip and palate)	Other trait
5549	GCST005079	Orofacial clefts (cleft lip vs. cleft lip and palate)	Orofacial clefts (cleft lip vs. cleft lip and palate)	Other disease
5550	GCST005079	Orofacial clefts (cleft lip vs. cleft lip and palate)	Orofacial clefts (cleft lip vs. cleft lip and palate)	Other trait
5551	GCST005057	Small vessel stroke	Small vessel stroke	Cardiovascular disease
5552	GCST005043	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
5553	GCST005144	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other trait
5554	GCST005144	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other measurement
5555	GCST005144	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other measurement
5556	GCST005117	Activities of daily living score	Activities of daily living score	Other measurement
5557	GCST005122	Hand grip strength	Hand grip strength	Other measurement
5558	GCST005119	Calf circumference	Calf circumference	Other measurement
5559	GCST005123	Cognitive performance	Cognitive performance	Other measurement
5560	GCST005123	Cognitive performance	Cognitive performance	Other measurement
5561	GCST005120	Four meter walk test score	Four meter walk test score	Other measurement
5562	GCST005118	Mid-arm muscle circumference	Mid-arm muscle circumference	Other measurement
5563	GCST005121	Short physical performance battery score	Short physical performance battery score	Other measurement
5564	GCST005143	Telomere length	Telomere length	Other measurement
5565	GCST005042	Restless legs syndrome	Restless legs syndrome	Neurological disorder
5566	GCST005125	Serum magnesium levels	Serum magnesium levels	Other measurement
5567	GCST005027	Anti-saccade error rate in psychotic disorders	Anti-saccade error rate in psychotic disorders	Neurological disorder
5568	GCST005027	Anti-saccade error rate in psychotic disorders	Anti-saccade error rate in psychotic disorders	Neurological disorder
5569	GCST005027	Anti-saccade error rate in psychotic disorders	Anti-saccade error rate in psychotic disorders	Other measurement
5570	GCST005027	Anti-saccade error rate in psychotic disorders	Anti-saccade error rate in psychotic disorders	Neurological disorder
5571	GCST005026	Initial pursuit acceleration in psychotic disorders	Initial pursuit acceleration in psychotic disorders	Neurological disorder
5572	GCST005026	Initial pursuit acceleration in psychotic disorders	Initial pursuit acceleration in psychotic disorders	Neurological disorder
5573	GCST005026	Initial pursuit acceleration in psychotic disorders	Initial pursuit acceleration in psychotic disorders	Neurological disorder
5574	GCST005026	Initial pursuit acceleration in psychotic disorders	Initial pursuit acceleration in psychotic disorders	Other measurement
5575	GCST005035	Fasting growth hormone levels	Fasting growth hormone levels	Other measurement
5576	GCST005025	Anti-saccade response	Anti-saccade response	Other measurement
5577	GCST005024	Pursuit maintenance gain	Pursuit maintenance gain	Other measurement
5578	GCST005023	Initial pursuit acceleration	Initial pursuit acceleration	Other measurement
5579	GCST004972	Putamen actvity during disappointment	Putamen actvity during disappointment	Other measurement
5580	GCST004972	Putamen actvity during disappointment	Putamen actvity during disappointment	Other measurement
5581	GCST004972	Putamen actvity during disappointment	Putamen actvity during disappointment	Biological process
5582	GCST004971	Putamen activity during reward	Putamen activity during reward	Other measurement
5583	GCST004971	Putamen activity during reward	Putamen activity during reward	Other measurement
5584	GCST004971	Putamen activity during reward	Putamen activity during reward	Biological process
5585	GCST004970	Caudate activity during reward	Caudate activity during reward	Other measurement
5586	GCST004970	Caudate activity during reward	Caudate activity during reward	Other measurement
5587	GCST004970	Caudate activity during reward	Caudate activity during reward	Biological process
5588	GCST004953	Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	Neurological disorder
5589	GCST004953	Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	Other measurement
5590	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
5591	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
5592	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Other measurement
5593	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
5594	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Cancer
5595	GCST004989	Early childhood caries	Early childhood caries	Digestive system disorder
5596	GCST004990	Alcohol consumption over the past year	Alcohol consumption over the past year	Other measurement
5597	GCST004945	Lumbar spinal stenosis	Lumbar spinal stenosis	Other disease
5598	GCST004954	Antisocial behavior	Antisocial behavior	Other measurement
5599	GCST006489	Antisocial behavior	Antisocial behavior	Other measurement
5600	GCST006490	Antisocial behavior	Antisocial behavior	Other measurement
5601	GCST004986	Idiopathic pulmonary fibrosis	Idiopathic pulmonary fibrosis	Cancer
5602	GCST007577	Blood pressure (parental or offspring effect)	Blood pressure (parental or offspring effect)	Other measurement
5603	GCST004981	Curve progression in adolescent idiopathic scoliosis	Curve progression in adolescent idiopathic scoliosis	Other disease
5604	GCST004981	Curve progression in adolescent idiopathic scoliosis	Curve progression in adolescent idiopathic scoliosis	Other measurement
5605	GCST004983	Parental lifespan	Parental lifespan	Other measurement
5606	GCST006036	Psoriasis vulgaris	Psoriasis vulgaris	Immune system disorder
5607	GCST006039	Peanut allergy	Peanut allergy	Other measurement
5608	GCST006038	Food allergy	Food allergy	Other measurement
5609	GCST004951	Post-term birth	Post-term birth	Other measurement
5610	GCST004951	Post-term birth	Post-term birth	Other measurement
5611	GCST004952	Ankle injury	Ankle injury	Other disease
5612	GCST004922	Tuberculosis	Tuberculosis	Other disease
5613	GCST004922	Tuberculosis	Tuberculosis	Other measurement
5614	GCST004922	Tuberculosis	Tuberculosis	Other measurement
5615	GCST004923	Tuberculosis	Tuberculosis	Other disease
5616	GCST004923	Tuberculosis	Tuberculosis	Other measurement
5617	GCST004923	Tuberculosis	Tuberculosis	Other measurement
5618	GCST006173	BMI x dairy intake interaction (1df interaction test)	BMI x dairy intake interaction (1df interaction test)	Body measurement
5619	GCST006173	BMI x dairy intake interaction (1df interaction test)	BMI x dairy intake interaction (1df interaction test)	Biological process
5620	GCST004901	Amyotrophic lateral sclerosis (sporadic)	Amyotrophic lateral sclerosis (sporadic)	Neurological disorder
5621	GCST008472	Amyotrophic lateral sclerosis (sporadic)	Amyotrophic lateral sclerosis (sporadic)	Neurological disorder
5622	GCST004918	Coronary artery disease severity measurement	Coronary artery disease severity measurement	Cardiovascular disease
5623	GCST004969	Caudate activity during disappointment	Caudate activity during disappointment	Other measurement
5624	GCST004969	Caudate activity during disappointment	Caudate activity during disappointment	Other measurement
5625	GCST004969	Caudate activity during disappointment	Caudate activity during disappointment	Biological process
5626	GCST005225	Osteoarthritis or lumbar spine bone mineral density	Osteoarthritis or lumbar spine bone mineral density	Other disease
5627	GCST005225	Osteoarthritis or lumbar spine bone mineral density	Osteoarthritis or lumbar spine bone mineral density	Other measurement
5628	GCST005224	Knee osteoarthritis or femoral neck bone mineral density	Knee osteoarthritis or femoral neck bone mineral density	Other measurement
5629	GCST005224	Knee osteoarthritis or femoral neck bone mineral density	Knee osteoarthritis or femoral neck bone mineral density	Other disease
5630	GCST005229	Hip osteoarthritis or femoral neck bone mineral density	Hip osteoarthritis or femoral neck bone mineral density	Other measurement
5631	GCST005229	Hip osteoarthritis or femoral neck bone mineral density	Hip osteoarthritis or femoral neck bone mineral density	Other disease
5632	GCST005228	Osteoarthritis or femoral neck bone mineral density	Osteoarthritis or femoral neck bone mineral density	Other disease
5633	GCST005228	Osteoarthritis or femoral neck bone mineral density	Osteoarthritis or femoral neck bone mineral density	Other measurement
5634	GCST005227	Knee osteoarthritis or lumbar spine bone mineral density	Knee osteoarthritis or lumbar spine bone mineral density	Other disease
5635	GCST005227	Knee osteoarthritis or lumbar spine bone mineral density	Knee osteoarthritis or lumbar spine bone mineral density	Other measurement
5636	GCST005226	Hip osteoarthritis or lumbar spine bone mineral density	Hip osteoarthritis or lumbar spine bone mineral density	Other measurement
5637	GCST005226	Hip osteoarthritis or lumbar spine bone mineral density	Hip osteoarthritis or lumbar spine bone mineral density	Other disease
5638	GCST004895	Colorectal cancer	Colorectal cancer	Cancer
5639	GCST004944	Migraine or coronary artery disease	Migraine or coronary artery disease	Cardiovascular disease
5640	GCST004944	Migraine or coronary artery disease	Migraine or coronary artery disease	Cardiovascular disease
5641	GCST004943	Pediatric nonalcoholic steatohepatitis	Pediatric nonalcoholic steatohepatitis	Digestive system disorder
5642	GCST004938	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Other trait
5643	GCST004938	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Digestive system disorder
5644	GCST004893	Suicide attempts	Suicide attempts	Biological process
5645	GCST004904	Body mass index	Body mass index	Body measurement
5646	GCST004904	Body mass index	Body mass index	Body measurement
5647	GCST004904	Body mass index	Body mass index	Other measurement
5648	GCST004902	Parkinson's disease	Parkinson's disease	Neurological disorder
5649	GCST004890	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5650	GCST004890	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5651	GCST004889	Hypertension	Hypertension	Cardiovascular disease
5652	GCST004892	Pulse pressure	Pulse pressure	Cardiovascular measurement
5653	GCST004840	Colorectal cancer	Colorectal cancer	Cancer
5654	GCST004888	Systolic blood pressure	Systolic blood pressure	Other measurement
5655	GCST004888	Systolic blood pressure	Systolic blood pressure	Other measurement
5656	GCST006288	Heel bone mineral density	Heel bone mineral density	Other measurement
5657	GCST004894	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5658	GCST004839	Colorectal cancer	Colorectal cancer	Cancer
5659	GCST004891	Mean arterial pressure	Mean arterial pressure	Other measurement
5660	GCST004873	Endometriosis	Endometriosis	Other disease
5661	GCST004825	Hyperuricemia	Hyperuricemia	Cardiovascular measurement
5662	GCST004825	Hyperuricemia	Hyperuricemia	Metabolic disorder
5663	GCST005549	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
5664	GCST005549	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
5665	GCST004899	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
5666	GCST004899	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
5667	GCST004899	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
5668	GCST004858	Dupuytren's disease	Dupuytren's disease	Other disease
5669	GCST004896	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Response to drug
5670	GCST004896	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Other measurement
5671	GCST004896	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Response to drug
5672	GCST004896	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Cancer
5673	GCST006037	Hepatocellular carcinoma in hepatitis C infection	Hepatocellular carcinoma in hepatitis C infection	Cancer
5674	GCST006037	Hepatocellular carcinoma in hepatitis C infection	Hepatocellular carcinoma in hepatitis C infection	Digestive system disorder
5675	GCST004859	Kawasaki disease	Kawasaki disease	Immune system disorder
5676	GCST004898	Preterm birth (maternal effect)	Preterm birth (maternal effect)	Other measurement
5677	GCST004898	Preterm birth (maternal effect)	Preterm birth (maternal effect)	Other trait
5678	GCST006040	Atopy	Atopy	Immune system disorder
5679	GCST004976	nicotine metabolite ratio in current smokers	nicotine metabolite ratio in current smokers	Biological process
5680	GCST004976	nicotine metabolite ratio in current smokers	nicotine metabolite ratio in current smokers	Other measurement
5681	GCST004881	Knee osteoarthritis	Knee osteoarthritis	Other disease
5682	GCST004942	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Cancer
5683	GCST004942	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Other measurement
5684	GCST004942	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Digestive system disorder
5685	GCST004860	Alcoholic chronic pancreatitis	Alcoholic chronic pancreatitis	Digestive system disorder
5686	GCST004975	Schizophrenia or general cognitive function (pleiotropy)	Schizophrenia or general cognitive function (pleiotropy)	Neurological disorder
5687	GCST004975	Schizophrenia or general cognitive function (pleiotropy)	Schizophrenia or general cognitive function (pleiotropy)	Other measurement
5688	GCST004973	Schizophrenia or verbal-numerical reasoning (pleiotropy)	Schizophrenia or verbal-numerical reasoning (pleiotropy)	Neurological disorder
5689	GCST004973	Schizophrenia or verbal-numerical reasoning (pleiotropy)	Schizophrenia or verbal-numerical reasoning (pleiotropy)	Other measurement
5690	GCST004974	Schizophrenia or reaction time (pleiotropy)	Schizophrenia or reaction time (pleiotropy)	Neurological disorder
5691	GCST004974	Schizophrenia or reaction time (pleiotropy)	Schizophrenia or reaction time (pleiotropy)	Other measurement
5692	GCST004947	Pulmonary arterial hypertension	Pulmonary arterial hypertension	Cardiovascular disease
5693	GCST006145	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5694	GCST004783	Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia in preterm infants	Other disease
5695	GCST004783	Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia in preterm infants	Other trait
5696	GCST004801	Response to ranibizumab in age-related macular degeneration (visual acuity)	Response to ranibizumab in age-related macular degeneration (visual acuity)	Neurological disorder
5697	GCST004801	Response to ranibizumab in age-related macular degeneration (visual acuity)	Response to ranibizumab in age-related macular degeneration (visual acuity)	Response to drug
5698	GCST004801	Response to ranibizumab in age-related macular degeneration (visual acuity)	Response to ranibizumab in age-related macular degeneration (visual acuity)	Other measurement
5699	GCST004838	Coronary artery disease and/or body mass index (pleiotropy)	Coronary artery disease and/or body mass index (pleiotropy)	Cardiovascular disease
5700	GCST004838	Coronary artery disease and/or body mass index (pleiotropy)	Coronary artery disease and/or body mass index (pleiotropy)	Body measurement
5701	GCST004779	Uterine fibroids	Uterine fibroids	Cancer
5702	GCST004802	Response to ranibizumab in age-related macular degeneration (dry maculae)	Response to ranibizumab in age-related macular degeneration (dry maculae)	Neurological disorder
5703	GCST004802	Response to ranibizumab in age-related macular degeneration (dry maculae)	Response to ranibizumab in age-related macular degeneration (dry maculae)	Response to drug
5704	GCST004802	Response to ranibizumab in age-related macular degeneration (dry maculae)	Response to ranibizumab in age-related macular degeneration (dry maculae)	Other measurement
5705	GCST004803	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Neurological disorder
5706	GCST004803	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Response to drug
5707	GCST004803	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Other measurement
5708	GCST008861	General cognitive ability	General cognitive ability	Biological process
5709	GCST004786	Thiazide-induced hyponatremia	Thiazide-induced hyponatremia	Other trait
5710	GCST004784	Alcoholic hepatitis	Alcoholic hepatitis	Digestive system disorder
5711	GCST004789	Change in LVEF in response to paclitaxel in HER2+ breast cancer	Change in LVEF in response to paclitaxel in HER2+ breast cancer	Cardiovascular measurement
5712	GCST004789	Change in LVEF in response to paclitaxel in HER2+ breast cancer	Change in LVEF in response to paclitaxel in HER2+ breast cancer	Response to drug
5713	GCST004788	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Cardiovascular measurement
5714	GCST004788	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Response to drug
5715	GCST004788	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Response to drug
5716	GCST004836	Femoral neck bone mineral density or breast cancer (pleiotropy)	Femoral neck bone mineral density or breast cancer (pleiotropy)	Other measurement
5717	GCST004836	Femoral neck bone mineral density or breast cancer (pleiotropy)	Femoral neck bone mineral density or breast cancer (pleiotropy)	Cancer
5718	GCST004837	Lumbar spine bone mineral density or breast cancer (pleiotropy)	Lumbar spine bone mineral density or breast cancer (pleiotropy)	Cancer
5719	GCST004837	Lumbar spine bone mineral density or breast cancer (pleiotropy)	Lumbar spine bone mineral density or breast cancer (pleiotropy)	Other measurement
5720	GCST004790	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Cardiovascular measurement
5721	GCST004790	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Response to drug
5722	GCST004790	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Response to drug
5723	GCST004782	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5724	GCST004778	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
5725	GCST004823	Cognitive function	Cognitive function	Biological process
5726	GCST004823	Cognitive function	Cognitive function	Biological process
5727	GCST004823	Cognitive function	Cognitive function	Other measurement
5728	GCST004823	Cognitive function	Cognitive function	Biological process
5729	GCST004833	Cervical cancer	Cervical cancer	Cancer
5730	GCST004780	Cortisol levels (saliva)	Cortisol levels (saliva)	Other measurement
5731	GCST004813	Laterality in neovascular age-related macular degeneration	Laterality in neovascular age-related macular degeneration	Neurological disorder
5732	GCST004813	Laterality in neovascular age-related macular degeneration	Laterality in neovascular age-related macular degeneration	Other measurement
5733	GCST004982	Prostate cancer	Prostate cancer	Cancer
5734	GCST004880	Alzheimer's disease or type 2 diabetes (pleiotropy)	Alzheimer's disease or type 2 diabetes (pleiotropy)	Neurological disorder
5735	GCST004880	Alzheimer's disease or type 2 diabetes (pleiotropy)	Alzheimer's disease or type 2 diabetes (pleiotropy)	Metabolic disorder
5736	GCST004772	Bone mineral density (paediatric, total body less head)	Bone mineral density (paediatric, total body less head)	Other measurement
5737	GCST004770	Lean body mass	Lean body mass	Other measurement
5738	GCST004767	Schizophrenia (age at onset)	Schizophrenia (age at onset)	Neurological disorder
5739	GCST004767	Schizophrenia (age at onset)	Schizophrenia (age at onset)	Other measurement
5740	GCST004771	TB-LM or TBLH-BMD (pleiotropy)	TB-LM or TBLH-BMD (pleiotropy)	Other measurement
5741	GCST004771	TB-LM or TBLH-BMD (pleiotropy)	TB-LM or TBLH-BMD (pleiotropy)	Other measurement
5742	GCST004777	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5743	GCST004777	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5744	GCST004800	Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	Other measurement
5745	GCST004800	Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	Other measurement
5746	GCST004775	Pulse pressure	Pulse pressure	Cardiovascular measurement
5747	GCST004776	Systolic blood pressure	Systolic blood pressure	Other measurement
5748	GCST004776	Systolic blood pressure	Systolic blood pressure	Other measurement
5749	GCST004752	Relapse in multiple sclerosis	Relapse in multiple sclerosis	Immune system disorder
5750	GCST004752	Relapse in multiple sclerosis	Relapse in multiple sclerosis	Other measurement
5751	GCST004726	Vitamin D levels	Vitamin D levels	Other measurement
5752	GCST005037	Appendicular lean mass	Appendicular lean mass	Other measurement
5753	GCST005036	Lean body mass	Lean body mass	Other measurement
5754	GCST004756	Alcohol dependence	Alcohol dependence	Other measurement
5755	GCST004756	Alcohol dependence	Alcohol dependence	Neurological disorder
5756	GCST004755	Chronic alcoholic pancreatitis or alcohol-related cirrhosis	Chronic alcoholic pancreatitis or alcohol-related cirrhosis	Digestive system disorder
5757	GCST004755	Chronic alcoholic pancreatitis or alcohol-related cirrhosis	Chronic alcoholic pancreatitis or alcohol-related cirrhosis	Cancer
5758	GCST004757	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Neurological disorder
5759	GCST004757	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Digestive system disorder
5760	GCST004757	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Cancer
5761	GCST004787	Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)	Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)	Cardiovascular disease
5762	GCST004737	Neovascular age-related macular degeneration	Neovascular age-related macular degeneration	Neurological disorder
5763	GCST004737	Neovascular age-related macular degeneration	Neovascular age-related macular degeneration	Neurological disorder
5764	GCST005826	Sero-negative rheumatoid arthritis	Sero-negative rheumatoid arthritis	Immune system disorder
5765	GCST007514	Hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	Digestive system disorder
5766	GCST007514	Hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	Cancer
5767	GCST004754	Follicular thyroid cancer	Follicular thyroid cancer	Cancer
5768	GCST004753	Papillary thyroid cancer	Papillary thyroid cancer	Cancer
5769	GCST004798	Differentiated thyroid cancer	Differentiated thyroid cancer	Cancer
5770	GCST005235	Hand grip strength	Hand grip strength	Other measurement
5771	GCST004807	Immunoglobulin light chain (AL) amyloidosis (liver involvement)	Immunoglobulin light chain (AL) amyloidosis (liver involvement)	Metabolic disorder
5772	GCST004807	Immunoglobulin light chain (AL) amyloidosis (liver involvement)	Immunoglobulin light chain (AL) amyloidosis (liver involvement)	Other measurement
5773	GCST004724	Foot ulcer in diabetes and neuropathy	Foot ulcer in diabetes and neuropathy	Cancer
5774	GCST004724	Foot ulcer in diabetes and neuropathy	Foot ulcer in diabetes and neuropathy	Neurological disorder
5775	GCST004724	Foot ulcer in diabetes and neuropathy	Foot ulcer in diabetes and neuropathy	Metabolic disorder
5776	GCST004724	Foot ulcer in diabetes and neuropathy	Foot ulcer in diabetes and neuropathy	Metabolic disorder
5777	GCST004725	Foot ulcer and neuropathy in diabetes	Foot ulcer and neuropathy in diabetes	Cancer
5778	GCST004725	Foot ulcer and neuropathy in diabetes	Foot ulcer and neuropathy in diabetes	Neurological disorder
5779	GCST004725	Foot ulcer and neuropathy in diabetes	Foot ulcer and neuropathy in diabetes	Metabolic disorder
5780	GCST004725	Foot ulcer and neuropathy in diabetes	Foot ulcer and neuropathy in diabetes	Metabolic disorder
5781	GCST004703	Obsessive-compulsive disorder or autism spectrum disorder	Obsessive-compulsive disorder or autism spectrum disorder	Neurological disorder
5782	GCST004703	Obsessive-compulsive disorder or autism spectrum disorder	Obsessive-compulsive disorder or autism spectrum disorder	Neurological disorder
5783	GCST004736	Familial hepatitis B virus-related hepatocellular carcinoma	Familial hepatitis B virus-related hepatocellular carcinoma	Digestive system disorder
5784	GCST004736	Familial hepatitis B virus-related hepatocellular carcinoma	Familial hepatitis B virus-related hepatocellular carcinoma	Cancer
5785	GCST004638	Benign prostatic hyperplasia and/or lower urinary tract symptoms	Benign prostatic hyperplasia and/or lower urinary tract symptoms	Other disease
5786	GCST004638	Benign prostatic hyperplasia and/or lower urinary tract symptoms	Benign prostatic hyperplasia and/or lower urinary tract symptoms	Other trait
5787	GCST005837	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
5788	GCST005837	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
5789	GCST005837	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
5790	GCST004735	Epstein-Barr virus copy number in lymphoblastoid cell lines	Epstein-Barr virus copy number in lymphoblastoid cell lines	Other disease
5791	GCST005945	ADAMTS13 levels	ADAMTS13 levels	Other measurement
5792	GCST004690	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	Other measurement
5793	GCST004690	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	Other trait
5794	GCST004585	Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)	Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)	Metabolic disorder
5795	GCST004689	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	Other measurement
5796	GCST004689	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	Other trait
5797	GCST004709	Fear of severe pain	Fear of severe pain	Other measurement
5798	GCST004706	Fear of pain	Fear of pain	Other measurement
5799	GCST004707	Fear of medical pain (dental)	Fear of medical pain (dental)	Other measurement
5800	GCST004708	Fear of minor pain	Fear of minor pain	Other measurement
5801	GCST004734	Heart rate variability traits (SDNN)	Heart rate variability traits (SDNN)	Cardiovascular measurement
5802	GCST004732	Heart rate variability traits (pvRSA/HF)	Heart rate variability traits (pvRSA/HF)	Cardiovascular measurement
5803	GCST004733	Heart rate variability traits (RMSSD)	Heart rate variability traits (RMSSD)	Cardiovascular measurement
5804	GCST004640	Western dietary pattern	Western dietary pattern	Other measurement
5805	GCST004639	Prudent dietary pattern	Prudent dietary pattern	Other measurement
5806	GCST004717	Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	Cardiovascular disease
5807	GCST004717	Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	Other measurement
5808	GCST004641	Borderline personality disorder	Borderline personality disorder	Other trait
5809	GCST004691	Huntington's disease progression	Huntington's disease progression	Neurological disorder
5810	GCST004691	Huntington's disease progression	Huntington's disease progression	Other measurement
5811	GCST004376	Cerebral blood flow	Cerebral blood flow	Other measurement
5812	GCST005234	Lean mass index	Lean mass index	Other measurement
5813	GCST005233	Fat mass index	Fat mass index	Other measurement
5814	GCST004740	Duloxetine response in major depressive disorder (remitter/non-remitter status)	Duloxetine response in major depressive disorder (remitter/non-remitter status)	Neurological disorder
5815	GCST004740	Duloxetine response in major depressive disorder (remitter/non-remitter status)	Duloxetine response in major depressive disorder (remitter/non-remitter status)	Response to drug
5816	GCST004739	Placebo response in major depressive disorder (% change in symptom score)	Placebo response in major depressive disorder (% change in symptom score)	Neurological disorder
5817	GCST004739	Placebo response in major depressive disorder (% change in symptom score)	Placebo response in major depressive disorder (% change in symptom score)	Biological process
5818	GCST004745	Immunoglobulin A vasculitis	Immunoglobulin A vasculitis	Immune system disorder
5819	GCST004738	Duloxetine response in major depressive disorder (% change in symptom score)	Duloxetine response in major depressive disorder (% change in symptom score)	Neurological disorder
5820	GCST004738	Duloxetine response in major depressive disorder (% change in symptom score)	Duloxetine response in major depressive disorder (% change in symptom score)	Response to drug
5821	GCST004743	Placebo response in major depressive disorder (responder/non-responder status)	Placebo response in major depressive disorder (responder/non-responder status)	Neurological disorder
5822	GCST004743	Placebo response in major depressive disorder (responder/non-responder status)	Placebo response in major depressive disorder (responder/non-responder status)	Biological process
5823	GCST004742	Placebo response in major depressive disorder (remitter/non-remitter status)	Placebo response in major depressive disorder (remitter/non-remitter status)	Neurological disorder
5824	GCST004742	Placebo response in major depressive disorder (remitter/non-remitter status)	Placebo response in major depressive disorder (remitter/non-remitter status)	Biological process
5825	GCST004741	Duloxetine response in major depressive disorder (responder/non-responder status)	Duloxetine response in major depressive disorder (responder/non-responder status)	Neurological disorder
5826	GCST004741	Duloxetine response in major depressive disorder (responder/non-responder status)	Duloxetine response in major depressive disorder (responder/non-responder status)	Response to drug
5827	GCST004799	Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	Cancer
5828	GCST004799	Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	Other trait
5829	GCST004804	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	Metabolic disorder
5830	GCST004804	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	Other measurement
5831	GCST004808	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	Metabolic disorder
5832	GCST004808	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	Other measurement
5833	GCST004812	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	Metabolic disorder
5834	GCST004812	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	Other measurement
5835	GCST004805	Immunoglobulin light chain (AL) amyloidosis (heart involvement)	Immunoglobulin light chain (AL) amyloidosis (heart involvement)	Metabolic disorder
5836	GCST004805	Immunoglobulin light chain (AL) amyloidosis (heart involvement)	Immunoglobulin light chain (AL) amyloidosis (heart involvement)	Cardiovascular measurement
5837	GCST004809	Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	Metabolic disorder
5838	GCST004809	Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	Other measurement
5839	GCST004811	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	Metabolic disorder
5840	GCST004811	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	Other measurement
5841	GCST004810	Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	Metabolic disorder
5842	GCST004810	Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	Other measurement
5843	GCST004806	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Metabolic disorder
5844	GCST004806	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Cardiovascular measurement
5845	GCST004806	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Other measurement
5846	GCST004486	Major depressive disorder	Major depressive disorder	Neurological disorder
5847	GCST004346	Psoriasis	Psoriasis	Immune system disorder
5848	GCST004353	Left ventricular function change in anthracycline treatment	Left ventricular function change in anthracycline treatment	Other trait
5849	GCST004353	Left ventricular function change in anthracycline treatment	Left ventricular function change in anthracycline treatment	Response to drug
5850	GCST004549	Endometriosis	Endometriosis	Other disease
5851	GCST004377	Restricted and repetitive behaviours in autism spectrum disorder	Restricted and repetitive behaviours in autism spectrum disorder	Other measurement
5852	GCST004377	Restricted and repetitive behaviours in autism spectrum disorder	Restricted and repetitive behaviours in autism spectrum disorder	Neurological disorder
5853	GCST004521	Autism spectrum disorder or schizophrenia	Autism spectrum disorder or schizophrenia	Neurological disorder
5854	GCST004521	Autism spectrum disorder or schizophrenia	Autism spectrum disorder or schizophrenia	Neurological disorder
5855	GCST004364	Intelligence	Intelligence	Biological process
5856	GCST004520	Autism spectrum disorder	Autism spectrum disorder	Neurological disorder
5857	GCST004678	Psychosis proneness (hypomanic personality scale)	Psychosis proneness (hypomanic personality scale)	Other measurement
5858	GCST004598	vWF levels in ischaemic stroke and hyperhomocysteinaemia	vWF levels in ischaemic stroke and hyperhomocysteinaemia	Hematological measurement
5859	GCST004598	vWF levels in ischaemic stroke and hyperhomocysteinaemia	vWF levels in ischaemic stroke and hyperhomocysteinaemia	Cardiovascular measurement
5860	GCST004598	vWF levels in ischaemic stroke and hyperhomocysteinaemia	vWF levels in ischaemic stroke and hyperhomocysteinaemia	Other trait
5861	GCST004773	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5862	GCST004774	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5863	GCST004372	Language performance in older adults (adjusted for episodic memory)	Language performance in older adults (adjusted for episodic memory)	Other measurement
5864	GCST004372	Language performance in older adults (adjusted for episodic memory)	Language performance in older adults (adjusted for episodic memory)	Other measurement
5865	GCST004372	Language performance in older adults (adjusted for episodic memory)	Language performance in older adults (adjusted for episodic memory)	Other measurement
5866	GCST004715	Heart rate	Heart rate	Cardiovascular measurement
5867	GCST004714	Heart rate variability traits (SDNN)	Heart rate variability traits (SDNN)	Cardiovascular measurement
5868	GCST004716	Heart rate variability traits (RMSSD)	Heart rate variability traits (RMSSD)	Cardiovascular measurement
5869	GCST004842	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Body measurement
5870	GCST004842	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Other measurement
5871	GCST004842	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Other trait
5872	GCST004843	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Body measurement
5873	GCST004843	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Other measurement
5874	GCST004843	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Other trait
5875	GCST004844	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
5876	GCST004844	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
5877	GCST004844	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
5878	GCST004845	Spontaneous preterm birth (maternal effect)	Spontaneous preterm birth (maternal effect)	Other trait
5879	GCST004845	Spontaneous preterm birth (maternal effect)	Spontaneous preterm birth (maternal effect)	Other measurement
5880	GCST004710	Renal cell carcinoma	Renal cell carcinoma	Cancer
5881	GCST004841	Preterm birth (maternal effect)	Preterm birth (maternal effect)	Other measurement
5882	GCST004841	Preterm birth (maternal effect)	Preterm birth (maternal effect)	Other trait
5883	GCST004713	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
5884	GCST004713	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
5885	GCST004642	QT interval (ambient particulate matter interaction)	QT interval (ambient particulate matter interaction)	Other measurement
5886	GCST004642	QT interval (ambient particulate matter interaction)	QT interval (ambient particulate matter interaction)	Cardiovascular measurement
5887	GCST004643	1,5-anhydroglucitol levels	1,5-anhydroglucitol levels	Other measurement
5888	GCST005755	Cognitive empathy	Cognitive empathy	Other measurement
5889	GCST004644	Vaso-occlusive pain in sickle-cell anemia	Vaso-occlusive pain in sickle-cell anemia	Neurological disorder
5890	GCST004644	Vaso-occlusive pain in sickle-cell anemia	Vaso-occlusive pain in sickle-cell anemia	Other measurement
5891	GCST004635	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
5892	GCST004635	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
5893	GCST004290	Multiple sclerosis	Multiple sclerosis	Immune system disorder
5894	GCST004352	Early onset atrial fibrillation	Early onset atrial fibrillation	Cardiovascular disease
5895	GCST004335	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
5896	GCST004334	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
5897	GCST004334	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
5898	GCST004333	Red cell distribution width	Red cell distribution width	Hematological measurement
5899	GCST004331	Hemoglobin	Hemoglobin	Hematological measurement
5900	GCST004332	Red blood cell count	Red blood cell count	Hematological measurement
5901	GCST004329	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
5902	GCST004329	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
5903	GCST004330	Hematocrit	Hematocrit	Hematological measurement
5904	GCST004292	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
5905	GCST004292	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
5906	GCST004398	Lipoprotein (a) levels	Lipoprotein (a) levels	Lipid or lipoprotein measurement
5907	GCST004573	Iron status biomarkers (ferritin levels)	Iron status biomarkers (ferritin levels)	Other measurement
5908	GCST004573	Iron status biomarkers (ferritin levels)	Iron status biomarkers (ferritin levels)	Other measurement
5909	GCST004490	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
5910	GCST004492	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
5911	GCST004492	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
5912	GCST004572	Iron status biomarkers (transferrin saturation)	Iron status biomarkers (transferrin saturation)	Other measurement
5913	GCST004572	Iron status biomarkers (transferrin saturation)	Iron status biomarkers (transferrin saturation)	Other measurement
5914	GCST004491	Cerebrospinal fluid t-tau levels	Cerebrospinal fluid t-tau levels	Other measurement
5915	GCST004571	Iron status biomarkers (total iron binding capacity)	Iron status biomarkers (total iron binding capacity)	Other measurement
5916	GCST004570	Iron status biomarkers (iron levels)	Iron status biomarkers (iron levels)	Other measurement
5917	GCST004570	Iron status biomarkers (iron levels)	Iron status biomarkers (iron levels)	Other measurement
5918	GCST004378	Mean corpuscular hemoglobin concentration in sickle cell disease	Mean corpuscular hemoglobin concentration in sickle cell disease	Neurological disorder
5919	GCST004378	Mean corpuscular hemoglobin concentration in sickle cell disease	Mean corpuscular hemoglobin concentration in sickle cell disease	Hematological measurement
5920	GCST004379	Red blood cell density in sickle cell anemia	Red blood cell density in sickle cell anemia	Neurological disorder
5921	GCST004379	Red blood cell density in sickle cell anemia	Red blood cell density in sickle cell anemia	Hematological measurement
5922	GCST004385	Systolic blood pressure	Systolic blood pressure	Other measurement
5923	GCST004385	Systolic blood pressure	Systolic blood pressure	Other measurement
5924	GCST004358	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Other disease
5925	GCST004358	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Immune system disorder
5926	GCST004358	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Response to drug
5927	GCST004388	Blood pressure traits (multi-trait analysis)	Blood pressure traits (multi-trait analysis)	Other measurement
5928	GCST004388	Blood pressure traits (multi-trait analysis)	Blood pressure traits (multi-trait analysis)	Other measurement
5929	GCST004388	Blood pressure traits (multi-trait analysis)	Blood pressure traits (multi-trait analysis)	Cardiovascular disease
5930	GCST004388	Blood pressure traits (multi-trait analysis)	Blood pressure traits (multi-trait analysis)	Cardiovascular measurement
5931	GCST004384	Hypertension	Hypertension	Cardiovascular disease
5932	GCST004387	Pulse pressure	Pulse pressure	Cardiovascular measurement
5933	GCST004386	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5934	GCST004386	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5935	GCST004367	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
5936	GCST004367	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
5937	GCST004366	Rheumatic heart disease	Rheumatic heart disease	Cardiovascular disease
5938	GCST004574	Skin aging (microtopography measurement)	Skin aging (microtopography measurement)	Other measurement
5939	GCST004487	Peak insulin response	Peak insulin response	Other measurement
5940	GCST004404	Alcohol consumption (drinkers vs non-drinkers)	Alcohol consumption (drinkers vs non-drinkers)	Biological process
5941	GCST004404	Alcohol consumption (drinkers vs non-drinkers)	Alcohol consumption (drinkers vs non-drinkers)	Other measurement
5942	GCST004524	Energy expenditure (24h)	Energy expenditure (24h)	Other measurement
5943	GCST004523	Resting metabolic rate	Resting metabolic rate	Other measurement
5944	GCST004350	Bone ultrasound measurement (velocity of sound)	Bone ultrasound measurement (velocity of sound)	Other measurement
5945	GCST004351	Bone ultrasound measurement (broadband ultrasound attenuation)	Bone ultrasound measurement (broadband ultrasound attenuation)	Other measurement
5946	GCST004345	Elevated serum prostate-specific antigen levels in healthy men	Elevated serum prostate-specific antigen levels in healthy men	Other measurement
5947	GCST004485	Survival in pancreatic cancer	Survival in pancreatic cancer	Other measurement
5948	GCST004485	Survival in pancreatic cancer	Survival in pancreatic cancer	Cancer
5949	GCST004390	Asthma	Asthma	Other disease
5950	GCST004293	Glomerular filtration rate (cystatin C)	Glomerular filtration rate (cystatin C)	Other measurement
5951	GCST004293	Glomerular filtration rate (cystatin C)	Glomerular filtration rate (cystatin C)	Other measurement
5952	GCST004526	Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)	Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)	Other measurement
5953	GCST004510	Sporadic neuroblastoma	Sporadic neuroblastoma	Cancer
5954	GCST004527	Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)	Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)	Other measurement
5955	GCST004525	Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)	Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)	Other measurement
5956	GCST004511	Smoking status (daily vs non-daily)	Smoking status (daily vs non-daily)	Other measurement
5957	GCST004514	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Biological process
5958	GCST004514	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Other measurement
5959	GCST004513	Smoking status (current vs former)	Smoking status (current vs former)	Other measurement
5960	GCST004512	Smoking status (heavy vs light)	Smoking status (heavy vs light)	Other measurement
5961	GCST004399	Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	Lipid or lipoprotein measurement
5962	GCST004399	Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	Lipid or lipoprotein measurement
5963	GCST006679	insulin secretion rate (BMI adjusted)	insulin secretion rate (BMI adjusted)	Other measurement
5964	GCST006677	Acute insulin response (insulin secretion adjusted)	Acute insulin response (insulin secretion adjusted)	Other measurement
5965	GCST006678	Acute insulin response (insulin secretion and BMI adjusted)	Acute insulin response (insulin secretion and BMI adjusted)	Other measurement
5966	GCST006676	Peak insulin response (insulin secretion adjusted)	Peak insulin response (insulin secretion adjusted)	Other measurement
5967	GCST006675	Peak insulin response (BMI and insulin secretion adjusted)	Peak insulin response (BMI and insulin secretion adjusted)	Other measurement
5968	GCST006681	Insulin disposition index (BMI adjusted)	Insulin disposition index (BMI adjusted)	Other measurement
5969	GCST004489	Insulin disposition index	Insulin disposition index	Other measurement
5970	GCST004488	Insulin secretion rate	Insulin secretion rate	Other measurement
5971	GCST004575	Acute insulin response	Acute insulin response	Other measurement
5972	GCST004405	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Biological process
5973	GCST004405	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Other measurement
5974	GCST004684	Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)	Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)	Other measurement
5975	GCST004683	Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)	Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)	Other measurement
5976	GCST004688	Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)	Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)	Other measurement
5977	GCST004682	Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)	Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)	Other measurement
5978	GCST004681	Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)	Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)	Other measurement
5979	GCST004687	Psychosis proneness (schizoidia scale)	Psychosis proneness (schizoidia scale)	Other measurement
5980	GCST004679	Psychosis proneness (hypomanic personality scale and perceptual aberration scale)	Psychosis proneness (hypomanic personality scale and perceptual aberration scale)	Other measurement
5981	GCST004686	Psychosis proneness (revised social anhedonia scale)	Psychosis proneness (revised social anhedonia scale)	Other measurement
5982	GCST004680	Psychosis proneness (revised physical anhedonia scale)	Psychosis proneness (revised physical anhedonia scale)	Other measurement
5983	GCST004685	Psychosis proneness (perceptual aberration scale)	Psychosis proneness (perceptual aberration scale)	Other measurement
5984	GCST004294	Nicotine dependence	Nicotine dependence	Neurological disorder
5985	GCST006054	High altitude adaptation	High altitude adaptation	Biological process
5986	GCST004283	Midgestational circulating levels of PCBs	Midgestational circulating levels of PCBs	Other measurement
5987	GCST004283	Midgestational circulating levels of PCBs	Midgestational circulating levels of PCBs	Other measurement
5988	GCST004282	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Other measurement
5989	GCST004282	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Other measurement
5990	GCST004282	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Other measurement
5991	GCST004286	Midgestational circulating levels of PBDEs (fetal genetic effect)	Midgestational circulating levels of PBDEs (fetal genetic effect)	Other measurement
5992	GCST004286	Midgestational circulating levels of PBDEs (fetal genetic effect)	Midgestational circulating levels of PBDEs (fetal genetic effect)	Other measurement
5993	GCST004286	Midgestational circulating levels of PBDEs (fetal genetic effect)	Midgestational circulating levels of PBDEs (fetal genetic effect)	Other measurement
5994	GCST004286	Midgestational circulating levels of PBDEs (fetal genetic effect)	Midgestational circulating levels of PBDEs (fetal genetic effect)	Other measurement
5995	GCST004285	Midgestational circulating levels of PBDEs	Midgestational circulating levels of PBDEs	Other measurement
5996	GCST004285	Midgestational circulating levels of PBDEs	Midgestational circulating levels of PBDEs	Other measurement
5997	GCST004285	Midgestational circulating levels of PBDEs	Midgestational circulating levels of PBDEs	Other measurement
5998	GCST004284	Midgestational circulating levels of PCBs (fetal genetic effect)	Midgestational circulating levels of PCBs (fetal genetic effect)	Other measurement
5999	GCST004284	Midgestational circulating levels of PCBs (fetal genetic effect)	Midgestational circulating levels of PCBs (fetal genetic effect)	Other measurement
6000	GCST004284	Midgestational circulating levels of PCBs (fetal genetic effect)	Midgestational circulating levels of PCBs (fetal genetic effect)	Other measurement
6001	GCST004264	Clopidogrel active metabolite levels	Clopidogrel active metabolite levels	Other measurement
6002	GCST004287	Monoclonal gammopathy of undetermined significance	Monoclonal gammopathy of undetermined significance	Other disease
6003	GCST004343	Chronic venous disease	Chronic venous disease	Other trait
6004	GCST004343	Chronic venous disease	Chronic venous disease	Other trait
6005	GCST004281	Midgestational circulating levels of organochlorine pesticides	Midgestational circulating levels of organochlorine pesticides	Other measurement
6006	GCST004281	Midgestational circulating levels of organochlorine pesticides	Midgestational circulating levels of organochlorine pesticides	Other measurement
6007	GCST004271	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	Neurological disorder
6008	GCST004271	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	Response to drug
6009	GCST004275	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	Neurological disorder
6010	GCST004275	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	Response to drug
6011	GCST004274	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	Neurological disorder
6012	GCST004274	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	Response to drug
6013	GCST004273	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	Neurological disorder
6014	GCST004273	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	Response to drug
6015	GCST004270	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	Neurological disorder
6016	GCST004270	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	Response to drug
6017	GCST004272	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	Neurological disorder
6018	GCST004272	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	Response to drug
6019	GCST004304	Prevalent type 2 diabetes	Prevalent type 2 diabetes	Metabolic disorder
6020	GCST004291	Residual cognition	Residual cognition	Biological process
6021	GCST004291	Residual cognition	Residual cognition	Biological process
6022	GCST004303	Aggressive periodontitis	Aggressive periodontitis	Digestive system disorder
6023	GCST004253	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Neurological disorder
6024	GCST004253	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Other measurement
6025	GCST004253	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Other trait
6026	GCST004518	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
6027	GCST004518	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
6028	GCST004519	Body mass index (adult)	Body mass index (adult)	Body measurement
6029	GCST004336	Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	Neurological disorder
6030	GCST004336	Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	Other measurement
6031	GCST004344	Tissue factor pathway inhibitor levels	Tissue factor pathway inhibitor levels	Other measurement
6032	GCST004373	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
6033	GCST004305	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6034	GCST004349	Glioblastoma	Glioblastoma	Cancer
6035	GCST004349	Glioblastoma	Glioblastoma	Cancer
6036	GCST004349	Glioblastoma	Glioblastoma	Cancer
6037	GCST004348	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
6038	GCST004348	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
6039	GCST004251	Paneth cell defects in Crohn's disease	Paneth cell defects in Crohn's disease	Digestive system disorder
6040	GCST004251	Paneth cell defects in Crohn's disease	Paneth cell defects in Crohn's disease	Other measurement
6041	GCST004277	Free thyroxine concentration	Free thyroxine concentration	Other measurement
6042	GCST004223	Attention deficit hyperactivity disorder and obsessive compulsive disorder	Attention deficit hyperactivity disorder and obsessive compulsive disorder	Neurological disorder
6043	GCST004223	Attention deficit hyperactivity disorder and obsessive compulsive disorder	Attention deficit hyperactivity disorder and obsessive compulsive disorder	Neurological disorder
6044	GCST004276	Plasma thyroid-stimulating hormone levels	Plasma thyroid-stimulating hormone levels	Other measurement
6045	GCST004218	Lean body mass	Lean body mass	Other measurement
6046	GCST004267	Blood osmolality (transformed sodium)	Blood osmolality (transformed sodium)	Other measurement
6047	GCST004217	Fuchs's corneal dystrophy	Fuchs's corneal dystrophy	Neurological disorder
6048	GCST004224	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	Other measurement
6049	GCST004224	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	Other measurement
6050	GCST004226	Tuberculosis	Tuberculosis	Other disease
6051	GCST004226	Tuberculosis	Tuberculosis	Other measurement
6052	GCST004226	Tuberculosis	Tuberculosis	Other measurement
6053	GCST004347	Glioma	Glioma	Cancer
6054	GCST004347	Glioma	Glioma	Cancer
6055	GCST004370	Deep ovarian and/or rectovaginal disease with dense adhesions	Deep ovarian and/or rectovaginal disease with dense adhesions	Other disease
6056	GCST004369	Ovarian disease with few adhesions	Ovarian disease with few adhesions	Other disease
6057	GCST004268	Immune response to measles vaccine (measles-induced IFN gamma)	Immune response to measles vaccine (measles-induced IFN gamma)	Response to drug
6058	GCST004266	Response to clopidogrel therapy	Response to clopidogrel therapy	Response to drug
6059	GCST004266	Response to clopidogrel therapy	Response to clopidogrel therapy	Cardiovascular measurement
6060	GCST004266	Response to clopidogrel therapy	Response to clopidogrel therapy	Response to drug
6061	GCST004168	Colorectal cancer	Colorectal cancer	Cancer
6062	GCST004167	Colon cancer	Colon cancer	Cancer
6063	GCST004169	Rectal cancer	Rectal cancer	Cancer
6064	GCST004255	Body mass index	Body mass index	Body measurement
6065	GCST004255	Body mass index	Body mass index	Body measurement
6066	GCST004255	Body mass index	Body mass index	Other measurement
6067	GCST004230	Sepsis in extremely premature infants	Sepsis in extremely premature infants	Other trait
6068	GCST004661	Uveal melanoma	Uveal melanoma	Cancer
6069	GCST004484	Plasma trimethylamine N-oxide levels	Plasma trimethylamine N-oxide levels	Other measurement
6070	GCST004202	Systemic sclerosis	Systemic sclerosis	Neurological disorder
6071	GCST004219	Skin pigmentation	Skin pigmentation	Other trait
6072	GCST004219	Skin pigmentation	Skin pigmentation	Other measurement
6073	GCST004339	Palmitoleic acid (16:1n-7) levels	Palmitoleic acid (16:1n-7) levels	Lipid or lipoprotein measurement
6074	GCST004339	Palmitoleic acid (16:1n-7) levels	Palmitoleic acid (16:1n-7) levels	Lipid or lipoprotein measurement
6075	GCST004341	Nervonic acid (24:1n-9) levels	Nervonic acid (24:1n-9) levels	Lipid or lipoprotein measurement
6076	GCST004340	Erucic acid (22:1n-9) levels	Erucic acid (22:1n-9) levels	Lipid or lipoprotein measurement
6077	GCST004337	Gondoic acid (20:1n-9) levels	Gondoic acid (20:1n-9) levels	Lipid or lipoprotein measurement
6078	GCST004338	Oleic acid (18:1n-9) levels	Oleic acid (18:1n-9) levels	Lipid or lipoprotein measurement
6079	GCST004338	Oleic acid (18:1n-9) levels	Oleic acid (18:1n-9) levels	Lipid or lipoprotein measurement
6080	GCST004342	Vaccenic acid (18:1n-7) levels	Vaccenic acid (18:1n-7) levels	Lipid or lipoprotein measurement
6081	GCST004254	Urinary 1,3-butadiene metabolite levels in smokers	Urinary 1,3-butadiene metabolite levels in smokers	Other measurement
6082	GCST004254	Urinary 1,3-butadiene metabolite levels in smokers	Urinary 1,3-butadiene metabolite levels in smokers	Other measurement
6083	GCST004368	Endometriosis	Endometriosis	Other disease
6084	GCST004256	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
6085	GCST004269	Immune response to measles vaccine (measles-specific neutralising antibody titre)	Immune response to measles vaccine (measles-specific neutralising antibody titre)	Response to drug
6086	GCST004127	White blood cell count (basophil)	White blood cell count (basophil)	Inflammatory measurement
6087	GCST004093	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
6088	GCST004140	Bronchiolitis	Bronchiolitis	Other trait
6089	GCST004094	Prostate-specific antigen levels (conditioned on lead SNPs)	Prostate-specific antigen levels (conditioned on lead SNPs)	Other measurement
6090	GCST004280	Diastolic blood pressure	Diastolic blood pressure	Other measurement
6091	GCST004280	Diastolic blood pressure	Diastolic blood pressure	Other measurement
6092	GCST004279	Systolic blood pressure	Systolic blood pressure	Other measurement
6093	GCST004279	Systolic blood pressure	Systolic blood pressure	Other measurement
6094	GCST004278	Pulse pressure	Pulse pressure	Cardiovascular measurement
6095	GCST004165	Acute-on-chronic liver failure in hepatitis B	Acute-on-chronic liver failure in hepatitis B	Digestive system disorder
6096	GCST004165	Acute-on-chronic liver failure in hepatitis B	Acute-on-chronic liver failure in hepatitis B	Digestive system disorder
6097	GCST004097	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	Cancer
6098	GCST004097	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	Response to drug
6099	GCST004758	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6100	GCST004069	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
6101	GCST004069	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
6102	GCST004071	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
6103	GCST004071	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
6104	GCST004070	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
6105	GCST004070	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
6106	GCST004288	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
6107	GCST004288	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
6108	GCST004171	Macular telangiectasia type 2	Macular telangiectasia type 2	Neurological disorder
6109	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6110	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6111	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6112	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6113	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6114	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6115	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6116	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6117	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6118	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6119	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6120	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6121	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6122	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6123	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6124	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6125	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6126	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6127	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6128	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6129	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6130	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6131	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6132	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6133	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6134	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6135	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6136	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6137	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6138	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6139	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6140	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6141	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6142	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6143	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6144	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6145	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6146	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6147	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6148	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6149	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6150	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6151	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6152	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6153	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6154	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6155	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6156	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6157	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6158	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6159	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6160	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6161	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6162	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6163	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6164	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6165	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6166	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6167	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6168	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6169	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6170	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6171	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6172	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6173	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6174	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6175	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6176	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6177	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6178	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6179	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6180	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6181	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6182	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6183	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6184	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6185	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6186	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6187	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6188	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6189	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6190	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6191	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6192	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6193	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6194	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6195	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6196	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6197	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6198	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6199	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6200	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6201	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6202	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6203	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6204	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6205	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6206	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6207	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6208	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6209	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6210	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6211	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6212	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6213	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6214	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6215	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6216	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6217	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6218	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6219	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6220	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6221	GCST004365	Blood protein levels	Blood protein levels	Hematological measurement
6222	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6223	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6224	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6225	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6226	GCST004365	Blood protein levels	Blood protein levels	Lipid or lipoprotein measurement
6227	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6228	GCST004365	Blood protein levels	Blood protein levels	Hematological measurement
6229	GCST004365	Blood protein levels	Blood protein levels	Hematological measurement
6230	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6231	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6232	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6233	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6234	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6235	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6236	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6237	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6238	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6239	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6240	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6241	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6242	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6243	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6244	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6245	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6246	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6247	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6248	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6249	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6250	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6251	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6252	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6253	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6254	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6255	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6256	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6257	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6258	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6259	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6260	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6261	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6262	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6263	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6264	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6265	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6266	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6267	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6268	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6269	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6270	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6271	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6272	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6273	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6274	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6275	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6276	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6277	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6278	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6279	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6280	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6281	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6282	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6283	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6284	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6285	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6286	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6287	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6288	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6289	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6290	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6291	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6292	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6293	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6294	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6295	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6296	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6297	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6298	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6299	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6300	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6301	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6302	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6303	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6304	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6305	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6306	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6307	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6308	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6309	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6310	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6311	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6312	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6313	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6314	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6315	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6316	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6317	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6318	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6319	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6320	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6321	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6322	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6323	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6324	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6325	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6326	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6327	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6328	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6329	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6330	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6331	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6332	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6333	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6334	GCST004365	Blood protein levels	Blood protein levels	Hematological measurement
6335	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6336	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6337	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6338	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6339	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6340	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6341	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6342	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6343	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6344	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6345	GCST004365	Blood protein levels	Blood protein levels	Cardiovascular measurement
6346	GCST004365	Blood protein levels	Blood protein levels	Liver enzyme measurement
6347	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6348	GCST004365	Blood protein levels	Blood protein levels	Inflammatory measurement
6349	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6350	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6351	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6352	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6353	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6354	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6355	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6356	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6357	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6358	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6359	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6360	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6361	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6362	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6363	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6364	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6365	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6366	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6367	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6368	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6369	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6370	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6371	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6372	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6373	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6374	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6375	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6376	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6377	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6378	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6379	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6380	GCST004365	Blood protein levels	Blood protein levels	Inflammatory measurement
6381	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6382	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6383	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6384	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6385	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6386	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6387	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6388	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6389	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6390	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6391	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6392	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6393	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6394	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6395	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6396	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6397	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6398	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6399	GCST004365	Blood protein levels	Blood protein levels	Other measurement
6400	GCST004161	Vitamin B12 levels	Vitamin B12 levels	Other measurement
6401	GCST004166	Nonsyndromic cleft lip with cleft palate	Nonsyndromic cleft lip with cleft palate	Other trait
6402	GCST004166	Nonsyndromic cleft lip with cleft palate	Nonsyndromic cleft lip with cleft palate	Other trait
6403	GCST004068	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	Cardiovascular disease
6404	GCST004170	Monocyte-lymphocyte ratio	Monocyte-lymphocyte ratio	Hematological measurement
6405	GCST006661	Male-pattern baldness	Male-pattern baldness	Other measurement
6406	GCST006661	Male-pattern baldness	Male-pattern baldness	Other disease
6407	GCST006661	Male-pattern baldness	Male-pattern baldness	Other disease
6408	GCST004164	Monocyte count	Monocyte count	Hematological measurement
6409	GCST004158	Self-reported tiredness	Self-reported tiredness	Other measurement
6410	GCST004144	Thyroid cancer	Thyroid cancer	Cancer
6411	GCST004159	Serum galactose-deficient IgA1 levels	Serum galactose-deficient IgA1 levels	Other measurement
6412	GCST004146	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
6413	GCST004249	Alzheimer's disease in APOE e4- carriers	Alzheimer's disease in APOE e4- carriers	Neurological disorder
6414	GCST004248	Alzheimer's disease in APOE e4+ carriers	Alzheimer's disease in APOE e4+ carriers	Neurological disorder
6415	GCST004185	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
6416	GCST004247	Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease (APOE e4 interaction)	Neurological disorder
6417	GCST004247	Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease (APOE e4 interaction)	Other measurement
6418	GCST004184	Lung function (FVC)	Lung function (FVC)	Other measurement
6419	GCST004246	Alzheimer's disease	Alzheimer's disease	Neurological disorder
6420	GCST004147	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
6421	GCST004183	Lung function (FEV1)	Lung function (FEV1)	Other measurement
6422	GCST004108	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Other measurement
6423	GCST004108	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Other disease
6424	GCST004108	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Other measurement
6425	GCST004172	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
6426	GCST004173	Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)	Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)	Immune system disorder
6427	GCST004174	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Other measurement
6428	GCST004174	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Other measurement
6429	GCST004174	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Immune system disorder
6430	GCST004139	Bipolar disorder	Bipolar disorder	Neurological disorder
6431	GCST004136	Methadone dose in opioid dependence	Methadone dose in opioid dependence	Neurological disorder
6432	GCST004136	Methadone dose in opioid dependence	Methadone dose in opioid dependence	Other measurement
6433	GCST004096	Frontotemporal dementia (age at onset)	Frontotemporal dementia (age at onset)	Neurological disorder
6434	GCST004096	Frontotemporal dementia (age at onset)	Frontotemporal dementia (age at onset)	Other measurement
6435	GCST004099	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	Cancer
6436	GCST004099	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	Cancer
6437	GCST004099	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	Cancer
6438	GCST004122	Fibrinogen levels	Fibrinogen levels	Hematological measurement
6439	GCST004121	Fibrinogen levels	Fibrinogen levels	Hematological measurement
6440	GCST004072	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Other disease
6441	GCST004072	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Response to drug
6442	GCST004072	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Other disease
6443	GCST004162	Carotid plaque burden	Carotid plaque burden	Cardiovascular measurement
6444	GCST004528	HER2 status in breast cancer	HER2 status in breast cancer	Cancer
6445	GCST004528	HER2 status in breast cancer	HER2 status in breast cancer	Other measurement
6446	GCST004098	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Other trait
6447	GCST004098	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Other disease
6448	GCST004098	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Other measurement
6449	GCST004113	Basal cell carcinoma	Basal cell carcinoma	Cancer
6450	GCST004141	Body fat mass	Body fat mass	Other measurement
6451	GCST004142	Melanoma	Melanoma	Cancer
6452	GCST004180	Pediatric bone mineral content (hip)	Pediatric bone mineral content (hip)	Other measurement
6453	GCST004182	Pediatric bone mineral content (spine)	Pediatric bone mineral content (spine)	Other measurement
6454	GCST004175	Pediatric bone mineral content (radius)	Pediatric bone mineral content (radius)	Other measurement
6455	GCST004178	Pediatric bone mineral density (hip)	Pediatric bone mineral density (hip)	Other measurement
6456	GCST004177	Pediatric bone mineral density (femoral neck)	Pediatric bone mineral density (femoral neck)	Other measurement
6457	GCST004179	Pediatric bone mineral content (femoral neck)	Pediatric bone mineral content (femoral neck)	Other measurement
6458	GCST004181	Pediatric bone mineral density (spine)	Pediatric bone mineral density (spine)	Other measurement
6459	GCST004176	Pediatric areal bone mineral density (radius)	Pediatric areal bone mineral density (radius)	Other measurement
6460	GCST004109	Agoraphobic traits	Agoraphobic traits	Other measurement
6461	GCST004107	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Other measurement
6462	GCST004107	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Other disease
6463	GCST004107	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Other measurement
6464	GCST004123	Mathematical ability	Mathematical ability	Biological process
6465	GCST004138	Early-onset Parkinson's disease	Early-onset Parkinson's disease	Neurological disorder
6466	GCST004160	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Other measurement
6467	GCST004160	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Response to drug
6468	GCST004160	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Cancer
6469	GCST004126	White blood cell count	White blood cell count	Hematological measurement
6470	GCST004126	White blood cell count	White blood cell count	Inflammatory measurement
6471	GCST004126	White blood cell count	White blood cell count	Hematological measurement
6472	GCST004126	White blood cell count	White blood cell count	Hematological measurement
6473	GCST004126	White blood cell count	White blood cell count	Hematological measurement
6474	GCST004128	White blood cell count (neutrophil)	White blood cell count (neutrophil)	Hematological measurement
6475	GCST004129	White blood cell count (monocyte)	White blood cell count (monocyte)	Hematological measurement
6476	GCST004130	White blood cell count (lymphocyte)	White blood cell count (lymphocyte)	Hematological measurement
6477	GCST004135	White blood cell count (eosinophil)	White blood cell count (eosinophil)	Hematological measurement
6478	GCST004225	Alcohol misuse (trauma interaction)	Alcohol misuse (trauma interaction)	Other measurement
6479	GCST004225	Alcohol misuse (trauma interaction)	Alcohol misuse (trauma interaction)	Other measurement
6480	GCST005550	Post traumatic stress disorder symptom count in trauma-exposed individuals	Post traumatic stress disorder symptom count in trauma-exposed individuals	Other measurement
6481	GCST005550	Post traumatic stress disorder symptom count in trauma-exposed individuals	Post traumatic stress disorder symptom count in trauma-exposed individuals	Biological process
6482	GCST004143	Hypertension	Hypertension	Cardiovascular disease
6483	GCST004201	Gallbladder cancer	Gallbladder cancer	Cancer
6484	GCST004252	Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	Neurological disorder
6485	GCST004252	Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	Neurological disorder
6486	GCST004199	Osteoarthritis (with total hip replacement)	Osteoarthritis (with total hip replacement)	Other disease
6487	GCST004199	Osteoarthritis (with total hip replacement)	Osteoarthritis (with total hip replacement)	Other measurement
6488	GCST004289	Adiponectin levels in pregnancy	Adiponectin levels in pregnancy	Other measurement
6489	GCST004200	High-altitude pulmonary edema	High-altitude pulmonary edema	Other disease
6490	GCST004132	Crohn's disease	Crohn's disease	Digestive system disorder
6491	GCST004053	Poor prognosis in Crohn's disease	Poor prognosis in Crohn's disease	Digestive system disorder
6492	GCST004053	Poor prognosis in Crohn's disease	Poor prognosis in Crohn's disease	Other measurement
6493	GCST004131	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
6494	GCST004131	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
6495	GCST004131	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
6496	GCST004133	Ulcerative colitis	Ulcerative colitis	Immune system disorder
6497	GCST004120	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
6498	GCST004120	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
6499	GCST004091	Palmar length-width ratio in Kashin-Beck disease	Palmar length-width ratio in Kashin-Beck disease	Other disease
6500	GCST004119	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
6501	GCST004125	Type 2 diabetes (age of onset)	Type 2 diabetes (age of onset)	Metabolic disorder
6502	GCST004250	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Liver enzyme measurement
6503	GCST004250	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Cancer
6504	GCST004250	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Response to drug
6505	GCST004095	Takotsubo syndrome	Takotsubo syndrome	Cardiovascular disease
6506	GCST004088	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
6507	GCST004088	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
6508	GCST004049	Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough in response to angiotensin-converting enzyme inhibitor drugs	Other trait
6509	GCST004049	Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough in response to angiotensin-converting enzyme inhibitor drugs	Response to drug
6510	GCST004089	Cleft palate	Cleft palate	Other trait
6511	GCST006119	Protein C levels	Protein C levels	Hematological measurement
6512	GCST004134	Multiple keratinocyte cancers	Multiple keratinocyte cancers	Cancer
6513	GCST004134	Multiple keratinocyte cancers	Multiple keratinocyte cancers	Cancer
6514	GCST004134	Multiple keratinocyte cancers	Multiple keratinocyte cancers	Other measurement
6515	GCST004034	Temporomandibular joint disorder	Temporomandibular joint disorder	Other disease
6516	GCST003881	Peanut allergy	Peanut allergy	Other measurement
6517	GCST003977	Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase	Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase	Immune system disorder
6518	GCST003902	Fast beta electroencephalogram	Fast beta electroencephalogram	Other measurement
6519	GCST003902	Fast beta electroencephalogram	Fast beta electroencephalogram	Other measurement
6520	GCST003976	Antineutrophil cytoplasmic antibody-associated vasculitis	Antineutrophil cytoplasmic antibody-associated vasculitis	Immune system disorder
6521	GCST003978	Vasculitis associated with antineutrophil cytoplasmic antibody reactive to proteinase-3	Vasculitis associated with antineutrophil cytoplasmic antibody reactive to proteinase-3	Immune system disorder
6522	GCST004028	Immunoglobulin light chain (AL) amyloidosis	Immunoglobulin light chain (AL) amyloidosis	Metabolic disorder
6523	GCST004012	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
6524	GCST004114	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Other disease
6525	GCST004114	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Digestive system disorder
6526	GCST004114	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Response to drug
6527	GCST004145	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
6528	GCST004145	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
6529	GCST004090	Lichen planus in hepatitis C	Lichen planus in hepatitis C	Other disease
6530	GCST004090	Lichen planus in hepatitis C	Lichen planus in hepatitis C	Digestive system disorder
6531	GCST004118	Nevirapine-induced hypersensitivity in HIV	Nevirapine-induced hypersensitivity in HIV	Other disease
6532	GCST004118	Nevirapine-induced hypersensitivity in HIV	Nevirapine-induced hypersensitivity in HIV	Immune system disorder
6533	GCST004118	Nevirapine-induced hypersensitivity in HIV	Nevirapine-induced hypersensitivity in HIV	Response to drug
6534	GCST004117	Nevirapine-induced hypersensitivity in HIV (rash)	Nevirapine-induced hypersensitivity in HIV (rash)	Other disease
6535	GCST004117	Nevirapine-induced hypersensitivity in HIV (rash)	Nevirapine-induced hypersensitivity in HIV (rash)	Response to drug
6536	GCST004117	Nevirapine-induced hypersensitivity in HIV (rash)	Nevirapine-induced hypersensitivity in HIV (rash)	Other disease
6537	GCST004116	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Other disease
6538	GCST004116	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Immune system disorder
6539	GCST004116	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Response to drug
6540	GCST004115	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Other disease
6541	GCST004115	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Other disease
6542	GCST004115	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Other disease
6543	GCST004115	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Response to drug
6544	GCST004050	Cleft lip with or without cleft palate	Cleft lip with or without cleft palate	Other trait
6545	GCST004050	Cleft lip with or without cleft palate	Cleft lip with or without cleft palate	Other trait
6546	GCST004051	Orofacial clefts	Orofacial clefts	Other trait
6547	GCST004051	Orofacial clefts	Orofacial clefts	Other measurement
6548	GCST004051	Orofacial clefts	Orofacial clefts	Other disease
6549	GCST004051	Orofacial clefts	Orofacial clefts	Other trait
6550	GCST004060	Exhaled nitric oxide output	Exhaled nitric oxide output	Other measurement
6551	GCST004059	Exhaled nitric oxide levels	Exhaled nitric oxide levels	Other measurement
6552	GCST004092	Plasma t-tau levels	Plasma t-tau levels	Other measurement
6553	GCST003961	Hippocampal volume	Hippocampal volume	Other measurement
6554	GCST004054	Glomerular load of uric acid	Glomerular load of uric acid	Cardiovascular measurement
6555	GCST004077	Cognitive function	Cognitive function	Biological process
6556	GCST004077	Cognitive function	Cognitive function	Biological process
6557	GCST004077	Cognitive function	Cognitive function	Other measurement
6558	GCST004077	Cognitive function	Cognitive function	Biological process
6559	GCST004056	Urinary uric acid to urinary creatinine ratio	Urinary uric acid to urinary creatinine ratio	Other measurement
6560	GCST004057	Creatinine clearance	Creatinine clearance	Other measurement
6561	GCST004055	Fractional excretion of uric acid	Fractional excretion of uric acid	Cardiovascular measurement
6562	GCST004058	Uric acid clearance	Uric acid clearance	Cardiovascular measurement
6563	GCST003928	Giant cell arteritis	Giant cell arteritis	Cardiovascular disease
6564	GCST004062	Sjgren's syndrome	Sjgren's syndrome	Neurological disorder
6565	GCST004061	Sjgren's syndrome	Sjgren's syndrome	Neurological disorder
6566	GCST004073	Cough	Cough	Other measurement
6567	GCST004048	Fast beta electroencephalogram	Fast beta electroencephalogram	Other measurement
6568	GCST004048	Fast beta electroencephalogram	Fast beta electroencephalogram	Other measurement
6569	GCST003962	Bipolar disorder	Bipolar disorder	Neurological disorder
6570	GCST004112	Dyspnea	Dyspnea	Other measurement
6571	GCST004111	Phlegm	Phlegm	Other measurement
6572	GCST004052	Cleft palate	Cleft palate	Other trait
6573	GCST004035	NHDL cholesterol to HDL cholesterol ratio	NHDL cholesterol to HDL cholesterol ratio	Lipid or lipoprotein measurement
6574	GCST004019	Behcet's disease	Behcet's disease	Cardiovascular disease
6575	GCST004037	Triglyceride to HDL cholesterol ratio	Triglyceride to HDL cholesterol ratio	Lipid or lipoprotein measurement
6576	GCST004036	LDL cholesterol to HDL cholesterol ratio	LDL cholesterol to HDL cholesterol ratio	Lipid or lipoprotein measurement
6577	GCST004163	Resistance to antihypertensive treatment in hypertension	Resistance to antihypertensive treatment in hypertension	Cardiovascular disease
6578	GCST004047	Optic nerve measurement (cup-to-disc ratio)	Optic nerve measurement (cup-to-disc ratio)	Other measurement
6579	GCST004047	Optic nerve measurement (cup-to-disc ratio)	Optic nerve measurement (cup-to-disc ratio)	Other measurement
6580	GCST004900	Migraine without aura	Migraine without aura	Cardiovascular disease
6581	GCST004900	Migraine without aura	Migraine without aura	Cardiovascular disease
6582	GCST003964	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Response to drug
6583	GCST003964	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Neurological disorder
6584	GCST003964	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Cancer
6585	GCST003974	Tonsillectomy	Tonsillectomy	Other measurement
6586	GCST003878	Heroin dependence	Heroin dependence	Neurological disorder
6587	GCST003922	Parkinson's disease	Parkinson's disease	Neurological disorder
6588	GCST004038	Circulating chromogranin peptide levels	Circulating chromogranin peptide levels	Other measurement
6589	GCST004038	Circulating chromogranin peptide levels	Circulating chromogranin peptide levels	Other measurement
6590	GCST003940	Trans-epidermal water loss	Trans-epidermal water loss	Other measurement
6591	GCST003901	Cognitive decline (age-related)	Cognitive decline (age-related)	Other trait
6592	GCST004023	Ischemic stroke	Ischemic stroke	Cardiovascular disease
6593	GCST004023	Ischemic stroke	Ischemic stroke	Other trait
6594	GCST004022	Large artery stroke	Large artery stroke	Cardiovascular disease
6595	GCST004020	Small vessel stroke	Small vessel stroke	Cardiovascular disease
6596	GCST004021	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
6597	GCST004021	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
6598	GCST004021	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
6599	GCST003979	Excessive daytime sleepiness	Excessive daytime sleepiness	Other measurement
6600	GCST003939	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Cardiovascular disease
6601	GCST003939	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Cancer
6602	GCST003939	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Response to drug
6603	GCST003939	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Response to drug
6604	GCST003981	Insomnia	Insomnia	Neurological disorder
6605	GCST003981	Insomnia	Insomnia	Other measurement
6606	GCST004030	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
6607	GCST003982	Sleep traits (multi-trait analysis)	Sleep traits (multi-trait analysis)	Biological process
6608	GCST003982	Sleep traits (multi-trait analysis)	Sleep traits (multi-trait analysis)	Other measurement
6609	GCST003982	Sleep traits (multi-trait analysis)	Sleep traits (multi-trait analysis)	Other measurement
6610	GCST003982	Sleep traits (multi-trait analysis)	Sleep traits (multi-trait analysis)	Other measurement
6611	GCST003980	Sleep duration	Sleep duration	Other measurement
6612	GCST004015	Extraversion	Extraversion	Biological process
6613	GCST004015	Extraversion	Extraversion	Other measurement
6614	GCST004014	Conscientiousness	Conscientiousness	Other measurement
6615	GCST004013	Agreeableness	Agreeableness	Other measurement
6616	GCST003929	Urinary electrolytes (magnesium/calcium ratio)	Urinary electrolytes (magnesium/calcium ratio)	Other measurement
6617	GCST003975	Childhood onset asthma (traffic air pollution exposure interaction)	Childhood onset asthma (traffic air pollution exposure interaction)	Other disease
6618	GCST003975	Childhood onset asthma (traffic air pollution exposure interaction)	Childhood onset asthma (traffic air pollution exposure interaction)	Other measurement
6619	GCST003877	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
6620	GCST003899	Response to clopidogrel therapy in coronary heart disease	Response to clopidogrel therapy in coronary heart disease	Cardiovascular disease
6621	GCST003899	Response to clopidogrel therapy in coronary heart disease	Response to clopidogrel therapy in coronary heart disease	Cardiovascular measurement
6622	GCST003899	Response to clopidogrel therapy in coronary heart disease	Response to clopidogrel therapy in coronary heart disease	Response to drug
6623	GCST004009	Leprosy	Leprosy	Neurological disorder
6624	GCST003918	Idiopathic osteonecrosis of the femoral head	Idiopathic osteonecrosis of the femoral head	Other disease
6625	GCST003900	Cluster headache	Cluster headache	Other measurement
6626	GCST003900	Cluster headache	Cluster headache	Other trait
6627	GCST004024	Depressive symptom measurement or major depressive disorder	Depressive symptom measurement or major depressive disorder	Neurological disorder
6628	GCST004024	Depressive symptom measurement or major depressive disorder	Depressive symptom measurement or major depressive disorder	Other measurement
6629	GCST004025	Systemic juvenile idiopathic arthritis	Systemic juvenile idiopathic arthritis	Immune system disorder
6630	GCST003879	Serum parathyroid hormone levels	Serum parathyroid hormone levels	Other measurement
6631	GCST003880	Schizophrenia	Schizophrenia	Neurological disorder
6632	GCST004016	Openness	Openness	Other measurement
6633	GCST004017	Neuroticism	Neuroticism	Neurological disorder
6634	GCST004017	Neuroticism	Neuroticism	Other measurement
6635	GCST004198	Severe gingival inflammation	Severe gingival inflammation	Other trait
6636	GCST003766	Subjective well-being	Subjective well-being	Other measurement
6637	GCST003770	Neuroticism	Neuroticism	Neurological disorder
6638	GCST003770	Neuroticism	Neuroticism	Other measurement
6639	GCST003769	Depression	Depression	Neurological disorder
6640	GCST003769	Depression	Depression	Other measurement
6641	GCST003420	Colorectal cancer	Colorectal cancer	Cancer
6642	GCST003768	Positive affect	Positive affect	Other measurement
6643	GCST003767	Life satisfaction	Life satisfaction	Other measurement
6644	GCST003725	Gallstone disease	Gallstone disease	Digestive system disorder
6645	GCST003725	Gallstone disease	Gallstone disease	Digestive system disorder
6646	GCST003674	Obstructive sleep apnea trait (apnea hypopnea index)	Obstructive sleep apnea trait (apnea hypopnea index)	Other measurement
6647	GCST003674	Obstructive sleep apnea trait (apnea hypopnea index)	Obstructive sleep apnea trait (apnea hypopnea index)	Neurological disorder
6648	GCST003675	Obstructive sleep apnea trait (average respiratory event duration)	Obstructive sleep apnea trait (average respiratory event duration)	Other measurement
6649	GCST003675	Obstructive sleep apnea trait (average respiratory event duration)	Obstructive sleep apnea trait (average respiratory event duration)	Neurological disorder
6650	GCST003673	Obstructive sleep apnea (average oxygen saturation during sleep)	Obstructive sleep apnea (average oxygen saturation during sleep)	Other measurement
6651	GCST003673	Obstructive sleep apnea (average oxygen saturation during sleep)	Obstructive sleep apnea (average oxygen saturation during sleep)	Neurological disorder
6652	GCST003452	Posterior cortical atrophy and Alzheimer's disease	Posterior cortical atrophy and Alzheimer's disease	Neurological disorder
6653	GCST003452	Posterior cortical atrophy and Alzheimer's disease	Posterior cortical atrophy and Alzheimer's disease	Neurological disorder
6654	GCST003445	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Immune system disorder
6655	GCST003445	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Immune system disorder
6656	GCST003445	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Response to drug
6657	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Immune system disorder
6658	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Digestive system disorder
6659	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Digestive system disorder
6660	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Immune system disorder
6661	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Immune system disorder
6662	GCST003671	Diastolic blood pressure	Diastolic blood pressure	Other measurement
6663	GCST003671	Diastolic blood pressure	Diastolic blood pressure	Other measurement
6664	GCST003670	Systolic blood pressure	Systolic blood pressure	Other measurement
6665	GCST003670	Systolic blood pressure	Systolic blood pressure	Other measurement
6666	GCST006802	Body mass index	Body mass index	Body measurement
6667	GCST006802	Body mass index	Body mass index	Body measurement
6668	GCST006802	Body mass index	Body mass index	Other measurement
6669	GCST006801	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6670	GCST003426	Drug-induced liver injury	Drug-induced liver injury	Response to drug
6671	GCST003426	Drug-induced liver injury	Drug-induced liver injury	Digestive system disorder
6672	GCST003454	Morning vs. evening chronotype	Morning vs. evening chronotype	Biological process
6673	GCST003483	S-phenylmercapturic acid levels in smokers	S-phenylmercapturic acid levels in smokers	Biological process
6674	GCST003483	S-phenylmercapturic acid levels in smokers	S-phenylmercapturic acid levels in smokers	Other measurement
6675	GCST003468	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
6676	GCST003453	Chronotype	Chronotype	Biological process
6677	GCST003453	Chronotype	Chronotype	Other measurement
6678	GCST003419	Congenital left-sided heart lesions	Congenital left-sided heart lesions	Cardiovascular disease
6679	GCST003493	Ischemic stroke (non-cardioembolic)	Ischemic stroke (non-cardioembolic)	Other trait
6680	GCST003490	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
6681	GCST003490	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
6682	GCST003490	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
6683	GCST003497	Memory performance	Memory performance	Other measurement
6684	GCST003499	Reaction time	Reaction time	Other measurement
6685	GCST003437	Discordance in emotional problems in monozygotic twins	Discordance in emotional problems in monozygotic twins	Other measurement
6686	GCST003496	Educational attainment	Educational attainment	Other measurement
6687	GCST003498	Verbal-numerical reasoning	Verbal-numerical reasoning	Biological process
6688	GCST003467	Glaucoma (primary angle closure)	Glaucoma (primary angle closure)	Neurological disorder
6689	GCST003467	Glaucoma (primary angle closure)	Glaucoma (primary angle closure)	Neurological disorder
6690	GCST003661	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
6691	GCST004482	Peripheral arterial disease (traffic-related air pollution interaction)	Peripheral arterial disease (traffic-related air pollution interaction)	Cardiovascular disease
6692	GCST004482	Peripheral arterial disease (traffic-related air pollution interaction)	Peripheral arterial disease (traffic-related air pollution interaction)	Other measurement
6693	GCST003447	Neuroticism	Neuroticism	Neurological disorder
6694	GCST003447	Neuroticism	Neuroticism	Other measurement
6695	GCST003418	Skin fluorescence in type 1 diabetes	Skin fluorescence in type 1 diabetes	Metabolic disorder
6696	GCST003418	Skin fluorescence in type 1 diabetes	Skin fluorescence in type 1 diabetes	Other measurement
6697	GCST003421	Mosaic loss of chromosome Y	Mosaic loss of chromosome Y	Other measurement
6698	GCST003438	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Response to drug
6699	GCST003438	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Neurological disorder
6700	GCST003438	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Cancer
6701	GCST003492	Ischemic stroke	Ischemic stroke	Cardiovascular disease
6702	GCST003492	Ischemic stroke	Ischemic stroke	Other trait
6703	GCST003491	Stroke	Stroke	Cardiovascular disease
6704	GCST003660	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
6705	GCST003663	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
6706	GCST003662	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
6707	GCST003662	LDL cholesterol	LDL cholesterol	Other measurement
6708	GCST003662	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
6709	GCST005078	Mortality	Mortality	Other measurement
6710	GCST003465	Cannabis dependence symptom count	Cannabis dependence symptom count	Other measurement
6711	GCST003455	Spherical equivalent (joint analysis main effects and education interaction)	Spherical equivalent (joint analysis main effects and education interaction)	Other measurement
6712	GCST003455	Spherical equivalent (joint analysis main effects and education interaction)	Spherical equivalent (joint analysis main effects and education interaction)	Other measurement
6713	GCST003472	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Neurological disorder
6714	GCST003472	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Other measurement
6715	GCST003382	Cannabis use	Cannabis use	Biological process
6716	GCST003399	Cognitive impairment (brain beta-amyloid deposition interaction)	Cognitive impairment (brain beta-amyloid deposition interaction)	Other measurement
6717	GCST003399	Cognitive impairment (brain beta-amyloid deposition interaction)	Cognitive impairment (brain beta-amyloid deposition interaction)	Other trait
6718	GCST003473	Aggressiveness in attention deficit hyperactivity disorder	Aggressiveness in attention deficit hyperactivity disorder	Neurological disorder
6719	GCST003473	Aggressiveness in attention deficit hyperactivity disorder	Aggressiveness in attention deficit hyperactivity disorder	Other measurement
6720	GCST003473	Aggressiveness in attention deficit hyperactivity disorder	Aggressiveness in attention deficit hyperactivity disorder	Other measurement
6721	GCST006251	High fetal hemoglobin in sickle cell disease	High fetal hemoglobin in sickle cell disease	Hematological measurement
6722	GCST006251	High fetal hemoglobin in sickle cell disease	High fetal hemoglobin in sickle cell disease	Other disease
6723	GCST003396	Developmental language disorder	Developmental language disorder	Neurological disorder
6724	GCST003398	Developmental language disorder (syntactic complexity)	Developmental language disorder (syntactic complexity)	Other measurement
6725	GCST003398	Developmental language disorder (syntactic complexity)	Developmental language disorder (syntactic complexity)	Neurological disorder
6726	GCST003397	Developmental language disorder (linguistic errors)	Developmental language disorder (linguistic errors)	Other measurement
6727	GCST003397	Developmental language disorder (linguistic errors)	Developmental language disorder (linguistic errors)	Neurological disorder
6728	GCST003424	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
6729	GCST003446	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
6730	GCST003667	Depressive symptoms measurement (somatic complaints domain)	Depressive symptoms measurement (somatic complaints domain)	Other measurement
6731	GCST003668	Depressive symptoms measurement (lack of positive affect domain)	Depressive symptoms measurement (lack of positive affect domain)	Other measurement
6732	GCST003669	Depressive symptoms measurement (lack of negative affect domain)	Depressive symptoms measurement (lack of negative affect domain)	Other measurement
6733	GCST003607	knee peak torque response	knee peak torque response	Other measurement
6734	GCST003608	Maximal oxygen uptake response	Maximal oxygen uptake response	Other measurement
6735	GCST003469	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Other trait
6736	GCST003469	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Neurological disorder
6737	GCST003436	Endometrial cancer	Endometrial cancer	Cancer
6738	GCST003436	Endometrial cancer	Endometrial cancer	Cancer
6739	GCST003665	Metabolite levels (lipoprotein measures)	Metabolite levels (lipoprotein measures)	Other measurement
6740	GCST003665	Metabolite levels (lipoprotein measures)	Metabolite levels (lipoprotein measures)	Other measurement
6741	GCST003666	Metabolite levels (small molecules and protein measures)	Metabolite levels (small molecules and protein measures)	Other measurement
6742	GCST003666	Metabolite levels (small molecules and protein measures)	Metabolite levels (small molecules and protein measures)	Other measurement
6743	GCST003666	Metabolite levels (small molecules and protein measures)	Metabolite levels (small molecules and protein measures)	Other measurement
6744	GCST003664	Metabolite levels (lipid measures)	Metabolite levels (lipid measures)	Other measurement
6745	GCST003664	Metabolite levels (lipid measures)	Metabolite levels (lipid measures)	Other measurement
6746	GCST003856	Central corneal thickness	Central corneal thickness	Other measurement
6747	GCST003856	Central corneal thickness	Central corneal thickness	Other measurement
6748	GCST003943	Hepcidin levels	Hepcidin levels	Other measurement
6749	GCST003944	Hepcidin/ferritin ratio	Hepcidin/ferritin ratio	Other measurement
6750	GCST003945	Hepcidin/transferrin saturation ratio	Hepcidin/transferrin saturation ratio	Other measurement
6751	GCST006078	Branched-chain amino acid levels (Valine)	Branched-chain amino acid levels (Valine)	Other measurement
6752	GCST006076	Branched-chain amino acid levels (Leucine)	Branched-chain amino acid levels (Leucine)	Other measurement
6753	GCST006077	Branched-chain amino acid levels (Isoleucine)	Branched-chain amino acid levels (Isoleucine)	Other measurement
6754	GCST004026	Alcohol consumption	Alcohol consumption	Biological process
6755	GCST004026	Alcohol consumption	Alcohol consumption	Other measurement
6756	GCST004027	Alcohol consumption (heavy vs. light/non-drinkers)	Alcohol consumption (heavy vs. light/non-drinkers)	Other measurement
6757	GCST004000	Cerebrospinal fluid biomarker levels	Cerebrospinal fluid biomarker levels	Other measurement
6758	GCST004040	Response to paliperidone in schizophrenia (positive Marder score)	Response to paliperidone in schizophrenia (positive Marder score)	Neurological disorder
6759	GCST004040	Response to paliperidone in schizophrenia (positive Marder score)	Response to paliperidone in schizophrenia (positive Marder score)	Other measurement
6760	GCST004040	Response to paliperidone in schizophrenia (positive Marder score)	Response to paliperidone in schizophrenia (positive Marder score)	Response to drug
6761	GCST003923	DDT metabolite (p,p'-DDE levels)	DDT metabolite (p,p'-DDE levels)	Other measurement
6762	GCST004039	Response to paliperidone in schizophrenia (CGI-S score)	Response to paliperidone in schizophrenia (CGI-S score)	Neurological disorder
6763	GCST004039	Response to paliperidone in schizophrenia (CGI-S score)	Response to paliperidone in schizophrenia (CGI-S score)	Other measurement
6764	GCST004039	Response to paliperidone in schizophrenia (CGI-S score)	Response to paliperidone in schizophrenia (CGI-S score)	Response to drug
6765	GCST004043	Response to paliperidone in schizophrenia (Multivariate)	Response to paliperidone in schizophrenia (Multivariate)	Neurological disorder
6766	GCST004043	Response to paliperidone in schizophrenia (Multivariate)	Response to paliperidone in schizophrenia (Multivariate)	Other measurement
6767	GCST004043	Response to paliperidone in schizophrenia (Multivariate)	Response to paliperidone in schizophrenia (Multivariate)	Response to drug
6768	GCST004042	Response to paliperidone in schizophrenia (PANSS score)	Response to paliperidone in schizophrenia (PANSS score)	Neurological disorder
6769	GCST004042	Response to paliperidone in schizophrenia (PANSS score)	Response to paliperidone in schizophrenia (PANSS score)	Other measurement
6770	GCST004042	Response to paliperidone in schizophrenia (PANSS score)	Response to paliperidone in schizophrenia (PANSS score)	Response to drug
6771	GCST004041	Response to paliperidone in schizophrenia (negative Marder score)	Response to paliperidone in schizophrenia (negative Marder score)	Neurological disorder
6772	GCST004041	Response to paliperidone in schizophrenia (negative Marder score)	Response to paliperidone in schizophrenia (negative Marder score)	Other measurement
6773	GCST004041	Response to paliperidone in schizophrenia (negative Marder score)	Response to paliperidone in schizophrenia (negative Marder score)	Response to drug
6774	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
6775	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
6776	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Cardiovascular measurement
6777	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
6778	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Lipid or lipoprotein measurement
6779	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Other measurement
6780	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
6781	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
6782	GCST003805	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Other measurement
6783	GCST003805	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Response to drug
6784	GCST003805	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Cardiovascular disease
6785	GCST006045	Age at first birth	Age at first birth	Other measurement
6786	GCST006044	Age at first birth	Age at first birth	Other measurement
6787	GCST006047	Number of children ever born	Number of children ever born	Other measurement
6788	GCST006046	Number of children ever born	Number of children ever born	Other measurement
6789	GCST003795	Age at first birth	Age at first birth	Other measurement
6790	GCST003818	Resting heart rate	Resting heart rate	Cardiovascular measurement
6791	GCST003807	Systolic blood pressure response to hydrochlorothiazide in hypertension	Systolic blood pressure response to hydrochlorothiazide in hypertension	Other measurement
6792	GCST003807	Systolic blood pressure response to hydrochlorothiazide in hypertension	Systolic blood pressure response to hydrochlorothiazide in hypertension	Response to drug
6793	GCST003807	Systolic blood pressure response to hydrochlorothiazide in hypertension	Systolic blood pressure response to hydrochlorothiazide in hypertension	Cardiovascular disease
6794	GCST003796	Number of children ever born	Number of children ever born	Other measurement
6795	GCST003830	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Other disease
6796	GCST003830	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Response to drug
6797	GCST003830	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Other measurement
6798	GCST005547	Major depressive disorder	Major depressive disorder	Neurological disorder
6799	GCST003841	Thiopurine S-methyltransferase activity	Thiopurine S-methyltransferase activity	Other measurement
6800	GCST003762	Essential tremor	Essential tremor	Other trait
6801	GCST003815	Late-onset Alzheimer's disease	Late-onset Alzheimer's disease	Neurological disorder
6802	GCST003763	Age-related hearing impairment	Age-related hearing impairment	Neurological disorder
6803	GCST003869	Sciatica	Sciatica	Other trait
6804	GCST004002	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	Neurological disorder
6805	GCST004002	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	Neurological disorder
6806	GCST003825	Systolic blood pressure change trajectories	Systolic blood pressure change trajectories	Other measurement
6807	GCST004001	Bipolar disorder or attention deficit hyperactivity disorder	Bipolar disorder or attention deficit hyperactivity disorder	Neurological disorder
6808	GCST004001	Bipolar disorder or attention deficit hyperactivity disorder	Bipolar disorder or attention deficit hyperactivity disorder	Neurological disorder
6809	GCST004018	Atrial fibrillation (SNPxSNP interaction)	Atrial fibrillation (SNPxSNP interaction)	Cardiovascular disease
6810	GCST003882	Parental longevity (at least one long-lived parent)	Parental longevity (at least one long-lived parent)	Other measurement
6811	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Other measurement
6812	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cardiovascular disease
6813	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cancer
6814	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cardiovascular disease
6815	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cardiovascular disease
6816	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cardiovascular disease
6817	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Metabolic disorder
6818	GCST007156	Social deprivation	Social deprivation	Other trait
6819	GCST007155	Household income	Household income	Other trait
6820	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Hematological measurement
6821	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Body measurement
6822	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Lipid or lipoprotein measurement
6823	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Other measurement
6824	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Other measurement
6825	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Lipid or lipoprotein measurement
6826	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Lipid or lipoprotein measurement
6827	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Cardiovascular measurement
6828	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Other measurement
6829	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Hematological measurement
6830	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Body measurement
6831	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Other measurement
6832	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular disease
6833	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cancer
6834	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular disease
6835	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular disease
6836	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Lipid or lipoprotein measurement
6837	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Other measurement
6838	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Other measurement
6839	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Lipid or lipoprotein measurement
6840	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Lipid or lipoprotein measurement
6841	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular measurement
6842	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Other measurement
6843	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular disease
6844	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Metabolic disorder
6845	GCST004785	Vitiligo	Vitiligo	Immune system disorder
6846	GCST003927	Dysmenorrheic pain	Dysmenorrheic pain	Other measurement
6847	GCST003853	Hip minimal joint space width	Hip minimal joint space width	Other measurement
6848	GCST003764	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
6849	GCST003798	Acute lymphoblastic leukemia in childhood (B cell precursor)	Acute lymphoblastic leukemia in childhood (B cell precursor)	Cancer
6850	GCST003855	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
6851	GCST003855	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
6852	GCST003834	Intracranial volume	Intracranial volume	Other measurement
6853	GCST003854	Gut microbiota (functional units)	Gut microbiota (functional units)	Other measurement
6854	GCST003857	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
6855	GCST003857	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
6856	GCST003857	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
6857	GCST003858	Oral cavity cancer	Oral cavity cancer	Cancer
6858	GCST003859	Oropharynx cancer	Oropharynx cancer	Cancer
6859	GCST003821	Estrogen receptor status in breast cancer	Estrogen receptor status in breast cancer	Cancer
6860	GCST003821	Estrogen receptor status in breast cancer	Estrogen receptor status in breast cancer	Other measurement
6861	GCST003843	Petaloid toenail	Petaloid toenail	Other trait
6862	GCST003823	Estrogen receptor status in HER2 negative breast cancer	Estrogen receptor status in HER2 negative breast cancer	Cancer
6863	GCST003823	Estrogen receptor status in HER2 negative breast cancer	Estrogen receptor status in HER2 negative breast cancer	Other measurement
6864	GCST003823	Estrogen receptor status in HER2 negative breast cancer	Estrogen receptor status in HER2 negative breast cancer	Other measurement
6865	GCST003822	Estrogen receptor status in HER2 positive breast cancer	Estrogen receptor status in HER2 positive breast cancer	Cancer
6866	GCST003822	Estrogen receptor status in HER2 positive breast cancer	Estrogen receptor status in HER2 positive breast cancer	Other measurement
6867	GCST003822	Estrogen receptor status in HER2 positive breast cancer	Estrogen receptor status in HER2 positive breast cancer	Other measurement
6868	GCST003876	Gut microbiota (beta diversity)	Gut microbiota (beta diversity)	Other measurement
6869	GCST003875	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
6870	GCST003875	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
6871	GCST003874	Colorectal cancer (smoking interaction)	Colorectal cancer (smoking interaction)	Other measurement
6872	GCST003874	Colorectal cancer (smoking interaction)	Colorectal cancer (smoking interaction)	Cancer
6873	GCST003873	Colorectal cancer (alcohol consumption interaction)	Colorectal cancer (alcohol consumption interaction)	Cancer
6874	GCST003873	Colorectal cancer (alcohol consumption interaction)	Colorectal cancer (alcohol consumption interaction)	Other measurement
6875	GCST003824	Depression in response to interferon-based therapy in chronic hepatitis C	Depression in response to interferon-based therapy in chronic hepatitis C	Response to drug
6876	GCST003824	Depression in response to interferon-based therapy in chronic hepatitis C	Depression in response to interferon-based therapy in chronic hepatitis C	Digestive system disorder
6877	GCST003824	Depression in response to interferon-based therapy in chronic hepatitis C	Depression in response to interferon-based therapy in chronic hepatitis C	Other measurement
6878	GCST003814	Selective IgA deficiency	Selective IgA deficiency	Immune system disorder
6879	GCST003816	Breast cancer-free interval (treatment with aromatase inhibitor)	Breast cancer-free interval (treatment with aromatase inhibitor)	Cancer
6880	GCST003816	Breast cancer-free interval (treatment with aromatase inhibitor)	Breast cancer-free interval (treatment with aromatase inhibitor)	Response to drug
6881	GCST003816	Breast cancer-free interval (treatment with aromatase inhibitor)	Breast cancer-free interval (treatment with aromatase inhibitor)	Other measurement
6882	GCST003868	Job-related exhaustion in shift workers	Job-related exhaustion in shift workers	Other measurement
6883	GCST003852	Response to dendritic cell-based immunotherapy in HIV infection	Response to dendritic cell-based immunotherapy in HIV infection	Other disease
6884	GCST003852	Response to dendritic cell-based immunotherapy in HIV infection	Response to dendritic cell-based immunotherapy in HIV infection	Response to drug
6885	GCST006023	Hypertension	Hypertension	Cardiovascular disease
6886	GCST006022	Pulse pressure	Pulse pressure	Cardiovascular measurement
6887	GCST006021	Systolic blood pressure	Systolic blood pressure	Other measurement
6888	GCST006021	Systolic blood pressure	Systolic blood pressure	Other measurement
6889	GCST006020	Diastolic blood pressure	Diastolic blood pressure	Other measurement
6890	GCST006020	Diastolic blood pressure	Diastolic blood pressure	Other measurement
6891	GCST003820	Knee osteoarthritis	Knee osteoarthritis	Other disease
6892	GCST003742	Bipolar disorder (early onset)	Bipolar disorder (early onset)	Neurological disorder
6893	GCST003760	Pre-treatment pain in head and neck squamous cell carcinoma	Pre-treatment pain in head and neck squamous cell carcinoma	Other trait
6894	GCST003760	Pre-treatment pain in head and neck squamous cell carcinoma	Pre-treatment pain in head and neck squamous cell carcinoma	Cancer
6895	GCST003870	QRS complex (Sokolow-Lyon)	QRS complex (Sokolow-Lyon)	Cardiovascular measurement
6896	GCST003870	QRS complex (Sokolow-Lyon)	QRS complex (Sokolow-Lyon)	Cardiovascular measurement
6897	GCST003871	QRS complex (Cornell)	QRS complex (Cornell)	Cardiovascular measurement
6898	GCST003871	QRS complex (Cornell)	QRS complex (Cornell)	Cardiovascular measurement
6899	GCST003872	QRS complex (12-leadsum)	QRS complex (12-leadsum)	Cardiovascular measurement
6900	GCST003872	QRS complex (12-leadsum)	QRS complex (12-leadsum)	Cardiovascular measurement
6901	GCST003844	QRS duration	QRS duration	Cardiovascular measurement
6902	GCST003844	QRS duration	QRS duration	Cardiovascular measurement
6903	GCST003844	QRS duration	QRS duration	Cardiovascular measurement
6904	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Response to drug
6905	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Response to drug
6906	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Response to drug
6907	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Cardiovascular disease
6908	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Metabolic disorder
6909	GCST003794	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Response to drug
6910	GCST003794	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Response to drug
6911	GCST003794	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Other measurement
6912	GCST003794	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Cancer
6913	GCST006258	Diastolic blood pressure	Diastolic blood pressure	Other measurement
6914	GCST006258	Diastolic blood pressure	Diastolic blood pressure	Other measurement
6915	GCST006259	Systolic blood pressure	Systolic blood pressure	Other measurement
6916	GCST006259	Systolic blood pressure	Systolic blood pressure	Other measurement
6917	GCST003791	Response to metformin (IC50)	Response to metformin (IC50)	Other measurement
6918	GCST003791	Response to metformin (IC50)	Response to metformin (IC50)	Response to drug
6919	GCST003765	Emotional dysregulation	Emotional dysregulation	Other measurement
6920	GCST003832	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
6921	GCST003832	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
6922	GCST003831	Asthma	Asthma	Other disease
6923	GCST003833	Adult asthma	Adult asthma	Other disease
6924	GCST003743	Hypertriglyceridemia	Hypertriglyceridemia	Metabolic disorder
6925	GCST003743	Hypertriglyceridemia	Hypertriglyceridemia	Lipid or lipoprotein measurement
6926	GCST003744	Chronic periodontitis (mean interproximal clinical attachment level)	Chronic periodontitis (mean interproximal clinical attachment level)	Other measurement
6927	GCST007015	Lumbar spine bone mineral density (integral)	Lumbar spine bone mineral density (integral)	Other measurement
6928	GCST007014	Lumbar spine bone mineral density (trabecular)	Lumbar spine bone mineral density (trabecular)	Other measurement
6929	GCST003826	Pre bronchodilator FEV1/FVC ratio in never-smokers	Pre bronchodilator FEV1/FVC ratio in never-smokers	Other measurement
6930	GCST003826	Pre bronchodilator FEV1/FVC ratio in never-smokers	Pre bronchodilator FEV1/FVC ratio in never-smokers	Other measurement
6931	GCST003941	Acute graft versus host disease in bone marrow transplantation (recipient effect)	Acute graft versus host disease in bone marrow transplantation (recipient effect)	Immune system disorder
6932	GCST003942	Acute graft versus host disease in bone marrow transplantation (donor effect)	Acute graft versus host disease in bone marrow transplantation (donor effect)	Immune system disorder
6933	GCST003942	Acute graft versus host disease in bone marrow transplantation (donor effect)	Acute graft versus host disease in bone marrow transplantation (donor effect)	Other measurement
6934	GCST003782	Breast cancer	Breast cancer	Cancer
6935	GCST003780	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
6936	GCST003780	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
6937	GCST003781	Breast cancer (estrogen-receptor positive)	Breast cancer (estrogen-receptor positive)	Cancer
6938	GCST003617	Response to statins (HDL cholesterol change)	Response to statins (HDL cholesterol change)	Lipid or lipoprotein measurement
6939	GCST003617	Response to statins (HDL cholesterol change)	Response to statins (HDL cholesterol change)	Response to drug
6940	GCST004522	Response to metformin in type 2 diabetes (HbA1c reduction)	Response to metformin in type 2 diabetes (HbA1c reduction)	Response to drug
6941	GCST004522	Response to metformin in type 2 diabetes (HbA1c reduction)	Response to metformin in type 2 diabetes (HbA1c reduction)	Other measurement
6942	GCST004522	Response to metformin in type 2 diabetes (HbA1c reduction)	Response to metformin in type 2 diabetes (HbA1c reduction)	Metabolic disorder
6943	GCST003790	Glomerular filtration rate	Glomerular filtration rate	Other measurement
6944	GCST003656	Acute kidney injury in critical illness	Acute kidney injury in critical illness	Other measurement
6945	GCST003656	Acute kidney injury in critical illness	Acute kidney injury in critical illness	Other trait
6946	GCST003598	QRS duration	QRS duration	Cardiovascular measurement
6947	GCST003598	QRS duration	QRS duration	Cardiovascular measurement
6948	GCST003598	QRS duration	QRS duration	Cardiovascular measurement
6949	GCST004403	Bone fracture in osteoporosis	Bone fracture in osteoporosis	Other disease
6950	GCST004403	Bone fracture in osteoporosis	Bone fracture in osteoporosis	Other disease
6951	GCST003609	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Response to drug
6952	GCST003609	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Other measurement
6953	GCST003609	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Cancer
6954	GCST003641	Cranial base width	Cranial base width	Other measurement
6955	GCST003646	Facial depth	Facial depth	Other measurement
6956	GCST003645	Lower facial height	Lower facial height	Other measurement
6957	GCST003644	Lip morphology	Lip morphology	Other measurement
6958	GCST003643	Nose morphology	Nose morphology	Other measurement
6959	GCST003642	Eye morphology	Eye morphology	Other measurement
6960	GCST003602	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
6961	GCST003602	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
6962	GCST003602	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
6963	GCST003621	Coffee consumption	Coffee consumption	Biological process
6964	GCST003621	Coffee consumption	Coffee consumption	Other measurement
6965	GCST003621	Coffee consumption	Coffee consumption	Other measurement
6966	GCST003827	Otitis media	Otitis media	Neurological disorder
6967	GCST003829	Otitis media (recurrent)	Otitis media (recurrent)	Neurological disorder
6968	GCST003828	Otitis media (chronic)	Otitis media (chronic)	Neurological disorder
6969	GCST003773	Loneliness (multivariate analysis)	Loneliness (multivariate analysis)	Other measurement
6970	GCST003718	Hepatitis B (viral clearance)	Hepatitis B (viral clearance)	Biological process
6971	GCST003718	Hepatitis B (viral clearance)	Hepatitis B (viral clearance)	Digestive system disorder
6972	GCST003761	Emphysema distribution in smoking	Emphysema distribution in smoking	Biological process
6973	GCST003761	Emphysema distribution in smoking	Emphysema distribution in smoking	Other measurement
6974	GCST003792	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Response to drug
6975	GCST003792	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Other disease
6976	GCST003792	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Digestive system disorder
6977	GCST003792	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Response to drug
6978	GCST003698	Brain activation in response to working memory task	Brain activation in response to working memory task	Other measurement
6979	GCST003698	Brain activation in response to working memory task	Brain activation in response to working memory task	Biological process
6980	GCST003698	Brain activation in response to working memory task	Brain activation in response to working memory task	Other measurement
6981	GCST003759	Resistin levels	Resistin levels	Other measurement
6982	GCST003719	Attention function	Attention function	Other measurement
6983	GCST003793	L-arginine levels	L-arginine levels	Other measurement
6984	GCST003774	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
6985	GCST003772	Loneliness (linear analysis)	Loneliness (linear analysis)	Other measurement
6986	GCST003771	Loneliness	Loneliness	Other measurement
6987	GCST003789	Body mass index	Body mass index	Body measurement
6988	GCST003789	Body mass index	Body mass index	Body measurement
6989	GCST003789	Body mass index	Body mass index	Other measurement
6990	GCST003784	Multiple system atrophy	Multiple system atrophy	Neurological disorder
6991	GCST003783	Multiple system atrophy (pathologically confirmed)	Multiple system atrophy (pathologically confirmed)	Neurological disorder
6992	GCST005716	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6993	GCST003639	Breslow thickness in cutaneous melanoma	Breslow thickness in cutaneous melanoma	Cancer
6994	GCST003639	Breslow thickness in cutaneous melanoma	Breslow thickness in cutaneous melanoma	Other measurement
6995	GCST003520	Breast cancer	Breast cancer	Cancer
6996	GCST003724	Bipolar disorder	Bipolar disorder	Neurological disorder
6997	GCST004493	Lower body strength	Lower body strength	Other measurement
6998	GCST004494	Hand grip strength	Hand grip strength	Other measurement
6999	GCST003591	Severity of facial solar lentigines	Severity of facial solar lentigines	Other measurement
7000	GCST003720	Migraine	Migraine	Cardiovascular disease
7001	GCST005181	Body mass index	Body mass index	Body measurement
7002	GCST005181	Body mass index	Body mass index	Body measurement
7003	GCST005181	Body mass index	Body mass index	Other measurement
7004	GCST004692	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7005	GCST003601	Drug abuse	Drug abuse	Neurological disorder
7006	GCST003589	Bronchial hyperresponsiveness in asthma	Bronchial hyperresponsiveness in asthma	Other disease
7007	GCST003584	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	Cancer
7008	GCST003584	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	Biological process
7009	GCST003583	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Cancer
7010	GCST003583	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Biological process
7011	GCST003583	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Other disease
7012	GCST003581	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Cancer
7013	GCST003581	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Biological process
7014	GCST003581	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Other trait
7015	GCST003582	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	Cancer
7016	GCST003582	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	Biological process
7017	GCST003578	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
7018	GCST003655	Cutaneous squamous cell carcinoma	Cutaneous squamous cell carcinoma	Cancer
7019	GCST003603	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Digestive system disorder
7020	GCST003603	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Other trait
7021	GCST003603	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Response to drug
7022	GCST003626	diarrhoeal disease at age 1	diarrhoeal disease at age 1	Other trait
7023	GCST003624	diarrhoeal disease at age 2 with doctor diagnosis	diarrhoeal disease at age 2 with doctor diagnosis	Other trait
7024	GCST003623	diarrhoeal disease at age 2	diarrhoeal disease at age 2	Other trait
7025	GCST003625	diarrhoeal disease at age 1 with doctor diagnosis	diarrhoeal disease at age 1 with doctor diagnosis	Other trait
7026	GCST003727	Joint destruction and growth retardation	Joint destruction and growth retardation	Body measurement
7027	GCST003727	Joint destruction and growth retardation	Joint destruction and growth retardation	Other disease
7028	GCST003727	Joint destruction and growth retardation	Joint destruction and growth retardation	Other measurement
7029	GCST003741	Sleep duration	Sleep duration	Other measurement
7030	GCST003726	Basal cell carcinoma	Basal cell carcinoma	Cancer
7031	GCST003860	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Other measurement
7032	GCST003860	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Neurological disorder
7033	GCST003860	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Other measurement
7034	GCST003836	Depressive symptoms	Depressive symptoms	Neurological disorder
7035	GCST003836	Depressive symptoms	Depressive symptoms	Other measurement
7036	GCST003835	Depressive symptoms (stressful life events interaction)	Depressive symptoms (stressful life events interaction)	Other measurement
7037	GCST003835	Depressive symptoms (stressful life events interaction)	Depressive symptoms (stressful life events interaction)	Other measurement
7038	GCST003738	Barrett's esophagus	Barrett's esophagus	Digestive system disorder
7039	GCST003740	Barrett's esophagus  or Esophageal adenocarcinoma	Barrett's esophagus  or Esophageal adenocarcinoma	Digestive system disorder
7040	GCST003740	Barrett's esophagus  or Esophageal adenocarcinoma	Barrett's esophagus  or Esophageal adenocarcinoma	Cancer
7041	GCST003739	Esophageal adenocarcinoma	Esophageal adenocarcinoma	Cancer
7042	GCST003605	EGFR mutation-positive lung adenocarcinoma	EGFR mutation-positive lung adenocarcinoma	Cancer
7043	GCST003819	Endometriosis	Endometriosis	Other disease
7044	GCST003604	Sjgren's syndrome	Sjgren's syndrome	Neurological disorder
7045	GCST003612	Bone mineral density (femoral neck)	Bone mineral density (femoral neck)	Other measurement
7046	GCST003610	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7047	GCST003610	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7048	GCST003611	Bone mineral density (total hip)	Bone mineral density (total hip)	Other measurement
7049	GCST003683	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Cardiovascular disease
7050	GCST003683	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Cardiovascular disease
7051	GCST003683	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Cardiovascular disease
7052	GCST003658	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	Body measurement
7053	GCST003658	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	Other measurement
7054	GCST005178	Modified Stumvoll Insulin Sensitivity Index	Modified Stumvoll Insulin Sensitivity Index	Other measurement
7055	GCST003659	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	Body measurement
7056	GCST003659	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	Other measurement
7057	GCST003723	Serum sulfate level	Serum sulfate level	Other measurement
7058	GCST003628	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Response to drug
7059	GCST003628	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Neurological disorder
7060	GCST003628	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Other trait
7061	GCST003590	Apolipoprotein A-IV levels	Apolipoprotein A-IV levels	Lipid or lipoprotein measurement
7062	GCST003651	Parkinson's disease (non-familial, age at onset)	Parkinson's disease (non-familial, age at onset)	Neurological disorder
7063	GCST003651	Parkinson's disease (non-familial, age at onset)	Parkinson's disease (non-familial, age at onset)	Other measurement
7064	GCST003622	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7065	GCST003652	Parkinson's disease (familial, age at onset)	Parkinson's disease (familial, age at onset)	Neurological disorder
7066	GCST003652	Parkinson's disease (familial, age at onset)	Parkinson's disease (familial, age at onset)	Other measurement
7067	GCST003653	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Neurological disorder
7068	GCST003653	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Other measurement
7069	GCST003682	Asthma (SNP x SNP interaction)	Asthma (SNP x SNP interaction)	Other disease
7070	GCST003654	Bone mineral density (Ward's triangle area)	Bone mineral density (Ward's triangle area)	Other measurement
7071	GCST003567	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to drug
7072	GCST003567	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Other measurement
7073	GCST003567	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Other disease
7074	GCST003758	Pancreatic cancer	Pancreatic cancer	Cancer
7075	GCST003787	Bronchial neuroendocrine tumor	Bronchial neuroendocrine tumor	Cancer
7076	GCST003788	Pancreatic neuroendocrine tumor	Pancreatic neuroendocrine tumor	Cancer
7077	GCST003786	Small intestine neuroendocrine tumor	Small intestine neuroendocrine tumor	Cancer
7078	GCST003606	Liver fibrosis severity in HIV/hepatitis C co-infection	Liver fibrosis severity in HIV/hepatitis C co-infection	Other disease
7079	GCST003606	Liver fibrosis severity in HIV/hepatitis C co-infection	Liver fibrosis severity in HIV/hepatitis C co-infection	Digestive system disorder
7080	GCST003606	Liver fibrosis severity in HIV/hepatitis C co-infection	Liver fibrosis severity in HIV/hepatitis C co-infection	Other trait
7081	GCST003657	Attention deficit hyperactivity disorder symptom score	Attention deficit hyperactivity disorder symptom score	Other measurement
7082	GCST003631	Gastroesophageal reflux disease	Gastroesophageal reflux disease	Digestive system disorder
7083	GCST003600	Parkinson's disease (pesticide exposure interaction)	Parkinson's disease (pesticide exposure interaction)	Neurological disorder
7084	GCST003600	Parkinson's disease (pesticide exposure interaction)	Parkinson's disease (pesticide exposure interaction)	Other measurement
7085	GCST003629	nicotine metabolite ratio in current smokers	nicotine metabolite ratio in current smokers	Biological process
7086	GCST003629	nicotine metabolite ratio in current smokers	nicotine metabolite ratio in current smokers	Other measurement
7087	GCST003613	Hypertension	Hypertension	Cardiovascular disease
7088	GCST003785	Neuroendocrine tumor	Neuroendocrine tumor	Cancer
7089	GCST003518	Daytime sleep phenotypes	Daytime sleep phenotypes	Other measurement
7090	GCST003542	Night sleep phenotypes	Night sleep phenotypes	Other measurement
7091	GCST003542	Night sleep phenotypes	Night sleep phenotypes	Other measurement
7092	GCST003542	Night sleep phenotypes	Night sleep phenotypes	Other measurement
7093	GCST003542	Night sleep phenotypes	Night sleep phenotypes	Other measurement
7094	GCST003845	Breast cancer	Breast cancer	Cancer
7095	GCST003842	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
7096	GCST003842	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
7097	GCST003500	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Cancer
7098	GCST003500	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Digestive system disorder
7099	GCST003501	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Cancer
7100	GCST003501	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Digestive system disorder
7101	GCST003489	Food addiction	Food addiction	Biological process
7102	GCST003489	Food addiction	Food addiction	Other measurement
7103	GCST003563	Presence of antiphospholipid antibodies	Presence of antiphospholipid antibodies	Other measurement
7104	GCST003526	Non-chemotherapy drug induced agranulocytosis	Non-chemotherapy drug induced agranulocytosis	Other trait
7105	GCST003526	Non-chemotherapy drug induced agranulocytosis	Non-chemotherapy drug induced agranulocytosis	Biological process
7106	GCST003482	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
7107	GCST003482	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
7108	GCST003672	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Cancer
7109	GCST003672	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Neurological disorder
7110	GCST003672	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Response to drug
7111	GCST003525	Endometrial endometrioid carcinoma	Endometrial endometrioid carcinoma	Cancer
7112	GCST003524	Endometrial cancer	Endometrial cancer	Cancer
7113	GCST003524	Endometrial cancer	Endometrial cancer	Cancer
7114	GCST003599	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7115	GCST005540	Sarcoidosis (Lofgren's syndrome)	Sarcoidosis (Lofgren's syndrome)	Other disease
7116	GCST005540	Sarcoidosis (Lofgren's syndrome)	Sarcoidosis (Lofgren's syndrome)	Other disease
7117	GCST005541	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	Other disease
7118	GCST005542	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	Other disease
7119	GCST005543	Sarcoidosis (non-Lofgren's syndrome)	Sarcoidosis (non-Lofgren's syndrome)	Other disease
7120	GCST003565	Cervical cancer	Cervical cancer	Cancer
7121	GCST003586	Prostate cancer	Prostate cancer	Cancer
7122	GCST003585	Aggressive prostate cancer	Aggressive prostate cancer	Cancer
7123	GCST003585	Aggressive prostate cancer	Aggressive prostate cancer	Other measurement
7124	GCST003649	Pneumococcal bacteremia	Pneumococcal bacteremia	Other disease
7125	GCST003650	Bacteremia	Bacteremia	Other disease
7126	GCST003640	Thyroid-associated orbitopathy in graves' disease	Thyroid-associated orbitopathy in graves' disease	Neurological disorder
7127	GCST003640	Thyroid-associated orbitopathy in graves' disease	Thyroid-associated orbitopathy in graves' disease	Immune system disorder
7128	GCST003615	Susceptibility to persistent hepatitis B virus infection	Susceptibility to persistent hepatitis B virus infection	Digestive system disorder
7129	GCST003615	Susceptibility to persistent hepatitis B virus infection	Susceptibility to persistent hepatitis B virus infection	Immune system disorder
7130	GCST003632	Survival in sporadic amyotrophic lateral sclerosis	Survival in sporadic amyotrophic lateral sclerosis	Other measurement
7131	GCST003632	Survival in sporadic amyotrophic lateral sclerosis	Survival in sporadic amyotrophic lateral sclerosis	Neurological disorder
7132	GCST003676	Educational attainment (years of education)	Educational attainment (years of education)	Other measurement
7133	GCST003722	Migraine with aura	Migraine with aura	Cardiovascular disease
7134	GCST003722	Migraine with aura	Migraine with aura	Cardiovascular disease
7135	GCST003721	Migraine without aura	Migraine without aura	Cardiovascular disease
7136	GCST003721	Migraine without aura	Migraine without aura	Cardiovascular disease
7137	GCST003566	Multiple sclerosis	Multiple sclerosis	Immune system disorder
7138	GCST003559	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7139	GCST003559	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7140	GCST003648	Pathological gambling	Pathological gambling	Neurological disorder
7141	GCST003647	Body mass index	Body mass index	Body measurement
7142	GCST003647	Body mass index	Body mass index	Body measurement
7143	GCST003647	Body mass index	Body mass index	Other measurement
7144	GCST003930	Complex regional pain syndrome	Complex regional pain syndrome	Neurological disorder
7145	GCST003562	Anxiety	Anxiety	Other measurement
7146	GCST003562	Anxiety	Anxiety	Other trait
7147	GCST003522	Dermatomyositis	Dermatomyositis	Neurological disorder
7148	GCST004413	Spontaneous dizygotic twinning	Spontaneous dizygotic twinning	Biological process
7149	GCST003538	Alcohol dependence symptom count	Alcohol dependence symptom count	Other measurement
7150	GCST003494	Colorectal cancer	Colorectal cancer	Cancer
7151	GCST003539	Mortality in heart failure	Mortality in heart failure	Other measurement
7152	GCST003539	Mortality in heart failure	Mortality in heart failure	Cardiovascular disease
7153	GCST003523	Coenzyme Q10 levels	Coenzyme Q10 levels	Other measurement
7154	GCST003521	Asthma	Asthma	Other disease
7155	GCST003481	Sleep latency	Sleep latency	Other measurement
7156	GCST003527	Anti-thyroid drug induced agranulocytosis	Anti-thyroid drug induced agranulocytosis	Response to drug
7157	GCST003527	Anti-thyroid drug induced agranulocytosis	Anti-thyroid drug induced agranulocytosis	Other trait
7158	GCST003616	Liver disease severity in Alagille syndrome	Liver disease severity in Alagille syndrome	Neurological disorder
7159	GCST003616	Liver disease severity in Alagille syndrome	Liver disease severity in Alagille syndrome	Digestive system disorder
7160	GCST003677	Educational attainment (college completion)	Educational attainment (college completion)	Other measurement
7161	GCST003558	Major depressive disorder	Major depressive disorder	Neurological disorder
7162	GCST003618	Primary spontaneous pneumothorax	Primary spontaneous pneumothorax	Other trait
7163	GCST003564	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
7164	GCST003564	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
7165	GCST003775	Lung cancer	Lung cancer	Cancer
7166	GCST003775	Lung cancer	Lung cancer	Cancer
7167	GCST003775	Lung cancer	Lung cancer	Cancer
7168	GCST003777	Squamous cell lung carcinoma	Squamous cell lung carcinoma	Cancer
7169	GCST003776	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
7170	GCST003561	Coronary artery disease	Coronary artery disease	Cardiovascular disease
7171	GCST003561	Coronary artery disease	Coronary artery disease	Cardiovascular disease
7172	GCST003779	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
7173	GCST003778	Smoking status (current vs former)	Smoking status (current vs former)	Other measurement
7174	GCST003560	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Immune system disorder
7175	GCST003560	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Cardiovascular disease
7176	GCST003495	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
7177	GCST003541	Survival in head and neck cancer	Survival in head and neck cancer	Other measurement
7178	GCST003541	Survival in head and neck cancer	Survival in head and neck cancer	Cancer
7179	GCST003619	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7180	GCST003620	Systemic lupus erythematosus or rheumatoid arthritis	Systemic lupus erythematosus or rheumatoid arthritis	Immune system disorder
7181	GCST003620	Systemic lupus erythematosus or rheumatoid arthritis	Systemic lupus erythematosus or rheumatoid arthritis	Immune system disorder
7182	GCST003402	Membranous nephropathy	Membranous nephropathy	Other disease
7183	GCST003427	Alzheimer disease and age of onset	Alzheimer disease and age of onset	Neurological disorder
7184	GCST003427	Alzheimer disease and age of onset	Alzheimer disease and age of onset	Other measurement
7185	GCST003428	Chronotype	Chronotype	Biological process
7186	GCST003428	Chronotype	Chronotype	Other measurement
7187	GCST003429	Morning vs. evening chronotype	Morning vs. evening chronotype	Biological process
7188	GCST003368	circulating leptin levels adjusted for BMI	circulating leptin levels adjusted for BMI	Other measurement
7189	GCST003471	Myocardial infarction	Myocardial infarction	Cardiovascular disease
7190	GCST003470	Coronary artery disease	Coronary artery disease	Cardiovascular disease
7191	GCST003470	Coronary artery disease	Coronary artery disease	Cardiovascular disease
7192	GCST003435	Body fat percentage	Body fat percentage	Body measurement
7193	GCST003466	Cotinine levels in current smokers	Cotinine levels in current smokers	Other measurement
7194	GCST003367	circulating leptin levels	circulating leptin levels	Other measurement
7195	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
7196	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
7197	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Other measurement
7198	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
7199	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Cancer
7200	GCST003358	Betaine levels in individuals undergoing cardiac evaluation	Betaine levels in individuals undergoing cardiac evaluation	Cardiovascular measurement
7201	GCST003358	Betaine levels in individuals undergoing cardiac evaluation	Betaine levels in individuals undergoing cardiac evaluation	Cardiovascular measurement
7202	GCST003459	Endurance athleticism	Endurance athleticism	Other measurement
7203	GCST003327	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
7204	GCST003327	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
7205	GCST003458	World class endurance athleticism	World class endurance athleticism	Other measurement
7206	GCST003400	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7207	GCST003341	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	Other measurement
7208	GCST003341	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	Neurological disorder
7209	GCST003341	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	Neurological disorder
7210	GCST003330	Rheumatoid factor seropositivity in rheumatoid arthritis	Rheumatoid factor seropositivity in rheumatoid arthritis	Other measurement
7211	GCST003330	Rheumatoid factor seropositivity in rheumatoid arthritis	Rheumatoid factor seropositivity in rheumatoid arthritis	Immune system disorder
7212	GCST003330	Rheumatoid factor seropositivity in rheumatoid arthritis	Rheumatoid factor seropositivity in rheumatoid arthritis	Other measurement
7213	GCST003383	Platelet count	Platelet count	Hematological measurement
7214	GCST003335	Waist circumference	Waist circumference	Body measurement
7215	GCST003337	Waist-hip ratio	Waist-hip ratio	Other measurement
7216	GCST003337	Waist-hip ratio	Waist-hip ratio	Body measurement
7217	GCST003336	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
7218	GCST003336	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
7219	GCST003338	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
7220	GCST003338	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
7221	GCST003377	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
7222	GCST003391	Low high density lipoprotein cholesterol levels	Low high density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
7223	GCST003422	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
7224	GCST003422	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
7225	GCST003450	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Response to drug
7226	GCST003450	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Neurological disorder
7227	GCST003450	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Other trait
7228	GCST003390	Thrombosis	Thrombosis	Other trait
7229	GCST003390	Thrombosis	Thrombosis	Cardiovascular disease
7230	GCST003390	Thrombosis	Thrombosis	Cardiovascular disease
7231	GCST003390	Thrombosis	Thrombosis	Cardiovascular disease
7232	GCST003390	Thrombosis	Thrombosis	Other trait
7233	GCST003390	Thrombosis	Thrombosis	Other trait
7234	GCST003434	Obsessive-compulsive symptoms	Obsessive-compulsive symptoms	Other measurement
7235	GCST003432	Early response to risperidone in schizophrenia	Early response to risperidone in schizophrenia	Response to drug
7236	GCST004412	Craniofacial microsomia	Craniofacial microsomia	Other disease
7237	GCST003433	Serum lycopene concentrations	Serum lycopene concentrations	Other measurement
7238	GCST003318	Brain arteriovenous malformations (sporadic)	Brain arteriovenous malformations (sporadic)	Cancer
7239	GCST003300	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cardiovascular disease
7240	GCST003300	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cancer
7241	GCST003300	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Response to drug
7242	GCST003299	Cardiomyopathy in childhood cancer survivors	Cardiomyopathy in childhood cancer survivors	Cardiovascular disease
7243	GCST003299	Cardiomyopathy in childhood cancer survivors	Cardiomyopathy in childhood cancer survivors	Cancer
7244	GCST003278	Ideal cardiovascular health (clinical and behavioural)	Ideal cardiovascular health (clinical and behavioural)	Other trait
7245	GCST003279	Ideal cardiovascular health (clinical)	Ideal cardiovascular health (clinical)	Other trait
7246	GCST003378	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Response to drug
7247	GCST003378	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Neurological disorder
7248	GCST003298	NT-proBNP levels in acute coronary syndrome	NT-proBNP levels in acute coronary syndrome	Cardiovascular measurement
7249	GCST003425	Longevity	Longevity	Other measurement
7250	GCST003381	Bone mineral density (femoral neck)	Bone mineral density (femoral neck)	Other measurement
7251	GCST003379	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7252	GCST003379	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7253	GCST003380	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7254	GCST003380	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7255	GCST003403	Vascular endothelial growth factor levels	Vascular endothelial growth factor levels	Cardiovascular measurement
7256	GCST003359	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
7257	GCST003457	Advanced glycation end-product levels	Advanced glycation end-product levels	Other measurement
7258	GCST003457	Advanced glycation end-product levels	Advanced glycation end-product levels	Other measurement
7259	GCST003457	Advanced glycation end-product levels	Advanced glycation end-product levels	Metabolic disorder
7260	GCST003423	Alzheimer's disease or small vessel stroke	Alzheimer's disease or small vessel stroke	Neurological disorder
7261	GCST003423	Alzheimer's disease or small vessel stroke	Alzheimer's disease or small vessel stroke	Cardiovascular disease
7262	GCST003360	Crohn's disease	Crohn's disease	Digestive system disorder
7263	GCST003799	Colorectal cancer	Colorectal cancer	Cancer
7264	GCST003430	Incident myocardial infarction	Incident myocardial infarction	Cardiovascular disease
7265	GCST003431	Incident coronary heart disease	Incident coronary heart disease	Cardiovascular disease
7266	GCST003329	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Immune system disorder
7267	GCST003329	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Response to drug
7268	GCST003385	Colorectal cancer (menopausal hormone therapy interaction)	Colorectal cancer (menopausal hormone therapy interaction)	Cancer
7269	GCST003385	Colorectal cancer (menopausal hormone therapy interaction)	Colorectal cancer (menopausal hormone therapy interaction)	Other trait
7270	GCST003387	Colorectal cancer (oestrogen hormone therapy interaction)	Colorectal cancer (oestrogen hormone therapy interaction)	Cancer
7271	GCST003387	Colorectal cancer (oestrogen hormone therapy interaction)	Colorectal cancer (oestrogen hormone therapy interaction)	Other trait
7272	GCST003386	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	Cancer
7273	GCST003386	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	Other trait
7274	GCST003451	Tuberculosis	Tuberculosis	Other disease
7275	GCST003451	Tuberculosis	Tuberculosis	Other measurement
7276	GCST003451	Tuberculosis	Tuberculosis	Other measurement
7277	GCST003267	Pre bronchodilator FEV1/FVC ratio	Pre bronchodilator FEV1/FVC ratio	Other measurement
7278	GCST003266	Pre bronchodilator FEV1	Pre bronchodilator FEV1	Other measurement
7279	GCST003265	Post bronchodilator FEV1/FVC ratio in COPD	Post bronchodilator FEV1/FVC ratio in COPD	Other disease
7280	GCST003265	Post bronchodilator FEV1/FVC ratio in COPD	Post bronchodilator FEV1/FVC ratio in COPD	Other measurement
7281	GCST003265	Post bronchodilator FEV1/FVC ratio in COPD	Post bronchodilator FEV1/FVC ratio in COPD	Response to drug
7282	GCST003262	Post bronchodilator FEV1	Post bronchodilator FEV1	Response to drug
7283	GCST003262	Post bronchodilator FEV1	Post bronchodilator FEV1	Other measurement
7284	GCST003264	Post bronchodilator FEV1/FVC ratio	Post bronchodilator FEV1/FVC ratio	Other measurement
7285	GCST003264	Post bronchodilator FEV1/FVC ratio	Post bronchodilator FEV1/FVC ratio	Response to drug
7286	GCST003250	Urinary albumin-to-creatinine ratio in diabetes	Urinary albumin-to-creatinine ratio in diabetes	Other measurement
7287	GCST003250	Urinary albumin-to-creatinine ratio in diabetes	Urinary albumin-to-creatinine ratio in diabetes	Metabolic disorder
7288	GCST003255	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
7289	GCST003253	Microalbuminuria	Microalbuminuria	Other trait
7290	GCST003254	Urinary albumin-to-creatinine ratio in non-diabetics	Urinary albumin-to-creatinine ratio in non-diabetics	Other measurement
7291	GCST003209	Colorectal or endometrial cancer	Colorectal or endometrial cancer	Cancer
7292	GCST003209	Colorectal or endometrial cancer	Colorectal or endometrial cancer	Cancer
7293	GCST003208	Colorectal or endometrial cancer	Colorectal or endometrial cancer	Cancer
7294	GCST003208	Colorectal or endometrial cancer	Colorectal or endometrial cancer	Cancer
7295	GCST003269	Cutaneous psoriasis	Cutaneous psoriasis	Other measurement
7296	GCST003269	Cutaneous psoriasis	Cutaneous psoriasis	Immune system disorder
7297	GCST003271	Psoriatic arthritis vs Cutaneous psoriasis	Psoriatic arthritis vs Cutaneous psoriasis	Other measurement
7298	GCST003271	Psoriatic arthritis vs Cutaneous psoriasis	Psoriatic arthritis vs Cutaneous psoriasis	Immune system disorder
7299	GCST003271	Psoriatic arthritis vs Cutaneous psoriasis	Psoriatic arthritis vs Cutaneous psoriasis	Immune system disorder
7300	GCST003270	Psoriatic arthritis	Psoriatic arthritis	Immune system disorder
7301	GCST003268	Psoriasis vulgaris	Psoriasis vulgaris	Immune system disorder
7302	GCST003252	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7303	GCST003188	Acute mountain sickness	Acute mountain sickness	Cardiovascular disease
7304	GCST003176	Asthma	Asthma	Other disease
7305	GCST003177	Childhood body mass index	Childhood body mass index	Body measurement
7306	GCST003189	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Digestive system disorder
7307	GCST003189	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Cancer
7308	GCST003249	Basal metabolic rate	Basal metabolic rate	Other measurement
7309	GCST003199	Atrophic age-related macular degeneration	Atrophic age-related macular degeneration	Neurological disorder
7310	GCST003198	Inguinal hernia	Inguinal hernia	Other trait
7311	GCST003195	Magnesium levels	Magnesium levels	Other measurement
7312	GCST003219	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
7313	GCST003219	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
7314	GCST003219	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
7315	GCST003258	Ischemic stroke	Ischemic stroke	Cardiovascular disease
7316	GCST003258	Ischemic stroke	Ischemic stroke	Other trait
7317	GCST003261	Ischemic stroke (undetermined subtype)	Ischemic stroke (undetermined subtype)	Other trait
7318	GCST003260	Ischemic stroke (small artery occlusion)	Ischemic stroke (small artery occlusion)	Cardiovascular disease
7319	GCST003260	Ischemic stroke (small artery occlusion)	Ischemic stroke (small artery occlusion)	Other trait
7320	GCST003259	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Cardiovascular disease
7321	GCST003259	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Other trait
7322	GCST003257	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
7323	GCST003257	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
7324	GCST003257	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
7325	GCST003245	White matter hyperintensities in ischemic stroke	White matter hyperintensities in ischemic stroke	Other measurement
7326	GCST003245	White matter hyperintensities in ischemic stroke	White matter hyperintensities in ischemic stroke	Other trait
7327	GCST003197	Thoracic-to-hip circumference ratio	Thoracic-to-hip circumference ratio	Body measurement
7328	GCST003191	Vitamin D levels	Vitamin D levels	Other measurement
7329	GCST003196	Calcaneal bone ultrasound measurement (speed of sound)	Calcaneal bone ultrasound measurement (speed of sound)	Other measurement
7330	GCST003579	Antipsychotic drug-induced weight gain in schizophrenia	Antipsychotic drug-induced weight gain in schizophrenia	Neurological disorder
7331	GCST003579	Antipsychotic drug-induced weight gain in schizophrenia	Antipsychotic drug-induced weight gain in schizophrenia	Other trait
7332	GCST003193	Response to interferon beta in multiple sclerosis	Response to interferon beta in multiple sclerosis	Immune system disorder
7333	GCST003193	Response to interferon beta in multiple sclerosis	Response to interferon beta in multiple sclerosis	Response to drug
7334	GCST003263	Post bronchodilator FEV1 in COPD	Post bronchodilator FEV1 in COPD	Other disease
7335	GCST003263	Post bronchodilator FEV1 in COPD	Post bronchodilator FEV1 in COPD	Response to drug
7336	GCST003263	Post bronchodilator FEV1 in COPD	Post bronchodilator FEV1 in COPD	Other measurement
7337	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Other measurement
7338	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Hematological measurement
7339	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Hematological measurement
7340	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Hematological measurement
7341	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Liver enzyme measurement
7342	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Other measurement
7343	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Other measurement
7344	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Other measurement
7345	GCST008644	Celiac disease and Rheumatoid arthritis	Celiac disease and Rheumatoid arthritis	Immune system disorder
7346	GCST008644	Celiac disease and Rheumatoid arthritis	Celiac disease and Rheumatoid arthritis	Immune system disorder
7347	GCST003211	C-reactive protein levels in ischemic stroke	C-reactive protein levels in ischemic stroke	Other trait
7348	GCST003211	C-reactive protein levels in ischemic stroke	C-reactive protein levels in ischemic stroke	Inflammatory measurement
7349	GCST003235	Prothrombin fragments F1+2 levels in ischemic stroke	Prothrombin fragments F1+2 levels in ischemic stroke	Other measurement
7350	GCST003235	Prothrombin fragments F1+2 levels in ischemic stroke	Prothrombin fragments F1+2 levels in ischemic stroke	Other trait
7351	GCST003212	Fibrinogen levels in ischemic stroke	Fibrinogen levels in ischemic stroke	Hematological measurement
7352	GCST003212	Fibrinogen levels in ischemic stroke	Fibrinogen levels in ischemic stroke	Other trait
7353	GCST003233	Thrombin-antithrombin complex levels in ischemic stroke	Thrombin-antithrombin complex levels in ischemic stroke	Other measurement
7354	GCST003233	Thrombin-antithrombin complex levels in ischemic stroke	Thrombin-antithrombin complex levels in ischemic stroke	Other trait
7355	GCST003213	Creatinine levels in ischemic stroke	Creatinine levels in ischemic stroke	Other measurement
7356	GCST003213	Creatinine levels in ischemic stroke	Creatinine levels in ischemic stroke	Other trait
7357	GCST003234	Thrombomodulin levels in ischemic stroke	Thrombomodulin levels in ischemic stroke	Other measurement
7358	GCST003234	Thrombomodulin levels in ischemic stroke	Thrombomodulin levels in ischemic stroke	Other trait
7359	GCST003218	Non-cardia gastric cancer	Non-cardia gastric cancer	Cancer
7360	GCST003248	Body mass index	Body mass index	Body measurement
7361	GCST003248	Body mass index	Body mass index	Body measurement
7362	GCST003248	Body mass index	Body mass index	Other measurement
7363	GCST003241	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	Lipid or lipoprotein measurement
7364	GCST003242	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	Lipid or lipoprotein measurement
7365	GCST003244	Delta-6 desaturase activity	Delta-6 desaturase activity	Other measurement
7366	GCST003243	Delta-5 desaturase activity	Delta-5 desaturase activity	Other measurement
7367	GCST003236	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Lipid or lipoprotein measurement
7368	GCST003236	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Lipid or lipoprotein measurement
7369	GCST003237	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Lipid or lipoprotein measurement
7370	GCST003237	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Lipid or lipoprotein measurement
7371	GCST003238	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Lipid or lipoprotein measurement
7372	GCST003238	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Lipid or lipoprotein measurement
7373	GCST003321	Small vessel stroke	Small vessel stroke	Cardiovascular disease
7374	GCST003323	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
7375	GCST003323	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
7376	GCST003323	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
7377	GCST003320	Ischemic stroke (undetermined subtype)	Ischemic stroke (undetermined subtype)	Other trait
7378	GCST003322	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Cardiovascular disease
7379	GCST003322	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Other trait
7380	GCST003325	Lung cancer	Lung cancer	Cancer
7381	GCST003325	Lung cancer	Lung cancer	Cancer
7382	GCST003325	Lung cancer	Lung cancer	Cancer
7383	GCST003326	Adenocarcinoma	Adenocarcinoma	Cancer
7384	GCST003334	Length of menstrual cycle	Length of menstrual cycle	Other measurement
7385	GCST003319	Major depressive disorder (stressful life events interaction)	Major depressive disorder (stressful life events interaction)	Other trait
7386	GCST003319	Major depressive disorder (stressful life events interaction)	Major depressive disorder (stressful life events interaction)	Other measurement
7387	GCST003319	Major depressive disorder (stressful life events interaction)	Major depressive disorder (stressful life events interaction)	Neurological disorder
7388	GCST003331	Sex ratio	Sex ratio	Other measurement
7389	GCST003370	Anxiety disorder	Anxiety disorder	Neurological disorder
7390	GCST003369	Anxiety disorder (factor score)	Anxiety disorder (factor score)	Other measurement
7391	GCST003580	Antithyroid drug-induced agranulocytosis	Antithyroid drug-induced agranulocytosis	Response to drug
7392	GCST003580	Antithyroid drug-induced agranulocytosis	Antithyroid drug-induced agranulocytosis	Other trait
7393	GCST003365	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
7394	GCST003365	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
7395	GCST003365	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
7396	GCST003366	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
7397	GCST003366	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
7398	GCST003366	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
7399	GCST003344	Glaucoma (high intraocular pressure)	Glaucoma (high intraocular pressure)	Neurological disorder
7400	GCST003343	Glaucoma (low intraocular pressure)	Glaucoma (low intraocular pressure)	Neurological disorder
7401	GCST003342	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
7402	GCST003376	Nicotine metabolite ratio	Nicotine metabolite ratio	Other measurement
7403	GCST003332	Rapid functional decline in sporadic amyotrophic lateral sclerosis	Rapid functional decline in sporadic amyotrophic lateral sclerosis	Other measurement
7404	GCST003332	Rapid functional decline in sporadic amyotrophic lateral sclerosis	Rapid functional decline in sporadic amyotrophic lateral sclerosis	Neurological disorder
7405	GCST003333	Moderate functional decline in sporadic amyotrophic lateral sclerosis	Moderate functional decline in sporadic amyotrophic lateral sclerosis	Other measurement
7406	GCST003333	Moderate functional decline in sporadic amyotrophic lateral sclerosis	Moderate functional decline in sporadic amyotrophic lateral sclerosis	Neurological disorder
7407	GCST003460	IgG1 response to Plasmodium falciparum antigen (GLURP)	IgG1 response to Plasmodium falciparum antigen (GLURP)	Other measurement
7408	GCST003464	IgG3 response to Plasmodium falciparum antigen (MSP2 FC27)	IgG3 response to Plasmodium falciparum antigen (MSP2 FC27)	Other measurement
7409	GCST003463	IgG3 response to Plasmodium falciparum antigen (MSP2 3D7)	IgG3 response to Plasmodium falciparum antigen (MSP2 3D7)	Other measurement
7410	GCST003462	IgG1 response to Plasmodium falciparum antigen (MSP1)	IgG1 response to Plasmodium falciparum antigen (MSP1)	Other measurement
7411	GCST003461	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)	Other measurement
7412	GCST003388	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7413	GCST003388	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7414	GCST003389	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7415	GCST003389	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7416	GCST003324	Ischemic stroke	Ischemic stroke	Cardiovascular disease
7417	GCST003324	Ischemic stroke	Ischemic stroke	Other trait
7418	GCST005546	Forearm bone mineral density	Forearm bone mineral density	Other measurement
7419	GCST003153	Cirrhosis (alcohol related)	Cirrhosis (alcohol related)	Cancer
7420	GCST003184	Atopic dermatitis	Atopic dermatitis	Immune system disorder
7421	GCST006960	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
7422	GCST006960	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
7423	GCST006960	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
7424	GCST003178	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Response to drug
7425	GCST003178	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Other measurement
7426	GCST003178	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Cancer
7427	GCST003251	Late-onset myasthenia gravis	Late-onset myasthenia gravis	Neurological disorder
7428	GCST003151	White matter lesion progression	White matter lesion progression	Other measurement
7429	GCST003157	Plasma homocysteine levels	Plasma homocysteine levels	Cardiovascular measurement
7430	GCST003247	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
7431	GCST003247	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
7432	GCST003246	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
7433	GCST003246	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
7434	GCST003161	Objective response to lithium treatment in bipolar disorder	Objective response to lithium treatment in bipolar disorder	Response to drug
7435	GCST003161	Objective response to lithium treatment in bipolar disorder	Objective response to lithium treatment in bipolar disorder	Neurological disorder
7436	GCST003159	Objective response to lithium treatment	Objective response to lithium treatment	Response to drug
7437	GCST003159	Objective response to lithium treatment	Objective response to lithium treatment	Neurological disorder
7438	GCST003160	Subjective response to lithium treatment in bipolar disorder	Subjective response to lithium treatment in bipolar disorder	Response to drug
7439	GCST003160	Subjective response to lithium treatment in bipolar disorder	Subjective response to lithium treatment in bipolar disorder	Neurological disorder
7440	GCST003158	Subjective response to lithium treatment	Subjective response to lithium treatment	Response to drug
7441	GCST003158	Subjective response to lithium treatment	Subjective response to lithium treatment	Neurological disorder
7442	GCST003156	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7443	GCST003155	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7444	GCST003154	Peripheral artery disease	Peripheral artery disease	Cardiovascular disease
7445	GCST003200	Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)	Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)	Other measurement
7446	GCST003194	Fibrinogen levels	Fibrinogen levels	Hematological measurement
7447	GCST003224	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Other measurement
7448	GCST003224	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Cancer
7449	GCST003224	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Response to drug
7450	GCST003183	Setpoint viral load in HIV-1 infection	Setpoint viral load in HIV-1 infection	Other measurement
7451	GCST003183	Setpoint viral load in HIV-1 infection	Setpoint viral load in HIV-1 infection	Other disease
7452	GCST003232	Response to Pazopanib in cancer (hepatotoxicity)	Response to Pazopanib in cancer (hepatotoxicity)	Liver enzyme measurement
7453	GCST003232	Response to Pazopanib in cancer (hepatotoxicity)	Response to Pazopanib in cancer (hepatotoxicity)	Response to drug
7454	GCST003232	Response to Pazopanib in cancer (hepatotoxicity)	Response to Pazopanib in cancer (hepatotoxicity)	Cancer
7455	GCST003225	Pelvic organ prolapse (moderate/severe)	Pelvic organ prolapse (moderate/severe)	Other disease
7456	GCST003180	Atopic march	Atopic march	Biological process
7457	GCST003180	Atopic march	Atopic march	Immune system disorder
7458	GCST003180	Atopic march	Atopic march	Other disease
7459	GCST003226	Pelvic organ prolapse	Pelvic organ prolapse	Other disease
7460	GCST003179	Multiple system atrophy	Multiple system atrophy	Neurological disorder
7461	GCST003221	Gut microbiome composition (summer)	Gut microbiome composition (summer)	Other measurement
7462	GCST008436	Nonobstructive coronary artery disease	Nonobstructive coronary artery disease	Cardiovascular disease
7463	GCST003223	Gut microbiome composition (winter)	Gut microbiome composition (winter)	Other measurement
7464	GCST003222	Gut microbiome composition (summer and winter)	Gut microbiome composition (summer and winter)	Other measurement
7465	GCST005879	Collagenous colitis	Collagenous colitis	Immune system disorder
7466	GCST003192	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Immune system disorder
7467	GCST003192	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Cardiovascular disease
7468	GCST005560	Menopause (age at onset)	Menopause (age at onset)	Other measurement
7469	GCST005354	Height	Height	Other measurement
7470	GCST005354	Height	Height	Body measurement
7471	GCST005312	Menopause (age at onset)	Menopause (age at onset)	Other measurement
7472	GCST003174	Sense of smell	Sense of smell	Biological process
7473	GCST003239	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Lipid or lipoprotein measurement
7474	GCST003239	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Lipid or lipoprotein measurement
7475	GCST003240	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	Lipid or lipoprotein measurement
7476	GCST003175	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7477	GCST003217	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
7478	GCST003215	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
7479	GCST003216	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7480	GCST003216	LDL cholesterol	LDL cholesterol	Other measurement
7481	GCST003216	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7482	GCST003214	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
7483	GCST003182	Staphylococcus aureus nasal carriage (persistent)	Staphylococcus aureus nasal carriage (persistent)	Other measurement
7484	GCST003181	Staphylococcus aureus nasal carriage (intermittent)	Staphylococcus aureus nasal carriage (intermittent)	Other measurement
7485	GCST003190	Schizophrenia	Schizophrenia	Neurological disorder
7486	GCST003149	Skin and soft tissue Staphylococcus aureus infection	Skin and soft tissue Staphylococcus aureus infection	Other disease
7487	GCST003152	White matter lesion progression (adjusted for white matter lesion burden at baseline)	White matter lesion progression (adjusted for white matter lesion burden at baseline)	Other measurement
7488	GCST003150	Staphylococcus aureus infection	Staphylococcus aureus infection	Other disease
7489	GCST003148	Prostate cancer	Prostate cancer	Cancer
7490	GCST003185	Nicotine dependence	Nicotine dependence	Neurological disorder
7491	GCST003147	Plasma lactate levels	Plasma lactate levels	Other measurement
7492	GCST003220	Glioblastoma	Glioblastoma	Cancer
7493	GCST003220	Glioblastoma	Glioblastoma	Cancer
7494	GCST003220	Glioblastoma	Glioblastoma	Cancer
7495	GCST003207	Response to exercise (triglyceride level interaction)	Response to exercise (triglyceride level interaction)	Biological process
7496	GCST003207	Response to exercise (triglyceride level interaction)	Response to exercise (triglyceride level interaction)	Lipid or lipoprotein measurement
7497	GCST003210	Low vWF levels	Low vWF levels	Hematological measurement
7498	GCST003099	Diabetic kidney disease	Diabetic kidney disease	Metabolic disorder
7499	GCST003100	Prostate cancer (survival)	Prostate cancer (survival)	Cancer
7500	GCST003100	Prostate cancer (survival)	Prostate cancer (survival)	Other measurement
7501	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7502	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Digestive system disorder
7503	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7504	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7505	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7506	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7507	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7508	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7509	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Metabolic disorder
7510	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7511	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
7512	GCST003095	Adiponectin levels (BMI-adjusted)	Adiponectin levels (BMI-adjusted)	Other measurement
7513	GCST003096	Adiponectin levels	Adiponectin levels	Other measurement
7514	GCST003094	Mitral valve prolapse	Mitral valve prolapse	Cardiovascular disease
7515	GCST003092	Myositis	Myositis	Immune system disorder
7516	GCST005545	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
7517	GCST005545	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
7518	GCST005544	Femoral neck bone mineral density	Femoral neck bone mineral density	Other measurement
7519	GCST003228	Glioma	Glioma	Cancer
7520	GCST003228	Glioma	Glioma	Cancer
7521	GCST003146	Postburn hypertrophic scarring severity	Postburn hypertrophic scarring severity	Other measurement
7522	GCST003227	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
7523	GCST003227	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
7524	GCST003145	Severe malaria	Severe malaria	Digestive system disorder
7525	GCST003143	Lung disease severity in cystic fibrosis	Lung disease severity in cystic fibrosis	Other disease
7526	GCST003143	Lung disease severity in cystic fibrosis	Lung disease severity in cystic fibrosis	Other measurement
7527	GCST003143	Lung disease severity in cystic fibrosis	Lung disease severity in cystic fibrosis	Other disease
7528	GCST003144	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
7529	GCST006879	Blood metabolite levels	Blood metabolite levels	Other measurement
7530	GCST006879	Blood metabolite levels	Blood metabolite levels	Other measurement
7531	GCST006879	Blood metabolite levels	Blood metabolite levels	Other measurement
7532	GCST006879	Blood metabolite levels	Blood metabolite levels	Other measurement
7533	GCST003130	Autism spectrum disorder	Autism spectrum disorder	Neurological disorder
7534	GCST003128	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
7535	GCST003128	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
7536	GCST003272	Systolic blood pressure	Systolic blood pressure	Other measurement
7537	GCST003272	Systolic blood pressure	Systolic blood pressure	Other measurement
7538	GCST003273	Diastolic blood pressure	Diastolic blood pressure	Other measurement
7539	GCST003273	Diastolic blood pressure	Diastolic blood pressure	Other measurement
7540	GCST003275	Mean arterial pressure	Mean arterial pressure	Other measurement
7541	GCST003274	Pulse pressure	Pulse pressure	Cardiovascular measurement
7542	GCST003276	Hypertension	Hypertension	Cardiovascular disease
7543	GCST003119	Urinary metabolites	Urinary metabolites	Other measurement
7544	GCST003119	Urinary metabolites	Urinary metabolites	Other measurement
7545	GCST003118	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	Response to drug
7546	GCST003118	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	Neurological disorder
7547	GCST003116	Coronary artery disease	Coronary artery disease	Cardiovascular disease
7548	GCST003116	Coronary artery disease	Coronary artery disease	Cardiovascular disease
7549	GCST003117	Myocardial infarction	Myocardial infarction	Cardiovascular disease
7550	GCST003115	Rotator cuff tears	Rotator cuff tears	Other disease
7551	GCST003114	Carotid intima media thickness	Carotid intima media thickness	Other measurement
7552	GCST003114	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular measurement
7553	GCST003114	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular disease
7554	GCST003127	Lipoprotein (a) levels	Lipoprotein (a) levels	Lipid or lipoprotein measurement
7555	GCST003123	Severe influenza A (H1N1) infection	Severe influenza A (H1N1) infection	Other disease
7556	GCST003124	Mild influenza (H1N1) infection	Mild influenza (H1N1) infection	Other disease
7557	GCST003125	Influenza A (H1N1) infection	Influenza A (H1N1) infection	Other disease
7558	GCST003126	Influenza A (H1N1) severity	Influenza A (H1N1) severity	Other measurement
7559	GCST005538	Sarcoidosis	Sarcoidosis	Other disease
7560	GCST003121	Alcohol dependence	Alcohol dependence	Other measurement
7561	GCST003121	Alcohol dependence	Alcohol dependence	Neurological disorder
7562	GCST003122	Hemoglobin levels	Hemoglobin levels	Hematological measurement
7563	GCST003122	Hemoglobin levels	Hemoglobin levels	Hematological measurement
7564	GCST003122	Hemoglobin levels	Hemoglobin levels	Hematological measurement
7565	GCST003122	Hemoglobin levels	Hemoglobin levels	Hematological measurement
7566	GCST003120	Extraversion	Extraversion	Biological process
7567	GCST003120	Extraversion	Extraversion	Other measurement
7568	GCST003108	Antipsychotic drug-induced weight gain (time interaction)	Antipsychotic drug-induced weight gain (time interaction)	Body measurement
7569	GCST003108	Antipsychotic drug-induced weight gain (time interaction)	Antipsychotic drug-induced weight gain (time interaction)	Other trait
7570	GCST003109	Antipsychotic drug-induced weight gain	Antipsychotic drug-induced weight gain	Other trait
7571	GCST003106	Low bone mineral density (spine)	Low bone mineral density (spine)	Other measurement
7572	GCST003105	Low bone mineral density (hip)	Low bone mineral density (hip)	Other measurement
7573	GCST003104	Autism spectrum disorder	Autism spectrum disorder	Neurological disorder
7574	GCST003103	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7575	GCST003101	Bone mineral density (spine) and age at menarche	Bone mineral density (spine) and age at menarche	Other measurement
7576	GCST003101	Bone mineral density (spine) and age at menarche	Bone mineral density (spine) and age at menarche	Other measurement
7577	GCST003102	Bone mineral density (hip) and age at menarche	Bone mineral density (hip) and age at menarche	Other measurement
7578	GCST003102	Bone mineral density (hip) and age at menarche	Bone mineral density (hip) and age at menarche	Other measurement
7579	GCST008643	Joint damage in rheumatoid arthritis	Joint damage in rheumatoid arthritis	Immune system disorder
7580	GCST008643	Joint damage in rheumatoid arthritis	Joint damage in rheumatoid arthritis	Other measurement
7581	GCST003098	Diabetic kidney disease	Diabetic kidney disease	Metabolic disorder
7582	GCST003113	Cingulate cortical amyloid beta load	Cingulate cortical amyloid beta load	Other measurement
7583	GCST003113	Cingulate cortical amyloid beta load	Cingulate cortical amyloid beta load	Other measurement
7584	GCST003110	Post-bronchodilator lung function in asthma (FEV1)	Post-bronchodilator lung function in asthma (FEV1)	Other measurement
7585	GCST003110	Post-bronchodilator lung function in asthma (FEV1)	Post-bronchodilator lung function in asthma (FEV1)	Response to drug
7586	GCST003110	Post-bronchodilator lung function in asthma (FEV1)	Post-bronchodilator lung function in asthma (FEV1)	Other measurement
7587	GCST003110	Post-bronchodilator lung function in asthma (FEV1)	Post-bronchodilator lung function in asthma (FEV1)	Other disease
7588	GCST003107	Post-bronchodilator lung function in asthma (FEV1/FVC)	Post-bronchodilator lung function in asthma (FEV1/FVC)	Other measurement
7589	GCST003107	Post-bronchodilator lung function in asthma (FEV1/FVC)	Post-bronchodilator lung function in asthma (FEV1/FVC)	Other measurement
7590	GCST003107	Post-bronchodilator lung function in asthma (FEV1/FVC)	Post-bronchodilator lung function in asthma (FEV1/FVC)	Response to drug
7591	GCST003107	Post-bronchodilator lung function in asthma (FEV1/FVC)	Post-bronchodilator lung function in asthma (FEV1/FVC)	Other disease
7592	GCST003132	Eating disorder in bipolar disorder	Eating disorder in bipolar disorder	Metabolic disorder
7593	GCST003132	Eating disorder in bipolar disorder	Eating disorder in bipolar disorder	Neurological disorder
7594	GCST003136	Bipolar disorder	Bipolar disorder	Neurological disorder
7595	GCST003135	Bipolar disorder and eating disorder	Bipolar disorder and eating disorder	Metabolic disorder
7596	GCST003135	Bipolar disorder and eating disorder	Bipolar disorder and eating disorder	Neurological disorder
7597	GCST003142	Proteinuria in chronic kidney disease	Proteinuria in chronic kidney disease	Other disease
7598	GCST003142	Proteinuria in chronic kidney disease	Proteinuria in chronic kidney disease	Other trait
7599	GCST003138	Juvenile osteochondritis dissecans	Juvenile osteochondritis dissecans	Other trait
7600	GCST003139	Glomerular filtration rate in chronic kidney disease	Glomerular filtration rate in chronic kidney disease	Other disease
7601	GCST003139	Glomerular filtration rate in chronic kidney disease	Glomerular filtration rate in chronic kidney disease	Other measurement
7602	GCST003141	Proteinuria and chronic kidney disease	Proteinuria and chronic kidney disease	Other disease
7603	GCST003141	Proteinuria and chronic kidney disease	Proteinuria and chronic kidney disease	Other trait
7604	GCST003140	Chronic kidney disease	Chronic kidney disease	Other disease
7605	GCST003140	Chronic kidney disease	Chronic kidney disease	Other measurement
7606	GCST003140	Chronic kidney disease	Chronic kidney disease	Other measurement
7607	GCST003048	Schizophrenia	Schizophrenia	Neurological disorder
7608	GCST003049	Lung cancer (asbestos exposure interaction)	Lung cancer (asbestos exposure interaction)	Cancer
7609	GCST003049	Lung cancer (asbestos exposure interaction)	Lung cancer (asbestos exposure interaction)	Other measurement
7610	GCST003046	Trichloroethylene-induced hypersensitivity syndrome	Trichloroethylene-induced hypersensitivity syndrome	Biological process
7611	GCST003047	Atrioventricular septal defects in Down syndrome	Atrioventricular septal defects in Down syndrome	Cardiovascular disease
7612	GCST003047	Atrioventricular septal defects in Down syndrome	Atrioventricular septal defects in Down syndrome	Other trait
7613	GCST003042	Sight-threatening diabetic retinopathy in type 2 diabetes	Sight-threatening diabetic retinopathy in type 2 diabetes	Metabolic disorder
7614	GCST003042	Sight-threatening diabetic retinopathy in type 2 diabetes	Sight-threatening diabetic retinopathy in type 2 diabetes	Metabolic disorder
7615	GCST003017	Colorectal cancer	Colorectal cancer	Cancer
7616	GCST003018	Thionamide-induced agranulocytosis in Graves' disease	Thionamide-induced agranulocytosis in Graves' disease	Immune system disorder
7617	GCST003018	Thionamide-induced agranulocytosis in Graves' disease	Thionamide-induced agranulocytosis in Graves' disease	Response to drug
7618	GCST003018	Thionamide-induced agranulocytosis in Graves' disease	Thionamide-induced agranulocytosis in Graves' disease	Other trait
7619	GCST003016	Hypersomnia during a major depressive episode in bipolar disorder	Hypersomnia during a major depressive episode in bipolar disorder	Neurological disorder
7620	GCST003016	Hypersomnia during a major depressive episode in bipolar disorder	Hypersomnia during a major depressive episode in bipolar disorder	Other trait
7621	GCST003016	Hypersomnia during a major depressive episode in bipolar disorder	Hypersomnia during a major depressive episode in bipolar disorder	Neurological disorder
7622	GCST003015	Alcohol consumption	Alcohol consumption	Biological process
7623	GCST003015	Alcohol consumption	Alcohol consumption	Other measurement
7624	GCST003014	Postprandial triglyceride response to high fat diet meal	Postprandial triglyceride response to high fat diet meal	Lipid or lipoprotein measurement
7625	GCST003014	Postprandial triglyceride response to high fat diet meal	Postprandial triglyceride response to high fat diet meal	Biological process
7626	GCST003013	White matter hyperintensity burden	White matter hyperintensity burden	Other measurement
7627	GCST003013	White matter hyperintensity burden	White matter hyperintensity burden	Other measurement
7628	GCST003627	Neuropathy in taxane-treated breast cancer	Neuropathy in taxane-treated breast cancer	Cancer
7629	GCST003627	Neuropathy in taxane-treated breast cancer	Neuropathy in taxane-treated breast cancer	Response to drug
7630	GCST003627	Neuropathy in taxane-treated breast cancer	Neuropathy in taxane-treated breast cancer	Neurological disorder
7631	GCST003627	Neuropathy in taxane-treated breast cancer	Neuropathy in taxane-treated breast cancer	Response to drug
7632	GCST003012	Obstructive sleep apnea	Obstructive sleep apnea	Neurological disorder
7633	GCST003011	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
7634	GCST006807	ACPA-negative rheumatoid arthritis (smoking interaction)	ACPA-negative rheumatoid arthritis (smoking interaction)	Other measurement
7635	GCST006807	ACPA-negative rheumatoid arthritis (smoking interaction)	ACPA-negative rheumatoid arthritis (smoking interaction)	Immune system disorder
7636	GCST006807	ACPA-negative rheumatoid arthritis (smoking interaction)	ACPA-negative rheumatoid arthritis (smoking interaction)	Immune system disorder
7637	GCST006410	ACPA-positive rheumatoid arthritis (smoking interaction)	ACPA-positive rheumatoid arthritis (smoking interaction)	Other measurement
7638	GCST006410	ACPA-positive rheumatoid arthritis (smoking interaction)	ACPA-positive rheumatoid arthritis (smoking interaction)	Immune system disorder
7639	GCST006410	ACPA-positive rheumatoid arthritis (smoking interaction)	ACPA-positive rheumatoid arthritis (smoking interaction)	Immune system disorder
7640	GCST005548	Parkinson's disease	Parkinson's disease	Neurological disorder
7641	GCST003085	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
7642	GCST003083	Glucocorticoid-induced osteonecrosis (time dependent analysis)	Glucocorticoid-induced osteonecrosis (time dependent analysis)	Other disease
7643	GCST003083	Glucocorticoid-induced osteonecrosis (time dependent analysis)	Glucocorticoid-induced osteonecrosis (time dependent analysis)	Response to drug
7644	GCST003084	Glucocorticoid-induced osteonecrosis	Glucocorticoid-induced osteonecrosis	Other disease
7645	GCST003084	Glucocorticoid-induced osteonecrosis	Glucocorticoid-induced osteonecrosis	Response to drug
7646	GCST003082	Longitudinal change in brain amyloid plaque burden	Longitudinal change in brain amyloid plaque burden	Other measurement
7647	GCST003081	Glucocorticoid-induced osteonecrosis (age 10 years and older)	Glucocorticoid-induced osteonecrosis (age 10 years and older)	Other disease
7648	GCST003081	Glucocorticoid-induced osteonecrosis (age 10 years and older)	Glucocorticoid-induced osteonecrosis (age 10 years and older)	Response to drug
7649	GCST003080	Glucocorticoid-induced osteonecrosis (time independent analysis)	Glucocorticoid-induced osteonecrosis (time independent analysis)	Other disease
7650	GCST003080	Glucocorticoid-induced osteonecrosis (time independent analysis)	Glucocorticoid-induced osteonecrosis (time independent analysis)	Response to drug
7651	GCST003073	Cerebral amyloid deposition (PET imaging)	Cerebral amyloid deposition (PET imaging)	Other measurement
7652	GCST003077	Cerebral amyloid deposition positivity (PET imaging)	Cerebral amyloid deposition positivity (PET imaging)	Other measurement
7653	GCST003076	Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	Other measurement
7654	GCST003076	Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	Other measurement
7655	GCST003079	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
7656	GCST003078	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Other measurement
7657	GCST003071	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
7658	GCST003071	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
7659	GCST003070	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
7660	GCST003070	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
7661	GCST003074	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	Other measurement
7662	GCST003075	Cognitive decline rate in late mild cognitive impairment	Cognitive decline rate in late mild cognitive impairment	Other measurement
7663	GCST003075	Cognitive decline rate in late mild cognitive impairment	Cognitive decline rate in late mild cognitive impairment	Other trait
7664	GCST003069	Left superior temporal gyrus thickness (schizophrenia interaction)	Left superior temporal gyrus thickness (schizophrenia interaction)	Neurological disorder
7665	GCST003069	Left superior temporal gyrus thickness (schizophrenia interaction)	Left superior temporal gyrus thickness (schizophrenia interaction)	Other measurement
7666	GCST003072	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
7667	GCST003072	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
7668	GCST003065	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	Other measurement
7669	GCST003064	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	Other measurement
7670	GCST003068	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)	Other measurement
7671	GCST003067	Exploratory eye movement dysfunction in schizophrenia (mean eye scanning length)	Exploratory eye movement dysfunction in schizophrenia (mean eye scanning length)	Other measurement
7672	GCST003066	Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)	Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)	Other measurement
7673	GCST003063	Neuropathic pain in type 2 diabetes	Neuropathic pain in type 2 diabetes	Metabolic disorder
7674	GCST003063	Neuropathic pain in type 2 diabetes	Neuropathic pain in type 2 diabetes	Other trait
7675	GCST003614	Opioid dependence	Opioid dependence	Neurological disorder
7676	GCST003062	Anthracycline-induced cardiotoxicity in childhood cancer	Anthracycline-induced cardiotoxicity in childhood cancer	Cardiovascular disease
7677	GCST003062	Anthracycline-induced cardiotoxicity in childhood cancer	Anthracycline-induced cardiotoxicity in childhood cancer	Cancer
7678	GCST003062	Anthracycline-induced cardiotoxicity in childhood cancer	Anthracycline-induced cardiotoxicity in childhood cancer	Response to drug
7679	GCST003061	Cutaneous malignant melanoma	Cutaneous malignant melanoma	Cancer
7680	GCST003060	Parkinson's disease in GBA mutation carriers (age at onset)	Parkinson's disease in GBA mutation carriers (age at onset)	Neurological disorder
7681	GCST003060	Parkinson's disease in GBA mutation carriers (age at onset)	Parkinson's disease in GBA mutation carriers (age at onset)	Other measurement
7682	GCST003060	Parkinson's disease in GBA mutation carriers (age at onset)	Parkinson's disease in GBA mutation carriers (age at onset)	Other measurement
7683	GCST003059	Parkinson's disease	Parkinson's disease	Neurological disorder
7684	GCST003058	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Cancer
7685	GCST003058	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Response to drug
7686	GCST003058	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Response to drug
7687	GCST003058	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Other measurement
7688	GCST003057	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Cancer
7689	GCST003057	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Response to drug
7690	GCST003057	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Response to drug
7691	GCST003057	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Other measurement
7692	GCST003054	Gait rhythm	Gait rhythm	Other measurement
7693	GCST003056	Gait variability	Gait variability	Other measurement
7694	GCST003055	Tandem gait	Tandem gait	Other measurement
7695	GCST003053	Cryptorchidism	Cryptorchidism	Other disease
7696	GCST003052	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
7697	GCST003052	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
7698	GCST003051	Multiple myeloma (survival)	Multiple myeloma (survival)	Other measurement
7699	GCST003051	Multiple myeloma (survival)	Multiple myeloma (survival)	Cancer
7700	GCST003050	Schizophrenia	Schizophrenia	Neurological disorder
7701	GCST003093	Nicotine dependence	Nicotine dependence	Neurological disorder
7702	GCST005269	Luteinizing hormone levels in polycystic ovary syndrome	Luteinizing hormone levels in polycystic ovary syndrome	Other disease
7703	GCST005269	Luteinizing hormone levels in polycystic ovary syndrome	Luteinizing hormone levels in polycystic ovary syndrome	Other measurement
7704	GCST005274	DHEAS levels in polycystic ovary syndrome	DHEAS levels in polycystic ovary syndrome	Other disease
7705	GCST005274	DHEAS levels in polycystic ovary syndrome	DHEAS levels in polycystic ovary syndrome	Other measurement
7706	GCST005273	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
7707	GCST005272	Testosterone levels in polycystic ovary syndrome	Testosterone levels in polycystic ovary syndrome	Other disease
7708	GCST005272	Testosterone levels in polycystic ovary syndrome	Testosterone levels in polycystic ovary syndrome	Other measurement
7709	GCST005271	Sex hormone-binding globulin levels in polycystic ovary syndrome	Sex hormone-binding globulin levels in polycystic ovary syndrome	Other measurement
7710	GCST005271	Sex hormone-binding globulin levels in polycystic ovary syndrome	Sex hormone-binding globulin levels in polycystic ovary syndrome	Other disease
7711	GCST005270	Follicule stimulating hormone levels in polycystic ovary syndrome	Follicule stimulating hormone levels in polycystic ovary syndrome	Other measurement
7712	GCST005270	Follicule stimulating hormone levels in polycystic ovary syndrome	Follicule stimulating hormone levels in polycystic ovary syndrome	Other disease
7713	GCST003087	Body mass index variance	Body mass index variance	Body measurement
7714	GCST003086	Kidney stones	Kidney stones	Other disease
7715	GCST003028	Serum alpha1-antitrypsin levels	Serum alpha1-antitrypsin levels	Other measurement
7716	GCST003029	Asperger syndrome	Asperger syndrome	Neurological disorder
7717	GCST003026	Yu-Zhi constitution type in type 2 diabetes	Yu-Zhi constitution type in type 2 diabetes	Other trait
7718	GCST003026	Yu-Zhi constitution type in type 2 diabetes	Yu-Zhi constitution type in type 2 diabetes	Metabolic disorder
7719	GCST003024	Ultraviolet-induced skin pigmentation (minimal erythema dose)	Ultraviolet-induced skin pigmentation (minimal erythema dose)	Other measurement
7720	GCST003025	Attention function in attention deficit hyperactive disorder	Attention function in attention deficit hyperactive disorder	Neurological disorder
7721	GCST003025	Attention function in attention deficit hyperactive disorder	Attention function in attention deficit hyperactive disorder	Other measurement
7722	GCST003027	Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough in response to angiotensin-converting enzyme inhibitor drugs	Other trait
7723	GCST003027	Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough in response to angiotensin-converting enzyme inhibitor drugs	Response to drug
7724	GCST003038	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
7725	GCST003030	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Neurological disorder
7726	GCST003030	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Other measurement
7727	GCST003031	MGMT methylation in smokers	MGMT methylation in smokers	Biological process
7728	GCST003031	MGMT methylation in smokers	MGMT methylation in smokers	Other measurement
7729	GCST002960	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
7730	GCST002963	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
7731	GCST002962	Asthma exacerbations	Asthma exacerbations	Other measurement
7732	GCST002958	Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	Immune system disorder
7733	GCST002958	Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	Biological process
7734	GCST002956	3-hydroxypropylmercapturic acid levels in smokers	3-hydroxypropylmercapturic acid levels in smokers	Biological process
7735	GCST002956	3-hydroxypropylmercapturic acid levels in smokers	3-hydroxypropylmercapturic acid levels in smokers	Biological process
7736	GCST002956	3-hydroxypropylmercapturic acid levels in smokers	3-hydroxypropylmercapturic acid levels in smokers	Other measurement
7737	GCST002957	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	Biological process
7738	GCST002957	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	Other measurement
7739	GCST002954	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
7740	GCST002954	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
7741	GCST002955	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Other measurement
7742	GCST002955	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Biological process
7743	GCST002955	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Biological process
7744	GCST002955	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Biological process
7745	GCST002953	Pediatric areal bone mineral density (radius)	Pediatric areal bone mineral density (radius)	Other measurement
7746	GCST002952	Pediatric bone mineral content (radius)	Pediatric bone mineral content (radius)	Other measurement
7747	GCST002951	Response to zileuton treatment in asthma (FEV1 change interaction)	Response to zileuton treatment in asthma (FEV1 change interaction)	Other measurement
7748	GCST002951	Response to zileuton treatment in asthma (FEV1 change interaction)	Response to zileuton treatment in asthma (FEV1 change interaction)	Other disease
7749	GCST002951	Response to zileuton treatment in asthma (FEV1 change interaction)	Response to zileuton treatment in asthma (FEV1 change interaction)	Response to drug
7750	GCST002950	Epilepsy	Epilepsy	Neurological disorder
7751	GCST002950	Epilepsy	Epilepsy	Neurological disorder
7752	GCST002950	Epilepsy	Epilepsy	Neurological disorder
7753	GCST002949	Epilepsy and lamotrigine-induced maculopapular eruptions	Epilepsy and lamotrigine-induced maculopapular eruptions	Response to drug
7754	GCST002949	Epilepsy and lamotrigine-induced maculopapular eruptions	Epilepsy and lamotrigine-induced maculopapular eruptions	Other disease
7755	GCST002949	Epilepsy and lamotrigine-induced maculopapular eruptions	Epilepsy and lamotrigine-induced maculopapular eruptions	Neurological disorder
7756	GCST002942	Percentage gas trapping	Percentage gas trapping	Other measurement
7757	GCST002943	IgA nephropathy	IgA nephropathy	Other disease
7758	GCST002944	Prostate cancer	Prostate cancer	Cancer
7759	GCST002940	Sporadic pituitary adenoma	Sporadic pituitary adenoma	Cancer
7760	GCST002989	LDL peak particle diameter (total fat intake interaction)	LDL peak particle diameter (total fat intake interaction)	Lipid or lipoprotein measurement
7761	GCST002989	LDL peak particle diameter (total fat intake interaction)	LDL peak particle diameter (total fat intake interaction)	Other measurement
7762	GCST002984	Early childhood aggressive behavior	Early childhood aggressive behavior	Other measurement
7763	GCST002987	Stroke	Stroke	Cardiovascular disease
7764	GCST002988	Ischemic stroke	Ischemic stroke	Cardiovascular disease
7765	GCST002988	Ischemic stroke	Ischemic stroke	Other trait
7766	GCST002986	Childhood and early adolescence aggressive behavior	Childhood and early adolescence aggressive behavior	Other measurement
7767	GCST002983	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
7768	GCST002983	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
7769	GCST002985	Middle childhood and early adolescence aggressive behavior	Middle childhood and early adolescence aggressive behavior	Other measurement
7770	GCST002976	HIV-1 viral setpoint	HIV-1 viral setpoint	Biological process
7771	GCST002976	HIV-1 viral setpoint	HIV-1 viral setpoint	Other measurement
7772	GCST002976	HIV-1 viral setpoint	HIV-1 viral setpoint	Other disease
7773	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7774	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7775	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7776	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7777	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7778	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7779	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7780	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7781	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
7782	GCST002926	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Response to drug
7783	GCST002926	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Other disease
7784	GCST002926	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Other measurement
7785	GCST002921	Multiple myeloma	Multiple myeloma	Cancer
7786	GCST002922	Multiple myeloma and monoclonal gammopathy	Multiple myeloma and monoclonal gammopathy	Other disease
7787	GCST002922	Multiple myeloma and monoclonal gammopathy	Multiple myeloma and monoclonal gammopathy	Cancer
7788	GCST002995	Dysphagia	Dysphagia	Other trait
7789	GCST002993	Platinum-induced hepatotoxicity in non-small cell lung cancer	Platinum-induced hepatotoxicity in non-small cell lung cancer	Response to drug
7790	GCST002993	Platinum-induced hepatotoxicity in non-small cell lung cancer	Platinum-induced hepatotoxicity in non-small cell lung cancer	Digestive system disorder
7791	GCST002993	Platinum-induced hepatotoxicity in non-small cell lung cancer	Platinum-induced hepatotoxicity in non-small cell lung cancer	Cancer
7792	GCST002991	Pancreatic cancer	Pancreatic cancer	Cancer
7793	GCST002970	Corticobasal degeneration	Corticobasal degeneration	Neurological disorder
7794	GCST002968	Response to stavudine in HIV (lipoatrophy)	Response to stavudine in HIV (lipoatrophy)	Response to drug
7795	GCST002968	Response to stavudine in HIV (lipoatrophy)	Response to stavudine in HIV (lipoatrophy)	Other disease
7796	GCST002968	Response to stavudine in HIV (lipoatrophy)	Response to stavudine in HIV (lipoatrophy)	Other trait
7797	GCST002967	Mucinous ovarian carcinoma	Mucinous ovarian carcinoma	Cancer
7798	GCST003256	Joint damage progression in ACPA-negative rheumatoid arthritis	Joint damage progression in ACPA-negative rheumatoid arthritis	Immune system disorder
7799	GCST003256	Joint damage progression in ACPA-negative rheumatoid arthritis	Joint damage progression in ACPA-negative rheumatoid arthritis	Other measurement
7800	GCST002978	Metastasis at diagnosis in osteosarcoma	Metastasis at diagnosis in osteosarcoma	Other measurement
7801	GCST002978	Metastasis at diagnosis in osteosarcoma	Metastasis at diagnosis in osteosarcoma	Cancer
7802	GCST002978	Metastasis at diagnosis in osteosarcoma	Metastasis at diagnosis in osteosarcoma	Other measurement
7803	GCST002979	Response to montelukast in asthma (change in FEV1)	Response to montelukast in asthma (change in FEV1)	Other measurement
7804	GCST002979	Response to montelukast in asthma (change in FEV1)	Response to montelukast in asthma (change in FEV1)	Other disease
7805	GCST002979	Response to montelukast in asthma (change in FEV1)	Response to montelukast in asthma (change in FEV1)	Response to drug
7806	GCST002980	Arterial stiffness (pulse-wave velocity)	Arterial stiffness (pulse-wave velocity)	Cardiovascular measurement
7807	GCST002981	Longitudinal alcohol consumption	Longitudinal alcohol consumption	Other measurement
7808	GCST002982	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Other trait
7809	GCST002982	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Other trait
7810	GCST002982	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Other measurement
7811	GCST002975	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Other trait
7812	GCST002975	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Cardiovascular disease
7813	GCST002971	Corticobasal degeneration	Corticobasal degeneration	Neurological disorder
7814	GCST002945	Emphysema imaging phenotypes	Emphysema imaging phenotypes	Other measurement
7815	GCST002941	Airway imaging phenotypes	Airway imaging phenotypes	Other measurement
7816	GCST002939	Platelet aggregation	Platelet aggregation	Biological process
7817	GCST003010	Gastric cancer	Gastric cancer	Cancer
7818	GCST003007	Non-cardia gastric cancer	Non-cardia gastric cancer	Cancer
7819	GCST003009	Cardia gastric cancer	Cardia gastric cancer	Cancer
7820	GCST003008	Triptolide cytotoxicity	Triptolide cytotoxicity	Other measurement
7821	GCST003008	Triptolide cytotoxicity	Triptolide cytotoxicity	Response to drug
7822	GCST003008	Triptolide cytotoxicity	Triptolide cytotoxicity	Other trait
7823	GCST003008	Triptolide cytotoxicity	Triptolide cytotoxicity	Other measurement
7824	GCST003006	Noise-induced hearing loss	Noise-induced hearing loss	Neurological disorder
7825	GCST002884	Cutaneous lupus erythematosus	Cutaneous lupus erythematosus	Immune system disorder
7826	GCST002882	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	Cardiovascular disease
7827	GCST002882	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	Other measurement
7828	GCST002883	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	Cardiovascular disease
7829	GCST002883	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	Other measurement
7830	GCST002881	ADAMTS13 activity	ADAMTS13 activity	Other measurement
7831	GCST004751	Serum uric acid levels in response to allopurinol in gout	Serum uric acid levels in response to allopurinol in gout	Cardiovascular measurement
7832	GCST004751	Serum uric acid levels in response to allopurinol in gout	Serum uric acid levels in response to allopurinol in gout	Metabolic disorder
7833	GCST004751	Serum uric acid levels in response to allopurinol in gout	Serum uric acid levels in response to allopurinol in gout	Response to drug
7834	GCST002880	Recalcitrant atopic dermatitis	Recalcitrant atopic dermatitis	Immune system disorder
7835	GCST008489	Celiac disease	Celiac disease	Immune system disorder
7836	GCST002879	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
7837	GCST002879	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
7838	GCST002877	Adult antisocial behavior	Adult antisocial behavior	Other measurement
7839	GCST002878	Creutzfeldt-Jakob disease (sporadic)	Creutzfeldt-Jakob disease (sporadic)	Neurological disorder
7840	GCST002903	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Other measurement
7841	GCST002903	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Cancer
7842	GCST002903	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Cancer
7843	GCST002903	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Other measurement
7844	GCST002896	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
7845	GCST002898	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7846	GCST002898	LDL cholesterol	LDL cholesterol	Other measurement
7847	GCST002898	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7848	GCST002897	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
7849	GCST002904	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	Cancer
7850	GCST002904	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	Metabolic disorder
7851	GCST002899	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
7852	GCST002900	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Biological process
7853	GCST002900	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Cancer
7854	GCST002900	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Metabolic disorder
7855	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Other measurement
7856	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Cancer
7857	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Cancer
7858	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Response to drug
7859	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Other measurement
7860	GCST002902	Survival in breast cancer (estrogen-receptor negative)	Survival in breast cancer (estrogen-receptor negative)	Other measurement
7861	GCST002902	Survival in breast cancer (estrogen-receptor negative)	Survival in breast cancer (estrogen-receptor negative)	Cancer
7862	GCST002902	Survival in breast cancer (estrogen-receptor negative)	Survival in breast cancer (estrogen-receptor negative)	Cancer
7863	GCST002895	Breast cancer	Breast cancer	Cancer
7864	GCST002876	Type 1 diabetes and autoimmune thyroid diseases	Type 1 diabetes and autoimmune thyroid diseases	Immune system disorder
7865	GCST002876	Type 1 diabetes and autoimmune thyroid diseases	Type 1 diabetes and autoimmune thyroid diseases	Metabolic disorder
7866	GCST002875	Diisocyanate-induced asthma	Diisocyanate-induced asthma	Biological process
7867	GCST002875	Diisocyanate-induced asthma	Diisocyanate-induced asthma	Other disease
7868	GCST002874	Psoriasis	Psoriasis	Immune system disorder
7869	GCST002873	Thyroid cancer	Thyroid cancer	Cancer
7870	GCST002872	Blood metabolite levels	Blood metabolite levels	Other measurement
7871	GCST002872	Blood metabolite levels	Blood metabolite levels	Other measurement
7872	GCST002872	Blood metabolite levels	Blood metabolite levels	Other measurement
7873	GCST002872	Blood metabolite levels	Blood metabolite levels	Other measurement
7874	GCST002868	Response to serotonin reuptake inhibitors in major depressive disorder	Response to serotonin reuptake inhibitors in major depressive disorder	Response to drug
7875	GCST002868	Response to serotonin reuptake inhibitors in major depressive disorder	Response to serotonin reuptake inhibitors in major depressive disorder	Neurological disorder
7876	GCST002848	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
7877	GCST002844	Atopic dermatitis	Atopic dermatitis	Immune system disorder
7878	GCST008391	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
7879	GCST002845	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7880	GCST002842	Basal cell carcinoma	Basal cell carcinoma	Cancer
7881	GCST008479	Psoriasis	Psoriasis	Immune system disorder
7882	GCST002843	Sitting height ratio	Sitting height ratio	Body measurement
7883	GCST002841	Developmental dysplasia of the hip	Developmental dysplasia of the hip	Other disease
7884	GCST002840	Myeloproliferative neoplasms	Myeloproliferative neoplasms	Cancer
7885	GCST002839	Polychlorinated biphenyl levels	Polychlorinated biphenyl levels	Other measurement
7886	GCST002919	Colorectal cancer	Colorectal cancer	Cancer
7887	GCST002920	Neuroticism	Neuroticism	Neurological disorder
7888	GCST002920	Neuroticism	Neuroticism	Other measurement
7889	GCST002918	Lapatinib-induced hepatotoxicity	Lapatinib-induced hepatotoxicity	Digestive system disorder
7890	GCST002918	Lapatinib-induced hepatotoxicity	Lapatinib-induced hepatotoxicity	Response to drug
7891	GCST002916	Cannabis use (initiation)	Cannabis use (initiation)	Neurological disorder
7892	GCST002916	Cannabis use (initiation)	Cannabis use (initiation)	Biological process
7893	GCST002917	Cannabis use (age at onset)	Cannabis use (age at onset)	Biological process
7894	GCST002917	Cannabis use (age at onset)	Cannabis use (age at onset)	Other measurement
7895	GCST002913	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Immune system disorder
7896	GCST002913	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Other trait
7897	GCST002913	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Other trait
7898	GCST002914	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
7899	GCST002915	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Cancer
7900	GCST002915	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Response to drug
7901	GCST002912	Narcolepsy with cataplexy	Narcolepsy with cataplexy	Neurological disorder
7902	GCST002869	Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	Immune system disorder
7903	GCST002869	Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	Response to drug
7904	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Other measurement
7905	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Cancer
7906	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Cancer
7907	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Cancer
7908	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Other measurement
7909	GCST002860	Magnesium levels	Magnesium levels	Other measurement
7910	GCST002858	Cytokine and corticosteroid-stimulated IL-6 production	Cytokine and corticosteroid-stimulated IL-6 production	Response to drug
7911	GCST002858	Cytokine and corticosteroid-stimulated IL-6 production	Cytokine and corticosteroid-stimulated IL-6 production	Inflammatory measurement
7912	GCST002858	Cytokine and corticosteroid-stimulated IL-6 production	Cytokine and corticosteroid-stimulated IL-6 production	Response to drug
7913	GCST002857	Calcium levels	Calcium levels	Other measurement
7914	GCST002859	Cytokine-stimulated IL-6 production	Cytokine-stimulated IL-6 production	Inflammatory measurement
7915	GCST002859	Cytokine-stimulated IL-6 production	Cytokine-stimulated IL-6 production	Response to drug
7916	GCST002893	Body mass index (age interaction)	Body mass index (age interaction)	Body measurement
7917	GCST002894	Body mass index	Body mass index	Body measurement
7918	GCST002894	Body mass index	Body mass index	Body measurement
7919	GCST002894	Body mass index	Body mass index	Other measurement
7920	GCST002892	Perioperative myocardial infarction in coronary artery bypass surgery	Perioperative myocardial infarction in coronary artery bypass surgery	Other trait
7921	GCST002892	Perioperative myocardial infarction in coronary artery bypass surgery	Perioperative myocardial infarction in coronary artery bypass surgery	Cardiovascular disease
7922	GCST002889	Psoriasis	Psoriasis	Immune system disorder
7923	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Response to drug
7924	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Neurological disorder
7925	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Neurological disorder
7926	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Neurological disorder
7927	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Other measurement
7928	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Response to drug
7929	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
7930	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
7931	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
7932	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Other measurement
7933	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
7934	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
7935	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
7936	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Other measurement
7937	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Response to drug
7938	GCST002886	Prostate cancer aggressiveness	Prostate cancer aggressiveness	Cancer
7939	GCST002886	Prostate cancer aggressiveness	Prostate cancer aggressiveness	Other measurement
7940	GCST002886	Prostate cancer aggressiveness	Prostate cancer aggressiveness	Other measurement
7941	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Neurological disorder
7942	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Neurological disorder
7943	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Neurological disorder
7944	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Other measurement
7945	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Response to drug
7946	GCST002890	Prostate cancer	Prostate cancer	Cancer
7947	GCST002856	Carotid artery intima media thickness (sex interaction)	Carotid artery intima media thickness (sex interaction)	Other measurement
7948	GCST002856	Carotid artery intima media thickness (sex interaction)	Carotid artery intima media thickness (sex interaction)	Other measurement
7949	GCST002855	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
7950	GCST002855	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
7951	GCST002851	Sasang constitutional medicine type (Tae-Yang)	Sasang constitutional medicine type (Tae-Yang)	Other trait
7952	GCST002851	Sasang constitutional medicine type (Tae-Yang)	Sasang constitutional medicine type (Tae-Yang)	Other trait
7953	GCST002852	Sasang constitutional medicine type (So-Yang)	Sasang constitutional medicine type (So-Yang)	Other trait
7954	GCST002852	Sasang constitutional medicine type (So-Yang)	Sasang constitutional medicine type (So-Yang)	Other trait
7955	GCST002853	Sasang constitutional medicine type (Tae-Eum)	Sasang constitutional medicine type (Tae-Eum)	Other trait
7956	GCST002853	Sasang constitutional medicine type (Tae-Eum)	Sasang constitutional medicine type (Tae-Eum)	Other trait
7957	GCST002854	Sasang constitutional medicine type (So-Eum)	Sasang constitutional medicine type (So-Eum)	Other trait
7958	GCST002854	Sasang constitutional medicine type (So-Eum)	Sasang constitutional medicine type (So-Eum)	Other trait
7959	GCST002850	Information processing speed	Information processing speed	Biological process
7960	GCST002849	Executive function	Executive function	Biological process
7961	GCST002847	Disease-free survival in breast cancer	Disease-free survival in breast cancer	Cancer
7962	GCST002847	Disease-free survival in breast cancer	Disease-free survival in breast cancer	Other measurement
7963	GCST002910	Response to interferon beta in multiple sclerosis	Response to interferon beta in multiple sclerosis	Immune system disorder
7964	GCST002910	Response to interferon beta in multiple sclerosis	Response to interferon beta in multiple sclerosis	Response to drug
7965	GCST002911	Calcium levels	Calcium levels	Other measurement
7966	GCST002909	Gout	Gout	Metabolic disorder
7967	GCST006799	Pyridoxal 5'-phosphate levels	Pyridoxal 5'-phosphate levels	Other measurement
7968	GCST006798	4-pyridoxic acid levels	4-pyridoxic acid levels	Other measurement
7969	GCST006797	Pyridoxal levels	Pyridoxal levels	Other measurement
7970	GCST002906	Skin colour saturation	Skin colour saturation	Other trait
7971	GCST002908	Skin sensitivity to sun	Skin sensitivity to sun	Immune system disorder
7972	GCST002907	Perceived skin darkness	Perceived skin darkness	Other trait
7973	GCST002905	Endophenotypes for schizophrenia in healthy individuals	Endophenotypes for schizophrenia in healthy individuals	Other trait
7974	GCST002787	Exfoliation syndrome	Exfoliation syndrome	Neurological disorder
7975	GCST002784	Blood pressure response to hydrochlorothiazide in hypertension	Blood pressure response to hydrochlorothiazide in hypertension	Other measurement
7976	GCST002784	Blood pressure response to hydrochlorothiazide in hypertension	Blood pressure response to hydrochlorothiazide in hypertension	Other measurement
7977	GCST002784	Blood pressure response to hydrochlorothiazide in hypertension	Blood pressure response to hydrochlorothiazide in hypertension	Response to drug
7978	GCST002784	Blood pressure response to hydrochlorothiazide in hypertension	Blood pressure response to hydrochlorothiazide in hypertension	Cardiovascular disease
7979	GCST002782	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
7980	GCST002782	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
7981	GCST004066	Hip circumference	Hip circumference	Body measurement
7982	GCST004063	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
7983	GCST004063	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
7984	GCST004067	Hip circumference adjusted for BMI	Hip circumference adjusted for BMI	Body measurement
7985	GCST004065	Waist circumference	Waist circumference	Body measurement
7986	GCST004064	Waist-hip ratio	Waist-hip ratio	Other measurement
7987	GCST004064	Waist-hip ratio	Waist-hip ratio	Body measurement
7988	GCST002783	Body mass index	Body mass index	Body measurement
7989	GCST002783	Body mass index	Body mass index	Body measurement
7990	GCST002783	Body mass index	Body mass index	Other measurement
7991	GCST002781	Periodontitis	Periodontitis	Digestive system disorder
7992	GCST002838	Myasthenia gravis	Myasthenia gravis	Neurological disorder
7993	GCST002838	Myasthenia gravis	Myasthenia gravis	Other disease
7994	GCST005536	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
7995	GCST002837	Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	Response to drug
7996	GCST002837	Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	Other measurement
7997	GCST002833	Platinum-induced myelosuppression in non-small cell lung cancer	Platinum-induced myelosuppression in non-small cell lung cancer	Response to drug
7998	GCST002833	Platinum-induced myelosuppression in non-small cell lung cancer	Platinum-induced myelosuppression in non-small cell lung cancer	Cancer
7999	GCST002833	Platinum-induced myelosuppression in non-small cell lung cancer	Platinum-induced myelosuppression in non-small cell lung cancer	Other trait
8000	GCST002834	Corneal curvature	Corneal curvature	Other measurement
8001	GCST002836	Axial length	Axial length	Other measurement
8002	GCST002835	Renal cell carcinoma	Renal cell carcinoma	Cancer
8003	GCST002831	Lead levels in blood	Lead levels in blood	Other measurement
8004	GCST002830	Urate levels in lean individuals	Urate levels in lean individuals	Body measurement
8005	GCST002830	Urate levels in lean individuals	Urate levels in lean individuals	Other measurement
8006	GCST006198	Giant cell arteritis	Giant cell arteritis	Cardiovascular disease
8007	GCST002827	Urate levels (BMI interaction)	Urate levels (BMI interaction)	Body measurement
8008	GCST002827	Urate levels (BMI interaction)	Urate levels (BMI interaction)	Other measurement
8009	GCST002828	Urate levels in obese individuals	Urate levels in obese individuals	Other measurement
8010	GCST002828	Urate levels in obese individuals	Urate levels in obese individuals	Body measurement
8011	GCST002829	Urate levels in overweight individuals	Urate levels in overweight individuals	Body measurement
8012	GCST002829	Urate levels in overweight individuals	Urate levels in overweight individuals	Other measurement
8013	GCST002826	Urate levels (BMI interaction)	Urate levels (BMI interaction)	Body measurement
8014	GCST002826	Urate levels (BMI interaction)	Urate levels (BMI interaction)	Other measurement
8015	GCST002823	Behcet's disease	Behcet's disease	Cardiovascular disease
8016	GCST002824	Behcet's disease	Behcet's disease	Cardiovascular disease
8017	GCST002825	Insulin resistance/response	Insulin resistance/response	Other trait
8018	GCST002820	Survival in microsatellite instability low/stable colorectal cancer	Survival in microsatellite instability low/stable colorectal cancer	Other measurement
8019	GCST002820	Survival in microsatellite instability low/stable colorectal cancer	Survival in microsatellite instability low/stable colorectal cancer	Cancer
8020	GCST002820	Survival in microsatellite instability low/stable colorectal cancer	Survival in microsatellite instability low/stable colorectal cancer	Other measurement
8021	GCST002820	Survival in microsatellite instability low/stable colorectal cancer	Survival in microsatellite instability low/stable colorectal cancer	Other measurement
8022	GCST002769	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Response to drug
8023	GCST002769	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Other measurement
8024	GCST002769	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Other disease
8025	GCST002770	Hand grip strength	Hand grip strength	Other measurement
8026	GCST002768	Behavioral disinhibition	Behavioral disinhibition	Other measurement
8027	GCST002767	Intraocular pressure	Intraocular pressure	Other measurement
8028	GCST002766	Exudative age-related macular degeneration	Exudative age-related macular degeneration	Neurological disorder
8029	GCST002780	Cisplatin-induced hearing loss in brain tumor patients	Cisplatin-induced hearing loss in brain tumor patients	Other trait
8030	GCST002780	Cisplatin-induced hearing loss in brain tumor patients	Cisplatin-induced hearing loss in brain tumor patients	Neurological disorder
8031	GCST002780	Cisplatin-induced hearing loss in brain tumor patients	Cisplatin-induced hearing loss in brain tumor patients	Response to drug
8032	GCST002779	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Other disease
8033	GCST002779	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Response to drug
8034	GCST002779	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Other disease
8035	GCST002778	Parkinson disease and lewy body pathology	Parkinson disease and lewy body pathology	Neurological disorder
8036	GCST002778	Parkinson disease and lewy body pathology	Parkinson disease and lewy body pathology	Other measurement
8037	GCST002777	Clozapine-induced cytotoxicity	Clozapine-induced cytotoxicity	Response to drug
8038	GCST002777	Clozapine-induced cytotoxicity	Clozapine-induced cytotoxicity	Other measurement
8039	GCST002776	Endometriosis	Endometriosis	Other disease
8040	GCST002775	Alzheimer's disease (survival time)	Alzheimer's disease (survival time)	Other measurement
8041	GCST002775	Alzheimer's disease (survival time)	Alzheimer's disease (survival time)	Neurological disorder
8042	GCST002774	Cognitive function	Cognitive function	Biological process
8043	GCST002774	Cognitive function	Cognitive function	Biological process
8044	GCST002774	Cognitive function	Cognitive function	Other measurement
8045	GCST002774	Cognitive function	Cognitive function	Biological process
8046	GCST002773	Gout	Gout	Metabolic disorder
8047	GCST002772	Leprosy	Leprosy	Neurological disorder
8048	GCST002771	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Response to drug
8049	GCST002771	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Other measurement
8050	GCST002771	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Other disease
8051	GCST002821	Survival in rectal cancer	Survival in rectal cancer	Other measurement
8052	GCST002821	Survival in rectal cancer	Survival in rectal cancer	Cancer
8053	GCST002821	Survival in rectal cancer	Survival in rectal cancer	Other measurement
8054	GCST002822	Survival in colon cancer	Survival in colon cancer	Cancer
8055	GCST002822	Survival in colon cancer	Survival in colon cancer	Other measurement
8056	GCST002822	Survival in colon cancer	Survival in colon cancer	Other measurement
8057	GCST002819	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
8058	GCST002819	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
8059	GCST002818	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
8060	GCST002818	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
8061	GCST002814	Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease (APOE e4 interaction)	Neurological disorder
8062	GCST002814	Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease (APOE e4 interaction)	Other measurement
8063	GCST002817	Alzheimer's disease in APOE e4- carriers	Alzheimer's disease in APOE e4- carriers	Neurological disorder
8064	GCST002813	Alzheimer's disease in APOE e4+ carriers	Alzheimer's disease in APOE e4+ carriers	Neurological disorder
8065	GCST002815	Bipolar disorder (inflammation and infection response interaction)	Bipolar disorder (inflammation and infection response interaction)	Neurological disorder
8066	GCST002815	Bipolar disorder (inflammation and infection response interaction)	Bipolar disorder (inflammation and infection response interaction)	Other measurement
8067	GCST002815	Bipolar disorder (inflammation and infection response interaction)	Bipolar disorder (inflammation and infection response interaction)	Other measurement
8068	GCST002816	Colorectal cancer (aspirin and/or NSAID use interaction)	Colorectal cancer (aspirin and/or NSAID use interaction)	Cancer
8069	GCST002816	Colorectal cancer (aspirin and/or NSAID use interaction)	Colorectal cancer (aspirin and/or NSAID use interaction)	Other measurement
8070	GCST002816	Colorectal cancer (aspirin and/or NSAID use interaction)	Colorectal cancer (aspirin and/or NSAID use interaction)	Other measurement
8071	GCST002816	Colorectal cancer (aspirin and/or NSAID use interaction)	Colorectal cancer (aspirin and/or NSAID use interaction)	Other measurement
8072	GCST002812	Schizophrenia (inflammation and infection response interaction)	Schizophrenia (inflammation and infection response interaction)	Neurological disorder
8073	GCST002812	Schizophrenia (inflammation and infection response interaction)	Schizophrenia (inflammation and infection response interaction)	Other measurement
8074	GCST002812	Schizophrenia (inflammation and infection response interaction)	Schizophrenia (inflammation and infection response interaction)	Other measurement
8075	GCST002812	Schizophrenia (inflammation and infection response interaction)	Schizophrenia (inflammation and infection response interaction)	Other measurement
8076	GCST002811	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
8077	GCST002811	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
8078	GCST002810	Tuberculosis	Tuberculosis	Other disease
8079	GCST002810	Tuberculosis	Tuberculosis	Other measurement
8080	GCST002810	Tuberculosis	Tuberculosis	Other measurement
8081	GCST002809	Bipolar disorder	Bipolar disorder	Neurological disorder
8082	GCST002808	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
8083	GCST002807	Classic bladder exstrophy	Classic bladder exstrophy	Other disease
8084	GCST002803	Red wine liking	Red wine liking	Other measurement
8085	GCST002802	White wine liking	White wine liking	Other measurement
8086	GCST002806	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8087	GCST002805	Body mass index	Body mass index	Body measurement
8088	GCST002805	Body mass index	Body mass index	Body measurement
8089	GCST002805	Body mass index	Body mass index	Other measurement
8090	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
8091	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
8092	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
8093	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
8094	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
8095	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
8096	GCST002794	Airway wall thickness	Airway wall thickness	Other measurement
8097	GCST002793	Vein graft stenosis in coronary artery bypass grafting	Vein graft stenosis in coronary artery bypass grafting	Other trait
8098	GCST002793	Vein graft stenosis in coronary artery bypass grafting	Vein graft stenosis in coronary artery bypass grafting	Other trait
8099	GCST008434	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8100	GCST002792	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Response to drug
8101	GCST002792	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Cancer
8102	GCST002792	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Neurological disorder
8103	GCST002790	Food allergy	Food allergy	Other measurement
8104	GCST002789	Egg allergy	Egg allergy	Other measurement
8105	GCST002788	Milk allergy	Milk allergy	Other measurement
8106	GCST002791	Peanut allergy	Peanut allergy	Other measurement
8107	GCST002786	Gene methylation in lung tissue	Gene methylation in lung tissue	Other measurement
8108	GCST008165	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
8109	GCST008165	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
8110	GCST008164	Free thyroxine concentration	Free thyroxine concentration	Other measurement
8111	GCST002800	Number of children (6+ vs. 0 or 1)	Number of children (6+ vs. 0 or 1)	Other measurement
8112	GCST002800	Number of children (6+ vs. 0 or 1)	Number of children (6+ vs. 0 or 1)	Other trait
8113	GCST002799	Number of pregnancies	Number of pregnancies	Other measurement
8114	GCST002799	Number of pregnancies	Number of pregnancies	Other trait
8115	GCST002799	Number of pregnancies	Number of pregnancies	Other measurement
8116	GCST002801	Number of children	Number of children	Other measurement
8117	GCST002801	Number of children	Number of children	Other trait
8118	GCST002796	Bronchodilator response in asthma	Bronchodilator response in asthma	Response to drug
8119	GCST002796	Bronchodilator response in asthma	Bronchodilator response in asthma	Other disease
8120	GCST005539	Alopecia areata	Alopecia areata	Other disease
8121	GCST002795	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
8122	GCST002797	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Other disease
8123	GCST002797	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Other trait
8124	GCST002798	Pulmonary artery enlargement and chronic obstructive pulmonary disease	Pulmonary artery enlargement and chronic obstructive pulmonary disease	Other disease
8125	GCST002798	Pulmonary artery enlargement and chronic obstructive pulmonary disease	Pulmonary artery enlargement and chronic obstructive pulmonary disease	Other trait
8126	GCST002755	Depressive symptoms (SSRI exposure interaction)	Depressive symptoms (SSRI exposure interaction)	Other measurement
8127	GCST002755	Depressive symptoms (SSRI exposure interaction)	Depressive symptoms (SSRI exposure interaction)	Other measurement
8128	GCST002755	Depressive symptoms (SSRI exposure interaction)	Depressive symptoms (SSRI exposure interaction)	Other measurement
8129	GCST002754	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Other measurement
8130	GCST002754	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Other disease
8131	GCST002754	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Response to drug
8132	GCST006575	Takayasu arteritis	Takayasu arteritis	Cardiovascular disease
8133	GCST002751	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other measurement
8134	GCST002751	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other trait
8135	GCST002752	Spontaneous preterm birth (preterm delivery)	Spontaneous preterm birth (preterm delivery)	Other measurement
8136	GCST002752	Spontaneous preterm birth (preterm delivery)	Spontaneous preterm birth (preterm delivery)	Other trait
8137	GCST002753	Lung cancer and family history of lung cancer	Lung cancer and family history of lung cancer	Other measurement
8138	GCST002753	Lung cancer and family history of lung cancer	Lung cancer and family history of lung cancer	Cancer
8139	GCST002750	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
8140	GCST002749	Response to Homoharringtonine (cytotoxicity)	Response to Homoharringtonine (cytotoxicity)	Other measurement
8141	GCST002749	Response to Homoharringtonine (cytotoxicity)	Response to Homoharringtonine (cytotoxicity)	Response to drug
8142	GCST002748	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
8143	GCST002748	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
8144	GCST002747	Response to Dalcetrapib treatment in acute coronary syndrome	Response to Dalcetrapib treatment in acute coronary syndrome	Response to drug
8145	GCST002747	Response to Dalcetrapib treatment in acute coronary syndrome	Response to Dalcetrapib treatment in acute coronary syndrome	Cardiovascular measurement
8146	GCST002747	Response to Dalcetrapib treatment in acute coronary syndrome	Response to Dalcetrapib treatment in acute coronary syndrome	Cardiovascular disease
8147	GCST002710	Anti-saccade response	Anti-saccade response	Other measurement
8148	GCST002707	Serum thyroid-stimulating hormone levels	Serum thyroid-stimulating hormone levels	Other measurement
8149	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
8150	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
8151	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
8152	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
8153	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
8154	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
8155	GCST002705	Hashimoto thyroiditis versus Graves' disease	Hashimoto thyroiditis versus Graves' disease	Immune system disorder
8156	GCST002705	Hashimoto thyroiditis versus Graves' disease	Hashimoto thyroiditis versus Graves' disease	Immune system disorder
8157	GCST002705	Hashimoto thyroiditis versus Graves' disease	Hashimoto thyroiditis versus Graves' disease	Immune system disorder
8158	GCST002703	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
8159	GCST002704	Fractional exhaled nitric oxide levels	Fractional exhaled nitric oxide levels	Other measurement
8160	GCST002702	Height	Height	Other measurement
8161	GCST002702	Height	Height	Body measurement
8162	GCST002701	Verbal declarative memory	Verbal declarative memory	Other measurement
8163	GCST002701	Verbal declarative memory	Verbal declarative memory	Other measurement
8164	GCST002701	Verbal declarative memory	Verbal declarative memory	Other measurement
8165	GCST002700	Cervical artery dissection	Cervical artery dissection	Cardiovascular disease
8166	GCST002699	Suicide in bipolar disorder	Suicide in bipolar disorder	Biological process
8167	GCST002699	Suicide in bipolar disorder	Suicide in bipolar disorder	Neurological disorder
8168	GCST002699	Suicide in bipolar disorder	Suicide in bipolar disorder	Other measurement
8169	GCST002760	Hippocampal atrophy	Hippocampal atrophy	Neurological disorder
8170	GCST002761	Hippocampal volume	Hippocampal volume	Other measurement
8171	GCST002759	Motion sickness	Motion sickness	Other trait
8172	GCST002758	Oligoclonal band status in multiple sclerosis	Oligoclonal band status in multiple sclerosis	Immune system disorder
8173	GCST002758	Oligoclonal band status in multiple sclerosis	Oligoclonal band status in multiple sclerosis	Other measurement
8174	GCST004866	Alopecia areata	Alopecia areata	Other disease
8175	GCST002757	Immunoglobulin G index levels in multiple sclerosis	Immunoglobulin G index levels in multiple sclerosis	Other measurement
8176	GCST002757	Immunoglobulin G index levels in multiple sclerosis	Immunoglobulin G index levels in multiple sclerosis	Immune system disorder
8177	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
8178	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
8179	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
8180	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
8181	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
8182	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Other measurement
8183	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Cancer
8184	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Cancer
8185	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Cancer
8186	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Other measurement
8187	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8188	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8189	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8190	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8191	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8192	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8193	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8194	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8195	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
8196	GCST004389	Circulating chemerin levels	Circulating chemerin levels	Cardiovascular measurement
8197	GCST002725	Sepsis from pneumonia (survival)	Sepsis from pneumonia (survival)	Other measurement
8198	GCST002725	Sepsis from pneumonia (survival)	Sepsis from pneumonia (survival)	Other trait
8199	GCST002725	Sepsis from pneumonia (survival)	Sepsis from pneumonia (survival)	Other trait
8200	GCST002725	Sepsis from pneumonia (survival)	Sepsis from pneumonia (survival)	Other disease
8201	GCST002724	Airway responsiveness in chronic obstructive pulmonary disease	Airway responsiveness in chronic obstructive pulmonary disease	Other disease
8202	GCST002724	Airway responsiveness in chronic obstructive pulmonary disease	Airway responsiveness in chronic obstructive pulmonary disease	Other measurement
8203	GCST002723	Urgency urinary incontinence	Urgency urinary incontinence	Other trait
8204	GCST002722	Heparin-induced thrombocytopenia	Heparin-induced thrombocytopenia	Response to drug
8205	GCST002722	Heparin-induced thrombocytopenia	Heparin-induced thrombocytopenia	Other trait
8206	GCST002720	Kidney function decline traits	Kidney function decline traits	Other disease
8207	GCST002720	Kidney function decline traits	Kidney function decline traits	Other measurement
8208	GCST002720	Kidney function decline traits	Kidney function decline traits	Other trait
8209	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
8210	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
8211	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
8212	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
8213	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
8214	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
8215	GCST002719	Seasonality	Seasonality	Other measurement
8216	GCST002746	Lipoprotein (a) - cholesterol levels	Lipoprotein (a) - cholesterol levels	Lipid or lipoprotein measurement
8217	GCST002744	HDL Cholesterol in HIV-infection	HDL Cholesterol in HIV-infection	Lipid or lipoprotein measurement
8218	GCST002744	HDL Cholesterol in HIV-infection	HDL Cholesterol in HIV-infection	Other disease
8219	GCST002743	Neutrophil count in HIV-infection	Neutrophil count in HIV-infection	Other disease
8220	GCST002743	Neutrophil count in HIV-infection	Neutrophil count in HIV-infection	Hematological measurement
8221	GCST002745	Total bilirubin levels in HIV-1 infection	Total bilirubin levels in HIV-1 infection	Other disease
8222	GCST002745	Total bilirubin levels in HIV-1 infection	Total bilirubin levels in HIV-1 infection	Other measurement
8223	GCST002742	Marginal zone lymphoma	Marginal zone lymphoma	Cancer
8224	GCST002738	Psoriasis	Psoriasis	Immune system disorder
8225	GCST002737	Atopic dermatitis	Atopic dermatitis	Immune system disorder
8226	GCST002739	Lung cancer (household air pollution interaction)	Lung cancer (household air pollution interaction)	Other measurement
8227	GCST002739	Lung cancer (household air pollution interaction)	Lung cancer (household air pollution interaction)	Cancer
8228	GCST002740	Inflammatory skin disease	Inflammatory skin disease	Immune system disorder
8229	GCST002740	Inflammatory skin disease	Inflammatory skin disease	Other disease
8230	GCST002740	Inflammatory skin disease	Inflammatory skin disease	Immune system disorder
8231	GCST002741	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
8232	GCST002686	Protein C levels	Protein C levels	Hematological measurement
8233	GCST002687	Fetal hemoglobin levels in sickle cell anemia	Fetal hemoglobin levels in sickle cell anemia	Neurological disorder
8234	GCST002687	Fetal hemoglobin levels in sickle cell anemia	Fetal hemoglobin levels in sickle cell anemia	Hematological measurement
8235	GCST002685	Refractive astigmatism	Refractive astigmatism	Other trait
8236	GCST002684	Diabetic retinopathy in type 2 diabetes	Diabetic retinopathy in type 2 diabetes	Metabolic disorder
8237	GCST002684	Diabetic retinopathy in type 2 diabetes	Diabetic retinopathy in type 2 diabetes	Metabolic disorder
8238	GCST002683	Pulmonary function	Pulmonary function	Other measurement
8239	GCST002683	Pulmonary function	Pulmonary function	Other measurement
8240	GCST002683	Pulmonary function	Pulmonary function	Other measurement
8241	GCST002683	Pulmonary function	Pulmonary function	Other measurement
8242	GCST002682	Tourette's syndrome or obsessive-compulsive disorder	Tourette's syndrome or obsessive-compulsive disorder	Neurological disorder
8243	GCST002682	Tourette's syndrome or obsessive-compulsive disorder	Tourette's syndrome or obsessive-compulsive disorder	Neurological disorder
8244	GCST002681	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
8245	GCST002718	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8246	GCST002716	Diabetic nephropathy in type 1 diabetes	Diabetic nephropathy in type 1 diabetes	Metabolic disorder
8247	GCST002716	Diabetic nephropathy in type 1 diabetes	Diabetic nephropathy in type 1 diabetes	Metabolic disorder
8248	GCST002717	Serum IgE levels	Serum IgE levels	Other measurement
8249	GCST002715	Breastfeeding duration	Breastfeeding duration	Other measurement
8250	GCST002714	Plasma renin activity levels	Plasma renin activity levels	Cardiovascular measurement
8251	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
8252	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
8253	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
8254	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
8255	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
8256	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
8257	GCST002713	Acute lymphoblastic leukemia (adolescents and young adults)	Acute lymphoblastic leukemia (adolescents and young adults)	Cancer
8258	GCST002711	Sleep duration	Sleep duration	Other measurement
8259	GCST002706	Electrodermal activity	Electrodermal activity	Other measurement
8260	GCST002706	Electrodermal activity	Electrodermal activity	Other measurement
8261	GCST002706	Electrodermal activity	Electrodermal activity	Other measurement
8262	GCST002706	Electrodermal activity	Electrodermal activity	Other measurement
8263	GCST002736	B-type natriuretic peptide levels	B-type natriuretic peptide levels	Cardiovascular measurement
8264	GCST002735	Breast cancer	Breast cancer	Cancer
8265	GCST002731	Endothelial growth factor levels	Endothelial growth factor levels	Cardiovascular measurement
8266	GCST002731	Endothelial growth factor levels	Endothelial growth factor levels	Cardiovascular measurement
8267	GCST002731	Endothelial growth factor levels	Endothelial growth factor levels	Cardiovascular measurement
8268	GCST002731	Endothelial growth factor levels	Endothelial growth factor levels	Cardiovascular measurement
8269	GCST002733	Platelet count	Platelet count	Hematological measurement
8270	GCST002730	Hepatitis	Hepatitis	Other trait
8271	GCST002732	Metabolic syndrome	Metabolic syndrome	Body measurement
8272	GCST002732	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
8273	GCST002732	Metabolic syndrome	Metabolic syndrome	Other measurement
8274	GCST002732	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
8275	GCST002732	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
8276	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Digestive system disorder
8277	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Immune system disorder
8278	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Immune system disorder
8279	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Other trait
8280	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Biological process
8281	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Biological process
8282	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Other trait
8283	GCST002734	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Other measurement
8284	GCST002734	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Body measurement
8285	GCST002734	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Biological process
8286	GCST002734	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Hematological measurement
8287	GCST002728	Yang-deficiency constitution	Yang-deficiency constitution	Other trait
8288	GCST002697	Eosinophilic esophagitis	Eosinophilic esophagitis	Digestive system disorder
8289	GCST002698	Serum VEGFR2 concentration	Serum VEGFR2 concentration	Other measurement
8290	GCST002696	Anxiety disorder	Anxiety disorder	Neurological disorder
8291	GCST002695	Episodic memory	Episodic memory	Biological process
8292	GCST002693	Enteric fever	Enteric fever	Other disease
8293	GCST002694	General cognitive ability	General cognitive ability	Biological process
8294	GCST002692	Body mass index (change over time)	Body mass index (change over time)	Body measurement
8295	GCST002691	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Neurological disorder
8296	GCST002691	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Biological process
8297	GCST002691	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Biological process
8298	GCST002648	Persistent attention-deficit hyperactivity disorder	Persistent attention-deficit hyperactivity disorder	Neurological disorder
8299	GCST002647	Height	Height	Other measurement
8300	GCST002647	Height	Height	Body measurement
8301	GCST002645	Bladder cancer	Bladder cancer	Cancer
8302	GCST002646	Infant length	Infant length	Body measurement
8303	GCST002644	Birth length	Birth length	Body measurement
8304	GCST002643	Follicular lymphoma	Follicular lymphoma	Cancer
8305	GCST002641	Hip circumference (psychosocial stress interaction)	Hip circumference (psychosocial stress interaction)	Other measurement
8306	GCST002641	Hip circumference (psychosocial stress interaction)	Hip circumference (psychosocial stress interaction)	Body measurement
8307	GCST002642	Response to simvastatin treatment (PCSK9 protein level change)	Response to simvastatin treatment (PCSK9 protein level change)	Other measurement
8308	GCST002642	Response to simvastatin treatment (PCSK9 protein level change)	Response to simvastatin treatment (PCSK9 protein level change)	Response to drug
8309	GCST002639	Autism spectrum disorder-related traits	Autism spectrum disorder-related traits	Neurological disorder
8310	GCST002639	Autism spectrum disorder-related traits	Autism spectrum disorder-related traits	Neurological disorder
8311	GCST002639	Autism spectrum disorder-related traits	Autism spectrum disorder-related traits	Other measurement
8312	GCST002599	Longevity (90 years and older)	Longevity (90 years and older)	Other measurement
8313	GCST002598	Educational attainment	Educational attainment	Other measurement
8314	GCST002597	Laryngeal squamous cell carcinoma	Laryngeal squamous cell carcinoma	Cancer
8315	GCST007144	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
8316	GCST007145	Amyotrophic lateral sclerosis (age of onset)	Amyotrophic lateral sclerosis (age of onset)	Neurological disorder
8317	GCST007145	Amyotrophic lateral sclerosis (age of onset)	Amyotrophic lateral sclerosis (age of onset)	Other measurement
8318	GCST007146	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
8319	GCST002596	Colorectal cancer (calcium intake interaction)	Colorectal cancer (calcium intake interaction)	Other measurement
8320	GCST002596	Colorectal cancer (calcium intake interaction)	Colorectal cancer (calcium intake interaction)	Cancer
8321	GCST002595	Clozapine-induced agranulocytosis	Clozapine-induced agranulocytosis	Response to drug
8322	GCST002595	Clozapine-induced agranulocytosis	Clozapine-induced agranulocytosis	Other trait
8323	GCST002657	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
8324	GCST002658	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
8325	GCST002656	Migraine in bipolar disorder	Migraine in bipolar disorder	Cardiovascular disease
8326	GCST002656	Migraine in bipolar disorder	Migraine in bipolar disorder	Neurological disorder
8327	GCST002655	IgA nephropathy	IgA nephropathy	Other disease
8328	GCST002654	Shingles	Shingles	Other disease
8329	GCST002654	Shingles	Shingles	Other measurement
8330	GCST002653	Circulating phylloquinone levels	Circulating phylloquinone levels	Other measurement
8331	GCST002652	Cotinine glucuronidation	Cotinine glucuronidation	Other measurement
8332	GCST002649	Nicotine glucouronidation	Nicotine glucouronidation	Other measurement
8333	GCST002651	Coffee consumption	Coffee consumption	Biological process
8334	GCST002651	Coffee consumption	Coffee consumption	Other measurement
8335	GCST002651	Coffee consumption	Coffee consumption	Other measurement
8336	GCST002650	Coffee consumption (cups per day)	Coffee consumption (cups per day)	Biological process
8337	GCST002650	Coffee consumption (cups per day)	Coffee consumption (cups per day)	Other measurement
8338	GCST002608	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
8339	GCST002608	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
8340	GCST002608	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
8341	GCST002608	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other disease
8342	GCST002606	Prostate cancer	Prostate cancer	Cancer
8343	GCST002607	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Digestive system disorder
8344	GCST002607	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Response to drug
8345	GCST002607	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Digestive system disorder
8346	GCST002605	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Digestive system disorder
8347	GCST002605	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Response to drug
8348	GCST002605	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Cancer
8349	GCST002604	Schizophrenia (treatment resistant)	Schizophrenia (treatment resistant)	Neurological disorder
8350	GCST007161	beta-lactam allergy measurement	beta-lactam allergy measurement	Other measurement
8351	GCST002603	Creatine kinase in statin users	Creatine kinase in statin users	Cardiovascular measurement
8352	GCST002603	Creatine kinase in statin users	Creatine kinase in statin users	Response to drug
8353	GCST002602	Vitamin D levels	Vitamin D levels	Other measurement
8354	GCST002601	Plasma plasminogen levels	Plasma plasminogen levels	Other measurement
8355	GCST002600	Response to thiazide diuretic treatment (hypokalemia)	Response to thiazide diuretic treatment (hypokalemia)	Response to drug
8356	GCST002600	Response to thiazide diuretic treatment (hypokalemia)	Response to thiazide diuretic treatment (hypokalemia)	Other trait
8357	GCST002666	Interferon alpha levels in systemic lupus erythematosus	Interferon alpha levels in systemic lupus erythematosus	Other measurement
8358	GCST002666	Interferon alpha levels in systemic lupus erythematosus	Interferon alpha levels in systemic lupus erythematosus	Immune system disorder
8359	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
8360	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
8361	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
8362	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
8363	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
8364	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Neurological disorder
8365	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Inflammatory measurement
8366	GCST002663	Superior frontal gyrus grey matter volume	Superior frontal gyrus grey matter volume	Other measurement
8367	GCST002664	Maximal oxygen uptake response	Maximal oxygen uptake response	Other measurement
8368	GCST002662	Breast cancer	Breast cancer	Cancer
8369	GCST002661	HDL cholesterol (SNP x SNP interaction)	HDL cholesterol (SNP x SNP interaction)	Lipid or lipoprotein measurement
8370	GCST002660	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Metabolic disorder
8371	GCST002660	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Other measurement
8372	GCST002660	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Other measurement
8373	GCST002659	Coronary artery disease-related phenotypes	Coronary artery disease-related phenotypes	Cardiovascular measurement
8374	GCST002659	Coronary artery disease-related phenotypes	Coronary artery disease-related phenotypes	Cardiovascular disease
8375	GCST002676	Mammographic density	Mammographic density	Other measurement
8376	GCST002675	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Lipid or lipoprotein measurement
8377	GCST002675	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Lipid or lipoprotein measurement
8378	GCST002675	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Response to drug
8379	GCST002672	Febrile seizures	Febrile seizures	Other trait
8380	GCST002672	Febrile seizures	Febrile seizures	Other trait
8381	GCST002674	Febrile seizures (MMR vaccine-related)	Febrile seizures (MMR vaccine-related)	Other trait
8382	GCST002673	Febrile seizures (MMR vaccine-unrelated)	Febrile seizures (MMR vaccine-unrelated)	Other trait
8383	GCST002640	Inflammatory biomarkers in Kawasaki disease	Inflammatory biomarkers in Kawasaki disease	Immune system disorder
8384	GCST002640	Inflammatory biomarkers in Kawasaki disease	Inflammatory biomarkers in Kawasaki disease	Other measurement
8385	GCST002640	Inflammatory biomarkers in Kawasaki disease	Inflammatory biomarkers in Kawasaki disease	Inflammatory measurement
8386	GCST002637	Medication adherence in chronic diseases	Medication adherence in chronic diseases	Biological process
8387	GCST002637	Medication adherence in chronic diseases	Medication adherence in chronic diseases	Cardiovascular disease
8388	GCST002637	Medication adherence in chronic diseases	Medication adherence in chronic diseases	Metabolic disorder
8389	GCST002636	Diffuse large B cell lymphoma	Diffuse large B cell lymphoma	Cancer
8390	GCST002633	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
8391	GCST002635	Aggressive periodontitis (sex interaction)	Aggressive periodontitis (sex interaction)	Digestive system disorder
8392	GCST002635	Aggressive periodontitis (sex interaction)	Aggressive periodontitis (sex interaction)	Other measurement
8393	GCST002634	Kashin-Beck disease	Kashin-Beck disease	Other disease
8394	GCST002628	Bilirubin levels in extreme obesity	Bilirubin levels in extreme obesity	Metabolic disorder
8395	GCST002628	Bilirubin levels in extreme obesity	Bilirubin levels in extreme obesity	Other measurement
8396	GCST002632	Hepatic lipid content in extreme obesity	Hepatic lipid content in extreme obesity	Lipid or lipoprotein measurement
8397	GCST002632	Hepatic lipid content in extreme obesity	Hepatic lipid content in extreme obesity	Metabolic disorder
8398	GCST002629	Irritable bowel syndrome	Irritable bowel syndrome	Digestive system disorder
8399	GCST002626	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
8400	GCST002626	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
8401	GCST002623	L-arginine levels	L-arginine levels	Other measurement
8402	GCST002621	Chronic bronchitis in chronic obstructive pulmonary disease	Chronic bronchitis in chronic obstructive pulmonary disease	Other disease
8403	GCST002621	Chronic bronchitis in chronic obstructive pulmonary disease	Chronic bronchitis in chronic obstructive pulmonary disease	Other disease
8404	GCST002625	Chronic bronchitis and chronic obstructive pulmonary disease	Chronic bronchitis and chronic obstructive pulmonary disease	Other disease
8405	GCST002625	Chronic bronchitis and chronic obstructive pulmonary disease	Chronic bronchitis and chronic obstructive pulmonary disease	Other disease
8406	GCST002622	Symmetrical dimethylarginine levels	Symmetrical dimethylarginine levels	Cardiovascular measurement
8407	GCST002622	Symmetrical dimethylarginine levels	Symmetrical dimethylarginine levels	Other measurement
8408	GCST002620	Asymmetrical dimethylarginine levels	Asymmetrical dimethylarginine levels	Cardiovascular measurement
8409	GCST002620	Asymmetrical dimethylarginine levels	Asymmetrical dimethylarginine levels	Other measurement
8410	GCST002624	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
8411	GCST002619	Age-related cataracts	Age-related cataracts	Other trait
8412	GCST002618	Age-related cataracts (age at onset)	Age-related cataracts (age at onset)	Other measurement
8413	GCST002618	Age-related cataracts (age at onset)	Age-related cataracts (age at onset)	Other trait
8414	GCST002616	Mitochondrial DNA levels	Mitochondrial DNA levels	Other measurement
8415	GCST002613	Chronic mucus hypersecretion	Chronic mucus hypersecretion	Other trait
8416	GCST002614	Multiple myeloma	Multiple myeloma	Cancer
8417	GCST002615	Myopia	Myopia	Other trait
8418	GCST002612	Chronic mucus hypersecretion in chronic obstructive pulmonary disease	Chronic mucus hypersecretion in chronic obstructive pulmonary disease	Other disease
8419	GCST002612	Chronic mucus hypersecretion in chronic obstructive pulmonary disease	Chronic mucus hypersecretion in chronic obstructive pulmonary disease	Other trait
8420	GCST002617	Hyperopia	Hyperopia	Other trait
8421	GCST002617	Hyperopia	Hyperopia	Neurological disorder
8422	GCST002610	Fasting plasma glucose (childhood)	Fasting plasma glucose (childhood)	Other measurement
8423	GCST002611	Expressive vocabulary in infants	Expressive vocabulary in infants	Biological process
8424	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
8425	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
8426	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
8427	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
8428	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
8429	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
8430	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
8431	GCST002546	Osteoprotegerin levels	Osteoprotegerin levels	Cardiovascular measurement
8432	GCST002547	Epilepsy	Epilepsy	Neurological disorder
8433	GCST002547	Epilepsy	Epilepsy	Neurological disorder
8434	GCST002547	Epilepsy	Epilepsy	Neurological disorder
8435	GCST004401	Reading disability or specific language impairment (pleiotropy)	Reading disability or specific language impairment (pleiotropy)	Neurological disorder
8436	GCST004401	Reading disability or specific language impairment (pleiotropy)	Reading disability or specific language impairment (pleiotropy)	Neurological disorder
8437	GCST004402	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Biological process
8438	GCST004402	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Neurological disorder
8439	GCST004402	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Neurological disorder
8440	GCST002544	Parkinson's disease	Parkinson's disease	Neurological disorder
8441	GCST002545	Ossification of the posterior longitudinal ligament of the spine	Ossification of the posterior longitudinal ligament of the spine	Other disease
8442	GCST002543	Hearing function	Hearing function	Biological process
8443	GCST002540	Osteoarthritis biomarkers	Osteoarthritis biomarkers	Other measurement
8444	GCST002541	Menarche (age at onset)	Menarche (age at onset)	Other measurement
8445	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
8446	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
8447	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
8448	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
8449	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
8450	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
8451	GCST002539	Schizophrenia	Schizophrenia	Neurological disorder
8452	GCST002538	Height adjusted BMI	Height adjusted BMI	Body measurement
8453	GCST002537	Breast cancer	Breast cancer	Cancer
8454	GCST002536	Hemoglobin A2 levels in sickle cell anemia	Hemoglobin A2 levels in sickle cell anemia	Neurological disorder
8455	GCST002536	Hemoglobin A2 levels in sickle cell anemia	Hemoglobin A2 levels in sickle cell anemia	Hematological measurement
8456	GCST002535	PR interval	PR interval	Cardiovascular measurement
8457	GCST002533	QRS duration	QRS duration	Cardiovascular measurement
8458	GCST002533	QRS duration	QRS duration	Cardiovascular measurement
8459	GCST002533	QRS duration	QRS duration	Cardiovascular measurement
8460	GCST002534	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Digestive system disorder
8461	GCST002534	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Immune system disorder
8462	GCST002529	Glaucoma	Glaucoma	Neurological disorder
8463	GCST002531	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Neurological disorder
8464	GCST002531	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Other measurement
8465	GCST002588	Cerebral amyloid angiopathy	Cerebral amyloid angiopathy	Metabolic disorder
8466	GCST002589	Hippocampal sclerosis	Hippocampal sclerosis	Neurological disorder
8467	GCST002590	Vascular brain injury	Vascular brain injury	Cardiovascular measurement
8468	GCST002590	Vascular brain injury	Vascular brain injury	Cardiovascular disease
8469	GCST002591	Lewy body disease	Lewy body disease	Other measurement
8470	GCST002591	Lewy body disease	Lewy body disease	Other trait
8471	GCST002592	Neuritic plaque	Neuritic plaque	Other measurement
8472	GCST002594	Neurofibrillary tangles	Neurofibrillary tangles	Other measurement
8473	GCST002593	Dementia and core Alzheimer's disease neuropathologic changes	Dementia and core Alzheimer's disease neuropathologic changes	Neurological disorder
8474	GCST002593	Dementia and core Alzheimer's disease neuropathologic changes	Dementia and core Alzheimer's disease neuropathologic changes	Other trait
8475	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Biological process
8476	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8477	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8478	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8479	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8480	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8481	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8482	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8483	GCST002585	Antinuclear antibody levels	Antinuclear antibody levels	Other measurement
8484	GCST002586	Fasting plasma glucose	Fasting plasma glucose	Other measurement
8485	GCST002555	Monocyte count	Monocyte count	Hematological measurement
8486	GCST002557	Neutrophil count	Neutrophil count	Hematological measurement
8487	GCST002554	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Other measurement
8488	GCST002554	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Other measurement
8489	GCST002554	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Other measurement
8490	GCST002554	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Other measurement
8491	GCST002553	Pancreatic cancer	Pancreatic cancer	Cancer
8492	GCST002552	Allergic rhinitis in asthma	Allergic rhinitis in asthma	Other disease
8493	GCST002552	Allergic rhinitis in asthma	Allergic rhinitis in asthma	Immune system disorder
8494	GCST002550	Allergic rhinitis	Allergic rhinitis	Immune system disorder
8495	GCST002550	Allergic rhinitis	Allergic rhinitis	Immune system disorder
8496	GCST002551	Allergic rhinitis in non-asthmatics	Allergic rhinitis in non-asthmatics	Immune system disorder
8497	GCST002549	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	Response to drug
8498	GCST002549	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	Neurological disorder
8499	GCST006522	Upper eyelid sagging severity	Upper eyelid sagging severity	Other measurement
8500	GCST002548	Ulcerative colitis	Ulcerative colitis	Immune system disorder
8501	GCST002564	Bipolar disorder (early onset)	Bipolar disorder (early onset)	Neurological disorder
8502	GCST002565	Sleep duration	Sleep duration	Other measurement
8503	GCST002563	Hypospadias	Hypospadias	Other disease
8504	GCST002563	Hypospadias	Hypospadias	Other disease
8505	GCST002562	Vogt-Koyanagi-Harada syndrome	Vogt-Koyanagi-Harada syndrome	Neurological disorder
8506	GCST002561	Colorectal cancer	Colorectal cancer	Cancer
8507	GCST002560	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8508	GCST002558	Phenytoin-induced severe cutaneous adverse reactions	Phenytoin-induced severe cutaneous adverse reactions	Response to drug
8509	GCST002558	Phenytoin-induced severe cutaneous adverse reactions	Phenytoin-induced severe cutaneous adverse reactions	Other disease
8510	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Other measurement
8511	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Cardiovascular disease
8512	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Other measurement
8513	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Other measurement
8514	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Other measurement
8515	GCST002556	White blood cell count	White blood cell count	Hematological measurement
8516	GCST002556	White blood cell count	White blood cell count	Inflammatory measurement
8517	GCST002556	White blood cell count	White blood cell count	Hematological measurement
8518	GCST002556	White blood cell count	White blood cell count	Hematological measurement
8519	GCST002556	White blood cell count	White blood cell count	Hematological measurement
8520	GCST002519	Asthma or chronic obstructive pulmonary disease	Asthma or chronic obstructive pulmonary disease	Other disease
8521	GCST002519	Asthma or chronic obstructive pulmonary disease	Asthma or chronic obstructive pulmonary disease	Other disease
8522	GCST002517	Rate of change of FEV1 (time interaction)	Rate of change of FEV1 (time interaction)	Other measurement
8523	GCST002517	Rate of change of FEV1 (time interaction)	Rate of change of FEV1 (time interaction)	Other measurement
8524	GCST002518	Food antigen IgG levels	Food antigen IgG levels	Biological process
8525	GCST002518	Food antigen IgG levels	Food antigen IgG levels	Other measurement
8526	GCST002515	Pneumoconiosis in silica exposure	Pneumoconiosis in silica exposure	Other disease
8527	GCST002515	Pneumoconiosis in silica exposure	Pneumoconiosis in silica exposure	Biological process
8528	GCST002516	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
8529	GCST002514	Melanoma	Melanoma	Cancer
8530	GCST002512	Colorectal cancer	Colorectal cancer	Cancer
8531	GCST002513	Colorectal cancer (SNP x SNP interaction)	Colorectal cancer (SNP x SNP interaction)	Cancer
8532	GCST002511	Response to radiotherapy in prostate cancer (toxicity)	Response to radiotherapy in prostate cancer (toxicity)	Cancer
8533	GCST002511	Response to radiotherapy in prostate cancer (toxicity)	Response to radiotherapy in prostate cancer (toxicity)	Biological process
8534	GCST002510	Amyotrophic lateral sclerosis or frontotemporal dementia	Amyotrophic lateral sclerosis or frontotemporal dementia	Neurological disorder
8535	GCST002510	Amyotrophic lateral sclerosis or frontotemporal dementia	Amyotrophic lateral sclerosis or frontotemporal dementia	Neurological disorder
8536	GCST002583	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Other measurement
8537	GCST002583	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Response to drug
8538	GCST002583	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Other measurement
8539	GCST002584	Exhaled carbon monoxide levels	Exhaled carbon monoxide levels	Biological process
8540	GCST002584	Exhaled carbon monoxide levels	Exhaled carbon monoxide levels	Other measurement
8541	GCST002581	Glaucoma (high intraocular pressure)	Glaucoma (high intraocular pressure)	Neurological disorder
8542	GCST002580	Intraocular pressure	Intraocular pressure	Other measurement
8543	GCST002582	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
8544	GCST002579	Heschl's gyrus morphology	Heschl's gyrus morphology	Other measurement
8545	GCST002578	Ferritin levels	Ferritin levels	Other measurement
8546	GCST002577	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Other measurement
8547	GCST002577	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Cancer
8548	GCST002576	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
8549	GCST002576	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
8550	GCST002574	Congenital left-sided heart lesions (maternal effect)	Congenital left-sided heart lesions (maternal effect)	Cardiovascular disease
8551	GCST002574	Congenital left-sided heart lesions (maternal effect)	Congenital left-sided heart lesions (maternal effect)	Other measurement
8552	GCST002570	Overweight status	Overweight status	Body measurement
8553	GCST002569	Underweight status	Underweight status	Body measurement
8554	GCST002573	Height	Height	Other measurement
8555	GCST002573	Height	Height	Body measurement
8556	GCST002575	Body mass index (change over time)	Body mass index (change over time)	Body measurement
8557	GCST002572	Congenital left-sided heart lesions	Congenital left-sided heart lesions	Cardiovascular disease
8558	GCST002571	Body mass index	Body mass index	Body measurement
8559	GCST002571	Body mass index	Body mass index	Body measurement
8560	GCST002571	Body mass index	Body mass index	Other measurement
8561	GCST002568	Esophageal squamous cell carcinoma	Esophageal squamous cell carcinoma	Cancer
8562	GCST005562	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
8563	GCST002567	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Cancer
8564	GCST002567	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Cardiovascular disease
8565	GCST002567	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Response to drug
8566	GCST002566	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Cancer
8567	GCST002566	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Cardiovascular disease
8568	GCST002566	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Response to drug
8569	GCST008149	Age at menopause	Age at menopause	Other measurement
8570	GCST008914	Alcohol or illicit drug dependence	Alcohol or illicit drug dependence	Neurological disorder
8571	GCST008912	Glioma (pediatric/youth onset)	Glioma (pediatric/youth onset)	Cancer
8572	GCST008911	Alcohol use disorder	Alcohol use disorder	Neurological disorder
8573	GCST008911	Alcohol use disorder	Alcohol use disorder	Other measurement
8574	GCST007832	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
8575	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Neurological disorder
8576	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Immune system disorder
8577	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Immune system disorder
8578	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Immune system disorder
8579	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Response to drug
8580	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Neurological disorder
8581	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Cardiovascular disease
8582	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Digestive system disorder
8583	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Other disease
8584	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Other disease
8585	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Immune system disorder
8586	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Cardiovascular disease
8587	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Cardiovascular disease
8588	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Neurological disorder
8589	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Neurological disorder
8590	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Biological process
8591	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Other disease
8592	GCST008910	Multiple traits (pleiotropy)	Multiple traits (pleiotropy)	Biological process
8593	GCST007711	Severe coronary artery calcification	Severe coronary artery calcification	Other trait
8594	GCST008907	Tourette syndrome or brain region volumes (pleiotropy)	Tourette syndrome or brain region volumes (pleiotropy)	Other measurement
8595	GCST008907	Tourette syndrome or brain region volumes (pleiotropy)	Tourette syndrome or brain region volumes (pleiotropy)	Neurological disorder
8596	GCST008909	Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	Other measurement
8597	GCST008909	Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	Other measurement
8598	GCST008909	Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	Neurological disorder
8599	GCST008908	Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	Other measurement
8600	GCST008908	Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	Other measurement
8601	GCST008908	Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	Neurological disorder
8602	GCST008770	Sleep duration	Sleep duration	Other measurement
8603	GCST007779	Pandemrix-induced narcolepsy	Pandemrix-induced narcolepsy	Neurological disorder
8604	GCST007779	Pandemrix-induced narcolepsy	Pandemrix-induced narcolepsy	Response to drug
8605	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
8606	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
8607	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
8608	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
8609	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
8610	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
8611	GCST007777	Psychiatric disorder	Psychiatric disorder	Metabolic disorder
8612	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
8613	GCST007019	Suicide attempt severity	Suicide attempt severity	Other measurement
8614	GCST007729	Small subcortical brain infarct	Small subcortical brain infarct	Cardiovascular disease
8615	GCST007357	Voxel-wise structural brain imaging measurements	Voxel-wise structural brain imaging measurements	Other measurement
8616	GCST007730	Brain infarct	Brain infarct	Cardiovascular disease
8617	GCST006987	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Response to drug
8618	GCST006987	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Neurological disorder
8619	GCST006987	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Hematological measurement
8620	GCST007956	Maternal chorioamnionitis	Maternal chorioamnionitis	Other disease
8621	GCST007774	Drug-induced liver injury	Drug-induced liver injury	Response to drug
8622	GCST007774	Drug-induced liver injury	Drug-induced liver injury	Digestive system disorder
8623	GCST006935	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other trait
8624	GCST006935	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other measurement
8625	GCST006979	Heel bone mineral density	Heel bone mineral density	Other measurement
8626	GCST006980	Fractures	Fractures	Other disease
8627	GCST007955	Low density lipoprotein triglyceride levels	Low density lipoprotein triglyceride levels	Lipid or lipoprotein measurement
8628	GCST007600	Alzheimer's disease	Alzheimer's disease	Neurological disorder
8629	GCST006956	Erectile dysfunction	Erectile dysfunction	Other disease
8630	GCST007020	Male-pattern baldness	Male-pattern baldness	Other measurement
8631	GCST007020	Male-pattern baldness	Male-pattern baldness	Other disease
8632	GCST007020	Male-pattern baldness	Male-pattern baldness	Other disease
8633	GCST007254	Broad depression or major depressive disorder (self-reported)	Broad depression or major depressive disorder (self-reported)	Neurological disorder
8634	GCST007257	Broad depression or schizophrenia	Broad depression or schizophrenia	Neurological disorder
8635	GCST007257	Broad depression or schizophrenia	Broad depression or schizophrenia	Neurological disorder
8636	GCST007255	Broad depression or bipolar disorder	Broad depression or bipolar disorder	Neurological disorder
8637	GCST007255	Broad depression or bipolar disorder	Broad depression or bipolar disorder	Neurological disorder
8638	GCST007256	Broad depression or major depressive disorder (recurrent)	Broad depression or major depressive disorder (recurrent)	Neurological disorder
8639	GCST007018	Serum bilirubin levels in metabolic syndrome	Serum bilirubin levels in metabolic syndrome	Metabolic disorder
8640	GCST007018	Serum bilirubin levels in metabolic syndrome	Serum bilirubin levels in metabolic syndrome	Other measurement
8641	GCST006977	Predicted suicide risk	Predicted suicide risk	Other measurement
8642	GCST007017	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Other measurement
8643	GCST007017	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Metabolic disorder
8644	GCST007017	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Other measurement
8645	GCST007016	Serum bilirubin levels x sex interaction in metabolic syndrome	Serum bilirubin levels x sex interaction in metabolic syndrome	Metabolic disorder
8646	GCST007016	Serum bilirubin levels x sex interaction in metabolic syndrome	Serum bilirubin levels x sex interaction in metabolic syndrome	Other measurement
8647	GCST007016	Serum bilirubin levels x sex interaction in metabolic syndrome	Serum bilirubin levels x sex interaction in metabolic syndrome	Other measurement
8648	GCST007782	Schizophrenia or intelligence (pleiotropy)	Schizophrenia or intelligence (pleiotropy)	Biological process
8649	GCST007782	Schizophrenia or intelligence (pleiotropy)	Schizophrenia or intelligence (pleiotropy)	Neurological disorder
8650	GCST007781	Bipolar disorder or intelligence (pleiotropy)	Bipolar disorder or intelligence (pleiotropy)	Biological process
8651	GCST007781	Bipolar disorder or intelligence (pleiotropy)	Bipolar disorder or intelligence (pleiotropy)	Neurological disorder
8652	GCST006983	Attention deficit hyperactivity disorder or cannabis use	Attention deficit hyperactivity disorder or cannabis use	Neurological disorder
8653	GCST006983	Attention deficit hyperactivity disorder or cannabis use	Attention deficit hyperactivity disorder or cannabis use	Biological process
8654	GCST006978	Suicide attempts	Suicide attempts	Biological process
8655	GCST007259	Severe skin toxicity response to cetuximab in colorectal cancer	Severe skin toxicity response to cetuximab in colorectal cancer	Other disease
8656	GCST007259	Severe skin toxicity response to cetuximab in colorectal cancer	Severe skin toxicity response to cetuximab in colorectal cancer	Response to drug
8657	GCST007259	Severe skin toxicity response to cetuximab in colorectal cancer	Severe skin toxicity response to cetuximab in colorectal cancer	Cancer
8658	GCST007043	Psoriatic arthritis	Psoriatic arthritis	Immune system disorder
8659	GCST007235	Pancreatic ductal adenocarcinoma	Pancreatic ductal adenocarcinoma	Cancer
8660	GCST007234	Acne (severe)	Acne (severe)	Other disease
8661	GCST006911	Asthma (moderate or severe)	Asthma (moderate or severe)	Other disease
8662	GCST006989	Brown vs. black hair color	Brown vs. black hair color	Other trait
8663	GCST006988	Blond vs. brown/black hair color	Blond vs. brown/black hair color	Other trait
8664	GCST006976	Macular thickness	Macular thickness	Other measurement
8665	GCST007233	Fragile X syndrome	Fragile X syndrome	Metabolic disorder
8666	GCST007435	Carotid plaque	Carotid plaque	Cardiovascular disease
8667	GCST007436	Carotid intima media thickness	Carotid intima media thickness	Other measurement
8668	GCST007436	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular measurement
8669	GCST007436	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular disease
8670	GCST007699	Developmental dysplasia of the hip	Developmental dysplasia of the hip	Other disease
8671	GCST007276	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
8672	GCST007276	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
8673	GCST007225	Varicose veins	Varicose veins	Other trait
8674	GCST007228	Pulmonary arterial hypertension	Pulmonary arterial hypertension	Cardiovascular disease
8675	GCST007230	Severe depressive disorders in coronary artery disease	Severe depressive disorders in coronary artery disease	Cardiovascular disease
8676	GCST007230	Severe depressive disorders in coronary artery disease	Severe depressive disorders in coronary artery disease	Neurological disorder
8677	GCST007330	Alzheimer's disease with memory domain impairment	Alzheimer's disease with memory domain impairment	Neurological disorder
8678	GCST007330	Alzheimer's disease with memory domain impairment	Alzheimer's disease with memory domain impairment	Other trait
8679	GCST007331	Alzheimer's disease	Alzheimer's disease	Neurological disorder
8680	GCST007333	Alzheimer's disease with no specific cognitive domain impairment	Alzheimer's disease with no specific cognitive domain impairment	Neurological disorder
8681	GCST007332	Alzheimer's disease with multiple cognitive domain impairments	Alzheimer's disease with multiple cognitive domain impairments	Neurological disorder
8682	GCST007332	Alzheimer's disease with multiple cognitive domain impairments	Alzheimer's disease with multiple cognitive domain impairments	Other trait
8683	GCST007318	Alzheimer's disease with visuospatial domain impairment	Alzheimer's disease with visuospatial domain impairment	Neurological disorder
8684	GCST007318	Alzheimer's disease with visuospatial domain impairment	Alzheimer's disease with visuospatial domain impairment	Neurological disorder
8685	GCST007334	Alzheimer's disease with language domain impairment	Alzheimer's disease with language domain impairment	Neurological disorder
8686	GCST007334	Alzheimer's disease with language domain impairment	Alzheimer's disease with language domain impairment	Neurological disorder
8687	GCST007210	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Neurological disorder
8688	GCST007210	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Biological process
8689	GCST007210	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Biological process
8690	GCST007209	Gallstone disease	Gallstone disease	Digestive system disorder
8691	GCST007209	Gallstone disease	Gallstone disease	Digestive system disorder
8692	GCST006984	Takayasu arteritis	Takayasu arteritis	Cardiovascular disease
8693	GCST007657	Alcohol and nicotine co-dependence	Alcohol and nicotine co-dependence	Neurological disorder
8694	GCST007716	Frailty index	Frailty index	Other measurement
8695	GCST007089	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
8696	GCST007448	Normal facial asymmetry (angle of surface orientation score)	Normal facial asymmetry (angle of surface orientation score)	Other measurement
8697	GCST007450	Normal facial asymmetry (deformation magnitude)	Normal facial asymmetry (deformation magnitude)	Other measurement
8698	GCST006916	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
8699	GCST008104	Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	Other measurement
8700	GCST008104	Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	Cancer
8701	GCST007449	Normal facial asymmetry (angle of deformation score)	Normal facial asymmetry (angle of deformation score)	Other measurement
8702	GCST007239	Ovarian cancer	Ovarian cancer	Cancer
8703	GCST006986	Red vs. brown/black hair color	Red vs. brown/black hair color	Other trait
8704	GCST007595	Appendicitis	Appendicitis	Immune system disorder
8705	GCST007206	Brain glucose metabolism (fluorodeoxyglucose uptake)	Brain glucose metabolism (fluorodeoxyglucose uptake)	Other measurement
8706	GCST007248	Stroke	Stroke	Cardiovascular disease
8707	GCST007249	Ischemic stroke	Ischemic stroke	Cardiovascular disease
8708	GCST007249	Ischemic stroke	Ischemic stroke	Other trait
8709	GCST006902	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
8710	GCST006902	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
8711	GCST007296	Chronic central serous retinopathy	Chronic central serous retinopathy	Neurological disorder
8712	GCST007403	Verbal intelligence quotient (cesarean section interaction)	Verbal intelligence quotient (cesarean section interaction)	Biological process
8713	GCST007403	Verbal intelligence quotient (cesarean section interaction)	Verbal intelligence quotient (cesarean section interaction)	Other trait
8714	GCST006904	Cerebral amyloid deposition (PET imaging)	Cerebral amyloid deposition (PET imaging)	Other measurement
8715	GCST007558	Response to long-term oxygen therapy in chronic obstructive pulmonary disease	Response to long-term oxygen therapy in chronic obstructive pulmonary disease	Other disease
8716	GCST007558	Response to long-term oxygen therapy in chronic obstructive pulmonary disease	Response to long-term oxygen therapy in chronic obstructive pulmonary disease	Response to drug
8717	GCST006660	DNA methylation variation (age effect)	DNA methylation variation (age effect)	Biological process
8718	GCST006959	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
8719	GCST007715	Heart failure	Heart failure	Cardiovascular disease
8720	GCST007714	Nonischemic cardiomyopathy	Nonischemic cardiomyopathy	Cardiovascular disease
8721	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Cardiovascular disease
8722	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Body measurement
8723	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Body measurement
8724	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Neurological disorder
8725	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Lipid or lipoprotein measurement
8726	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Lipid or lipoprotein measurement
8727	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Lipid or lipoprotein measurement
8728	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Lipid or lipoprotein measurement
8729	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Metabolic disorder
8730	GCST008669	Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
8731	GCST008669	Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
8732	GCST008671	Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
8733	GCST008671	Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
8734	GCST008670	Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
8735	GCST008670	Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
8736	GCST007505	Nevus count or cutaneous melanoma	Nevus count or cutaneous melanoma	Cancer
8737	GCST007505	Nevus count or cutaneous melanoma	Nevus count or cutaneous melanoma	Other measurement
8738	GCST007504	Nevus count	Nevus count	Other measurement
8739	GCST007405	Full scale intelligence quotient (cesarean section interaction)	Full scale intelligence quotient (cesarean section interaction)	Biological process
8740	GCST007405	Full scale intelligence quotient (cesarean section interaction)	Full scale intelligence quotient (cesarean section interaction)	Other trait
8741	GCST007404	Performance intelligence quotient (cesarean section interaction)	Performance intelligence quotient (cesarean section interaction)	Biological process
8742	GCST007404	Performance intelligence quotient (cesarean section interaction)	Performance intelligence quotient (cesarean section interaction)	Other trait
8743	GCST007258	Non-steroidal anti-inflammatory drug-induced enteropathy	Non-steroidal anti-inflammatory drug-induced enteropathy	Response to drug
8744	GCST007258	Non-steroidal anti-inflammatory drug-induced enteropathy	Non-steroidal anti-inflammatory drug-induced enteropathy	Digestive system disorder
8745	GCST006925	Knee osteoarthritis	Knee osteoarthritis	Other disease
8746	GCST006926	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
8747	GCST006926	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
8748	GCST007508	Self-reported childhood asthma in adult smokers	Self-reported childhood asthma in adult smokers	Other measurement
8749	GCST007508	Self-reported childhood asthma in adult smokers	Self-reported childhood asthma in adult smokers	Other disease
8750	GCST006896	Free thyroxine concentration	Free thyroxine concentration	Other measurement
8751	GCST006897	Hyperthyroidism	Hyperthyroidism	Other disease
8752	GCST006898	Hypothyroidism	Hypothyroidism	Other disease
8753	GCST006899	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
8754	GCST006899	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
8755	GCST007652	Platelet count and reactivity phenotypes	Platelet count and reactivity phenotypes	Hematological measurement
8756	GCST007652	Platelet count and reactivity phenotypes	Platelet count and reactivity phenotypes	Cardiovascular measurement
8757	GCST007540	PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	Cancer
8758	GCST007540	PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	Response to drug
8759	GCST007541	PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	Cancer
8760	GCST007541	PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	Response to drug
8761	GCST007539	Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	Cancer
8762	GCST007539	Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	Other measurement
8763	GCST007651	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
8764	GCST007578	Plasma homocysteine levels	Plasma homocysteine levels	Cardiovascular measurement
8765	GCST007579	Serum folate levels	Serum folate levels	Other measurement
8766	GCST007580	Red blood cell folate levels	Red blood cell folate levels	Other measurement
8767	GCST006936	Mitochondrial DNA levels	Mitochondrial DNA levels	Other measurement
8768	GCST006903	Hip shape (DXA scan)	Hip shape (DXA scan)	Body measurement
8769	GCST006719	BRCA1/2-negative high-risk breast cancer	BRCA1/2-negative high-risk breast cancer	Cancer
8770	GCST007199	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
8771	GCST007023	Psoriasis	Psoriasis	Immune system disorder
8772	GCST007195	Chronic periodontitis (slight)	Chronic periodontitis (slight)	Digestive system disorder
8773	GCST007196	Chronic periodontitis	Chronic periodontitis	Digestive system disorder
8774	GCST006707	Gastric cancer	Gastric cancer	Cancer
8775	GCST007724	Chromosomal aberration frequency (chromosome type)	Chromosomal aberration frequency (chromosome type)	Other measurement
8776	GCST007723	Chromosomal aberration frequency (chromatid type)	Chromosomal aberration frequency (chromatid type)	Other measurement
8777	GCST007722	Chromosomal aberration frequency (total)	Chromosomal aberration frequency (total)	Other measurement
8778	GCST007138	Hashimoto thyroiditis	Hashimoto thyroiditis	Immune system disorder
8779	GCST006635	Eudaimonic well-being	Eudaimonic well-being	Other measurement
8780	GCST006633	Initial alcohol sensitivity	Initial alcohol sensitivity	Biological process
8781	GCST007154	Paediatric migraine	Paediatric migraine	Cardiovascular disease
8782	GCST007192	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Immune system disorder
8783	GCST007192	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Cardiovascular disease
8784	GCST007191	Hypersomnia (HLA-DQB1*06:02 negative)	Hypersomnia (HLA-DQB1*06:02 negative)	Neurological disorder
8785	GCST007152	Chronic back pain	Chronic back pain	Other trait
8786	GCST006634	Hedonic well-being	Hedonic well-being	Other measurement
8787	GCST006705	Infantile hypertrophic pyloric stenosis	Infantile hypertrophic pyloric stenosis	Digestive system disorder
8788	GCST006905	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
8789	GCST006982	Waldenstrm macroglobulinemia / lymphoplasmacytic lymphoma	Waldenstrm macroglobulinemia / lymphoplasmacytic lymphoma	Cancer
8790	GCST006777	Brain imaging measurements	Brain imaging measurements	Other measurement
8791	GCST007118	Erectile dysfunction	Erectile dysfunction	Other disease
8792	GCST007200	Radiation-induced brain injury in nasopharyngeal carcinoma	Radiation-induced brain injury in nasopharyngeal carcinoma	Cancer
8793	GCST007200	Radiation-induced brain injury in nasopharyngeal carcinoma	Radiation-induced brain injury in nasopharyngeal carcinoma	Biological process
8794	GCST007200	Radiation-induced brain injury in nasopharyngeal carcinoma	Radiation-induced brain injury in nasopharyngeal carcinoma	Neurological disorder
8795	GCST007139	Shingles	Shingles	Other disease
8796	GCST007139	Shingles	Shingles	Other measurement
8797	GCST007198	Parkinson's disease (age at diagnosis)	Parkinson's disease (age at diagnosis)	Neurological disorder
8798	GCST007198	Parkinson's disease (age at diagnosis)	Parkinson's disease (age at diagnosis)	Other measurement
8799	GCST007153	Delayed reward discounting	Delayed reward discounting	Other measurement
8800	GCST007147	Lateral ventricular volume in normal aging	Lateral ventricular volume in normal aging	Other measurement
8801	GCST007247	Latent autoimmune diabetes vs. type 1 diabetes	Latent autoimmune diabetes vs. type 1 diabetes	Metabolic disorder
8802	GCST007247	Latent autoimmune diabetes vs. type 1 diabetes	Latent autoimmune diabetes vs. type 1 diabetes	Metabolic disorder
8803	GCST007246	Latent autoimmune diabetes vs. type 2 diabetes	Latent autoimmune diabetes vs. type 2 diabetes	Metabolic disorder
8804	GCST007246	Latent autoimmune diabetes vs. type 2 diabetes	Latent autoimmune diabetes vs. type 2 diabetes	Metabolic disorder
8805	GCST007245	Latent autoimmune diabetes	Latent autoimmune diabetes	Metabolic disorder
8806	GCST006672	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
8807	GCST006672	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
8808	GCST007197	Chronic periodontitis (localised)	Chronic periodontitis (localised)	Digestive system disorder
8809	GCST006619	Tuberculosis	Tuberculosis	Other disease
8810	GCST006619	Tuberculosis	Tuberculosis	Other measurement
8811	GCST006619	Tuberculosis	Tuberculosis	Other measurement
8812	GCST007193	Chronic periodontitis (generalised)	Chronic periodontitis (generalised)	Digestive system disorder
8813	GCST007194	Chronic periodontitis (severe)	Chronic periodontitis (severe)	Digestive system disorder
8814	GCST007106	Response to opioid analgesics in cancer (pain decrease)	Response to opioid analgesics in cancer (pain decrease)	Cancer
8815	GCST007106	Response to opioid analgesics in cancer (pain decrease)	Response to opioid analgesics in cancer (pain decrease)	Response to drug
8816	GCST006486	Periodontitis	Periodontitis	Digestive system disorder
8817	GCST006491	Circulating fibroblast growth factor 23 levels	Circulating fibroblast growth factor 23 levels	Other measurement
8818	GCST006432	Multiple myeloma	Multiple myeloma	Cancer
8819	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Biological process
8820	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8821	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8822	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8823	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8824	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8825	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8826	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
8827	GCST007617	Blood pressure x alcohol consumption interaction	Blood pressure x alcohol consumption interaction	Other measurement
8828	GCST007617	Blood pressure x alcohol consumption interaction	Blood pressure x alcohol consumption interaction	Other measurement
8829	GCST007360	Bronchodilator response in asthma	Bronchodilator response in asthma	Response to drug
8830	GCST007360	Bronchodilator response in asthma	Bronchodilator response in asthma	Other disease
8831	GCST006680	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Other trait
8832	GCST006680	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Other trait
8833	GCST006680	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Other measurement
8834	GCST006682	HDL cholesterol and triglyceride levels	HDL cholesterol and triglyceride levels	Lipid or lipoprotein measurement
8835	GCST006682	HDL cholesterol and triglyceride levels	HDL cholesterol and triglyceride levels	Lipid or lipoprotein measurement
8836	GCST006669	HDL cholesterol and triglyceride levels (pleiotropy)	HDL cholesterol and triglyceride levels (pleiotropy)	Lipid or lipoprotein measurement
8837	GCST006669	HDL cholesterol and triglyceride levels (pleiotropy)	HDL cholesterol and triglyceride levels (pleiotropy)	Lipid or lipoprotein measurement
8838	GCST006663	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
8839	GCST006664	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
8840	GCST007425	Carotid plaques in rheumatoid arthritis	Carotid plaques in rheumatoid arthritis	Immune system disorder
8841	GCST007425	Carotid plaques in rheumatoid arthritis	Carotid plaques in rheumatoid arthritis	Cardiovascular disease
8842	GCST007088	Ischemic heart disease in rheumatoid arthritis	Ischemic heart disease in rheumatoid arthritis	Immune system disorder
8843	GCST007088	Ischemic heart disease in rheumatoid arthritis	Ischemic heart disease in rheumatoid arthritis	Cardiovascular disease
8844	GCST007041	Cardiovascular event in rheumatoid arthritis	Cardiovascular event in rheumatoid arthritis	Other disease
8845	GCST007041	Cardiovascular event in rheumatoid arthritis	Cardiovascular event in rheumatoid arthritis	Immune system disorder
8846	GCST007040	Carotid intima media thickness in rheumatoid arthritis	Carotid intima media thickness in rheumatoid arthritis	Immune system disorder
8847	GCST007040	Carotid intima media thickness in rheumatoid arthritis	Carotid intima media thickness in rheumatoid arthritis	Other measurement
8848	GCST006706	Eyebrow thickness	Eyebrow thickness	Other measurement
8849	GCST006671	Cognitive impairment test score	Cognitive impairment test score	Other measurement
8850	GCST006674	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Other measurement
8851	GCST006673	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
8852	GCST006493	Systemic sclerosis	Systemic sclerosis	Neurological disorder
8853	GCST007177	Perceptual rivalry (binocular rivalry task)	Perceptual rivalry (binocular rivalry task)	Other measurement
8854	GCST007178	Perceptual rivalry (voluntary modulation strength)	Perceptual rivalry (voluntary modulation strength)	Other measurement
8855	GCST007176	Perceptual rivalry (Necker cube stimulus)	Perceptual rivalry (Necker cube stimulus)	Other measurement
8856	GCST007179	Fasting glucose in pregnancy (gestational week 14-16)	Fasting glucose in pregnancy (gestational week 14-16)	Other measurement
8857	GCST007149	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Response to drug
8858	GCST007149	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Cancer
8859	GCST007149	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Other measurement
8860	GCST007148	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Response to drug
8861	GCST007148	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Cancer
8862	GCST007148	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Other measurement
8863	GCST007366	Homocysteine level response to multivitamin in cerebral infarction	Homocysteine level response to multivitamin in cerebral infarction	Cardiovascular disease
8864	GCST007366	Homocysteine level response to multivitamin in cerebral infarction	Homocysteine level response to multivitamin in cerebral infarction	Biological process
8865	GCST007366	Homocysteine level response to multivitamin in cerebral infarction	Homocysteine level response to multivitamin in cerebral infarction	Cardiovascular measurement
8866	GCST007365	Progression-free survival response to gemcitabine in breast cancer	Progression-free survival response to gemcitabine in breast cancer	Cancer
8867	GCST007365	Progression-free survival response to gemcitabine in breast cancer	Progression-free survival response to gemcitabine in breast cancer	Other measurement
8868	GCST007365	Progression-free survival response to gemcitabine in breast cancer	Progression-free survival response to gemcitabine in breast cancer	Response to drug
8869	GCST007151	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Response to drug
8870	GCST007151	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Cancer
8871	GCST007151	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Other measurement
8872	GCST007150	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Response to drug
8873	GCST007150	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Cancer
8874	GCST007150	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Other measurement
8875	GCST007359	Type 2 diabetes or coronary artery disease (pleiotropy)	Type 2 diabetes or coronary artery disease (pleiotropy)	Cardiovascular disease
8876	GCST007359	Type 2 diabetes or coronary artery disease (pleiotropy)	Type 2 diabetes or coronary artery disease (pleiotropy)	Metabolic disorder
8877	GCST006958	Length of menstrual cycle	Length of menstrual cycle	Other measurement
8878	GCST006427	Depression in smokers	Depression in smokers	Biological process
8879	GCST006427	Depression in smokers	Depression in smokers	Neurological disorder
8880	GCST007062	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
8881	GCST006462	Uterine fibroids	Uterine fibroids	Cancer
8882	GCST007548	Uterine fibroids	Uterine fibroids	Cancer
8883	GCST007109	Diarrhoea-associated Entamoeba histolytica infection	Diarrhoea-associated Entamoeba histolytica infection	Other disease
8884	GCST007186	Timing of glucose curve peak in pregnancy (gestational week 30-32)	Timing of glucose curve peak in pregnancy (gestational week 30-32)	Other measurement
8885	GCST007185	Timing of glucose curve peak in pregnancy (gestational week 14-16)	Timing of glucose curve peak in pregnancy (gestational week 14-16)	Other measurement
8886	GCST007184	General glucose level in pregnancy (gestational week 30-32)	General glucose level in pregnancy (gestational week 30-32)	Other measurement
8887	GCST007183	General glucose level in pregnancy (gestational week 14-16)	General glucose level in pregnancy (gestational week 14-16)	Other measurement
8888	GCST007182	Two-hour glucose in pregnancy (gestational week 30-32)	Two-hour glucose in pregnancy (gestational week 30-32)	Other measurement
8889	GCST007181	Two-hour glucose in pregnancy (gestational week 14-16)	Two-hour glucose in pregnancy (gestational week 14-16)	Other measurement
8890	GCST007180	Fasting glucose in pregnancy (gestational week 30-32)	Fasting glucose in pregnancy (gestational week 30-32)	Other measurement
8891	GCST006683	Response to fenofibrate	Response to fenofibrate	Response to drug
8892	GCST006485	Telomere length	Telomere length	Other measurement
8893	GCST006424	Severe diabetic retinopathy in type 2 diabetes	Severe diabetic retinopathy in type 2 diabetes	Metabolic disorder
8894	GCST006424	Severe diabetic retinopathy in type 2 diabetes	Severe diabetic retinopathy in type 2 diabetes	Metabolic disorder
8895	GCST006425	Gout in chronic kidney disease	Gout in chronic kidney disease	Other disease
8896	GCST006425	Gout in chronic kidney disease	Gout in chronic kidney disease	Metabolic disorder
8897	GCST006461	Self-reported risk-taking behaviour	Self-reported risk-taking behaviour	Biological process
8898	GCST006426	Serum urate levels in chronic kidney disease	Serum urate levels in chronic kidney disease	Other disease
8899	GCST006426	Serum urate levels in chronic kidney disease	Serum urate levels in chronic kidney disease	Other measurement
8900	GCST006479	Diverticular disease	Diverticular disease	Digestive system disorder
8901	GCST007129	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
8902	GCST006401	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
8903	GCST006421	Cannabis use	Cannabis use	Biological process
8904	GCST006480	Glioblastoma (age-stratified)	Glioblastoma (age-stratified)	Cancer
8905	GCST006480	Glioblastoma (age-stratified)	Glioblastoma (age-stratified)	Other measurement
8906	GCST006658	Longevity	Longevity	Other measurement
8907	GCST006860	Low HDL-cholesterol levels	Low HDL-cholesterol levels	Lipid or lipoprotein measurement
8908	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8909	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Inflammatory measurement
8910	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8911	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8912	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8913	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8914	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8915	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8916	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8917	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8918	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8919	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8920	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8921	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8922	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8923	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8924	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8925	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8926	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Inflammatory measurement
8927	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Inflammatory measurement
8928	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8929	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
8930	GCST006623	Midgestational cytokine/chemokine levels (fetal genetic effect)	Midgestational cytokine/chemokine levels (fetal genetic effect)	Other measurement
8931	GCST006623	Midgestational cytokine/chemokine levels (fetal genetic effect)	Midgestational cytokine/chemokine levels (fetal genetic effect)	Other measurement
8932	GCST006623	Midgestational cytokine/chemokine levels (fetal genetic effect)	Midgestational cytokine/chemokine levels (fetal genetic effect)	Other measurement
8933	GCST006623	Midgestational cytokine/chemokine levels (fetal genetic effect)	Midgestational cytokine/chemokine levels (fetal genetic effect)	Other measurement
8934	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
8935	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
8936	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
8937	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
8938	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
8939	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
8940	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Inflammatory measurement
8941	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
8942	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
8943	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
8944	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
8945	GCST006447	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
8946	GCST006447	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
8947	GCST006446	Ulna and radius bone mineral density	Ulna and radius bone mineral density	Other measurement
8948	GCST006445	Femoral neck bone mineral density	Femoral neck bone mineral density	Other measurement
8949	GCST006444	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
8950	GCST006444	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
8951	GCST006443	Total body bone mineral density	Total body bone mineral density	Other measurement
8952	GCST006423	Fractures	Fractures	Other disease
8953	GCST006422	Fractures	Fractures	Other disease
8954	GCST007130	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
8955	GCST006616	Uterine fibroid number (single vs multiple)	Uterine fibroid number (single vs multiple)	Other measurement
8956	GCST006617	Uterine fibroid size (maximum volume)	Uterine fibroid size (maximum volume)	Other measurement
8957	GCST006618	Uterine fibroid size (maximum dimension)	Uterine fibroid size (maximum dimension)	Other measurement
8958	GCST008492	Severe cutaneous adverse drug reactions	Severe cutaneous adverse drug reactions	Other disease
8959	GCST006607	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Inflammatory measurement
8960	GCST006607	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Immune system disorder
8961	GCST006607	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Response to drug
8962	GCST006610	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Immune system disorder
8963	GCST006610	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Response to drug
8964	GCST006610	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Other measurement
8965	GCST006609	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Immune system disorder
8966	GCST006609	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Response to drug
8967	GCST006609	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Other measurement
8968	GCST006608	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Other trait
8969	GCST006608	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Immune system disorder
8970	GCST006608	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Response to drug
8971	GCST006900	Body mass index	Body mass index	Body measurement
8972	GCST006900	Body mass index	Body mass index	Body measurement
8973	GCST006900	Body mass index	Body mass index	Other measurement
8974	GCST006606	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Immune system disorder
8975	GCST006606	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Response to drug
8976	GCST006606	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Other measurement
8977	GCST006861	Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	Other measurement
8978	GCST006861	Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	Metabolic disorder
8979	GCST006496	Glomerular filtration rate change in heart transplantation	Glomerular filtration rate change in heart transplantation	Other measurement
8980	GCST006496	Glomerular filtration rate change in heart transplantation	Glomerular filtration rate change in heart transplantation	Biological process
8981	GCST006484	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8982	GCST008308	Infection persistence (>18 months) in genital human papillomavirus 16 infection	Infection persistence (>18 months) in genital human papillomavirus 16 infection	Other disease
8983	GCST006387	Thyroid nodules	Thyroid nodules	Other disease
8984	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8985	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8986	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8987	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8988	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8989	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8990	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8991	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8992	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8993	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8994	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8995	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8996	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8997	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8998	GCST006585	Blood protein levels	Blood protein levels	Other measurement
8999	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9000	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9001	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9002	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9003	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9004	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9005	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9006	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9007	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9008	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9009	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9010	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9011	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9012	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9013	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9014	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9015	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9016	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9017	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9018	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9019	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9020	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9021	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9022	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9023	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9024	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9025	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9026	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9027	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9028	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9029	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9030	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9031	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9032	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9033	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9034	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9035	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9036	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9037	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9038	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9039	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9040	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9041	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9042	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9043	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9044	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9045	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9046	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9047	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9048	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9049	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9050	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9051	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9052	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9053	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9054	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9055	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9056	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9057	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9058	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9059	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9060	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9061	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9062	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9063	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9064	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9065	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9066	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9067	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9068	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9069	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9070	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9071	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9072	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9073	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9074	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9075	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9076	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9077	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9078	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9079	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9080	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9081	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9082	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9083	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9084	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9085	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9086	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9087	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9088	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9089	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9090	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9091	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9092	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9093	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9094	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9095	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9096	GCST006585	Blood protein levels	Blood protein levels	Hematological measurement
9097	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9098	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9099	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9100	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9101	GCST006585	Blood protein levels	Blood protein levels	Lipid or lipoprotein measurement
9102	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9103	GCST006585	Blood protein levels	Blood protein levels	Hematological measurement
9104	GCST006585	Blood protein levels	Blood protein levels	Hematological measurement
9105	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9106	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9107	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9108	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9109	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9110	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9111	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9112	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9113	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9114	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9115	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9116	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9117	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9118	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9119	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9120	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9121	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9122	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9123	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9124	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9125	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9126	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9127	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9128	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9129	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9130	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9131	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9132	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9133	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9134	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9135	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9136	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9137	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9138	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9139	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9140	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9141	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9142	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9143	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9144	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9145	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9146	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9147	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9148	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9149	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9150	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9151	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9152	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9153	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9154	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9155	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9156	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9157	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9158	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9159	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9160	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9161	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9162	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9163	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9164	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9165	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9166	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9167	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9168	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9169	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9170	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9171	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9172	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9173	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9174	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9175	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9176	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9177	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9178	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9179	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9180	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9181	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9182	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9183	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9184	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9185	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9186	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9187	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9188	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9189	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9190	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9191	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9192	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9193	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9194	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9195	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9196	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9197	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9198	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9199	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9200	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9201	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9202	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9203	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9204	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9205	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9206	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9207	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9208	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9209	GCST006585	Blood protein levels	Blood protein levels	Hematological measurement
9210	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9211	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9212	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9213	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9214	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9215	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9216	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9217	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9218	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9219	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9220	GCST006585	Blood protein levels	Blood protein levels	Cardiovascular measurement
9221	GCST006585	Blood protein levels	Blood protein levels	Liver enzyme measurement
9222	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9223	GCST006585	Blood protein levels	Blood protein levels	Inflammatory measurement
9224	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9225	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9226	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9227	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9228	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9229	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9230	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9231	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9232	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9233	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9234	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9235	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9236	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9237	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9238	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9239	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9240	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9241	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9242	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9243	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9244	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9245	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9246	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9247	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9248	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9249	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9250	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9251	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9252	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9253	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9254	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9255	GCST006585	Blood protein levels	Blood protein levels	Inflammatory measurement
9256	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9257	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9258	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9259	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9260	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9261	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9262	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9263	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9264	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9265	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9266	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9267	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9268	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9269	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9270	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9271	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9272	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9273	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9274	GCST006585	Blood protein levels	Blood protein levels	Other measurement
9275	GCST006402	Energy intake	Energy intake	Other measurement
9276	GCST006416	Chronic central serous retinopathy	Chronic central serous retinopathy	Neurological disorder
9277	GCST006417	Plasma factor VII activating protease levels	Plasma factor VII activating protease levels	Other measurement
9278	GCST006403	Energy expenditure	Energy expenditure	Other measurement
9279	GCST006836	Guillain-Barr syndrome	Guillain-Barr syndrome	Immune system disorder
9280	GCST006276	Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy	Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy	Neurological disorder
9281	GCST006481	Lung function (FEV1)	Lung function (FEV1)	Other measurement
9282	GCST006483	Lung function (FVC)	Lung function (FVC)	Other measurement
9283	GCST006414	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
9284	GCST006482	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
9285	GCST006277	Response to ranibizumab in age-related macular degeneration (exudative)	Response to ranibizumab in age-related macular degeneration (exudative)	Neurological disorder
9286	GCST006277	Response to ranibizumab in age-related macular degeneration (exudative)	Response to ranibizumab in age-related macular degeneration (exudative)	Response to drug
9287	GCST006857	Leisure-time exercise behaviour	Leisure-time exercise behaviour	Biological process
9288	GCST006858	Leisure-time exercise behaviour (age-stratified)	Leisure-time exercise behaviour (age-stratified)	Biological process
9289	GCST006465	Endometrial cancer (endometrioid histology)	Endometrial cancer (endometrioid histology)	Cancer
9290	GCST006464	Endometrial cancer	Endometrial cancer	Cancer
9291	GCST006464	Endometrial cancer	Endometrial cancer	Cancer
9292	GCST006467	Ewing sarcoma	Ewing sarcoma	Cancer
9293	GCST006466	Endometrial cancer (Non-endometrioid histology)	Endometrial cancer (Non-endometrioid histology)	Cancer
9294	GCST006418	Progressive supranuclear palsy	Progressive supranuclear palsy	Neurological disorder
9295	GCST006957	Severe aortic features in Marfan syndrome	Severe aortic features in Marfan syndrome	Neurological disorder
9296	GCST006957	Severe aortic features in Marfan syndrome	Severe aortic features in Marfan syndrome	Cardiovascular disease
9297	GCST006576	Anorexia nervosa or obsessive-compulsive disorder	Anorexia nervosa or obsessive-compulsive disorder	Neurological disorder
9298	GCST006576	Anorexia nervosa or obsessive-compulsive disorder	Anorexia nervosa or obsessive-compulsive disorder	Metabolic disorder
9299	GCST006400	Lung cancer in ever smokers	Lung cancer in ever smokers	Other measurement
9300	GCST006400	Lung cancer in ever smokers	Lung cancer in ever smokers	Cancer
9301	GCST006927	Anhedonia in major depressive disorder	Anhedonia in major depressive disorder	Other measurement
9302	GCST006927	Anhedonia in major depressive disorder	Anhedonia in major depressive disorder	Neurological disorder
9303	GCST006390	Biliary atresia	Biliary atresia	Digestive system disorder
9304	GCST006399	Lung cancer	Lung cancer	Cancer
9305	GCST006399	Lung cancer	Lung cancer	Cancer
9306	GCST006399	Lung cancer	Lung cancer	Cancer
9307	GCST006435	Thrombocytopenia in coronary artery bypass surgery	Thrombocytopenia in coronary artery bypass surgery	Other trait
9308	GCST006435	Thrombocytopenia in coronary artery bypass surgery	Thrombocytopenia in coronary artery bypass surgery	Other trait
9309	GCST006398	Lung cancer (SNP x SNP interaction)	Lung cancer (SNP x SNP interaction)	Cancer
9310	GCST006310	Post bronchodilator FEV1/FVC ratio in smoking	Post bronchodilator FEV1/FVC ratio in smoking	Other measurement
9311	GCST006310	Post bronchodilator FEV1/FVC ratio in smoking	Post bronchodilator FEV1/FVC ratio in smoking	Biological process
9312	GCST006415	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
9313	GCST006415	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
9314	GCST006278	Adverse response to antithyroid drugs in Graves disease	Adverse response to antithyroid drugs in Graves disease	Response to drug
9315	GCST006278	Adverse response to antithyroid drugs in Graves disease	Adverse response to antithyroid drugs in Graves disease	Immune system disorder
9316	GCST006407	Philtrum width	Philtrum width	Other measurement
9317	GCST006309	Post bronchodilator percent predicted FEV1 in smoking	Post bronchodilator percent predicted FEV1 in smoking	Other measurement
9318	GCST006309	Post bronchodilator percent predicted FEV1 in smoking	Post bronchodilator percent predicted FEV1 in smoking	Biological process
9319	GCST007058	Hip circumference	Hip circumference	Body measurement
9320	GCST007057	Height	Height	Other measurement
9321	GCST007057	Height	Height	Body measurement
9322	GCST007056	Waist-hip ratio	Waist-hip ratio	Other measurement
9323	GCST007056	Waist-hip ratio	Waist-hip ratio	Body measurement
9324	GCST007055	Waist circumference	Waist circumference	Body measurement
9325	GCST007054	Weight	Weight	Body measurement
9326	GCST007053	Body mass index	Body mass index	Body measurement
9327	GCST007053	Body mass index	Body mass index	Body measurement
9328	GCST007053	Body mass index	Body mass index	Other measurement
9329	GCST007052	Lipoprotein (a) levels	Lipoprotein (a) levels	Lipid or lipoprotein measurement
9330	GCST006419	Suicide attempts	Suicide attempts	Biological process
9331	GCST006420	Affective disorder and suicide attempts	Affective disorder and suicide attempts	Biological process
9332	GCST006420	Affective disorder and suicide attempts	Affective disorder and suicide attempts	Neurological disorder
9333	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9334	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9335	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9336	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9337	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9338	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9339	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9340	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9341	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9342	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9343	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9344	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9345	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9346	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9347	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9348	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9349	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9350	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9351	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9352	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9353	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9354	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9355	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9356	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9357	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9358	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9359	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9360	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9361	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9362	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9363	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9364	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9365	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9366	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9367	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9368	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9369	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9370	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9371	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9372	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9373	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9374	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9375	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9376	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9377	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9378	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9379	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9380	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9381	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9382	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9383	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9384	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9385	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9386	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9387	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9388	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9389	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9390	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9391	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9392	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9393	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9394	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9395	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9396	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9397	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9398	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9399	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9400	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9401	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9402	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9403	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9404	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9405	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9406	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9407	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9408	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9409	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9410	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9411	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9412	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9413	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9414	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9415	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9416	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9417	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9418	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9419	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9420	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9421	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9422	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9423	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9424	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9425	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9426	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9427	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9428	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9429	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9430	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9431	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9432	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9433	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9434	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9435	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9436	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9437	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9438	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9439	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9440	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9441	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9442	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9443	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9444	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9445	GCST007128	Blood protein levels	Blood protein levels	Hematological measurement
9446	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9447	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9448	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9449	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9450	GCST007128	Blood protein levels	Blood protein levels	Lipid or lipoprotein measurement
9451	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9452	GCST007128	Blood protein levels	Blood protein levels	Hematological measurement
9453	GCST007128	Blood protein levels	Blood protein levels	Hematological measurement
9454	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9455	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9456	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9457	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9458	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9459	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9460	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9461	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9462	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9463	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9464	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9465	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9466	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9467	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9468	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9469	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9470	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9471	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9472	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9473	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9474	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9475	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9476	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9477	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9478	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9479	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9480	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9481	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9482	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9483	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9484	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9485	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9486	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9487	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9488	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9489	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9490	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9491	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9492	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9493	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9494	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9495	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9496	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9497	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9498	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9499	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9500	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9501	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9502	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9503	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9504	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9505	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9506	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9507	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9508	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9509	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9510	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9511	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9512	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9513	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9514	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9515	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9516	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9517	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9518	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9519	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9520	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9521	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9522	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9523	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9524	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9525	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9526	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9527	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9528	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9529	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9530	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9531	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9532	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9533	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9534	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9535	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9536	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9537	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9538	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9539	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9540	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9541	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9542	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9543	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9544	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9545	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9546	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9547	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9548	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9549	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9550	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9551	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9552	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9553	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9554	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9555	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9556	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9557	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9558	GCST007128	Blood protein levels	Blood protein levels	Hematological measurement
9559	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9560	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9561	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9562	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9563	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9564	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9565	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9566	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9567	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9568	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9569	GCST007128	Blood protein levels	Blood protein levels	Cardiovascular measurement
9570	GCST007128	Blood protein levels	Blood protein levels	Liver enzyme measurement
9571	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9572	GCST007128	Blood protein levels	Blood protein levels	Inflammatory measurement
9573	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9574	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9575	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9576	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9577	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9578	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9579	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9580	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9581	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9582	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9583	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9584	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9585	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9586	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9587	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9588	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9589	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9590	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9591	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9592	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9593	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9594	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9595	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9596	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9597	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9598	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9599	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9600	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9601	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9602	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9603	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9604	GCST007128	Blood protein levels	Blood protein levels	Inflammatory measurement
9605	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9606	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9607	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9608	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9609	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9610	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9611	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9612	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9613	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9614	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9615	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9616	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9617	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9618	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9619	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9620	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9621	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9622	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9623	GCST007128	Blood protein levels	Blood protein levels	Other measurement
9624	GCST007051	Pulse rate	Pulse rate	Cardiovascular measurement
9625	GCST007051	Pulse rate	Pulse rate	Cardiovascular measurement
9626	GCST006901	Height	Height	Other measurement
9627	GCST006901	Height	Height	Body measurement
9628	GCST006460	Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia in preterm infants	Other disease
9629	GCST006460	Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia in preterm infants	Other trait
9630	GCST002442	Blood metabolite ratios	Blood metabolite ratios	Other measurement
9631	GCST002443	Blood metabolite levels	Blood metabolite levels	Other measurement
9632	GCST002443	Blood metabolite levels	Blood metabolite levels	Other measurement
9633	GCST002443	Blood metabolite levels	Blood metabolite levels	Other measurement
9634	GCST002443	Blood metabolite levels	Blood metabolite levels	Other measurement
9635	GCST002440	Staphylococcus aureus infection	Staphylococcus aureus infection	Other disease
9636	GCST002441	Immune response to measles-mumps-rubella vaccine	Immune response to measles-mumps-rubella vaccine	Response to drug
9637	GCST002439	Mathematical ability	Mathematical ability	Biological process
9638	GCST002438	Conotruncal heart defects	Conotruncal heart defects	Cardiovascular disease
9639	GCST002438	Conotruncal heart defects	Conotruncal heart defects	Other measurement
9640	GCST002437	Telomere length	Telomere length	Other measurement
9641	GCST002435	Body mass index	Body mass index	Body measurement
9642	GCST002435	Body mass index	Body mass index	Body measurement
9643	GCST002435	Body mass index	Body mass index	Other measurement
9644	GCST002483	Lung function (forced vital capacity)	Lung function (forced vital capacity)	Other measurement
9645	GCST002482	Carotid plaque burden (smoking interaction)	Carotid plaque burden (smoking interaction)	Other measurement
9646	GCST002482	Carotid plaque burden (smoking interaction)	Carotid plaque burden (smoking interaction)	Cardiovascular measurement
9647	GCST002481	Acne (severe)	Acne (severe)	Other disease
9648	GCST002479	Lupus nephritis in systemic lupus erythematosus	Lupus nephritis in systemic lupus erythematosus	Immune system disorder
9649	GCST002479	Lupus nephritis in systemic lupus erythematosus	Lupus nephritis in systemic lupus erythematosus	Immune system disorder
9650	GCST002480	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
9651	GCST002476	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
9652	GCST002475	Myocardial infarction	Myocardial infarction	Cardiovascular disease
9653	GCST002477	Alcohol dependence (age at onset)	Alcohol dependence (age at onset)	Neurological disorder
9654	GCST002477	Alcohol dependence (age at onset)	Alcohol dependence (age at onset)	Other measurement
9655	GCST002478	Coronary heart disease in familial hypercholesterolemia	Coronary heart disease in familial hypercholesterolemia	Cardiovascular disease
9656	GCST002478	Coronary heart disease in familial hypercholesterolemia	Coronary heart disease in familial hypercholesterolemia	Metabolic disorder
9657	GCST002474	Glioma (high-grade)	Glioma (high-grade)	Cancer
9658	GCST002509	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
9659	GCST002508	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
9660	GCST002507	Neuropathic pain in type 2 diabetes	Neuropathic pain in type 2 diabetes	Metabolic disorder
9661	GCST002507	Neuropathic pain in type 2 diabetes	Neuropathic pain in type 2 diabetes	Other trait
9662	GCST002506	Blood pressure	Blood pressure	Other measurement
9663	GCST002506	Blood pressure	Blood pressure	Other measurement
9664	GCST002506	Blood pressure	Blood pressure	Other measurement
9665	GCST002506	Blood pressure	Blood pressure	Other measurement
9666	GCST002506	Blood pressure	Blood pressure	Cardiovascular measurement
9667	GCST002505	Suicidal ideation in depression or bipolar disorder	Suicidal ideation in depression or bipolar disorder	Biological process
9668	GCST002505	Suicidal ideation in depression or bipolar disorder	Suicidal ideation in depression or bipolar disorder	Neurological disorder
9669	GCST002505	Suicidal ideation in depression or bipolar disorder	Suicidal ideation in depression or bipolar disorder	Neurological disorder
9670	GCST002503	Suicide attempts in depression or bipolar disorder	Suicide attempts in depression or bipolar disorder	Biological process
9671	GCST002503	Suicide attempts in depression or bipolar disorder	Suicide attempts in depression or bipolar disorder	Neurological disorder
9672	GCST002503	Suicide attempts in depression or bipolar disorder	Suicide attempts in depression or bipolar disorder	Neurological disorder
9673	GCST002504	Peripheral artery disease	Peripheral artery disease	Cardiovascular disease
9674	GCST002502	Corneal curvature	Corneal curvature	Other measurement
9675	GCST002500	QT interval	QT interval	Cardiovascular measurement
9676	GCST002501	Birdshot chorioretinopathy	Birdshot chorioretinopathy	Cardiovascular disease
9677	GCST002498	Age-related nuclear cataracts	Age-related nuclear cataracts	Other trait
9678	GCST002499	Birth weight	Birth weight	Body measurement
9679	GCST002496	Bone mineral density (paediatric, upper limb)	Bone mineral density (paediatric, upper limb)	Other measurement
9680	GCST002493	Bone mineral density (paediatric, skull)	Bone mineral density (paediatric, skull)	Other measurement
9681	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Other measurement
9682	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Other measurement
9683	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Other measurement
9684	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Other measurement
9685	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Cardiovascular measurement
9686	GCST002497	Blood pressure	Blood pressure	Other measurement
9687	GCST002497	Blood pressure	Blood pressure	Other measurement
9688	GCST002497	Blood pressure	Blood pressure	Other measurement
9689	GCST002497	Blood pressure	Blood pressure	Other measurement
9690	GCST002497	Blood pressure	Blood pressure	Cardiovascular measurement
9691	GCST002492	Bone mineral density (paediatric, lower limb)	Bone mineral density (paediatric, lower limb)	Other measurement
9692	GCST002494	Bone mineral density (paediatric, total body less head)	Bone mineral density (paediatric, total body less head)	Other measurement
9693	GCST002490	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
9694	GCST002490	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
9695	GCST002488	Anti-citrullinated peptide antibody	Anti-citrullinated peptide antibody	Other measurement
9696	GCST002487	Age-related hearing impairment (SNP x SNP interaction)	Age-related hearing impairment (SNP x SNP interaction)	Neurological disorder
9697	GCST002485	Elevated serum carcinoembryonic antigen levels	Elevated serum carcinoembryonic antigen levels	Other measurement
9698	GCST002489	Rheumatoid factor	Rheumatoid factor	Other measurement
9699	GCST002486	Exfoliation glaucoma or exfoliation syndrome	Exfoliation glaucoma or exfoliation syndrome	Neurological disorder
9700	GCST002491	Age-related hearing impairment	Age-related hearing impairment	Neurological disorder
9701	GCST002484	Skin fluorescence	Skin fluorescence	Other measurement
9702	GCST002464	End-stage renal disease or diabetic nephropathy in type 1 diabetes	End-stage renal disease or diabetic nephropathy in type 1 diabetes	Other disease
9703	GCST002464	End-stage renal disease or diabetic nephropathy in type 1 diabetes	End-stage renal disease or diabetic nephropathy in type 1 diabetes	Metabolic disorder
9704	GCST002464	End-stage renal disease or diabetic nephropathy in type 1 diabetes	End-stage renal disease or diabetic nephropathy in type 1 diabetes	Metabolic disorder
9705	GCST002463	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
9706	GCST002462	Alzheimer's disease (SNP x SNP interaction)	Alzheimer's disease (SNP x SNP interaction)	Neurological disorder
9707	GCST002460	Urinary bladder cancer	Urinary bladder cancer	Cancer
9708	GCST002461	Body mass index	Body mass index	Body measurement
9709	GCST002461	Body mass index	Body mass index	Body measurement
9710	GCST002461	Body mass index	Body mass index	Other measurement
9711	GCST002459	Lean body mass	Lean body mass	Other measurement
9712	GCST002458	Serum thyroid-stimulating hormone levels	Serum thyroid-stimulating hormone levels	Other measurement
9713	GCST002457	P wave duration	P wave duration	Cardiovascular measurement
9714	GCST002456	PR segment	PR segment	Cardiovascular measurement
9715	GCST002455	Parkinson's disease	Parkinson's disease	Neurological disorder
9716	GCST006055	Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	Lipid or lipoprotein measurement
9717	GCST006055	Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	Biological process
9718	GCST002454	Colorectal cancer	Colorectal cancer	Cancer
9719	GCST002452	Substance dependence phenotypes	Substance dependence phenotypes	Neurological disorder
9720	GCST002453	Ulcerative colitis	Ulcerative colitis	Immune system disorder
9721	GCST002445	Asthma (sex interaction)	Asthma (sex interaction)	Other disease
9722	GCST002445	Asthma (sex interaction)	Asthma (sex interaction)	Other measurement
9723	GCST002447	Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	Other disease
9724	GCST002447	Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	Other measurement
9725	GCST002434	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9726	GCST002433	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9727	GCST002436	Irritable bowel syndrome	Irritable bowel syndrome	Digestive system disorder
9728	GCST002432	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to drug
9729	GCST002432	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Other measurement
9730	GCST002432	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Other disease
9731	GCST002431	Response to radiotherapy in cancer (late toxicity)	Response to radiotherapy in cancer (late toxicity)	Cancer
9732	GCST002431	Response to radiotherapy in cancer (late toxicity)	Response to radiotherapy in cancer (late toxicity)	Cancer
9733	GCST002431	Response to radiotherapy in cancer (late toxicity)	Response to radiotherapy in cancer (late toxicity)	Biological process
9734	GCST002430	Hippocampal sclerosis of aging	Hippocampal sclerosis of aging	Neurological disorder
9735	GCST002429	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9736	GCST002428	Cardiovascular event reduction in the elderly at risk for vascular disease (statin therapy interaction)	Cardiovascular event reduction in the elderly at risk for vascular disease (statin therapy interaction)	Response to drug
9737	GCST002528	Colorectal cancer	Colorectal cancer	Cancer
9738	GCST002527	Eosinophilic esophagitis	Eosinophilic esophagitis	Digestive system disorder
9739	GCST002526	Cortisol levels (plasma)	Cortisol levels (plasma)	Other measurement
9740	GCST002525	Local histogram emphysema pattern	Local histogram emphysema pattern	Other measurement
9741	GCST002524	Chronic periodontitis	Chronic periodontitis	Digestive system disorder
9742	GCST002522	Reading or mathematical ability	Reading or mathematical ability	Biological process
9743	GCST002522	Reading or mathematical ability	Reading or mathematical ability	Biological process
9744	GCST002523	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9745	GCST002521	Lung function (forced expiratory volume in 1 second)	Lung function (forced expiratory volume in 1 second)	Other measurement
9746	GCST002520	Celiac disease	Celiac disease	Immune system disorder
9747	GCST002473	Response to rate control therapy in atrial fibrillation	Response to rate control therapy in atrial fibrillation	Cardiovascular disease
9748	GCST002473	Response to rate control therapy in atrial fibrillation	Response to rate control therapy in atrial fibrillation	Response to drug
9749	GCST002472	Morphine dose requirement in tonsillectomy and adenoidectomy surgery	Morphine dose requirement in tonsillectomy and adenoidectomy surgery	Response to drug
9750	GCST004705	Blood pressure	Blood pressure	Other measurement
9751	GCST004705	Blood pressure	Blood pressure	Other measurement
9752	GCST004705	Blood pressure	Blood pressure	Other measurement
9753	GCST004705	Blood pressure	Blood pressure	Other measurement
9754	GCST004705	Blood pressure	Blood pressure	Cardiovascular measurement
9755	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Other measurement
9756	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Body measurement
9757	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Body measurement
9758	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Other measurement
9759	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Other measurement
9760	GCST002470	Pulse pressure in young-onset hypertension	Pulse pressure in young-onset hypertension	Cardiovascular disease
9761	GCST002470	Pulse pressure in young-onset hypertension	Pulse pressure in young-onset hypertension	Cardiovascular measurement
9762	GCST002467	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
9763	GCST002468	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
9764	GCST002469	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
9765	GCST002465	Response to haloperidol in psychosis	Response to haloperidol in psychosis	Response to drug
9766	GCST002465	Response to haloperidol in psychosis	Response to haloperidol in psychosis	Neurological disorder
9767	GCST002466	Lung cancer	Lung cancer	Cancer
9768	GCST002466	Lung cancer	Lung cancer	Cancer
9769	GCST002466	Lung cancer	Lung cancer	Cancer
9770	GCST002359	Plasma amyloid beta peptide concentrations (ABx-42)	Plasma amyloid beta peptide concentrations (ABx-42)	Other measurement
9771	GCST002361	Smooth-surface caries	Smooth-surface caries	Digestive system disorder
9772	GCST002360	Plasma amyloid beta peptide concentrations (ABx-40)	Plasma amyloid beta peptide concentrations (ABx-40)	Other measurement
9773	GCST002357	Rheumatoid arthritis (ACPA-negative)	Rheumatoid arthritis (ACPA-negative)	Immune system disorder
9774	GCST006048	Rheumatoid arthritis (ACPA-positive)	Rheumatoid arthritis (ACPA-positive)	Immune system disorder
9775	GCST002355	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
9776	GCST002356	Intraocular pressure	Intraocular pressure	Other measurement
9777	GCST002354	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
9778	GCST002354	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
9779	GCST002353	Parkinson's disease	Parkinson's disease	Neurological disorder
9780	GCST002352	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9781	GCST002379	Pyoderma gangrenosum in inflammatory bowel disease	Pyoderma gangrenosum in inflammatory bowel disease	Digestive system disorder
9782	GCST002379	Pyoderma gangrenosum in inflammatory bowel disease	Pyoderma gangrenosum in inflammatory bowel disease	Other trait
9783	GCST002380	Erythema nodosum in inflammatory bowel disease	Erythema nodosum in inflammatory bowel disease	Digestive system disorder
9784	GCST002380	Erythema nodosum in inflammatory bowel disease	Erythema nodosum in inflammatory bowel disease	Other trait
9785	GCST002376	Urinary uromodulin levels	Urinary uromodulin levels	Other measurement
9786	GCST002374	Plasma plasminogen activator levels	Plasma plasminogen activator levels	Cardiovascular measurement
9787	GCST002377	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	Cardiovascular disease
9788	GCST002377	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	Other measurement
9789	GCST002375	Response to methotrexate in rheumatoid arthritis	Response to methotrexate in rheumatoid arthritis	Immune system disorder
9790	GCST002375	Response to methotrexate in rheumatoid arthritis	Response to methotrexate in rheumatoid arthritis	Response to drug
9791	GCST002373	Thyroid peroxidase antibody levels	Thyroid peroxidase antibody levels	Other measurement
9792	GCST002378	Thyroid peroxidase antibody positivity	Thyroid peroxidase antibody positivity	Other measurement
9793	GCST002371	Parent of origin effect on language impairment (paternal)	Parent of origin effect on language impairment (paternal)	Neurological disorder
9794	GCST002369	Parent of origin effect on language impairment (maternal)	Parent of origin effect on language impairment (maternal)	Neurological disorder
9795	GCST002372	Political ideology	Political ideology	Other trait
9796	GCST002368	Maternal genotype effects in autism spectrum disorder families	Maternal genotype effects in autism spectrum disorder families	Neurological disorder
9797	GCST002368	Maternal genotype effects in autism spectrum disorder families	Maternal genotype effects in autism spectrum disorder families	Other measurement
9798	GCST002367	Social communication problems	Social communication problems	Other measurement
9799	GCST002366	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Response to drug
9800	GCST002366	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Other disease
9801	GCST002366	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Neurological disorder
9802	GCST002365	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Response to drug
9803	GCST002365	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Other disease
9804	GCST002365	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Neurological disorder
9805	GCST002363	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Response to drug
9806	GCST002363	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Other disease
9807	GCST002363	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Neurological disorder
9808	GCST002364	Urinary metabolites (H-NMR features)	Urinary metabolites (H-NMR features)	Other measurement
9809	GCST002362	Preschool internalizing problems	Preschool internalizing problems	Other measurement
9810	GCST002358	Pit-and-Fissure caries	Pit-and-Fissure caries	Digestive system disorder
9811	GCST002390	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
9812	GCST002389	Intracerebral hemorrhage	Intracerebral hemorrhage	Cardiovascular disease
9813	GCST002388	Serum metabolite levels	Serum metabolite levels	Other measurement
9814	GCST002387	Musical aptitude	Musical aptitude	Biological process
9815	GCST002386	Cognitive function	Cognitive function	Biological process
9816	GCST002386	Cognitive function	Cognitive function	Biological process
9817	GCST002386	Cognitive function	Cognitive function	Other measurement
9818	GCST002386	Cognitive function	Cognitive function	Biological process
9819	GCST002385	Bipolar disorder	Bipolar disorder	Neurological disorder
9820	GCST002384	NHDL cholesterol	NHDL cholesterol	Lipid or lipoprotein measurement
9821	GCST002383	Anterior chamber depth	Anterior chamber depth	Other measurement
9822	GCST002382	Urinary albumin excretion rate in type 1 diabetes	Urinary albumin excretion rate in type 1 diabetes	Other measurement
9823	GCST002382	Urinary albumin excretion rate in type 1 diabetes	Urinary albumin excretion rate in type 1 diabetes	Metabolic disorder
9824	GCST002381	Resistin levels	Resistin levels	Other measurement
9825	GCST002400	Plasma trimethylamine N-oxide levels	Plasma trimethylamine N-oxide levels	Other measurement
9826	GCST002399	Clubfoot	Clubfoot	Other disease
9827	GCST002398	Resting heart rate	Resting heart rate	Cardiovascular measurement
9828	GCST002393	Smoking quantity	Smoking quantity	Other measurement
9829	GCST002397	Bladder cancer (smoking interaction)	Bladder cancer (smoking interaction)	Cancer
9830	GCST002395	Smoking cessation	Smoking cessation	Biological process
9831	GCST002394	Age of smoking initiation	Age of smoking initiation	Biological process
9832	GCST002394	Age of smoking initiation	Age of smoking initiation	Other measurement
9833	GCST002396	Smoking initiation	Smoking initiation	Biological process
9834	GCST002392	Lung cancer (smoking interaction)	Lung cancer (smoking interaction)	Other measurement
9835	GCST002392	Lung cancer (smoking interaction)	Lung cancer (smoking interaction)	Cancer
9836	GCST002391	Plasma homocysteine levels (post-methionine load test)	Plasma homocysteine levels (post-methionine load test)	Cardiovascular measurement
9837	GCST002424	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
9838	GCST002423	Autoimmune hepatitis type-1	Autoimmune hepatitis type-1	Immune system disorder
9839	GCST002422	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9840	GCST002421	Prostate cancer	Prostate cancer	Cancer
9841	GCST002420	Binge eating behaviour in bipolar disorder	Binge eating behaviour in bipolar disorder	Metabolic disorder
9842	GCST002420	Binge eating behaviour in bipolar disorder	Binge eating behaviour in bipolar disorder	Neurological disorder
9843	GCST002419	Binge eating behaviour and bipolar disorder	Binge eating behaviour and bipolar disorder	Metabolic disorder
9844	GCST002419	Binge eating behaviour and bipolar disorder	Binge eating behaviour and bipolar disorder	Neurological disorder
9845	GCST002415	Colorectal cancer (diet interaction)	Colorectal cancer (diet interaction)	Other measurement
9846	GCST002415	Colorectal cancer (diet interaction)	Colorectal cancer (diet interaction)	Cancer
9847	GCST002414	Serum vitamin D-binding protein levels	Serum vitamin D-binding protein levels	Other measurement
9848	GCST002413	Prostate cancer (early onset)	Prostate cancer (early onset)	Cancer
9849	GCST002412	Non-small cell lung cancer (recurrence rate)	Non-small cell lung cancer (recurrence rate)	Other measurement
9850	GCST002412	Non-small cell lung cancer (recurrence rate)	Non-small cell lung cancer (recurrence rate)	Cancer
9851	GCST002411	Colorectal cancer	Colorectal cancer	Cancer
9852	GCST002409	White matter microstructure (global fractional anisotropy)	White matter microstructure (global fractional anisotropy)	Other measurement
9853	GCST002410	Osteoarthritis (hand, severe)	Osteoarthritis (hand, severe)	Other disease
9854	GCST002407	Chronic mucus hypersecretion	Chronic mucus hypersecretion	Other trait
9855	GCST002404	Longevity (90 years and older)	Longevity (90 years and older)	Other measurement
9856	GCST002403	Longevity (85 years and older)	Longevity (85 years and older)	Other measurement
9857	GCST002401	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
9858	GCST002408	Response to methotrexate in juvenile idiopathic arthritis	Response to methotrexate in juvenile idiopathic arthritis	Response to drug
9859	GCST002408	Response to methotrexate in juvenile idiopathic arthritis	Response to methotrexate in juvenile idiopathic arthritis	Immune system disorder
9860	GCST002406	Plasma cystastin c levels in acute coronary syndrome	Plasma cystastin c levels in acute coronary syndrome	Cardiovascular disease
9861	GCST002406	Plasma cystastin c levels in acute coronary syndrome	Plasma cystastin c levels in acute coronary syndrome	Other measurement
9862	GCST002405	Cervical cancer	Cervical cancer	Cancer
9863	GCST002320	Cognitive decline (age-related)	Cognitive decline (age-related)	Other trait
9864	GCST002319	Musician's dystonia	Musician's dystonia	Neurological disorder
9865	GCST002318	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9866	GCST002317	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9867	GCST006524	Nasopharyngeal carcinoma (SNP x SNP interaction)	Nasopharyngeal carcinoma (SNP x SNP interaction)	Cancer
9868	GCST002316	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
9869	GCST002315	Thrombin generation potential phenotypes	Thrombin generation potential phenotypes	Other measurement
9870	GCST002313	Chronic kidney disease	Chronic kidney disease	Other disease
9871	GCST002313	Chronic kidney disease	Chronic kidney disease	Other measurement
9872	GCST002313	Chronic kidney disease	Chronic kidney disease	Other measurement
9873	GCST002314	Glomerular filtration rate	Glomerular filtration rate	Other measurement
9874	GCST002312	Periodontal disease-related phenotype (Socransky)	Periodontal disease-related phenotype (Socransky)	Other measurement
9875	GCST002312	Periodontal disease-related phenotype (Socransky)	Periodontal disease-related phenotype (Socransky)	Digestive system disorder
9876	GCST002283	Amyotrophic lateral sclerosis (sporadic)	Amyotrophic lateral sclerosis (sporadic)	Neurological disorder
9877	GCST002277	Schizophrenia	Schizophrenia	Neurological disorder
9878	GCST002276	Bone mineral density	Bone mineral density	Other measurement
9879	GCST002275	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
9880	GCST002275	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
9881	GCST002274	Multiple sclerosis or amyotrophic lateral sclerosis	Multiple sclerosis or amyotrophic lateral sclerosis	Immune system disorder
9882	GCST002274	Multiple sclerosis or amyotrophic lateral sclerosis	Multiple sclerosis or amyotrophic lateral sclerosis	Neurological disorder
9883	GCST002273	Renal cell carcinoma	Renal cell carcinoma	Cancer
9884	GCST005533	Limited cutaneous systemic scleroderma	Limited cutaneous systemic scleroderma	Neurological disorder
9885	GCST005534	Systemic sclerosis	Systemic sclerosis	Neurological disorder
9886	GCST005535	Diffuse cutaneous systemic sclerosis	Diffuse cutaneous systemic sclerosis	Neurological disorder
9887	GCST002325	Memory performance	Memory performance	Other measurement
9888	GCST002323	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9889	GCST004712	Alcohol dependence	Alcohol dependence	Other measurement
9890	GCST004712	Alcohol dependence	Alcohol dependence	Neurological disorder
9891	GCST004711	Alcohol dependence	Alcohol dependence	Other measurement
9892	GCST004711	Alcohol dependence	Alcohol dependence	Neurological disorder
9893	GCST002324	Anger	Anger	Biological process
9894	GCST002321	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
9895	GCST002321	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
9896	GCST002321	Lipid traits	Lipid traits	Other measurement
9897	GCST002321	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
9898	GCST002321	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
9899	GCST002322	Asthma and hay fever	Asthma and hay fever	Other disease
9900	GCST002322	Asthma and hay fever	Asthma and hay fever	Immune system disorder
9901	GCST006523	General cognitive ability	General cognitive ability	Biological process
9902	GCST002345	Response to cytadine analogues (cytosine arabinoside)	Response to cytadine analogues (cytosine arabinoside)	Response to drug
9903	GCST002343	Response to cytidine analogues (gemcitabine)	Response to cytidine analogues (gemcitabine)	Response to drug
9904	GCST002342	Asthma (corticosteroid response)	Asthma (corticosteroid response)	Response to drug
9905	GCST002342	Asthma (corticosteroid response)	Asthma (corticosteroid response)	Other disease
9906	GCST002340	Colorectal cancer	Colorectal cancer	Cancer
9907	GCST002341	Telomere length	Telomere length	Other measurement
9908	GCST002339	Type 2 diabetes (young onset) and obesity	Type 2 diabetes (young onset) and obesity	Metabolic disorder
9909	GCST002339	Type 2 diabetes (young onset) and obesity	Type 2 diabetes (young onset) and obesity	Metabolic disorder
9910	GCST002338	Bipolar I disorder	Bipolar I disorder	Neurological disorder
9911	GCST002338	Bipolar I disorder	Bipolar I disorder	Neurological disorder
9912	GCST002337	Amyotrophic lateral sclerosis (sporadic)	Amyotrophic lateral sclerosis (sporadic)	Neurological disorder
9913	GCST002336	Telomere length	Telomere length	Other measurement
9914	GCST002311	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
9915	GCST002310	Pulse pressure (alcohol consumption interaction)	Pulse pressure (alcohol consumption interaction)	Biological process
9916	GCST002310	Pulse pressure (alcohol consumption interaction)	Pulse pressure (alcohol consumption interaction)	Cardiovascular measurement
9917	GCST002308	Mean arterial pressure (alcohol consumption interaction)	Mean arterial pressure (alcohol consumption interaction)	Biological process
9918	GCST002308	Mean arterial pressure (alcohol consumption interaction)	Mean arterial pressure (alcohol consumption interaction)	Other measurement
9919	GCST002308	Mean arterial pressure (alcohol consumption interaction)	Mean arterial pressure (alcohol consumption interaction)	Other measurement
9920	GCST002309	Diastolic blood pressure (alcohol consumption interaction)	Diastolic blood pressure (alcohol consumption interaction)	Biological process
9921	GCST002309	Diastolic blood pressure (alcohol consumption interaction)	Diastolic blood pressure (alcohol consumption interaction)	Other measurement
9922	GCST002307	Systolic blood pressure (alcohol consumption interaction)	Systolic blood pressure (alcohol consumption interaction)	Biological process
9923	GCST002307	Systolic blood pressure (alcohol consumption interaction)	Systolic blood pressure (alcohol consumption interaction)	Other measurement
9924	GCST002306	Bipolar disorder (body mass index interaction)	Bipolar disorder (body mass index interaction)	Body measurement
9925	GCST002306	Bipolar disorder (body mass index interaction)	Bipolar disorder (body mass index interaction)	Neurological disorder
9926	GCST002305	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	Cancer
9927	GCST006866	Lung cancer (SNP x SNP interaction)	Lung cancer (SNP x SNP interaction)	Cancer
9928	GCST002304	Fractional exhaled nitric oxide (childhood)	Fractional exhaled nitric oxide (childhood)	Other measurement
9929	GCST002303	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
9930	GCST002335	Bone properties (heel)	Bone properties (heel)	Other measurement
9931	GCST002335	Bone properties (heel)	Bone properties (heel)	Other measurement
9932	GCST002335	Bone properties (heel)	Bone properties (heel)	Other measurement
9933	GCST002333	Bone properties (heel)	Bone properties (heel)	Other measurement
9934	GCST002333	Bone properties (heel)	Bone properties (heel)	Other measurement
9935	GCST002333	Bone properties (heel)	Bone properties (heel)	Other measurement
9936	GCST002334	Bone properties (heel)	Bone properties (heel)	Other measurement
9937	GCST002334	Bone properties (heel)	Bone properties (heel)	Other measurement
9938	GCST002334	Bone properties (heel)	Bone properties (heel)	Other measurement
9939	GCST002332	Hypertension (young onset)	Hypertension (young onset)	Cardiovascular disease
9940	GCST002331	Basal cell carcinoma	Basal cell carcinoma	Cancer
9941	GCST002329	Acne (severe)	Acne (severe)	Other disease
9942	GCST002330	Asthma	Asthma	Other disease
9943	GCST002328	Lung function	Lung function	Other measurement
9944	GCST002327	Bipolar disorder	Bipolar disorder	Neurological disorder
9945	GCST002326	Pulmonary emphysema	Pulmonary emphysema	Other disease
9946	GCST002292	Response to alcohol consumption (flushing response)	Response to alcohol consumption (flushing response)	Biological process
9947	GCST002291	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Response to drug
9948	GCST002291	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Response to drug
9949	GCST002291	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Other disease
9950	GCST002289	Coronary artery disease	Coronary artery disease	Cardiovascular disease
9951	GCST002289	Coronary artery disease	Coronary artery disease	Cardiovascular disease
9952	GCST002290	Coronary artery disease or large artery stroke	Coronary artery disease or large artery stroke	Cardiovascular disease
9953	GCST002290	Coronary artery disease or large artery stroke	Coronary artery disease or large artery stroke	Cardiovascular disease
9954	GCST002287	Coronary artery disease or ischemic stroke	Coronary artery disease or ischemic stroke	Cardiovascular disease
9955	GCST002287	Coronary artery disease or ischemic stroke	Coronary artery disease or ischemic stroke	Cardiovascular disease
9956	GCST002288	Large artery stroke	Large artery stroke	Cardiovascular disease
9957	GCST002286	Ischemic stroke	Ischemic stroke	Cardiovascular disease
9958	GCST002286	Ischemic stroke	Ischemic stroke	Other trait
9959	GCST002302	IgE levels	IgE levels	Other measurement
9960	GCST002301	Body mass index	Body mass index	Body measurement
9961	GCST002301	Body mass index	Body mass index	Body measurement
9962	GCST002301	Body mass index	Body mass index	Other measurement
9963	GCST002300	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9964	GCST002298	Coronary heart disease	Coronary heart disease	Cardiovascular disease
9965	GCST002299	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
9966	GCST002297	Hepatitis B vaccine response	Hepatitis B vaccine response	Response to drug
9967	GCST002296	Body mass index (education interaction)	Body mass index (education interaction)	Body measurement
9968	GCST002293	Alcohol dependence	Alcohol dependence	Other measurement
9969	GCST002293	Alcohol dependence	Alcohol dependence	Neurological disorder
9970	GCST002294	Alcohol consumption (max-drinks)	Alcohol consumption (max-drinks)	Biological process
9971	GCST002294	Alcohol consumption (max-drinks)	Alcohol consumption (max-drinks)	Other measurement
9972	GCST002351	Chronic obstructive pulmonary disease (moderate to severe)	Chronic obstructive pulmonary disease (moderate to severe)	Other disease
9973	GCST002350	Chronic obstructive pulmonary disease (severe)	Chronic obstructive pulmonary disease (severe)	Other disease
9974	GCST002347	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Response to drug
9975	GCST002347	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Other measurement
9976	GCST002347	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Digestive system disorder
9977	GCST002349	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Response to drug
9978	GCST002349	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Other measurement
9979	GCST002349	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Digestive system disorder
9980	GCST002348	Cleft plate (environmental tobacco smoke interaction)	Cleft plate (environmental tobacco smoke interaction)	Other trait
9981	GCST002348	Cleft plate (environmental tobacco smoke interaction)	Cleft plate (environmental tobacco smoke interaction)	Other measurement
9982	GCST002346	Breast cancer (early onset)	Breast cancer (early onset)	Cancer
9983	GCST002344	Receptive language ability	Receptive language ability	Biological process
9984	GCST002226	Fat body mass	Fat body mass	Other measurement
9985	GCST002225	Disc degeneration (lumbar)	Disc degeneration (lumbar)	Other disease
9986	GCST002224	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9987	GCST002217	Sjgren's syndrome	Sjgren's syndrome	Neurological disorder
9988	GCST002215	Endometrial cancer	Endometrial cancer	Cancer
9989	GCST002215	Endometrial cancer	Endometrial cancer	Cancer
9990	GCST002218	Endometrial cancer	Endometrial cancer	Cancer
9991	GCST002218	Endometrial cancer	Endometrial cancer	Cancer
9992	GCST002245	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9993	GCST002245	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9994	GCST002246	Hepatitis B	Hepatitis B	Digestive system disorder
9995	GCST002246	Hepatitis B	Hepatitis B	Other measurement
9996	GCST002244	Fractures (vertebral)	Fractures (vertebral)	Other disease
9997	GCST002243	Bladder cancer	Bladder cancer	Cancer
9998	GCST002240	Bladder cancer	Bladder cancer	Cancer
9999	GCST002242	Serum dimethylarginine levels (asymmetric/symetric ratio)	Serum dimethylarginine levels (asymmetric/symetric ratio)	Other measurement
10000	GCST002239	Symmetrical dimethylarginine levels	Symmetrical dimethylarginine levels	Cardiovascular measurement
10001	GCST002239	Symmetrical dimethylarginine levels	Symmetrical dimethylarginine levels	Other measurement
10002	GCST002241	Asymmetrical dimethylarginine levels	Asymmetrical dimethylarginine levels	Cardiovascular measurement
10003	GCST002241	Asymmetrical dimethylarginine levels	Asymmetrical dimethylarginine levels	Other measurement
10004	GCST002238	Contrast sensitivity	Contrast sensitivity	Other measurement
10005	GCST002237	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
10006	GCST005531	Multiple sclerosis	Multiple sclerosis	Immune system disorder
10007	GCST005532	Sjgren's syndrome	Sjgren's syndrome	Neurological disorder
10008	GCST004879	Sjgren's syndrome	Sjgren's syndrome	Neurological disorder
10009	GCST004878	Sjgren's syndrome	Sjgren's syndrome	Neurological disorder
10010	GCST002262	Blood pressure (response to antihypertensive medication)	Blood pressure (response to antihypertensive medication)	Other measurement
10011	GCST002262	Blood pressure (response to antihypertensive medication)	Blood pressure (response to antihypertensive medication)	Response to drug
10012	GCST002261	Narcolepsy (age of onset)	Narcolepsy (age of onset)	Neurological disorder
10013	GCST002261	Narcolepsy (age of onset)	Narcolepsy (age of onset)	Other measurement
10014	GCST002259	Narcolepsy (onset before 2009 H1N1 influenza pandemic)	Narcolepsy (onset before 2009 H1N1 influenza pandemic)	Neurological disorder
10015	GCST002260	Narcolepsy	Narcolepsy	Neurological disorder
10016	GCST002214	Serum alkaline phosphatase levels	Serum alkaline phosphatase levels	Liver enzyme measurement
10017	GCST002213	Coronary artery calcification (smoking interaction)	Coronary artery calcification (smoking interaction)	Other trait
10018	GCST002213	Coronary artery calcification (smoking interaction)	Coronary artery calcification (smoking interaction)	Other measurement
10019	GCST002212	Colorectal adenoma (advanced)	Colorectal adenoma (advanced)	Cancer
10020	GCST002210	Acute myeloid leukemia	Acute myeloid leukemia	Cancer
10021	GCST002211	Psychosis (atypical)	Psychosis (atypical)	Neurological disorder
10022	GCST002207	Liver enzyme levels (alanine transaminase)	Liver enzyme levels (alanine transaminase)	Liver enzyme measurement
10023	GCST002208	Liver enzyme levels (aspartate transaminase)	Liver enzyme levels (aspartate transaminase)	Liver enzyme measurement
10024	GCST002209	Orthostatic hypotension	Orthostatic hypotension	Cardiovascular disease
10025	GCST002272	Renal cell carcinoma	Renal cell carcinoma	Cancer
10026	GCST002271	Delayed encephalopathy in acute carbon monoxide poisoning	Delayed encephalopathy in acute carbon monoxide poisoning	Neurological disorder
10027	GCST002270	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
10028	GCST002269	Drug-induced torsades de pointes	Drug-induced torsades de pointes	Biological process
10029	GCST002269	Drug-induced torsades de pointes	Drug-induced torsades de pointes	Cardiovascular disease
10030	GCST002268	Autism	Autism	Neurological disorder
10031	GCST002267	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
10032	GCST002267	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
10033	GCST002265	Breast cancer (menopausal hormone therapy interaction)	Breast cancer (menopausal hormone therapy interaction)	Cancer
10034	GCST002265	Breast cancer (menopausal hormone therapy interaction)	Breast cancer (menopausal hormone therapy interaction)	Other trait
10035	GCST002266	Lobular breast cancer (menopausal hormone therapy interaction)	Lobular breast cancer (menopausal hormone therapy interaction)	Cancer
10036	GCST002266	Lobular breast cancer (menopausal hormone therapy interaction)	Lobular breast cancer (menopausal hormone therapy interaction)	Other trait
10037	GCST002264	Prostate cancer	Prostate cancer	Cancer
10038	GCST002263	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Other disease
10039	GCST002263	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Cardiovascular disease
10040	GCST002263	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Response to drug
10041	GCST002197	Tuberculosis	Tuberculosis	Other disease
10042	GCST002197	Tuberculosis	Tuberculosis	Other measurement
10043	GCST002197	Tuberculosis	Tuberculosis	Other measurement
10044	GCST002198	Tuberculosis	Tuberculosis	Other disease
10045	GCST002198	Tuberculosis	Tuberculosis	Other measurement
10046	GCST002198	Tuberculosis	Tuberculosis	Other measurement
10047	GCST002194	Social communication problems	Social communication problems	Other measurement
10048	GCST002193	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
10049	GCST002192	Menopause (age at onset)	Menopause (age at onset)	Other measurement
10050	GCST002190	Schizophrenia	Schizophrenia	Neurological disorder
10051	GCST002191	Menarche (age at onset)	Menarche (age at onset)	Other measurement
10052	GCST002187	Systolic blood pressure in sickle cell anemia	Systolic blood pressure in sickle cell anemia	Neurological disorder
10053	GCST002187	Systolic blood pressure in sickle cell anemia	Systolic blood pressure in sickle cell anemia	Other measurement
10054	GCST002188	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Neurological disorder
10055	GCST002188	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Neurological disorder
10056	GCST002188	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Neurological disorder
10057	GCST002188	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Other measurement
10058	GCST002189	Skin youthfulness	Skin youthfulness	Biological process
10059	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Other measurement
10060	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
10061	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
10062	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Response to drug
10063	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
10064	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
10065	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
10066	GCST002254	Schizophrenia, schizoaffective disorder or bipolar disorder	Schizophrenia, schizoaffective disorder or bipolar disorder	Neurological disorder
10067	GCST002254	Schizophrenia, schizoaffective disorder or bipolar disorder	Schizophrenia, schizoaffective disorder or bipolar disorder	Neurological disorder
10068	GCST002254	Schizophrenia, schizoaffective disorder or bipolar disorder	Schizophrenia, schizoaffective disorder or bipolar disorder	Neurological disorder
10069	GCST002251	Homeostasis model assessment of beta-cell function (dietary factor interaction)	Homeostasis model assessment of beta-cell function (dietary factor interaction)	Other measurement
10070	GCST002251	Homeostasis model assessment of beta-cell function (dietary factor interaction)	Homeostasis model assessment of beta-cell function (dietary factor interaction)	Other measurement
10071	GCST002253	Homeostasis model assessment of insulin resistance (dietary factor interaction)	Homeostasis model assessment of insulin resistance (dietary factor interaction)	Other measurement
10072	GCST002253	Homeostasis model assessment of insulin resistance (dietary factor interaction)	Homeostasis model assessment of insulin resistance (dietary factor interaction)	Other measurement
10073	GCST002248	Fasting insulin (dietary factor interaction)	Fasting insulin (dietary factor interaction)	Other measurement
10074	GCST002248	Fasting insulin (dietary factor interaction)	Fasting insulin (dietary factor interaction)	Other measurement
10075	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Other measurement
10076	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Other measurement
10077	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Other measurement
10078	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Other measurement
10079	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Biological process
10080	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Other measurement
10081	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Other measurement
10082	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Other measurement
10083	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Other measurement
10084	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Biological process
10085	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Other measurement
10086	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Other measurement
10087	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Other measurement
10088	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Other measurement
10089	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Biological process
10090	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Biological process
10091	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Other measurement
10092	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Other measurement
10093	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Other measurement
10094	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Other measurement
10095	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Biological process
10096	GCST002236	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
10097	GCST002235	Opioid sensitivity	Opioid sensitivity	Response to drug
10098	GCST002234	Breast cancer	Breast cancer	Cancer
10099	GCST002233	Adiponectin levels	Adiponectin levels	Other measurement
10100	GCST002232	Esophageal adenocarcinoma	Esophageal adenocarcinoma	Cancer
10101	GCST002230	Barrett's esophagus	Barrett's esophagus	Digestive system disorder
10102	GCST002231	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Digestive system disorder
10103	GCST002231	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Cancer
10104	GCST002231	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Other disease
10105	GCST002229	Acne (severe teenage)	Acne (severe teenage)	Other disease
10106	GCST002228	Social autistic-like traits	Social autistic-like traits	Other measurement
10107	GCST002227	Body mass index	Body mass index	Body measurement
10108	GCST002227	Body mass index	Body mass index	Body measurement
10109	GCST002227	Body mass index	Body mass index	Other measurement
10110	GCST002205	Handedness	Handedness	Other trait
10111	GCST002206	Handedness	Handedness	Other trait
10112	GCST002204	Liver disease in chronic hepatitis B virus infection	Liver disease in chronic hepatitis B virus infection	Digestive system disorder
10113	GCST002204	Liver disease in chronic hepatitis B virus infection	Liver disease in chronic hepatitis B virus infection	Digestive system disorder
10114	GCST002203	Gray matter volume (schizophrenia interaction)	Gray matter volume (schizophrenia interaction)	Neurological disorder
10115	GCST002203	Gray matter volume (schizophrenia interaction)	Gray matter volume (schizophrenia interaction)	Other measurement
10116	GCST002201	Calcium levels	Calcium levels	Other measurement
10117	GCST002200	Anxiety and major depressive disorder	Anxiety and major depressive disorder	Neurological disorder
10118	GCST002200	Anxiety and major depressive disorder	Anxiety and major depressive disorder	Other trait
10119	GCST002202	Anxiety in major depressive disorder	Anxiety in major depressive disorder	Neurological disorder
10120	GCST002202	Anxiety in major depressive disorder	Anxiety in major depressive disorder	Other trait
10121	GCST002156	Response to mTOR inhibitor (rapamycin)	Response to mTOR inhibitor (rapamycin)	Response to drug
10122	GCST002155	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
10123	GCST002155	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
10124	GCST002154	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Response to drug
10125	GCST002154	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Other disease
10126	GCST002153	Cardiovascular heart disease in diabetics	Cardiovascular heart disease in diabetics	Other disease
10127	GCST002153	Cardiovascular heart disease in diabetics	Cardiovascular heart disease in diabetics	Metabolic disorder
10128	GCST002152	Airway hyperresponsiveness	Airway hyperresponsiveness	Other trait
10129	GCST002151	Dermatomyositis	Dermatomyositis	Neurological disorder
10130	GCST002150	Borderline personality disorder features	Borderline personality disorder features	Other trait
10131	GCST002149	Schizophrenia	Schizophrenia	Neurological disorder
10132	GCST002148	Otitis media (chronic/recurrent)	Otitis media (chronic/recurrent)	Neurological disorder
10133	GCST002147	Fibrinogen	Fibrinogen	Hematological measurement
10134	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10135	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10136	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10137	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10138	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10139	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10140	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10141	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10142	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
10143	GCST002110	Glycemic traits (pregnancy)	Glycemic traits (pregnancy)	Other measurement
10144	GCST002110	Glycemic traits (pregnancy)	Glycemic traits (pregnancy)	Other measurement
10145	GCST002110	Glycemic traits (pregnancy)	Glycemic traits (pregnancy)	Other measurement
10146	GCST002103	Telomere length	Telomere length	Other measurement
10147	GCST002104	Bronchopulmonary dysplasia	Bronchopulmonary dysplasia	Other disease
10148	GCST002102	Thyroid cancer	Thyroid cancer	Cancer
10149	GCST002101	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
10150	GCST002101	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
10151	GCST002100	Atopic dermatitis	Atopic dermatitis	Immune system disorder
10152	GCST002099	Colorectal cancer	Colorectal cancer	Cancer
10153	GCST002098	Brugada syndrome	Brugada syndrome	Cardiovascular disease
10154	GCST002097	Coronary artery calcification	Coronary artery calcification	Other trait
10155	GCST002146	Serum alpha1-antitrypsin levels	Serum alpha1-antitrypsin levels	Other measurement
10156	GCST002145	Infantile hypertrophic pyloric stenosis	Infantile hypertrophic pyloric stenosis	Digestive system disorder
10157	GCST002142	Cocaine dependence	Cocaine dependence	Neurological disorder
10158	GCST002143	Blood pressure	Blood pressure	Other measurement
10159	GCST002143	Blood pressure	Blood pressure	Other measurement
10160	GCST002143	Blood pressure	Blood pressure	Other measurement
10161	GCST002143	Blood pressure	Blood pressure	Other measurement
10162	GCST002143	Blood pressure	Blood pressure	Cardiovascular measurement
10163	GCST002144	Bitter taste perception	Bitter taste perception	Biological process
10164	GCST002141	Epilepsy (remission after treatment)	Epilepsy (remission after treatment)	Biological process
10165	GCST002141	Epilepsy (remission after treatment)	Epilepsy (remission after treatment)	Neurological disorder
10166	GCST002140	Multiple myeloma	Multiple myeloma	Cancer
10167	GCST002139	Joint damage progression in ACPA-positive rheumatoid arthritis	Joint damage progression in ACPA-positive rheumatoid arthritis	Immune system disorder
10168	GCST002139	Joint damage progression in ACPA-positive rheumatoid arthritis	Joint damage progression in ACPA-positive rheumatoid arthritis	Other measurement
10169	GCST002137	Waist circumference	Waist circumference	Body measurement
10170	GCST002138	Waist-hip ratio	Waist-hip ratio	Other measurement
10171	GCST002138	Waist-hip ratio	Waist-hip ratio	Body measurement
10172	GCST002174	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
10173	GCST002174	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
10174	GCST002174	Lipid traits	Lipid traits	Other measurement
10175	GCST002174	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
10176	GCST002174	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
10177	GCST002173	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
10178	GCST002173	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
10179	GCST002173	Lipid traits	Lipid traits	Other measurement
10180	GCST002173	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
10181	GCST002173	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
10182	GCST002172	Alcohol dependence	Alcohol dependence	Other measurement
10183	GCST002172	Alcohol dependence	Alcohol dependence	Neurological disorder
10184	GCST002171	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
10185	GCST002170	Mesial temporal lobe epilepsy with hippocampal sclerosis	Mesial temporal lobe epilepsy with hippocampal sclerosis	Neurological disorder
10186	GCST002169	Adolescent idiopathic scoliosis (severe)	Adolescent idiopathic scoliosis (severe)	Other disease
10187	GCST002168	Intraocular pressure	Intraocular pressure	Other measurement
10188	GCST002166	Serum protein levels (sST2)	Serum protein levels (sST2)	Cardiovascular measurement
10189	GCST002115	Axial length	Axial length	Other measurement
10190	GCST002116	Blood pressure variability	Blood pressure variability	Other measurement
10191	GCST002114	Molar-incisor hypomineralization	Molar-incisor hypomineralization	Other disease
10192	GCST002113	Pulmonary function	Pulmonary function	Other measurement
10193	GCST002113	Pulmonary function	Pulmonary function	Other measurement
10194	GCST002113	Pulmonary function	Pulmonary function	Other measurement
10195	GCST002113	Pulmonary function	Pulmonary function	Other measurement
10196	GCST002112	Celiac disease	Celiac disease	Immune system disorder
10197	GCST002111	Personality dimensions	Personality dimensions	Other trait
10198	GCST002128	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
10199	GCST002123	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
10200	GCST002121	Alcohol consumption	Alcohol consumption	Biological process
10201	GCST002121	Alcohol consumption	Alcohol consumption	Other measurement
10202	GCST002125	IgE levels in asthmatics (D.f. specific)	IgE levels in asthmatics (D.f. specific)	Other disease
10203	GCST002125	IgE levels in asthmatics (D.f. specific)	IgE levels in asthmatics (D.f. specific)	Other measurement
10204	GCST002124	IgE levels in asthmatics (D.p. specific)	IgE levels in asthmatics (D.p. specific)	Other disease
10205	GCST002124	IgE levels in asthmatics (D.p. specific)	IgE levels in asthmatics (D.p. specific)	Other measurement
10206	GCST002122	IgE levels in asthmatics	IgE levels in asthmatics	Other disease
10207	GCST002122	IgE levels in asthmatics	IgE levels in asthmatics	Other measurement
10208	GCST002120	Metabolite levels (Dihydroxy docosatrienoic acid)	Metabolite levels (Dihydroxy docosatrienoic acid)	Other measurement
10209	GCST002119	Metabolite levels  (X-11787)	Metabolite levels  (X-11787)	Other measurement
10210	GCST002118	Metabolite levels (Pyroglutamine)	Metabolite levels (Pyroglutamine)	Other measurement
10211	GCST002117	Myopia (severe)	Myopia (severe)	Other trait
10212	GCST002129	Periodontitis (DPAL)	Periodontitis (DPAL)	Digestive system disorder
10213	GCST002126	Periodontitis (CDC/AAP)	Periodontitis (CDC/AAP)	Digestive system disorder
10214	GCST002127	Periodontitis (Mean PAL)	Periodontitis (Mean PAL)	Digestive system disorder
10215	GCST002136	Periodontitis (PAL4Q3)	Periodontitis (PAL4Q3)	Digestive system disorder
10216	GCST002167	Blood pressure	Blood pressure	Other measurement
10217	GCST002167	Blood pressure	Blood pressure	Other measurement
10218	GCST002167	Blood pressure	Blood pressure	Other measurement
10219	GCST002167	Blood pressure	Blood pressure	Other measurement
10220	GCST002167	Blood pressure	Blood pressure	Cardiovascular measurement
10221	GCST002165	Lung function (FEV1)	Lung function (FEV1)	Other measurement
10222	GCST002163	Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	Other measurement
10223	GCST002162	Lung function (FVC)	Lung function (FVC)	Other measurement
10224	GCST002164	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
10225	GCST002160	Wegener's granulomatosis	Wegener's granulomatosis	Cardiovascular disease
10226	GCST002159	Wegener's granulomatosis	Wegener's granulomatosis	Cardiovascular disease
10227	GCST002161	Alzheimer's disease (neuritic plaque pathology)	Alzheimer's disease (neuritic plaque pathology)	Neurological disorder
10228	GCST002157	Response to mTOR inhibitor (everolimus)	Response to mTOR inhibitor (everolimus)	Response to drug
10229	GCST002183	Relative hand skill in reading disability	Relative hand skill in reading disability	Other trait
10230	GCST002183	Relative hand skill in reading disability	Relative hand skill in reading disability	Neurological disorder
10231	GCST002182	End-stage renal disease in Type 1 diabetics	End-stage renal disease in Type 1 diabetics	Other disease
10232	GCST002182	End-stage renal disease in Type 1 diabetics	End-stage renal disease in Type 1 diabetics	Metabolic disorder
10233	GCST002184	Mean platelet volume	Mean platelet volume	Hematological measurement
10234	GCST002185	Relative hand skill	Relative hand skill	Other trait
10235	GCST002186	Platelet count	Platelet count	Hematological measurement
10236	GCST006863	Takayasu arteritis	Takayasu arteritis	Cardiovascular disease
10237	GCST002086	C-reactive protein	C-reactive protein	Inflammatory measurement
10238	GCST002085	Malignant mesothelioma	Malignant mesothelioma	Cancer
10239	GCST005530	Ankylosing spondylitis (SNP x SNP interaction)	Ankylosing spondylitis (SNP x SNP interaction)	Immune system disorder
10240	GCST005529	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
10241	GCST002083	Self-reported allergy	Self-reported allergy	Immune system disorder
10242	GCST002084	Allergic sensitization	Allergic sensitization	Other measurement
10243	GCST002082	Cervical cancer	Cervical cancer	Cancer
10244	GCST002068	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
10245	GCST002068	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
10246	GCST002069	Systemic lupus erythematosus and Systemic sclerosis	Systemic lupus erythematosus and Systemic sclerosis	Neurological disorder
10247	GCST002069	Systemic lupus erythematosus and Systemic sclerosis	Systemic lupus erythematosus and Systemic sclerosis	Immune system disorder
10248	GCST002067	Response to diuretic therapy in hypertension	Response to diuretic therapy in hypertension	Response to drug
10249	GCST002066	B cell non-Hodgkin lymphoma	B cell non-Hodgkin lymphoma	Cancer
10250	GCST002065	Alcohol consumption	Alcohol consumption	Biological process
10251	GCST002065	Alcohol consumption	Alcohol consumption	Other measurement
10252	GCST002063	Sexual dimorphism in anthropometric traits	Sexual dimorphism in anthropometric traits	Other measurement
10253	GCST002063	Sexual dimorphism in anthropometric traits	Sexual dimorphism in anthropometric traits	Body measurement
10254	GCST002063	Sexual dimorphism in anthropometric traits	Sexual dimorphism in anthropometric traits	Body measurement
10255	GCST002063	Sexual dimorphism in anthropometric traits	Sexual dimorphism in anthropometric traits	Other trait
10256	GCST002064	Corneal astigmatism	Corneal astigmatism	Neurological disorder
10257	GCST002064	Corneal astigmatism	Corneal astigmatism	Other trait
10258	GCST002061	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
10259	GCST002076	Hippocampal volume in schizophrenia	Hippocampal volume in schizophrenia	Neurological disorder
10260	GCST002076	Hippocampal volume in schizophrenia	Hippocampal volume in schizophrenia	Other measurement
10261	GCST002077	Parkinson's disease	Parkinson's disease	Neurological disorder
10262	GCST002075	Lipopolysaccharide induced cytokine levels	Lipopolysaccharide induced cytokine levels	Other measurement
10263	GCST002074	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Response to drug
10264	GCST002074	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
10265	GCST002074	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Other measurement
10266	GCST002074	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
10267	GCST002073	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
10268	GCST002072	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Immune system disorder
10269	GCST002072	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Other measurement
10270	GCST002071	Retinal arteriolar caliber	Retinal arteriolar caliber	Other measurement
10271	GCST002070	Smoking behavior	Smoking behavior	Biological process
10272	GCST002096	Psychosis	Psychosis	Neurological disorder
10273	GCST002095	Major depressive disorder	Major depressive disorder	Neurological disorder
10274	GCST002094	Crohn's disease	Crohn's disease	Digestive system disorder
10275	GCST002093	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
10276	GCST002093	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
10277	GCST002092	Callous-unemotional behaviour	Callous-unemotional behaviour	Biological process
10278	GCST002090	Sensory disturbances after bilateral sagittal split ramus osteotomy	Sensory disturbances after bilateral sagittal split ramus osteotomy	Other trait
10279	GCST002091	Angioedema in response to angiotensin-converting enzyme inhibitor	Angioedema in response to angiotensin-converting enzyme inhibitor	Cardiovascular disease
10280	GCST002091	Angioedema in response to angiotensin-converting enzyme inhibitor	Angioedema in response to angiotensin-converting enzyme inhibitor	Response to drug
10281	GCST002089	Intraocular pressure	Intraocular pressure	Other measurement
10282	GCST002088	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
10283	GCST002088	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
10284	GCST002087	Homocysteine levels	Homocysteine levels	Cardiovascular measurement
10285	GCST002057	DNA methylation (parent-of-origin)	DNA methylation (parent-of-origin)	Biological process
10286	GCST002058	DNA methylation (variation)	DNA methylation (variation)	Biological process
10287	GCST002056	Osteosarcoma	Osteosarcoma	Cancer
10288	GCST002055	Cognitive decline	Cognitive decline	Other trait
10289	GCST002055	Cognitive decline	Cognitive decline	Biological process
10290	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Digestive system disorder
10291	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Digestive system disorder
10292	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Immune system disorder
10293	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Immune system disorder
10294	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Immune system disorder
10295	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Other disease
10296	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Immune system disorder
10297	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Metabolic disorder
10298	GCST006670	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
10299	GCST002048	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
10300	GCST002046	Response to antidepressant treatment (citalopram)	Response to antidepressant treatment (citalopram)	Response to drug
10301	GCST002039	Blood trace element (Se levels)	Blood trace element (Se levels)	Other measurement
10302	GCST002033	Malaria	Malaria	Digestive system disorder
10303	GCST002029	Temporomandibular joint disorder	Temporomandibular joint disorder	Other disease
10304	GCST002032	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Other measurement
10305	GCST002032	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Cancer
10306	GCST002030	Primary tooth development (time to first tooth eruption)	Primary tooth development (time to first tooth eruption)	Biological process
10307	GCST002030	Primary tooth development (time to first tooth eruption)	Primary tooth development (time to first tooth eruption)	Biological process
10308	GCST002028	Serum selenium levels	Serum selenium levels	Other measurement
10309	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10310	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10311	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10312	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10313	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10314	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10315	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10316	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10317	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
10318	GCST002026	Coronary arterial lesions in patients with Kawasaki disease	Coronary arterial lesions in patients with Kawasaki disease	Immune system disorder
10319	GCST002026	Coronary arterial lesions in patients with Kawasaki disease	Coronary arterial lesions in patients with Kawasaki disease	Cardiovascular disease
10320	GCST002024	Prostate cancer	Prostate cancer	Cancer
10321	GCST002025	Cystic fibrosis-related diabetes	Cystic fibrosis-related diabetes	Other disease
10322	GCST002025	Cystic fibrosis-related diabetes	Cystic fibrosis-related diabetes	Metabolic disorder
10323	GCST002022	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
10324	GCST002022	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
10325	GCST002040	Blood trace element (Zn levels)	Blood trace element (Zn levels)	Other measurement
10326	GCST002041	Blood trace element (Cu levels)	Blood trace element (Cu levels)	Other measurement
10327	GCST002038	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
10328	GCST002037	Post-traumatic stress disorder (asjusted for relatedness)	Post-traumatic stress disorder (asjusted for relatedness)	Neurological disorder
10329	GCST002036	Congenital heart malformation	Congenital heart malformation	Cardiovascular disease
10330	GCST002034	Adverse response to radiation therapy	Adverse response to radiation therapy	Biological process
10331	GCST002035	Congenital heart disease	Congenital heart disease	Cardiovascular disease
10332	GCST002031	Primary tooth development (number of teeth)	Primary tooth development (number of teeth)	Biological process
10333	GCST002023	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
10334	GCST002023	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
10335	GCST002021	Body mass index	Body mass index	Body measurement
10336	GCST002021	Body mass index	Body mass index	Body measurement
10337	GCST002021	Body mass index	Body mass index	Other measurement
10338	GCST002020	Scoliosis	Scoliosis	Other disease
10339	GCST002019	IgE levels	IgE levels	Other measurement
10340	GCST002018	Crohn's disease (time to surgery)	Crohn's disease (time to surgery)	Digestive system disorder
10341	GCST002017	Crohn's disease (need for surgery)	Crohn's disease (need for surgery)	Digestive system disorder
10342	GCST002015	Personality dimensions	Personality dimensions	Other trait
10343	GCST002016	Personality dimensions	Personality dimensions	Other trait
10344	GCST002014	Helicobacter pylori serologic status	Helicobacter pylori serologic status	Other measurement
10345	GCST002013	Menarche (age at onset)	Menarche (age at onset)	Other measurement
10346	GCST001972	Methamphetamine dependence	Methamphetamine dependence	Neurological disorder
10347	GCST001972	Methamphetamine dependence	Methamphetamine dependence	Neurological disorder
10348	GCST001973	Menarche (age at onset)	Menarche (age at onset)	Other measurement
10349	GCST001971	Hypersomnia (HLA-DQB1*06:02 negative)	Hypersomnia (HLA-DQB1*06:02 negative)	Neurological disorder
10350	GCST001970	Menopause (age at onset)	Menopause (age at onset)	Other measurement
10351	GCST001969	Heart rate	Heart rate	Cardiovascular measurement
10352	GCST001967	Body mass index	Body mass index	Body measurement
10353	GCST001967	Body mass index	Body mass index	Body measurement
10354	GCST001967	Body mass index	Body mass index	Other measurement
10355	GCST001968	Interstitial lung disease	Interstitial lung disease	Other disease
10356	GCST001966	Rhegmatogenous retinal detachment	Rhegmatogenous retinal detachment	Neurological disorder
10357	GCST001965	Glycemic traits	Glycemic traits	Metabolic disorder
10358	GCST001963	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
10359	GCST001963	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
10360	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Other measurement
10361	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Body measurement
10362	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Other measurement
10363	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Other measurement
10364	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Other trait
10365	GCST001962	Bone mineral density	Bone mineral density	Other measurement
10366	GCST001960	Eating disorders	Eating disorders	Metabolic disorder
10367	GCST001960	Eating disorders	Eating disorders	Neurological disorder
10368	GCST001959	Eating disorders (purging via substances)	Eating disorders (purging via substances)	Metabolic disorder
10369	GCST001958	Bulimia nervosa	Bulimia nervosa	Metabolic disorder
10370	GCST001961	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
10371	GCST001961	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
10372	GCST001957	Obesity (early onset extreme)	Obesity (early onset extreme)	Metabolic disorder
10373	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
10374	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
10375	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
10376	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Neurological disorder
10377	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
10378	GCST001950	Femoral neck bone geometry and menarche (age at onset)	Femoral neck bone geometry and menarche (age at onset)	Other measurement
10379	GCST001952	Self-employment	Self-employment	Other measurement
10380	GCST001947	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
10381	GCST001947	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
10382	GCST001949	Preeclampsia	Preeclampsia	Cardiovascular disease
10383	GCST001948	Anxiety	Anxiety	Other measurement
10384	GCST001948	Anxiety	Anxiety	Other trait
10385	GCST001941	Ovarian cancer	Ovarian cancer	Cancer
10386	GCST001942	Prostate cancer	Prostate cancer	Cancer
10387	GCST001936	Telomere length	Telomere length	Other measurement
10388	GCST001937	Breast cancer	Breast cancer	Cancer
10389	GCST001982	Graves' disease	Graves' disease	Immune system disorder
10390	GCST001981	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
10391	GCST001979	Circulating myeloperoxidase levels (serum)	Circulating myeloperoxidase levels (serum)	Cardiovascular measurement
10392	GCST001980	Circulating myeloperoxidase levels (plasma)	Circulating myeloperoxidase levels (plasma)	Cardiovascular measurement
10393	GCST001978	Malignant pleural mesothelioma	Malignant pleural mesothelioma	Cancer
10394	GCST005528	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Immune system disorder
10395	GCST005528	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Immune system disorder
10396	GCST005528	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Immune system disorder
10397	GCST001976	Bilirubin levels	Bilirubin levels	Other measurement
10398	GCST001977	Diabetic retinopathy	Diabetic retinopathy	Metabolic disorder
10399	GCST001975	Psychosis (methamphetamine induced)	Psychosis (methamphetamine induced)	Neurological disorder
10400	GCST001930	Breast cancer	Breast cancer	Cancer
10401	GCST001924	Chronic kidney disease	Chronic kidney disease	Other disease
10402	GCST001924	Chronic kidney disease	Chronic kidney disease	Other measurement
10403	GCST001924	Chronic kidney disease	Chronic kidney disease	Other measurement
10404	GCST001992	Vitiligo (non-segmental)	Vitiligo (non-segmental)	Immune system disorder
10405	GCST001991	Weight loss (gastric bypass surgery)	Weight loss (gastric bypass surgery)	Other trait
10406	GCST001991	Weight loss (gastric bypass surgery)	Weight loss (gastric bypass surgery)	Other trait
10407	GCST001986	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
10408	GCST001986	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
10409	GCST001987	Age-related macular degeneration (extreme sampling)	Age-related macular degeneration (extreme sampling)	Neurological disorder
10410	GCST001990	Age-related macular degeneration (smoking status interaction)	Age-related macular degeneration (smoking status interaction)	Other measurement
10411	GCST001990	Age-related macular degeneration (smoking status interaction)	Age-related macular degeneration (smoking status interaction)	Neurological disorder
10412	GCST001989	Dietary macronutrient intake	Dietary macronutrient intake	Biological process
10413	GCST001988	Dietary macronutrient intake	Dietary macronutrient intake	Biological process
10414	GCST001985	Weight loss (gastric bypass surgery)	Weight loss (gastric bypass surgery)	Other trait
10415	GCST001985	Weight loss (gastric bypass surgery)	Weight loss (gastric bypass surgery)	Other trait
10416	GCST001984	Graves' disease	Graves' disease	Immune system disorder
10417	GCST002010	Esophageal squamous cell cancer (length of survival)	Esophageal squamous cell cancer (length of survival)	Cancer
10418	GCST002010	Esophageal squamous cell cancer (length of survival)	Esophageal squamous cell cancer (length of survival)	Other measurement
10419	GCST002010	Esophageal squamous cell cancer (length of survival)	Esophageal squamous cell cancer (length of survival)	Cancer
10420	GCST002011	Bone mineral density	Bone mineral density	Other measurement
10421	GCST002012	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
10422	GCST001854	Retinopathy in non-diabetics	Retinopathy in non-diabetics	Neurological disorder
10423	GCST001853	Circulating vasoactive peptide levels	Circulating vasoactive peptide levels	Cardiovascular measurement
10424	GCST001851	Schizophrenia	Schizophrenia	Neurological disorder
10425	GCST001852	Metabolite levels	Metabolite levels	Other trait
10426	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10427	GCST001852	Metabolite levels	Metabolite levels	Liver enzyme measurement
10428	GCST001852	Metabolite levels	Metabolite levels	Cardiovascular measurement
10429	GCST001852	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10430	GCST001852	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10431	GCST001852	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10432	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10433	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10434	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10435	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10436	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10437	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10438	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10439	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10440	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10441	GCST001852	Metabolite levels	Metabolite levels	Other measurement
10442	GCST001850	Major depressive disorder	Major depressive disorder	Neurological disorder
10443	GCST001848	IgG glycosylation	IgG glycosylation	Other measurement
10444	GCST001846	Bilirubin levels	Bilirubin levels	Other measurement
10445	GCST001845	Coronary heart disease	Coronary heart disease	Cardiovascular disease
10446	GCST001847	Urinary symptoms in response to radiotherapy in prostate cancer	Urinary symptoms in response to radiotherapy in prostate cancer	Cancer
10447	GCST001847	Urinary symptoms in response to radiotherapy in prostate cancer	Urinary symptoms in response to radiotherapy in prostate cancer	Biological process
10448	GCST001847	Urinary symptoms in response to radiotherapy in prostate cancer	Urinary symptoms in response to radiotherapy in prostate cancer	Other trait
10449	GCST001849	IgG glycosylation	IgG glycosylation	Other measurement
10450	GCST001865	Aortic-valve calcification	Aortic-valve calcification	Cardiovascular disease
10451	GCST001863	Beta-2 microglubulin plasma levels	Beta-2 microglubulin plasma levels	Other measurement
10452	GCST001861	Confectionary intake	Confectionary intake	Biological process
10453	GCST001862	Sickle cell anemia (haemolysis)	Sickle cell anemia (haemolysis)	Neurological disorder
10454	GCST001860	Multiple sclerosis	Multiple sclerosis	Immune system disorder
10455	GCST001859	Thiazide-induced adverse metabolic effects in hypertensive patients	Thiazide-induced adverse metabolic effects in hypertensive patients	Response to drug
10456	GCST001859	Thiazide-induced adverse metabolic effects in hypertensive patients	Thiazide-induced adverse metabolic effects in hypertensive patients	Lipid or lipoprotein measurement
10457	GCST001859	Thiazide-induced adverse metabolic effects in hypertensive patients	Thiazide-induced adverse metabolic effects in hypertensive patients	Other measurement
10458	GCST001857	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
10459	GCST001857	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
10460	GCST001858	Refractive error	Refractive error	Other trait
10461	GCST001856	Thyroid hormone levels	Thyroid hormone levels	Other measurement
10462	GCST001856	Thyroid hormone levels	Thyroid hormone levels	Other measurement
10463	GCST001856	Thyroid hormone levels	Thyroid hormone levels	Other measurement
10464	GCST001855	Response to antiplatelet therapy	Response to antiplatelet therapy	Biological process
10465	GCST001894	Endometriosis	Endometriosis	Other disease
10466	GCST001891	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Immune system disorder
10467	GCST001891	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Other measurement
10468	GCST001892	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Immune system disorder
10469	GCST001892	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Other measurement
10470	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
10471	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
10472	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
10473	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
10474	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
10475	GCST001890	QT interval (drug interaction)	QT interval (drug interaction)	Cardiovascular measurement
10476	GCST001890	QT interval (drug interaction)	QT interval (drug interaction)	Response to drug
10477	GCST001890	QT interval (drug interaction)	QT interval (drug interaction)	Response to drug
10478	GCST001890	QT interval (drug interaction)	QT interval (drug interaction)	Response to drug
10479	GCST001889	Brain connectivity	Brain connectivity	Other measurement
10480	GCST001888	Periodontitis	Periodontitis	Digestive system disorder
10481	GCST001884	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
10482	GCST001884	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
10483	GCST001887	Monocyte count	Monocyte count	Hematological measurement
10484	GCST001918	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
10485	GCST001918	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
10486	GCST001918	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
10487	GCST001918	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other disease
10488	GCST001919	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
10489	GCST001916	Breast Cancer in BRCA1 mutation carriers	Breast Cancer in BRCA1 mutation carriers	Cancer
10490	GCST001916	Breast Cancer in BRCA1 mutation carriers	Breast Cancer in BRCA1 mutation carriers	Other measurement
10491	GCST001917	Ovarian cancer in BRCA1 mutation carriers	Ovarian cancer in BRCA1 mutation carriers	Other measurement
10492	GCST001917	Ovarian cancer in BRCA1 mutation carriers	Ovarian cancer in BRCA1 mutation carriers	Cancer
10493	GCST001915	Alzheimer's disease (cognitive decline)	Alzheimer's disease (cognitive decline)	Neurological disorder
10494	GCST001914	Estradiol plasma levels (breast cancer)	Estradiol plasma levels (breast cancer)	Other measurement
10495	GCST001913	Venous thromboembolism (SNP x SNP interaction)	Venous thromboembolism (SNP x SNP interaction)	Cardiovascular disease
10496	GCST001912	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
10497	GCST001911	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Response to drug
10498	GCST001911	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Other disease
10499	GCST001909	Narcolepsy with cataplexy	Narcolepsy with cataplexy	Neurological disorder
10500	GCST001910	Aspirin hydrolysis (plasma)	Aspirin hydrolysis (plasma)	Other measurement
10501	GCST001908	Pulmonary arterial hypertension (without BMPR2 mutations)	Pulmonary arterial hypertension (without BMPR2 mutations)	Cardiovascular disease
10502	GCST001906	Multiple myeloma (IgH translocation)	Multiple myeloma (IgH translocation)	Cancer
10503	GCST001907	Multiple myeloma (hyperdiploidy)	Multiple myeloma (hyperdiploidy)	Cancer
10504	GCST001905	Hypertriglyceridemia	Hypertriglyceridemia	Metabolic disorder
10505	GCST001905	Hypertriglyceridemia	Hypertriglyceridemia	Lipid or lipoprotein measurement
10506	GCST001875	Pubertal anthropometrics	Pubertal anthropometrics	Body measurement
10507	GCST001875	Pubertal anthropometrics	Pubertal anthropometrics	Body measurement
10508	GCST001875	Pubertal anthropometrics	Pubertal anthropometrics	Biological process
10509	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10510	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10511	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10512	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10513	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10514	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10515	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10516	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10517	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
10518	GCST001872	Presence of antiphospholipid antibodies	Presence of antiphospholipid antibodies	Other measurement
10519	GCST001870	Bone mineral density	Bone mineral density	Other measurement
10520	GCST001871	Renal transplant outcome	Renal transplant outcome	Other measurement
10521	GCST001869	Breast cancer (menopausal hormone therapy interaction)	Breast cancer (menopausal hormone therapy interaction)	Cancer
10522	GCST001869	Breast cancer (menopausal hormone therapy interaction)	Breast cancer (menopausal hormone therapy interaction)	Other trait
10523	GCST001867	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
10524	GCST001866	Mathematical ability in children with dyslexia	Mathematical ability in children with dyslexia	Biological process
10525	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
10526	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
10527	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
10528	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Neurological disorder
10529	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
10530	GCST001864	Mitral annular calcification	Mitral annular calcification	Other trait
10531	GCST001886	Melanoma	Melanoma	Cancer
10532	GCST001883	Alcohol dependence	Alcohol dependence	Other measurement
10533	GCST001883	Alcohol dependence	Alcohol dependence	Neurological disorder
10534	GCST001882	Metabolite levels	Metabolite levels	Other trait
10535	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10536	GCST001882	Metabolite levels	Metabolite levels	Liver enzyme measurement
10537	GCST001882	Metabolite levels	Metabolite levels	Cardiovascular measurement
10538	GCST001882	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10539	GCST001882	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10540	GCST001882	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10541	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10542	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10543	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10544	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10545	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10546	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10547	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10548	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10549	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10550	GCST001882	Metabolite levels	Metabolite levels	Other measurement
10551	GCST001879	Breast cancer	Breast cancer	Cancer
10552	GCST001881	Myopia (pathological)	Myopia (pathological)	Other trait
10553	GCST001880	Addiction	Addiction	Neurological disorder
10554	GCST001876	Pubertal anthropometrics	Pubertal anthropometrics	Body measurement
10555	GCST001876	Pubertal anthropometrics	Pubertal anthropometrics	Body measurement
10556	GCST001876	Pubertal anthropometrics	Pubertal anthropometrics	Biological process
10557	GCST001878	Coronary arterial lesions in patients with Kawasaki disease	Coronary arterial lesions in patients with Kawasaki disease	Immune system disorder
10558	GCST001878	Coronary arterial lesions in patients with Kawasaki disease	Coronary arterial lesions in patients with Kawasaki disease	Cardiovascular disease
10559	GCST001874	Alcohol dependence	Alcohol dependence	Other measurement
10560	GCST001874	Alcohol dependence	Alcohol dependence	Neurological disorder
10561	GCST001904	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
10562	GCST001903	Central corneal thickness	Central corneal thickness	Other measurement
10563	GCST001903	Central corneal thickness	Central corneal thickness	Other measurement
10564	GCST001902	Coronary artery calcification	Coronary artery calcification	Other trait
10565	GCST001900	Cervical cancer	Cervical cancer	Cancer
10566	GCST001901	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	Response to drug
10567	GCST001901	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	Cancer
10568	GCST001899	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
10569	GCST001899	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
10570	GCST001897	Pit-and-Fissure caries	Pit-and-Fissure caries	Digestive system disorder
10571	GCST001896	Smooth-surface caries	Smooth-surface caries	Digestive system disorder
10572	GCST001898	Refractive error	Refractive error	Other trait
10573	GCST001895	Response to dabigatran etexilate treatment	Response to dabigatran etexilate treatment	Response to drug
10574	GCST001842	Drinking behavior	Drinking behavior	Biological process
10575	GCST001844	Dietary macronutrient intake	Dietary macronutrient intake	Biological process
10576	GCST001843	Type 2 diabetes (dietary heme iron intake interaction)	Type 2 diabetes (dietary heme iron intake interaction)	Metabolic disorder
10577	GCST001843	Type 2 diabetes (dietary heme iron intake interaction)	Type 2 diabetes (dietary heme iron intake interaction)	Other measurement
10578	GCST001837	Intelligence (childhood)	Intelligence (childhood)	Biological process
10579	GCST001839	Schizophrenia	Schizophrenia	Neurological disorder
10580	GCST001833	Schizophrenia (cytomegalovirus infection interaction)	Schizophrenia (cytomegalovirus infection interaction)	Neurological disorder
10581	GCST001833	Schizophrenia (cytomegalovirus infection interaction)	Schizophrenia (cytomegalovirus infection interaction)	Other disease
10582	GCST001835	Response to cholinesterase inhibitors in Alzheimer's disease	Response to cholinesterase inhibitors in Alzheimer's disease	Response to drug
10583	GCST001835	Response to cholinesterase inhibitors in Alzheimer's disease	Response to cholinesterase inhibitors in Alzheimer's disease	Neurological disorder
10584	GCST001772	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to TNF-alpha inhibitors in rheumatoid arthritis	Immune system disorder
10585	GCST001772	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to drug
10586	GCST001767	Aging (facial)	Aging (facial)	Biological process
10587	GCST001769	Alcohol and nicotine co-dependence	Alcohol and nicotine co-dependence	Neurological disorder
10588	GCST001768	Behcet's disease	Behcet's disease	Cardiovascular disease
10589	GCST001766	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Liver enzyme measurement
10590	GCST001766	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Cancer
10591	GCST001766	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Digestive system disorder
10592	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10593	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10594	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10595	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10596	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10597	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10598	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10599	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10600	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
10601	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10602	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10603	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10604	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10605	GCST001762	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
10606	GCST001762	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
10607	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10608	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10609	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10610	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10611	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10612	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10613	GCST001762	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
10614	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10615	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10616	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
10617	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10618	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10619	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10620	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10621	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10622	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
10623	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10624	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10625	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10626	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10627	GCST001762	Obesity-related traits	Obesity-related traits	Biological process
10628	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10629	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10630	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
10631	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10632	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10633	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10634	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10635	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10636	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10637	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
10638	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
10639	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10640	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
10641	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10642	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10643	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10644	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10645	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
10646	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10647	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10648	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10649	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10650	GCST001762	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
10651	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
10652	GCST001762	Obesity-related traits	Obesity-related traits	Metabolic disorder
10653	GCST001762	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
10654	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
10655	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10656	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
10657	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
10658	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10659	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10660	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10661	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10662	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10663	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
10664	GCST001762	Obesity-related traits	Obesity-related traits	Biological process
10665	GCST001762	Obesity-related traits	Obesity-related traits	Biological process
10666	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
10667	GCST001761	Cognitive decline	Cognitive decline	Other trait
10668	GCST001761	Cognitive decline	Cognitive decline	Biological process
10669	GCST001790	Gout	Gout	Metabolic disorder
10670	GCST001789	Lipoprotein diameter	Lipoprotein diameter	Other disease
10671	GCST001788	Digit length ratio	Digit length ratio	Body measurement
10672	GCST001785	Crohn's disease	Crohn's disease	Digestive system disorder
10673	GCST001787	Colorectal cancer	Colorectal cancer	Cancer
10674	GCST001786	Dental caries	Dental caries	Digestive system disorder
10675	GCST001784	Pulmonary function (smoking interaction)	Pulmonary function (smoking interaction)	Other measurement
10676	GCST001784	Pulmonary function (smoking interaction)	Pulmonary function (smoking interaction)	Other measurement
10677	GCST001784	Pulmonary function (smoking interaction)	Pulmonary function (smoking interaction)	Other measurement
10678	GCST001784	Pulmonary function (smoking interaction)	Pulmonary function (smoking interaction)	Other measurement
10679	GCST001763	Asthma	Asthma	Other disease
10680	GCST001759	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
10681	GCST001758	Birth weight	Birth weight	Body measurement
10682	GCST001757	Schizophrenia	Schizophrenia	Neurological disorder
10683	GCST005524	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Immune system disorder
10684	GCST005524	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Immune system disorder
10685	GCST005524	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Immune system disorder
10686	GCST005527	Psoriasis	Psoriasis	Immune system disorder
10687	GCST005525	Hashimoto thyroiditis	Hashimoto thyroiditis	Immune system disorder
10688	GCST001814	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
10689	GCST001814	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
10690	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10691	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10692	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10693	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10694	GCST001813	Hematology traits	Hematology traits	Cardiovascular measurement
10695	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10696	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10697	GCST001813	Hematology traits	Hematology traits	Other measurement
10698	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10699	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10700	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10701	GCST001813	Hematology traits	Hematology traits	Hematological measurement
10702	GCST001811	Bipolar disorder (mania)	Bipolar disorder (mania)	Neurological disorder
10703	GCST001812	Epstein-Barr virus immune response (EBNA-1)	Epstein-Barr virus immune response (EBNA-1)	Other disease
10704	GCST001812	Epstein-Barr virus immune response (EBNA-1)	Epstein-Barr virus immune response (EBNA-1)	Other measurement
10705	GCST001810	Menopause (age at onset)	Menopause (age at onset)	Other measurement
10706	GCST001809	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
10707	GCST001808	Tumor biomarkers	Tumor biomarkers	Other measurement
10708	GCST001807	Tetralogy of Fallot	Tetralogy of Fallot	Other trait
10709	GCST001806	Corneal structure	Corneal structure	Other measurement
10710	GCST001806	Corneal structure	Corneal structure	Neurological disorder
10711	GCST001795	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
10712	GCST001794	Colorectal cancer (SNP x SNP interaction)	Colorectal cancer (SNP x SNP interaction)	Cancer
10713	GCST001793	Coagulation factor levels	Coagulation factor levels	Other measurement
10714	GCST001791	Urate levels	Urate levels	Metabolic disorder
10715	GCST001791	Urate levels	Urate levels	Other measurement
10716	GCST001792	Colorectal cancer	Colorectal cancer	Cancer
10717	GCST001818	Metabolite levels (HVA/5-HIAA ratio)	Metabolite levels (HVA/5-HIAA ratio)	Other measurement
10718	GCST001818	Metabolite levels (HVA/5-HIAA ratio)	Metabolite levels (HVA/5-HIAA ratio)	Other measurement
10719	GCST001823	Metabolite levels (HVA/MHPG ratio)	Metabolite levels (HVA/MHPG ratio)	Other measurement
10720	GCST001823	Metabolite levels (HVA/MHPG ratio)	Metabolite levels (HVA/MHPG ratio)	Other measurement
10721	GCST001819	Corneal astigmatism	Corneal astigmatism	Neurological disorder
10722	GCST001819	Corneal astigmatism	Corneal astigmatism	Other trait
10723	GCST001821	Metabolite levels (5-HIAA/ MHPG Ratio)	Metabolite levels (5-HIAA/ MHPG Ratio)	Other measurement
10724	GCST001821	Metabolite levels (5-HIAA/ MHPG Ratio)	Metabolite levels (5-HIAA/ MHPG Ratio)	Other measurement
10725	GCST001822	Metabolite levels (MHPG)	Metabolite levels (MHPG)	Other measurement
10726	GCST001820	Metabolite levels (5-HIAA)	Metabolite levels (5-HIAA)	Other measurement
10727	GCST001824	Metabolite levels (HVA)	Metabolite levels (HVA)	Other measurement
10728	GCST001817	Metabolite levels (HVA-5-HIAA Factor score)	Metabolite levels (HVA-5-HIAA Factor score)	Other measurement
10729	GCST001817	Metabolite levels (HVA-5-HIAA Factor score)	Metabolite levels (HVA-5-HIAA Factor score)	Other measurement
10730	GCST001816	Breast cancer (prognosis)	Breast cancer (prognosis)	Cancer
10731	GCST001815	Hepatitis C induced liver cirrhosis	Hepatitis C induced liver cirrhosis	Cancer
10732	GCST001836	Schizophrenia (negative symptoms)	Schizophrenia (negative symptoms)	Neurological disorder
10733	GCST001832	Colorectal cancer	Colorectal cancer	Cancer
10734	GCST001831	Breast cancer	Breast cancer	Cancer
10735	GCST001830	Osteoporosis	Osteoporosis	Other disease
10736	GCST001829	Fat intake	Fat intake	Biological process
10737	GCST001828	Vascular constriction	Vascular constriction	Other disease
10738	GCST001826	Lymphoma	Lymphoma	Cancer
10739	GCST001827	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
10740	GCST001827	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
10741	GCST001825	Beta-trace protein levels	Beta-trace protein levels	Other measurement
10742	GCST001804	Behcet's disease	Behcet's disease	Cardiovascular disease
10743	GCST001803	Corneal curvature	Corneal curvature	Other measurement
10744	GCST001801	Uric acid levels	Uric acid levels	Cardiovascular measurement
10745	GCST001802	Depression (quantitative trait)	Depression (quantitative trait)	Neurological disorder
10746	GCST001800	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	Other measurement
10747	GCST001799	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
10748	GCST005522	Narcolepsy	Narcolepsy	Neurological disorder
10749	GCST001798	End-stage coagulation	End-stage coagulation	Hematological measurement
10750	GCST001798	End-stage coagulation	End-stage coagulation	Other measurement
10751	GCST001798	End-stage coagulation	End-stage coagulation	Hematological measurement
10752	GCST001797	Cardiac structure and function	Cardiac structure and function	Other measurement
10753	GCST001796	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
10754	GCST001778	Hypertrophic cardiomyopathy	Hypertrophic cardiomyopathy	Cardiovascular disease
10755	GCST001777	LDL (oxidized)	LDL (oxidized)	Lipid or lipoprotein measurement
10756	GCST001775	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Digestive system disorder
10757	GCST001775	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Cancer
10758	GCST001776	Cardiac Troponin-T levels	Cardiac Troponin-T levels	Cardiovascular measurement
10759	GCST001774	Reporting of stressful life event	Reporting of stressful life event	Other trait
10760	GCST001774	Reporting of stressful life event	Reporting of stressful life event	Other measurement
10761	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
10762	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
10763	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
10764	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
10765	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
10766	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
10767	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
10768	GCST001770	Methotrexate clearance (acute lymphoblastic leukemia)	Methotrexate clearance (acute lymphoblastic leukemia)	Response to drug
10769	GCST005526	Graves' disease	Graves' disease	Immune system disorder
10770	GCST001756	Spine bone size	Spine bone size	Other measurement
10771	GCST001755	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Response to drug
10772	GCST001755	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
10773	GCST001755	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Other measurement
10774	GCST001755	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
10775	GCST001715	Bipolar disorder with mood-incongruent psychosis	Bipolar disorder with mood-incongruent psychosis	Neurological disorder
10776	GCST006249	Serum metabolite levels	Serum metabolite levels	Other measurement
10777	GCST001714	Prostate cancer	Prostate cancer	Cancer
10778	GCST001713	Dental caries	Dental caries	Digestive system disorder
10779	GCST001710	HbA2 levels	HbA2 levels	Hematological measurement
10780	GCST001711	Protein biomarker	Protein biomarker	Other measurement
10781	GCST001712	Myopia (pathological)	Myopia (pathological)	Other trait
10782	GCST001709	Atopic dermatitis	Atopic dermatitis	Immune system disorder
10783	GCST001708	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
10784	GCST001707	Behcet's disease	Behcet's disease	Cardiovascular disease
10785	GCST001688	Type 1 diabetes nephropathy	Type 1 diabetes nephropathy	Metabolic disorder
10786	GCST001687	Disc degeneration (lumbar)	Disc degeneration (lumbar)	Other disease
10787	GCST001685	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
10788	GCST001685	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
10789	GCST001684	Plasminogen activator inhibitor type 1 levels (PAI-1)	Plasminogen activator inhibitor type 1 levels (PAI-1)	Other measurement
10790	GCST001686	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
10791	GCST001677	Paraoxonase activity	Paraoxonase activity	Cardiovascular measurement
10792	GCST001683	Breast cancer	Breast cancer	Cancer
10793	GCST001680	Corneal curvature	Corneal curvature	Other measurement
10794	GCST001745	Sagittal craniosynostosis	Sagittal craniosynostosis	Neurological disorder
10795	GCST001744	Serum tamsulosin hydrochloride concentration	Serum tamsulosin hydrochloride concentration	Response to drug
10796	GCST001743	Alzheimer's disease	Alzheimer's disease	Neurological disorder
10797	GCST001742	Panic disorder	Panic disorder	Neurological disorder
10798	GCST001741	Pancreatitis	Pancreatitis	Digestive system disorder
10799	GCST001740	Lung cancer	Lung cancer	Cancer
10800	GCST001740	Lung cancer	Lung cancer	Cancer
10801	GCST001740	Lung cancer	Lung cancer	Cancer
10802	GCST001738	Response to fenofibrate (adiponectin levels)	Response to fenofibrate (adiponectin levels)	Response to drug
10803	GCST001739	IgE levels	IgE levels	Other measurement
10804	GCST001736	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Neurological disorder
10805	GCST001736	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Neurological disorder
10806	GCST001736	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Metabolic disorder
10807	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Other disease
10808	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Hematological measurement
10809	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Inflammatory measurement
10810	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Other measurement
10811	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Other measurement
10812	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Inflammatory measurement
10813	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Inflammatory measurement
10814	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Inflammatory measurement
10815	GCST001706	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
10816	GCST001705	Platelet reactivity	Platelet reactivity	Cardiovascular measurement
10817	GCST001703	Apolipoprotein Levels	Apolipoprotein Levels	Other measurement
10818	GCST001704	Cholesterol and Triglycerides	Cholesterol and Triglycerides	Lipid or lipoprotein measurement
10819	GCST001704	Cholesterol and Triglycerides	Cholesterol and Triglycerides	Lipid or lipoprotein measurement
10820	GCST005581	Primary biliary cirrhosis	Primary biliary cirrhosis	Cancer
10821	GCST001702	Prostate cancer	Prostate cancer	Cancer
10822	GCST001701	Asthma	Asthma	Other disease
10823	GCST001700	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Cancer
10824	GCST001700	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Other disease
10825	GCST001700	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Biological process
10826	GCST001699	Serum albumin level	Serum albumin level	Other measurement
10827	GCST001698	Serum total protein level	Serum total protein level	Hematological measurement
10828	GCST001698	Serum total protein level	Serum total protein level	Other measurement
10829	GCST001734	Non-small cell lung cancer	Non-small cell lung cancer	Cancer
10830	GCST001735	PR interval	PR interval	Cardiovascular measurement
10831	GCST001733	Schizophrenia	Schizophrenia	Neurological disorder
10832	GCST001732	Obesity	Obesity	Other measurement
10833	GCST001732	Obesity	Obesity	Metabolic disorder
10834	GCST001731	Colorectal cancer (environment interaction)	Colorectal cancer (environment interaction)	Other measurement
10835	GCST001731	Colorectal cancer (environment interaction)	Colorectal cancer (environment interaction)	Body measurement
10836	GCST001731	Colorectal cancer (environment interaction)	Colorectal cancer (environment interaction)	Cancer
10837	GCST001731	Colorectal cancer (environment interaction)	Colorectal cancer (environment interaction)	Other measurement
10838	GCST001726	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	Lipid or lipoprotein measurement
10839	GCST001730	Response to temozolomide	Response to temozolomide	Response to drug
10840	GCST001681	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
10841	GCST001678	Facial morphology	Facial morphology	Other trait
10842	GCST001678	Facial morphology	Facial morphology	Other measurement
10843	GCST001676	Body mass index	Body mass index	Body measurement
10844	GCST001676	Body mass index	Body mass index	Body measurement
10845	GCST001676	Body mass index	Body mass index	Other measurement
10846	GCST001674	Esophageal cancer (squamous cell)	Esophageal cancer (squamous cell)	Cancer
10847	GCST001674	Esophageal cancer (squamous cell)	Esophageal cancer (squamous cell)	Cancer
10848	GCST001675	Barrett's esophagus	Barrett's esophagus	Digestive system disorder
10849	GCST001672	Esophageal cancer  (alcohol interaction)	Esophageal cancer  (alcohol interaction)	Cancer
10850	GCST001673	Drug-induced liver injury	Drug-induced liver injury	Response to drug
10851	GCST001673	Drug-induced liver injury	Drug-induced liver injury	Digestive system disorder
10852	GCST001671	IgG levels	IgG levels	Other measurement
10853	GCST001667	Breast cancer	Breast cancer	Cancer
10854	GCST001695	Bipolar disorder (Negative mood delusions)	Bipolar disorder (Negative mood delusions)	Neurological disorder
10855	GCST001696	Smoking behavior	Smoking behavior	Biological process
10856	GCST001697	Telomere length	Telomere length	Other measurement
10857	GCST001691	Monocyte chemoattractant protein-1 levels	Monocyte chemoattractant protein-1 levels	Other measurement
10858	GCST001692	Response to taxane treatment (docetaxel)	Response to taxane treatment (docetaxel)	Response to drug
10859	GCST001694	Response to taxane treatment (placlitaxel)	Response to taxane treatment (placlitaxel)	Response to drug
10860	GCST001693	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
10861	GCST001690	Breast cancer (male)	Breast cancer (male)	Cancer
10862	GCST001689	Stroke (pediatric)	Stroke (pediatric)	Cardiovascular disease
10863	GCST001752	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
10864	GCST001751	Opioid sensitivity	Opioid sensitivity	Response to drug
10865	GCST001750	Renal cell carcinoma	Renal cell carcinoma	Cancer
10866	GCST001749	Pancreatic cancer	Pancreatic cancer	Cancer
10867	GCST001748	Resting heart rate	Resting heart rate	Cardiovascular measurement
10868	GCST001747	Aspirin exacerbated respiratory disease in asthmatics	Aspirin exacerbated respiratory disease in asthmatics	Other trait
10869	GCST001746	QT interval	QT interval	Cardiovascular measurement
10870	GCST001727	Lipoprotein-associated phospholipase A2 activity and mass	Lipoprotein-associated phospholipase A2 activity and mass	Lipid or lipoprotein measurement
10871	GCST001723	Eye color	Eye color	Other measurement
10872	GCST001723	Eye color	Eye color	Other trait
10873	GCST001724	IgM levels	IgM levels	Other measurement
10874	GCST001722	Body mass (lean)	Body mass (lean)	Other measurement
10875	GCST001721	Lung Cancer (DNA repair capacity)	Lung Cancer (DNA repair capacity)	Cancer
10876	GCST001719	Prostate cancer	Prostate cancer	Cancer
10877	GCST001720	Endometriosis	Endometriosis	Other disease
10878	GCST001717	Otitis media (chronic/recurrent)	Otitis media (chronic/recurrent)	Neurological disorder
10879	GCST001718	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Cancer
10880	GCST001718	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Cancer
10881	GCST001718	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Cancer
10882	GCST001716	Response to statin therapy	Response to statin therapy	Response to drug
10883	GCST001652	Crohn's disease	Crohn's disease	Digestive system disorder
10884	GCST001651	Response to amphetamines	Response to amphetamines	Biological process
10885	GCST001650	C-reactive protein	C-reactive protein	Inflammatory measurement
10886	GCST001649	Glaucoma (primary angle closure)	Glaucoma (primary angle closure)	Neurological disorder
10887	GCST001649	Glaucoma (primary angle closure)	Glaucoma (primary angle closure)	Neurological disorder
10888	GCST001648	Breast cancer	Breast cancer	Cancer
10889	GCST001647	Bipolar disorder	Bipolar disorder	Neurological disorder
10890	GCST001646	Prostate cancer	Prostate cancer	Cancer
10891	GCST001645	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10892	GCST001645	LDL cholesterol	LDL cholesterol	Other measurement
10893	GCST001645	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10894	GCST001644	Eating disorders	Eating disorders	Metabolic disorder
10895	GCST001644	Eating disorders	Eating disorders	Neurological disorder
10896	GCST001643	Depression (age of onset)	Depression (age of onset)	Neurological disorder
10897	GCST001643	Depression (age of onset)	Depression (age of onset)	Other measurement
10898	GCST001612	Sex hormone-binding globulin levels	Sex hormone-binding globulin levels	Other measurement
10899	GCST001611	Myasthenia gravis	Myasthenia gravis	Neurological disorder
10900	GCST001611	Myasthenia gravis	Myasthenia gravis	Other disease
10901	GCST001610	Renal function-related traits (BUN)	Renal function-related traits (BUN)	Other measurement
10902	GCST001610	Renal function-related traits (BUN)	Renal function-related traits (BUN)	Other measurement
10903	GCST001609	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
10904	GCST001608	Renal function-related traits (urea)	Renal function-related traits (urea)	Other measurement
10905	GCST001608	Renal function-related traits (urea)	Renal function-related traits (urea)	Cardiovascular measurement
10906	GCST001607	Renal function-related traits (eGRFcrea)	Renal function-related traits (eGRFcrea)	Other measurement
10907	GCST001606	Renal function-related traits (sCR)	Renal function-related traits (sCR)	Other measurement
10908	GCST001605	C-reactive protein and white blood cell count	C-reactive protein and white blood cell count	Hematological measurement
10909	GCST001605	C-reactive protein and white blood cell count	C-reactive protein and white blood cell count	Inflammatory measurement
10910	GCST001603	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
10911	GCST001604	Insulin-related traits	Insulin-related traits	Other measurement
10912	GCST001604	Insulin-related traits	Insulin-related traits	Other measurement
10913	GCST001604	Insulin-related traits	Insulin-related traits	Other trait
10914	GCST001661	CYP3A4 enzyme activity	CYP3A4 enzyme activity	Liver enzyme measurement
10915	GCST001660	Neuroblastoma	Neuroblastoma	Cancer
10916	GCST001659	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
10917	GCST001657	Schizophrenia	Schizophrenia	Neurological disorder
10918	GCST005047	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
10919	GCST001658	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
10920	GCST001658	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
10921	GCST001656	Comprehensive strength and appendicular lean mass	Comprehensive strength and appendicular lean mass	Other measurement
10922	GCST001656	Comprehensive strength and appendicular lean mass	Comprehensive strength and appendicular lean mass	Other measurement
10923	GCST001655	Autism	Autism	Neurological disorder
10924	GCST001653	Androgen levels	Androgen levels	Other measurement
10925	GCST001653	Androgen levels	Androgen levels	Other measurement
10926	GCST001641	Response to antidepressants	Response to antidepressants	Response to drug
10927	GCST001642	Vaspin levels	Vaspin levels	Other measurement
10928	GCST001640	Lentiform nucleus volume	Lentiform nucleus volume	Other measurement
10929	GCST001638	Lung cancer	Lung cancer	Cancer
10930	GCST001638	Lung cancer	Lung cancer	Cancer
10931	GCST001638	Lung cancer	Lung cancer	Cancer
10932	GCST001639	Metabolite levels	Metabolite levels	Other trait
10933	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10934	GCST001639	Metabolite levels	Metabolite levels	Liver enzyme measurement
10935	GCST001639	Metabolite levels	Metabolite levels	Cardiovascular measurement
10936	GCST001639	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10937	GCST001639	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10938	GCST001639	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10939	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10940	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10941	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10942	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10943	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10944	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10945	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10946	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10947	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10948	GCST001639	Metabolite levels	Metabolite levels	Other measurement
10949	GCST001637	Malaria	Malaria	Digestive system disorder
10950	GCST001635	Tourette syndrome	Tourette syndrome	Neurological disorder
10951	GCST001636	Obsessive-compulsive disorder	Obsessive-compulsive disorder	Neurological disorder
10952	GCST001634	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
10953	GCST001633	Glioma	Glioma	Cancer
10954	GCST001633	Glioma	Glioma	Cancer
10955	GCST001632	Response to fenofibrate	Response to fenofibrate	Response to drug
10956	GCST001631	Schizophrenia	Schizophrenia	Neurological disorder
10957	GCST001629	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to drug
10958	GCST001629	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to platinum-based chemotherapy in non-small-cell lung cancer	Cancer
10959	GCST001630	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
10960	GCST001628	Orofacial clefts	Orofacial clefts	Other trait
10961	GCST001628	Orofacial clefts	Orofacial clefts	Other measurement
10962	GCST001628	Orofacial clefts	Orofacial clefts	Other disease
10963	GCST001628	Orofacial clefts	Orofacial clefts	Other trait
10964	GCST001627	Thyrotoxic hypokalemic periodic paralysis	Thyrotoxic hypokalemic periodic paralysis	Metabolic disorder
10965	GCST001626	IgA levels	IgA levels	Other measurement
10966	GCST001624	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Response to drug
10967	GCST001624	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
10968	GCST001624	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Other measurement
10969	GCST001624	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
10970	GCST001625	Sex ratio at birth	Sex ratio at birth	Other measurement
10971	GCST001621	Airflow obstruction	Airflow obstruction	Other measurement
10972	GCST001591	Response to citalopram treatment	Response to citalopram treatment	Response to drug
10973	GCST001592	Osteoarthritis	Osteoarthritis	Other disease
10974	GCST001590	Essential tremor	Essential tremor	Other trait
10975	GCST001588	Periodontal microbiota	Periodontal microbiota	Digestive system disorder
10976	GCST001586	Insomnia (caffeine-induced)	Insomnia (caffeine-induced)	Other measurement
10977	GCST001587	Coronary heart disease	Coronary heart disease	Cardiovascular disease
10978	GCST001589	Ovarian cancer	Ovarian cancer	Cancer
10979	GCST001585	Breast size	Breast size	Body measurement
10980	GCST001584	Lean body mass and age at menarche (combined)	Lean body mass and age at menarche (combined)	Other measurement
10981	GCST001584	Lean body mass and age at menarche (combined)	Lean body mass and age at menarche (combined)	Body measurement
10982	GCST001583	Adiposity	Adiposity	Metabolic disorder
10983	GCST001622	Sarcoidosis	Sarcoidosis	Other disease
10984	GCST001623	Hepatitis C induced liver fibrosis	Hepatitis C induced liver fibrosis	Cancer
10985	GCST001623	Hepatitis C induced liver fibrosis	Hepatitis C induced liver fibrosis	Digestive system disorder
10986	GCST001619	Autism	Autism	Neurological disorder
10987	GCST001620	Resistin levels	Resistin levels	Other measurement
10988	GCST001616	Cannabis use (initiation)	Cannabis use (initiation)	Neurological disorder
10989	GCST001616	Cannabis use (initiation)	Cannabis use (initiation)	Biological process
10990	GCST001618	Neural processing (facial expression)	Neural processing (facial expression)	Other measurement
10991	GCST001617	Parkinson's disease	Parkinson's disease	Neurological disorder
10992	GCST001615	Sclerosing cholangitis and ulcerative colitis (combined)	Sclerosing cholangitis and ulcerative colitis (combined)	Digestive system disorder
10993	GCST001615	Sclerosing cholangitis and ulcerative colitis (combined)	Sclerosing cholangitis and ulcerative colitis (combined)	Immune system disorder
10994	GCST001614	Central corneal thickness	Central corneal thickness	Other measurement
10995	GCST001614	Central corneal thickness	Central corneal thickness	Other measurement
10996	GCST001613	Antineutrophil cytoplasmic antibody-associated vasculitis	Antineutrophil cytoplasmic antibody-associated vasculitis	Immune system disorder
10997	GCST001668	Pain	Pain	Other trait
10998	GCST001665	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
10999	GCST001670	Vitiligo	Vitiligo	Immune system disorder
11000	GCST001669	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
11001	GCST001663	Amyotrophic lateral sclerosis (age of onset)	Amyotrophic lateral sclerosis (age of onset)	Neurological disorder
11002	GCST001663	Amyotrophic lateral sclerosis (age of onset)	Amyotrophic lateral sclerosis (age of onset)	Other measurement
11003	GCST004792	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals	Neurological disorder
11004	GCST004793	Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals	Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals	Neurological disorder
11005	GCST004791	Amyotrophic lateral sclerosis (C9orf72 mutation interaction)	Amyotrophic lateral sclerosis (C9orf72 mutation interaction)	Neurological disorder
11006	GCST001664	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
11007	GCST001662	Generalized epilepsy	Generalized epilepsy	Neurological disorder
11008	GCST001662	Generalized epilepsy	Generalized epilepsy	Neurological disorder
11009	GCST001601	Gambling	Gambling	Biological process
11010	GCST001602	Alzheimer's disease	Alzheimer's disease	Neurological disorder
11011	GCST001599	Aging	Aging	Biological process
11012	GCST001600	IgG levels	IgG levels	Other measurement
11013	GCST001598	Blood pressure	Blood pressure	Other measurement
11014	GCST001598	Blood pressure	Blood pressure	Other measurement
11015	GCST001598	Blood pressure	Blood pressure	Other measurement
11016	GCST001598	Blood pressure	Blood pressure	Other measurement
11017	GCST001598	Blood pressure	Blood pressure	Cardiovascular measurement
11018	GCST001593	Cortical thickness	Cortical thickness	Other measurement
11019	GCST001597	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Response to drug
11020	GCST001597	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Other disease
11021	GCST001594	Bone mineral density	Bone mineral density	Other measurement
11022	GCST001595	Bone mineral density	Bone mineral density	Other measurement
11023	GCST001596	Glaucoma	Glaucoma	Neurological disorder
11024	GCST001530	Hippocampal atrophy	Hippocampal atrophy	Neurological disorder
11025	GCST001531	Temperament	Temperament	Other measurement
11026	GCST001528	Response to antidepressants	Response to antidepressants	Response to drug
11027	GCST001529	Alzheimer's disease	Alzheimer's disease	Neurological disorder
11028	GCST001526	Fasting blood insulin (BMI interaction)	Fasting blood insulin (BMI interaction)	Body measurement
11029	GCST001526	Fasting blood insulin (BMI interaction)	Fasting blood insulin (BMI interaction)	Other measurement
11030	GCST005186	Fasting blood glucose	Fasting blood glucose	Other measurement
11031	GCST005185	Fasting blood insulin	Fasting blood insulin	Other measurement
11032	GCST001527	Fasting blood glucose (BMI interaction)	Fasting blood glucose (BMI interaction)	Body measurement
11033	GCST001527	Fasting blood glucose (BMI interaction)	Fasting blood glucose (BMI interaction)	Other measurement
11034	GCST001521	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
11035	GCST001571	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
11036	GCST001571	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
11037	GCST001572	Erectile dysfunction in type 1 diabetes	Erectile dysfunction in type 1 diabetes	Other disease
11038	GCST001572	Erectile dysfunction in type 1 diabetes	Erectile dysfunction in type 1 diabetes	Metabolic disorder
11039	GCST001570	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
11040	GCST001565	Schizophrenia	Schizophrenia	Neurological disorder
11041	GCST001569	Bipolar disorder	Bipolar disorder	Neurological disorder
11042	GCST001566	Bone mineral density (sex interaction)	Bone mineral density (sex interaction)	Other measurement
11043	GCST001566	Bone mineral density (sex interaction)	Bone mineral density (sex interaction)	Other measurement
11044	GCST001567	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
11045	GCST001567	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
11046	GCST001567	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
11047	GCST001568	Influenza (severity)	Influenza (severity)	Biological process
11048	GCST001564	Asthma	Asthma	Other disease
11049	GCST001563	Migraine	Migraine	Cardiovascular disease
11050	GCST001582	Hepatitis B (viral clearance)	Hepatitis B (viral clearance)	Biological process
11051	GCST001582	Hepatitis B (viral clearance)	Hepatitis B (viral clearance)	Digestive system disorder
11052	GCST001580	QT interval	QT interval	Cardiovascular measurement
11053	GCST001581	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11054	GCST001579	Age-related macular degeneration (choroidal neovascularisation)	Age-related macular degeneration (choroidal neovascularisation)	Neurological disorder
11055	GCST001577	Age-related macular degeneration (CNV vs. GA)	Age-related macular degeneration (CNV vs. GA)	Neurological disorder
11056	GCST001577	Age-related macular degeneration (CNV vs. GA)	Age-related macular degeneration (CNV vs. GA)	Neurological disorder
11057	GCST001578	Age-related macular degeneration (geographic atrophy)	Age-related macular degeneration (geographic atrophy)	Neurological disorder
11058	GCST001575	Factor XI	Factor XI	Hematological measurement
11059	GCST001576	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
11060	GCST001573	Prothrombin time	Prothrombin time	Hematological measurement
11061	GCST001574	Activated partial thromboplastin time	Activated partial thromboplastin time	Hematological measurement
11062	GCST001551	Amygdala reactivity	Amygdala reactivity	Other measurement
11063	GCST001552	Central corneal thickness	Central corneal thickness	Other measurement
11064	GCST001552	Central corneal thickness	Central corneal thickness	Other measurement
11065	GCST001549	Formal thought disorder in schizophrenia	Formal thought disorder in schizophrenia	Other trait
11066	GCST001550	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11067	GCST001548	Male-pattern baldness	Male-pattern baldness	Other measurement
11068	GCST001548	Male-pattern baldness	Male-pattern baldness	Other disease
11069	GCST001548	Male-pattern baldness	Male-pattern baldness	Other disease
11070	GCST001547	Immune response to anthrax vaccine	Immune response to anthrax vaccine	Response to drug
11071	GCST001545	Coronary heart disease event reduction (statin therapy interaction)	Coronary heart disease event reduction (statin therapy interaction)	Cardiovascular disease
11072	GCST001545	Coronary heart disease event reduction (statin therapy interaction)	Coronary heart disease event reduction (statin therapy interaction)	Response to drug
11073	GCST001546	Parkinson's disease (motor and cognition)	Parkinson's disease (motor and cognition)	Neurological disorder
11074	GCST001543	Lung cancer (asbestos exposure interaction)	Lung cancer (asbestos exposure interaction)	Cancer
11075	GCST001543	Lung cancer (asbestos exposure interaction)	Lung cancer (asbestos exposure interaction)	Other measurement
11076	GCST001544	Colorectal cancer	Colorectal cancer	Cancer
11077	GCST001504	Tuberculosis	Tuberculosis	Other disease
11078	GCST001504	Tuberculosis	Tuberculosis	Other measurement
11079	GCST001504	Tuberculosis	Tuberculosis	Other measurement
11080	GCST001505	Multiple sclerosis	Multiple sclerosis	Immune system disorder
11081	GCST001502	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
11082	GCST001502	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
11083	GCST001501	Platelet thrombus formation	Platelet thrombus formation	Cardiovascular measurement
11084	GCST001501	Platelet thrombus formation	Platelet thrombus formation	Hematological measurement
11085	GCST001500	Wilms tumor	Wilms tumor	Cancer
11086	GCST001499	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
11087	GCST001498	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
11088	GCST001496	Non-albumin protein levels	Non-albumin protein levels	Other measurement
11089	GCST001496	Non-albumin protein levels	Non-albumin protein levels	Other measurement
11090	GCST001496	Non-albumin protein levels	Non-albumin protein levels	Other measurement
11091	GCST001497	Cholelithiasis-related traits in sickle cell anemia	Cholelithiasis-related traits in sickle cell anemia	Digestive system disorder
11092	GCST001497	Cholelithiasis-related traits in sickle cell anemia	Cholelithiasis-related traits in sickle cell anemia	Neurological disorder
11093	GCST001497	Cholelithiasis-related traits in sickle cell anemia	Cholelithiasis-related traits in sickle cell anemia	Other measurement
11094	GCST001495	Asthma	Asthma	Other disease
11095	GCST001523	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
11096	GCST001523	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
11097	GCST001524	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11098	GCST001524	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11099	GCST001525	Visceral fat	Visceral fat	Other measurement
11100	GCST001522	Pericardial fat	Pericardial fat	Other measurement
11101	GCST001520	Response to angiotensin II receptor blocker therapy	Response to angiotensin II receptor blocker therapy	Response to drug
11102	GCST001520	Response to angiotensin II receptor blocker therapy	Response to angiotensin II receptor blocker therapy	Cardiovascular disease
11103	GCST001518	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	Response to drug
11104	GCST001518	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	Cardiovascular disease
11105	GCST001517	Antipsychotic drug-induced weight gain	Antipsychotic drug-induced weight gain	Other trait
11106	GCST001516	Osteoarthritis	Osteoarthritis	Other disease
11107	GCST001509	Vitiligo	Vitiligo	Immune system disorder
11108	GCST001510	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to TNF-alpha inhibitors in rheumatoid arthritis	Immune system disorder
11109	GCST001510	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to drug
11110	GCST001508	Asthma	Asthma	Other disease
11111	GCST001507	Hair color	Hair color	Other measurement
11112	GCST001507	Hair color	Hair color	Other trait
11113	GCST001503	Electroencephalographic traits in alcoholism	Electroencephalographic traits in alcoholism	Neurological disorder
11114	GCST001503	Electroencephalographic traits in alcoholism	Electroencephalographic traits in alcoholism	Other measurement
11115	GCST001541	Personality dimensions	Personality dimensions	Other trait
11116	GCST001542	HIV-associated dementia	HIV-associated dementia	Neurological disorder
11117	GCST001540	Male fertility	Male fertility	Other measurement
11118	GCST001540	Male fertility	Male fertility	Other trait
11119	GCST001540	Male fertility	Male fertility	Other measurement
11120	GCST001539	Smoking behavior	Smoking behavior	Biological process
11121	GCST001562	Migraine	Migraine	Cardiovascular disease
11122	GCST001561	Myopia (pathological)	Myopia (pathological)	Other trait
11123	GCST001560	Vitamin D levels	Vitamin D levels	Other measurement
11124	GCST001559	Cardiac repolarization		
11125	GCST001557	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
11126	GCST001558	Response to irinotecan in non-small-cell lung cancer	Response to irinotecan in non-small-cell lung cancer	Response to drug
11127	GCST001558	Response to irinotecan in non-small-cell lung cancer	Response to irinotecan in non-small-cell lung cancer	Cancer
11128	GCST001554	Sex hormone-binding globulin levels	Sex hormone-binding globulin levels	Other measurement
11129	GCST001555	Testosterone levels	Testosterone levels	Other measurement
11130	GCST001555	Testosterone levels	Testosterone levels	Other measurement
11131	GCST001553	Estradiol levels	Estradiol levels	Other measurement
11132	GCST001556	Pancreatic cancer	Pancreatic cancer	Cancer
11133	GCST001464	Podoconiosis	Podoconiosis	Immune system disorder
11134	GCST001465	Adiponectin levels	Adiponectin levels	Other measurement
11135	GCST001463	Adiponectin levels	Adiponectin levels	Other measurement
11136	GCST001466	Chronic kidney disease	Chronic kidney disease	Other disease
11137	GCST001466	Chronic kidney disease	Chronic kidney disease	Other measurement
11138	GCST001466	Chronic kidney disease	Chronic kidney disease	Other measurement
11139	GCST001461	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11140	GCST001460	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
11141	GCST001459	Multiple sclerosis	Multiple sclerosis	Immune system disorder
11142	GCST001457	Breast cancer	Breast cancer	Cancer
11143	GCST001458	Schizophrenia (treatment resistant)	Schizophrenia (treatment resistant)	Neurological disorder
11144	GCST001454	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
11145	GCST001481	Brain structure	Brain structure	Other measurement
11146	GCST001481	Brain structure	Brain structure	Other measurement
11147	GCST001481	Brain structure	Brain structure	Other measurement
11148	GCST001483	Intracranial volume	Intracranial volume	Other measurement
11149	GCST001485	Hippocampal volume	Hippocampal volume	Other measurement
11150	GCST001479	Type 1 diabetes autoantibodies	Type 1 diabetes autoantibodies	Other measurement
11151	GCST001479	Type 1 diabetes autoantibodies	Type 1 diabetes autoantibodies	Metabolic disorder
11152	GCST001480	Oral cancers (chewing tobacco related)	Oral cancers (chewing tobacco related)	Cancer
11153	GCST001480	Oral cancers (chewing tobacco related)	Oral cancers (chewing tobacco related)	Other measurement
11154	GCST001478	Circulating cell-free DNA	Circulating cell-free DNA	Other measurement
11155	GCST001477	Sexual dysfunction (female)	Sexual dysfunction (female)	Other trait
11156	GCST001476	Response to tocilizumab in rheumatoid arthritis	Response to tocilizumab in rheumatoid arthritis	Immune system disorder
11157	GCST001476	Response to tocilizumab in rheumatoid arthritis	Response to tocilizumab in rheumatoid arthritis	Biological process
11158	GCST001415	Body mass index	Body mass index	Body measurement
11159	GCST001415	Body mass index	Body mass index	Body measurement
11160	GCST001415	Body mass index	Body mass index	Other measurement
11161	GCST001416	Body mass index (SNP x SNP interaction)	Body mass index (SNP x SNP interaction)	Body measurement
11162	GCST001414	Phospholipid levels (plasma)	Phospholipid levels (plasma)	Lipid or lipoprotein measurement
11163	GCST001412	Facial morphology	Facial morphology	Other trait
11164	GCST001412	Facial morphology	Facial morphology	Other measurement
11165	GCST001411	Occipital cortical area (total cortical area interaction)	Occipital cortical area (total cortical area interaction)	Other measurement
11166	GCST001411	Occipital cortical area (total cortical area interaction)	Occipital cortical area (total cortical area interaction)	Other measurement
11167	GCST001413	Sphingolipid levels	Sphingolipid levels	Other measurement
11168	GCST001413	Sphingolipid levels	Sphingolipid levels	Lipid or lipoprotein measurement
11169	GCST001409	Body mass index (SNP x SNP interaction)	Body mass index (SNP x SNP interaction)	Body measurement
11170	GCST001410	Cardiac repolarization		
11171	GCST001408	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Lipid or lipoprotein measurement
11172	GCST001408	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Lipid or lipoprotein measurement
11173	GCST001408	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Response to drug
11174	GCST001407	Ewing sarcoma	Ewing sarcoma	Cancer
11175	GCST001475	Obesity	Obesity	Other measurement
11176	GCST001475	Obesity	Obesity	Metabolic disorder
11177	GCST001474	Hypothyroidism	Hypothyroidism	Other disease
11178	GCST001473	Crohn's disease and psoriasis	Crohn's disease and psoriasis	Digestive system disorder
11179	GCST001473	Crohn's disease and psoriasis	Crohn's disease and psoriasis	Immune system disorder
11180	GCST001472	C-reactive protein	C-reactive protein	Inflammatory measurement
11181	GCST001471	Alcohol and nicotine co-dependence	Alcohol and nicotine co-dependence	Neurological disorder
11182	GCST001470	Glioblastoma	Glioblastoma	Cancer
11183	GCST001470	Glioblastoma	Glioblastoma	Cancer
11184	GCST001470	Glioblastoma	Glioblastoma	Cancer
11185	GCST001469	Major depressive disorder	Major depressive disorder	Neurological disorder
11186	GCST001468	Cystic fibrosis (meconium ileus)	Cystic fibrosis (meconium ileus)	Digestive system disorder
11187	GCST001462	Brachial circumference	Brachial circumference	Body measurement
11188	GCST001436	Metabolic syndrome	Metabolic syndrome	Body measurement
11189	GCST001436	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
11190	GCST001436	Metabolic syndrome	Metabolic syndrome	Other measurement
11191	GCST001436	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
11192	GCST001436	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
11193	GCST001435	Haptoglobin levels	Haptoglobin levels	Hematological measurement
11194	GCST001434	Naphthyl-keratin adduct levels	Naphthyl-keratin adduct levels	Other measurement
11195	GCST001433	Duodenal ulcer	Duodenal ulcer	Digestive system disorder
11196	GCST001430	Parkinson's disease	Parkinson's disease	Neurological disorder
11197	GCST001431	Adverse response to lamotrigine and phenytoin	Adverse response to lamotrigine and phenytoin	Response to drug
11198	GCST001432	Nephrolithiasis	Nephrolithiasis	Other disease
11199	GCST001429	Drinking behavior	Drinking behavior	Biological process
11200	GCST001428	Intelligence	Intelligence	Biological process
11201	GCST001427	Nicotine dependence	Nicotine dependence	Neurological disorder
11202	GCST001456	Kawasaki disease	Kawasaki disease	Immune system disorder
11203	GCST001455	Kawasaki disease	Kawasaki disease	Immune system disorder
11204	GCST001453	Sexual dysfunction (SSRI/SNRI-related)	Sexual dysfunction (SSRI/SNRI-related)	Other trait
11205	GCST001451	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
11206	GCST001452	Pemphigus vulgaris	Pemphigus vulgaris	Immune system disorder
11207	GCST001450	Response to Vitamin E supplementation	Response to Vitamin E supplementation	Biological process
11208	GCST001449	Alzheimer's disease	Alzheimer's disease	Neurological disorder
11209	GCST001447	Endometrial cancer	Endometrial cancer	Cancer
11210	GCST001447	Endometrial cancer	Endometrial cancer	Cancer
11211	GCST001448	Body mass index	Body mass index	Body measurement
11212	GCST001448	Body mass index	Body mass index	Body measurement
11213	GCST001448	Body mass index	Body mass index	Other measurement
11214	GCST001444	Pulmonary function decline	Pulmonary function decline	Other measurement
11215	GCST001444	Pulmonary function decline	Pulmonary function decline	Other measurement
11216	GCST001445	Parkinson's disease	Parkinson's disease	Neurological disorder
11217	GCST001446	White matter integrity	White matter integrity	Other measurement
11218	GCST001442	Orofacial clefts	Orofacial clefts	Other trait
11219	GCST001442	Orofacial clefts	Orofacial clefts	Other measurement
11220	GCST001442	Orofacial clefts	Orofacial clefts	Other disease
11221	GCST001442	Orofacial clefts	Orofacial clefts	Other trait
11222	GCST001443	Preeclampsia	Preeclampsia	Cardiovascular disease
11223	GCST001441	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
11224	GCST001440	Body mass index and cholesterol (psychopharmacological treatment)	Body mass index and cholesterol (psychopharmacological treatment)	Body measurement
11225	GCST001440	Body mass index and cholesterol (psychopharmacological treatment)	Body mass index and cholesterol (psychopharmacological treatment)	Biological process
11226	GCST001440	Body mass index and cholesterol (psychopharmacological treatment)	Body mass index and cholesterol (psychopharmacological treatment)	Lipid or lipoprotein measurement
11227	GCST001437	Thyrotoxic hypokalemic periodic paralysis	Thyrotoxic hypokalemic periodic paralysis	Metabolic disorder
11228	GCST001438	Crohn's disease	Crohn's disease	Digestive system disorder
11229	GCST001493	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
11230	GCST001494	Non-obstructive azoospermia	Non-obstructive azoospermia	Other disease
11231	GCST001491	Immune response to smallpox vaccine (IL-6)	Immune response to smallpox vaccine (IL-6)	Response to drug
11232	GCST001491	Immune response to smallpox vaccine (IL-6)	Immune response to smallpox vaccine (IL-6)	Other measurement
11233	GCST001492	Longevity	Longevity	Other measurement
11234	GCST001490	Nicotine dependence	Nicotine dependence	Neurological disorder
11235	GCST001489	Percent mammographic density	Percent mammographic density	Other measurement
11236	GCST001489	Percent mammographic density	Percent mammographic density	Cancer
11237	GCST001489	Percent mammographic density	Percent mammographic density	Other measurement
11238	GCST001488	Gout	Gout	Metabolic disorder
11239	GCST001486	Fasting plasma glucose	Fasting plasma glucose	Other measurement
11240	GCST001487	Thyroid function	Thyroid function	Other trait
11241	GCST001484	Head circumference (infant)	Head circumference (infant)	Body measurement
11242	GCST001426	Prostate cancer (SNP x SNP interaction)	Prostate cancer (SNP x SNP interaction)	Cancer
11243	GCST001426	Prostate cancer (SNP x SNP interaction)	Prostate cancer (SNP x SNP interaction)	Other measurement
11244	GCST001424	Vitamin B12 levels	Vitamin B12 levels	Other measurement
11245	GCST001423	Hypertension	Hypertension	Cardiovascular disease
11246	GCST001425	Response to statin therapy	Response to statin therapy	Response to drug
11247	GCST001420	Breast cancer	Breast cancer	Cancer
11248	GCST001422	Odorant perception	Odorant perception	Biological process
11249	GCST001421	Arsenic metabolism	Arsenic metabolism	Other measurement
11250	GCST001419	Temperament (bipolar disorder)	Temperament (bipolar disorder)	Other measurement
11251	GCST001419	Temperament (bipolar disorder)	Temperament (bipolar disorder)	Neurological disorder
11252	GCST001419	Temperament (bipolar disorder)	Temperament (bipolar disorder)	Other trait
11253	GCST001418	Lipid levels in hepatitis C treatment	Lipid levels in hepatitis C treatment	Lipid or lipoprotein measurement
11254	GCST001418	Lipid levels in hepatitis C treatment	Lipid levels in hepatitis C treatment	Digestive system disorder
11255	GCST001417	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
11256	GCST001376	Life threatening arrhythmia	Life threatening arrhythmia	Cardiovascular disease
11257	GCST001375	Diabetes (gestational)	Diabetes (gestational)	Metabolic disorder
11258	GCST001374	Uric acid levels	Uric acid levels	Cardiovascular measurement
11259	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Other measurement
11260	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Cancer
11261	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Cancer
11262	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Cancer
11263	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Other measurement
11264	GCST001372	Alzheimer's disease	Alzheimer's disease	Neurological disorder
11265	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Other measurement
11266	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11267	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11268	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Response to drug
11269	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11270	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11271	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11272	GCST001370	Prostate cancer (SNP x SNP interaction)	Prostate cancer (SNP x SNP interaction)	Cancer
11273	GCST001370	Prostate cancer (SNP x SNP interaction)	Prostate cancer (SNP x SNP interaction)	Other measurement
11274	GCST001369	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11275	GCST001368	Capecitabine sensitivity	Capecitabine sensitivity	Response to drug
11276	GCST001366	Prion diseases	Prion diseases	Neurological disorder
11277	GCST001341	Multiple sclerosis	Multiple sclerosis	Immune system disorder
11278	GCST001340	Pelvic organ prolapse	Pelvic organ prolapse	Other disease
11279	GCST001339	Corneal astigmatism	Corneal astigmatism	Neurological disorder
11280	GCST001339	Corneal astigmatism	Corneal astigmatism	Other trait
11281	GCST001334	Creutzfeldt-Jakob disease (variant)	Creutzfeldt-Jakob disease (variant)	Neurological disorder
11282	GCST001337	Platelet count	Platelet count	Hematological measurement
11283	GCST001335	Mean platelet volume	Mean platelet volume	Hematological measurement
11284	GCST001336	Menarche and menopause (age at onset)	Menarche and menopause (age at onset)	Other measurement
11285	GCST001336	Menarche and menopause (age at onset)	Menarche and menopause (age at onset)	Other measurement
11286	GCST001333	Bilirubin levels	Bilirubin levels	Other measurement
11287	GCST001332	Cognitive function	Cognitive function	Biological process
11288	GCST001332	Cognitive function	Cognitive function	Biological process
11289	GCST001332	Cognitive function	Cognitive function	Other measurement
11290	GCST001332	Cognitive function	Cognitive function	Biological process
11291	GCST001331	Multiple myeloma	Multiple myeloma	Cancer
11292	GCST001367	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
11293	GCST006102	Interleukin-10 levels	Interleukin-10 levels	Inflammatory measurement
11294	GCST006104	Interleukin-1-receptor antagonist levels	Interleukin-1-receptor antagonist levels	Inflammatory measurement
11295	GCST006103	Interleukin-6 levels	Interleukin-6 levels	Inflammatory measurement
11296	GCST001365	Anticoagulant levels	Anticoagulant levels	Other measurement
11297	GCST001365	Anticoagulant levels	Anticoagulant levels	Hematological measurement
11298	GCST001365	Anticoagulant levels	Anticoagulant levels	Hematological measurement
11299	GCST001362	Non-obstructive azoospermia	Non-obstructive azoospermia	Other disease
11300	GCST001364	IgA nephropathy	IgA nephropathy	Other disease
11301	GCST001363	Atopic dermatitis	Atopic dermatitis	Immune system disorder
11302	GCST001361	Ankle-brachial index	Ankle-brachial index	Cardiovascular measurement
11303	GCST001359	Bipolar disorder	Bipolar disorder	Neurological disorder
11304	GCST001384	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
11305	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Other measurement
11306	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11307	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11308	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Response to drug
11309	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11310	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11311	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11312	GCST001386	Acute graft versus host disease	Acute graft versus host disease	Immune system disorder
11313	GCST001383	Acute lung injury	Acute lung injury	Other disease
11314	GCST001382	Thyroid cancer	Thyroid cancer	Cancer
11315	GCST001381	Menopause (age at onset)	Menopause (age at onset)	Other measurement
11316	GCST001380	Gaucher disease severity	Gaucher disease severity	Metabolic disorder
11317	GCST001379	Longevity	Longevity	Other measurement
11318	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
11319	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Inflammatory measurement
11320	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Other measurement
11321	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Cardiovascular measurement
11322	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
11323	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
11324	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Other measurement
11325	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
11326	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Biological process
11327	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
11328	GCST001377	Tuberculosis	Tuberculosis	Other disease
11329	GCST001377	Tuberculosis	Tuberculosis	Other measurement
11330	GCST001377	Tuberculosis	Tuberculosis	Other measurement
11331	GCST001396	Crohn's disease	Crohn's disease	Digestive system disorder
11332	GCST001397	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11333	GCST001395	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
11334	GCST001393	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
11335	GCST001391	Metabolite levels	Metabolite levels	Other trait
11336	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11337	GCST001391	Metabolite levels	Metabolite levels	Liver enzyme measurement
11338	GCST001391	Metabolite levels	Metabolite levels	Cardiovascular measurement
11339	GCST001391	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
11340	GCST001391	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
11341	GCST001391	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
11342	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11343	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11344	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11345	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11346	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11347	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11348	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11349	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11350	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11351	GCST001391	Metabolite levels	Metabolite levels	Other measurement
11352	GCST001392	Lipid metabolism phenotypes	Lipid metabolism phenotypes	Other measurement
11353	GCST001390	Response to gemcitabine in pancreatic cancer	Response to gemcitabine in pancreatic cancer	Response to drug
11354	GCST001390	Response to gemcitabine in pancreatic cancer	Response to gemcitabine in pancreatic cancer	Cancer
11355	GCST001389	Lymphocyte counts	Lymphocyte counts	Hematological measurement
11356	GCST001388	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
11357	GCST001387	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
11358	GCST001360	Asthma	Asthma	Other disease
11359	GCST001358	Bipolar disorder	Bipolar disorder	Neurological disorder
11360	GCST001357	Response to tamoxifen in breast cancer	Response to tamoxifen in breast cancer	Response to drug
11361	GCST001356	Gout	Gout	Metabolic disorder
11362	GCST001354	Heart rate variability traits	Heart rate variability traits	Cardiovascular measurement
11363	GCST005046	N-glycan levels	N-glycan levels	Other measurement
11364	GCST001355	Psoriatic arthritis	Psoriatic arthritis	Immune system disorder
11365	GCST001352	HIV-1 viral setpoint	HIV-1 viral setpoint	Biological process
11366	GCST001352	HIV-1 viral setpoint	HIV-1 viral setpoint	Other measurement
11367	GCST001352	HIV-1 viral setpoint	HIV-1 viral setpoint	Other disease
11368	GCST001353	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
11369	GCST001353	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
11370	GCST001350	Pancreatic cancer	Pancreatic cancer	Cancer
11371	GCST001329	Epilepsy	Epilepsy	Neurological disorder
11372	GCST001329	Epilepsy	Epilepsy	Neurological disorder
11373	GCST001329	Epilepsy	Epilepsy	Neurological disorder
11374	GCST001330	Ovarian reserve	Ovarian reserve	Other measurement
11375	GCST001328	Vascular dementia	Vascular dementia	Cardiovascular disease
11376	GCST001327	Memory performance	Memory performance	Other measurement
11377	GCST001326	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11378	GCST001325	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
11379	GCST001324	Bilirubin levels	Bilirubin levels	Other measurement
11380	GCST001323	Nodular sclerosis Hodgkin lymphoma	Nodular sclerosis Hodgkin lymphoma	Cancer
11381	GCST004371	Rate of cognitive decline in mild cognitive impairment (time interaction)	Rate of cognitive decline in mild cognitive impairment (time interaction)	Other measurement
11382	GCST004371	Rate of cognitive decline in mild cognitive impairment (time interaction)	Rate of cognitive decline in mild cognitive impairment (time interaction)	Other trait
11383	GCST004371	Rate of cognitive decline in mild cognitive impairment (time interaction)	Rate of cognitive decline in mild cognitive impairment (time interaction)	Other measurement
11384	GCST001322	Kawasaki disease	Kawasaki disease	Immune system disorder
11385	GCST001406	Premature ovarian failure	Premature ovarian failure	Other disease
11386	GCST001404	Gallbladder cancer	Gallbladder cancer	Cancer
11387	GCST001405	Hypertension risk in short sleep duration	Hypertension risk in short sleep duration	Cardiovascular disease
11388	GCST001405	Hypertension risk in short sleep duration	Hypertension risk in short sleep duration	Other measurement
11389	GCST001402	Treatment response for severe sepsis	Treatment response for severe sepsis	Biological process
11390	GCST001401	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11391	GCST001403	Fluorouracil treatment response in colorectal cancer	Fluorouracil treatment response in colorectal cancer	Response to drug
11392	GCST001399	Infantile hypertrophic pyloric stenosis	Infantile hypertrophic pyloric stenosis	Digestive system disorder
11393	GCST001398	Tuberculosis	Tuberculosis	Other disease
11394	GCST001398	Tuberculosis	Tuberculosis	Other measurement
11395	GCST001398	Tuberculosis	Tuberculosis	Other measurement
11396	GCST001400	Stroke	Stroke	Cardiovascular disease
11397	GCST001394	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
11398	GCST001351	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11399	GCST001349	Brain development	Brain development	Body measurement
11400	GCST001348	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
11401	GCST001347	Coronary artery calcification	Coronary artery calcification	Other trait
11402	GCST001346	Response to gemcitabine in pancreatic cancer	Response to gemcitabine in pancreatic cancer	Response to drug
11403	GCST001346	Response to gemcitabine in pancreatic cancer	Response to gemcitabine in pancreatic cancer	Cancer
11404	GCST001345	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
11405	GCST001344	Testicular dysgenesis syndrome	Testicular dysgenesis syndrome	Other disease
11406	GCST001338	Prostate cancer	Prostate cancer	Cancer
11407	GCST001241	Bipolar disorder	Bipolar disorder	Neurological disorder
11408	GCST001242	Schizophrenia	Schizophrenia	Neurological disorder
11409	GCST001240	Obesity (extreme)	Obesity (extreme)	Metabolic disorder
11410	GCST001240	Obesity (extreme)	Obesity (extreme)	Body measurement
11411	GCST001239	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Other disease
11412	GCST001239	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Other disease
11413	GCST001252	Asthma treatment response	Asthma treatment response	Response to drug
11414	GCST001248	Pulmonary function	Pulmonary function	Other measurement
11415	GCST001248	Pulmonary function	Pulmonary function	Other measurement
11416	GCST001248	Pulmonary function	Pulmonary function	Other measurement
11417	GCST001248	Pulmonary function	Pulmonary function	Other measurement
11418	GCST001250	Basal cell carcinoma	Basal cell carcinoma	Cancer
11419	GCST001251	Pulmonary function	Pulmonary function	Other measurement
11420	GCST001251	Pulmonary function	Pulmonary function	Other measurement
11421	GCST001251	Pulmonary function	Pulmonary function	Other measurement
11422	GCST001251	Pulmonary function	Pulmonary function	Other measurement
11423	GCST001249	Spine bone size	Spine bone size	Other measurement
11424	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11425	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Cardiovascular measurement
11426	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
11427	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other disease
11428	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11429	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11430	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11431	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11432	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11433	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
11434	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Inflammatory measurement
11435	GCST001246	Stroke	Stroke	Cardiovascular disease
11436	GCST001245	Melanoma	Melanoma	Cancer
11437	GCST001243	Stroke	Stroke	Cardiovascular disease
11438	GCST001244	Dental caries	Dental caries	Digestive system disorder
11439	GCST001282	Psychosis in Alzheimer's disease	Psychosis in Alzheimer's disease	Neurological disorder
11440	GCST001282	Psychosis in Alzheimer's disease	Psychosis in Alzheimer's disease	Other trait
11441	GCST001285	Psychosis and Alzheimer's disease	Psychosis and Alzheimer's disease	Neurological disorder
11442	GCST001285	Psychosis and Alzheimer's disease	Psychosis and Alzheimer's disease	Other trait
11443	GCST001286	Smoking behavior	Smoking behavior	Biological process
11444	GCST001279	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
11445	GCST001275	Liver enzyme levels (alanine transaminase)	Liver enzyme levels (alanine transaminase)	Liver enzyme measurement
11446	GCST001277	Liver enzyme levels (gamma-glutamyl transferase)	Liver enzyme levels (gamma-glutamyl transferase)	Liver enzyme measurement
11447	GCST001276	Liver enzyme levels (alkaline phosphatase)	Liver enzyme levels (alkaline phosphatase)	Liver enzyme measurement
11448	GCST001278	Dengue shock syndrome	Dengue shock syndrome	Other disease
11449	GCST001273	Lipoprotein-associated phospholipase A2 activity and mass	Lipoprotein-associated phospholipase A2 activity and mass	Lipid or lipoprotein measurement
11450	GCST001274	Corneal structure	Corneal structure	Other measurement
11451	GCST001274	Corneal structure	Corneal structure	Neurological disorder
11452	GCST001319	Alcohol withdrawal symptoms	Alcohol withdrawal symptoms	Neurological disorder
11453	GCST001320	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
11454	GCST001321	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
11455	GCST001318	Serum ceruloplasmin levels	Serum ceruloplasmin levels	Other measurement
11456	GCST001316	IgE levels	IgE levels	Other measurement
11457	GCST001317	Aortic stiffness	Aortic stiffness	Cardiovascular measurement
11458	GCST001315	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
11459	GCST001315	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
11460	GCST001314	Adiponectin levels	Adiponectin levels	Other measurement
11461	GCST005523	Celiac disease	Celiac disease	Immune system disorder
11462	GCST001313	Depression and alcohol dependence	Depression and alcohol dependence	Neurological disorder
11463	GCST001264	Testosterone levels	Testosterone levels	Other measurement
11464	GCST001264	Testosterone levels	Testosterone levels	Other measurement
11465	GCST001263	Height	Height	Other measurement
11466	GCST001263	Height	Height	Body measurement
11467	GCST001260	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11468	GCST001259	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Response to drug
11469	GCST001259	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Neurological disorder
11470	GCST001258	Ovarian cancer	Ovarian cancer	Cancer
11471	GCST001257	Hepatitis B	Hepatitis B	Digestive system disorder
11472	GCST001257	Hepatitis B	Hepatitis B	Other measurement
11473	GCST001256	Postoperative ventricular dysfunction	Postoperative ventricular dysfunction	Cardiovascular disease
11474	GCST001255	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
11475	GCST001254	Alcohol dependence	Alcohol dependence	Other measurement
11476	GCST001254	Alcohol dependence	Alcohol dependence	Neurological disorder
11477	GCST001253	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
11478	GCST001312	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
11479	GCST001311	Cognitive decline	Cognitive decline	Other trait
11480	GCST001311	Cognitive decline	Cognitive decline	Biological process
11481	GCST001303	IgE grass sensitization	IgE grass sensitization	Immune system disorder
11482	GCST001310	Allergic rhinitis	Allergic rhinitis	Immune system disorder
11483	GCST001310	Allergic rhinitis	Allergic rhinitis	Immune system disorder
11484	GCST001306	Asthma	Asthma	Other disease
11485	GCST001307	Gamma glutamyl transferase levels	Gamma glutamyl transferase levels	Liver enzyme measurement
11486	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
11487	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
11488	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
11489	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Other trait
11490	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
11491	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Other trait
11492	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Other trait
11493	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Other trait
11494	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
11495	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
11496	GCST001309	Asthma	Asthma	Other disease
11497	GCST001304	Renal sinus fat	Renal sinus fat	Other measurement
11498	GCST001300	Gastric cancer	Gastric cancer	Cancer
11499	GCST001272	Cytomegalovirus antibody response	Cytomegalovirus antibody response	Biological process
11500	GCST001270	Blood pressure	Blood pressure	Other measurement
11501	GCST001270	Blood pressure	Blood pressure	Other measurement
11502	GCST001270	Blood pressure	Blood pressure	Other measurement
11503	GCST001270	Blood pressure	Blood pressure	Other measurement
11504	GCST001270	Blood pressure	Blood pressure	Cardiovascular measurement
11505	GCST001271	Response to antipsychotic therapy (extrapyramidal side effects)	Response to antipsychotic therapy (extrapyramidal side effects)	Response to drug
11506	GCST001266	Melanoma	Melanoma	Cancer
11507	GCST001269	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
11508	GCST001268	Gout	Gout	Metabolic disorder
11509	GCST001267	Melanoma	Melanoma	Cancer
11510	GCST001265	Hypothyroidism	Hypothyroidism	Other disease
11511	GCST001262	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11512	GCST001262	LDL cholesterol	LDL cholesterol	Other measurement
11513	GCST001262	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11514	GCST001298	Breast cancer	Breast cancer	Cancer
11515	GCST001299	Schizophrenia	Schizophrenia	Neurological disorder
11516	GCST001302	White blood cell count	White blood cell count	Hematological measurement
11517	GCST001302	White blood cell count	White blood cell count	Inflammatory measurement
11518	GCST001302	White blood cell count	White blood cell count	Hematological measurement
11519	GCST001302	White blood cell count	White blood cell count	Hematological measurement
11520	GCST001302	White blood cell count	White blood cell count	Hematological measurement
11521	GCST001301	Schizophrenia	Schizophrenia	Neurological disorder
11522	GCST001297	Male-pattern baldness	Male-pattern baldness	Other measurement
11523	GCST001297	Male-pattern baldness	Male-pattern baldness	Other disease
11524	GCST001297	Male-pattern baldness	Male-pattern baldness	Other disease
11525	GCST001295	Alopecia areata	Alopecia areata	Other disease
11526	GCST001296	Suicidal ideation	Suicidal ideation	Biological process
11527	GCST001296	Suicidal ideation	Suicidal ideation	Other measurement
11528	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11529	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Cardiovascular measurement
11530	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
11531	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other disease
11532	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11533	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11534	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11535	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11536	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11537	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
11538	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Inflammatory measurement
11539	GCST001292	Leprosy	Leprosy	Neurological disorder
11540	GCST001293	Scoliosis	Scoliosis	Other disease
11541	GCST001290	Height	Height	Other measurement
11542	GCST001290	Height	Height	Body measurement
11543	GCST001291	Response to platinum-based agents	Response to platinum-based agents	Response to drug
11544	GCST001289	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11545	GCST001289	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11546	GCST001289	Lipid traits	Lipid traits	Other measurement
11547	GCST001289	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11548	GCST001289	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11549	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11550	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11551	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11552	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11553	GCST001288	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
11554	GCST001288	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
11555	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11556	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11557	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11558	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11559	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11560	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11561	GCST001288	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
11562	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11563	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11564	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
11565	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11566	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11567	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11568	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11569	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11570	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
11571	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11572	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11573	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11574	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11575	GCST001288	Obesity-related traits	Obesity-related traits	Biological process
11576	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11577	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11578	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
11579	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11580	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11581	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11582	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11583	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11584	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11585	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
11586	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
11587	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11588	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
11589	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11590	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11591	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11592	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11593	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
11594	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11595	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11596	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11597	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11598	GCST001288	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
11599	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
11600	GCST001288	Obesity-related traits	Obesity-related traits	Metabolic disorder
11601	GCST001288	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
11602	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
11603	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11604	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
11605	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
11606	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11607	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11608	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11609	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11610	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11611	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
11612	GCST001288	Obesity-related traits	Obesity-related traits	Biological process
11613	GCST001288	Obesity-related traits	Obesity-related traits	Biological process
11614	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
11615	GCST001287	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
11616	GCST001283	Renal cell carcinoma	Renal cell carcinoma	Cancer
11617	GCST001281	Alcohol dependence	Alcohol dependence	Other measurement
11618	GCST001281	Alcohol dependence	Alcohol dependence	Neurological disorder
11619	GCST001235	Blood pressure	Blood pressure	Other measurement
11620	GCST001235	Blood pressure	Blood pressure	Other measurement
11621	GCST001235	Blood pressure	Blood pressure	Other measurement
11622	GCST001235	Blood pressure	Blood pressure	Other measurement
11623	GCST001235	Blood pressure	Blood pressure	Cardiovascular measurement
11624	GCST001236	Blood pressure	Blood pressure	Other measurement
11625	GCST001236	Blood pressure	Blood pressure	Other measurement
11626	GCST001236	Blood pressure	Blood pressure	Other measurement
11627	GCST001236	Blood pressure	Blood pressure	Other measurement
11628	GCST001236	Blood pressure	Blood pressure	Cardiovascular measurement
11629	GCST001225	HPV seropositivity	HPV seropositivity	Other measurement
11630	GCST001226	Asthma	Asthma	Other disease
11631	GCST001223	Chronic fatigue syndrome	Chronic fatigue syndrome	Immune system disorder
11632	GCST001224	Breast cancer	Breast cancer	Cancer
11633	GCST001200	Graves' disease	Graves' disease	Immune system disorder
11634	GCST001199	Iris characteristics	Iris characteristics	Other measurement
11635	GCST001198	Multiple sclerosis	Multiple sclerosis	Immune system disorder
11636	GCST001197	Bronchopulmonary dysplasia	Bronchopulmonary dysplasia	Other disease
11637	GCST001195	Intelligence	Intelligence	Biological process
11638	GCST001196	Tardive dyskinesia	Tardive dyskinesia	Neurological disorder
11639	GCST001194	Glioma	Glioma	Cancer
11640	GCST001194	Glioma	Glioma	Cancer
11641	GCST001193	Bladder cancer	Bladder cancer	Cancer
11642	GCST001192	Response to statin therapy	Response to statin therapy	Response to drug
11643	GCST001159	Restless legs syndrome	Restless legs syndrome	Neurological disorder
11644	GCST001154	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
11645	GCST001152	Schizophrenia	Schizophrenia	Neurological disorder
11646	GCST001151	Schizophrenia	Schizophrenia	Neurological disorder
11647	GCST001150	Hepatitis B	Hepatitis B	Digestive system disorder
11648	GCST001150	Hepatitis B	Hepatitis B	Other measurement
11649	GCST001153	Bladder cancer	Bladder cancer	Cancer
11650	GCST001149	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
11651	GCST001148	Prostate cancer	Prostate cancer	Cancer
11652	GCST001147	Prostate cancer	Prostate cancer	Cancer
11653	GCST001146	Systemic sclerosis	Systemic sclerosis	Neurological disorder
11654	GCST001187	Cortical thickness	Cortical thickness	Other measurement
11655	GCST001183	Asthma	Asthma	Other disease
11656	GCST001182	Asthma	Asthma	Other disease
11657	GCST001184	Meningioma	Meningioma	Cancer
11658	GCST001181	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
11659	GCST001181	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
11660	GCST001180	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	Lipid or lipoprotein measurement
11661	GCST001179	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	Lipid or lipoprotein measurement
11662	GCST001177	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	Lipid or lipoprotein measurement
11663	GCST001178	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	Lipid or lipoprotein measurement
11664	GCST001175	Epirubicin-induced leukopenia	Epirubicin-induced leukopenia	Other trait
11665	GCST001221	Permanent tooth development	Permanent tooth development	Biological process
11666	GCST001222	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
11667	GCST001219	Graves' disease	Graves' disease	Immune system disorder
11668	GCST001220	Metabolite levels	Metabolite levels	Other trait
11669	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11670	GCST001220	Metabolite levels	Metabolite levels	Liver enzyme measurement
11671	GCST001220	Metabolite levels	Metabolite levels	Cardiovascular measurement
11672	GCST001220	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
11673	GCST001220	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
11674	GCST001220	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
11675	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11676	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11677	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11678	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11679	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11680	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11681	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11682	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11683	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11684	GCST001220	Metabolite levels	Metabolite levels	Other measurement
11685	GCST001218	Lp (a) levels	Lp (a) levels	Lipid or lipoprotein measurement
11686	GCST001217	Metabolic traits	Metabolic traits	Other measurement
11687	GCST001217	Metabolic traits	Metabolic traits	Biological process
11688	GCST001217	Metabolic traits	Metabolic traits	Lipid or lipoprotein measurement
11689	GCST001217	Metabolic traits	Metabolic traits	Other measurement
11690	GCST001217	Metabolic traits	Metabolic traits	Other measurement
11691	GCST001215	Coffee consumption	Coffee consumption	Biological process
11692	GCST001215	Coffee consumption	Coffee consumption	Other measurement
11693	GCST001215	Coffee consumption	Coffee consumption	Other measurement
11694	GCST001216	Retinol levels	Retinol levels	Other measurement
11695	GCST001216	Retinol levels	Retinol levels	Other measurement
11696	GCST001214	Coronary restenosis	Coronary restenosis	Cardiovascular disease
11697	GCST001213	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11698	GCST001211	Alcohol dependence	Alcohol dependence	Other measurement
11699	GCST001211	Alcohol dependence	Alcohol dependence	Neurological disorder
11700	GCST001212	Proinsulin levels	Proinsulin levels	Other measurement
11701	GCST001210	Non-small cell lung cancer	Non-small cell lung cancer	Cancer
11702	GCST001209	Osteoarthritis	Osteoarthritis	Other disease
11703	GCST001208	Insulin resistance/response	Insulin resistance/response	Other trait
11704	GCST001207	Butyrylcholinesterase levels	Butyrylcholinesterase levels	Liver enzyme measurement
11705	GCST001206	Uric acid levels (SNP x SNP interaction)	Uric acid levels (SNP x SNP interaction)	Cardiovascular measurement
11706	GCST001205	Parkinson's disease (coffee consumption interaction)	Parkinson's disease (coffee consumption interaction)	Neurological disorder
11707	GCST001205	Parkinson's disease (coffee consumption interaction)	Parkinson's disease (coffee consumption interaction)	Biological process
11708	GCST001203	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
11709	GCST001164	Bipolar disorder	Bipolar disorder	Neurological disorder
11710	GCST001165	Adiponectin levels	Adiponectin levels	Other measurement
11711	GCST001163	Urate levels	Urate levels	Metabolic disorder
11712	GCST001163	Urate levels	Urate levels	Other measurement
11713	GCST001162	Hepatitis B vaccine response	Hepatitis B vaccine response	Response to drug
11714	GCST001161	Colorectal cancer	Colorectal cancer	Cancer
11715	GCST001158	Fibrinogen	Fibrinogen	Hematological measurement
11716	GCST001155	Vascular endothelial growth factor levels	Vascular endothelial growth factor levels	Cardiovascular measurement
11717	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11718	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Cardiovascular measurement
11719	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
11720	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other disease
11721	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11722	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11723	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11724	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
11725	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
11726	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
11727	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Inflammatory measurement
11728	GCST001176	Schizophrenia	Schizophrenia	Neurological disorder
11729	GCST001174	Hepcidin levels	Hepcidin levels	Other measurement
11730	GCST001173	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11731	GCST001171	HIV-1 progression	HIV-1 progression	Other disease
11732	GCST001170	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11733	GCST001170	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11734	GCST001170	Lipid traits	Lipid traits	Other measurement
11735	GCST001170	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11736	GCST001170	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11737	GCST001172	Asthma	Asthma	Other disease
11738	GCST001169	Response to platinum-based chemotherapy in small cell and non-small cell lung cancers	Response to platinum-based chemotherapy in small cell and non-small cell lung cancers	Response to drug
11739	GCST001166	Aging (time to event)	Aging (time to event)	Biological process
11740	GCST001168	Recombination measurement	Recombination measurement	Other measurement
11741	GCST001167	Aging (time to death)	Aging (time to death)	Other measurement
11742	GCST001167	Aging (time to death)	Aging (time to death)	Biological process
11743	GCST001135	Bipolar disorder	Bipolar disorder	Neurological disorder
11744	GCST001132	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
11745	GCST001133	White blood cell count	White blood cell count	Hematological measurement
11746	GCST001133	White blood cell count	White blood cell count	Inflammatory measurement
11747	GCST001133	White blood cell count	White blood cell count	Hematological measurement
11748	GCST001133	White blood cell count	White blood cell count	Hematological measurement
11749	GCST001133	White blood cell count	White blood cell count	Hematological measurement
11750	GCST001134	White blood cell types	White blood cell types	Hematological measurement
11751	GCST001134	White blood cell types	White blood cell types	Inflammatory measurement
11752	GCST001134	White blood cell types	White blood cell types	Hematological measurement
11753	GCST001134	White blood cell types	White blood cell types	Hematological measurement
11754	GCST001134	White blood cell types	White blood cell types	Hematological measurement
11755	GCST001134	White blood cell types	White blood cell types	Hematological measurement
11756	GCST001131	Longevity	Longevity	Other measurement
11757	GCST001130	Obesity	Obesity	Other measurement
11758	GCST001130	Obesity	Obesity	Metabolic disorder
11759	GCST001128	Adiposity	Adiposity	Metabolic disorder
11760	GCST001129	Melanoma	Melanoma	Cancer
11761	GCST001127	Response to platinum-based agents	Response to platinum-based agents	Response to drug
11762	GCST001124	Basal cell carcinoma	Basal cell carcinoma	Cancer
11763	GCST001144	Dupuytren's disease	Dupuytren's disease	Other disease
11764	GCST001145	Chemotherapeutic susceptibility	Chemotherapeutic susceptibility	Response to drug
11765	GCST001142	Vitamin E levels	Vitamin E levels	Other measurement
11766	GCST001143	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
11767	GCST001141	Suicidal ideation	Suicidal ideation	Biological process
11768	GCST001141	Suicidal ideation	Suicidal ideation	Other measurement
11769	GCST001140	Lung cancer	Lung cancer	Cancer
11770	GCST001140	Lung cancer	Lung cancer	Cancer
11771	GCST001140	Lung cancer	Lung cancer	Cancer
11772	GCST001139	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
11773	GCST001136	Interstitial lung disease	Interstitial lung disease	Other disease
11774	GCST001137	White blood cell count	White blood cell count	Hematological measurement
11775	GCST001137	White blood cell count	White blood cell count	Inflammatory measurement
11776	GCST001137	White blood cell count	White blood cell count	Hematological measurement
11777	GCST001137	White blood cell count	White blood cell count	Hematological measurement
11778	GCST001137	White blood cell count	White blood cell count	Hematological measurement
11779	GCST001138	Postoperative nausea and vomiting	Postoperative nausea and vomiting	Other trait
11780	GCST001105	Migraine	Migraine	Cardiovascular disease
11781	GCST001102	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
11782	GCST001099	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
11783	GCST001101	Corneal curvature	Corneal curvature	Other measurement
11784	GCST001104	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
11785	GCST001100	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
11786	GCST001100	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
11787	GCST001098	Peripartum cardiomyopathy	Peripartum cardiomyopathy	Cardiovascular disease
11788	GCST001103	Alcohol consumption (transferrin glycosylation)	Alcohol consumption (transferrin glycosylation)	Biological process
11789	GCST001096	Multiple sclerosis	Multiple sclerosis	Immune system disorder
11790	GCST001085	Hypertension (SNP x SNP interaction)	Hypertension (SNP x SNP interaction)	Cardiovascular disease
11791	GCST001084	Coronary heart disease (SNP X SNP interaction)	Coronary heart disease (SNP X SNP interaction)	Cardiovascular disease
11792	GCST001082	Orofacial clefts (maternal alcohol consumption interaction)	Orofacial clefts (maternal alcohol consumption interaction)	Other disease
11793	GCST001082	Orofacial clefts (maternal alcohol consumption interaction)	Orofacial clefts (maternal alcohol consumption interaction)	Other trait
11794	GCST001082	Orofacial clefts (maternal alcohol consumption interaction)	Orofacial clefts (maternal alcohol consumption interaction)	Other measurement
11795	GCST001083	Major depressive disorder	Major depressive disorder	Neurological disorder
11796	GCST001081	Longevity	Longevity	Other measurement
11797	GCST001080	Fracture-related traits	Fracture-related traits	Other measurement
11798	GCST001079	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11799	GCST001078	Prostate cancer	Prostate cancer	Cancer
11800	GCST001077	Cystic fibrosis severity	Cystic fibrosis severity	Other disease
11801	GCST001075	Atopy	Atopy	Immune system disorder
11802	GCST001064	Sarcoidosis	Sarcoidosis	Other disease
11803	GCST001063	Chronic myeloid leukemia	Chronic myeloid leukemia	Cancer
11804	GCST001065	Platelet function and related traits	Platelet function and related traits	Hematological measurement
11805	GCST001061	Platelet count	Platelet count	Hematological measurement
11806	GCST001059	Neutrophil count	Neutrophil count	Hematological measurement
11807	GCST001062	Glaucoma	Glaucoma	Neurological disorder
11808	GCST001060	AIDS progression	AIDS progression	Immune system disorder
11809	GCST001058	Glioma	Glioma	Cancer
11810	GCST001058	Glioma	Glioma	Cancer
11811	GCST001057	Obesity	Obesity	Other measurement
11812	GCST001057	Obesity	Obesity	Metabolic disorder
11813	GCST001056	Major depressive disorder	Major depressive disorder	Neurological disorder
11814	GCST001076	IFN-related cytopenia	IFN-related cytopenia	Digestive system disorder
11815	GCST001072	Blood pressure	Blood pressure	Other measurement
11816	GCST001072	Blood pressure	Blood pressure	Other measurement
11817	GCST001072	Blood pressure	Blood pressure	Other measurement
11818	GCST001072	Blood pressure	Blood pressure	Other measurement
11819	GCST001072	Blood pressure	Blood pressure	Cardiovascular measurement
11820	GCST001070	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11821	GCST001071	Osteoporosis	Osteoporosis	Other disease
11822	GCST001073	Urinary metabolites	Urinary metabolites	Other measurement
11823	GCST001073	Urinary metabolites	Urinary metabolites	Other measurement
11824	GCST001074	Blood pressure	Blood pressure	Other measurement
11825	GCST001074	Blood pressure	Blood pressure	Other measurement
11826	GCST001074	Blood pressure	Blood pressure	Other measurement
11827	GCST001074	Blood pressure	Blood pressure	Other measurement
11828	GCST001074	Blood pressure	Blood pressure	Cardiovascular measurement
11829	GCST001069	Thyroid volume	Thyroid volume	Other measurement
11830	GCST001068	Telomere length	Telomere length	Other measurement
11831	GCST001067	Testicular cancer	Testicular cancer	Cancer
11832	GCST001066	Dialysis-related mortality	Dialysis-related mortality	Other disease
11833	GCST001095	Response to antineoplastic agents	Response to antineoplastic agents	Response to drug
11834	GCST001094	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
11835	GCST001093	C-reactive protein	C-reactive protein	Inflammatory measurement
11836	GCST001092	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11837	GCST001090	Schizophrenia	Schizophrenia	Neurological disorder
11838	GCST001091	Bilirubin levels	Bilirubin levels	Other measurement
11839	GCST001089	Esophageal cancer	Esophageal cancer	Cancer
11840	GCST001088	Myopia (pathological)	Myopia (pathological)	Other trait
11841	GCST001087	Alzheimer's disease	Alzheimer's disease	Neurological disorder
11842	GCST001086	Paget's disease	Paget's disease	Other disease
11843	GCST001123	Body mass index	Body mass index	Body measurement
11844	GCST001123	Body mass index	Body mass index	Body measurement
11845	GCST001123	Body mass index	Body mass index	Other measurement
11846	GCST001125	Body mass index	Body mass index	Body measurement
11847	GCST001125	Body mass index	Body mass index	Body measurement
11848	GCST001125	Body mass index	Body mass index	Other measurement
11849	GCST001126	Parkinson's disease	Parkinson's disease	Neurological disorder
11850	GCST001122	Adiponectin levels	Adiponectin levels	Other measurement
11851	GCST001120	Erythrocyte sedimentation rate	Erythrocyte sedimentation rate	Inflammatory measurement
11852	GCST001121	Alcohol dependence	Alcohol dependence	Other measurement
11853	GCST001121	Alcohol dependence	Alcohol dependence	Neurological disorder
11854	GCST001118	Ulcerative colitis or Crohn's disease	Ulcerative colitis or Crohn's disease	Digestive system disorder
11855	GCST001118	Ulcerative colitis or Crohn's disease	Ulcerative colitis or Crohn's disease	Immune system disorder
11856	GCST001119	Schizophrenia	Schizophrenia	Neurological disorder
11857	GCST001117	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
11858	GCST001117	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
11859	GCST001116	Progressive supranuclear palsy	Progressive supranuclear palsy	Neurological disorder
11860	GCST001115	Schizophrenia (age at onset)	Schizophrenia (age at onset)	Neurological disorder
11861	GCST001115	Schizophrenia (age at onset)	Schizophrenia (age at onset)	Other measurement
11862	GCST001114	Schizophrenia (age at onset) (sex interaction)	Schizophrenia (age at onset) (sex interaction)	Neurological disorder
11863	GCST001114	Schizophrenia (age at onset) (sex interaction)	Schizophrenia (age at onset) (sex interaction)	Other measurement
11864	GCST001107	End-stage renal disease	End-stage renal disease	Other disease
11865	GCST001112	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	Other disease
11866	GCST001112	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	Other measurement
11867	GCST001111	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other disease
11868	GCST001111	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
11869	GCST001111	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
11870	GCST001108	Smoking cessation in chronic obstructive pulmonary disease	Smoking cessation in chronic obstructive pulmonary disease	Other disease
11871	GCST001108	Smoking cessation in chronic obstructive pulmonary disease	Smoking cessation in chronic obstructive pulmonary disease	Biological process
11872	GCST001109	White matter hyperintensity burden	White matter hyperintensity burden	Other measurement
11873	GCST001109	White matter hyperintensity burden	White matter hyperintensity burden	Other measurement
11874	GCST001110	Schizophrenia	Schizophrenia	Neurological disorder
11875	GCST001113	Age at smoking initiation in chronic obstructive pulmonary disease	Age at smoking initiation in chronic obstructive pulmonary disease	Other disease
11876	GCST001113	Age at smoking initiation in chronic obstructive pulmonary disease	Age at smoking initiation in chronic obstructive pulmonary disease	Biological process
11877	GCST001106	Atopic dermatitis	Atopic dermatitis	Immune system disorder
11878	GCST001190	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11879	GCST004383	Thyroid peroxidase autoantibody levels in type 1 diabetes	Thyroid peroxidase autoantibody levels in type 1 diabetes	Other measurement
11880	GCST004383	Thyroid peroxidase autoantibody levels in type 1 diabetes	Thyroid peroxidase autoantibody levels in type 1 diabetes	Metabolic disorder
11881	GCST004382	Gastric parietal cell autoantibody levels in type 1 diabetes	Gastric parietal cell autoantibody levels in type 1 diabetes	Other measurement
11882	GCST004382	Gastric parietal cell autoantibody levels in type 1 diabetes	Gastric parietal cell autoantibody levels in type 1 diabetes	Metabolic disorder
11883	GCST004381	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	Other measurement
11884	GCST004381	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	Metabolic disorder
11885	GCST004380	Glutamate decarboxylase autoantibody levels in type 1 diabetes	Glutamate decarboxylase autoantibody levels in type 1 diabetes	Other measurement
11886	GCST004380	Glutamate decarboxylase autoantibody levels in type 1 diabetes	Glutamate decarboxylase autoantibody levels in type 1 diabetes	Metabolic disorder
11887	GCST001191	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
11888	GCST001189	Parkinson's disease	Parkinson's disease	Neurological disorder
11889	GCST001188	vWF and FVIII levels	vWF and FVIII levels	Hematological measurement
11890	GCST001188	vWF and FVIII levels	vWF and FVIII levels	Other measurement
11891	GCST001188	vWF and FVIII levels	vWF and FVIII levels	Hematological measurement
11892	GCST001186	Nevirapine-induced rash	Nevirapine-induced rash	Response to drug
11893	GCST000985	Bipolar disorder	Bipolar disorder	Neurological disorder
11894	GCST000983	5-HTT brain serotonin transporter levels	5-HTT brain serotonin transporter levels	Other measurement
11895	GCST000984	Idiopathic membranous nephropathy	Idiopathic membranous nephropathy	Other disease
11896	GCST000981	Vitiligo	Vitiligo	Immune system disorder
11897	GCST000980	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
11898	GCST000980	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
11899	GCST000982	F-cell distribution in sickle cell anaemia	F-cell distribution in sickle cell anaemia	Neurological disorder
11900	GCST000982	F-cell distribution in sickle cell anaemia	F-cell distribution in sickle cell anaemia	Hematological measurement
11901	GCST000979	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
11902	GCST000979	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
11903	GCST000977	Alcohol dependence	Alcohol dependence	Other measurement
11904	GCST000977	Alcohol dependence	Alcohol dependence	Neurological disorder
11905	GCST000978	Cortisol secretion	Cortisol secretion	Other measurement
11906	GCST000972	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11907	GCST000999	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11908	GCST001001	Sick sinus syndrome	Sick sinus syndrome	Cardiovascular disease
11909	GCST001000	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11910	GCST001002	Cerivastatin-induced rhabdomyolysis	Cerivastatin-induced rhabdomyolysis	Other disease
11911	GCST001002	Cerivastatin-induced rhabdomyolysis	Cerivastatin-induced rhabdomyolysis	Response to drug
11912	GCST000998	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11913	GCST000997	Blood pressure	Blood pressure	Other measurement
11914	GCST000997	Blood pressure	Blood pressure	Other measurement
11915	GCST000997	Blood pressure	Blood pressure	Other measurement
11916	GCST000997	Blood pressure	Blood pressure	Other measurement
11917	GCST000997	Blood pressure	Blood pressure	Cardiovascular measurement
11918	GCST000996	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
11919	GCST001015	Suicide attempts in bipolar disorder	Suicide attempts in bipolar disorder	Biological process
11920	GCST001015	Suicide attempts in bipolar disorder	Suicide attempts in bipolar disorder	Neurological disorder
11921	GCST001014	Adverse response to carbamazepine	Adverse response to carbamazepine	Response to drug
11922	GCST001013	Longevity	Longevity	Other measurement
11923	GCST001012	Breast cancer	Breast cancer	Cancer
11924	GCST001011	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
11925	GCST001011	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
11926	GCST001011	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
11927	GCST001010	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
11928	GCST001010	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
11929	GCST001009	Nephropathy	Nephropathy	Other disease
11930	GCST001008	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
11931	GCST001044	Myopia (pathological)	Myopia (pathological)	Other trait
11932	GCST001045	Caudate nucleus volume	Caudate nucleus volume	Other measurement
11933	GCST001046	Obesity	Obesity	Other measurement
11934	GCST001046	Obesity	Obesity	Metabolic disorder
11935	GCST001043	Response to interferon beta therapy	Response to interferon beta therapy	Response to drug
11936	GCST001041	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
11937	GCST001040	Endometrial cancer	Endometrial cancer	Cancer
11938	GCST001040	Endometrial cancer	Endometrial cancer	Cancer
11939	GCST001039	Common variable immunodeficiency	Common variable immunodeficiency	Immune system disorder
11940	GCST001038	Dehydroepiandrosterone sulphate levels	Dehydroepiandrosterone sulphate levels	Other measurement
11941	GCST001038	Dehydroepiandrosterone sulphate levels	Dehydroepiandrosterone sulphate levels	Other measurement
11942	GCST001037	Neuranatomic and neurocognitive phenotypes	Neuranatomic and neurocognitive phenotypes	Other measurement
11943	GCST001037	Neuranatomic and neurocognitive phenotypes	Neuranatomic and neurocognitive phenotypes	Other measurement
11944	GCST001036	Drug-induced liver injury (amoxicillin-clavulanate)	Drug-induced liver injury (amoxicillin-clavulanate)	Digestive system disorder
11945	GCST001035	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to drug
11946	GCST001035	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to platinum-based chemotherapy in non-small-cell lung cancer	Cancer
11947	GCST001034	Cutaneous nevi	Cutaneous nevi	Cancer
11948	GCST001030	Attention deficit hyperactivity disorder motor coordination	Attention deficit hyperactivity disorder motor coordination	Neurological disorder
11949	GCST001032	Caffeine consumption	Caffeine consumption	Biological process
11950	GCST001033	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11951	GCST001031	Large B-cell lymphoma	Large B-cell lymphoma	Cancer
11952	GCST001029	Alcohol consumption	Alcohol consumption	Biological process
11953	GCST001029	Alcohol consumption	Alcohol consumption	Other measurement
11954	GCST001028	Prostate cancer	Prostate cancer	Cancer
11955	GCST001025	Alzheimer's disease	Alzheimer's disease	Neurological disorder
11956	GCST000973	Hypertension	Hypertension	Cardiovascular disease
11957	GCST000974	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
11958	GCST000975	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11959	GCST000975	LDL cholesterol	LDL cholesterol	Other measurement
11960	GCST000975	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11961	GCST000976	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11962	GCST000971	PR interval	PR interval	Cardiovascular measurement
11963	GCST000970	Optic disc area	Optic disc area	Other measurement
11964	GCST000970	Optic disc area	Optic disc area	Other measurement
11965	GCST000969	Bipolar disorder (age of onset and psychotic symptoms)	Bipolar disorder (age of onset and psychotic symptoms)	Other trait
11966	GCST000969	Bipolar disorder (age of onset and psychotic symptoms)	Bipolar disorder (age of onset and psychotic symptoms)	Neurological disorder
11967	GCST000969	Bipolar disorder (age of onset and psychotic symptoms)	Bipolar disorder (age of onset and psychotic symptoms)	Other measurement
11968	GCST000967	Response to platinum-based chemotherapy in head and neck cancers	Response to platinum-based chemotherapy in head and neck cancers	Response to drug
11969	GCST000966	Diabetic retinopathy	Diabetic retinopathy	Metabolic disorder
11970	GCST000968	Response to platinum-based chemotherapy in head and neck cancers	Response to platinum-based chemotherapy in head and neck cancers	Response to drug
11971	GCST001052	Alcoholism (heaviness of drinking)	Alcoholism (heaviness of drinking)	Neurological disorder
11972	GCST001054	Alcoholism (alcohol dependence factor score)	Alcoholism (alcohol dependence factor score)	Neurological disorder
11973	GCST001053	Alcoholism (alcohol use disorder factor score)	Alcoholism (alcohol use disorder factor score)	Neurological disorder
11974	GCST001055	Alcoholism (12-month weekly alcohol consumption)	Alcoholism (12-month weekly alcohol consumption)	Neurological disorder
11975	GCST001048	Monocyte early outgrowth colony forming units	Monocyte early outgrowth colony forming units	Other measurement
11976	GCST001050	Bone mineral density	Bone mineral density	Other measurement
11977	GCST001049	D-dimer levels	D-dimer levels	Cardiovascular measurement
11978	GCST001051	Follicular lymphoma	Follicular lymphoma	Cancer
11979	GCST001047	Soluble ICAM-1	Soluble ICAM-1	Cardiovascular measurement
11980	GCST001042	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
11981	GCST001027	Uterine fibroids	Uterine fibroids	Cancer
11982	GCST001024	Telomere length	Telomere length	Other measurement
11983	GCST001022	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
11984	GCST001023	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
11985	GCST001023	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
11986	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
11987	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
11988	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
11989	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
11990	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
11991	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
11992	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
11993	GCST001020	Iron deficiency	Iron deficiency	Other trait
11994	GCST001019	Migraine	Migraine	Cardiovascular disease
11995	GCST001018	Nephrotic syndrome (acquired)	Nephrotic syndrome (acquired)	Other disease
11996	GCST001017	Diabetic retinopathy	Diabetic retinopathy	Metabolic disorder
11997	GCST001016	Vaccine-related adverse events	Vaccine-related adverse events	Response to drug
11998	GCST000995	Personality traits in bipolar disorder	Personality traits in bipolar disorder	Neurological disorder
11999	GCST000995	Personality traits in bipolar disorder	Personality traits in bipolar disorder	Other trait
12000	GCST000994	Drinking behavior	Drinking behavior	Biological process
12001	GCST000992	Coffee consumption	Coffee consumption	Biological process
12002	GCST000992	Coffee consumption	Coffee consumption	Other measurement
12003	GCST000992	Coffee consumption	Coffee consumption	Other measurement
12004	GCST000993	Vascular dementia	Vascular dementia	Cardiovascular disease
12005	GCST000988	Urinary albumin excretion	Urinary albumin excretion	Other trait
12006	GCST000989	Colorectal cancer	Colorectal cancer	Cancer
12007	GCST000990	HIV-1 replication	HIV-1 replication	Other disease
12008	GCST000991	Autism spectrum disorders (language delay)	Autism spectrum disorders (language delay)	Neurological disorder
12009	GCST000986	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
12010	GCST000986	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
12011	GCST000987	Celiac disease or Rheumatoid arthritis	Celiac disease or Rheumatoid arthritis	Other disease
12012	GCST000965	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
12013	GCST000964	Ulcerative colitis	Ulcerative colitis	Immune system disorder
12014	GCST000962	Kawasaki disease	Kawasaki disease	Immune system disorder
12015	GCST000963	Uric acid levels	Uric acid levels	Cardiovascular measurement
12016	GCST000961	Bipolar disorder	Bipolar disorder	Neurological disorder
12017	GCST000959	Parkinson's disease	Parkinson's disease	Neurological disorder
12018	GCST000960	Cardiac hypertrophy	Cardiac hypertrophy	Other trait
12019	GCST000958	Percent mammographic density	Percent mammographic density	Other measurement
12020	GCST000958	Percent mammographic density	Percent mammographic density	Cancer
12021	GCST000958	Percent mammographic density	Percent mammographic density	Other measurement
12022	GCST000957	Natriuretic peptide levels	Natriuretic peptide levels	Cardiovascular measurement
12023	GCST000888	Hypospadias	Hypospadias	Other disease
12024	GCST000888	Hypospadias	Hypospadias	Other disease
12025	GCST000887	Myocardial infarction	Myocardial infarction	Cardiovascular disease
12026	GCST000886	Alzheimer's disease	Alzheimer's disease	Neurological disorder
12027	GCST000883	Response to antipsychotic treatment in schizophrenia (working memory)	Response to antipsychotic treatment in schizophrenia (working memory)	Biological process
12028	GCST000885	Response to antipsychotic treatment in schizophrenia (reasoning)	Response to antipsychotic treatment in schizophrenia (reasoning)	Biological process
12029	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12030	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12031	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12032	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12033	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12034	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12035	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12036	GCST000882	Response to bleomycin (chromatid breaks)	Response to bleomycin (chromatid breaks)	Response to drug
12037	GCST000882	Response to bleomycin (chromatid breaks)	Response to bleomycin (chromatid breaks)	Response to drug
12038	GCST000882	Response to bleomycin (chromatid breaks)	Response to bleomycin (chromatid breaks)	Other measurement
12039	GCST000881	Bone mineral density (wrist)	Bone mineral density (wrist)	Other measurement
12040	GCST000879	Crohn's disease	Crohn's disease	Digestive system disorder
12041	GCST000910	Asthma	Asthma	Other disease
12042	GCST000908	Ileal carcinoids	Ileal carcinoids	Cancer
12043	GCST000907	Renal cell carcinoma	Renal cell carcinoma	Cancer
12044	GCST000905	Information processing speed	Information processing speed	Biological process
12045	GCST000906	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
12046	GCST000904	Asperger disorder	Asperger disorder	Neurological disorder
12047	GCST000901	Neuroblastoma	Neuroblastoma	Cancer
12048	GCST000902	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
12049	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
12050	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
12051	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
12052	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Neurological disorder
12053	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
12054	GCST000903	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	Response to drug
12055	GCST000920	Myocardial infarction	Myocardial infarction	Cardiovascular disease
12056	GCST000918	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
12057	GCST000918	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
12058	GCST000917	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
12059	GCST000914	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
12060	GCST000915	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
12061	GCST000916	Endometriosis	Endometriosis	Other disease
12062	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
12063	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
12064	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
12065	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
12066	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
12067	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
12068	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
12069	GCST000912	Adverse response to carbamazepine	Adverse response to carbamazepine	Response to drug
12070	GCST000911	Progranulin levels	Progranulin levels	Other measurement
12071	GCST000909	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
12072	GCST000909	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
12073	GCST000926	Maximal oxygen uptake response	Maximal oxygen uptake response	Other measurement
12074	GCST000924	Response to acetaminophen (hepatotoxicity)	Response to acetaminophen (hepatotoxicity)	Response to drug
12075	GCST000923	Osteoarthritis	Osteoarthritis	Other disease
12076	GCST006329	Agreeableness	Agreeableness	Other measurement
12077	GCST006328	Extraversion	Extraversion	Biological process
12078	GCST006328	Extraversion	Extraversion	Other measurement
12079	GCST006327	Neuroticism	Neuroticism	Neurological disorder
12080	GCST006327	Neuroticism	Neuroticism	Other measurement
12081	GCST006326	Conscientiousness	Conscientiousness	Other measurement
12082	GCST000922	Openness	Openness	Other measurement
12083	GCST000921	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
12084	GCST000921	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
12085	GCST000919	Serum prostate-specific antigen levels	Serum prostate-specific antigen levels	Other measurement
12086	GCST000946	Myocardial infarction in coronary artery disease	Myocardial infarction in coronary artery disease	Cardiovascular disease
12087	GCST000946	Myocardial infarction in coronary artery disease	Myocardial infarction in coronary artery disease	Cardiovascular disease
12088	GCST000944	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
12089	GCST000943	Aortic root size	Aortic root size	Cardiovascular measurement
12090	GCST000940	Stroke	Stroke	Cardiovascular disease
12091	GCST000941	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
12092	GCST000942	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
12093	GCST000942	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
12094	GCST000939	Kawasaki disease	Kawasaki disease	Immune system disorder
12095	GCST000937	Insulin-like growth factors	Insulin-like growth factors	Other measurement
12096	GCST000937	Insulin-like growth factors	Insulin-like growth factors	Other measurement
12097	GCST000938	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
12098	GCST000938	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
12099	GCST000936	Cardiac muscle measurement	Cardiac muscle measurement	Other trait
12100	GCST000936	Cardiac muscle measurement	Cardiac muscle measurement	Other measurement
12101	GCST000955	Crohn's disease and celiac disease	Crohn's disease and celiac disease	Digestive system disorder
12102	GCST000955	Crohn's disease and celiac disease	Crohn's disease and celiac disease	Immune system disorder
12103	GCST000954	Alcohol consumption	Alcohol consumption	Biological process
12104	GCST000954	Alcohol consumption	Alcohol consumption	Other measurement
12105	GCST000953	Lapatinib-induced hepatotoxicity in breast cancer	Lapatinib-induced hepatotoxicity in breast cancer	Response to drug
12106	GCST000952	Breast cancer	Breast cancer	Cancer
12107	GCST000951	Nephrolithiasis	Nephrolithiasis	Other disease
12108	GCST000950	Parkinson's disease	Parkinson's disease	Neurological disorder
12109	GCST000949	Multiple sclerosis	Multiple sclerosis	Immune system disorder
12110	GCST000947	Lung adenocarcinoma (clinical stage)	Lung adenocarcinoma (clinical stage)	Cancer
12111	GCST000948	Colorectal cancer	Colorectal cancer	Cancer
12112	GCST000945	Coronary artery disease	Coronary artery disease	Cardiovascular disease
12113	GCST000945	Coronary artery disease	Coronary artery disease	Cardiovascular disease
12114	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
12115	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
12116	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
12117	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
12118	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
12119	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
12120	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
12121	GCST000934	Asthma or atopy (farm exposure interaction)	Asthma or atopy (farm exposure interaction)	Other disease
12122	GCST000934	Asthma or atopy (farm exposure interaction)	Asthma or atopy (farm exposure interaction)	Other measurement
12123	GCST000933	C-reactive protein	C-reactive protein	Inflammatory measurement
12124	GCST000932	Hoarding	Hoarding	Neurological disorder
12125	GCST000927	Response to metformin in type 2 diabetes (glycemic)	Response to metformin in type 2 diabetes (glycemic)	Response to drug
12126	GCST000928	Waist-to-hip ratio (sex interaction)	Waist-to-hip ratio (sex interaction)	Body measurement
12127	GCST000928	Waist-to-hip ratio (sex interaction)	Waist-to-hip ratio (sex interaction)	Other measurement
12128	GCST000929	Body mass index	Body mass index	Body measurement
12129	GCST000929	Body mass index	Body mass index	Body measurement
12130	GCST000929	Body mass index	Body mass index	Other measurement
12131	GCST000931	Waist circumference (sex interaction)	Waist circumference (sex interaction)	Body measurement
12132	GCST000931	Waist circumference (sex interaction)	Waist circumference (sex interaction)	Other measurement
12133	GCST000930	Body mass index (sex interaction)	Body mass index (sex interaction)	Body measurement
12134	GCST000930	Body mass index (sex interaction)	Body mass index (sex interaction)	Other measurement
12135	GCST000925	N-glycan levels	N-glycan levels	Other measurement
12136	GCST000896	Small-cell lung cancer (survival)	Small-cell lung cancer (survival)	Cancer
12137	GCST000821	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
12138	GCST000821	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
12139	GCST000821	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
12140	GCST000818	Urate levels	Urate levels	Metabolic disorder
12141	GCST000818	Urate levels	Urate levels	Other measurement
12142	GCST000817	Height	Height	Other measurement
12143	GCST000817	Height	Height	Body measurement
12144	GCST000816	Suicidal ideation	Suicidal ideation	Biological process
12145	GCST000816	Suicidal ideation	Suicidal ideation	Other measurement
12146	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12147	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12148	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12149	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12150	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12151	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12152	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12153	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12154	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
12155	GCST000815	Non-small cell lung cancer	Non-small cell lung cancer	Cancer
12156	GCST000812	Adiponectin levels	Adiponectin levels	Other measurement
12157	GCST000813	Adverse response to aromatase inhibitors	Adverse response to aromatase inhibitors	Response to drug
12158	GCST000810	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
12159	GCST000811	Breast cancer	Breast cancer	Cancer
12160	GCST000809	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
12161	GCST000806	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
12162	GCST000806	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
12163	GCST000808	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
12164	GCST000808	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
12165	GCST000804	Asthma	Asthma	Other disease
12166	GCST000805	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
12167	GCST000807	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12168	GCST000807	LDL cholesterol	LDL cholesterol	Other measurement
12169	GCST000807	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12170	GCST000803	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
12171	GCST000800	Ovarian cancer	Ovarian cancer	Cancer
12172	GCST000801	Breast cancer	Breast cancer	Cancer
12173	GCST000802	Ovarian cancer	Ovarian cancer	Cancer
12174	GCST000830	Body mass index	Body mass index	Body measurement
12175	GCST000830	Body mass index	Body mass index	Body measurement
12176	GCST000830	Body mass index	Body mass index	Other measurement
12177	GCST000826	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
12178	GCST000826	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
12179	GCST000827	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
12180	GCST000827	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
12181	GCST000828	Adiponectin levels	Adiponectin levels	Other measurement
12182	GCST000825	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
12183	GCST000825	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
12184	GCST000824	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Cancer
12185	GCST000824	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Other disease
12186	GCST000824	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Biological process
12187	GCST000822	Antipsychotic drug-induced QTc interval prolongation	Antipsychotic drug-induced QTc interval prolongation	Response to drug
12188	GCST000822	Antipsychotic drug-induced QTc interval prolongation	Antipsychotic drug-induced QTc interval prolongation	Response to drug
12189	GCST000822	Antipsychotic drug-induced QTc interval prolongation	Antipsychotic drug-induced QTc interval prolongation	Response to drug
12190	GCST000823	Radiation response	Radiation response	Biological process
12191	GCST000820	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
12192	GCST000869	Osteoarthritis	Osteoarthritis	Other disease
12193	GCST000867	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
12194	GCST000867	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
12195	GCST000868	Handedness in dyslexia	Handedness in dyslexia	Other trait
12196	GCST000868	Handedness in dyslexia	Handedness in dyslexia	Neurological disorder
12197	GCST000865	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Immune system disorder
12198	GCST000865	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Response to drug
12199	GCST000864	Alzheimer's disease	Alzheimer's disease	Neurological disorder
12200	GCST000866	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12201	GCST000866	LDL cholesterol	LDL cholesterol	Other measurement
12202	GCST000866	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12203	GCST000862	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
12204	GCST000862	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
12205	GCST000862	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
12206	GCST000861	Cannabis dependence	Cannabis dependence	Neurological disorder
12207	GCST000860	Moyamoya disease	Moyamoya disease	Cardiovascular disease
12208	GCST000863	HIV-1 control	HIV-1 control	Other disease
12209	GCST000839	Height	Height	Other measurement
12210	GCST000839	Height	Height	Body measurement
12211	GCST000840	Body mass index	Body mass index	Body measurement
12212	GCST000840	Body mass index	Body mass index	Body measurement
12213	GCST000840	Body mass index	Body mass index	Other measurement
12214	GCST000838	Waist circumference	Waist circumference	Body measurement
12215	GCST000834	Psoriasis	Psoriasis	Immune system disorder
12216	GCST000835	Psoriatic arthritis	Psoriatic arthritis	Immune system disorder
12217	GCST000836	Psoriasis	Psoriasis	Immune system disorder
12218	GCST000833	Psoriasis	Psoriasis	Immune system disorder
12219	GCST000832	Stevens-Johnson syndrome	Stevens-Johnson syndrome	Other disease
12220	GCST000831	Tardive dyskinesia in schizophrenia	Tardive dyskinesia in schizophrenia	Neurological disorder
12221	GCST000829	Waist-hip ratio	Waist-hip ratio	Other measurement
12222	GCST000829	Waist-hip ratio	Waist-hip ratio	Body measurement
12223	GCST000880	Menarche (age at onset)	Menarche (age at onset)	Other measurement
12224	GCST000878	Myopia (pathological)	Myopia (pathological)	Other trait
12225	GCST000877	Bone mineral density	Bone mineral density	Other measurement
12226	GCST000876	Amyloid A serum levels	Amyloid A serum levels	Lipid or lipoprotein measurement
12227	GCST000875	Coronary heart disease	Coronary heart disease	Cardiovascular disease
12228	GCST000874	Parkinson's disease	Parkinson's disease	Neurological disorder
12229	GCST000873	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
12230	GCST000873	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
12231	GCST000872	QRS duration	QRS duration	Cardiovascular measurement
12232	GCST000872	QRS duration	QRS duration	Cardiovascular measurement
12233	GCST000872	QRS duration	QRS duration	Cardiovascular measurement
12234	GCST000871	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Other measurement
12235	GCST000871	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Cancer
12236	GCST000870	Atopy	Atopy	Immune system disorder
12237	GCST000859	Aspirin intolerance in asthmatics	Aspirin intolerance in asthmatics	Other trait
12238	GCST000858	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
12239	GCST000855	Parkinson's disease	Parkinson's disease	Neurological disorder
12240	GCST000856	Major depressive disorder	Major depressive disorder	Neurological disorder
12241	GCST000857	Event-related brain oscillations	Event-related brain oscillations	Other measurement
12242	GCST000854	Suicide risk	Suicide risk	Biological process
12243	GCST000854	Suicide risk	Suicide risk	Neurological disorder
12244	GCST000853	Ulcerative colitis	Ulcerative colitis	Immune system disorder
12245	GCST000852	Atrioventricular conduction	Atrioventricular conduction	Cardiovascular measurement
12246	GCST000851	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
12247	GCST000850	Body mass in chronic obstructive pulmonary disease	Body mass in chronic obstructive pulmonary disease	Other disease
12248	GCST000850	Body mass in chronic obstructive pulmonary disease	Body mass in chronic obstructive pulmonary disease	Body measurement
12249	GCST000847	Retinal vascular caliber	Retinal vascular caliber	Other measurement
12250	GCST000845	Recombination measurement (males)	Recombination measurement (males)	Other measurement
12251	GCST000848	Recombination measurement (females)	Recombination measurement (females)	Other measurement
12252	GCST000846	Breast cancer in BRCA2 mutation carriers	Breast cancer in BRCA2 mutation carriers	Cancer
12253	GCST000849	Hypertension	Hypertension	Cardiovascular disease
12254	GCST000844	Prostate cancer mortality	Prostate cancer mortality	Cancer
12255	GCST000844	Prostate cancer mortality	Prostate cancer mortality	Other measurement
12256	GCST000844	Prostate cancer mortality	Prostate cancer mortality	Cancer
12257	GCST000843	Colorectal cancer	Colorectal cancer	Cancer
12258	GCST000842	Bladder cancer	Bladder cancer	Cancer
12259	GCST000841	Dupuytren's disease	Dupuytren's disease	Other disease
12260	GCST000837	Weight	Weight	Body measurement
12261	GCST000799	Hypertension	Hypertension	Cardiovascular disease
12262	GCST000796	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12263	GCST000798	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
12264	GCST000797	Endometriosis	Endometriosis	Other disease
12265	GCST000795	Refractive error	Refractive error	Other trait
12266	GCST000794	Refractive error	Refractive error	Other trait
12267	GCST000793	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
12268	GCST000792	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
12269	GCST000791	Thyroid function	Thyroid function	Other trait
12270	GCST000790	Fuchs's corneal dystrophy	Fuchs's corneal dystrophy	Neurological disorder
12271	GCST000757	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
12272	GCST000755	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
12273	GCST000761	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
12274	GCST000759	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12275	GCST000759	LDL cholesterol	LDL cholesterol	Other measurement
12276	GCST000759	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12277	GCST000760	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
12278	GCST000756	Magnesium levels	Magnesium levels	Other measurement
12279	GCST000753	Metabolic syndrome	Metabolic syndrome	Body measurement
12280	GCST000753	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
12281	GCST000753	Metabolic syndrome	Metabolic syndrome	Other measurement
12282	GCST000753	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
12283	GCST000753	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
12284	GCST000754	Personality dimensions	Personality dimensions	Other trait
12285	GCST000749	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
12286	GCST000770	Emphysema-related traits	Emphysema-related traits	Other disease
12287	GCST000769	Calcium levels	Calcium levels	Other measurement
12288	GCST000766	Non-alcoholic fatty liver disease histology (lobular)	Non-alcoholic fatty liver disease histology (lobular)	Cancer
12289	GCST000766	Non-alcoholic fatty liver disease histology (lobular)	Non-alcoholic fatty liver disease histology (lobular)	Digestive system disorder
12290	GCST000767	Non-alcoholic fatty liver disease histology (AST)	Non-alcoholic fatty liver disease histology (AST)	Cancer
12291	GCST000767	Non-alcoholic fatty liver disease histology (AST)	Non-alcoholic fatty liver disease histology (AST)	Digestive system disorder
12292	GCST000765	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Liver enzyme measurement
12293	GCST000765	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Cancer
12294	GCST000765	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Digestive system disorder
12295	GCST000768	Asthma	Asthma	Other disease
12296	GCST000764	Tuberculosis	Tuberculosis	Other disease
12297	GCST000764	Tuberculosis	Tuberculosis	Other measurement
12298	GCST000764	Tuberculosis	Tuberculosis	Other measurement
12299	GCST000762	Meningococcal disease	Meningococcal disease	Other disease
12300	GCST000763	Immunoglobulin A	Immunoglobulin A	Other measurement
12301	GCST000758	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
12302	GCST000740	Autism	Autism	Neurological disorder
12303	GCST000738	Neonatal lupus	Neonatal lupus	Immune system disorder
12304	GCST000739	Serologic markers in systemic lupus erythematosus	Serologic markers in systemic lupus erythematosus	Immune system disorder
12305	GCST000737	Hypertriglyceridemia	Hypertriglyceridemia	Metabolic disorder
12306	GCST000737	Hypertriglyceridemia	Hypertriglyceridemia	Lipid or lipoprotein measurement
12307	GCST000736	Calcium levels	Calcium levels	Other measurement
12308	GCST000734	Follicular lymphoma	Follicular lymphoma	Cancer
12309	GCST000735	Lumiracoxib-related liver injury	Lumiracoxib-related liver injury	Digestive system disorder
12310	GCST000733	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
12311	GCST000733	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
12312	GCST000732	Nevus count	Nevus count	Other measurement
12313	GCST000731	Resting heart rate	Resting heart rate	Cardiovascular measurement
12314	GCST000721	Endometriosis	Endometriosis	Other disease
12315	GCST000720	Peripheral artery disease	Peripheral artery disease	Cardiovascular disease
12316	GCST000717	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Neurological disorder
12317	GCST000717	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Neurological disorder
12318	GCST000717	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Metabolic disorder
12319	GCST000718	Nephropathy	Nephropathy	Other disease
12320	GCST000719	Alopecia areata	Alopecia areata	Other disease
12321	GCST000715	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Cancer
12322	GCST000715	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Response to drug
12323	GCST000716	Multiple sclerosis	Multiple sclerosis	Immune system disorder
12324	GCST000712	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12325	GCST000714	Conduct disorder	Conduct disorder	Neurological disorder
12326	GCST000713	Conduct disorder (symptom count)	Conduct disorder (symptom count)	Neurological disorder
12327	GCST000781	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
12328	GCST000779	Depression (quantitative trait)	Depression (quantitative trait)	Neurological disorder
12329	GCST000778	Smoking cessation	Smoking cessation	Biological process
12330	GCST000776	Esophageal cancer	Esophageal cancer	Cancer
12331	GCST000777	Esophageal cancer and gastric cancer	Esophageal cancer and gastric cancer	Cancer
12332	GCST000777	Esophageal cancer and gastric cancer	Esophageal cancer and gastric cancer	Cancer
12333	GCST000775	Central corneal thickness	Central corneal thickness	Other measurement
12334	GCST000775	Central corneal thickness	Central corneal thickness	Other measurement
12335	GCST000774	Schizophrenia, bipolar disorder and depression (combined)	Schizophrenia, bipolar disorder and depression (combined)	Neurological disorder
12336	GCST000774	Schizophrenia, bipolar disorder and depression (combined)	Schizophrenia, bipolar disorder and depression (combined)	Neurological disorder
12337	GCST000774	Schizophrenia, bipolar disorder and depression (combined)	Schizophrenia, bipolar disorder and depression (combined)	Neurological disorder
12338	GCST000772	Parkinson's disease	Parkinson's disease	Neurological disorder
12339	GCST000771	Narcolepsy	Narcolepsy	Neurological disorder
12340	GCST000773	Keloid	Keloid	Other disease
12341	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Body measurement
12342	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Other disease
12343	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Lipid or lipoprotein measurement
12344	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Lipid or lipoprotein measurement
12345	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Lipid or lipoprotein measurement
12346	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Body measurement
12347	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Other disease
12348	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Lipid or lipoprotein measurement
12349	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Lipid or lipoprotein measurement
12350	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Lipid or lipoprotein measurement
12351	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Other measurement
12352	GCST000788	Schizophrenia	Schizophrenia	Neurological disorder
12353	GCST000787	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12354	GCST000786	Diabetic retinopathy	Diabetic retinopathy	Metabolic disorder
12355	GCST000783	Multiple sclerosis--Brain Glutamate Levels	Multiple sclerosis--Brain Glutamate Levels	Immune system disorder
12356	GCST000785	Longevity	Longevity	Other measurement
12357	GCST000784	Pseudoexfoliation syndrome	Pseudoexfoliation syndrome	Neurological disorder
12358	GCST000782	Migraine	Migraine	Cardiovascular disease
12359	GCST000780	Protein C levels	Protein C levels	Hematological measurement
12360	GCST000711	Vitamin D levels	Vitamin D levels	Other measurement
12361	GCST000707	Hair color	Hair color	Other measurement
12362	GCST000707	Hair color	Hair color	Other trait
12363	GCST000710	Eye color	Eye color	Other measurement
12364	GCST000710	Eye color	Eye color	Other trait
12365	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
12366	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
12367	GCST000706	Common traits (Other)	Common traits (Other)	Biological process
12368	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
12369	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
12370	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
12371	GCST000706	Common traits (Other)	Common traits (Other)	Biological process
12372	GCST000706	Common traits (Other)	Common traits (Other)	Biological process
12373	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
12374	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
12375	GCST000708	Freckling	Freckling	Other trait
12376	GCST000709	Breast cancer	Breast cancer	Cancer
12377	GCST000704	Hemoglobin levels	Hemoglobin levels	Hematological measurement
12378	GCST000704	Hemoglobin levels	Hemoglobin levels	Hematological measurement
12379	GCST000704	Hemoglobin levels	Hemoglobin levels	Hematological measurement
12380	GCST000704	Hemoglobin levels	Hemoglobin levels	Hematological measurement
12381	GCST000705	Crohn's disease	Crohn's disease	Digestive system disorder
12382	GCST000702	Schizophrenia	Schizophrenia	Neurological disorder
12383	GCST000703	Phosphorus levels	Phosphorus levels	Other measurement
12384	GCST000730	Bilirubin levels	Bilirubin levels	Other measurement
12385	GCST000729	Ribavirin-induced anemia	Ribavirin-induced anemia	Other trait
12386	GCST000729	Ribavirin-induced anemia	Ribavirin-induced anemia	Response to drug
12387	GCST000726	Behcet's disease	Behcet's disease	Cardiovascular disease
12388	GCST000725	Ventricular fibrillation	Ventricular fibrillation	Cardiovascular disease
12389	GCST000728	Behcet's disease	Behcet's disease	Cardiovascular disease
12390	GCST000727	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
12391	GCST000724	Neuroticism (age interaction)	Neuroticism (age interaction)	Neurological disorder
12392	GCST000724	Neuroticism (age interaction)	Neuroticism (age interaction)	Other measurement
12393	GCST004569	Neuroticism	Neuroticism	Neurological disorder
12394	GCST004569	Neuroticism	Neuroticism	Other measurement
12395	GCST000723	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
12396	GCST000722	Colorectal cancer	Colorectal cancer	Cancer
12397	GCST000752	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
12398	GCST000747	Self-rated health	Self-rated health	Other trait
12399	GCST000748	Response to anti-TNF alpha therapy in inflammatory bowel disease	Response to anti-TNF alpha therapy in inflammatory bowel disease	Response to drug
12400	GCST000750	Prostate cancer	Prostate cancer	Cancer
12401	GCST000746	Bitter taste response	Bitter taste response	Biological process
12402	GCST000743	Major depressive disorder	Major depressive disorder	Neurological disorder
12403	GCST000742	Chronic kidney disease and serum creatinine levels	Chronic kidney disease and serum creatinine levels	Other disease
12404	GCST000742	Chronic kidney disease and serum creatinine levels	Chronic kidney disease and serum creatinine levels	Other measurement
12405	GCST000745	Pancreatic cancer	Pancreatic cancer	Cancer
12406	GCST000744	Height	Height	Other measurement
12407	GCST000744	Height	Height	Body measurement
12408	GCST000741	Glomerulosclerosis	Glomerulosclerosis	Other disease
12409	GCST000671	Lipoprotein-associated phospholipase A2 activity and mass	Lipoprotein-associated phospholipase A2 activity and mass	Lipid or lipoprotein measurement
12410	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
12411	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
12412	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
12413	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
12414	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
12415	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
12416	GCST000669	Telomere length	Telomere length	Other measurement
12417	GCST000667	Smoking behavior	Smoking behavior	Biological process
12418	GCST000668	Smoking behavior	Smoking behavior	Biological process
12419	GCST000666	Smoking behavior	Smoking behavior	Biological process
12420	GCST000664	Vitamin D levels	Vitamin D levels	Other measurement
12421	GCST000665	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12422	GCST000663	Obesity (early onset extreme)	Obesity (early onset extreme)	Metabolic disorder
12423	GCST000662	Vitiligo	Vitiligo	Immune system disorder
12424	GCST000650	Systemic sclerosis	Systemic sclerosis	Neurological disorder
12425	GCST000651	Creatinine levels	Creatinine levels	Other measurement
12426	GCST000649	Chronic kidney disease	Chronic kidney disease	Other disease
12427	GCST000649	Chronic kidney disease	Chronic kidney disease	Other measurement
12428	GCST000649	Chronic kidney disease	Chronic kidney disease	Other measurement
12429	GCST000648	Birth weight	Birth weight	Body measurement
12430	GCST000647	Cholesterol	Cholesterol	Lipid or lipoprotein measurement
12431	GCST000646	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
12432	GCST000645	Glaucoma	Glaucoma	Neurological disorder
12433	GCST000642	Body mass index	Body mass index	Body measurement
12434	GCST000642	Body mass index	Body mass index	Body measurement
12435	GCST000642	Body mass index	Body mass index	Other measurement
12436	GCST000643	Response to antidepressants	Response to antidepressants	Response to drug
12437	GCST000644	Height	Height	Other measurement
12438	GCST000644	Height	Height	Body measurement
12439	GCST000681	Biliary atresia	Biliary atresia	Digestive system disorder
12440	GCST000678	Breast cancer	Breast cancer	Cancer
12441	GCST000679	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
12442	GCST000677	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
12443	GCST000680	Multiple sclerosis	Multiple sclerosis	Immune system disorder
12444	GCST000676	Alzheimer's disease	Alzheimer's disease	Neurological disorder
12445	GCST000674	Bipolar disorder	Bipolar disorder	Neurological disorder
12446	GCST000675	Heart failure	Heart failure	Cardiovascular disease
12447	GCST000673	Cleft lip	Cleft lip	Other trait
12448	GCST000672	Paget's disease	Paget's disease	Other disease
12449	GCST000661	Mortality in heart failure	Mortality in heart failure	Other measurement
12450	GCST000661	Mortality in heart failure	Mortality in heart failure	Cardiovascular disease
12451	GCST000660	Anthropometric traits	Anthropometric traits	Other measurement
12452	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12453	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12454	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12455	GCST000660	Anthropometric traits	Anthropometric traits	Other measurement
12456	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12457	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12458	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12459	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12460	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12461	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
12462	GCST000659	Optic nerve measurement (cup area)	Optic nerve measurement (cup area)	Other measurement
12463	GCST000655	Optic nerve measurement (cup-to-disc ratio)	Optic nerve measurement (cup-to-disc ratio)	Other measurement
12464	GCST000655	Optic nerve measurement (cup-to-disc ratio)	Optic nerve measurement (cup-to-disc ratio)	Other measurement
12465	GCST000657	Optic nerve measurement (disc area)	Optic nerve measurement (disc area)	Other measurement
12466	GCST000656	HIV-1 viral setpoint	HIV-1 viral setpoint	Biological process
12467	GCST000656	HIV-1 viral setpoint	HIV-1 viral setpoint	Other measurement
12468	GCST000656	HIV-1 viral setpoint	HIV-1 viral setpoint	Other disease
12469	GCST000658	Optic nerve measurement (rim area)	Optic nerve measurement (rim area)	Other measurement
12470	GCST000654	Bipolar I disorder	Bipolar I disorder	Neurological disorder
12471	GCST000654	Bipolar I disorder	Bipolar I disorder	Neurological disorder
12472	GCST000653	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
12473	GCST000653	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
12474	GCST000652	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
12475	GCST000652	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
12476	GCST000701	Testicular germ cell cancer	Testicular germ cell cancer	Cancer
12477	GCST000700	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
12478	GCST000700	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
12479	GCST000698	Osteoporosis-related phenotypes	Osteoporosis-related phenotypes	Other disease
12480	GCST000699	Optic disc parameters	Optic disc parameters	Other measurement
12481	GCST000697	Vitamin D insufficiency	Vitamin D insufficiency	Other trait
12482	GCST000696	End-stage renal disease (non-diabetic)	End-stage renal disease (non-diabetic)	Other disease
12483	GCST000695	Migraine in psychiatric disorder	Migraine in psychiatric disorder	Cardiovascular disease
12484	GCST000695	Migraine in psychiatric disorder	Migraine in psychiatric disorder	Neurological disorder
12485	GCST000694	Phytosterol levels	Phytosterol levels	Other measurement
12486	GCST000692	Vitiligo	Vitiligo	Immune system disorder
12487	GCST000693	Platelet aggregation	Platelet aggregation	Biological process
12488	GCST000624	Ulcerative colitis	Ulcerative colitis	Immune system disorder
12489	GCST000622	Creatinine levels	Creatinine levels	Other measurement
12490	GCST000621	C4b binding protein levels	C4b binding protein levels	Cardiovascular measurement
12491	GCST000620	Eosinophilic esophagitis (pediatric)	Eosinophilic esophagitis (pediatric)	Digestive system disorder
12492	GCST000619	Alcohol dependence	Alcohol dependence	Other measurement
12493	GCST000619	Alcohol dependence	Alcohol dependence	Neurological disorder
12494	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12495	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12496	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12497	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12498	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12499	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12500	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12501	GCST000615	Brain structure (hippocampal volume)	Brain structure (hippocampal volume)	Other measurement
12502	GCST000615	Brain structure (hippocampal volume)	Brain structure (hippocampal volume)	Other measurement
12503	GCST000614	Brain structure (temporal lobe volume)	Brain structure (temporal lobe volume)	Neurological disorder
12504	GCST000617	Alcohol dependence	Alcohol dependence	Other measurement
12505	GCST000617	Alcohol dependence	Alcohol dependence	Neurological disorder
12506	GCST000691	Partial epilepsies	Partial epilepsies	Neurological disorder
12507	GCST000688	Response to platinum-based chemotherapy in small-cell lung cancer	Response to platinum-based chemotherapy in small-cell lung cancer	Response to drug
12508	GCST000689	Major depressive disorder	Major depressive disorder	Neurological disorder
12509	GCST000690	Heroin addiction	Heroin addiction	Neurological disorder
12510	GCST000687	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
12511	GCST000686	Pancreatic cancer	Pancreatic cancer	Cancer
12512	GCST000685	Eye color traits	Eye color traits	Other trait
12513	GCST000684	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
12514	GCST000683	Central corneal thickness	Central corneal thickness	Other measurement
12515	GCST000683	Central corneal thickness	Central corneal thickness	Other measurement
12516	GCST000682	Alzheimer's disease	Alzheimer's disease	Neurological disorder
12517	GCST000641	Bipolar disorder or major depressive disorder	Bipolar disorder or major depressive disorder	Neurological disorder
12518	GCST000641	Bipolar disorder or major depressive disorder	Bipolar disorder or major depressive disorder	Neurological disorder
12519	GCST006582	Major depressive disorder	Major depressive disorder	Neurological disorder
12520	GCST006865	Bipolar disorder	Bipolar disorder	Neurological disorder
12521	GCST000640	Thyroid cancer (Papillary, radiation-related)	Thyroid cancer (Papillary, radiation-related)	Cancer
12522	GCST000639	Urinary bladder cancer	Urinary bladder cancer	Cancer
12523	GCST000638	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
12524	GCST000636	Brain cytoarchitecture	Brain cytoarchitecture	Other measurement
12525	GCST000637	Breast cancer (prognosis)	Breast cancer (prognosis)	Cancer
12526	GCST000635	Response to statin therapy	Response to statin therapy	Response to drug
12527	GCST000634	Cognitive ability	Cognitive ability	Biological process
12528	GCST000633	Lung cancer	Lung cancer	Cancer
12529	GCST000633	Lung cancer	Lung cancer	Cancer
12530	GCST000633	Lung cancer	Lung cancer	Cancer
12531	GCST000631	Activated partial thromboplastin time	Activated partial thromboplastin time	Hematological measurement
12532	GCST000629	Knee osteoarthritis	Knee osteoarthritis	Other disease
12533	GCST000630	Digit length ratio	Digit length ratio	Body measurement
12534	GCST000632	Longevity	Longevity	Other measurement
12535	GCST000628	Chemerin levels	Chemerin levels	Cardiovascular measurement
12536	GCST000626	Factor VIII levels	Factor VIII levels	Hematological measurement
12537	GCST000627	vWF levels	vWF levels	Hematological measurement
12538	GCST000625	Factor VII levels	Factor VII levels	Other measurement
12539	GCST000623	Ulcerative colitis	Ulcerative colitis	Immune system disorder
12540	GCST000550	Metabolite levels	Metabolite levels	Other trait
12541	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12542	GCST000550	Metabolite levels	Metabolite levels	Liver enzyme measurement
12543	GCST000550	Metabolite levels	Metabolite levels	Cardiovascular measurement
12544	GCST000550	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
12545	GCST000550	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
12546	GCST000550	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
12547	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12548	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12549	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12550	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12551	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12552	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12553	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12554	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12555	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12556	GCST000550	Metabolite levels	Metabolite levels	Other measurement
12557	GCST000549	HIV-1 control	HIV-1 control	Other disease
12558	GCST000548	Asthma	Asthma	Other disease
12559	GCST000547	Orofacial clefts	Orofacial clefts	Other trait
12560	GCST000547	Orofacial clefts	Orofacial clefts	Other measurement
12561	GCST000547	Orofacial clefts	Orofacial clefts	Other disease
12562	GCST000547	Orofacial clefts	Orofacial clefts	Other trait
12563	GCST000546	Leprosy	Leprosy	Neurological disorder
12564	GCST000545	Fetal hemoglobin levels	Fetal hemoglobin levels	Hematological measurement
12565	GCST000544	Pulmonary function	Pulmonary function	Other measurement
12566	GCST000544	Pulmonary function	Pulmonary function	Other measurement
12567	GCST000544	Pulmonary function	Pulmonary function	Other measurement
12568	GCST000544	Pulmonary function	Pulmonary function	Other measurement
12569	GCST000542	Pulmonary function	Pulmonary function	Other measurement
12570	GCST000542	Pulmonary function	Pulmonary function	Other measurement
12571	GCST000542	Pulmonary function	Pulmonary function	Other measurement
12572	GCST000542	Pulmonary function	Pulmonary function	Other measurement
12573	GCST000543	Social and non-social autistic-like traits	Social and non-social autistic-like traits	Other measurement
12574	GCST000541	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
12575	GCST000541	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
12576	GCST000573	Brain imaging	Brain imaging	Other measurement
12577	GCST000572	Bone mineral density	Bone mineral density	Other measurement
12578	GCST000571	Fasting blood insulin	Fasting blood insulin	Other measurement
12579	GCST005180	Homeostasis model assessment of beta-cell function	Homeostasis model assessment of beta-cell function	Other measurement
12580	GCST005179	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other measurement
12581	GCST005179	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other trait
12582	GCST000568	Fasting blood glucose	Fasting blood glucose	Other measurement
12583	GCST000569	Two-hour glucose challenge	Two-hour glucose challenge	Other measurement
12584	GCST000570	Major mood disorders	Major mood disorders	Neurological disorder
12585	GCST000567	Parkinson's disease	Parkinson's disease	Neurological disorder
12586	GCST000566	Hearing impairment	Hearing impairment	Neurological disorder
12587	GCST000579	Cognitive performance	Cognitive performance	Other measurement
12588	GCST000579	Cognitive performance	Cognitive performance	Other measurement
12589	GCST000578	Major depressive disorder	Major depressive disorder	Neurological disorder
12590	GCST000576	Asthma	Asthma	Other disease
12591	GCST000577	Multiple sclerosis (severity)	Multiple sclerosis (severity)	Immune system disorder
12592	GCST000575	Osteoporosis-related phenotypes	Osteoporosis-related phenotypes	Other disease
12593	GCST000574	Pancreatic cancer	Pancreatic cancer	Cancer
12594	GCST000613	HIV (mother-to-child transmission)	HIV (mother-to-child transmission)	Biological process
12595	GCST000612	Celiac disease	Celiac disease	Immune system disorder
12596	GCST000611	Height	Height	Other measurement
12597	GCST000611	Height	Height	Body measurement
12598	GCST000609	Primary tooth development (time to first tooth eruption)	Primary tooth development (time to first tooth eruption)	Biological process
12599	GCST000609	Primary tooth development (time to first tooth eruption)	Primary tooth development (time to first tooth eruption)	Biological process
12600	GCST000610	Primary tooth development (number of teeth)	Primary tooth development (number of teeth)	Biological process
12601	GCST000608	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
12602	GCST000607	Schizophrenia	Schizophrenia	Neurological disorder
12603	GCST000606	E-selectin levels	E-selectin levels	Inflammatory measurement
12604	GCST000605	Soluble leptin receptor levels	Soluble leptin receptor levels	Other measurement
12605	GCST000603	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
12606	GCST000565	Angiotensin-converting enzyme activity	Angiotensin-converting enzyme activity	Other measurement
12607	GCST000563	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
12608	GCST000562	PR interval	PR interval	Cardiovascular measurement
12609	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12610	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12611	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12612	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12613	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12614	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12615	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12616	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12617	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12618	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12619	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12620	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
12621	GCST000560	Osteoporosis	Osteoporosis	Other disease
12622	GCST000559	Cholesterol	Cholesterol	Lipid or lipoprotein measurement
12623	GCST000558	Osteoarthritis	Osteoarthritis	Other disease
12624	GCST000557	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
12625	GCST000556	Functional MRI	Functional MRI	Other measurement
12626	GCST000540	Atopy	Atopy	Immune system disorder
12627	GCST000539	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
12628	GCST000538	Adiponectin levels	Adiponectin levels	Other measurement
12629	GCST000537	Adiponectin levels	Adiponectin levels	Other measurement
12630	GCST000536	Sasang constitutional medicine type	Sasang constitutional medicine type	Other trait
12631	GCST000535	Systemic sclerosis	Systemic sclerosis	Neurological disorder
12632	GCST000534	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
12633	GCST000533	Lipid metabolism phenotypes	Lipid metabolism phenotypes	Other measurement
12634	GCST000532	Beta thalassemia/hemoglobin E disease	Beta thalassemia/hemoglobin E disease	Other disease
12635	GCST000528	Parkinson's disease	Parkinson's disease	Neurological disorder
12636	GCST000604	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
12637	GCST000602	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
12638	GCST000601	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12639	GCST000600	Neutrophil count	Neutrophil count	Hematological measurement
12640	GCST000599	Soluble levels of adhesion molecules	Soluble levels of adhesion molecules	Cardiovascular measurement
12641	GCST000599	Soluble levels of adhesion molecules	Soluble levels of adhesion molecules	Other measurement
12642	GCST000599	Soluble levels of adhesion molecules	Soluble levels of adhesion molecules	Cardiovascular measurement
12643	GCST000597	Brain structure	Brain structure	Other measurement
12644	GCST000597	Brain structure	Brain structure	Other measurement
12645	GCST000597	Brain structure	Brain structure	Other measurement
12646	GCST000598	Bone mineral density	Bone mineral density	Other measurement
12647	GCST000596	HIV-1 progression	HIV-1 progression	Other disease
12648	GCST000595	Frontotemporal lobar degeneration	Frontotemporal lobar degeneration	Neurological disorder
12649	GCST000594	Homocysteine levels	Homocysteine levels	Cardiovascular measurement
12650	GCST000555	Carotid atherosclerosis in HIV infection	Carotid atherosclerosis in HIV infection	Cardiovascular disease
12651	GCST000555	Carotid atherosclerosis in HIV infection	Carotid atherosclerosis in HIV infection	Cardiovascular measurement
12652	GCST000555	Carotid atherosclerosis in HIV infection	Carotid atherosclerosis in HIV infection	Other disease
12653	GCST000555	Carotid atherosclerosis in HIV infection	Carotid atherosclerosis in HIV infection	Cardiovascular measurement
12654	GCST000554	Subclinical brain infarct	Subclinical brain infarct	Cardiovascular disease
12655	GCST000552	Memory (short-term)	Memory (short-term)	Biological process
12656	GCST000551	Major depressive disorder (broad)	Major depressive disorder (broad)	Neurological disorder
12657	GCST000593	Multiple sclerosis	Multiple sclerosis	Immune system disorder
12658	GCST000592	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
12659	GCST000590	Interleukin-18 levels	Interleukin-18 levels	Inflammatory measurement
12660	GCST000591	Fasting plasma glucose	Fasting plasma glucose	Other measurement
12661	GCST000586	Telomere length	Telomere length	Other measurement
12662	GCST000463	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
12663	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12664	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12665	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12666	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12667	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12668	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12669	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12670	GCST000461	Hippocampal atrophy	Hippocampal atrophy	Neurological disorder
12671	GCST000460	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
12672	GCST000459	Lung cancer	Lung cancer	Cancer
12673	GCST000459	Lung cancer	Lung cancer	Cancer
12674	GCST000459	Lung cancer	Lung cancer	Cancer
12675	GCST000458	Orofacial clefts	Orofacial clefts	Other trait
12676	GCST000458	Orofacial clefts	Orofacial clefts	Other measurement
12677	GCST000458	Orofacial clefts	Orofacial clefts	Other disease
12678	GCST000458	Orofacial clefts	Orofacial clefts	Other trait
12679	GCST000457	Fasting plasma glucose	Fasting plasma glucose	Other measurement
12680	GCST000455	Ovarian cancer	Ovarian cancer	Cancer
12681	GCST000456	Pancreatic cancer	Pancreatic cancer	Cancer
12682	GCST000454	Bladder cancer	Bladder cancer	Cancer
12683	GCST000531	Inflammatory bowel disease (early onset)	Inflammatory bowel disease (early onset)	Digestive system disorder
12684	GCST000527	Ulcerative colitis	Ulcerative colitis	Immune system disorder
12685	GCST000529	Ulcerative colitis	Ulcerative colitis	Immune system disorder
12686	GCST000530	Parkinson's disease	Parkinson's disease	Neurological disorder
12687	GCST000524	Mathematical ability	Mathematical ability	Biological process
12688	GCST000525	Asthma	Asthma	Other disease
12689	GCST000526	Insulin-related traits	Insulin-related traits	Other measurement
12690	GCST000526	Insulin-related traits	Insulin-related traits	Other measurement
12691	GCST000526	Insulin-related traits	Insulin-related traits	Other trait
12692	GCST000523	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	Response to drug
12693	GCST000522	Height	Height	Other measurement
12694	GCST000522	Height	Height	Body measurement
12695	GCST000521	Periodontitis	Periodontitis	Digestive system disorder
12696	GCST000520	Vitiligo	Vitiligo	Immune system disorder
12697	GCST000519	Hair morphology	Hair morphology	Other trait
12698	GCST000518	End-stage renal disease	End-stage renal disease	Other disease
12699	GCST004867	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
12700	GCST000517	Iron levels	Iron levels	Other measurement
12701	GCST000515	Bone mineral density	Bone mineral density	Other measurement
12702	GCST000516	Glycemic control in type 1 diabetes (HbA1c)	Glycemic control in type 1 diabetes (HbA1c)	Other measurement
12703	GCST000514	Response to antipsychotic therapy (extrapyramidal side effects)	Response to antipsychotic therapy (extrapyramidal side effects)	Response to drug
12704	GCST000513	Sickle cell anemia (severity)	Sickle cell anemia (severity)	Neurological disorder
12705	GCST000511	Weight	Weight	Body measurement
12706	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
12707	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
12708	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
12709	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Cardiovascular measurement
12710	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
12711	GCST000482	Amyotrophic lateral sclerosis (SNP x SNP interaction)	Amyotrophic lateral sclerosis (SNP x SNP interaction)	Neurological disorder
12712	GCST000481	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
12713	GCST000480	Alzheimer's disease	Alzheimer's disease	Neurological disorder
12714	GCST000478	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12715	GCST000479	Alzheimer's disease	Alzheimer's disease	Neurological disorder
12716	GCST000477	Cognitive performance	Cognitive performance	Other measurement
12717	GCST000477	Cognitive performance	Cognitive performance	Other measurement
12718	GCST000476	Soluble E-selectin levels	Soluble E-selectin levels	Inflammatory measurement
12719	GCST000475	Height	Height	Other measurement
12720	GCST000475	Height	Height	Body measurement
12721	GCST000474	Leisure-time exercise behaviour	Leisure-time exercise behaviour	Biological process
12722	GCST000512	Body mass index	Body mass index	Body measurement
12723	GCST000512	Body mass index	Body mass index	Body measurement
12724	GCST000512	Body mass index	Body mass index	Other measurement
12725	GCST000508	Neuromyelitis optica	Neuromyelitis optica	Immune system disorder
12726	GCST000509	Response to citalopram treatment	Response to citalopram treatment	Response to drug
12727	GCST000507	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
12728	GCST000506	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
12729	GCST000504	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
12730	GCST000504	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
12731	GCST000500	Other erythrocyte phenotypes	Other erythrocyte phenotypes	Hematological measurement
12732	GCST000500	Other erythrocyte phenotypes	Other erythrocyte phenotypes	Hematological measurement
12733	GCST000499	Hemoglobin	Hemoglobin	Hematological measurement
12734	GCST000503	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
12735	GCST000502	Hematocrit	Hematocrit	Hematological measurement
12736	GCST000501	Hemoglobin	Hemoglobin	Hematological measurement
12737	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
12738	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
12739	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
12740	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
12741	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
12742	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
12743	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
12744	GCST000496	Autism	Autism	Neurological disorder
12745	GCST000495	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
12746	GCST000495	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
12747	GCST000494	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
12748	GCST000494	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
12749	GCST000493	Sphingolipid levels	Sphingolipid levels	Other measurement
12750	GCST000493	Sphingolipid levels	Sphingolipid levels	Lipid or lipoprotein measurement
12751	GCST000492	Speech perception in dyslexia	Speech perception in dyslexia	Biological process
12752	GCST000491	Myopia (pathological)	Myopia (pathological)	Other trait
12753	GCST000490	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Neurological disorder
12754	GCST000490	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Other measurement
12755	GCST000488	Prostate cancer	Prostate cancer	Cancer
12756	GCST000489	Prostate cancer	Prostate cancer	Cancer
12757	GCST000487	AIDS	AIDS	Immune system disorder
12758	GCST000486	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
12759	GCST000485	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
12760	GCST000484	Alzheimer's disease	Alzheimer's disease	Neurological disorder
12761	GCST000471	Response to antidepressant treatment	Response to antidepressant treatment	Response to drug
12762	GCST000472	Colorectal cancer	Colorectal cancer	Cancer
12763	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12764	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12765	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12766	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12767	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12768	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12769	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
12770	GCST000470	Response to antidepressant treatment	Response to antidepressant treatment	Response to drug
12771	GCST000468	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
12772	GCST000468	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
12773	GCST000469	Obesity and osteoporosis	Obesity and osteoporosis	Other disease
12774	GCST000469	Obesity and osteoporosis	Obesity and osteoporosis	Metabolic disorder
12775	GCST000467	Response to clopidogrel therapy	Response to clopidogrel therapy	Response to drug
12776	GCST000467	Response to clopidogrel therapy	Response to clopidogrel therapy	Cardiovascular measurement
12777	GCST000467	Response to clopidogrel therapy	Response to clopidogrel therapy	Response to drug
12778	GCST000466	Esophageal cancer	Esophageal cancer	Cancer
12779	GCST000465	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
12780	GCST000432	Alcohol dependence	Alcohol dependence	Other measurement
12781	GCST000432	Alcohol dependence	Alcohol dependence	Neurological disorder
12782	GCST000433	Schizophrenia	Schizophrenia	Neurological disorder
12783	GCST000431	Height	Height	Other measurement
12784	GCST000431	Height	Height	Body measurement
12785	GCST000435	Schizophrenia	Schizophrenia	Neurological disorder
12786	GCST000429	Kidney stones	Kidney stones	Other disease
12787	GCST000428	Adiposity	Adiposity	Metabolic disorder
12788	GCST000427	Waist circumference	Waist circumference	Body measurement
12789	GCST000426	Obesity (extreme)	Obesity (extreme)	Metabolic disorder
12790	GCST000426	Obesity (extreme)	Obesity (extreme)	Body measurement
12791	GCST000424	Multiple sclerosis	Multiple sclerosis	Immune system disorder
12792	GCST000425	Multiple sclerosis	Multiple sclerosis	Immune system disorder
12793	GCST000413	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
12794	GCST000412	Male infertility	Male infertility	Other disease
12795	GCST000411	Autism	Autism	Neurological disorder
12796	GCST000410	Malaria	Malaria	Digestive system disorder
12797	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12798	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12799	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12800	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12801	GCST000409	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
12802	GCST000409	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
12803	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12804	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12805	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12806	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12807	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12808	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12809	GCST000409	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
12810	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12811	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12812	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
12813	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12814	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12815	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12816	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12817	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12818	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
12819	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12820	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12821	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12822	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12823	GCST000409	Obesity-related traits	Obesity-related traits	Biological process
12824	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12825	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12826	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
12827	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12828	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12829	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12830	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12831	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12832	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12833	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
12834	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
12835	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12836	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
12837	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12838	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12839	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12840	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12841	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
12842	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12843	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12844	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12845	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12846	GCST000409	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
12847	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
12848	GCST000409	Obesity-related traits	Obesity-related traits	Metabolic disorder
12849	GCST000409	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
12850	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
12851	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12852	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
12853	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
12854	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12855	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12856	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12857	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12858	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12859	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
12860	GCST000409	Obesity-related traits	Obesity-related traits	Biological process
12861	GCST000409	Obesity-related traits	Obesity-related traits	Biological process
12862	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
12863	GCST000408	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
12864	GCST000408	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
12865	GCST000407	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
12866	GCST000407	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
12867	GCST000406	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
12868	GCST000405	Menarche (age at onset)	Menarche (age at onset)	Other measurement
12869	GCST000452	QT interval	QT interval	Cardiovascular measurement
12870	GCST000453	Response to interferon beta therapy	Response to interferon beta therapy	Response to drug
12871	GCST000450	Matrix metalloproteinase levels	Matrix metalloproteinase levels	Other measurement
12872	GCST000451	RR interval (heart rate)	RR interval (heart rate)	Cardiovascular measurement
12873	GCST000449	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
12874	GCST000448	Follicular lymphoma	Follicular lymphoma	Cancer
12875	GCST000447	Hypertension	Hypertension	Cardiovascular disease
12876	GCST000445	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
12877	GCST000446	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
12878	GCST000444	QT interval	QT interval	Cardiovascular measurement
12879	GCST000442	Aortic root size	Aortic root size	Cardiovascular measurement
12880	GCST000443	Body mass index and fat mass	Body mass index and fat mass	Other measurement
12881	GCST000443	Body mass index and fat mass	Body mass index and fat mass	Body measurement
12882	GCST000441	Cardiac structure and function	Cardiac structure and function	Other measurement
12883	GCST000440	Glioma (high-grade)	Glioma (high-grade)	Cancer
12884	GCST000437	Melanoma	Melanoma	Cancer
12885	GCST000438	Cutaneous nevi	Cutaneous nevi	Cancer
12886	GCST000439	Glioma	Glioma	Cancer
12887	GCST000439	Glioma	Glioma	Cancer
12888	GCST000436	Acenocoumarol maintenance dosage	Acenocoumarol maintenance dosage	Response to drug
12889	GCST000434	Schizophrenia	Schizophrenia	Neurological disorder
12890	GCST004948	Breast cancer	Breast cancer	Cancer
12891	GCST004949	Breast cancer	Breast cancer	Cancer
12892	GCST000383	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12893	GCST000382	Autism	Autism	Neurological disorder
12894	GCST000380	Height	Height	Other measurement
12895	GCST000380	Height	Height	Body measurement
12896	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Body measurement
12897	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Body measurement
12898	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Cardiovascular measurement
12899	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Other measurement
12900	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Other measurement
12901	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Other measurement
12902	GCST000379	Stroke	Stroke	Cardiovascular disease
12903	GCST000378	Aging	Aging	Biological process
12904	GCST000377	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
12905	GCST000376	Telomere length	Telomere length	Other measurement
12906	GCST000375	Hepatitis B	Hepatitis B	Digestive system disorder
12907	GCST000375	Hepatitis B	Hepatitis B	Other measurement
12908	GCST000374	Atopic dermatitis	Atopic dermatitis	Immune system disorder
12909	GCST000373	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
12910	GCST000372	Height	Height	Other measurement
12911	GCST000372	Height	Height	Body measurement
12912	GCST000371	Tanning	Tanning	Other trait
12913	GCST000366	Fibrinogen	Fibrinogen	Hematological measurement
12914	GCST000367	Homocysteine levels	Homocysteine levels	Cardiovascular measurement
12915	GCST000368	Fibrinogen	Fibrinogen	Hematological measurement
12916	GCST000370	Arterial stiffness	Arterial stiffness	Cardiovascular measurement
12917	GCST000369	Response to statin therapy	Response to statin therapy	Response to drug
12918	GCST000396	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12919	GCST000396	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12920	GCST000393	Systolic blood pressure	Systolic blood pressure	Other measurement
12921	GCST000393	Systolic blood pressure	Systolic blood pressure	Other measurement
12922	GCST000391	Insulin resistance/response	Insulin resistance/response	Other trait
12923	GCST000389	Asthma	Asthma	Other disease
12924	GCST000390	Hypertension (young onset)	Hypertension (young onset)	Cardiovascular disease
12925	GCST000388	Bilirubin levels	Bilirubin levels	Other measurement
12926	GCST000387	Bipolar disorder	Bipolar disorder	Neurological disorder
12927	GCST000386	Bilirubin levels	Bilirubin levels	Other measurement
12928	GCST000384	Neuroblastoma (high-risk)	Neuroblastoma (high-risk)	Cancer
12929	GCST000385	Narcolepsy	Narcolepsy	Neurological disorder
12930	GCST000404	Menarche (age at onset)	Menarche (age at onset)	Other measurement
12931	GCST000400	Menarche (age at onset)	Menarche (age at onset)	Other measurement
12932	GCST000401	Menopause (age at onset)	Menopause (age at onset)	Other measurement
12933	GCST000402	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Response to drug
12934	GCST000402	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Neurological disorder
12935	GCST000399	Behcet's disease	Behcet's disease	Cardiovascular disease
12936	GCST000398	Hypertension	Hypertension	Cardiovascular disease
12937	GCST000394	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12938	GCST000394	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12939	GCST000395	Systolic blood pressure	Systolic blood pressure	Other measurement
12940	GCST000395	Systolic blood pressure	Systolic blood pressure	Other measurement
12941	GCST000423	Homocysteine levels	Homocysteine levels	Cardiovascular measurement
12942	GCST000422	Premature ovarian failure	Premature ovarian failure	Other disease
12943	GCST000421	Osteoarthritis	Osteoarthritis	Other disease
12944	GCST000420	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
12945	GCST000419	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
12946	GCST000418	Uric acid levels	Uric acid levels	Cardiovascular measurement
12947	GCST000417	Bipolar disorder	Bipolar disorder	Neurological disorder
12948	GCST000414	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
12949	GCST000414	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
12950	GCST000416	Testicular cancer	Testicular cancer	Cancer
12951	GCST000415	Drug-induced liver injury (flucloxacillin)	Drug-induced liver injury (flucloxacillin)	Digestive system disorder
12952	GCST000345	Otosclerosis	Otosclerosis	Neurological disorder
12953	GCST000343	Breast cancer	Breast cancer	Cancer
12954	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
12955	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
12956	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
12957	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
12958	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
12959	GCST000342	Mean platelet volume	Mean platelet volume	Hematological measurement
12960	GCST000341	Coronary heart disease	Coronary heart disease	Cardiovascular disease
12961	GCST000338	Coronary heart disease	Coronary heart disease	Cardiovascular disease
12962	GCST000340	Myocardial infarction (early onset)	Myocardial infarction (early onset)	Cardiovascular disease
12963	GCST000339	Eosinophil counts	Eosinophil counts	Hematological measurement
12964	GCST000337	Quantitative traits	Quantitative traits	Other measurement
12965	GCST000337	Quantitative traits	Quantitative traits	Body measurement
12966	GCST000337	Quantitative traits	Quantitative traits	Body measurement
12967	GCST000337	Quantitative traits	Quantitative traits	Body measurement
12968	GCST000337	Quantitative traits	Quantitative traits	Body measurement
12969	GCST000337	Quantitative traits	Quantitative traits	Body measurement
12970	GCST000337	Quantitative traits	Quantitative traits	Lipid or lipoprotein measurement
12971	GCST000337	Quantitative traits	Quantitative traits	Lipid or lipoprotein measurement
12972	GCST000337	Quantitative traits	Quantitative traits	Other measurement
12973	GCST000337	Quantitative traits	Quantitative traits	Other measurement
12974	GCST000337	Quantitative traits	Quantitative traits	Lipid or lipoprotein measurement
12975	GCST000337	Quantitative traits	Quantitative traits	Lipid or lipoprotein measurement
12976	GCST000337	Quantitative traits	Quantitative traits	Inflammatory measurement
12977	GCST000325	Bone mineral density	Bone mineral density	Other measurement
12978	GCST000324	Carotenoid and tocopherol levels	Carotenoid and tocopherol levels	Other measurement
12979	GCST000324	Carotenoid and tocopherol levels	Carotenoid and tocopherol levels	Other measurement
12980	GCST000323	Response to treatment for acute lymphoblastic leukemia	Response to treatment for acute lymphoblastic leukemia	Response to drug
12981	GCST000323	Response to treatment for acute lymphoblastic leukemia	Response to treatment for acute lymphoblastic leukemia	Cancer
12982	GCST000322	Psoriasis	Psoriasis	Immune system disorder
12983	GCST000321	Psoriasis	Psoriasis	Immune system disorder
12984	GCST000320	Panic disorder	Panic disorder	Neurological disorder
12985	GCST000319	Adiponectin levels	Adiponectin levels	Other measurement
12986	GCST000317	Obesity	Obesity	Other measurement
12987	GCST000317	Obesity	Obesity	Metabolic disorder
12988	GCST000318	Basal cell carcinoma	Basal cell carcinoma	Cancer
12989	GCST000316	Polyunsaturated fatty acid levels	Polyunsaturated fatty acid levels	Other measurement
12990	GCST000286	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
12991	GCST000287	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12992	GCST000287	LDL cholesterol	LDL cholesterol	Other measurement
12993	GCST000287	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12994	GCST000279	Inattentive symptoms	Inattentive symptoms	Biological process
12995	GCST000281	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
12996	GCST000278	Hyperactive-impulsive symptoms	Hyperactive-impulsive symptoms	Biological process
12997	GCST000280	Attention deficit hyperactivity disorder (time to onset)	Attention deficit hyperactivity disorder (time to onset)	Neurological disorder
12998	GCST000277	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12999	GCST000275	Hearing impairment	Hearing impairment	Neurological disorder
13000	GCST000305	Mean platelet volume	Mean platelet volume	Hematological measurement
13001	GCST000304	Major depressive disorder	Major depressive disorder	Neurological disorder
13002	GCST000303	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
13003	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
13004	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
13005	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
13006	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
13007	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
13008	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
13009	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
13010	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
13011	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
13012	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
13013	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
13014	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
13015	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
13016	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
13017	GCST000300	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
13018	GCST000299	Weight	Weight	Body measurement
13019	GCST000296	Body mass index	Body mass index	Body measurement
13020	GCST000296	Body mass index	Body mass index	Body measurement
13021	GCST000296	Body mass index	Body mass index	Other measurement
13022	GCST000315	Alzheimer's disease	Alzheimer's disease	Neurological disorder
13023	GCST000314	Kawasaki disease	Kawasaki disease	Immune system disorder
13024	GCST000312	Lp (a) levels	Lp (a) levels	Lipid or lipoprotein measurement
13025	GCST000313	Alzheimer's disease	Alzheimer's disease	Neurological disorder
13026	GCST000311	Ulcerative colitis	Ulcerative colitis	Immune system disorder
13027	GCST000310	Alzheimer's disease	Alzheimer's disease	Neurological disorder
13028	GCST000309	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
13029	GCST000307	Prostate cancer	Prostate cancer	Cancer
13030	GCST000308	AIDS progression	AIDS progression	Immune system disorder
13031	GCST000306	Blood pressure	Blood pressure	Other measurement
13032	GCST000306	Blood pressure	Blood pressure	Other measurement
13033	GCST000306	Blood pressure	Blood pressure	Other measurement
13034	GCST000306	Blood pressure	Blood pressure	Other measurement
13035	GCST000306	Blood pressure	Blood pressure	Cardiovascular measurement
13036	GCST000365	Breast cancer	Breast cancer	Cancer
13037	GCST000364	QT interval	QT interval	Cardiovascular measurement
13038	GCST000363	QT interval	QT interval	Cardiovascular measurement
13039	GCST000362	Pulmonary function	Pulmonary function	Other measurement
13040	GCST000362	Pulmonary function	Pulmonary function	Other measurement
13041	GCST000362	Pulmonary function	Pulmonary function	Other measurement
13042	GCST000362	Pulmonary function	Pulmonary function	Other measurement
13043	GCST000360	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
13044	GCST000359	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
13045	GCST000361	Hypertension	Hypertension	Cardiovascular disease
13046	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
13047	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
13048	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
13049	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Cardiovascular measurement
13050	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
13051	GCST000357	Myeloproliferative neoplasms	Myeloproliferative neoplasms	Cancer
13052	GCST000356	Anti-cyclic Citrullinated Peptide Antibody	Anti-cyclic Citrullinated Peptide Antibody	Other measurement
13053	GCST000336	Schizophrenia	Schizophrenia	Neurological disorder
13054	GCST000334	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
13055	GCST000333	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
13056	GCST000332	Smoking behavior	Smoking behavior	Biological process
13057	GCST000327	Anthropometric traits	Anthropometric traits	Other measurement
13058	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13059	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13060	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13061	GCST000327	Anthropometric traits	Anthropometric traits	Other measurement
13062	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13063	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13064	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13065	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13066	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13067	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
13068	GCST000331	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
13069	GCST000330	Asthma (toluene diisocyanate-induced)	Asthma (toluene diisocyanate-induced)	Other disease
13070	GCST000328	Biochemical measures	Biochemical measures	Cardiovascular measurement
13071	GCST000328	Biochemical measures	Biochemical measures	Hematological measurement
13072	GCST000328	Biochemical measures	Biochemical measures	Lipid or lipoprotein measurement
13073	GCST000328	Biochemical measures	Biochemical measures	Lipid or lipoprotein measurement
13074	GCST000328	Biochemical measures	Biochemical measures	Other measurement
13075	GCST000328	Biochemical measures	Biochemical measures	Lipid or lipoprotein measurement
13076	GCST000328	Biochemical measures	Biochemical measures	Lipid or lipoprotein measurement
13077	GCST000326	Pain	Pain	Other trait
13078	GCST000329	Essential tremor	Essential tremor	Other trait
13079	GCST000355	Menarche (age at onset)	Menarche (age at onset)	Other measurement
13080	GCST000354	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
13081	GCST000353	Orofacial clefts	Orofacial clefts	Other trait
13082	GCST000353	Orofacial clefts	Orofacial clefts	Other measurement
13083	GCST000353	Orofacial clefts	Orofacial clefts	Other disease
13084	GCST000353	Orofacial clefts	Orofacial clefts	Other trait
13085	GCST000352	Body mass (lean)	Body mass (lean)	Other measurement
13086	GCST000351	Smoking behavior	Smoking behavior	Biological process
13087	GCST000350	Bipolar disorder	Bipolar disorder	Neurological disorder
13088	GCST000348	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
13089	GCST000348	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
13090	GCST000349	Smoking behavior	Smoking behavior	Biological process
13091	GCST000347	Bone mineral density	Bone mineral density	Other measurement
13092	GCST000346	Cystic fibrosis severity	Cystic fibrosis severity	Other disease
13093	GCST000298	Body mass index	Body mass index	Body measurement
13094	GCST000298	Body mass index	Body mass index	Body measurement
13095	GCST000298	Body mass index	Body mass index	Other measurement
13096	GCST000294	Creutzfeldt-Jakob disease	Creutzfeldt-Jakob disease	Neurological disorder
13097	GCST000293	Major depressive disorder	Major depressive disorder	Neurological disorder
13098	GCST000290	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
13099	GCST000262	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
13100	GCST000264	Nicotine dependence	Nicotine dependence	Neurological disorder
13101	GCST000263	Multiple sclerosis	Multiple sclerosis	Immune system disorder
13102	GCST000261	Parkinson's disease (familial)	Parkinson's disease (familial)	Neurological disorder
13103	GCST000260	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
13104	GCST000259	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
13105	GCST000258	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
13106	GCST000257	Lung cancer	Lung cancer	Cancer
13107	GCST000257	Lung cancer	Lung cancer	Cancer
13108	GCST000257	Lung cancer	Lung cancer	Cancer
13109	GCST000256	Lung cancer	Lung cancer	Cancer
13110	GCST000256	Lung cancer	Lung cancer	Cancer
13111	GCST000256	Lung cancer	Lung cancer	Cancer
13112	GCST000224	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
13113	GCST000225	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
13114	GCST000225	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
13115	GCST000225	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
13116	GCST000223	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
13117	GCST000222	IgE levels	IgE levels	Other measurement
13118	GCST000219	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13119	GCST000220	Bipolar disorder	Bipolar disorder	Neurological disorder
13120	GCST000221	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13121	GCST000218	Sarcoidosis	Sarcoidosis	Other disease
13122	GCST000217	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
13123	GCST000216	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
13124	GCST000255	Alzheimer's disease	Alzheimer's disease	Neurological disorder
13125	GCST000254	Height	Height	Other measurement
13126	GCST000254	Height	Height	Body measurement
13127	GCST000253	Attention deficit hyperactivity disorder and conduct disorder	Attention deficit hyperactivity disorder and conduct disorder	Neurological disorder
13128	GCST000253	Attention deficit hyperactivity disorder and conduct disorder	Attention deficit hyperactivity disorder and conduct disorder	Neurological disorder
13129	GCST000252	Multiple sclerosis	Multiple sclerosis	Immune system disorder
13130	GCST000249	Basal cell carcinoma	Basal cell carcinoma	Cancer
13131	GCST000251	Male-pattern baldness	Male-pattern baldness	Other measurement
13132	GCST000251	Male-pattern baldness	Male-pattern baldness	Other disease
13133	GCST000251	Male-pattern baldness	Male-pattern baldness	Other disease
13134	GCST000250	Male-pattern baldness	Male-pattern baldness	Other measurement
13135	GCST000250	Male-pattern baldness	Male-pattern baldness	Other disease
13136	GCST000250	Male-pattern baldness	Male-pattern baldness	Other disease
13137	GCST000248	Liver enzyme levels	Liver enzyme levels	Liver enzyme measurement
13138	GCST000248	Liver enzyme levels	Liver enzyme levels	Liver enzyme measurement
13139	GCST000248	Liver enzyme levels	Liver enzyme levels	Liver enzyme measurement
13140	GCST000248	Liver enzyme levels	Liver enzyme levels	Other measurement
13141	GCST000246	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
13142	GCST000198	Melanoma	Melanoma	Cancer
13143	GCST000190	Black vs. blond hair color	Black vs. blond hair color	Other trait
13144	GCST000191	Black vs. red hair color	Black vs. red hair color	Other trait
13145	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13146	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13147	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13148	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13149	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13150	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13151	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13152	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Liver enzyme measurement
13153	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13154	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Hematological measurement
13155	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13156	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Lipid or lipoprotein measurement
13157	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13158	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13159	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13160	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13161	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13162	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Hematological measurement
13163	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13164	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13165	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Liver enzyme measurement
13166	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Liver enzyme measurement
13167	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13168	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13169	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Hematological measurement
13170	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13171	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13172	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13173	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13174	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13175	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13176	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13177	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13178	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13179	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13180	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13181	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13182	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
13183	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13184	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
13185	GCST000188	Neuroblastoma	Neuroblastoma	Cancer
13186	GCST000186	Knee osteoarthritis	Knee osteoarthritis	Other disease
13187	GCST000215	Schizophrenia	Schizophrenia	Neurological disorder
13188	GCST000214	Restless legs syndrome	Restless legs syndrome	Neurological disorder
13189	GCST000213	Response to statin therapy	Response to statin therapy	Response to drug
13190	GCST000212	Crohn's disease and sarcoidosis (combined)	Crohn's disease and sarcoidosis (combined)	Digestive system disorder
13191	GCST000212	Crohn's disease and sarcoidosis (combined)	Crohn's disease and sarcoidosis (combined)	Other disease
13192	GCST000211	Response to TNF antagonist treatment	Response to TNF antagonist treatment	Response to drug
13193	GCST000210	Soluble ICAM-1	Soluble ICAM-1	Cardiovascular measurement
13194	GCST000209	Osteonecrosis of the jaw	Osteonecrosis of the jaw	Other disease
13195	GCST000208	Response to diuretic therapy	Response to diuretic therapy	Response to drug
13196	GCST000207	Crohn's disease	Crohn's disease	Digestive system disorder
13197	GCST000206	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
13198	GCST000276	Fasting plasma glucose	Fasting plasma glucose	Other measurement
13199	GCST000274	Metabolite levels	Metabolite levels	Other trait
13200	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13201	GCST000274	Metabolite levels	Metabolite levels	Liver enzyme measurement
13202	GCST000274	Metabolite levels	Metabolite levels	Cardiovascular measurement
13203	GCST000274	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
13204	GCST000274	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
13205	GCST000274	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
13206	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13207	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13208	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13209	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13210	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13211	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13212	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13213	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13214	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13215	GCST000274	Metabolite levels	Metabolite levels	Other measurement
13216	GCST000273	Personality dimensions	Personality dimensions	Other trait
13217	GCST000272	Height	Height	Other measurement
13218	GCST000272	Height	Height	Body measurement
13219	GCST000271	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Neurological disorder
13220	GCST000271	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Other measurement
13221	GCST000271	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Other measurement
13222	GCST000270	Colorectal cancer	Colorectal cancer	Cancer
13223	GCST000235	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
13224	GCST000234	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
13225	GCST000234	LDL cholesterol	LDL cholesterol	Other measurement
13226	GCST000234	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
13227	GCST000233	Lung cancer	Lung cancer	Cancer
13228	GCST000233	Lung cancer	Lung cancer	Cancer
13229	GCST000233	Lung cancer	Lung cancer	Cancer
13230	GCST000231	Urinary bladder cancer	Urinary bladder cancer	Cancer
13231	GCST000232	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
13232	GCST000230	Hearing impairment	Hearing impairment	Neurological disorder
13233	GCST000229	Hip bone size	Hip bone size	Body measurement
13234	GCST000228	Vitamin B12 levels	Vitamin B12 levels	Other measurement
13235	GCST000227	Uric acid levels	Uric acid levels	Cardiovascular measurement
13236	GCST000226	Neuroticism	Neuroticism	Neurological disorder
13237	GCST000226	Neuroticism	Neuroticism	Other measurement
13238	GCST000244	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
13239	GCST000243	Ulcerative colitis	Ulcerative colitis	Immune system disorder
13240	GCST000242	Urate levels	Urate levels	Metabolic disorder
13241	GCST000242	Urate levels	Urate levels	Other measurement
13242	GCST000239	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
13243	GCST000241	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
13244	GCST000241	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
13245	GCST000241	Lipid traits	Lipid traits	Other measurement
13246	GCST000241	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
13247	GCST000241	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
13248	GCST000240	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
13249	GCST000238	Idiopathic pulmonary fibrosis	Idiopathic pulmonary fibrosis	Cancer
13250	GCST000237	Alzheimer's disease	Alzheimer's disease	Neurological disorder
13251	GCST000236	Narcolepsy	Narcolepsy	Neurological disorder
13252	GCST000205	Fasting plasma glucose	Fasting plasma glucose	Other measurement
13253	GCST000204	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
13254	GCST000202	Fasting plasma glucose	Fasting plasma glucose	Other measurement
13255	GCST000203	Smoking cessation	Smoking cessation	Biological process
13256	GCST000200	Response to iloperidone treatment (PANSS-T score)	Response to iloperidone treatment (PANSS-T score)	Response to drug
13257	GCST000201	Response to iloperidone treatment (QT prolongation)	Response to iloperidone treatment (QT prolongation)	Response to drug
13258	GCST000199	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
13259	GCST000199	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
13260	GCST000174	Height	Height	Other measurement
13261	GCST000174	Height	Height	Body measurement
13262	GCST000175	Height	Height	Other measurement
13263	GCST000175	Height	Height	Body measurement
13264	GCST000173	Psoriasis	Psoriasis	Immune system disorder
13265	GCST000171	Nicotine dependence	Nicotine dependence	Neurological disorder
13266	GCST000172	Lung cancer	Lung cancer	Cancer
13267	GCST000172	Lung cancer	Lung cancer	Cancer
13268	GCST000172	Lung cancer	Lung cancer	Cancer
13269	GCST000170	Lung cancer	Lung cancer	Cancer
13270	GCST000170	Lung cancer	Lung cancer	Cancer
13271	GCST000170	Lung cancer	Lung cancer	Cancer
13272	GCST000167	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13273	GCST000168	Colorectal cancer	Colorectal cancer	Cancer
13274	GCST000169	Colorectal cancer	Colorectal cancer	Cancer
13275	GCST000166	Environmental confusion in the home	Environmental confusion in the home	Other measurement
13276	GCST000184	Waist circumference and related phenotypes	Waist circumference and related phenotypes	Body measurement
13277	GCST000184	Waist circumference and related phenotypes	Waist circumference and related phenotypes	Lipid or lipoprotein measurement
13278	GCST000184	Waist circumference and related phenotypes	Waist circumference and related phenotypes	Lipid or lipoprotein measurement
13279	GCST000185	Body mass index	Body mass index	Body measurement
13280	GCST000185	Body mass index	Body mass index	Body measurement
13281	GCST000185	Body mass index	Body mass index	Other measurement
13282	GCST000183	Alzheimer's disease	Alzheimer's disease	Neurological disorder
13283	GCST000182	Bone mineral density	Bone mineral density	Other measurement
13284	GCST000180	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
13285	GCST000180	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
13286	GCST000181	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
13287	GCST000181	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
13288	GCST000179	C-reactive protein	C-reactive protein	Inflammatory measurement
13289	GCST000178	C-reactive protein	C-reactive protein	Inflammatory measurement
13290	GCST000177	YKL-40 levels	YKL-40 levels	Inflammatory measurement
13291	GCST000176	Height	Height	Other measurement
13292	GCST000176	Height	Height	Body measurement
13293	GCST000155	Schizophrenia	Schizophrenia	Neurological disorder
13294	GCST000153	Prostate cancer	Prostate cancer	Cancer
13295	GCST000152	Prostate cancer	Prostate cancer	Cancer
13296	GCST000154	Prostate cancer	Prostate cancer	Cancer
13297	GCST000151	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
13298	GCST000151	LDL cholesterol	LDL cholesterol	Other measurement
13299	GCST000151	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
13300	GCST000150	Fetal hemoglobin levels	Fetal hemoglobin levels	Hematological measurement
13301	GCST000148	Recombination rate (males)	Recombination rate (males)	Other measurement
13302	GCST000149	Recombination rate (females)	Recombination rate (females)	Other measurement
13303	GCST000147	Nicotine dependence	Nicotine dependence	Neurological disorder
13304	GCST000146	Iris color	Iris color	Other trait
13305	GCST000136	Height	Height	Other measurement
13306	GCST000136	Height	Height	Body measurement
13307	GCST000137	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
13308	GCST000131	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
13309	GCST000131	LDL cholesterol	LDL cholesterol	Other measurement
13310	GCST000131	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
13311	GCST000130	Urate levels	Urate levels	Metabolic disorder
13312	GCST000130	Urate levels	Urate levels	Other measurement
13313	GCST000129	Obesity (early onset extreme)	Obesity (early onset extreme)	Metabolic disorder
13314	GCST000128	Prostate cancer	Prostate cancer	Cancer
13315	GCST000127	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
13316	GCST000126	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
13317	GCST000165	Psoriasis	Psoriasis	Immune system disorder
13318	GCST000164	Schizophrenia	Schizophrenia	Neurological disorder
13319	GCST000163	Schizophrenia	Schizophrenia	Neurological disorder
13320	GCST000162	Breast cancer	Breast cancer	Cancer
13321	GCST000161	Urate levels	Urate levels	Metabolic disorder
13322	GCST000161	Urate levels	Urate levels	Other measurement
13323	GCST000160	Urate levels	Urate levels	Metabolic disorder
13324	GCST000160	Urate levels	Urate levels	Other measurement
13325	GCST000159	Obesity	Obesity	Other measurement
13326	GCST000159	Obesity	Obesity	Metabolic disorder
13327	GCST000158	Bipolar disorder	Bipolar disorder	Neurological disorder
13328	GCST000157	Celiac disease	Celiac disease	Immune system disorder
13329	GCST000156	Methamphetamine dependence	Methamphetamine dependence	Neurological disorder
13330	GCST000156	Methamphetamine dependence	Methamphetamine dependence	Neurological disorder
13331	GCST000145	General cognitive ability	General cognitive ability	Biological process
13332	GCST000142	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
13333	GCST000143	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
13334	GCST000144	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
13335	GCST000141	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
13336	GCST000140	Response to interferon beta therapy	Response to interferon beta therapy	Response to drug
13337	GCST000125	Coronary spasm	Coronary spasm	Cardiovascular disease
13338	GCST000124	Alzheimer's disease	Alzheimer's disease	Neurological disorder
13339	GCST000123	Urate levels	Urate levels	Metabolic disorder
13340	GCST000123	Urate levels	Urate levels	Other measurement
13341	GCST000122	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
13342	GCST000121	Alzheimer's disease	Alzheimer's disease	Neurological disorder
13343	GCST000114	Skin pigmentation	Skin pigmentation	Other trait
13344	GCST000114	Skin pigmentation	Skin pigmentation	Other measurement
13345	GCST000113	Colorectal cancer	Colorectal cancer	Cancer
13346	GCST000112	Lupus	Lupus	Immune system disorder
13347	GCST000046	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
13348	GCST000046	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
13349	GCST000039	Crohn's disease	Crohn's disease	Digestive system disorder
13350	GCST000038	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
13351	GCST000036	Breast cancer	Breast cancer	Cancer
13352	GCST000055	Gallstone disease	Gallstone disease	Digestive system disorder
13353	GCST000055	Gallstone disease	Gallstone disease	Digestive system disorder
13354	GCST000054	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
13355	GCST000053	Colorectal cancer	Colorectal cancer	Cancer
13356	GCST000052	Colorectal cancer	Colorectal cancer	Cancer
13357	GCST000051	Atrial fibrillation/atrial flutter	Atrial fibrillation/atrial flutter	Cardiovascular disease
13358	GCST000050	Prostate cancer	Prostate cancer	Cancer
13359	GCST000049	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13360	GCST000048	Celiac disease	Celiac disease	Immune system disorder
13361	GCST000065	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
13362	GCST000064	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
13363	GCST000064	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
13364	GCST000063	Neuroticism	Neuroticism	Neurological disorder
13365	GCST000063	Neuroticism	Neuroticism	Other measurement
13366	GCST000062	Multiple sclerosis	Multiple sclerosis	Immune system disorder
13367	GCST000061	Asthma	Asthma	Other disease
13368	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13369	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13370	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13371	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13372	GCST000060	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
13373	GCST000060	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
13374	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13375	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13376	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13377	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13378	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13379	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13380	GCST000060	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
13381	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13382	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13383	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
13384	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13385	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13386	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13387	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13388	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13389	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
13390	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13391	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13392	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13393	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13394	GCST000060	Obesity-related traits	Obesity-related traits	Biological process
13395	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13396	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13397	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
13398	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13399	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13400	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13401	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13402	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13403	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13404	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
13405	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
13406	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13407	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
13408	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13409	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13410	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13411	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13412	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
13413	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13414	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13415	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13416	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13417	GCST000060	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
13418	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
13419	GCST000060	Obesity-related traits	Obesity-related traits	Metabolic disorder
13420	GCST000060	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
13421	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
13422	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13423	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
13424	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
13425	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13426	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13427	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13428	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13429	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13430	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
13431	GCST000060	Obesity-related traits	Obesity-related traits	Biological process
13432	GCST000060	Obesity-related traits	Obesity-related traits	Biological process
13433	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
13434	GCST000058	Restless legs syndrome	Restless legs syndrome	Neurological disorder
13435	GCST000059	HIV-1 viral setpoint	HIV-1 viral setpoint	Biological process
13436	GCST000059	HIV-1 viral setpoint	HIV-1 viral setpoint	Other measurement
13437	GCST000059	HIV-1 viral setpoint	HIV-1 viral setpoint	Other disease
13438	GCST000057	Coronary heart disease	Coronary heart disease	Cardiovascular disease
13439	GCST000056	Restless legs syndrome	Restless legs syndrome	Neurological disorder
13440	GCST000027	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13441	GCST000024	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13442	GCST000023	Crohn's disease	Crohn's disease	Digestive system disorder
13443	GCST000022	Body mass index	Body mass index	Body measurement
13444	GCST000022	Body mass index	Body mass index	Body measurement
13445	GCST000022	Body mass index	Body mass index	Other measurement
13446	GCST000021	Nicotine dependence	Nicotine dependence	Neurological disorder
13447	GCST000019	Prostate cancer	Prostate cancer	Cancer
13448	GCST000090	Body mass index	Body mass index	Body measurement
13449	GCST000090	Body mass index	Body mass index	Body measurement
13450	GCST000090	Body mass index	Body mass index	Other measurement
13451	GCST000084	Waist circumference	Waist circumference	Body measurement
13452	GCST000083	Select biomarker traits	Select biomarker traits	Other measurement
13453	GCST000083	Select biomarker traits	Select biomarker traits	Liver enzyme measurement
13454	GCST000083	Select biomarker traits	Select biomarker traits	Cardiovascular measurement
13455	GCST000083	Select biomarker traits	Select biomarker traits	Inflammatory measurement
13456	GCST000083	Select biomarker traits	Select biomarker traits	Other measurement
13457	GCST000083	Select biomarker traits	Select biomarker traits	Other measurement
13458	GCST000083	Select biomarker traits	Select biomarker traits	Inflammatory measurement
13459	GCST000083	Select biomarker traits	Select biomarker traits	Liver enzyme measurement
13460	GCST000083	Select biomarker traits	Select biomarker traits	Other measurement
13461	GCST000083	Select biomarker traits	Select biomarker traits	Inflammatory measurement
13462	GCST000073	Type 2 diabetes and 6 quantitative traits	Type 2 diabetes and 6 quantitative traits	Metabolic disorder
13463	GCST000073	Type 2 diabetes and 6 quantitative traits	Type 2 diabetes and 6 quantitative traits	Other measurement
13464	GCST000073	Type 2 diabetes and 6 quantitative traits	Type 2 diabetes and 6 quantitative traits	Other measurement
13465	GCST000076	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13466	GCST000075	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13467	GCST000074	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13468	GCST000072	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
13469	GCST000070	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
13470	GCST000071	Crohn's disease	Crohn's disease	Digestive system disorder
13471	GCST000069	F-cell distribution	F-cell distribution	Hematological measurement
13472	GCST000068	Height	Height	Other measurement
13473	GCST000068	Height	Height	Body measurement
13474	GCST000067	Glaucoma (exfoliation)	Glaucoma (exfoliation)	Neurological disorder
13475	GCST000066	Crohn's disease	Crohn's disease	Digestive system disorder
13476	GCST000017	Prostate cancer	Prostate cancer	Cancer
13477	GCST000018	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
13478	GCST000018	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
13479	GCST000016	Schizophrenia	Schizophrenia	Neurological disorder
13480	GCST000015	Progressive supranuclear palsy	Progressive supranuclear palsy	Neurological disorder
13481	GCST000014	Crohn's disease	Crohn's disease	Digestive system disorder
13482	GCST000013	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
13483	GCST000012	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13484	GCST000011	Lung cancer	Lung cancer	Cancer
13485	GCST000011	Lung cancer	Lung cancer	Cancer
13486	GCST000011	Lung cancer	Lung cancer	Cancer
13487	GCST000010	Nicotine dependence	Nicotine dependence	Neurological disorder
13488	GCST000009	Addiction	Addiction	Neurological disorder
13489	GCST000037	Breast cancer	Breast cancer	Cancer
13490	GCST000034	Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	Liver enzyme measurement
13491	GCST000034	Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	Response to drug
13492	GCST000033	Bipolar disorder	Bipolar disorder	Neurological disorder
13493	GCST000032	Stroke	Stroke	Cardiovascular disease
13494	GCST000031	Coronary heart disease	Coronary heart disease	Cardiovascular disease
13495	GCST000030	Myocardial infarction	Myocardial infarction	Cardiovascular disease
13496	GCST000029	Episodic memory	Episodic memory	Biological process
13497	GCST000025	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13498	GCST005907	Major depressive disorder	Major depressive disorder	Neurological disorder
13499	GCST007114	Cholesterol efflux capacity	Cholesterol efflux capacity	Lipid or lipoprotein measurement
13500	GCST007115	Cholesterol efflux capacity (cAMP stimulated assay)	Cholesterol efflux capacity (cAMP stimulated assay)	Lipid or lipoprotein measurement
13501	GCST007116	Cholesterol efflux capacity (ABCA-1 dependent assay)	Cholesterol efflux capacity (ABCA-1 dependent assay)	Lipid or lipoprotein measurement
13502	GCST007117	Cholesterol efflux capacity (BHK stimulated assay)	Cholesterol efflux capacity (BHK stimulated assay)	Lipid or lipoprotein measurement
13503	GCST006856	Methadone dose in opioid dependence	Methadone dose in opioid dependence	Neurological disorder
13504	GCST006856	Methadone dose in opioid dependence	Methadone dose in opioid dependence	Other measurement
13505	GCST006697	Parental longevity (combined parental attained age, Martingale residuals)	Parental longevity (combined parental attained age, Martingale residuals)	Other measurement
13506	GCST006698	Parental longevity (both parents in top 10%)	Parental longevity (both parents in top 10%)	Other measurement
13507	GCST006699	Parental longevity (mother's age at death)	Parental longevity (mother's age at death)	Other measurement
13508	GCST006696	Parental longevity (mother's attained age)	Parental longevity (mother's attained age)	Other measurement
13509	GCST006700	Parental longevity (father's age at death)	Parental longevity (father's age at death)	Other measurement
13510	GCST006701	Parental longevity (father's attained age)	Parental longevity (father's attained age)	Other measurement
13511	GCST006702	Parental longevity (combined parental age at death)	Parental longevity (combined parental age at death)	Other measurement
13512	GCST006299	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
13513	GCST006300	Smoking behaviour (maximum cigarettes in a 24 hour period)	Smoking behaviour (maximum cigarettes in a 24 hour period)	Other measurement
13514	GCST006301	Nicotine dependence symptom count	Nicotine dependence symptom count	Other measurement
13515	GCST006302	Nicotine dependence	Nicotine dependence	Neurological disorder
13516	GCST006303	Nicotine withdrawal symptom count	Nicotine withdrawal symptom count	Other measurement
13517	GCST006869	Nicotine withdrawal	Nicotine withdrawal	Other measurement
13518	GCST004930	IgG sialylation phenotypes (multivariate analysis)	IgG sialylation phenotypes (multivariate analysis)	Other measurement
13519	GCST004931	IgG disialylation phenotypes (multivariate analysis)	IgG disialylation phenotypes (multivariate analysis)	Other measurement
13520	GCST004932	IgG monosialylation phenotypes (multivariate analysis)	IgG monosialylation phenotypes (multivariate analysis)	Other measurement
13521	GCST004929	IgG fucosylation phenotypes (multivariate analysis)	IgG fucosylation phenotypes (multivariate analysis)	Other measurement
13522	GCST004928	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)	Other measurement
13523	GCST004927	IgG galactosylation phenotypes (multivariate analysis)	IgG galactosylation phenotypes (multivariate analysis)	Other measurement
13524	GCST004924	IgG monogalactosylation phenotypes (multivariate analysis)	IgG monogalactosylation phenotypes (multivariate analysis)	Other measurement
13525	GCST004926	IgG digalactosylation phenotypes (multivariate analysis)	IgG digalactosylation phenotypes (multivariate analysis)	Other measurement
13526	GCST004925	IgG N-glycosylation phenotypes (multivariate analysis)	IgG N-glycosylation phenotypes (multivariate analysis)	Other measurement
13527	GCST004261	Liver injury in anti-retroviral drug treated HIV	Liver injury in anti-retroviral drug treated HIV	Response to drug
13528	GCST004261	Liver injury in anti-retroviral drug treated HIV	Liver injury in anti-retroviral drug treated HIV	Other disease
13529	GCST004261	Liver injury in anti-retroviral drug treated HIV	Liver injury in anti-retroviral drug treated HIV	Digestive system disorder
13530	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Response to drug
13531	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Response to drug
13532	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Other disease
13533	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Other disease
13534	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Digestive system disorder
13535	GCST006703	Bitter taste perception (multivariate analysis)	Bitter taste perception (multivariate analysis)	Biological process
13536	GCST006704	Bitter taste perception	Bitter taste perception	Biological process
13537	GCST006175	Cannabis-related aggression	Cannabis-related aggression	Biological process
13538	GCST006175	Cannabis-related aggression	Cannabis-related aggression	Biological process
13539	GCST004600	Eosinophil percentage of white cells	Eosinophil percentage of white cells	Hematological measurement
13540	GCST004602	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
13541	GCST004603	Platelet count	Platelet count	Hematological measurement
13542	GCST004604	Hematocrit	Hematocrit	Hematological measurement
13543	GCST004605	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
13544	GCST004605	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
13545	GCST004606	Eosinophil counts	Eosinophil counts	Hematological measurement
13546	GCST004607	Plateletcrit	Plateletcrit	Hematological measurement
13547	GCST004608	Granulocyte percentage of myeloid white cells	Granulocyte percentage of myeloid white cells	Hematological measurement
13548	GCST004609	Monocyte percentage of white cells	Monocyte percentage of white cells	Hematological measurement
13549	GCST004610	White blood cell count	White blood cell count	Hematological measurement
13550	GCST004610	White blood cell count	White blood cell count	Inflammatory measurement
13551	GCST004610	White blood cell count	White blood cell count	Hematological measurement
13552	GCST004610	White blood cell count	White blood cell count	Hematological measurement
13553	GCST004610	White blood cell count	White blood cell count	Hematological measurement
13554	GCST004611	High light scatter reticulocyte count	High light scatter reticulocyte count	Hematological measurement
13555	GCST004613	Sum neutrophil eosinophil counts	Sum neutrophil eosinophil counts	Hematological measurement
13556	GCST004613	Sum neutrophil eosinophil counts	Sum neutrophil eosinophil counts	Hematological measurement
13557	GCST004613	Sum neutrophil eosinophil counts	Sum neutrophil eosinophil counts	Hematological measurement
13558	GCST004614	Granulocyte count	Granulocyte count	Hematological measurement
13559	GCST004612	High light scatter reticulocyte percentage of red cells	High light scatter reticulocyte percentage of red cells	Hematological measurement
13560	GCST004615	Hemoglobin concentration	Hemoglobin concentration	Hematological measurement
13561	GCST004616	Platelet distribution width	Platelet distribution width	Hematological measurement
13562	GCST004617	Eosinophil percentage of granulocytes	Eosinophil percentage of granulocytes	Hematological measurement
13563	GCST004618	White blood cell count (basophil)	White blood cell count (basophil)	Inflammatory measurement
13564	GCST004619	Reticulocyte fraction of red cells	Reticulocyte fraction of red cells	Hematological measurement
13565	GCST004620	Sum basophil neutrophil counts	Sum basophil neutrophil counts	Inflammatory measurement
13566	GCST004620	Sum basophil neutrophil counts	Sum basophil neutrophil counts	Hematological measurement
13567	GCST004620	Sum basophil neutrophil counts	Sum basophil neutrophil counts	Hematological measurement
13568	GCST004621	Red cell distribution width	Red cell distribution width	Hematological measurement
13569	GCST004622	Reticulocyte count	Reticulocyte count	Hematological measurement
13570	GCST004623	Neutrophil percentage of granulocytes	Neutrophil percentage of granulocytes	Hematological measurement
13571	GCST004624	Sum eosinophil basophil counts	Sum eosinophil basophil counts	Inflammatory measurement
13572	GCST004624	Sum eosinophil basophil counts	Sum eosinophil basophil counts	Hematological measurement
13573	GCST004624	Sum eosinophil basophil counts	Sum eosinophil basophil counts	Hematological measurement
13574	GCST004625	Monocyte count	Monocyte count	Hematological measurement
13575	GCST004626	Myeloid white cell count	Myeloid white cell count	Hematological measurement
13576	GCST004627	Lymphocyte counts	Lymphocyte counts	Hematological measurement
13577	GCST004628	Immature fraction of reticulocytes	Immature fraction of reticulocytes	Hematological measurement
13578	GCST004629	Neutrophil count	Neutrophil count	Hematological measurement
13579	GCST004630	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
13580	GCST004630	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
13581	GCST004631	Basophil percentage of white cells	Basophil percentage of white cells	Inflammatory measurement
13582	GCST004632	Lymphocyte percentage of white cells	Lymphocyte percentage of white cells	Hematological measurement
13583	GCST004633	Neutrophil percentage of white cells	Neutrophil percentage of white cells	Hematological measurement
13584	GCST004634	Basophil percentage of granulocytes	Basophil percentage of granulocytes	Inflammatory measurement
13585	GCST004599	Mean platelet volume	Mean platelet volume	Hematological measurement
13586	GCST004601	Red blood cell count	Red blood cell count	Hematological measurement
13587	GCST007537	Modic changes	Modic changes	Other trait
13588	GCST007324	Adventurousness	Adventurousness	Biological process
13589	GCST007329	Automobile speeding propensity	Automobile speeding propensity	Biological process
13590	GCST007328	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Biological process
13591	GCST007328	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Other measurement
13592	GCST007327	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Biological process
13593	GCST007327	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Other measurement
13594	GCST007326	Number of sexual partners	Number of sexual partners	Other measurement
13595	GCST007325	General risk tolerance (MTAG)	General risk tolerance (MTAG)	Biological process
13596	GCST007323	Risk-taking tendency (4-domain principal component model)	Risk-taking tendency (4-domain principal component model)	Biological process
13597	GCST007322	General risk tolerance	General risk tolerance	Biological process
13598	GCST007469	Rapid automised naming of digits	Rapid automised naming of digits	Biological process
13599	GCST007473	Rapid automised naming of pictures	Rapid automised naming of pictures	Biological process
13600	GCST007471	Short-term memory (digit-span task)	Short-term memory (digit-span task)	Biological process
13601	GCST007471	Short-term memory (digit-span task)	Short-term memory (digit-span task)	Other measurement
13602	GCST007478	Non-word reading	Non-word reading	Biological process
13603	GCST007467	Word spelling	Word spelling	Biological process
13604	GCST007466	Word reading	Word reading	Biological process
13605	GCST007465	Phoneme awareness	Phoneme awareness	Biological process
13606	GCST007479	Reading ability (multivariate)	Reading ability (multivariate)	Biological process
13607	GCST007470	Rapid automised naming of letters	Rapid automised naming of letters	Biological process
13608	GCST007718	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
13609	GCST007721	Urinary potassium to creatinine ratio	Urinary potassium to creatinine ratio	Other measurement
13610	GCST007778	Urinary sodium to creatinine ratio	Urinary sodium to creatinine ratio	Other measurement
13611	GCST007717	Urinary sodium to potassium ratio	Urinary sodium to potassium ratio	Other measurement
13612	GCST007719	Albuminuria	Albuminuria	Other trait
13613	GCST007112	Vitiligo (late onset)	Vitiligo (late onset)	Immune system disorder
13614	GCST007111	Vitiligo (early onset)	Vitiligo (early onset)	Immune system disorder
13615	GCST007100	Asthma exacerbations in inhaled corticosteroid treatment	Asthma exacerbations in inhaled corticosteroid treatment	Response to drug
13616	GCST007100	Asthma exacerbations in inhaled corticosteroid treatment	Asthma exacerbations in inhaled corticosteroid treatment	Other measurement
13617	GCST007900	Chemerin levels	Chemerin levels	Cardiovascular measurement
13618	GCST007406	Healthspan	Healthspan	Other measurement
13619	GCST007282	HDL cholesterol x physical activity interaction (2df test)	HDL cholesterol x physical activity interaction (2df test)	Lipid or lipoprotein measurement
13620	GCST007282	HDL cholesterol x physical activity interaction (2df test)	HDL cholesterol x physical activity interaction (2df test)	Biological process
13621	GCST007284	LDL cholesterol x physical activity interaction (2df test)	LDL cholesterol x physical activity interaction (2df test)	Lipid or lipoprotein measurement
13622	GCST007284	LDL cholesterol x physical activity interaction (2df test)	LDL cholesterol x physical activity interaction (2df test)	Biological process
13623	GCST007286	Triglycerides x physical activity interaction (2df test)	Triglycerides x physical activity interaction (2df test)	Lipid or lipoprotein measurement
13624	GCST007286	Triglycerides x physical activity interaction (2df test)	Triglycerides x physical activity interaction (2df test)	Biological process
13625	GCST007283	LDL cholesterol x physical activity interaction (1df test)	LDL cholesterol x physical activity interaction (1df test)	Lipid or lipoprotein measurement
13626	GCST007283	LDL cholesterol x physical activity interaction (1df test)	LDL cholesterol x physical activity interaction (1df test)	Biological process
13627	GCST007281	HDL cholesterol x physical activity interaction (1df test)	HDL cholesterol x physical activity interaction (1df test)	Lipid or lipoprotein measurement
13628	GCST007281	HDL cholesterol x physical activity interaction (1df test)	HDL cholesterol x physical activity interaction (1df test)	Biological process
13629	GCST007285	Triglycerides x physical activity interaction (1df test)	Triglycerides x physical activity interaction (1df test)	Lipid or lipoprotein measurement
13630	GCST007285	Triglycerides x physical activity interaction (1df test)	Triglycerides x physical activity interaction (1df test)	Biological process
13631	GCST007609	Resting heart rate	Resting heart rate	Cardiovascular measurement
13632	GCST007610	Hypertension	Hypertension	Cardiovascular disease
13633	GCST007611	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Other disease
13634	GCST007611	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Other measurement
13635	GCST007611	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Cardiovascular disease
13636	GCST007612	Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	Other disease
13637	GCST007612	Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	Cardiovascular disease
13638	GCST007613	Chronic obstructive pulmonary disease or stroke (pleiotropy)	Chronic obstructive pulmonary disease or stroke (pleiotropy)	Other disease
13639	GCST007613	Chronic obstructive pulmonary disease or stroke (pleiotropy)	Chronic obstructive pulmonary disease or stroke (pleiotropy)	Cardiovascular disease
13640	GCST007656	Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	Other disease
13641	GCST007656	Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	Cardiovascular measurement
13642	GCST007725	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
13643	GCST007733	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
13644	GCST007490	Anthropometric traits (multi-trait analysis)	Anthropometric traits (multi-trait analysis)	Other measurement
13645	GCST007485	Anthropometric traits	Anthropometric traits	Other measurement
13646	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13647	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13648	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13649	GCST007485	Anthropometric traits	Anthropometric traits	Other measurement
13650	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13651	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13652	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13653	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13654	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13655	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
13656	GCST007480	Disorders of lipid metabolism	Disorders of lipid metabolism	Other trait
13657	GCST007489	Eye color traits	Eye color traits	Other trait
13658	GCST007488	Skin pigmentation traits	Skin pigmentation traits	Other trait
13659	GCST007488	Skin pigmentation traits	Skin pigmentation traits	Other trait
13660	GCST007488	Skin pigmentation traits	Skin pigmentation traits	Other trait
13661	GCST007486	Hair morphology traits	Hair morphology traits	Other measurement
13662	GCST007486	Hair morphology traits	Hair morphology traits	Other measurement
13663	GCST007486	Hair morphology traits	Hair morphology traits	Other measurement
13664	GCST007482	Handedness	Handedness	Other trait
13665	GCST007481	Heart rate	Heart rate	Cardiovascular measurement
13666	GCST007631	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Other trait
13667	GCST007631	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Digestive system disorder
13668	GCST007632	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Other trait
13669	GCST007632	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Digestive system disorder
13670	GCST007633	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Other trait
13671	GCST007633	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Digestive system disorder
13672	GCST007634	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Other trait
13673	GCST007634	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Digestive system disorder
13674	GCST007669	Two-hour insulin response	Two-hour insulin response	Other measurement
13675	GCST007670	Fasting blood glucose	Fasting blood glucose	Other measurement
13676	GCST007671	Fasting blood insulin	Fasting blood insulin	Other measurement
13677	GCST007668	Two-hour glucose	Two-hour glucose	Other measurement
13678	GCST007437	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13679	GCST007442	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13680	GCST007438	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13681	GCST007441	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
13682	GCST007439	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
13683	GCST007440	Alanine aminotransferase levels	Alanine aminotransferase levels	Liver enzyme measurement
13684	GCST007407	Depressive symptoms	Depressive symptoms	Neurological disorder
13685	GCST007407	Depressive symptoms	Depressive symptoms	Other measurement
13686	GCST007408	Depressive symptoms x stressful life events interaction (1df test)	Depressive symptoms x stressful life events interaction (1df test)	Other measurement
13687	GCST007408	Depressive symptoms x stressful life events interaction (1df test)	Depressive symptoms x stressful life events interaction (1df test)	Other measurement
13688	GCST007409	Depressive symptoms x stressful life events interaction (2df test)	Depressive symptoms x stressful life events interaction (2df test)	Other measurement
13689	GCST007409	Depressive symptoms x stressful life events interaction (2df test)	Depressive symptoms x stressful life events interaction (2df test)	Other measurement
13690	GCST007410	Depressive symptoms x dependent stressful life events interaction (1df test)	Depressive symptoms x dependent stressful life events interaction (1df test)	Other measurement
13691	GCST007410	Depressive symptoms x dependent stressful life events interaction (1df test)	Depressive symptoms x dependent stressful life events interaction (1df test)	Other measurement
13692	GCST007411	Depressive symptoms x dependent stressful life events interaction (2df test)	Depressive symptoms x dependent stressful life events interaction (2df test)	Other measurement
13693	GCST007411	Depressive symptoms x dependent stressful life events interaction (2df test)	Depressive symptoms x dependent stressful life events interaction (2df test)	Other measurement
13694	GCST007412	Depressive symptoms x independent stressful life events interaction (1df test)	Depressive symptoms x independent stressful life events interaction (1df test)	Other measurement
13695	GCST007412	Depressive symptoms x independent stressful life events interaction (1df test)	Depressive symptoms x independent stressful life events interaction (1df test)	Other measurement
13696	GCST007413	Depressive symptoms x independent stressful life events interaction (2df test)	Depressive symptoms x independent stressful life events interaction (2df test)	Other measurement
13697	GCST007413	Depressive symptoms x independent stressful life events interaction (2df test)	Depressive symptoms x independent stressful life events interaction (2df test)	Other measurement
13698	GCST007219	Schizophrenia	Schizophrenia	Neurological disorder
13699	GCST007221	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13700	GCST007223	Schizophrenia vs type 2 diabetes	Schizophrenia vs type 2 diabetes	Neurological disorder
13701	GCST007223	Schizophrenia vs type 2 diabetes	Schizophrenia vs type 2 diabetes	Metabolic disorder
13702	GCST007224	Type 2 diabetes vs schizophrenia and type 2 diabetes	Type 2 diabetes vs schizophrenia and type 2 diabetes	Neurological disorder
13703	GCST007224	Type 2 diabetes vs schizophrenia and type 2 diabetes	Type 2 diabetes vs schizophrenia and type 2 diabetes	Metabolic disorder
13704	GCST007220	Schizophrenia and type 2 diabetes	Schizophrenia and type 2 diabetes	Neurological disorder
13705	GCST007220	Schizophrenia and type 2 diabetes	Schizophrenia and type 2 diabetes	Metabolic disorder
13706	GCST007222	Schizophrenia vs schizophrenia and type 2 diabetes	Schizophrenia vs schizophrenia and type 2 diabetes	Neurological disorder
13707	GCST007222	Schizophrenia vs schizophrenia and type 2 diabetes	Schizophrenia vs schizophrenia and type 2 diabetes	Metabolic disorder
13708	GCST007090	Knee osteoarthritis	Knee osteoarthritis	Other disease
13709	GCST007091	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
13710	GCST007091	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
13711	GCST007092	Osteoarthritis of the hip or knee	Osteoarthritis of the hip or knee	Other disease
13712	GCST007092	Osteoarthritis of the hip or knee	Osteoarthritis of the hip or knee	Other disease
13713	GCST007093	Osteoarthritis	Osteoarthritis	Other disease
13714	GCST008758	Pre-treatment viral load in HIV-1 infection	Pre-treatment viral load in HIV-1 infection	Other measurement
13715	GCST008758	Pre-treatment viral load in HIV-1 infection	Pre-treatment viral load in HIV-1 infection	Other disease
13716	GCST008549	Mental health study participation (provided email address)	Mental health study participation (provided email address)	Other trait
13717	GCST008550	Mental health study participation (completed survey)	Mental health study participation (completed survey)	Other trait
13718	GCST008395	End-stage kidney disease	End-stage kidney disease	Other disease
13719	GCST008394	Mild to moderate chronic kidney disease	Mild to moderate chronic kidney disease	Other disease
13720	GCST008645	Alcohol dependence or heroin dependence or methamphetamine dependence	Alcohol dependence or heroin dependence or methamphetamine dependence	Neurological disorder
13721	GCST008645	Alcohol dependence or heroin dependence or methamphetamine dependence	Alcohol dependence or heroin dependence or methamphetamine dependence	Neurological disorder
13722	GCST008645	Alcohol dependence or heroin dependence or methamphetamine dependence	Alcohol dependence or heroin dependence or methamphetamine dependence	Neurological disorder
13723	GCST008448	Diabetes (gestational)	Diabetes (gestational)	Metabolic disorder
13724	GCST008139	Gout	Gout	Metabolic disorder
13725	GCST007565	Morning person	Morning person	Other measurement
13726	GCST007576	Chronotype	Chronotype	Biological process
13727	GCST007576	Chronotype	Chronotype	Other measurement
13728	GCST007507	Benign prostatic hyperplasia and lower urinary tract symptoms	Benign prostatic hyperplasia and lower urinary tract symptoms	Other disease
13729	GCST007507	Benign prostatic hyperplasia and lower urinary tract symptoms	Benign prostatic hyperplasia and lower urinary tract symptoms	Other trait
13730	GCST007512	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	Other disease
13731	GCST007512	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	Other trait
13732	GCST007506	Prostate cancer	Prostate cancer	Cancer
13733	GCST007513	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
13734	GCST007596	Adult asthma	Adult asthma	Other disease
13735	GCST007599	Adult asthma	Adult asthma	Other disease
13736	GCST007598	Adult asthma	Adult asthma	Other disease
13737	GCST007597	Adult asthma	Adult asthma	Other disease
13738	GCST008018	Sweet taste perception in obesity with metabolic syndrome	Sweet taste perception in obesity with metabolic syndrome	Biological process
13739	GCST008024	Salty taste perception in obesity with metabolic syndrome	Salty taste perception in obesity with metabolic syndrome	Biological process
13740	GCST008023	Sour taste perception in obesity with metabolic syndrome	Sour taste perception in obesity with metabolic syndrome	Biological process
13741	GCST008022	Umami taste perception in obesity with metabolic syndrome	Umami taste perception in obesity with metabolic syndrome	Biological process
13742	GCST008020	Taste perception (total score including phenylthiocarbamide) in obesity with metabolic syndrome	Taste perception (total score including phenylthiocarbamide) in obesity with metabolic syndrome	Biological process
13743	GCST008021	Taste perception (total score including 6-n-propylthiouracil) in obesity with metabolic syndrome	Taste perception (total score including 6-n-propylthiouracil) in obesity with metabolic syndrome	Biological process
13744	GCST008017	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	Biological process
13745	GCST008019	Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome	Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome	Biological process
13746	GCST007119	Cervical cancer	Cervical cancer	Cancer
13747	GCST007614	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
13748	GCST007615	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
13749	GCST007549	Osteolysis in total hip arthroplasty	Osteolysis in total hip arthroplasty	Other trait
13750	GCST007549	Osteolysis in total hip arthroplasty	Osteolysis in total hip arthroplasty	Other disease
13751	GCST007550	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Other trait
13752	GCST007550	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Other disease
13753	GCST007550	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Other measurement
13754	GCST008105	Diverticular disease	Diverticular disease	Digestive system disorder
13755	GCST007536	Serum urea levels	Serum urea levels	Other measurement
13756	GCST007712	Cortical brain region measurements (area, volume and thickness)	Cortical brain region measurements (area, volume and thickness)	Other measurement
13757	GCST007712	Cortical brain region measurements (area, volume and thickness)	Cortical brain region measurements (area, volume and thickness)	Other measurement
13758	GCST007997	Obesity (extreme) (SNP x SNP interaction)	Obesity (extreme) (SNP x SNP interaction)	Metabolic disorder
13759	GCST007289	Proliferative diabetic retinopathy (vs NPDR and no DR)	Proliferative diabetic retinopathy (vs NPDR and no DR)	Metabolic disorder
13760	GCST007290	Diabetic retinopathy (moderate NPDR and PDR)	Diabetic retinopathy (moderate NPDR and PDR)	Metabolic disorder
13761	GCST007291	Proliferative diabetic retinopathy (vs no DR)	Proliferative diabetic retinopathy (vs no DR)	Metabolic disorder
13762	GCST007292	Diabetic retinopathy (all NPDR and PDR)	Diabetic retinopathy (all NPDR and PDR)	Metabolic disorder
13763	GCST007104	QRS duration	QRS duration	Cardiovascular measurement
13764	GCST007104	QRS duration	QRS duration	Cardiovascular measurement
13765	GCST007104	QRS duration	QRS duration	Cardiovascular measurement
13766	GCST007103	QRS duration	QRS duration	Cardiovascular measurement
13767	GCST007103	QRS duration	QRS duration	Cardiovascular measurement
13768	GCST007103	QRS duration	QRS duration	Cardiovascular measurement
13769	GCST007105	QRS duration	QRS duration	Cardiovascular measurement
13770	GCST007105	QRS duration	QRS duration	Cardiovascular measurement
13771	GCST007105	QRS duration	QRS duration	Cardiovascular measurement
13772	GCST008437	Alzheimer's disease in hypertension-negative individuals	Alzheimer's disease in hypertension-negative individuals	Neurological disorder
13773	GCST008438	Alzheimer's disease in hypertension	Alzheimer's disease in hypertension	Neurological disorder
13774	GCST008438	Alzheimer's disease in hypertension	Alzheimer's disease in hypertension	Cardiovascular disease
13775	GCST007830	Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Other measurement
13776	GCST007830	Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Immune system disorder
13777	GCST007831	Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Immune system disorder
13778	GCST007831	Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Other measurement
13779	GCST007851	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Other measurement
13780	GCST007851	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Immune system disorder
13781	GCST007851	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Other measurement
13782	GCST008503	Fasting glucose change	Fasting glucose change	Other measurement
13783	GCST008504	Fasting glucose change (long-term)	Fasting glucose change (long-term)	Other measurement
13784	GCST008505	Fasting glucose change (short-term)	Fasting glucose change (short-term)	Other measurement
13785	GCST008374	Warfarin maintenance dose (adjusted for clinical factors)	Warfarin maintenance dose (adjusted for clinical factors)	Response to drug
13786	GCST008363	Offspring birth weight	Offspring birth weight	Body measurement
13787	GCST008363	Offspring birth weight	Offspring birth weight	Other measurement
13788	GCST008362	Birth weight	Birth weight	Body measurement
13789	GCST008096	Psoriasis	Psoriasis	Immune system disorder
13790	GCST007203	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
13791	GCST007202	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13792	GCST007204	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13793	GCST007510	Cleft lip with or without cleft palate	Cleft lip with or without cleft palate	Other trait
13794	GCST007510	Cleft lip with or without cleft palate	Cleft lip with or without cleft palate	Other trait
13795	GCST007509	Cleft palate	Cleft palate	Other trait
13796	GCST007297	Psychological distress	Psychological distress	Other measurement
13797	GCST007108	Systolic blood pressure x sodium interaction (1df test)	Systolic blood pressure x sodium interaction (1df test)	Other measurement
13798	GCST007108	Systolic blood pressure x sodium interaction (1df test)	Systolic blood pressure x sodium interaction (1df test)	Other measurement
13799	GCST007107	Diastolic blood pressure x sodium interaction (1df test)	Diastolic blood pressure x sodium interaction (1df test)	Other measurement
13800	GCST007107	Diastolic blood pressure x sodium interaction (1df test)	Diastolic blood pressure x sodium interaction (1df test)	Other measurement
13801	GCST007135	Resistant hypertension	Resistant hypertension	Cardiovascular disease
13802	GCST007136	Resistant hypertension	Resistant hypertension	Cardiovascular disease
13803	GCST007538	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	Other measurement
13804	GCST008170	Thyroglobulin plasma levels	Thyroglobulin plasma levels	Other measurement
13805	GCST007305	White matter hyperintensity volume	White matter hyperintensity volume	Other measurement
13806	GCST007976	Postoperative myocardial infarction after cardiac surgery	Postoperative myocardial infarction after cardiac surgery	Cardiovascular disease
13807	GCST007976	Postoperative myocardial infarction after cardiac surgery	Postoperative myocardial infarction after cardiac surgery	Biological process
13808	GCST007977	Postoperative stroke after cardiac surgery	Postoperative stroke after cardiac surgery	Neurological disorder
13809	GCST007977	Postoperative stroke after cardiac surgery	Postoperative stroke after cardiac surgery	Biological process
13810	GCST007979	Postoperative acute renal failure after cardiac surgery	Postoperative acute renal failure after cardiac surgery	Other disease
13811	GCST007979	Postoperative acute renal failure after cardiac surgery	Postoperative acute renal failure after cardiac surgery	Biological process
13812	GCST007978	Postoperative atrial fibrillation after cardiac surgery	Postoperative atrial fibrillation after cardiac surgery	Biological process
13813	GCST007978	Postoperative atrial fibrillation after cardiac surgery	Postoperative atrial fibrillation after cardiac surgery	Cardiovascular disease
13814	GCST007980	Postoperative delirium after cardiac surgery	Postoperative delirium after cardiac surgery	Neurological disorder
13815	GCST007980	Postoperative delirium after cardiac surgery	Postoperative delirium after cardiac surgery	Biological process
13816	GCST007981	Postoperative complication after cardiac surgery	Postoperative complication after cardiac surgery	Biological process
13817	GCST007981	Postoperative complication after cardiac surgery	Postoperative complication after cardiac surgery	Other trait
13818	GCST008514	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	Response to drug
13819	GCST008514	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	Digestive system disorder
13820	GCST008058	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13821	GCST008059	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13822	GCST008060	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13823	GCST008061	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13824	GCST008062	Blood urea nitrogen levels	Blood urea nitrogen levels	Other measurement
13825	GCST008063	Blood urea nitrogen levels	Blood urea nitrogen levels	Other measurement
13826	GCST008064	Chronic kidney disease	Chronic kidney disease	Other disease
13827	GCST008064	Chronic kidney disease	Chronic kidney disease	Other measurement
13828	GCST008064	Chronic kidney disease	Chronic kidney disease	Other measurement
13829	GCST008065	Chronic kidney disease	Chronic kidney disease	Other disease
13830	GCST008065	Chronic kidney disease	Chronic kidney disease	Other measurement
13831	GCST008065	Chronic kidney disease	Chronic kidney disease	Other measurement
13832	GCST008066	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13833	GCST007713	Frontal fibrosing alopecia	Frontal fibrosing alopecia	Other disease
13834	GCST007780	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Neurological disorder
13835	GCST007780	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Other measurement
13836	GCST007391	Deliberate self-harm	Deliberate self-harm	Other measurement
13837	GCST007390	Suicidality (suicidal ideation/attempts)	Suicidality (suicidal ideation/attempts)	Other measurement
13838	GCST007389	Suicidality	Suicidality	Other measurement
13839	GCST007921	Right-sided colonic diverticulosis	Right-sided colonic diverticulosis	Other trait
13840	GCST007922	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	Other measurement
13841	GCST007923	Medication use (drugs used in diabetes)	Medication use (drugs used in diabetes)	Other measurement
13842	GCST007924	Medication use (antithrombotic agents)	Medication use (antithrombotic agents)	Other measurement
13843	GCST007925	Medication use (vasodilators used in cardiac diseases)	Medication use (vasodilators used in cardiac diseases)	Other measurement
13844	GCST007926	Medication use (antihypertensives)	Medication use (antihypertensives)	Other measurement
13845	GCST007928	Medication use (diuretics)	Medication use (diuretics)	Other measurement
13846	GCST007927	Medication use (beta blocking agents)	Medication use (beta blocking agents)	Other measurement
13847	GCST007929	Medication use (calcium channel blockers)	Medication use (calcium channel blockers)	Other measurement
13848	GCST007930	Medication use (agents acting on the renin-angiotensin system)	Medication use (agents acting on the renin-angiotensin system)	Other measurement
13849	GCST007931	Medication use (HMG CoA reductase inhibitors)	Medication use (HMG CoA reductase inhibitors)	Other measurement
13850	GCST007932	Medication use (thyroid preparations)	Medication use (thyroid preparations)	Other measurement
13851	GCST007933	Medication use (immunosuppressants)	Medication use (immunosuppressants)	Other measurement
13852	GCST007934	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	Other measurement
13853	GCST007935	Medication use (drugs affecting bone structure and mineralization)	Medication use (drugs affecting bone structure and mineralization)	Other measurement
13854	GCST007936	Medication use (opioids)	Medication use (opioids)	Other measurement
13855	GCST007937	Medication use (salicylic acid and derivatives)	Medication use (salicylic acid and derivatives)	Other measurement
13856	GCST007938	Medication use (anilides)	Medication use (anilides)	Other measurement
13857	GCST007939	Medication use (antimigraine preparations)	Medication use (antimigraine preparations)	Other measurement
13858	GCST007940	Medication use (antidepressants)	Medication use (antidepressants)	Other measurement
13859	GCST007941	Medication use (adrenergics, inhalants)	Medication use (adrenergics, inhalants)	Other measurement
13860	GCST007942	Medication use (glucocorticoids)	Medication use (glucocorticoids)	Other measurement
13861	GCST007943	Medication use (antihistamines for systemic use)	Medication use (antihistamines for systemic use)	Other measurement
13862	GCST007944	Medication use (antiglaucoma preparations and miotics)	Medication use (antiglaucoma preparations and miotics)	Other measurement
13863	GCST008595	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Other measurement
13864	GCST008595	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Biological process
13865	GCST008595	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Neurological disorder
13866	GCST008743	Predicted visceral adipose tissue	Predicted visceral adipose tissue	Other measurement
13867	GCST008742	Predicted visceral adipose tissue	Predicted visceral adipose tissue	Other measurement
13868	GCST008744	Predicted visceral adipose tissue	Predicted visceral adipose tissue	Other measurement
13869	GCST008202	Soluble E-selectin levels	Soluble E-selectin levels	Inflammatory measurement
13870	GCST008210	Soluble ICAM-1	Soluble ICAM-1	Cardiovascular measurement
13871	GCST008196	Soluble VCAM-1 levels	Soluble VCAM-1 levels	Other measurement
13872	GCST008207	Interleukin-1-alpha levels	Interleukin-1-alpha levels	Other measurement
13873	GCST008208	Soluble CD40 ligand levels	Soluble CD40 ligand levels	Inflammatory measurement
13874	GCST008206	Plasminogen activator inhibitor-1 (PAI-1) levels	Plasminogen activator inhibitor-1 (PAI-1) levels	Other measurement
13875	GCST008198	Vascular endothelial growth factor levels	Vascular endothelial growth factor levels	Cardiovascular measurement
13876	GCST008205	Interleukin-17 levels	Interleukin-17 levels	Other measurement
13877	GCST008204	Monocyte chemoattractant protein-1 levels	Monocyte chemoattractant protein-1 levels	Other measurement
13878	GCST008209	Interleukin-1-beta levels	Interleukin-1-beta levels	Inflammatory measurement
13879	GCST008203	Interleukin-1-receptor antagonist levels	Interleukin-1-receptor antagonist levels	Inflammatory measurement
13880	GCST008201	Interleukin-4 levels	Interleukin-4 levels	Other measurement
13881	GCST008200	Interleukin-6 levels	Interleukin-6 levels	Inflammatory measurement
13882	GCST008197	Interleukin-8 levels	Interleukin-8 levels	Other measurement
13883	GCST008197	Interleukin-8 levels	Interleukin-8 levels	Inflammatory measurement
13884	GCST008199	Interferon gamma-induced protein 10 levels	Interferon gamma-induced protein 10 levels	Other measurement
13885	GCST008211	Tumor necrosis factor alpha levels	Tumor necrosis factor alpha levels	Inflammatory measurement
13886	GCST008577	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other trait
13887	GCST008577	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other measurement
13888	GCST008577	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other measurement
13889	GCST008582	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Other trait
13890	GCST008582	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Other measurement
13891	GCST008582	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Other trait
13892	GCST008582	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Response to drug
13893	GCST008581	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Other trait
13894	GCST008581	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Other measurement
13895	GCST008581	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Other trait
13896	GCST008581	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Response to drug
13897	GCST008580	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Other trait
13898	GCST008580	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Other trait
13899	GCST008580	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Response to drug
13900	GCST008579	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Other trait
13901	GCST008579	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Response to drug
13902	GCST008579	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Other trait
13903	GCST008578	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	Other trait
13904	GCST008578	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	Response to drug
13905	GCST008578	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	Metabolic disorder
13906	GCST008171	Platelet aggregation	Platelet aggregation	Biological process
13907	GCST008167	Mean platelet volume	Mean platelet volume	Hematological measurement
13908	GCST008166	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
13909	GCST008168	Platelet count	Platelet count	Hematological measurement
13910	GCST007250	Nonunion in individuals with fractures	Nonunion in individuals with fractures	Other disease
13911	GCST007250	Nonunion in individuals with fractures	Nonunion in individuals with fractures	Other disease
13912	GCST000187	Breast cancer	Breast cancer	Cancer
13913	GCST008136	Alcohol withdrawal symptoms	Alcohol withdrawal symptoms	Neurological disorder
13914	GCST008137	Alcohol withdrawal symptoms	Alcohol withdrawal symptoms	Neurological disorder
13915	GCST007094	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13916	GCST007094	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13917	GCST007096	Pulse pressure	Pulse pressure	Cardiovascular measurement
13918	GCST007099	Systolic blood pressure	Systolic blood pressure	Other measurement
13919	GCST007099	Systolic blood pressure	Systolic blood pressure	Other measurement
13920	GCST007098	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13921	GCST007098	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13922	GCST007097	Pulse pressure	Pulse pressure	Cardiovascular measurement
13923	GCST007095	Systolic blood pressure	Systolic blood pressure	Other measurement
13924	GCST007095	Systolic blood pressure	Systolic blood pressure	Other measurement
13925	GCST008760	Perceived sweetness of sucrose		
13926	GCST008761	Sucrose liking	Sucrose liking	Other measurement
13927	GCST008762	Intake of sweets	Intake of sweets	Other measurement
13928	GCST008763	Perceived intensity of fructose		
13929	GCST008764	Perceived intensity of neohesperidin dihydrochalcone		
13930	GCST008765	Perceived intensity of aspartame		
13931	GCST008766	Perceived intensity of sweet substances		
13932	GCST008767	Perceived intensity of sucrose		
13933	GCST008768	Perceived intensity of sweet substances		
13934	GCST008759	Intake of total sugars	Intake of total sugars	Other measurement
13935	GCST008769	Perceived intensity of glucose		
13936	GCST008258	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
13937	GCST008258	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
13938	GCST008258	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
13939	GCST008259	Alcohol use disorder	Alcohol use disorder	Neurological disorder
13940	GCST008259	Alcohol use disorder	Alcohol use disorder	Other measurement
13941	GCST007336	Age at first birth	Age at first birth	Other measurement
13942	GCST007335	Age at first sexual intercourse	Age at first sexual intercourse	Other measurement
13943	GCST007856	Colorectal cancer or advanced adenoma	Colorectal cancer or advanced adenoma	Cancer
13944	GCST007856	Colorectal cancer or advanced adenoma	Colorectal cancer or advanced adenoma	Cancer
13945	GCST008148	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Cardiovascular measurement
13946	GCST008148	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Metabolic disorder
13947	GCST008148	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Response to drug
13948	GCST008147	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Cardiovascular measurement
13949	GCST008147	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Metabolic disorder
13950	GCST008147	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Response to drug
13951	GCST008070	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
13952	GCST008086	LDL cholesterol levels in current drinkers	LDL cholesterol levels in current drinkers	Biological process
13953	GCST008086	LDL cholesterol levels in current drinkers	LDL cholesterol levels in current drinkers	Lipid or lipoprotein measurement
13954	GCST008085	HDL cholesterol levels in current drinkers	HDL cholesterol levels in current drinkers	Biological process
13955	GCST008085	HDL cholesterol levels in current drinkers	HDL cholesterol levels in current drinkers	Lipid or lipoprotein measurement
13956	GCST008087	Triglyceride levels in current drinkers	Triglyceride levels in current drinkers	Biological process
13957	GCST008087	Triglyceride levels in current drinkers	Triglyceride levels in current drinkers	Lipid or lipoprotein measurement
13958	GCST008084	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Biological process
13959	GCST008084	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Lipid or lipoprotein measurement
13960	GCST008083	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Biological process
13961	GCST008083	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Lipid or lipoprotein measurement
13962	GCST008082	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Biological process
13963	GCST008082	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Lipid or lipoprotein measurement
13964	GCST008081	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Biological process
13965	GCST008081	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Lipid or lipoprotein measurement
13966	GCST008080	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Biological process
13967	GCST008080	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Lipid or lipoprotein measurement
13968	GCST008079	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Biological process
13969	GCST008079	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Lipid or lipoprotein measurement
13970	GCST008078	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Lipid or lipoprotein measurement
13971	GCST008078	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Other measurement
13972	GCST008077	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
13973	GCST008077	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
13974	GCST008076	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13975	GCST008075	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Lipid or lipoprotein measurement
13976	GCST008075	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Other measurement
13977	GCST008074	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Lipid or lipoprotein measurement
13978	GCST008074	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Other measurement
13979	GCST008073	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Lipid or lipoprotein measurement
13980	GCST008073	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Other measurement
13981	GCST008072	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Lipid or lipoprotein measurement
13982	GCST008072	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Other measurement
13983	GCST008071	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Lipid or lipoprotein measurement
13984	GCST008071	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Other measurement
13985	GCST007277	Tourette syndrome	Tourette syndrome	Neurological disorder
13986	GCST007897	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Response to drug
13987	GCST007897	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Other disease
13988	GCST007897	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Digestive system disorder
13989	GCST007897	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Response to drug
13990	GCST007267	Systolic blood pressure	Systolic blood pressure	Other measurement
13991	GCST007267	Systolic blood pressure	Systolic blood pressure	Other measurement
13992	GCST007268	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13993	GCST007268	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13994	GCST007269	Pulse pressure	Pulse pressure	Cardiovascular measurement
13995	GCST007270	Systolic blood pressure	Systolic blood pressure	Other measurement
13996	GCST007270	Systolic blood pressure	Systolic blood pressure	Other measurement
13997	GCST007271	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13998	GCST007271	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13999	GCST007272	Pulse pressure	Pulse pressure	Cardiovascular measurement
14000	GCST007800	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
14001	GCST007800	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
14002	GCST007799	Asthma (adult onset)	Asthma (adult onset)	Other disease
14003	GCST007798	Asthma	Asthma	Other disease
14004	GCST007797	Asthma onset (childhood vs adult)	Asthma onset (childhood vs adult)	Other disease
14005	GCST007797	Asthma onset (childhood vs adult)	Asthma onset (childhood vs adult)	Other measurement
14006	GCST008568	IgA levels	IgA levels	Other measurement
14007	GCST008569	Composite immunoglobulin trait (IgA x IgG x IgM)	Composite immunoglobulin trait (IgA x IgG x IgM)	Other measurement
14008	GCST008570	Composite immunoglobulin trait (IgA x IgG/IgM)	Composite immunoglobulin trait (IgA x IgG/IgM)	Other measurement
14009	GCST008571	Composite immunoglobulin trait (IgA x IgG)	Composite immunoglobulin trait (IgA x IgG)	Other measurement
14010	GCST008572	Composite immunoglobulin trait (IgA/IgG)	Composite immunoglobulin trait (IgA/IgG)	Other measurement
14011	GCST008573	Composite immunoglobulin trait (IgA/IgM)	Composite immunoglobulin trait (IgA/IgM)	Other measurement
14012	GCST008574	Composite immunoglobulin trait (IgG/IgM)	Composite immunoglobulin trait (IgG/IgM)	Other measurement
14013	GCST008575	IgM levels	IgM levels	Other measurement
14014	GCST008576	IgG levels	IgG levels	Other measurement
14015	GCST008757	Alcohol consumption	Alcohol consumption	Biological process
14016	GCST008757	Alcohol consumption	Alcohol consumption	Other measurement
14017	GCST008646	Gastric cancer	Gastric cancer	Cancer
14018	GCST000553	CD4:CD8 lymphocyte ratio	CD4:CD8 lymphocyte ratio	Inflammatory measurement
14019	GCST008636	CD3-positive T-lymphocyte count	CD3-positive T-lymphocyte count	Hematological measurement
14020	GCST008637	CD4-positive T-lymphocyte count	CD4-positive T-lymphocyte count	Hematological measurement
14021	GCST008638	CD8-positive T-lymphocyte count	CD8-positive T-lymphocyte count	Hematological measurement
14022	GCST008639	CD19-positive B-lymphocyte count	CD19-positive B-lymphocyte count	Hematological measurement
14023	GCST008640	CD56-positive NK-lymphocyte cell count	CD56-positive NK-lymphocyte cell count	Hematological measurement
14024	GCST008490	Post-traumatic stress disorder (re-experiencing symptoms)	Post-traumatic stress disorder (re-experiencing symptoms)	Other measurement
14025	GCST008366	Leukocyte telomere length	Leukocyte telomere length	Other measurement
14026	GCST007363	Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age	Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age	Other measurement
14027	GCST007603	Smoking initiation	Smoking initiation	Biological process
14028	GCST007602	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
14029	GCST007601	Smoking behaviour (cigarette pack-years)	Smoking behaviour (cigarette pack-years)	Other measurement
14030	GCST007601	Smoking behaviour (cigarette pack-years)	Smoking behaviour (cigarette pack-years)	Other measurement
14031	GCST007604	Smoking cessation	Smoking cessation	Biological process
14032	GCST008383	Carbamazepine-induced liver injury	Carbamazepine-induced liver injury	Digestive system disorder
14033	GCST008383	Carbamazepine-induced liver injury	Carbamazepine-induced liver injury	Response to drug
14034	GCST008384	Carbamazepine-induced reaction with eosinophilia and systemic symptoms	Carbamazepine-induced reaction with eosinophilia and systemic symptoms	Immune system disorder
14035	GCST008384	Carbamazepine-induced reaction with eosinophilia and systemic symptoms	Carbamazepine-induced reaction with eosinophilia and systemic symptoms	Response to drug
14036	GCST008385	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
14037	GCST008385	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
14038	GCST008385	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Response to drug
14039	GCST008386	Carbamazepine-induced serious cutaneous adverse reaction	Carbamazepine-induced serious cutaneous adverse reaction	Other disease
14040	GCST008386	Carbamazepine-induced serious cutaneous adverse reaction	Carbamazepine-induced serious cutaneous adverse reaction	Response to drug
14041	GCST007644	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Other measurement
14042	GCST007644	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Other measurement
14043	GCST007644	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Other measurement
14044	GCST007649	Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	Other measurement
14045	GCST007649	Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	Other measurement
14046	GCST007648	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Other measurement
14047	GCST007648	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Other measurement
14048	GCST007648	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Other measurement
14049	GCST007647	Estimated glomerular filtration rate change in renal transplantation (recipient effect)	Estimated glomerular filtration rate change in renal transplantation (recipient effect)	Other measurement
14050	GCST007647	Estimated glomerular filtration rate change in renal transplantation (recipient effect)	Estimated glomerular filtration rate change in renal transplantation (recipient effect)	Other measurement
14051	GCST007646	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Other measurement
14052	GCST007646	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Other measurement
14053	GCST007646	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Other measurement
14054	GCST007645	Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	Other measurement
14055	GCST007645	Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	Other measurement
14056	GCST008465	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
14057	GCST008465	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
14058	GCST007606	Drug-induced liver injury (flucloxacillin)	Drug-induced liver injury (flucloxacillin)	Digestive system disorder
14059	GCST007608	Drug-induced liver injury (isoxazolyl penicillins)	Drug-induced liver injury (isoxazolyl penicillins)	Digestive system disorder
14060	GCST007607	Drug-induced liver injury (amoxicillin)	Drug-induced liver injury (amoxicillin)	Digestive system disorder
14061	GCST008483	Ulcerative colitis	Ulcerative colitis	Immune system disorder
14062	GCST007260	B6 vitamer levels (multivariate analysis)	B6 vitamer levels (multivariate analysis)	Other measurement
14063	GCST007261	Cerebrospinal fluid pyridoxal phosphate levels	Cerebrospinal fluid pyridoxal phosphate levels	Other measurement
14064	GCST007262	Plasma pyridoxal phosphate levels	Plasma pyridoxal phosphate levels	Other measurement
14065	GCST007263	Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio	Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio	Other measurement
14066	GCST007264	Plasma pyridoxal phosphate to pyridoxal ratio	Plasma pyridoxal phosphate to pyridoxal ratio	Other measurement
14067	GCST007265	Plasma pyridoxic acid to pyridoxal phosphate ratio	Plasma pyridoxic acid to pyridoxal phosphate ratio	Other measurement
14068	GCST008108	N-glycan levels	N-glycan levels	Other measurement
14069	GCST007739	Skin reflectance (Melanin index)	Skin reflectance (Melanin index)	Other measurement
14070	GCST007740	Iris color (a* coordinate)	Iris color (a* coordinate)	Other measurement
14071	GCST007740	Iris color (a* coordinate)	Iris color (a* coordinate)	Other trait
14072	GCST007741	Iris color (b* coordinate)	Iris color (b* coordinate)	Other measurement
14073	GCST007741	Iris color (b* coordinate)	Iris color (b* coordinate)	Other trait
14074	GCST007743	Iris color (L* coordinate)	Iris color (L* coordinate)	Other measurement
14075	GCST007743	Iris color (L* coordinate)	Iris color (L* coordinate)	Other trait
14076	GCST007742	Iris heterochromicity	Iris heterochromicity	Other measurement
14077	GCST007742	Iris heterochromicity	Iris heterochromicity	Other trait
14078	GCST008901	Gut microbiota (beta diversity)	Gut microbiota (beta diversity)	Other measurement
14079	GCST008900	Gut microbiota (alpha diversity)	Gut microbiota (alpha diversity)	Other measurement
14080	GCST008903	Gut microbiota relative abundance (bacterial taxa)	Gut microbiota relative abundance (bacterial taxa)	Other measurement
14081	GCST008902	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
14082	GCST008902	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
14083	GCST008862	Triacylglycerol 56:6 levels	Triacylglycerol 56:6 levels	Lipid or lipoprotein measurement
14084	GCST008863	Malate levels	Malate levels	Other measurement
14085	GCST008864	Niacinamide levels	Niacinamide levels	Other measurement
14086	GCST008865	Sphingomyelin 24:0 levels	Sphingomyelin 24:0 levels	Lipid or lipoprotein measurement
14087	GCST008894	Uridine levels	Uridine levels	Other measurement
14088	GCST008866	Triacylglycerol 56:2 levels	Triacylglycerol 56:2 levels	Lipid or lipoprotein measurement
14089	GCST008867	Tyrosine levels	Tyrosine levels	Other measurement
14090	GCST008868	Xanthine levels	Xanthine levels	Other measurement
14091	GCST008869	Metabolite risk score for predicting weight gain	Metabolite risk score for predicting weight gain	Other measurement
14092	GCST008869	Metabolite risk score for predicting weight gain	Metabolite risk score for predicting weight gain	Other trait
14093	GCST008356	Geographic atrophy lesion growth rate in age-related macular degeneration	Geographic atrophy lesion growth rate in age-related macular degeneration	Other measurement
14094	GCST008356	Geographic atrophy lesion growth rate in age-related macular degeneration	Geographic atrophy lesion growth rate in age-related macular degeneration	Neurological disorder
14095	GCST008860	Prostate cancer	Prostate cancer	Cancer
14096	GCST007638	Glycine levels	Glycine levels	Other measurement
14097	GCST007650	Postoperative survival time in hepatocellular carcinoma	Postoperative survival time in hepatocellular carcinoma	Other measurement
14098	GCST007650	Postoperative survival time in hepatocellular carcinoma	Postoperative survival time in hepatocellular carcinoma	Cancer
14099	GCST007726	Anti-Toxoplasma gondii IgG seropositivity	Anti-Toxoplasma gondii IgG seropositivity	Other measurement
14100	GCST008916	Asthma	Asthma	Other disease
14101	GCST008917	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
14102	GCST008917	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
14103	GCST008918	Asthma (adult onset)	Asthma (adult onset)	Other disease
14104	GCST008919	Asthma and attention deficit hyperactivity disorder	Asthma and attention deficit hyperactivity disorder	Neurological disorder
14105	GCST008919	Asthma and attention deficit hyperactivity disorder	Asthma and attention deficit hyperactivity disorder	Other disease
14106	GCST008920	Asthma and anxiety disorder	Asthma and anxiety disorder	Other disease
14107	GCST008920	Asthma and anxiety disorder	Asthma and anxiety disorder	Neurological disorder
14108	GCST008921	Asthma and major depressive disorder	Asthma and major depressive disorder	Other disease
14109	GCST008921	Asthma and major depressive disorder	Asthma and major depressive disorder	Neurological disorder
14110	GCST007376	Gamma glutamyl transferase levels in excessive alcohol consumption	Gamma glutamyl transferase levels in excessive alcohol consumption	Liver enzyme measurement
14111	GCST007376	Gamma glutamyl transferase levels in excessive alcohol consumption	Gamma glutamyl transferase levels in excessive alcohol consumption	Other measurement
14112	GCST007381	Alanine aminotransferase levels in excessive alcohol consumption	Alanine aminotransferase levels in excessive alcohol consumption	Liver enzyme measurement
14113	GCST007381	Alanine aminotransferase levels in excessive alcohol consumption	Alanine aminotransferase levels in excessive alcohol consumption	Other measurement
14114	GCST007377	Aspartate aminotransferase levels in excessive alcohol consumption	Aspartate aminotransferase levels in excessive alcohol consumption	Liver enzyme measurement
14115	GCST007377	Aspartate aminotransferase levels in excessive alcohol consumption	Aspartate aminotransferase levels in excessive alcohol consumption	Other measurement
14116	GCST007380	Gamma glutamyl transferase levels in low alcohol consumption	Gamma glutamyl transferase levels in low alcohol consumption	Liver enzyme measurement
14117	GCST007380	Gamma glutamyl transferase levels in low alcohol consumption	Gamma glutamyl transferase levels in low alcohol consumption	Other measurement
14118	GCST007379	Alanine aminotransferase levels in low alcohol consumption	Alanine aminotransferase levels in low alcohol consumption	Liver enzyme measurement
14119	GCST007379	Alanine aminotransferase levels in low alcohol consumption	Alanine aminotransferase levels in low alcohol consumption	Other measurement
14120	GCST007378	Aspartate aminotransferase levels in low alcohol consumption	Aspartate aminotransferase levels in low alcohol consumption	Liver enzyme measurement
14121	GCST007378	Aspartate aminotransferase levels in low alcohol consumption	Aspartate aminotransferase levels in low alcohol consumption	Other measurement
14122	GCST008468	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
14123	GCST008471	Non-alcoholic fatty liver disease activity score	Non-alcoholic fatty liver disease activity score	Other measurement
14124	GCST008469	Liver fibrosis in non-alcoholic fatty acid liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	Other trait
14125	GCST008469	Liver fibrosis in non-alcoholic fatty acid liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	Digestive system disorder
14126	GCST008467	Aspartate aminotransferase levels in non-alcoholic fatty liver disease	Aspartate aminotransferase levels in non-alcoholic fatty liver disease	Liver enzyme measurement
14127	GCST008467	Aspartate aminotransferase levels in non-alcoholic fatty liver disease	Aspartate aminotransferase levels in non-alcoholic fatty liver disease	Digestive system disorder
14128	GCST008466	Alanine aminotransferase levels in non-alcoholic fatty liver disease	Alanine aminotransferase levels in non-alcoholic fatty liver disease	Liver enzyme measurement
14129	GCST008466	Alanine aminotransferase levels in non-alcoholic fatty liver disease	Alanine aminotransferase levels in non-alcoholic fatty liver disease	Digestive system disorder
14130	GCST008470	Nonalcoholic fatty liver disease (SNP x SNP interaction)	Nonalcoholic fatty liver disease (SNP x SNP interaction)	Digestive system disorder
14131	GCST008381	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Cancer
14132	GCST008381	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Biological process
14133	GCST008381	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Other trait
14134	GCST008378	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Cancer
14135	GCST008378	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Biological process
14136	GCST008378	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Other trait
14137	GCST008380	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Cancer
14138	GCST008380	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Other trait
14139	GCST008380	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Biological process
14140	GCST008379	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Cancer
14141	GCST008379	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Biological process
14142	GCST008379	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Other disease
14143	GCST008382	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Cancer
14144	GCST008382	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Biological process
14145	GCST008382	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Other trait
14146	GCST008557	Dentate gyrus volume x schizophrenia interaction	Dentate gyrus volume x schizophrenia interaction	Neurological disorder
14147	GCST008557	Dentate gyrus volume x schizophrenia interaction	Dentate gyrus volume x schizophrenia interaction	Other measurement
14148	GCST008558	Dentate gyrus volume	Dentate gyrus volume	Other measurement
14149	GCST007683	Triiodothyronine levels	Triiodothyronine levels	Other measurement
14150	GCST007682	Thyroxine levels	Thyroxine levels	Other measurement
14151	GCST007681	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
14152	GCST007681	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
14153	GCST007680	Triiodothyronine levels and thyroxine levels	Triiodothyronine levels and thyroxine levels	Other measurement
14154	GCST007680	Triiodothyronine levels and thyroxine levels	Triiodothyronine levels and thyroxine levels	Other measurement
14155	GCST007862	Latent naming speed	Latent naming speed	Biological process
14156	GCST007861	Latent naming speed	Latent naming speed	Biological process
14157	GCST007859	Rapid automised naming and rapid alternating stimulus test performance	Rapid automised naming and rapid alternating stimulus test performance	Biological process
14158	GCST007860	Latent naming speed	Latent naming speed	Biological process
14159	GCST007865	Rapid automised naming of objects	Rapid automised naming of objects	Biological process
14160	GCST007864	Rapid automised naming of letters	Rapid automised naming of letters	Biological process
14161	GCST007863	Rapid alternating stimulus test for letters/numbers	Rapid alternating stimulus test for letters/numbers	Biological process
14162	GCST008270	Post-traumatic stress disorder symptoms in trauma-exposed soldiers	Post-traumatic stress disorder symptoms in trauma-exposed soldiers	Other measurement
14163	GCST008270	Post-traumatic stress disorder symptoms in trauma-exposed soldiers	Post-traumatic stress disorder symptoms in trauma-exposed soldiers	Biological process
14164	GCST008497	Change in neurofilament light levels	Change in neurofilament light levels	Other measurement
14165	GCST008424	Opioid dependence	Opioid dependence	Neurological disorder
14166	GCST007559	Sleep duration (short sleep)	Sleep duration (short sleep)	Other measurement
14167	GCST007560	Sleep duration (long sleep)	Sleep duration (long sleep)	Other measurement
14168	GCST007561	Sleep duration	Sleep duration	Other measurement
14169	GCST008831	Barrett's esophagus  or Esophageal adenocarcinoma	Barrett's esophagus  or Esophageal adenocarcinoma	Digestive system disorder
14170	GCST008831	Barrett's esophagus  or Esophageal adenocarcinoma	Barrett's esophagus  or Esophageal adenocarcinoma	Cancer
14171	GCST008832	Gastroesophageal reflux disease	Gastroesophageal reflux disease	Digestive system disorder
14172	GCST008828	Hypertension	Hypertension	Cardiovascular disease
14173	GCST008826	Waist circumference	Waist circumference	Body measurement
14174	GCST008827	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
14175	GCST008825	Body mass index	Body mass index	Body measurement
14176	GCST008825	Body mass index	Body mass index	Body measurement
14177	GCST008825	Body mass index	Body mass index	Other measurement
14178	GCST008824	Subscapular skin fold thickness	Subscapular skin fold thickness	Other measurement
14179	GCST008829	Neuritic plaque	Neuritic plaque	Other measurement
14180	GCST008821	Neurofibrillary tangles	Neurofibrillary tangles	Other measurement
14181	GCST008830	Neurofibrillary tangles	Neurofibrillary tangles	Other measurement
14182	GCST008822	Neuritic plaque	Neuritic plaque	Other measurement
14183	GCST007621	Sensation seeking	Sensation seeking	Other measurement
14184	GCST007622	Impulsivity	Impulsivity	Other measurement
14185	GCST007623	Lack of premeditation	Lack of premeditation	Other measurement
14186	GCST007624	Positive urgency	Positive urgency	Other measurement
14187	GCST007625	Negative urgency	Negative urgency	Other measurement
14188	GCST007626	Lack of perseverance	Lack of perseverance	Other measurement
14189	GCST007627	Impulsivity (attentional)	Impulsivity (attentional)	Other measurement
14190	GCST007628	Impulsivity (motor)	Impulsivity (motor)	Other measurement
14191	GCST007629	Impulsivity (non-planning)	Impulsivity (non-planning)	Other measurement
14192	GCST007630	Drug experimentation measurement	Drug experimentation measurement	Other measurement
14193	GCST008820	Handedness (non-right-handed vs right-handed)	Handedness (non-right-handed vs right-handed)	Other trait
14194	GCST008818	Handedness (Left-handed vs. non-left-handed)	Handedness (Left-handed vs. non-left-handed)	Other trait
14195	GCST008819	Handedness (left-handed vs. right-handed)	Handedness (left-handed vs. right-handed)	Other trait
14196	GCST008513	Health literacy	Health literacy	Other measurement
14197	GCST008890	Autistic traits score (Social and Communication Disorders Checklist)	Autistic traits score (Social and Communication Disorders Checklist)	Other measurement
14198	GCST008887	Systemising	Systemising	Other measurement
14199	GCST008888	Systemising	Systemising	Other measurement
14200	GCST008889	Systemising	Systemising	Other measurement
14201	GCST008311	Lymphangioleiomyomatosis (sporadic)		
14202	GCST007101	Seasonality in depression	Seasonality in depression	Neurological disorder
14203	GCST007101	Seasonality in depression	Seasonality in depression	Neurological disorder
14204	GCST007101	Seasonality in depression	Seasonality in depression	Other measurement
14205	GCST007102	Seasonality and depression	Seasonality and depression	Neurological disorder
14206	GCST007102	Seasonality and depression	Seasonality and depression	Neurological disorder
14207	GCST007102	Seasonality and depression	Seasonality and depression	Other measurement
14208	GCST007231	Tuberculosis	Tuberculosis	Other disease
14209	GCST007231	Tuberculosis	Tuberculosis	Other measurement
14210	GCST007231	Tuberculosis	Tuberculosis	Other measurement
14211	GCST007232	Tuberculosis (SNP x SNP interaction)	Tuberculosis (SNP x SNP interaction)	Other disease
14212	GCST007658	Triglyceride levels (parental genotype effect)	Triglyceride levels (parental genotype effect)	Other measurement
14213	GCST007658	Triglyceride levels (parental genotype effect)	Triglyceride levels (parental genotype effect)	Lipid or lipoprotein measurement
14214	GCST007660	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Response to drug
14215	GCST007660	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Other measurement
14216	GCST007660	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Lipid or lipoprotein measurement
14217	GCST007659	Triglyceride change in response to fenofibrate (parental genotype effect)	Triglyceride change in response to fenofibrate (parental genotype effect)	Response to drug
14218	GCST007659	Triglyceride change in response to fenofibrate (parental genotype effect)	Triglyceride change in response to fenofibrate (parental genotype effect)	Other measurement
14219	GCST007659	Triglyceride change in response to fenofibrate (parental genotype effect)	Triglyceride change in response to fenofibrate (parental genotype effect)	Lipid or lipoprotein measurement
14220	GCST007661	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
14221	GCST007662	Triglyceride levels in response to fenofibrate	Triglyceride levels in response to fenofibrate	Response to drug
14222	GCST007662	Triglyceride levels in response to fenofibrate	Triglyceride levels in response to fenofibrate	Lipid or lipoprotein measurement
14223	GCST007663	Triglyceride change in response to fenofibrate treatment	Triglyceride change in response to fenofibrate treatment	Response to drug
14224	GCST007663	Triglyceride change in response to fenofibrate treatment	Triglyceride change in response to fenofibrate treatment	Lipid or lipoprotein measurement
14225	GCST007367	Meconium ileus in cystic fibrosis	Meconium ileus in cystic fibrosis	Digestive system disorder
14226	GCST007829	Systolic blood pressure	Systolic blood pressure	Other measurement
14227	GCST007829	Systolic blood pressure	Systolic blood pressure	Other measurement
14228	GCST007828	Diastolic blood pressure	Diastolic blood pressure	Other measurement
14229	GCST007828	Diastolic blood pressure	Diastolic blood pressure	Other measurement
14230	GCST007279	Attention deficit hyperactivity disorder symptom score	Attention deficit hyperactivity disorder symptom score	Other measurement
14231	GCST007429	Lung function (FVC)	Lung function (FVC)	Other measurement
14232	GCST007432	FEV1	FEV1	Other measurement
14233	GCST007431	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
14234	GCST007430	Peak expiratory flow	Peak expiratory flow	Other measurement
14235	GCST007562	Asthma	Asthma	Other disease
14236	GCST007563	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Other disease
14237	GCST007563	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Immune system disorder
14238	GCST007564	Asthma or allergic disease (pleiotropy)	Asthma or allergic disease (pleiotropy)	Other disease
14239	GCST007564	Asthma or allergic disease (pleiotropy)	Asthma or allergic disease (pleiotropy)	Immune system disorder
14240	GCST007238	Diastolic blood pressure	Diastolic blood pressure	Other measurement
14241	GCST007238	Diastolic blood pressure	Diastolic blood pressure	Other measurement
14242	GCST007237	Systolic blood pressure	Systolic blood pressure	Other measurement
14243	GCST007237	Systolic blood pressure	Systolic blood pressure	Other measurement
14244	GCST007616	Calcaneus stiffness index	Calcaneus stiffness index	Other measurement
14245	GCST007876	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
14246	GCST007877	Creatinine levels	Creatinine levels	Other measurement
14247	GCST007878	Urea levels	Urea levels	Other measurement
14248	GCST007878	Urea levels	Urea levels	Other measurement
14249	GCST007879	Chronic kidney disease	Chronic kidney disease	Other disease
14250	GCST007879	Chronic kidney disease	Chronic kidney disease	Other measurement
14251	GCST007879	Chronic kidney disease	Chronic kidney disease	Other measurement
14252	GCST008312	Sural nerve amplitude potential	Sural nerve amplitude potential	Other measurement
14253	GCST008313	Sural nerve conduction velocity	Sural nerve conduction velocity	Other measurement
14254	GCST006034	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
14255	GCST005973	White blood cell count	White blood cell count	Hematological measurement
14256	GCST005973	White blood cell count	White blood cell count	Inflammatory measurement
14257	GCST005973	White blood cell count	White blood cell count	Hematological measurement
14258	GCST005973	White blood cell count	White blood cell count	Hematological measurement
14259	GCST005973	White blood cell count	White blood cell count	Hematological measurement
14260	GCST005974	Neutrophil count	Neutrophil count	Hematological measurement
14261	GCST005975	Eosinophil counts	Eosinophil counts	Hematological measurement
14262	GCST005976	White blood cell count (basophil)	White blood cell count (basophil)	Inflammatory measurement
14263	GCST005977	Monocyte count	Monocyte count	Hematological measurement
14264	GCST005997	Lymphocyte counts	Lymphocyte counts	Hematological measurement
14265	GCST005996	Red blood cell count	Red blood cell count	Hematological measurement
14266	GCST005995	Hemoglobin	Hemoglobin	Hematological measurement
14267	GCST005994	Hematocrit	Hematocrit	Hematological measurement
14268	GCST006011	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
14269	GCST005993	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
14270	GCST005993	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
14271	GCST005992	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
14272	GCST005992	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
14273	GCST005991	Platelet count	Platelet count	Hematological measurement
14274	GCST005990	Non-albumin protein levels	Non-albumin protein levels	Other measurement
14275	GCST005990	Non-albumin protein levels	Non-albumin protein levels	Other measurement
14276	GCST005990	Non-albumin protein levels	Non-albumin protein levels	Other measurement
14277	GCST005989	Serum total protein level	Serum total protein level	Hematological measurement
14278	GCST005989	Serum total protein level	Serum total protein level	Other measurement
14279	GCST005988	Serum albumin level	Serum albumin level	Other measurement
14280	GCST005987	Albumin-globulin ratio	Albumin-globulin ratio	Cardiovascular measurement
14281	GCST005986	Blood urea nitrogen levels	Blood urea nitrogen levels	Other measurement
14282	GCST005985	Creatinine levels	Creatinine levels	Other measurement
14283	GCST005984	Glomerular filtration rate	Glomerular filtration rate	Other measurement
14284	GCST005983	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
14285	GCST006032	Sodium levels	Sodium levels	Other measurement
14286	GCST006031	Potassium levels	Potassium levels	Other measurement
14287	GCST006030	Chloride levels	Chloride levels	Other measurement
14288	GCST005982	Calcium levels	Calcium levels	Other measurement
14289	GCST005981	Phosphorus levels	Phosphorus levels	Other measurement
14290	GCST005980	Total bilirubin levels	Total bilirubin levels	Other measurement
14291	GCST005979	Systolic blood pressure	Systolic blood pressure	Other measurement
14292	GCST005979	Systolic blood pressure	Systolic blood pressure	Other measurement
14293	GCST005978	Diastolic blood pressure	Diastolic blood pressure	Other measurement
14294	GCST005978	Diastolic blood pressure	Diastolic blood pressure	Other measurement
14295	GCST006010	Mean arterial pressure	Mean arterial pressure	Other measurement
14296	GCST006009	Pulse pressure	Pulse pressure	Cardiovascular measurement
14297	GCST006008	Left ventricular internal dimension in diastole	Left ventricular internal dimension in diastole	Cardiovascular measurement
14298	GCST006007	Left ventricular internal dimension in systole	Left ventricular internal dimension in systole	Cardiovascular measurement
14299	GCST006033	Relative wall thickness	Relative wall thickness	Cardiovascular measurement
14300	GCST006029	Fractional shortening	Fractional shortening	Cardiovascular measurement
14301	GCST006006	Ejection fraction	Ejection fraction	Cardiovascular measurement
14302	GCST006028	Interventricular septum thickness	Interventricular septum thickness	Cardiovascular measurement
14303	GCST006027	Posterior wall thickness	Posterior wall thickness	Cardiovascular measurement
14304	GCST006026	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
14305	GCST006026	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
14306	GCST006025	Left ventricular mass index	Left ventricular mass index	Cardiovascular measurement
14307	GCST006024	E/A ratio	E/A ratio	Cardiovascular measurement
14308	GCST006005	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
14309	GCST006004	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
14310	GCST006003	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
14311	GCST006002	Blood sugar levels	Blood sugar levels	Other measurement
14312	GCST006001	Hemoglobin A1c levels	Hemoglobin A1c levels	Other measurement
14313	GCST006001	Hemoglobin A1c levels	Hemoglobin A1c levels	Hematological measurement
14314	GCST006000	Immunoglobulin measurement (zinc sulfate turbidity test)	Immunoglobulin measurement (zinc sulfate turbidity test)	Other measurement
14315	GCST005999	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
14316	GCST005998	Alanine transaminase levels	Alanine transaminase levels	Liver enzyme measurement
14317	GCST006016	Serum alkaline phosphatase levels	Serum alkaline phosphatase levels	Liver enzyme measurement
14318	GCST006019	Gamma glutamyl transferase levels	Gamma glutamyl transferase levels	Liver enzyme measurement
14319	GCST006018	Activated partial thromboplastin time	Activated partial thromboplastin time	Hematological measurement
14320	GCST006017	Prothrombin time	Prothrombin time	Hematological measurement
14321	GCST006015	Fibrinogen levels	Fibrinogen levels	Hematological measurement
14322	GCST006014	Creatine kinase levels	Creatine kinase levels	Cardiovascular measurement
14323	GCST006013	Lactate dehydrogenase levels	Lactate dehydrogenase levels	Hematological measurement
14324	GCST006012	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
14325	GCST007037	Educational attainment (years of education)	Educational attainment (years of education)	Other measurement
14326	GCST007038	Balding type 1	Balding type 1	Other measurement
14327	GCST007039	Body mass index	Body mass index	Body measurement
14328	GCST007039	Body mass index	Body mass index	Body measurement
14329	GCST007039	Body mass index	Body mass index	Other measurement
14330	GCST007066	Heel bone mineral density	Heel bone mineral density	Other measurement
14331	GCST007841	Height	Height	Other measurement
14332	GCST007841	Height	Height	Body measurement
14333	GCST007067	Waist-hip ratio	Waist-hip ratio	Other measurement
14334	GCST007067	Waist-hip ratio	Waist-hip ratio	Body measurement
14335	GCST007065	Eosinophil counts	Eosinophil counts	Hematological measurement
14336	GCST007068	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
14337	GCST007068	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
14338	GCST007069	Red blood cell count	Red blood cell count	Hematological measurement
14339	GCST007074	Red cell distribution width	Red cell distribution width	Hematological measurement
14340	GCST007070	White blood cell count	White blood cell count	Hematological measurement
14341	GCST007070	White blood cell count	White blood cell count	Inflammatory measurement
14342	GCST007070	White blood cell count	White blood cell count	Hematological measurement
14343	GCST007070	White blood cell count	White blood cell count	Hematological measurement
14344	GCST007070	White blood cell count	White blood cell count	Hematological measurement
14345	GCST007071	Autoimmune traits	Autoimmune traits	Immune system disorder
14346	GCST007072	Cardiovascular disease	Cardiovascular disease	Other disease
14347	GCST007075	Eczema	Eczema	Other trait
14348	GCST007073	Hypothyroidism	Hypothyroidism	Other disease
14349	GCST007076	Respiratory diseases	Respiratory diseases	Other disease
14350	GCST007077	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
14351	GCST007078	Menarche (age at onset)	Menarche (age at onset)	Other measurement
14352	GCST007079	Age at menopause	Age at menopause	Other measurement
14353	GCST007080	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
14354	GCST007081	Lung function (FVC)	Lung function (FVC)	Other measurement
14355	GCST007082	Hair color	Hair color	Other measurement
14356	GCST007082	Hair color	Hair color	Other trait
14357	GCST007083	Morning person	Morning person	Other measurement
14358	GCST007084	Neuroticism	Neuroticism	Neurological disorder
14359	GCST007084	Neuroticism	Neuroticism	Other measurement
14360	GCST007085	Smoking status	Smoking status	Other measurement
14361	GCST007086	Sunburns	Sunburns	Other disease
14362	GCST007087	Systolic blood pressure	Systolic blood pressure	Other measurement
14363	GCST007087	Systolic blood pressure	Systolic blood pressure	Other measurement
